{"doc_id": 216555194, "title": "The sensitivity and specificity analyses of ambient temperature and population size on the transmission rate of the novel coronavirus (COVID-19) in different provinces of Iran", "abstract": ["Abstract On 10 April 2020, Iran reported 68,192 COVID-19 cumulative cases including 4232 death and 35,465 recovery cases.", "Numerous factors could influence the transmission rate and survival of coronavirus.", "On this basis and according to the latest epidemiological researches, both ambient temperature (AT) and population size (PS) can be considered as significant transmissibility factors for coronavirus.", "The analysis of receiver operating characteristics (ROC) allows measuring the performance of a classification model using the confusion matrix.", "This study intends to investigate the sensitivity of AT and PS on the transmission rate of the novel coronavirus in different provinces of Iran.", "For this purpose, the information of each province of Iran including the annual average of AT and the number of healthy and diseased cases are categorized.", "Subsequently, the sensitivity and specificity analyses of both AT and PS factors are performed.", "The obtained results confirm that AT and PS have low sensibility and high sensitivity, respectively.", "Thus, there is no scientific reason to confirm that the number of COVID-19 cases in warmer climates is less than that of moderate or cold climates.", "Therefore, it is recommended that the cities/provinces with a population of over 1.7 million people have stricter inspections and more precise controls as their management policy."], "journal": "Science of The Total Environment", "publish_time": "2020-08-01", "aliases": []}
{"doc_id": 234879591, "title": "Effects of Location-Specific Meteorological Factors on COVID-19 Daily Infection in a Tropical Climate: A Case of Kuala Lumpur, Malaysia", "abstract": ["Insufficient information on the novel coronavirus (COVID-19) has made it more difficult for the world to tackle its continuous implosion meteorological and environmental factors, in both laboratory and epidemiological studies, have been reported to affect the survival and transmission of the virus.", "In this study, the possible effects of location-specific meteorological parameters in a tropical climate on new daily COVID-19 infection (ndi) are investigated in kuala.", "Lumpur from 14 March 2020 to 31 August 2020 A generalized additive model (gam) was imposed on ambient temperature (T) and absolute humidity (AH) to explore their nonlinear relationship with ndi.", "Piecewise linear regression was then used to further discern the relationships below and above the threshold values of both T and AH The relationship between T and ndi, which was linear and statistically significant for T & gt; 29 7\u00b0C, showed that each unit rise in temperature increases NDI by about 3 210% (CI: 1 372\u20137 976) AH had a more pronounced linear association with ndi for ah \u2264 22 6 g/m3 but tended to flatten the exposure-response curve above this value A 1 g/m3 increase in AH increases NDI by 3 807% (CI: 2 064\u20135 732) Generally, the results indicated a positive association between T and ndi, particularly above 29 7\u00b0C, while the association with ah showed a stronger positive relationship below 22 6 g/m3 The implication of this is that COVID-19 could not be suppressed on account of warmer weather as such public health interventions remain imperative [ ABSTRACT FROM AUTHOR ] Copyright of Advances in meteorology is the property of hindawi limited and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission.", "However, users may print, download, or email articles for individual use.", "This abstract may be abridged.", "No warranty is given about the accuracy of the copy.", "Users should refer to the original published version of the material for the full abstract (copyright applies to all Abstracts)."], "journal": "Advances in Meteorology", "publish_time": "2021", "aliases": []}
{"doc_id": 226725932, "title": "Spatial Model Of COVID-19 Distribution Based On Differences An Climate Characteristics And Environment Of According To The Earth Latitude", "abstract": ["The purpose of this research is to analyze the spread of COVID-19 on the earth's surface.", "The method used is a spatial method with the geographic information system (gis) analysis technique.", "The results of this study explain that the spread of COVID-19 very much occurs in the region of moderate latitude.", "Besides, tropical climate conditions can also make the virus more quickly become unstable.", "The coronavirus spreads faster in countries with high latitudes and humid climates.", "The spread and concentration of the COVID-19 virus increasingly to the poles are easier to develop, current conditions at high latitudes or poles are not significantly affected due to a small population concentration and population activity, so the virus can not spread, because the body's virus does not find a host (human) to live and develop."], "journal": "Sumatra Journal Of Disaster, Geography And Geography Education", "publish_time": "2020", "aliases": []}
{"doc_id": 221158637, "title": "Spatio-temporal analysis of meteorological factors in abating the spread of COVID-19 in Africa", "abstract": ["In Asia, Europe and South America, the role of atmospheric condition in aiding or abating the growth curve of COVID-19 has been analysed.", "However, no study to date has examined such climatic extensions for the growth or otherwise of the novel coronavirus in Africa.", "Africa, with a mostly relatively warmer temperature differs from other regions of the world and in addition, has recorded far fewer cases compared to Asian, Europeans and the Americans (North and South).", "It then becomes imperative to examine the influence of meteorological indices in the growth or otherwise of coronavirus diseases in Africa to establish whether findings on the climatic conditions-COVID-19 growth are regionally specific.", "In this study, we examined the influence of meteorological factors for aiding or abating the spread of the aerosolised pathogen of COVID-19 in Africa.", "We rely on the generalised additive model (GAM) and found wind speed to positively relate to COVID-19 growth while mean temperature and relative humidity to inversely relates to COVID-19 growth curve in Africa.", "We accounted for potential cofounders in the core GAM model and discuss policy implications."], "journal": "Heliyon", "publish_time": "2020-08-18", "aliases": []}
{"doc_id": 215782584, "title": "Susceptible supply limits the role of climate in the COVID-19 pandemic", "abstract": ["Preliminary evidence suggests that climate may modulate the transmission of SARS-CoV-2.", "Yet it remains unclear whether seasonal and geographic variations in climate can substantially alter the pandemic trajectory, given high susceptibility is a core driver.", "Here, we use a climate-dependent epidemic model to simulate the SARS-CoV-2 pandemic probing different scenarios of climate-dependence based on known coronavirus biology.", "We find that while variations in humidity may be important for endemic infections, during the pandemic stage of an emerging pathogen such as SARS-CoV-2 climate may drive only modest changes to pandemic size and duration.", "Our results suggest that, in the absence of effective control measures, significant cases in the coming months are likely to occur in more humid (warmer) climates, irrespective of the climate-dependence of transmission and that summer temperatures will not substantially limit pandemic growth."], "journal": "", "publish_time": "2020-04-07", "aliases": []}
{"doc_id": 220962847, "title": "Correlation of ambient temperature and COVID-19 incidence in Canada", "abstract": ["Abstract The SARS-CoV-2 is a novel coronavirus identified as the cause of COVID-19, and as the pandemic evolves, many have made parallels to previous epidemics such as SARS-CoV (the cause of an outbreak of severe acute respiratory syndrome [SARS]) in 2003.", "Many have speculated that, like SARS, the activity of SARS-CoV-2 will subside when the climate becomes warmer.", "We sought to determine the relationship between ambient temperature and COVID-19 incidence in Canada.", "We analyzed over 77,700 COVID-19 cases from four Canadian provinces (Alberta, British Columbia, Ontario, and Quebec) from January to May 2020.", "After adjusting for precipitation, wind gust speed, and province in multiple linear regression models, we found a positive, but not statistically significant, association between cumulative incidence and ambient temperature (14.2 per 100,000 people; 95%CI: \u22120.60\u201329.0).", "We also did not find a statistically significant association between total cases or effective reproductive number of COVID-19 and ambient temperature.", "Our findings do not support the hypothesis that higher temperatures will reduce transmission of COVID-19 and warns the public not to lose vigilance, and to continue practicing safety measures such as hand washing, social distancing, and use of facial masks despite the warming climates."], "journal": "Sci Total Environ", "publish_time": "2020-08-04", "aliases": []}
{"doc_id": 219534602, "title": "The effects of regional climatic condition on the spread of COVID-19 at global scale", "abstract": ["The pandemic outbreak of the novel coronavirus epidemic disease (COVID-19) is spreading like a diffusion-reaction in the world and almost 208 countries and territories are being affected around the globe.", "It became a sever health and socio-economic problem, while the world has no vaccine to combat this virus.", "This research aims to analyze the connection between the fast spread of COVID-19 and regional climate parameters over a global scale.", "In this research, we collected the data of COVID-19 cases from the time of 1st reported case to the 5th June 2020 in different affected countries and regional climatic parameters data from January 2020 to 5th June 2020.", "It was found that most of the countries located in the relatively lower temperature region show a rapid increase in the COVID-19 cases than the countries locating in the warmer climatic regions despite their better socio-economic conditions.", "A correlation between metrological parameters and COVID-19 cases was observed.", "Average daylight hours are correlated to total the COVID-19 cases with a coefficient of determination of 0.42, while average high-temperature shows a correlation of 0.59 and 0.42 with total COVID-19 cases and death cases respectively.", "The finding of the study will help international health organizations and local administrations to combat and well manage the spread of COVID-19."], "journal": "Sci Total Environ", "publish_time": "2020", "aliases": []}
{"doc_id": 215782131, "title": "Spatial modeling cannot currently differentiate SARS-CoV-2 coronavirus and human distributions on the basis of climate in the United States", "abstract": ["The SARS-CoV-2 coronavirus is wreaking havoc globally, yet knowledge of its biology is limited.", "Climate and seasonality influence the distributions of many diseases, and studies suggest a link between SARS-CoV-2 and cool weather.", "One such study, building species distribution models (SDMs), predicted SARS-CoV-2 risk may remain concentrated in the Northern Hemisphere, shifting northward in summer months.", "Others have highlighted issues with SARS-CoV-2 SDMs, notably: the primary niche of the virus is the host it infects, climate may be a weak distributional predictor, global prevalence data have issues, and the virus is not in a population equilibrium.", "While these issues should be considered, climate still may be important for predicting the future distribution of SARS-CoV-2.", "To further examine if there is a link, we model with raw cases and population scaled cases for SARS-CoV-2 county-level data from the United States.", "We show that SDMs built from population scaled cases data cannot be distinguished from control models built from raw human population data, while SDMs built on raw data fail to predict the current known distribution of cases in the US.", "The population scaled analyses indicate that climate may not play a central role in current US viral distribution and that human population density is likely a primary driver.", "Still, we do find slightly more population scaled viral cases in cooler areas.", "This coupled with our geographically constrained focus make it so we cannot rule out climate as a partial driver of the US SARS-CoV-2 distribution.", "Climate's role on SARS-CoV-2 should continue to be cautiously examined, but at this time we should assume that SARS-CoV-2 can spread anywhere in the US."], "journal": "", "publish_time": "2020-04-10", "aliases": []}
{"doc_id": 233646407, "title": "Factors Affecting COVID-19 Outbreaks across the Globe: Role of Extreme Climate Change", "abstract": ["The coronavirus.", "Disease 2019 (COVID-19) pandemic poses a serious threat to global health system and economy.", "It was first reported in wuhan, china, and later appeared in central asia, europe, north america, and south.", "America.", "The spatial COVID-19 distribution pattern highly resembles the global population distribution and international travel routes.", "We select 48 cities in 16 countries across 4 continents having infection counts higher than 10,000 (by 25 April 2020) as the COVID-19 epicenters.", "At the initial stage, daily COVID-19 counts co-varies strongly with local temperature and humidity, which are clustered within 0\u201310 \u00b0C and 70\u201395%, respectively.", "Later, it spreads in colder (\u221215 \u00b0C) and warmer (25 \u00b0C) countries, due to faster adaptability in diverse environmental conditions.", "We introduce a combined temperature-humidity profile, which is essential for prediction of COVID-19 cases based on environmental conditions.", "The COVID-19 epicenters are collocated on global co2 emission hotspots and its distribution maximizes at 7 49 \u00b0C, which is 1 35 \u00b0C/2 44 \u00b0C higher than current (2020) /historical (1961\u20131990) mean.", "Approximately 75% of the COVID-19 cases are clustered at severe-extreme end of historical temperature distribution spectrum, which establish its tighter and possible association with extreme climate change A strong mitigation measure is essential to abate the ghg emissions, which may reduce the probability of such pandemics in the future."], "journal": "Sustainability", "publish_time": "2021", "aliases": []}
{"doc_id": 218595280, "title": "Genetic drift and environmental spreading dynamics of COVID-19", "abstract": ["Objective To delineate the genetic and environmental determinants of COVID-19 spreading.", "Design Retrospective case series.", "Setting Spain, Italy, Sweden, Finland, Norway.", "Participants All laboratory-confirmed infection cases (n=168,089) collected from February 21st to April 14th 2020.", "Main outcome measures Infection spreading velocity according to viral mutation load and to climate region.", "Results The mean doubling time of COVID-19 was 6.63 days in northern Italy, 5.87 days in central areas, and 5.38 days in southern Italy, with shorter COVID-19 doubling time in warmer regions.", "Spain extended this trend, with a mean COVID-19 doubling time of 4.2 days.", "At the other end of the spectrum, slower diffusion across progressively colder regions was observed in Scandinavia, with 9.4 days COVID-19 doubling time in Sweden, 10.8 days in Finland and 12.95 days in Norway.", "Mutations and mutation rates of SARS-CoV-2 versus COVID-19 spreading were analyzed worldwide.", "Models of increased aggressiveness of SARS-CoV-2 upon progressive acquisition of genetic changes were not supported by regional mutation data.", "Conclusion Current propagation models suggest dependence of COVID-19 pandemic spreading on wintertime conditions, with expected waning over the summer.", "Our findings indicate association of COVID-19 to a sharp North/South climate gradient, with faster spreading in southern regions.", "Thus, warmer climate conditions may not limit SARS-CoV-2 diffusion.", "Very cold regions may be better spared by recurrent courses of infection."], "journal": "", "publish_time": "2020-05-12", "aliases": []}
{"doc_id": 226282561, "title": "Spatial modeling could not differentiate early SARS-CoV-2 cases from the distribution of humans on the basis of climate in the United States", "abstract": ["The SARS-CoV-2 coronavirus is wreaking havoc globally, yet, as a novel pathogen, knowledge of its biology is still emerging.", "Climate and seasonality influence the distributions of many diseases, and studies suggest at least some link between SARS-CoV-2 and weather.", "One such study, building species distribution models (SDMs), predicted SARS-CoV-2 risk may remain concentrated in the Northern Hemisphere, shifting northward in summer months.", "Others have highlighted issues with SARS-CoV-2 SDMs, notably: the primary niche of the virus is the host it infects, climate may be a weak distributional predictor, global prevalence data have issues, and the virus is not in population equilibrium.", "While these issues should be considered, we believe climate\u2019s relationship with SARS-CoV-2 is still worth exploring, as it may have some impact on the distribution of cases.", "To further examine if there is a link to climate, we build model projections with raw SARS-CoV-2 case data and population-scaled case data in the USA.", "The case data were from across March 2020, before large travel restrictions and public health policies were impacting cases across the country.", "We show that SDMs built from population-scaled case data cannot be distinguished from control models (built from raw human population data), while SDMs built on raw case data fail to predict the known distribution of cases in the U.S. from March.", "The population-scaled analyses indicate that climate did not play a central role in early U.S. viral distribution and that human population density was likely the primary driver.", "We do find slightly more population-scaled viral cases in cooler areas.", "Ultimately, the temporal and geographic constraints on this study mean that we cannot rule out climate as a partial driver of the SARS-CoV-2 distribution.", "Climate\u2019s role on SARS-CoV-2 should continue to be cautiously examined, but at this time we should assume that SARS-CoV-2 will continue to spread anywhere in the U.S. where governmental policy does not prevent spread."], "journal": "PeerJ", "publish_time": "2020-10-26", "aliases": []}
{"doc_id": 221652639, "title": "Global expansion of COVID-19 pandemic is driven by population size and airport connections", "abstract": ["The pandemic state of COVID-19 caused by the sars CoV-2 put the world in quarantine, led to hundreds of thousands of deaths and is causing an unprecedented economic crisis.", "However, COVID-19 is spreading in different rates at different countries.", "Here, we tested the effect of three classes of predictors, i e, socioeconomic, climatic and transport, on the rate of daily increase of COVID-19 on its exponential phase.", "We found that population size and global connections, represented by countries' importance in the global air transportation network, are the main explanations for the early growth rate of COVID-19 in different countries climate and socioeconomics had no significant effect in this big picture analysis.", "Our results indicate that the current claims that the growth rate of COVID-19 may be lower in warmer and humid countries should be taken very carefully, risking to disturb well-established and effective policy of social isolation that may help to avoid higher mortality rates due to the collapse of national health systems."], "journal": "Peerj", "publish_time": "2020", "aliases": []}
{"doc_id": 227033918, "title": "Lessons learned and questions raised during and post-COVID-19 anthropopause period in relation to the environment and climate", "abstract": ["In the first part, this work reports that during the global \"anthropopause\" period, that was imposed in March and April 2020 for limiting the spread of COVID-19, the concentrations of basic air pollutants over Europe were reduced by up to 70%.", "During May and June, the gradual lift of the stringent measures resulted in the recovery of these reductions with pollution concentrations approaching the levels before the lockdown by the end of June 2020.", "In the second part, this work examines the alleged correlations between the reported cases of COVID-19 and temperature, humidity and particulate matter for March and April 2020 in Europe.", "It was found that decreasing temperatures and relative humidity with increasing concentrations of particulate matter are correlated with an increase in the number of reported cases during these 2 months.", "However, when these calculations were repeated for May and June, we found a remarkable drop in the significance of the correlations which leads us to question the generally accepted inverse relation between pandemics and air temperature at least during the warmer months.", "Such a relationship could not be supported in our study for SARS-CoV-2 virus and the question remains open.", "In the third and last part of this work, we examine the question referring to the origin of pandemics.", "In this context we have examined the hypothesis that the observed climate warming in Siberia and the Arctic and the thawing of permafrost could result to the release of trapped in the permafrost pathogens in the atmosphere.", "We find that although such relations cannot be directly justified, they present a possible horrifying mechanism for the origin of viruses in the future during the developing global warming of our planet in the decades to come.", "Overall the findings of our study indicate that: (1) the reduction of anthropogenic emissions in Europe during the \"anthropopause\" period of March and April 2020 was significant, but when the lockdown measures were raised the concentrations of atmospheric pollutants quickly recovered to pre-pandemic levels and therefore any possible climatic feedbacks were negligible; (2) no robust relationship between atmospheric parameters and the spread of COVID-19 cases can be justified in the warmer part of the year and (3) more research needs to be done regarding the possible links between climate change and the release of new pathogens from thawing of permafrost areas."], "journal": "Environ Dev Sustain", "publish_time": "2020", "aliases": []}
{"doc_id": 234800063, "title": "Association between climatic conditions, population density and covid-19 in indonesia", "abstract": ["The first emergence of Corona Virus Disease 2019 (COVID-19) confirmed cases found in Wuhan, China, has become a global crisis.", "At least 177 countries have been affected over 43,000,000 confirmed cases of corona positive and more than one million deaths until October 27th, 2020.", "Recent research has analyzed any possible factors causing the COVID-19 spreads were climate factors and population density.", "Indonesia was a tropical region known as the high-populated country in the World, with a 52.9% area with a high mean air temperature and over 267.7 million populations.", "Our study aims to analyze the correlation between climate, population density, and COVID-19 in Indonesia.", "We used the K-means cluster method and Fisher's exact test to determine climatic conditions, population density, and COVID-19 clusters and study the correlation.", "Our research found that there is a correlation between climatic conditions and population density with COVID-19 (p: 0,034;p:0,004).", "Warmer climate conditions and densely populated regions contributed to the risen COVID-19 transmission in Indonesia.", "These are highlighted by the evidence of the top six provinces with highest COVID-19 cases are province classified in warmer climatic conditions (high air temperature, low rainfall, and humidity) and a fairly-dense to densely populated region.", "\u00a9 2021 Penerbit Universiti Kebangsaan Malaysia.", "All rights reserved."], "journal": "Sains Malaysiana", "publish_time": "2021", "aliases": []}
{"doc_id": 232066913, "title": "Effects of climate variables on the COVID-19 outbreak in Spain", "abstract": ["An outbreak of the novel COVID-19 virus occurred during February 2020 onwards in almost all the European countries, including Spain.", "This study covers the correlation found between weather variables (Maximum Temperature, Minimum Temperature, Mean Temperature, Atmospheric Pressure, Daily Rainfall, Daily Sun hours) and the coronavirus propagation in Spain.", "A strong relationship is found when correlating the virus spread to the mean temperature, minimum temperature, and atmospheric pressure in different Spanish provinces.", "In this analysis we have used the ratio of the PCR COVID-19 positives with respect to the population size.", "A linear regression model using the mean temperature is implemented.", "Moreover, an analysis of variance is used to confirm the influence of mean temperature on the spread of virus.", "As a second measurement of the COVID-19 outbreak we have used the results of the antibodies tests carried out in Spain that provide an estimation of the heard immunity achieved.", "Based on this analysis, an estimation of the asymptomatic population is performed.", "All these results exhibit significant correlation with weather variables.", "The most affected provinces were Soria, Segovia and Ciudad Real, which are the coldest.", "On the opposite side, places such as Southern Spain, the Baleares, and Canary Islands showed a lower rate of spread.", "This might be related to the warmer climate and the insularity of these islands.", "Besides, the coastal influence and the daily sun hours might also influence the lower rates in the east and west regions in Spain.", "This analysis provides a deeper insight of the influence of weather variables onto the COVID-19 spread in Spain."], "journal": "Int J Hyg Environ Health", "publish_time": "2021", "aliases": []}
{"doc_id": 245387143, "title": "Genetic Drift Versus Climate Region Spreading Dynamics of COVID-19", "abstract": ["Background: The current propagation models of COVID-19 are poorly consistent with existing epidemiological data and with evidence that the SARS-CoV-2 genome is mutating, for potential aggressive evolution of the disease.", "Objectives: We looked for fundamental variables that were missing from current analyses.", "Among them were regional climate heterogeneity, viral evolution processes versus founder effects, and large-scale virus containment measures.", "Methods: We challenged regional versus genetic evolution models of COVID-19 at a whole-population level, over 168,089 laboratory-confirmed SARS-CoV-2 infection cases in Italy, Spain, and Scandinavia at early time-points of the pandemic.", "Diffusion data in Germany, France, and the United Kingdom provided a validation dataset of 210,239 additional cases.", "Results: Mean doubling time of COVID-19 cases was 6.63 days in Northern versus 5.38 days in Southern Italy.", "Spain extended this trend of faster diffusion in Southern Europe, with a doubling time of 4.2 days.", "Slower doubling times were observed in Sweden (9.4 days), Finland (10.8 days), and Norway (12.95 days).", "COVID-19 doubling time in Germany (7.0 days), France (7.5 days), and the United Kingdom (7.2 days) supported the North/South gradient model.", "Clusters of SARS-CoV-2 mutations upon sequential diffusion were not found to clearly correlate with regional distribution dynamics.", "Conclusion: Acquisition of mutations upon SARS-CoV-2 spreading failed to explain regional diffusion heterogeneity at early pandemic times.", "Our findings indicate that COVID-19 transmission rates are rather associated with a sharp North/South climate gradient, with faster spreading in Southern regions.", "Thus, warmer climate conditions may not limit SARS-CoV-2 infectivity.", "Very cold regions may be better spared by recurrent courses of SARS-CoV-2 infection."], "journal": "Front Genet", "publish_time": "2021-12-23", "aliases": []}
{"doc_id": 237366041, "title": "Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2", "abstract": ["The seasonal nature of outbreaks of respiratory viral infections with increased transmission during low temperatures has been well established.", "Accordingly, temperature has been suggested to play a role on the viability and transmissibility of SARS-CoV-2, the virus responsible for the COVID-19 pandemic.", "The receptor binding domain (RBD) of the Spike glycoprotein is known to bind to its host receptor angiotensin-converting enzyme 2 (ACE2) to initiate viral fusion.", "Using biochemical, biophysical and functional assays to dissect the effect of temperature on the receptor-Spike interaction, we observed a significant and stepwise increase in RBD-ACE2 affinity at low temperatures, resulting in slower dissociation kinetics.", "This translated into enhanced interaction of the full Spike glycoprotein with the ACE2 receptor and higher viral attachment at low temperatures.", "Interestingly, the RBD N501Y mutation, present in emerging variants of concern (VOCs) that are fueling the pandemic worldwide (including the B.1.1.7 (\u03b1) lineage), bypassed this requirement.", "This data suggests that the acquisition of N501Y reflects an adaptation to warmer climates, a hypothesis that remains to be tested."], "journal": "J Biol Chem", "publish_time": "2021-08-31", "aliases": [235799473]}
{"doc_id": 229527499, "title": "A review of the impact of weather and climate variables to COVID-19: In the absence of public health measures high temperatures cannot probably mitigate outbreaks", "abstract": ["The new severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) pandemic was first recognized at the end of 2019 and has caused one of the most serious global public health crises in the last years.", "In this paper, we review current literature on the effect of weather (temperature, humidity, precipitation, wind, etc.)", "and climate (temperature as an essential climate variable, solar radiation in the ultraviolet, sunshine duration) variables on SARS-CoV-2 and discuss their impact to the COVID-19 pandemic; the review also refers to respective effect of urban parameters and air pollution.", "Most studies suggest that a negative correlation exists between ambient temperature and humidity on the one hand and the number of COVID-19 cases on the other, while there have been studies which support the absence of any correlation or even a positive one.", "The urban environment and specifically the air ventilation rate, as well as air pollution, can probably affect, also, the transmission dynamics and the case fatality rate of COVID-19.", "Due to the inherent limitations in previously published studies, it remains unclear if the magnitude of the effect of temperature or humidity on COVID-19 is confounded by the public health measures implemented widely during the first pandemic wave.", "The effect of weather and climate variables, as suggested previously for other viruses, cannot be excluded, however, under the conditions of the first pandemic wave, it might be difficult to be uncovered.", "The increase in the number of cases observed during summertime in the Northern hemisphere, and especially in countries with high average ambient temperatures, demonstrates that in the absence of public health interventions, cannot mitigate the resurgence of COVID-19 outbreaks."], "journal": "Sci Total Environ", "publish_time": "2020-12-27", "aliases": []}
{"doc_id": 231858243, "title": "Climate change and epilepsy: Insights from clinical and basic science studies.", "abstract": ["Climate change is with us.", "As professionals who place value on evidence-based practice, climate change is something we cannot ignore.", "The current pandemic of the novel coronavirus, SARS-CoV-2, has demonstrated how global crises can arise suddenly and have a significant impact on public health.", "Global warming, a chronic process punctuated by acute episodes of extreme weather events, is an insidious global health crisis needing at least as much attention.", "Many neurological diseases are complex chronic conditions influenced at many levels by changes in the environment.", "This review aimed to collate and evaluate reports from clinical and basic science about the relationship between climate change and epilepsy.", "The keywords climate change, seasonal variation, temperature, humidity, thermoregulation, biorhythm, gene, circadian rhythm, heat, and weather were used to search the published evidence.", "A number of climatic variables are associated with increased seizure frequency in people with epilepsy.", "Climate change-induced increase in seizure precipitants such as fevers, stress, and sleep deprivation (e.g.", "as a result of more frequent extreme weather events) or vector-borne infections may trigger or exacerbate seizures, lead to deterioration of seizure control, and affect neurological, cerebrovascular, or cardiovascular comorbidities and risk of sudden unexpected death in epilepsy.", "Risks are likely to be modified by many factors, ranging from individual genetic variation and temperature-dependent channel function, to housing quality and global supply chains.", "According to the results of the limited number of experimental studies with animal models of seizures or epilepsy, different seizure types appear to have distinct susceptibility to seasonal influences.", "Increased body temperature, whether in the context of fever or not, has a critical role in seizure threshold and seizure-related brain damage.", "Links between climate change and epilepsy are likely to be multifactorial, complex, and often indirect, which makes predictions difficult.", "We need more data on possible climate-driven altered risks for seizures, epilepsy, and epileptogenesis, to identify underlying mechanisms at systems, cellular, and molecular levels for better understanding of the impact of climate change on epilepsy.", "Further focussed data would help us to develop evidence for mitigation methods to do more to protect people with epilepsy from the effects of climate change."], "journal": "Epilepsy & behavior : E&B", "publish_time": "2021-02-09", "aliases": []}
{"doc_id": 216197881, "title": "Climate effect on COVID-19 spread rate: an online surveillance tool", "abstract": ["Background: COVID-19 outbreak poses an unprecedented challenge for societies, healthcare organizations and economies.", "In the present analysis we coupled climate data with COVID-19 spread rates worldwide, and in a single country (USA).", "Methods: Data of confirmed COVID-19 cases was derived from the COVID-19 Global Cases by the CSSE at Johns Hopkins University up to March 19, 2020.", "We assessed disease spread by two measures: replication rate (RR), the slope of the logarithmic curve of confirmed cases, and the rate of spread (RoS), the slope of the linear regression of the logarithmic curve.", "Results: Based on predefined criteria, the mean COVID-19 RR was significantly lower in warm climate countries (0.12\u00b1 0.02) compared with cold countries (0.24\u00b1 0.01), (P<0.0001).", "Similarly, RoS was significantly lower in warm climate countries 0.12\u00b1 0.02 vs. 0.25\u00b1 0.01 than in cold climate countries (P<0.001).", "In all countries (independent of climate classification) both RR and RoS displayed a moderate negative correlation with temperature R= -0.69, 95% confidence interval [CI], -0.87 to -0.36; P<0.001 and R= -0.72, 95% confidence interval [CI], -0.87 to -0.36; P<0.001, respectively.", "We identified a similar moderate negative correlation with the dew point temperature.", "Additional climate variables did not display a significant correlation with neither RR nor RoS.", "Finally, in an ancillary analysis, COVID-19 intra-country model using an inter-state analysis of the USA did not identify yet correlation between climate parameters and RR or RoS as of March, 19, 2020.", "Conclusions: Our analysis suggests a plausible negative correlation between warmer climate and COVID-19 spread rate as defined by RR and RoS worldwide.", "This initial correlation should be interpreted cautiously and be further validated over time, the pandemic is at different stages in various countries as well as in regions within these countries.", "As such, some associations may be more affected by local transmission patterns rather than by climate.", "Importantly, we provide an online surveillance dashboard (https://covid19.net.technion.ac.il/) to further assess the association between climate parameters and outbreak dynamics worldwide as time goes by"], "journal": "", "publish_time": "2020-03-30", "aliases": []}
{"doc_id": 220458989, "title": "Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature", "abstract": ["INTRODUCTION: On February 11, 2020 WHO designated the name \"COVID-19\" for the disease caused by \"severe acute respiratory syndrome coronavirus 2\" (SARS-CoV-2), a novel virus that quickly turned into a global pandemic.", "Risks associated with acquiring the virus have been found to most significantly vary by age and presence of underlying comorbidity.", "In this rapid literature review we explore the prevalence of comorbidities and associated adverse outcomes among individuals with COVID-19 and summarize our findings based on information available as of May 15, 2020.", "METHODS: A comprehensive systematic search was performed on PubMed, Medline, Scopus, Embase, and Google Scholar to find articles published until May 15, 2020.", "All relevant articles providing information on PCR tested COVID-19 positive patient population with clinical characteristics and epidemiological information were selected for review and analysis.", "RESULTS: A total of 27 articles consisting of 22,753 patient cases from major epicenters worldwide were included in the study.", "Major comorbidities seen in overall population were CVD (8.9%), HTN (27.4%), Diabetes (17.4%), COPD (7.5%), Cancer (3.5%), CKD (2.6%), and other (15.5%).", "Major comorbidity specific to countries included in the study were China (HTN 39.5%), South Korea (CVD 25.6%), Italy (HTN 35.9%), USA (HTN 38.9%), Mexico, (Other 42.3%), UK (HTN 27.8%), Iran (Diabetes 35.0%).", "Within fatal cases, an estimated 84.1% had presence of one or more comorbidity.", "Subgroup analysis of fatality association with having comorbidity had an estimated OR 0.83, CI [0.60-0.99], p<0.05.", "CONCLUSIONS: Based on our findings, hypertension followed by diabetes and cardiovascular diseases were the most common comorbidity seen in COVID-19 positive patients across major epicenters world-wide.", "Although having one or more comorbidity is linked to increased disease severity, no clear association was found between having these risk factors and increased risk of fatality."], "journal": "Am. j. infect. control", "publish_time": "2020", "aliases": []}
{"doc_id": 232480253, "title": "Frequency of Comorbidities in Admitting COVID-19 Pneumonia Patients in a Tertiary Care Setup: An Observational Study", "abstract": ["Background.", "The novel coronavirus disease 2019 (COVID-19) is a highly infectious and pandemic disease with a variable mode of action.", "Patients with underlying illnesses such as diabetes, hypertension, and other diseases are more prone to infection.", "An understanding of the different comorbidities that place patients at the highest risk of COVID-19 pneumonia and other fatal complications associated with COVID-19 is necessary for healthcare professionals.", "This study aimed to determine the frequency of different comorbid illnesses among COVID-19 patients admitted to a tertiary care hospital in karachi, pakistan methodology.", "All patients diagnosed with COVID-19 who required admission for the care of their symptoms were included in this observational, cross-sectional study conducted from May 1 to July 30, 2020 The patients were treated at a specialized COVID-19 isolation ward built at the dow university of health.", "Sciences at the ojha campus.", "The patients were referred from the emergency department, medical and allied wards, and COVID-19 screening units A detailed history and clinical examination were performed, and comorbidities were evaluated results A total of 212 patients were admitted during the study with a mean age of 52 +/- 16 years.", "The study population consisted of 120 (56 6%) males and 92 (43 39%) females, and the most common comorbidities were uncontrolled diabetes with hypertension (n = 56; 26 4%), controlled diabetes (n = 22; 10 37%), obstructive airway disease (n = 16; 7 5%), and interstitial lung disease (n = 14; 6 6%) A total of 48 (22 64%) patients had no comorbidities.", "Conclusions.", "Most COVID-19-positive patients with pneumonia were male, and common comorbidities included uncontrolled diabetes, hypertension, and obstructive and restrictive lung disease.", "The presence of comorbidities was associated with a marked increase in the risk of morbidity and mortality.", "Further studies are warranted to confirm these findings."], "journal": "Cureus", "publish_time": "2021", "aliases": []}
{"doc_id": 221143375, "title": "The Coronavirus Disease 2019 (COVID-19) in Children: A Study in an Iranian Children's Referral Hospital.", "abstract": ["Background Despite the worldwide spread of the coronavirus disease 2019 (COVID-19), the epidemiological and clinical patterns of the COVID-19 infection remain largely unclear, particularly among children.", "In this study, we explored the epidemiological characteristics, clinical patterns, and laboratory and imaging findings of pediatric patients with COVID-19.", "Materials and Methods From March 7 to March 30, 2020, there were a total of 35 patients who had confirmed COVID-19 infection by laboratory virus nucleic acid test (RT-PCR) assay with throat swab samples or typical chest CT manifestation compatible with COVID-19, in addition to a history of close contact with suspected or confirmed SARS-CoV-2 in family members.", "Information recorded included demographic data, medical history, exposure history, underlying comorbidities, symptoms, signs, laboratory findings and radiologic assessments, severity of disease, treatment, and mortality.", "Results The median age of the patients was 7.5 years (IQR=4-11; range=4 months to 15 years).", "A total of 63% were male.", "Cough was present in 80% of the patients, followed by fever (77%), nausea or vomiting (29%), diarrhea (26%), shortness of breath (29%), headache (20%), and myalgia (14%).", "Lymphopenia was present in 43% of the patients, thrombocytopenia in 9%, neutopenia in 8%, and leucopenia in 26%.", "We reported severe pneumonia in 40% of the hospitalized patients and 18 (51%) had underlying diseases.", "Of 35 patients, 11 had positive RT-PCR results (31%).", "The chest CT images of 24 patients (69%) suggested COVID-19, while their RT-PCR assays from throat swab samples were negative.", "Conclusion This study demonstrates different clinical findings of pediatrics compared to the previous reports of children.", "Since a high rate of false negative RT-PCR test was observed, early detection of children with COVID-19 infection by CT is conducive to reasonable management and early treatment."], "journal": "Infection and drug resistance", "publish_time": "2020", "aliases": []}
{"doc_id": 228089106, "title": "Development and external validation of a prognostic tool for COVID-19 critical disease", "abstract": ["BACKGROUND: The rapid spread of coronavirus disease 2019 (COVID-19) revealed significant constraints in critical care capacity.", "In anticipation of subsequent waves, reliable prediction of disease severity is essential for critical care capacity management and may enable earlier targeted interventions to improve patient outcomes.", "The purpose of this study is to develop and externally validate a prognostic model/clinical tool for predicting COVID-19 critical disease at presentation to medical care.", "METHODS: This is a retrospective study of a prognostic model for the prediction of COVID-19 critical disease where critical disease was defined as ICU admission, ventilation, and/or death.", "The derivation cohort was used to develop a multivariable logistic regression model.", "Covariates included patient comorbidities, presenting vital signs, and laboratory values.", "Model performance was assessed on the validation cohort by concordance statistics.", "The model was developed with consecutive patients with COVID-19 who presented to University of California Irvine Medical Center in Orange County, California.", "External validation was performed with a random sample of patients with COVID-19 at Emory Healthcare in Atlanta, Georgia.", "RESULTS: Of a total 3208 patients tested in the derivation cohort, 9% (299/3028) were positive for COVID-19.", "Clinical data including past medical history and presenting laboratory values were available for 29% (87/299) of patients (median age, 48 years [range, 21\u201388 years]; 64% [36/55] male).", "The most common comorbidities included obesity (37%, 31/87), hypertension (37%, 32/87), and diabetes (24%, 24/87).", "Critical disease was present in 24% (21/87).", "After backward stepwise selection, the following factors were associated with greatest increased risk of critical disease: number of comorbidities, body mass index, respiratory rate, white blood cell count, % lymphocytes, serum creatinine, lactate dehydrogenase, high sensitivity troponin I, ferritin, procalcitonin, and C-reactive protein.", "Of a total of 40 patients in the validation cohort (median age, 60 years [range, 27\u201388 years]; 55% [22/40] male), critical disease was present in 65% (26/40).", "Model discrimination in the validation cohort was high (concordance statistic: 0.94, 95% confidence interval 0.87\u20131.01).", "A web-based tool was developed to enable clinicians to input patient data and view likelihood of critical disease.", "CONCLUSIONS AND RELEVANCE: We present a model which accurately predicted COVID-19 critical disease risk using comorbidities and presenting vital signs and laboratory values, on derivation and validation cohorts from two different institutions.", "If further validated on additional cohorts of patients, this model/clinical tool may provide useful prognostication of critical care needs."], "journal": "PLoS One", "publish_time": "2020-12-09", "aliases": [218580251]}
{"doc_id": 233917383, "title": "Is leukopenia and lymphopenia a characteristic feature of covid-19 in children?", "abstract": ["objective: To describe the blood picture of children with COVID-19 Study.", "Design: Descriptive cross-sectional study place and duration of study: The study was conducted in The children's hospital & ich, lahore from March 2020 to October 2020 Material and methods: All confirmed cases of COVID-19 infection and post-COVID (MIS-C) /Kawasaki disease (KD) like illness diagnosed on the basis of RT-PCR from nasopharyngeal swab and antibody test admitted were included complete blood (cbc) and differential counts was performed on the day of admission.", "Results: Out of a total of 83 patients 60 (72%) were diagnosed as COVID-19 and 23 (28%) as post covid MIS-C/ KD The mean age of children was 7 0 \u00b1 4 3 years (95% CI: 6 07 -8 75) with a male preponderance 51 (61%) twenty (24%) children had some underlying comorbidity and 7 (8%) were surgical cases.", "Our case fatality rate was 5 (6%) and all children who died had some underlying comorbid condition.", "In both group (covid and MIS-C/KD) the mean leucocyte count was (14 0 \u00b1 12 5 vs 13 6 \u00b1 6 9) respectively (p=0 888) The mean lymphocyte count in children with covid was 39 1 \u00b1 21 4 Patients with MIS-C/KD showed significantly higher levels of neutrophil count (76 5 \u00b1 15 0) as compared to children with covid (52 0 \u00b1 22 1) (p= & lt; 0 001) In 60 COVID-19 patients the mean NLR in mild-moderate and severe-critical group was 2 00 and 5 08 respectively (p=0 009) Conclusion: The blood picture of COVID-19 in children does not show leucopenia nlr was a prognostic factor to assess the severity in COVID-19 patients.", "The presence of an underlying comorbid conditions is a significant risk factor for poor outcome."], "journal": "Pakistan Paediatric Journal", "publish_time": "2020", "aliases": []}
{"doc_id": 219189145, "title": "Prevalence and mortality of Lung Comorbidities Among Patients with COVID-19: A systematic review and meta-analysis", "abstract": ["Abstract Background The World Health Organization declared COVID-19 associated infections as a global health public emergency that has led to more than 3,50,000 deaths worldwide.", "COVID-19 infections are seen across all age groups but they have shown to have a predisposition for the elderly and those with underlying comorbidities.", "Specifically, these include cardiovascular diseases, diabetes and underlying lung conditions.", "Further, patients with severe COVID-19 infections and comorbidities are more prone to respiratory distress syndrome (ARDS), mechanical ventilator use and ultimately succumb to these complications.", "Little evidence exists of the prevalence of underlying lung comorbidities among COVID-19 patients and associated mortality.", "Methods We performed a systematic review of the literature including PubMed (Medline), Embase (Ovid), Google Scholar and Cochrane Library.", "The last date for our search was 29th April 2020.", "We included all original research articles on COVID-19 and calculated prevalence of chronic lung disease patients among COVID-19 patients using random effects model.", "Further we assessed for mortality rates among COVID-19 patients associated with these lung comorbidities.", "We calculated pooled prevalence of these conditions among COVID-19 patients using random effects model.", "Results The authors identified 29 articles that reported the prevalence of chronic lung conditions among COVID-19 patients.", "Among those, 26 were from China and 3 from the United States.", "The pooled prevalence of lung comorbidities including Asthma, COPD, and lung cancer was 3% (95% CI=0-14%), 2.2% (95% CI=0.02-0.03%) and 2.1% (95% CI=0.00-0.21%) respectively.", "Mortality rates associated with these comorbidities was 30% (41/137) for COPD and 19% (7/37) for lung cancer respectively.", "No mortality rates were reported for patients with asthma.", "Conclusion This study provides preliminary evidence of the prevalence of chronic lung conditions among patients with COVID-19.", "Future studies are needed to assess other lung comorbidities and associated mortality among patients diagnosed with COVID-19."], "journal": "", "publish_time": "2020-06-03", "aliases": []}
{"doc_id": 238409031, "title": "Association between chronic hepatitis B infection and COVID-19 outcomes: A Korean nationwide cohort study", "abstract": ["BACKGROUND/AIMS: We measured the association between underlying chronic hepatitis B (CHB) and antiviral use with infection rates among patients who underwent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing.", "METHODS: In total, 204,418 patients who were tested for SARS-CoV-2 between January and June 2020 were included.", "For each case patient (n = 7,723) with a positive SARS-CoV-2 test, random controls (n = 46,231) were selected from the target population who had been exposed to someone with coronavirus disease 2019 (COVID-19) but had a negative SARS-CoV-2 test result.", "We merged claim-based data from the Korean National Health Insurance Service database collected.", "Primary endpoints were SARS-CoV-2 infection and severe clinical outcomes of COVID-19.", "RESULTS: The proportion of underlying CHB was lower in COVID-19 positive patients (n = 267, 3.5%) than in COVID-19 negative controls (n = 2482, 5.4%).", "Underlying CHB was associated with a lower SARS-CoV-2 positivity rate, after adjusting for comorbidities (adjusted odds ratio [aOR] 0.65; 95% confidence interval [CI], 0.57\u20130.74).", "Among patients with confirmed COVID-19, underlying CHB tended to confer a 66% greater risk of severe clinical outcomes of COVID-19, although this value was statistically insignificant.", "Antiviral treatment including tenofovir and entecavir was associated with a reduced SARS-CoV-2 positivity rate (aOR 0.49; 95% CI, 0.37\u20130.66), while treatment was not associated with severe clinical outcomes of COVID-19.", "CONCLUSIONS: Underlying CHB and antiviral agents including tenofovir decreased susceptibility to SARS-CoV-2 infection.", "HBV coinfection did not increase the risk of disease severity or lead to a worse prognosis in COVID-19."], "journal": "PLoS One", "publish_time": "2021-10-05", "aliases": []}
{"doc_id": 237855518, "title": "Clinical characteristics of covid-19 infection in the pediatric age group", "abstract": ["Aim: To investigate the complaints and findings of COVID-19 infection in a paediatric age group.", "Material and Method: The study included 130 patients with COVID-19 infection confirmed with reverse-transcription polymerase chain reaction (RT-PCR) test positivity.", "The cases were evaluated in respect of demographic data, such as age and gender, and clinical findings, such as fever, weight, cough, shortness of breath, and history of infectious contact.", "Results: Evaluation was made of 130 COVID-19-positive paediatric patients, comprising 69 (53%) males and 61 (47%) females, of which 54% were asymptomatic and 5.4% had severe clinical findings requiring follow up in the Intensive Care Unit (ICU).", "Of the symptomatic patients, fever was determined in 30%, listlessness in 24%, cough in 10.8%, respiratory problems in 9.2%, diarrhea in 6.2%, abdominal pain in 6.2%, vomiting in 2.3%, joint pain in 2.3%, and convulsions developed in 1.5% who had no previous history of convulsions.", "Of the 7 patients who required intensive care, 2 had cerebral palsy, 1 had hydrocephaly+shunt, 1 had metabolic disease (propionic acidemia), 2 had a history of trauma (struck by a motor vehicle), and in 1 there was no comorbidity.", "Mortality developed in 6 of the 7 patients in ICU.", "Conclusion: In a significant proportion of children, COVID-19 has an asymptomatic course, which contributes greatly to the spread of the disease.", "While COVID-19 can cause morbidities such as convulsions in the paediatric population, it may also result in mortality in children with underlying serious diseases.", "\u00a9 2021 by Author/s and Licensed by Modestum."], "journal": "Electronic Journal of General Medicine", "publish_time": "2021", "aliases": []}
{"doc_id": 232208295, "title": "The clinical characteristics and prognosis of COVID-19 patients with comorbidities: a retrospective analysis of the infection peak in Wuhan", "abstract": ["background: This study aims to determine the clinical characteristics and prognosis of COVID-19 patients with comorbidities and to identify survival factors.", "Methods: A retrospective study was conducted in wuhan, china, between February 8, 2020, and March 9, 2020 Based on underlying diseases, patients were assigned to either the comorbidity group or the non-comorbidity group.", "The clinical characteristics and outcomes of COVID-19 were analyzed and a Kaplan-Meier survival analysis was used to evaluate the prognosis predictive value of each comorbidity.", "Results: During the study period, 278 COVID-19 patients were enrolled, 175 (62 95%) were assigned to the comorbidity group, and 103 (37 05%) to the non-comorbidity group.", "Of the patients in the comorbidity group, 34 86% were classified as critical.", "Further, patients in the comorbidity group had lower lymphocyte cell counts, and higher concentrations of D-dimer, high sensitivity C-reactive protein, interleukin 6, and serum ferritin as well as higher critical illness severity scores than patients in the non-comorbidity group (P2=4 202, P=0 040) and patients with chronic obstructive pulmonary disease (copd) (log-rank test: chi2=4 839, P=0 028) or diabetes mellitus (log-rank test: chi2=4 377, P=0 036) had shorter survival than those without comorbidities.", "Conclusions: Patients with comorbidities were more severely affected and had a higher mortality rate.", "Age, copd and diabetes mellitus were the main factors affecting the survival of patients."], "journal": "Annals of Translational Medicine", "publish_time": "2021", "aliases": []}
{"doc_id": 221666373, "title": "Hepatic and gastrointestinal manifestations of SARS-COV-2 infection (COVID-19)", "abstract": ["background and aim: Abnormal liver function tests (lfts) and gastrointestinal (GI) symptoms have been reported up to 50% in patients with COVID-19, and in 5% they can precede respiratory symptoms.", "The objective of this work is to describe the lfts and gi symptoms of patients with COVID-19 and their association with admission to the intensive care unit (icu) and mortality.", "Material and methods.", "We conducted a retrospective, cross sectional, descriptive study, using files from patients with a positive gen finder COVID-19 test, admitted to medica sur clinic and foundation between March 13th through May 14th, 2020 We performed descriptive analysis of data and its association with clinical outcomes.", "Results: A total of 108 patients with COVID-19 were identified; 68 5% (n = 74) were men, the mean age was 53 \u00b1 14 years and the body mass index was 28 6 \u00b1 5 8 kg/m2 The most frequent comorbidity was hypertension with 24% (n = 26) The presence of comorbidities was associated with risk of icu admission (OR 3 9 [ 95% CI 1 6-9 9 ], p = 0 002) The most frequent symptoms were cough (72 2%, n = 78), fever (69 4%, n = 75) and dyspnea (48 1%, n = 52) At least one abnormal lft was present in 94% (n = 103) of patients at admission, the most frequent was ldh (88 9%, n = 96), ast and ggt (63%, n = 65), which are summarized in Table 1 Patients presented abnormal lfts and respiratory symptoms in 48 1% (n = 52), while 16 6% (n = 18) presented abnormal lfts without respiratory symptoms.", "Among GI symptoms, 37% (n = 4) reported at least one, including diarrhea (28 7%, n = 31), hyporexia (9 3%, n = 10), nausea (8 3%, n = 9) or vomiting (4 6%, n = 5) Of patients admitted to the icu (n = 39), 27 5% (n = 10) presented at least one GI symptom mortality was 7 4% (n = 8) No associations were found between abnormal lfts, gi symptoms, and outcomes of mortality and icu admission.", "Conclusions: In patients with covid 19, the presence of metabolic comorbidities confers a higher risk of icu admission, in contrast to abnormal lfts and gi symptoms that were not associated with clinical outcomes.", "Conflicts of interest: The authors have no conflicts of interest to declare."], "journal": "Annals of Hepatology", "publish_time": "2020", "aliases": []}
{"doc_id": 234325818, "title": "Clinical characteristics of patients infected with SARS-CoV-2 in North Wollo Zone, North-East Ethiopia", "abstract": ["Introduction: severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); the causative agent of coronavirus disease 2019 (COVID-19), pandemics has remained to be a public health emergency of international concern.", "This ongoing pandemic has resulted in the death of millions of people globally.", "About one and a half thousand people have died due to this illness in Ethiopia.", "The clinical presentations of the disease vary with geography and populations.", "We therefore aimed at investigating the clinical characteristics of patients infected with SARS-CoV-2 in North-East Ethiopia.", "Methods: real time polymerase chain reaction (PCR) was conducted for 18,112 individuals suspected of SARS-CoV-2 infection during June 27 to October 20, 2020, at Woldia university COVID-19 testing center.", "Recorded data of 372 Ethiopians who tested positive for SARS-CoV-2 infection at Woldia university COVID-19 testing center were retrospectively extracted and analyzed using SPSS v25.0.", "A P-value of < 0.05 was considered statistically significant.", "Results: nearly 2.1% of the screened participants were found positive for SARS-CoV-2 infection.", "Among them, three fourth of SARS-CoV-2 infected patients were male, with an overall median age of 30 years.", "About 85% of the patients were asymptomatic.", "The most common clinical manifestations were cough (14.2%), followed by fever (11.0%) and headache (8.6%), whereas hypertension (1.6%), human immunodeficiency virus (HIV) (1.6%) diabetes mellitus (1.1%), and chronic respiratory diseases (1.1%) were relatively the most common comorbidities noted.", "The case-fatality ratio was found at 1.6%.", "Age and underlying comorbidities had a statistically significant association with severity and poor outcome of patients (P < 0.001).", "Conclusion: the finding from this study indicated that older age and people with underlying comorbidities are at high risk of having the severe disease and poor outcomes.", "Hence, appropriate care and priority should be given to these people to decrease the morbidity and mortality caused by this illness.", "The presence of higher asymptomatic infection is the possible indicator of potential asymptomatic transmissions within the community.", "This highlights the need for widespread testing, and contact tracing to flatten the transmission curve."], "journal": "Pan Afr Med J", "publish_time": "2021", "aliases": []}
{"doc_id": 230803638, "title": "461. Presentation and Demographics of Veterans Tested for COVID-19 Infection", "abstract": ["BACKGROUND: COVID-19, caused by the Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2), has been a major cause of morbidity and mortality in the United States since its emergence in Wuhan, China.", "As of June 2020, there are over 20,000 confirmed cases and nearly 700 deaths due to COVID-19 in Wisconsin, with the majority of COVID-19 related deaths occurring within Milwaukee County.", "COVID-19 infections are disproportionately affecting minority communities across the United States.", "Presentation and outcomes vary, with the elderly and those with underlying diseases having poorer outcomes.", "METHODS: This retrospective chart review of patients tested for COVID-19 infection from March 2020-May 2020 at the Zablocki VA Medical Center, Milwaukee, WI evaluated demographics, comorbidities, presenting symptoms, and duration of symptoms.", "The primary outcomes analyzed were whether there were significant differences in demographic data, comorbidities, and presentation between patients testing positive or not positive for COVID-19.", "RESULTS: A total of 173 patients tested for COVID-19 were included during the study period, 82 positive and 91 otherwise.", "Univariate analysis of patient demographics and presenting symptoms are summarized in Table 1.", "A multivariable logistic regression using stepwise selection (AUC=0.7188) determined patients that tested positive for COVID-19, when controlling for demographics and comorbidities, were more likely to be African-American than White (OR 3.455, CI 1.733\u20136.887), and more likely to have a diagnosis of diabetes (OR 2.698, CI 1.36\u20135.353).", "However, race and diabetes were not informative when symptoms were included in a subsequent model (AUC=0.8458); patients testing positive for COVID-19 were more likely to present with diarrhea (OR 6.926, CI 1.760\u20136.926) and a higher temperature (OR 2.651, CI 1.533\u20134.584), but less likely to present with vomiting (OR 0.007, CI < .001-0.161) when compared to patients testing otherwise for COVID-19.", "Table 1: Univariate Analysis of Variables Associated with Testing Positive for COVID-19 at Zablocki VA Medical Center 3/2020\u20135/2020 [Image: see text] CONCLUSION: Patients testing positive in Milwaukee County are more likely to be African-American and/or diabetic; further highlighting racial disparities in COVID-19.", "Symptomology at presentation is more related to positive COVID-19 test results than demographics and comorbidities.", "DISCLOSURES: All Authors: No reported disclosures"], "journal": "Open Forum Infect Dis", "publish_time": "2020-12-31", "aliases": []}
{"doc_id": 218584852, "title": "SARS\u2010CoV\u20102 Testing and Outcomes in the First 30 Days after the First Case of COVID\u201019 at an Australian Children\u2019s Hospital", "abstract": ["OBJECTIVE: International studies describing COVID\u201019 in children have shown low proportions of paediatric cases and generally a mild clinical course.", "We aimed to present early data on children tested for SARS\u2010CoV\u20102 at a large Australian tertiary children\u2019s hospital according to the state health department guidelines, which varied over time.", "METHODS: We conducted a retrospective cohort study at The Royal Children\u2019s Hospital, Melbourne, Australia.", "It included all paediatric patients (aged 0\u201318 years) who presented to the Emergency Department (ED) or the Respiratory Infection Clinic (RIC) and were tested for SARS\u2010CoV\u20102.", "The 30\u2010day study period commenced after the first confirmed positive case was detected at the hospital on 21(st) March 2020, until 19(th) April 2020.", "We recorded epidemiological and clinical data.", "RESULTS: There were 433 patients in whom SARS\u2010CoV\u20102 testing was performed in ED (331 (76%)) or RIC (102 (24%)).", "There were 4 (0.9%) who had positive SARS\u2010CoV\u20102 detected, none of whom were admitted to hospital or developed severe disease.", "Of these SARS\u2010CoV\u20102 positive patients, 1/4 (25%) had a comorbidity, which was asthma.", "Of the SARS\u2010CoV\u20102 negative patients, 196/429 (46%) had comorbidities.", "Risk factors for COVID\u201019 were identified in 4/4 SARS\u2010CoV\u20102 positive patients and 47/429 (11%) SARS\u2010CoV\u20102 negative patients.", "CONCLUSIONS: Our study identified a very low rate of SARS\u2010CoV\u20102 positive cases in children presenting to a tertiary ED or RIC, none of whom were admitted to hospital.", "A high proportion of patients who were SARS\u2010CoV\u20102 negative had comorbidities."], "journal": "Emerg Med Australas", "publish_time": "2020-05-10", "aliases": []}
{"doc_id": 235760932, "title": "BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully-vaccinated hospitalized COVID-19 patients in Israel", "abstract": ["OBJECTIVES: mRNA COVID-19 vaccines have shown high effectiveness in the prevention of symptomatic COVID-19, hospitalization, severe disease, and death.", "Nevertheless, a minority of vaccinated individuals might get infected and suffer significant morbidity.", "Characteristics of vaccine breakthrough infections have not been studied.", "We sought to portray the population of Israeli patients, who were hospitalized with COVID-19 despite full vaccination.", "METHODS: A retrospective multicenter cohort study of 17 hospitals included Pfizer/BioNTech's BNT162b2 fully-vaccinated patients who developed COVID-19 more than 7 days after the second vaccine dose and required hospitalization.", "The risk for poor outcome, defined as a composite of mechanical ventilation or death, was assessed.", "RESULTS: 152 patients were included, accounting for half of hospitalized fully-vaccinated patients in Israel.", "Poor outcome was noted in 38 patients and mortality rate reached 22% (34/152).", "Notable, the cohort was characterized by a high rate of comorbidities predisposing to severe COVID-19, including hypertension (108, 71%), diabetes (73, 48%), CHF (41, 27%), chronic kidney and lung diseases (37, 24% each), dementia (29, 19%), and cancer (36, 24%), and only 6 (%) had no comorbidities.", "Sixty (40%) of the patients were immunocompromised.", "Higher SARS-CoV-2 viral-load was associated with a significant risk for poor outcome.", "Risk also appeared higher in patients receiving anti-CD20 treatment and in patients with low titers of anti-spike IgG, but these differences did not reach statistical significance.", "CONCLUSIONS: We found that severe COVID-19 infection, associated with a high mortality rate, might develop in a minority of fully-vaccinated individuals with multiple comorbidities.", "Our patients had a higher rate of comorbidities and immunosuppression compared to previously reported non-vaccinated hospitalized COVID-19 patients.", "Further characterization of this vulnerable population may help to develop guidance to augment their protection, either by continued social-distancing, or by additional active or passive vaccinations."], "journal": "Clin Microbiol Infect", "publish_time": "2021-07-07", "aliases": []}
{"doc_id": 221012859, "title": "Asthma among hospitalized patients with COVID-19 and related outcomes", "abstract": ["BACKGROUND: Several underlying conditions have been associated with severe acute respiratory syndrome coronavirus 2 illness, but it remains unclear whether underlying asthma is associated with worse coronavirus disease 2019 (COVID-19) outcomes.", "OBJECTIVE: Given the high prevalence of asthma in the New York City area, our objective was to determine whether underlying asthma was associated with poor outcomes among hospitalized patients with severe COVID-19 compared with patients without asthma.", "METHODS: Electronic heath records were reviewed for 1298 sequential patients 65 years or younger without chronic obstructive pulmonary disease who were admitted to our hospital system with a confirmed positive severe acute respiratory syndrome coronavirus 2 test result.", "RESULTS: The overall prevalence of asthma among all hospitalized patients with COVID-19 was 12.6%, yet a higher prevalence (23.6%) was observed in the subset of 55 patients younger than 21 years.", "There was no significant difference in hospital length of stay, need for intubation, length of intubation, tracheostomy tube placement, hospital readmission, or mortality between patients with and without asthma.", "Observations between patients with and without asthma were similar when stratified by obesity, other comorbid conditions (ie, hypertension, hyperlipidemia, and diabetes), use of controller asthma medication, and absolute eosinophil count.", "CONCLUSIONS: Among hospitalized patients 65 years or younger with severe COVID-19, asthma diagnosis was not associated with worse outcomes, regardless of age, obesity, or other high-risk comorbidities.", "Future population-based studies are needed to investigate the risk of developing COVID-19 among patients with asthma once universal testing becomes readily available."], "journal": "J Allergy Clin Immunol", "publish_time": "2020", "aliases": []}
{"doc_id": 237587169, "title": "1578P Clinical outcomes of patients with cancer who tested positive for COVID-19 hospitalised in a UK district general hospital", "abstract": ["Background: Individuals diagnosed with cancer have been particularly affected by the COVID-19 pandemic.", "Most of the relevant information so far has come from tertiary cancer centres and less is known of the outcomes of patients in District General Hospitals (DGH).", "In this audit, we aimed to investigate the clinical outcomes of patients with cancer who tested positive for COVID-19 and were admitted in a DGH.", "Methods: Electronic records of patients admitted at Tameside General Hospital (TGH) (>500 beds) between March 2020\u2013March 2021 were reviewed retrospectively.", "Clinical outcomes of those who tested positive for COVID-19 and factors relating to death were analysed.", "Cox regression and Kaplan-Meier survival analyses were performed (SPSS v26.0).", "Results: Within the 12-month study period, there were 2417 inpatients who tested positive for COVID-19 at TGH.", "Of 235 individual patients with cancer admitted during this period, 14% (n=33) tested positive.", "Median age was 75 (68;81) years;majority female (67%).", "The most prevalent primary site of cancer were lung (21%) and breast (12%).", "Most were ECOG PS 1 (39%) or PS 2 (36%), and had high Charlson Comorbidity Index (median 5 (3;6), range 0-10).", "24% of patients were on curative treatment, 39% palliative treatment, 18% best supportive care and 18% not on treatment.", "Types of treatment included chemotherapy (37%), hormonal treatment (26%), radiotherapy (21%) and immunotherapy (5%).", "On average, patients were admitted at least once (range 0-4) prior to positive test for COVID-19.", "At last follow-up, there were n=664/2417 (27%) and n=22/33 (67%) deaths in the non-cancer and cancer patient subgroups, respectively.", "The median time from diagnosis of COVID-19 to death/censor date was 44 (4;85) days.", "In univariate Cox regression analysis, only ECOG PS was significantly correlated with death, HR 1.523 (95% CI 1.064-2.181, p=0.022).", "Conclusions: The outcomes of our cohort of patients with cancer who tested positive for COVID-19 and hospitalised were poor.", "The high comorbidity burden and poor ECOG PS could potentially account for this rather than the recent oncological treatment.", "Acute oncology input to general medical teams treating cancer patients with COVID-19 is pivotal for best possible outcomes for patients.", "Legal entity responsible for the study: Konstantinos Kamposioras.", "Funding: Has not received any funding.", "Disclosure: All authors have declared no conflicts of interest."], "journal": "Annals of Oncology", "publish_time": "2021-09-30", "aliases": []}
{"doc_id": 232480412, "title": "Characteristics of COVID-19 Recurrence: A Systematic Review and Meta-Analysis", "abstract": ["BACKGROUND: Previous studies reported the recurrence of coronavirus disease 2019 (COVID-19) among discharge patients.", "This study aimed to examine the characteristic of COVID-19 recurrence cases by performing a systematic review and meta-analysis.", "METHODS: A systematic search was performed in PubMed and Embase and gray literature up to September 19, 2020.", "A random-effects model was applied to obtain the pooled prevalence of disease recurrence among recovered patients and the prevalence of subjects underlying comorbidity among recurrence cases.", "The other characteristics were calculated based on the summary data of individual studies.", "RESULTS: A total of 41 studies were included in the final analysis, we have described the epidemiological characteristics of COVID-19 recurrence cases.", "Of 3,644 patients recovering from COVID-19 and being discharged, an estimate of 15% (95% CI, 12% to 19%) patients was re-positive with SARS-CoV-2 during the follow-up.", "This proportion was 14% (95% CI, 11% to 17%) for China and 31% (95% CI, 26% to 37%) for Korea.", "Among recurrence cases, it was estimated 39% (95% CI, 31% to 48%) subjects underlying at least one comorbidity.", "The estimates for times from disease onset to admission, from admission to discharge, and from discharge to RNA positive conversion were 4.8, 16.4, and 10.4 days, respectively.", "CONCLUSION: This study summarized up-to-date evidence from case reports, case series, and observational studies for the characteristic of COVID-19 recurrence cases after discharge.", "It is recommended to pay attention to follow-up patients after discharge, even if they have been in discharge quarantine."], "journal": "Annals of global health", "publish_time": "2021-03-24", "aliases": [221520692]}
{"doc_id": 226207164, "title": "The Role of COVID-19 in the Death of SARS-CoV-2\u2013Positive Patients: A Study Based on Death Certificates", "abstract": ["Background: Death certificates are considered the most reliable source of information to compare cause-specific mortality across countries.", "The aim of the present study was to examine death certificates of persons who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to (a) quantify the number of deaths directly caused by coronavirus 2019 (COVID-19); (b) estimate the most common complications leading to death; and (c) identify the most common comorbidities.", "Methods: Death certificates of persons who tested positive for SARS-CoV-2 provided to the National Surveillance system were coded according to the 10th edition of the International Classification of Diseases.", "Deaths due to COVID-19 were defined as those in which COVID-19 was the underlying cause of death.", "Complications were defined as those conditions reported as originating from COVID-19, and comorbidities were conditions independent of COVID-19.", "Results: A total of 5311 death certificates of persons dying in March through May 2020 were analysed (16.7% of total deaths).", "COVID-19 was the underlying cause of death in 88% of cases.", "Pneumonia and respiratory failure were the most common complications, being identified in 78% and 54% of certificates, respectively.", "Other complications, including shock, respiratory distress and pulmonary oedema, and heart complications demonstrated a low prevalence, but they were more commonly observed in the 30\u201359 years age group.", "Comorbidities were reported in 72% of certificates, with little variation by age and gender.", "The most common comorbidities were hypertensive heart disease, diabetes, ischaemic heart disease, and neoplasms.", "Neoplasms and obesity were the main comorbidities among younger people.", "Discussion: In most persons dying after testing positive for SARS-CoV-2, COVID-19 was the cause directly leading to death.", "In a large proportion of death certificates, no comorbidities were reported, suggesting that this condition can be fatal in healthy persons.", "Respiratory complications were common, but non-respiratory complications were also observed."], "journal": "J Clin Med", "publish_time": "2020-10-27", "aliases": []}
{"doc_id": 234346059, "title": "Su319 KEY PRO-INFLAMMATORY/INJURY FEATURES OF COVID-19 PATIENTS WITH ALCOHOL USE", "abstract": ["INTRODUCTION: SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2;causes coronavirus disease [COVID-19]).", "Alcohol Use Disorder (AUD) comorbid with COVID-19 (AUD+COVID-19) could present with severe symptoms, if the pre-existing proinflammatory state of AUD were aggravated by the inflammation of COVID-19.", "However, the exacerbation of clinical and laboratory markers is understudied in COVID-19 patients with excessive alcohol drinking.", "We previously reported two patients with alcohol-associated hepatitis and COVID who died.", "Thus, we aimed to evaluate the impact of alcohol use in the inflammatory response in patients with COVID-19.", "Methods: We conducted a retrospective study of 238 patients with COVID-19 from a single hospital registry who had a known drinking history.", "Patients were grouped by their reported amount of alcohol consumption: alcohol abstainers (AlcA, n= 183, 77 % as disease controls);social drinkers (SD, drank < 4, if females, and < 5, if males, drinks/week, n=37 [16%] as intermediate responders of alcohol intake);and excessive drinkers (ExD, drank >4, if females, and > 5, if males, drinks/week n=16 [7%] as the comorbid condition).", "Clinical and laboratory markers were compared between the groups for identifying any key differences.", "Results: Mean age of the patients was 43 yrs.", "in this study.", "Among the patients, 37% were African American, 37.5% Caucasians and 23% Hispanics.", "Only 18 patients had an underlying liver disease.", "Males represented 46 % of the total population, there were no other demographic differences.", "The lymphocyte count was significantly elevated, (p=0.008) in the in SD compared to AlcA.", "Discussion: Lymphopenia and increased levels of inflammatory and injury markers has been associated with disease severity inCOVID-19.", "Inonemeta-analysis, potential biomarkers were examined for correlation with severity of COVID-19.", "Severe COVID-19 cases were found to have significantly lower lymphocyte count.", "We found a significant difference in lymphocyte count in patients with alcohol consumption as compared to non-drinkers.", "Lymphopenia has previously been correlated with alcohol use.", "Conclusion: Determination of lymphocyte count could potentially be useful in determining and distinguishing the severity of inflammation/injury in COVID- 19 patients comorbid with excessive drinking.", "This study is underpowered, but is potentially useful for the care of COVID patients with excessive drinking.", "(Table presented.)"], "journal": "Gastroenterology", "publish_time": "2021-05-31", "aliases": []}
{"doc_id": 235086764, "title": "P050 Influence factors in mortality of COVID-19 pateints with underlying rheumatological disorders", "abstract": ["Background/Aims Since the outbreak and rapid spread of COVID-19, rheumatologists have sought to provide the best solutions to provide proper shielding of patients vulnerable to COVID-19.", "Set aside from social distancing and self-isolating, the British Society for Rheumatology proposed pragmatic guidance for different groups of patients for shielding.", "Clinical presentation, epidemiology, and potential treatment opinions of the management of COVID-19 patients with rheumatic disease had been reported, but a few reports which show a comparison between survivors and non-survivors in relation to their co-morbidities.", "Methods We collected data from a search identifying 1,200 patients testing positive for SARS-COV-2 with an identified rheumatological condition until 31st April 2020 at Imperial College NHS Trust.", "A positive laboratory finding is defined as one or more positive result for SARS-COV-2 PCR on nasopharyngeal swab done for inpatients.", "Results Among 1,200 patients, 39 patients had underlying rheumatological diseases.12 patients died, and 27 patients were discharged.", "50% of the patients who died had chronic kidney disease as an existing comorbidity (OR 26, 95%CI ( 2.6-258.1), p value 0.001) compared with only 3% of patients who survived.", "All the patients with heart failure in this sample died in hospital (33%, OR 29, 95%CI (1.4-597.4, p value 0.006).", "Regarding drug therapy, 50% of patients who died were receiving more than one immunosuppressant compared with 37% of those who survived.", "There was a significant association linking non-survivors with a high CRP value (54% , OR 25.2, 95% CI ( 2.44-258.2), p value 0.009) compared with only 4.5% in patients who survived.", "70% of patients who died had d-dimer of (>2000ng/ml) compared with 16% of those who survived (OR 11.6, 95% CI ( 1.86-73.06), p value 0.011).", "Creatinine level also had a significant link with non-survival.", "58% patients who died had an initial creatinine (>140umol/l) compared with 18% of survivors (p value 0.0232).", "Additionally the patients with an elevated creatinine prior to deterioration (which is an indication of acute kidney injury) represented 32% of the total sample and of those, 66% did not survive compared with 13% who did (p value 0.007).We also reviewed the medication adjustment according to NICE guideline.", "In our study, it was observed that medications were properly adjusted after discussion with rheumatologist.", "Conclusion Patients with chronic kidney disease and cardiovascular disease should be strictly shielded as a same priority as patient who are taking high dose of immunosuppressive therapy.", "Follow-up could only be considered for remote consultation in virtual clinic apart from severity of sickness that require for hospital admission.", "I believe many questions remain for the rheumatology society: How will we continue better rheumatology service during and beyond the pandemic?", "How particularly important to shield the high-risk patients by widespread adoption of the virtual clinic?", "Disclosure W.W. Soe: None.", "F. Hassan: None.", "W. Phyu: None."], "journal": "Rheumatology (Oxford)", "publish_time": "2021-04-26", "aliases": []}
{"doc_id": 216595714, "title": "Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough", "abstract": ["The COVID-19 pandemic caused the shutdown of entire nations all over the world.", "In addition to mobility restrictions of people, the World Health Organization and the Governments have prescribed maintaining an inter-personal distance of 1.5 or 2 m (about 6 feet) from each other in order to minimize the risk of contagion through the droplets that we usually disseminate around us from nose and mouth.", "However, recently published studies support the hypothesis of virus transmission over a distance of 2 m from an infected person.", "Researchers have proved the higher aerosol and surface stability of SARS-COV-2 as compared with SARS-COV-1 (with the virus remaining viable and infectious in aerosol for hours) and that airborne transmission of SARS-CoV can occur besides close-distance contacts.", "Indeed, there is reasonable evidence about the possibility of SARS-COV-2 airborne transmission due to its persistence into aerosol droplets in a viable and infectious form.", "Based on the available knowledge and epidemiological observations, it is plausible that small particles containing the virus may diffuse in indoor environments covering distances up to 10 m from the emission sources, thus representing a kind of aerosol transmission.", "On-field studies carried out inside Wuhan Hospitals showed the presence of SARS-COV-2 RNA in air samples collected in the hospitals and also in the surroundings, leading to the conclusion that the airborne route has to be considered an important pathway for viral diffusion.", "Similar findings are reported in analyses concerning air samples collected at the Nebraska University Hospital.", "On March 16th, we have released a Position Paper emphasizing the airborne route as a possible additional factor for interpreting the anomalous COVID-19 outbreaks in northern Italy, ranked as one of the most polluted areas in Europe and characterized by high particulate matter (PM) concentrations.", "The available information on the SARS-COV-2 spreading supports the hypothesis of airborne diffusion of infected droplets from person to person at a distance greater than two meters (6 feet).", "The inter-personal distance of 2 m can be reasonably considered as an effective protection only if everybody wears face masks in daily life activities."], "journal": "Int J Environ Res Public Health", "publish_time": "2020-04-23", "aliases": []}
{"doc_id": 233381073, "title": "SARS-CoV-2 aerosol and droplets: an overview", "abstract": ["Aerosol particles can spread respiratory infections, especially those caused by viruses; however, the perceived threat is small for many technical reasons, as identified in this article.", "Under controlled conditions, aerosol particles can travel up to a distance of 28 feet (or 8 m); however, such aerosol particles are less likely to have sufficient quantities of viable viruses to spread infection.", "Additionally, nearly all the experimental models examined the behavior of the aerosols only in confined spaces, not in open areas; these findings, therefore, cannot be considered generally applicable.", "In the absence of scientific information and education, only misconceptions, unfounded fears, and unsubstantiated myths will prevail.", "Given that an effective vaccine and drugs are still not available, prevention remains the only option of protection against SARS-CoV-2, the new coronavirus.", "Wearing a mask is not only necessary but also critical to reduce the probability of viral spread by contact (fomite), not aerosol, transmission."], "journal": "Virusdisease", "publish_time": "2021-04-22", "aliases": []}
{"doc_id": 215803946, "title": "Airborne or droplet precautions for health workers treating COVID-19?", "abstract": ["Cases of COVID-19 have been reported in over 200 countries.", "Thousands of health workers have been infected and outbreaks have occurred in hospitals, aged care facilities and prisons.", "World Health Organization (WHO) has issued guidelines for contact and droplet precautions for Healthcare Workers (HCWs) caring for suspected COVID-19 patients, whilst the US Centre for Disease Control (CDC) has recommended airborne precautions.", "The 1 - 2 m (&#8776;3 - 6 ft) rule of spatial separation is central to droplet precautions and assumes large droplets do not travel further than 2 m (&#8776;6 ft).", "We aimed to review the evidence for horizontal distance travelled by droplets and the guidelines issued by the World Health Organization (WHO), US Center for Diseases Control (CDC) and European Centre for Disease Prevention and Control (ECDC) on respiratory protection for COVID-19.", "We found that the evidence base for current guidelines is sparse, and the available data do not support the 1 - 2 m (&#8776;3 - 6 ft) rule of spatial separation.", "Of ten studies on horizontal droplet distance, eight showed droplets travel more than 2 m (&#8776;6 ft), in some cases more than 8 meters (&#8776;26 ft).", "Several studies of SARS-CoV-2 support aerosol transmission and one study documented virus at a distance of 4 meters (&#8776;13 ft) from the patient.", "Moreover, evidence suggests infections cannot neatly be separated into the dichotomy of droplet versus airborne transmission routes.", "Available studies also show that SARS-CoV-2 can be detected in the air, 3 hours after aeroslisation.", "The weight of combined evidence supports airborne precautions for the occupational health and safety of health workers treating patients with COVID-19."], "journal": "J. infect. dis", "publish_time": "2020", "aliases": []}
{"doc_id": 220060616, "title": "[risk Assessment for Aerosol Infection by the New Corona Virus and Protection by Respirators]", "abstract": ["INTRODUCTION: SARS-CoV-2 is dispersed from patients by talking, coughing and sneezing.", "The generated micro-droplets aerosols can travel up to 8 meters, stay suspended for long periods and preserve viral infectivity for a median of 2.7 hours.", "An unprotected person exposed to this cloud, might inhale a considerable amount of infectious viral doses, which will attach to the ACE 2 receptors on alveoli epithelium, resulting in infection.", "N95 respirators and surgical masks block 95% and 50-60% respectively of inhalable particles and protect the wearer from infection.", "Surgical masks and N95 without exhalation valve, protect both the wearer and the environment from carriers and sick people."], "journal": "Harefuah", "publish_time": "2020", "aliases": []}
{"doc_id": 232074225, "title": "Characterization of the indoor near-field and far-field aerosol transmission in a model commercial office building", "abstract": ["To simulate the exposure potential of infectious aerosol such as SARS-CoV-2 in an office building setting, experimental studies for airborne particle transmission have been conducted in a model commercial office building at the Oak Ridge National Laboratory.", "The synthetic test aerosol particles had diameters similar to that of viral particles, in the nanometer size range of genetic fragments.", "Thus, the test aerosol provided a realistic representation of SARS-CoV-2 viral particle transmission.", "The study results, which are still being analyzed carefully at the present, suggest that in a door-closed single room setting, the heating, ventilating, and air-conditioning (HVAC) system can facilitate aerosol transmission, and 10 measuring points in a single room report the normalized concentration ranged from 0.45 to 0.66.", "Additionally, at a measuring point 6 feet away from the source, the aerosol concentration can reach a plateau normalized concentration of about 0.6 within 30 minutes.", "When interior doors were closed, aerosol particle transmission into adjacent rooms occurred through the building HVAC system, at a lower rate compared to the open-door scenario.", "If the interior doors were open, however, then the transmission into adjacent rooms depends on building indoor air movement and distance from the source.", "The building HVAC system provided an approximately less than 10% aerosol transmission rate, while transmission through a door opening can add up to 40% of transmission into adjacent rooms from the source location."], "journal": "", "publish_time": "2021-03-01", "aliases": []}
{"doc_id": 218652686, "title": "The role of environmental factors to transmission of SARS-CoV-2 (COVID-19)", "abstract": ["The current outbreak of the novel coronavirus disease 2019 (COVID-19) in more than 250 countries has become a serious threat to the health of people around the world.", "Human-to-human transmission of the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurs most often when people are in the incubation stage of the disease or are carriers and have no symptoms.", "Therefore, in this study, was discussed the role of environmental factors and conditions such as temperature, humidity, wind speed as well as food, water and sewage, air, insects, inanimate surfaces, and hands in COVID-19 transmission.", "The results of studies on the stability of the SARS-CoV-2 on different levels showed that the resistance of this virus on smooth surfaces was higher than others.", "Temperature increase and sunlight can facilitate the destruction of SARS-COV-2 and the stability of it on surfaces.", "When the minimum ambient air temperature increases by 1 \u00b0C, the cumulative number of cases decreases by 0.86%.", "According to the latest evidence, the presence of coronavirus in the sewer has been confirmed, but there is no evidence that it is transmitted through sewage or contaminated drinking water.", "Also, SARS-COV-2 transmission through food, food packages, and food handlers has not been identified as a risk factor for the disease.", "According to the latest studies, the possibility of transmitting SARS-COV-2 bioaerosol through the air has been reported in the internal environment of ophthalmology.", "The results additionally show that infectious bio-aerosols can move up to 6 feet.", "There have been no reports of SARS-COV-2 transmission by blood-feeding arthropods such as mosquitoes."], "journal": "AMB Express", "publish_time": "2020", "aliases": []}
{"doc_id": 218674875, "title": "Influence of wind and relative humidity on the social distancing effectiveness to prevent COVID-19 airborne transmission: A numerical study", "abstract": ["It has been confirmed that the coronavirus disease 2019 (COVID-19) can transmit through droplets created when an infected human coughs or sneezes.", "Accordingly, 1.83-m (6-feet) social distancing is advised to reduce the spread of the disease among humans.", "This is based on the assumption that no air circulation exists around people.", "However, it is not well investigated whether the ambient wind and relative humidity (RH) will cause SARS-CoV-2 laden droplets to transport farther in the air, and make the current social distancing policy insufficient.", "To provide evidence and insight into the \"social distancing\" guidelines, a validated computational fluid-particle dynamics (CFPD) model was employed to simulate the transient transport, condensation/evaporation, and deposition of SARS-CoV-2 laden droplets emitted by coughs, with different environmental wind velocities and RHs.", "Initial droplet diameters range from 2 to 2000 \u00b5m, and the wind velocities range from 0 to 16 km/h, representing different wind forces from calm air to moderate breeze.", "The comparison between a steady-state wind and a gust with a constant frequency has also been performed.", "Ambient RHs are 40% and 99.5%.", "The distances between the two virtual humans are 1.83 m and 3.05 m (6 feet and 10 feet).", "The facial covering effect on reducing the airborne transmission of the cough droplets has also been evaluated.", "Numerical results indicate that the ambient wind will enhance the complexity of the secondary flows with recirculation between the two virtual humans.", "Microdroplets follow the airflow streamlines well and deposit on both human bodies and head regions, even with the 3.05-m (10-feet) separation distance.", "The rest of the microdroplets can transport in the air farther than 3.05 m (10 feet) due to wind convection, causing a potential health risk to nearby people.", "High RH will increase the droplet sizes due to the hygroscopic growth effect, which increases the deposition fractions on both humans and the ground.", "With the complex environmental wind and RH conditions, the 6-feet social distancing policy may not be sufficient to protect the inter-person aerosol transmission, since the suspending micro-droplets were influenced by convection effects and can transport from the human coughs/sneezes to the other human in less than 5 seconds.", "Due to the complex real-world environmental ventilation conditions, a social distance longer than 1.83 m (6 feet) needs to be considered.", "Wearing masks should also be recommended for both infected and healthy humans to reduce the airborne cough droplet numbers."], "journal": "J Aerosol Sci", "publish_time": "2020", "aliases": []}
{"doc_id": 245635269, "title": "Biosensor detection of airborne respiratory viruses such as SARS-CoV-2", "abstract": ["Airborne SARS-CoV-2 transmission represents a significant route for possible human infection that is not yet fully understood.", "Viruses in droplets and aerosols are difficult to detect because they are typically present in low amounts.", "In addition, the current techniques used, such as RT-PCR and virus culturing, require large amounts of time to get results.", "Biosensor technology can provide rapid, handheld, and point-of-care systems that can identify virus presence quickly and accurately.", "This paper reviews the background of airborne virus transmission and the characteristics of SARS-CoV-2, its relative risk for transmission even at distances greater than the currently suggested 6 feet (or 2 m) physical distancing.", "Publications on biosensor technology that may be applied to the detection of airborne SARS-CoV-2 and other respiratory viruses are also summarized.", "Based on the current research we believe that there is a pressing need for continued research into handheld and rapid methods for sensitive collection and detection of airborne viruses.", "We propose a paper-based microfluidic chip and immunofluorescence assay as one method that could be investigated as a low-cost and portable option."], "journal": "SLAS Technol", "publish_time": "2022-01-02", "aliases": []}
{"doc_id": 235076428, "title": "Turbulent Airflow Costume Compromises Occupational Safety and Infection Control: A Hospital Risk Management Case Report", "abstract": ["Objectives: To inform hospital infection control, risk management, hospital administrators, and healthcare workers about a new and surprising threat to infection control: air-powered costumes.", "Background: Air-powered costumes use a small motor to create positive pressure within the costume.", "This mechanism is similar to powered air purifying respirator (papr) 1 However, unlike a PAPR the air-powered costume does not filter the incoming air through a hepa filter.", "Nor does it capture the air inside a contained space and filter it before it is released into the environment.", "The affect is that droplets from the person in the costume or from air that is drawn into the costume, which would normally be too heavy to travel farther than 6 feet, are aerosolized by traveling through the turbulent blower.", "These small particles can easily penetrate the thin fabric that makes the costume.", "This creates an infection control problem by aerosolizing the particles and then propelling them with the force of positive pressure `` case.", "Description: In.", "January of 2021, a Covid-19 outbreak in san jose, ca, was contact traced back to a surprising source.", "On.", "Christmas day, a worker wishing to lift spirits, unknowingly spread.", "Covid-19 via an air-powered.", "Christmas tree costume.", "The worker did not have symptoms of SARS-COV-2 and did not know they were infected.", "The result is tragic.", "In san jose, at least 60 people were infected, and one person died `` Conclusion: This case manifests a tragic outcome to what was meant to be a benevolent action.", "All evidence points to lack of information guiding this well-intentioned action.", "What was meant to decrease the stress and burden of the pandemic, became a greater stress and burden.", "Tragically with a loss of life and unknown morbidity further, there is the potential for a psychologic toll on the person who thought they were helping others, only to learn that they had harmed them Given that these costumes in hospitals are rare, further tragedies such as this one should be preventable.", "Covid-19 is not the only pathogen that could theoretically be spread by this mechanism hospital should have a policy that restricts the use of these costumes.", "Education about the danger of these costumes should be provided to staff.", "Given that personal may act by finding replacement, risk management and infection control should create an adequate policy to address the mental health needs of staff and patients, while maintain appropriate infection control.", "Now that there is documentation of this methods of pathogenic spread, hospitals may face liability if they fail to establish a reasonable policy and education regarding turbulent flow air-powered costumes."], "journal": "The Journal of Legal Medicine", "publish_time": "2021", "aliases": []}
{"doc_id": 231583642, "title": "Aerosolized SARS-CoV-2 exposure assessment: dispersion modeling with AERMOD", "abstract": ["COVID-19 is now a pandemic and the knowledge gap on SARS-CoV-2, i.e., the COVID-19 disease agent, dispersion persists.", "The US Centers for Disease Control and Prevention suggests fomites may not be the main route through which the novel coronavirus spreads.", "Supporting the same view, the latest the World Health Organization report recommends wearing masks for every individual in public, highlighting the transmission through the air.", "In the current study AERMOD, one of the most validated and tested models suggested by the USEPA, is used to model SARS-CoV-2-laden PM10 in a hypothetical outdoor environment.", "Multiple scenarios including particle size, wind speed, source height variations as well as and combined scenarios were modeled to estimated how exposure risk changes with the above-mentioned variables.", "The results reveal that wind speed majorly narrows infectious plume rather than transferring the peak concentration.", "The particle size variation indicated that small particles, i.e.,0.01 - 2.5 \u00b5m, could reach more than 9 m away from the source in concentration range of 10 - 20 (\u00b5g/m 3).", "On the other hand, source height contributes to peak plume shift rather than dispersing the infected particles.", "This idea was further studies by using combined scenarios which indicated height difference can impact peak plume displacement rather than wind speed.", "In the worst-case scenario, the results indicate that the virus-laden particles can travel outdoors more than 8 m away from an infected source.", "The video output of the model results clearly shows the dynamic of viral peak shifts in several scenarios.", "The results also indicate that in specific conditions the airborne SARS-CoV-2 can be transported to 9 m away from the source.", "These findings can be useful for individuals as well as decision-makers to mitigated exposure risk in real-world conditions.", "Supplementary Information: The online version contains supplementary material available at 10.1007/s40201-020-00602-9."], "journal": "J Environ Health Sci Eng", "publish_time": "2021", "aliases": []}
{"doc_id": 235734457, "title": "Combined Effects of Masking and Distance on Aerosol Exposure Potential.", "abstract": ["OBJECTIVE To quantify the efficacy of masking and \"social distancing\" on the transmission of airborne particles from a phantom aerosol source (simulating an infected individual) to a nearby target (simulating a healthy bystander) in a well-controlled setting.", "METHODS An aerosol was created using monodisperse polystyrene latex beads in place of infectious respiratory secretions.", "Detection was by aerodynamic particle spectrometry.", "Both reusable cloth masks and disposable paper masks were studied.", "Transmission was simulated indoors during a 3-minute interval to eliminate the effect of variable ventilation rate on aerosol exposure.", "The study commenced on September 16, 2020, and concluded on December 15, 2020.", "RESULTS Compared with a baseline of 1-foot separation with no masks employed, particle count was reduced by 84% at 3 feet of separation and 97% at 6 feet.", "A modest decrease in particle count was observed when only the receiver was masked.", "The most substantial exposure reduction occurred when the aerosol source was masked (or both parties were masked).", "When both the source and target were masked, particle count was reduced by more than 99.5% of baseline, regardless of separation distance or which type of mask was employed.", "CONCLUSION These results support the principle of layered protection to mitigate transmission of SARS-CoV-2, the virus causing COVID-19, and other respiratory viruses and emphasize the importance of controlling the spread of aerosol at its source.", "The combination of masking and distancing reduced the exposure to exhaled particulates more than any individual measure.", "Combined measures remain the most effective way to combat the spread of respiratory infection."], "journal": "Mayo Clinic proceedings", "publish_time": "2021-07-01", "aliases": []}
{"doc_id": 232074219, "title": "Reducing COVID-19 Airborne Transmission Risks on Public Transportation Buses: An Empirical Study on Aerosol Dispersion and Control", "abstract": ["This study is one of the first COVID-19 related bus studies to fully characterize cough aerosol dispersion and control in the highly turbulent real-world environment of driving regular bus routes on both a school bus and a transit bus.", "While several other bus studies have been conducted, they were limited to clinical contact tracing, simulation, or partial characterization of aerosol transmission in the passenger areas with constraint conditions.", "When considering the risk of transmission of SARS-CoV-2 (COVID-19) and other highly infectious airborne diseases, ground based public transportation systems are high-risk environments for airborne transmission particularly since social distancing of six feet is not practical on most buses.", "This study demonstrates that wearing of masks reduced the overall particle count released into the bus by an average of 50% or more depending on mask quality and reduced the dispersion distance by several feet.", "The study also demonstrates an 84.36% reduction in aerosol particles and an 80.28% reduction in the mean aerosol residence time for some test cases.", "We conducted 84 experimental runs using nebulized 10% sodium chloride and a mechanical exhalation simulator that resulted in 78.3 million data points and 124 miles of on-the-road testing.", "Our study not only captures the dispersion patterns using 28 networked particle counters, as well as quantifies the effectiveness of using on-board fans, opening of various windows, use of face coverings or masks, and the use of the transit bus HVAC system.", "This work also provides empirical observations of aerosol dispersion in a real-world turbulent air environment, which are remarkably different than many existing fluid dynamics simulations, and also offers substantial discussion on the implications for inclement weather conditions, driver safety, retrofit applications to improve bus air quality, and operational considerations for public transportation organizations."], "journal": "", "publish_time": "2021-03-01", "aliases": []}
{"doc_id": 233024915, "title": "Simulating near-field enhancement in transmission of airborne viruses with a quadrature-based model", "abstract": ["Airborne viruses, such as influenza, tuberculosis, and SARS-CoV-2, are transmitted through virus-laden particles expelled when an infectious person sneezes, coughs, talks, or breathes.", "These virus-laden particles are more highly concentrated in the expiratory jet of an infectious person than in a well-mixed room, but this near-field enhancement in virion exposure has not been well quantified.", "Transmission of airborne viruses depends on factors that are inherently variable and, in many cases, poorly constrained, and quantifying this uncertainty requires large ensembles of model simulations that span the variability in input parameters.", "However, models that are well-suited to simulate the near-field evolution of respiratory particles are also computationally expensive, which limits the exploration of parametric uncertainty.", "In order to perform many simulations that span the wide variability in factors governing transmission, we developed the Quadrature-based model of Respiratory Aerosol and Droplets (QuaRAD).", "QuaRAD is an efficient framework for simulating the evolution of virus-laden particles after they are expelled from an infectious person, their deposition to the nasal cavity of a susceptible person, and the subsequent risk of initial infection.", "We simulated 10,000 scenarios to quantify the risk of initial infection by a particular virus, SARS-CoV-2.", "The predicted risk of infection was highly variable among scenarios and, in each scenario, was strongly enhanced near the infectious individual.", "In more than 50% of scenarios, the physical distancing needed to avoid near-field enhancements in airborne transmission was beyond the recommended safe distance of two meters (six feet) if the infectious person is not wearing a mask, though this distance defining the near-field extent was also highly variable among scenarios."], "journal": "", "publish_time": "2021-04-02", "aliases": []}
{"doc_id": 230548121, "title": "Aerosol Particles Generated by Coughing and Sneezing of a SARS-CoV-2 (COVID-19) Host Travel over 30 m Distance", "abstract": ["A fast-computational 3D model comprising fluid dynamics with heat transfer, mass transfer and diffusion of diluted species has been adapted and employed to evaluate dispersion of aerosol particles in various environments.", "Effects of convection flow, atmospheric diffusivity and humidity on evolution and travel distances of exhaled aerosol clouds by an infected person are modelled.", "The modelling clearly demonstrates how aerosol particle dispersion is influenced by weather and geometry of the environment.", "The results obtained demonstrate that aerosol particles of sizes from 10 mu m to 100 mu m that potentially can carry SARS-CoV-2 (COVID-19) viruses travel over 30 m in some atmospheric conditions.", "Modelling of the evolution of aerosol clouds generated by coughing and sneezing enables us to evaluate the deposition dose of aerosol particles in healthy individuals.", "In realistic weather scenarios viruses can be deposited in the respiratory tract of a healthy individual at up to 200 virus copies in several minutes A metric based on aerosol particle (volume) size distribution and the icrp lung deposition model is suggested."], "journal": "Aerosol and Air Quality Research", "publish_time": "2021", "aliases": []}
{"doc_id": 218642094, "title": "A Systems Approach to Assess Transport and Diffusion of Hazardous Airborne Particles in a Large Surgical Suite: Potential Impacts on Viral Airborne Transmission", "abstract": ["Airborne transmission of viruses, such as the coronavirus 2 (SARS-CoV-2), in hospital systems are under debate: it has been shown that transmission of SARS-CoV-2 virus goes beyond droplet dynamics that is limited to 3-6 feet, but it is unclear if the airborne viral load is significant enough to ensure transmission of the disease.", "Surgical smoke can act as a carrier for tissue particles, viruses, and bacteria.", "To quantify airborne transmission from a physical point of view, we consider surgical smoke produced by thermal destruction of tissue during the use of electrosurgical instruments as a marker of airborne particle diffusion-transportation.", "Surgical smoke plumes are also known to be dangerous for human health, especially to surgical staff who receive long-term exposure over the years.", "There are limited quantified metrics reported on long-term effects of surgical smoke on staff's health.", "The purpose of this paper is to provide a mathematical framework and experimental protocol to assess the transport and diffusion of hazardous airborne particles in every large operating room suite.", "Measurements from a network of air quality sensors gathered during a clinical study provide validation for the main part of the model.", "Overall, the model estimates staff exposure to airborne contamination from surgical smoke and biological material.", "To address the clinical implication over a long period of time, the systems approach is built upon previous work on multi-scale modeling of surgical flow in a large operating room suite and takes into account human behavior factors."], "journal": "", "publish_time": "2020-05-15", "aliases": []}
{"doc_id": 218647339, "title": "High SARS-CoV-2 Attack Rate Following Exposure at a Choir Practice - Skagit County, Washington, March 2020", "abstract": ["On March 17, 2020, a member of a Skagit County, Washington, choir informed Skagit County Public Health (SCPH) that several members of the 122-member choir had become ill. Three persons, two from Skagit County and one from another area, had test results positive for SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19).", "Another 25 persons had compatible symptoms.", "SCPH obtained the choir's member list and began an investigation on March 18.", "Among 61 persons who attended a March 10 choir practice at which one person was known to be symptomatic, 53 cases were identified, including 33 confirmed and 20 probable cases (secondary attack rates of 53.3% among confirmed cases and 86.7% among all cases).", "Three of the 53 persons who became ill were hospitalized (5.7%), and two died (3.7%).", "The 2.5-hour singing practice provided several opportunities for droplet and fomite transmission, including members sitting close to one another, sharing snacks, and stacking chairs at the end of the practice.", "The act of singing, itself, might have contributed to transmission through emission of aerosols, which is affected by loudness of vocalization (1).", "Certain persons, known as superemitters, who release more aerosol particles during speech than do their peers, might have contributed to this and previously reported COVID-19 superspreading events (2-5).", "These data demonstrate the high transmissibility of SARS-CoV-2 and the possibility of superemitters contributing to broad transmission in certain unique activities and circumstances.", "It is recommended that persons avoid face-to-face contact with others, not gather in groups, avoid crowded places, maintain physical distancing of at least 6 feet to reduce transmission, and wear cloth face coverings in public settings where other social distancing measures are difficult to maintain."], "journal": "MMWR Morb Mortal Wkly Rep", "publish_time": "2020", "aliases": []}
{"doc_id": 239991372, "title": "Evaluation of Residual Infectivity after SARS-CoV-2 Aerosol Transmission in a Controlled Laboratory Setting", "abstract": ["Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is mainly transmitted through respiratory droplets, aerosols, or direct contact with fomites from an infected subject.", "It has been reported that SARS-CoV-2 is stable and viable in aerosol up to 16 h in controlled laboratory conditions.", "However, the aerosolization conditions varied a lot between the studies.", "In this work, an experimental laboratory model of SARS-CoV-2 aerosolization was established, employing an impinger nebulizer, a cylindrical chamber for aerosol travel, and a SKC biosampler for the collection of particles.", "The efficiency of the system was assessed based on the molecular determination of the viral load in the nebulizer after the aerosolization and in the aerosol collected at the end of the travel.", "Moreover, the residual infectivity was tested in vitro on the Vero E6 cell line, through the observation of the cytopathic effect (CPE), and the quantification of the viral load in the supernatants at 7 days post inoculation (dpi).", "A high RNA viral load was found in the SKC biosampler after aerosolization, indicating that it was possible to transport a high virus titer through the 30-cm chamber with all the dilutions (initial 10(5), 10(4), 10(3) plaque forming unit\u2014PFU/mL).", "At the 7 dpi, an increment of the RNA viral load was determined for the dilutions 10(5) and 10(4) PFU/mL tested, while only the initial 10(5) PFU/mL resulted in visible CPE.", "Our findings allowed us to achieve the resilience of SARS-CoV-2 in aerosol form, at a concentration comparable to those reported for clinical samples.", "This mode of transmission should be considered for the mitigation and preventive measures to counteract SARS-CoV-2 spreading."], "journal": "Int J Environ Res Public Health", "publish_time": "2021-10-24", "aliases": []}
{"doc_id": 220521194, "title": "Air filtration and SARS-CoV-2", "abstract": ["Air filtration in various implementations has become a critical intervention in managing the spread of coronavirus disease 2019 (COVID-19).", "However, the proper deployment of air filtration has been hampered by an insufficient understanding of its principles.", "These misconceptions have led to uncertainty about the effectiveness of air filtration at arresting potentially infectious aerosol particles.", "A correct understanding of how air filtration works is critical for further decision-making regarding its use in managing the spread of COVID-19.", "The issue is significant because recent evidence has shown that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can remain airborne longer and travel farther than anticipated earlier in the COVID-19 pandemic, albeit with diminishing concentrations and viability.", "While SARS-CoV-2 virions are around 60-140 nm in diameter, larger respiratory droplets and air pollution particles (>1 \u00b5m) have been found to harbor the virions.", "Removing particles that could carry SARS-CoV-2 from the air is possible using air filtration, which relies on the natural or mechanical movement of air.", "Among various types of air filters, high-efficiency particle arrestance (HEPA) filters have been recommended.", "Other types of filters are less or more effective and, correspondingly, are easier or harder to move air through.", "The use of masks, respirators, air filtration modules, and other dedicated equipment is an essential intervention in the management of COVID-19 spread.", "It is critical to consider the mechanisms of air filtration and to understand how aerosol particles containing SARS-CoV-2 virions interact with filter materials to determine the best practices for the use of air filtration to reduce the spread of COVID-19."], "journal": "Epidemiol Health", "publish_time": "2020-07-04", "aliases": [225584688]}
{"doc_id": 220633659, "title": "The Infectious Nature of Patient-Generated SARS-CoV-2 Aerosol", "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission causing coronavirus disease 2019 (COVID-19) may occur through multiple routes.", "We collected aerosol samples around six patients admitted into mixed acuity wards in April of 2020 to identify the risk of airborne SARS-CoV-2.", "Measurements were made to characterize the size distribution of aerosol particles, and size-fractionated, aerosol samples were collected to assess the presence of infectious virus in particles sizes of >4.1 m, 1-4 m, and <1 m in the patient environment.", "Samples were analyzed by real-time reverse-transcriptase polymerase chain reaction (rRT-PCR), cell culture, western blot, and transmission electron microscopy (TEM).", "SARS-CoV-2 RNA was detected in all six rooms in all particle size fractions (>4.1 m, 1-4 m, and <1 m).", "Increases in viral RNA during cell culture of the virus from recovered aerosol samples demonstrated the presence of infectious, replicating virions in three <1 m aerosol samples (P<0.05).", "Viral replication of aerosol was also observed in the 1-4 m stage but did not reach statistical significance (0.05<P<0.10).", "Western blot and TEM analysis of these samples also showed evidence of viral proteins and intact virions.", "The infectious nature of aerosol collected in this study further suggests that airborne transmission of COVID-19 is possible, and that aerosol prevention measures are necessary to effectively stem the spread of SARS-CoV-2."], "journal": "", "publish_time": "2020-07-20", "aliases": []}
{"doc_id": 235700769, "title": "Comparison of the Filtration Efficiency of Different Face Masks Against Aerosols", "abstract": ["Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic can spread through virus-containing aerosols ( \u2264 5 \u03bcm) and larger airborne droplets.", "Quantifying filtration efficiency of different kinds of masks and linings for aerosols that fall within the most penetrating particle size (80-400 nm) is critical to limiting viral transmission.", "The objective of our experiment was to compare the \u201creal-world\u201d filtering efficiency of different face masks for fine aerosols (350 nm) in laboratory simulations.", "Methods: We performed a simulated bench test that measured the filtering efficiency of N95 vs. N99 masks with elastomeric lining in relation to baseline (\u201cbackground\u201d) aerosol generation.", "A mannequin head was placed within a chamber and was attached to an artificial lung simulator.", "Particles of known size (350 \u00b1 6 nm aerodynamic diameter) were aerosolized into the chamber while simulating breathing at physiological settings of tidal volume, respiratory rate, and airflow.", "Particle counts were measured between the mannequin head and the lung simulator at the tracheal airway location.", "Results: Baseline particle counts without a filter (background) were 2,935 \u00b1 555 (SD) cm(\u22123), while the N95 (1348 \u00b1 92 cm(\u22123)) and N99 mask with elastomeric lining (279 \u00b1 164 cm(\u22123); p <0.0001) exhibit lower counts due to filtration.", "Conclusion: The filtration efficiency of the N95 (54.1%) and N99 (90.5%) masks were lower than the filtration efficiency rating.", "N99 masks with elastomeric lining exhibit greater filtration efficiency than N95 masks without elastomeric lining and may be preferred to contain the spread of SARS-CoV-2 infection."], "journal": "Front Med (Lausanne)", "publish_time": "2021-07-02", "aliases": []}
{"doc_id": 220908386, "title": "Thoracic imaging in COVID-19", "abstract": ["The typical findings of COVID-19 on chest radiography and computed tomography (CT) include bilateral, multifocal parenchymal opacities (ground-glass opacities with or without consolidation, and \"crazy paving\").", "In most cases, the opacities are predominantly in the peripheral and lower lung zones, and several have rounded morphology.", "However, these imaging findings are not pathognomonic for COVID-19 pneumonia and can be seen in other viral and bacterial infections, as well as with noninfectious causes such as drug toxicity and connective tissue disease.", "Most radiology professional organizations and societies recommend against routine screening CT to diagnose or exclude COVID-19."], "journal": "Cleve Clin J Med", "publish_time": "2020", "aliases": []}
{"doc_id": 221796236, "title": "Chest Computed Tomography findings in patients with Corona Virus disease 2019 (COVID-19): An Initial Experience in three Centres in Ghana, West Africa", "abstract": ["Background Radiological examinations have a significant role in the diagnosis and management of Coronavirus disease 2019 (COVID-19),the disease caused by the novel coronavirus SARS-CoV-2.", "Many COVID-19 patients show typical Chest Computed Tomography (CT Scan) features which can aid in the diagnoses and triaging of such patients.", "This is especially so in resource-limited settings where access to molecular diagnostic techniques such as Reverse Transcription Polymerase Chain Reaction (RT-PCR) is not optimal.", "We report chest CT findings in 28 patients diagnosed with COVID-19 in Ghana.", "Objective To document common chest CT scan findings amongst patients with COVID-19 infection in Ghana.", "Method Chest CT scans of twenty-eight COVID-19 patients (n=28) were retrieved and reviewed independently by 2 experienced radiologists and their findings documented.", "Two 64 and one 32 slice spiral CT scanners were used at three centres.", "Results Chest CT Images from 16 males(57.1.7%) and 12 females(42.9%) patients aged between 36 and 65 years with mean age of 55.9 years (SD-8.4years) were evaluated.", "Of these, 21 (75.0%) of them were COVID-19 patients who were undiagnosed at the time of imaging while 7(25.0%) were known confirmed COVID-19 patients.", "On the chest CT scans (n=28), 17(66.7%) patients showed predominantly ground glass opacities while 12(42.9%) had evidence of consolidation predominantly.", "In 26(92.9%) of the patients, the opacities were bilateral and peripheral in distribution.", "None of these patients had pleural effusion.", "Conclusion COVID-19 patients tend to manifest typical imaging features on chest CT scan .", "The most common chest imaging finding was bilateral, peripheral and predominantly basal ground glass opacities.", "Importantly, these findings were frequently obtained before PCR diagnosis.", "Chest CT scan can help in the diagnosis and triaging of suspected or confirmed COVID-19 patients in jurisdictions with limited PCR diagnostic capacity and can improve early isolation, contact tracing and treatment thus helping to reduce community spread, morbidity and mortality."], "journal": "J Med Imaging Radiat Sci", "publish_time": "2020-09-19", "aliases": []}
{"doc_id": 212941895, "title": "CT image of novel coronavirus pneumonia: a case report", "abstract": ["OBJECTIVE: Knowledge of CT characteristics of COVID-19 pneumonia might be helpful to the early diagnosis and treatment of patients, and to control the spread of infection.", "METHODS: The chest CT images of the patient were collected to describe the CT manifestations and characteristics, and they were compared with the previous studies.", "RESULTS: Multiple patchy ground-glass opacities (GGOs) were seen in bilateral lung, mostly in subpleural areas.", "They progressed within 3 days, and nodular GGOs were also seen together with subpleural patchy GGOs.", "CONCLUSION: Our case of COVID-19 pneumonia showed multiple subpleural GGOs in bilateral lung, rapid progression, and it also accompanied nodular GGOs on chest CT.", "These findings were consistent with the previous reports, and they might be useful for early detection and evaluation of severity of COVID-19 pneumonia."], "journal": "Jpn J Radiol", "publish_time": "2020", "aliases": []}
{"doc_id": 213556006, "title": "Imaging Profile of the COVID-19 Infection: Radiologic Findings and Literature Review", "abstract": ["PURPOSE: To present the findings of 21 coronavirus disease 2019 (COVID-19) cases from two chinese centers with ct and chest radiographic findings, as well as follow-up imaging in five cases materials and methods: This was a retrospective study in shenzhen and hong kong.", "Patients with COVID-19 infection were included A systematic review of the published literature on radiologic features of COVID-19 infection was conducted RESULTS: The predominant imaging pattern was of ground-glass opacification with occasional consolidation in the peripheries.", "Pleural effusions and lymphadenopathy were absent in all cases patients demonstrated evolution of the ground-glass opacities into consolidation and subsequent resolution of the airspace changes.", "Ground-glass and consolidative opacities visible on CT are sometimes undetectable on chest radiography, suggesting that ct is a more sensitive imaging modality for investigation.", "The systematic review identified four other studies confirming the findings of bilateral and peripheral ground glass with or without consolidation as the predominant finding at ct chest examinations CONCLUSION: Pulmonary manifestation of COVID-19 infection is predominantly characterized by ground-glass opacification with occasional consolidation on ct radiographic findings in patients presenting in shenzhen and hong kong are in keeping with four previous publications from other sites \u00a9 rsna, 2020See editorial by kay and abbara in this issue."], "journal": "Radiol Cardiothorac Imaging", "publish_time": "2020", "aliases": []}
{"doc_id": 215759868, "title": "[Diagnostic imaging findings in COVID-19]", "abstract": ["This is a review of diagnostic imaging findings in coronavirus disease-2019 (COVID-19).", "CT findings are frequently bilateral, multilobar and peripheral ground-glass opacities with vascular enlargements.", "Consolidations often appear during progression as well as crazy paving and reticulation.", "Lymphadenopathy, pleural effusions and pneumothorax are rare and should raise concern for other disease.", "Initially the CT can be normal, and the diagnostic performance for COVID-19 is not optimal.", "However, findings of characteristic ground-glass opacities during the ongoing epidemic should lead to considerations, that the patient may have COVID-19."], "journal": "Ugeskr. laeg", "publish_time": "2020", "aliases": []}
{"doc_id": 218618251, "title": "[Ichthyosis vulgaris].", "abstract": ["This is a review of diagnostic imaging findings in coronavirus disease-2019 (COVID-19).", "CT findings are frequently bilateral, multilobar and peripheral ground-glass opacities with vascular enlargements.", "Consolidations often appear during progression as well as crazy paving and reticulation.", "Lymphadenopathy, pleural effusions and pneumothorax are rare and should raise concern for other disease.", "Initially the CT can be normal, and the diagnostic performance for COVID-19 is not optimal.", "However, findings of characteristic ground-glass opacities during the ongoing epidemic should lead to considerations, that the patient may have COVID-19."], "journal": "Ugeskrift for laeger", "publish_time": "2020-04-20", "aliases": []}
{"doc_id": 220846145, "title": "Computed Tomography (CT) Imaging Features of Patients with COVID-19: Systematic Review and Meta-Analysis", "abstract": ["Introduction.", "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious disease, and its first outbreak was reported in Wuhan, China.", "A coronavirus disease (COVID-19) causes severe respiratory distress (ARDS).", "Due to the primary involvement of the respiratory system, chest CT is strongly recommended in suspected COVID-19 cases, for both initial evaluation and follow-up.", "Objective.", "The aim of this review was to systematically analyze the existing literature on CT imaging features of patients with COVID-19 pneumonia.", "Methods.", "A systematic search was conducted on PubMed, Embase, Cochrane Library, Open Access Journals (OAJ), and Google Scholar databases until April 15, 2020.", "All articles with a report of CT findings in COVID-19 patients published in English from the onset of COVID-19 outbreak to April 20, 2020, were included in the study.", "Result.", "From a total of 5041 COVID-19-infected patients, about 98% (4940/5041) had abnormalities in chest CT, while about 2% have normal chest CT findings.", "Among COVID-19 patients with abnormal chest CT findings, 80% (3952/4940) had bilateral lung involvement.", "Ground-glass opacity (GGO) and mixed GGO with consolidation were observed in 2482 (65%) and 768 (18%) patients, respectively.", "Consolidations were detected in 1259 (22%) patients with COVID-19 pneumonia.", "CT images also showed interlobular septal thickening in about 691 (27%) patients.", "Conclusion.", "Frequent involvement of bilateral lung infections, ground-glass opacities, consolidation, crazy paving pattern, air bronchogram signs, and intralobular septal thickening were common CT imaging features of patients with COVID-19 pneumonia."], "journal": "Radiol. Res. Pract.", "publish_time": "2020", "aliases": []}
{"doc_id": 218989144, "title": "CT in coronavirus disease 2019 (COVID-19): a systematic review of chest CT findings in 4410 adult patients", "abstract": ["OBJECTIVE: The objective of this systematic review was to evaluate the key imaging manifestations of COVID-19 on chest CT in adult patients by providing a comprehensive review of the published literature.", "METHODS: We performed a systematic literature search from the PubMed, Google Scholar, Embase, and WHO databases for studies mentioning the chest CT imaging findings of adult COVID-19 patients.", "RESULTS: A total of 45 studies comprising 4410 patients were included.", "Ground glass opacities (GGO), in isolation (50.2%) or coexisting with consolidations (44.2%), were the most common lesions.", "Distribution of GGOs was most commonly bilateral, peripheral/subpleural, and posterior with predilection for lower lobes.", "Common ancillary findings included pulmonary vascular enlargement (64%), intralobular septal thickening (60%), adjacent pleural thickening (41.7%), air bronchograms (41.2%), subpleural lines, crazy paving, bronchus distortion, bronchiectasis, and interlobular septal thickening.", "CT in early follow-up period generally showed an increase in size, number, and density of GGOs, with progression into mixed areas of GGOs plus consolidations and crazy paving, peaking at 10\u201311 days, before gradually resolving or persisting as patchy fibrosis.", "While younger adults more commonly had GGOs, extensive/multilobar involvement with consolidations was prevalent in the older population and those with severe disease.", "CONCLUSION: This review describes the imaging features for diagnosis, stratification, and follow-up of COVID-19 patients.", "The most common CT manifestations are bilateral, peripheral/subpleural, posterior GGOs with or without consolidations with a lower lobe predominance.", "It is pertinent to be familiar with the various imaging findings to positively impact the management of these patients.", "KEY POINTS: \u2022 Ground glass opacities (GGOs), whether isolated or coexisting with consolidations, in bilateral and subpleural distribution, are the most prevalent chest CT findings in adult COVID-19 patients.", "\u2022 Follow-up CT shows a progression of GGOs into a mixed pattern, reaching a peak at 10\u201311 days, before gradually resolving or persisting as patchy fibrosis.", "\u2022 Younger people tend to have more GGOs.", "Older or sicker people tend to have more extensive involvement with consolidations.", "ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00330-020-06975-7) contains supplementary material, which is available to authorized users."], "journal": "Eur Radiol", "publish_time": "2020-05-30", "aliases": []}
{"doc_id": 233909941, "title": "Characteristics of chest high resolution computed tomography images of COVID-19: A retrospective study of 46 patients", "abstract": ["objective: To analyze the characteristics of chest high resolution computed tomography (CT) images of coronavirus disease 2019 (COVID-19) Methods: This is a retrospective study analyzing the clinical records and chest high-resolution CT images of 46 consecutive patients who were diagnosed with COVID-19 by nucleic acid tests and treated at our hospitals between January 2020 and February 2020 Results: Abnormalities in the ct images were found in 44 patients (95 6%) The lesions were unilateral in eight patients (17 4%), bilateral in 36 patients (78 3%), single in seven patients (15 9%), and multiple in 37 patients (84 1%) The morphology of the lesions was scattered opacity in 10 patients (21 7%), patchy opacity in 38 patients (82 6%), fibrotic cord in 17 patients (37 0%), and wedge-shaped opacity in two patients (4 3%) The lesions can be classified as ground-glass opacity in eight patients (17 4%), consolidation in one patient (2 2%), and ground-glass opacity plus consolidation in 28 patients (60 9%) Conclusion: Most COVID-19 patients showed abnormalities in chest CT images and the most common findings were ground-glass opacity plus consolidation."], "journal": "Pakistan Journal of Medical Sciences", "publish_time": "2021", "aliases": []}
{"doc_id": 230567723, "title": "X-ray patterns of COVID-19 in patients presenting to Lady Reading Hospital, Peshawar, Pakistan", "abstract": ["OBJECTIVE: To determine the pattern of COVID-19 on chest radiograph in patients presenting to Lady Reading Hospital, Peshawar, Pakistan.", "METHODS: This prospective observational study was conducted on 178 consecutive swab positive COVID-19 patients presenting to Lady Reading Hospital, Peshawar, Pakistan from 15(th) March to 15(th) June 2020.", "Patients of all ages and both genders were included.", "Chest X-rays performed by portable radiography unit were viewed for different patterns by two consultant radiologists independently and results were analyzed using IBM SPSS 20.", "RESULTS: Out of 178 patients 134 were male.", "Mean age was 55.67 years.", "Radiographic patterns observed were ground glass haze without or with reticulation and/or consolidation (45.5 % and 33.2% respectively) and predominant consolidation either alone or in combination with ground glass haze or other findings (27.1% collectively).", "Peripheral distribution pattern was seen in 69.1% of patients with bilateral findings in 84.3%.", "Further categorization was based on pulmonary zonal demarcation with changes most commonly involving four zones (33.1%) i.e., the lower and mid zones bilaterally.", "CONCLUSION: Portable chest radiography is an essential supporting tool for assessing different patterns in COVID-19 infection.", "The most common pattern observed is alveolar opacities with predominant peripheral distribution either unilateral or more frequently bilateral, starting from the lower and mid zones extending to the upper zones and becoming diffuse with disease progression."], "journal": "Pak J Med Sci", "publish_time": "2021", "aliases": []}
{"doc_id": 221051153, "title": "Predictors of coronavirus disease 19 (COVID-19) pneumonitis outcome based on computed tomography (CT) imaging obtained prior to hospitalization: a retrospective study", "abstract": ["PURPOSE: Computed tomography (CT) has been utilized as a diagnostic modality in the coronavirus disease 19 (COVID-19), while some studies have also suggested a prognostic role for it.", "This study aimed to assess the diagnostic and prognostic value of computed tomography (CT) imaging in COVID-19 patients.", "METHODS: This was a retrospective study of fifty patients with COVID-19 pneumonia.", "Twenty-seven patients survived, while 23 passed away.", "CT imaging was performed in all of the patients on the day of admission.", "Imaging findings were interpreted based on current guidelines by two expert radiologists.", "Imaging findings were compared between surviving and deceased patients.", "Lung scores were assigned to patients based on CT chest findings.", "Then, the receiver operating characteristic curve was used to determine cutoff values for lung scores.", "RESULTS: The common radiologic findings were ground-glass opacities (82%) and airspace consolidation (42%), respectively.", "Air bronchogram was more commonly seen in deceased patients (p = 0.04).", "Bilateral and multilobar involvement was more frequently found in deceased patients (p = 0.049 and 0.014, respectively).", "The mean number of involved lobes was 3.46 \u00b1 1.80 lobes in surviving patients and 4.57 \u00b1 0.60 lobes in the deceased patients (p = 0.009).", "The difference was statistically significant.", "The area under the curve for a lung score cutoff of 12 was 0.790.", "CONCLUSION: Air bronchogram and bilateral and multilobar involvement were more frequently seen in deceased patients and may suggest a poor outcome for COVID-19 pneumonia."], "journal": "Emerg Radiol", "publish_time": "2020-08-08", "aliases": []}
{"doc_id": 238412046, "title": "Chest imaging findings in COVID\u201019\u2010positive patients in an Australian tertiary hospital", "abstract": ["INTRODUCTION: Coronavirus disease 2019 (COVID\u201019) has infected over 215 million individuals worldwide.", "Chest radiographs (CXR) and computed tomography (CT) have assisted with diagnosis and assessment of COVID\u201019.", "Previous reports have described peripheral and lower zone predominant opacities on chest radiographs.", "Whilst the most common patterns on CT are bilateral, peripheral basal predominant ground glass opacities (Wong et al., Radiology, 296, 2020, E72; Karimian and Azami, Pol J Radiol, 86, 2021, e31).", "This study describes the imaging findings in an Australian tertiary hospital population.", "METHODS: COVID\u2010PCR\u2010positive patients who had chest imaging (CXR, CT and ventilation perfusion (V/Q) scans) from January 2020 to August 2020 were included.", "Distribution, location and pattern of involvement was recorded.", "Evaluation of the assessors was performed using Fleiss Kappa calculations for review of radiographic findings and qualitative analysis of CT findings.", "RESULTS: A total of 681 studies (616 CXRs, 59 CTs, 6 V/Q) from 181 patients were reviewed.", "The most common chest radiograph finding was bilateral lower lobe predominant diffuse opacification and most common CT pattern being ground glass opacities.", "Of the CT imaging, 33 were CT Pulmonary Angiograms of which five demonstrated acute pulmonary emboli.", "There was good inter\u2010rater agreement between radiologists in assessment of imaging appearances on CXR (kappa 0.29\u20130.73) and CT studies.", "CONCLUSION: A review of imaging in an Australian tertiary hospital demonstrates similar patterns of COVID\u201019 infection on chest X\u2010ray and CT imaging when compared to the international population."], "journal": "J Med Imaging Radiat Oncol", "publish_time": "2021-10-05", "aliases": []}
{"doc_id": 238748271, "title": "Chest X-ray Findings and Temporal Changes Among Adult Patients with COVID-19 Admitted in a Tertiary Referral Center", "abstract": ["PURPOSE: To describe the radiographic findings of hospitalized adult Filipino COVID-19 patients on serial chest x-ray imaging.", "METHOD: We performed a retrospective review of records and chest x-rays of eligible adult Filipinos with confirmed COVID-19 admitted from 1 March 2020 to 31 July 2020.", "Demographics, clinical outcomes, and chest radiographic findings were recorded.", "Serial chest x-ray findings were correlated with the clinical outcome.", "RESULTS: From 144 adult patients (93 males and 51 females), a total of 785 chest x-rays were reviewed (144 baseline and 641 follow-up).", "The most common finding overall is ground-glass opacity.", "The most common distribution pattern is bilateral, patchy/diffuse involvement of the central/peripheral zones.", "In x-rays taken after the third admission day, reticular opacities become more common than consolidation.", "The radiographic extent score was higher for deceased patients compared to the survivors at Day 7-9 (6 vs 4.4, p-value = 0.0011), Day 10-12 (5.9 vs 4.3, p-value = 0.0079) and Day 13-15 (5.5 vs 4.1, p-value = 0.0297).", "The presence of endotracheal tubes (68% vs 7.5%, p-value < 0.001) and pleural effusion (70% vs. 36%, p-value = 0.0004) were higher among the deceased.", "Reticular opacities were more common for discharged patients (50% vs 30%, p-value = 0.0021).", "CONCLUSION: Ground-glass opacities with bilateral, patchy/diffuse involvement of the central/peripheral zones are the most common findings.", "The presence of endotracheal intubation, pleural effusion, and persistently elevated radiographic extent scores are typically seen in deceased patients.", "Serial chest radiography with radiographic extent scoring is a useful tool in monitoring COVID-19 for hospitalized adult patients."], "journal": "Eur J Radiol Open", "publish_time": "2021-10-14", "aliases": []}
{"doc_id": 221294651, "title": "Positive Chest CT Features in Patients With COVID-19 Pneumonia and Negative Real-Time Polymerase Chain Reaction Test", "abstract": ["Objectives Clinically suspicious novel coronavirus (COVID-19) lung pneumonia can be observed typically on computed tomography (CT) chest scans even in patients with a negative real-time polymerase chain reaction (RT-PCR) test.", "The purpose of the study was to describe the CT imaging findings of five patients with negative RT-PCR results on initial and repeated testing but a high radiological suspicion of COVID-19 pneumonia.", "Methods Out of 19 clinically and/or radiologically diagnosed COVID-19 patients from our institution, five patients were selected for our study who had typical findings of COVID-19 on CT scan despite two negative RT-PCR results.", "Two district general hospital radiologists reviewed the chest CT images without prior knowledge of the RT-PCR test results.", "Scans were analyzed for the density of opacification and the distribution of disease.", "Results Out of 19 patients, five (26%) had initial negative RT-PCR test findings but positive CT chest features consistent with COVID-19.", "All patients had typical CT imaging findings of COVID-19.", "These included one patient with purely ground-glass opacities (GGO) and four patients with mixed GGO and consolidation.", "The typical distribution of parenchymal involvement was bilateral, posterior, and peripheral.", "Of the five patients with negative RT-PCR and positive CT findings, the range of CT severity score was 5 to 14.", "The median score, seen in three patients, was a score of 5, which corresponded to mild disease.", "One patient had a score of 8, corresponding to moderate disease, and one patient had severe disease with a score of 14.", "Conclusion Lung parenchymal changes related to COVID-19 can be seen on chest CT clearly despite repeated RT-PCR negative results."], "journal": "Cureus", "publish_time": "2020-08-22", "aliases": []}
{"doc_id": 222135282, "title": "Imaging Features of Pediatric COVID-19 on Chest Radiography and Chest CT: A Retrospective, Single-Center Study", "abstract": ["RATIONALE AND OBJECTIVES: This study aims to reveal the imaging features of Coronavirus Disease 2019 (COVID-19) in children.", "MATERIALS AND METHODS: Sixty-nine chest radiographs and 37 chest CT examinations of 74 children (36 male; median (interquartile range) age:11 (6.25-15) years, 38 female; median (interquartile range) age: 12 (5.75-16) years) with positive real-time reverse transcription-polymerase chain reaction results between March 10 and May 31, 2020, were evaluated in this retrospective study.", "Differences in 0-<6, 6-<12, and 12-18 years of age groups were assessed with the Fisher's exact test or Kruskal-Wallis tests.", "RESULTS: Right-sided (3/69, 4.3%) or bilateral (3/69, 4.3%) ground-glass opacities without significant difference in age groups were depicted as radiographic findings related to COVID-19 in children.", "Opacities were either single (7/37, 18.9%) or bilateral (7/37, 18.9%) around the distal third of the bronchovascular bundle on CT.", "There was no significant difference in the median size of the largest opacities, total numbers of opacities and involved lobes, and the distance of the closest opacity to the pleura among age groups (p > 0.05).", "The rate of ground-glass opacities with or without consolidation (17/37, 45.94%) was higher than consolidation alone (6/37, 16.2%).", "Feeding vessel sign (16/37, 43.2%), halo sign (9/37, 24.3%), pleural thickening (6/37, 16.2%), interlobular interstitial thickening (5/37, 13.5%), and lymphadenopathy (3/37, 8.1%) were other imaging findings.", "CONCLUSION: Unilateral or bilateral distributed ground-glass opacities often associated with feeding vessel sign, halo sign, and pleural thickening on chest CT without significant differences between age groups were findings of COVID-19 in children."], "journal": "Acad. radiol", "publish_time": "2020", "aliases": []}
{"doc_id": 235467034, "title": "Chest CT performance and features of COVID-19 in the region of Abu Dhabi, UAE: a single institute study", "abstract": ["Objective: We aim to investigate high-resolution CT features of COVID-19 infection in Abu Dhabi, UAE, and to compare the diagnostic performance of CT scan with RT-PCR test.", "Methods: Data of consecutive patients who were suspected to have COVID-19 infection and presented to our hospital were collected from March 2, 2020, until April 12, 2020.", "All patients underwent RT-PCR test; out of which 53.8% had chest CT scan done.", "Using RT-PCR as a standard reference, the sensitivity and specificity of the CT scan were calculated.", "We also analyzed the most common imaging findings in patients with positive RT-PCR results.", "Results: The typical HRCT findings were seen in 50 scans (65.8%) out of total positive ones; 44 (77.2%) with positive RT-PCR results and 6 (31.6%) with negative results.", "The peripheral disease distribution was seen in 86%, multilobe involvement in 70%, bilateral in 82%, and posterior in 82% of the 50 scans.", "The ground glass opacities were seen in 50/74 (89.3%) of the positive RT-PCR group.", "The recognized GGO patterns in these scans were: rounded 50%, linear 38%, and crazy-paving 24%.", "Using RT-PCR as a standard of reference, chest HRCT scan revealed a sensitivity of 68.8% and specificity of 70%.", "Conclusion: The commonest HRCT findings in patients with COVID-19 pneumonia were peripheral, posterior, bilateral, multilobe rounded ground-glass opacities.", "The performance of HRCT scan can vary depending on multiple factors."], "journal": "Chin J Acad Radiol", "publish_time": "2021", "aliases": [226963837]}
{"doc_id": 233421753, "title": "Ct in patients with covid-19: Imaging patterns, disease extent and evolution;our experience in a Greek reference university hospital", "abstract": ["purpose: To present our experience from a large greek reference university hospital regarding the imaging patterns, severity and evolution of disease, in patients hospitalised with laboratory-confirmed COVID-19 infection.", "Material and methods: 79 consecutive reverse transcription polymerase chain reaction (RT-PCR) confirmed COVID-19 infected patients undergoing chest CT at our hospital between 03/03/2020 and 10/05/2020 were included in the study.", "All initial scans were evaluated for the presence of various imaging findings and their distribution, as well as for disease extent/severity using the covid visual assessment scale.", "Follow-up CTs acquired in 14 of these patients were also examined in order to estimate disease evolution.", "Results: The most typical imaging findings were bilateral (86%), multilobar (92 4%) ground glass opacities (ggos) \u00b1 consolidations (89 9%), ggos with concomitant intralobular or interlobular thickening (crazy paving pattern) (53 1%) and subpleural line (s) /band (s) (55 7%), most often distributed peripherally (77 2%), posteriorly (55 7%) and in the lower zones (49 4%) common findings included bronchial wall thickening (39 2%), bronchial dilatation (40 5%), vascular enlargement (46 8%), pleural thickening (32 9%) and air bronchogram (s) (29 1%) less common findings were lymphadenopathy (25 3%), pleural effusion (s) (19%) and nodule (s) (20 2%) Most patients suffered from a mild (& lt; 25%) to moderate (& lt; 50%) imaging extent of disease.", "Increase in extent of disease was seen in 10/14 (71 4%) patients, with increase of both consolidations and ggos seen in 8/10 (80%) of these patients.", "Conclusions: Our findings further confirm formerly published radiological patterns of COVID-19 pneumonia and raise awareness regarding the prevalence of subtler findings such as the frequently occurring subpleural line (s) /band (s) more often noted in this study than previously described further research is necessary in order to detect a possible connection between certain imaging findings, clinical status, disease severity and outcome \u00a9 2021, zita medical.", "Managent.", "All rights reserved."], "journal": "Hellenic Journal of Radiology", "publish_time": "2021", "aliases": []}
{"doc_id": 225693041, "title": "Spectrum of ground-glass opacities in chest CT of COVID-19 patients in Karbala", "abstract": ["objective.", "To describe the ground-glass opacities (ggo) seen in chest CT scans of COVID-19 patients and to estimate the association between these opacities and the time of clinical presentation.", "Methods A cross-sectional study involving 81 COVID-19 confirmed patients in imam.", "Al-Hussein.", "Medical city in Karbala-Iraq during the period from March 1 to April 20, 2020 chest ct scan findings were evaluated by two radiologists and categorized accordingly.", "Chi-square test was used for statistical analysis and a p-value of less than 0 05 was considered statistically significant.", "Results.", "The mean age +/- standard deviation of patients was 53 5 +/- 17 1 years, with male predominance as 63 (77 8%) of cases were males.", "Nearly half of the patients were presented within the second week of starting the sign and symptoms ggo was present in 79 scans (97 5%), followed by consolidation opacity in 29 patients (35 8%) Four types of ggo were described bilateral multiple subpleural ggo was the most prevalent type.", "There was a significant association between late time of patient presentation and more extensive ggo type conclusion chest CT scan is valuable in diagnosis and management of COVID-19 cases.", "The presence of ggo in ct scan of a patient that previously had no chest illness is highly suggestive of COVID-19 disease, different types of ggo were seen bilateral confluent type of ggo is associated with more serious and delayed status and warns the need for intensive care unit admission."], "journal": "Journal of Contemporary Medical Sciences", "publish_time": "2020", "aliases": []}
{"doc_id": 221345436, "title": "COVID-19 variant radiological findings with high lightening other coronavirus family (SARS and MERS) findings: radiological impact and findings spectrum of corona virus (COVID-19) with comparison to SARS and MERS", "abstract": ["BACKGROUND: Chest CT is remarkably considered as an imminent diagnostic tool and follow-up study in pulmonary changes in COVID-19 patients; being familiar to other coronavirus family CT findings, this improve our diagnostic experience and hence enhance our ability to early diagnose and combat the outbreak of COVID-19.", "The purpose is to investigate the wide spectrum of radiological pulmonary changes in COVID-19 patients and compare them to the variable CT findings reported in MERS and SARS.", "RESULTS: From March 15 to May 12, 2020, 50 patients in Cairo, Egypt, who have positive RT-PCR tests, were included in our study.", "MSCT of the chest was performed to all patients and processed in a separate work station.", "Two experienced radiologists assessed each study for the type and location of different pulmonary affection.", "The most imminent radiological finding was patchy peripheral subpleural ground glass opacity found in 42 patients (84% of cases), followed by consolidation found in 30 patients (60% of cases) and ground glass and consolidation together found in 22 patients (44% of cases).", "Unlike SARS, where initial chest imaging abnormalities are more frequently unilateral, COVID-19 is more likely to involve both lungs on initial imaging presented as bilateral peripheral subpleural scattered ground-glass opacities.", "Pleural effusion is absent in COVID-19 patients while it is not rare in MERS and might be observed in 20\u201333% of affected individuals.", "CONCLUSION: The imaging features of COVID-19 pneumonia are highly sensitive mainly in the outbreak pandemic.", "The imaging features of SARS, MERS, and COVID-19 overlap, but differences still exist especially early in disease course."], "journal": "Egypt J Radiol Nucl Med", "publish_time": "2020-08-28", "aliases": []}
{"doc_id": 221070392, "title": "Hilar lymphadenopathy, a novel finding in the setting of coronavirus disease (COVID-19): a case report", "abstract": ["BACKGROUND: As the outbreak of coronavirus disease 2019 (COVID-19) has progressed, computed tomography has emerged as an integral part of the diagnosis alongside reverse transcriptase-polymerase chain reaction assays.", "Frequently encountered imaging findings include peripheral airspace consolidations; bilateral ground-glass opacities; and, less commonly, cavitation.", "Hilar lymphadenopathy is a rarely reported finding in the setting of COVID-19.", "CASE PRESENTATION: A 73-year-old Caucasian woman presented to our hospital with fever and fatigue.", "She had a maximum body temperature of 102.3 \u00b0F with lymphopenia and thrombocytopenia.", "She was diagnosed with severe acute respiratory syndrome coronavirus 2 infection on the basis of a positive result from a reverse transcriptase-polymerase chain reaction of a nasopharyngeal swab sample.", "Contrast-enhanced chest computed tomography revealed multifocal, subpleural ground-glass opacities with nodular consolidations bilaterally.", "Computed tomography also demonstrated atypical bilateral hilar lymphadenopathy, a rarely reported imaging feature of COVID-19.", "Chest computed tomography 1 month before the presentation did not show focal consolidations or lymphadenopathy.", "This indicated that the findings were due to the patient's severe acute respiratory syndrome coronavirus 2 infection.", "She received 5 days of oral hydroxychloroquine and experienced resolution of her symptoms.", "CONCLUSION: Chest computed tomography has been used extensively to diagnose and characterize the distinguishing radiological findings associated with viral pneumonia.", "It has emerged as an integral part of the diagnosis of COVID-19 alongside reverse transcriptase-polymerase chain reaction assays.", "Clinicians must be aware of uncommon clinical and radiological findings in order to diagnose this entity.", "Hilar lymphadenopathy is commonly seen with fungal infections, mycobacterial infections, and sarcoidosis.", "An extensive literature review found that bilateral hilar lymphadenopathy has not been reported in the setting of COVID-19.", "More data are needed to establish the clinical impact of this novel finding."], "journal": "J Med Case Rep", "publish_time": "2020", "aliases": []}
{"doc_id": 226302719, "title": "Contextualizing cardiac dysfunction in critically ill patients with COVID-19.", "abstract": ["Acute cardiac injury incidence in COVID-19 is about 13 times higher in the ICU/severely ill than in less critical patients.", "Patients with cardiovascular comorbidities seem to be more prone to develop higher acuity of the infection, and myocardial injury has been reported amongst them in up to 15% of those hospitalized and up to 30% of ICU-admitted ones.", "The symptoms of over ischemia/heart failure may be challenging to distinguish as dyspnoea and chest discomfort overlap with those due to COVID-19.", "Therefore, beside close monitoring with ECG, biomarkes and, in case of demonstrated cardiac involvement, echocardiography, strategies to improve myocardial oxygen delivery should be promptly applied.", "The cytokine release with complement and iNO dysregulation are established mechanisms potentially leading to sepsis-related cardiomyopathy, making sepsis per se one of the potential mechanism leading to acute cardiac injury in COVID-19 patients.", "Moreover, the hyper-inflammation with endothelial dysfunction is likely be responsible of both pulmonary in-situ platelet aggregation and deep thrombosis potentially leading to severe pulmonary embolism and right ventricular failure.", "Besides the customary antithrombotic prophylaxis for critical patients, D-dimer levels and tighter coagulation monitoring are recommended and should guide the choice for anticoagulation treatment.", "We summarize the current knowledge regarding cardiovascular involvement in patient with COVID-19."], "journal": "Minerva anestesiologica", "publish_time": "2020-11-11", "aliases": []}
{"doc_id": 229928908, "title": "Prevalence and impact of cardiac injury on COVID\u201019: A systematic review and meta\u2010analysis", "abstract": ["BACKGROUND: The exact prevalence and impact of cardiac injury in hospitalized patients with coronavirus disease 2019 (COVID\u201019) is still controversial.", "Hence, we aim to investigate prevalence of cardiac injury and its impact on the outcomes in patients with COVID\u201019.", "HYPOTHESIS: Cardiac injury is common and associated with higher risk of death.", "METHODS: We searched the Cochrane Library, PubMed, MedRxiv, and EMBASE databases from December 2019 to July 15, 2020 for studies that evaluated the prevalence and impact of cardiac injury on COVID\u201019.", "This study has been registered with PROSPERO (International prospective register of systematic reviews)\u2010registration number\u2010CRD\u201042020186120.", "RESULTS: Twenty\u2010one studies including 6297 participants were identified.", "The proportions of cardiac injury were 22%, 28% among hospitalized patients with COVID\u201019 or severe COVID\u201019 patients, respectively.", "The incidences of cardiac injury in advance age (>60 years) (30%) was about two\u2010fold than young patients (<60 years) (15%) with COVID\u201019.", "Severe cases (42%) have seven\u2010fold prevalence cardiac injury than in their non\u2010 severe counterparts (6%).", "Furthermore, cardiac injury is associated with an increased risk of all\u2010cause mortality in patients with COVID\u201019 (OR 10.11, 95% CI 4.49\u201322.77).", "In patients with severe COVID\u201019, cardiac injury is associated with an increased risk of all\u2010cause mortality (OR: 16.79, 95% CI: 5.52\u201351.02).", "CONCLUSIONS: This was the first meta\u2010analysis exploring the prevalence and impact of cardiac injury on COVID\u201019.", "Cardiac injury is common in hospitalized patients and advanced age and severe COVID\u201019 patients prone to experience more risk of cardiac injury.", "Furthermore, cardiac injury is associated with increased risk of all\u2010cause mortality."], "journal": "Clin Cardiol", "publish_time": "2020-12-31", "aliases": []}
{"doc_id": 220487862, "title": "Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week", "abstract": ["Increases in cardiac troponin indicative of myocardial injury are common in patients with coronavirus disease-2019 (COVID-19) and are associated with adverse outcomes such as arrhythmias and death.", "These increases are more likely to occur in those with chronic cardiovascular conditions and in those with severe COVID-19 presentations.", "The increased inflammatory, prothrombotic, and procoagulant responses following severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection increase the risk for acute nonischemic myocardial injury and acute myocardial infarction, particularly type 2 myocardial infarction, because of respiratory failure with hypoxia and hemodynamic instability in critically ill patients.", "Myocarditis, stress cardiomyopathy, acute heart failure, and direct injury from SARS-CoV-2 are important etiologies, but primary noncardiac conditions, such as pulmonary embolism, critical illness, and sepsis, probably cause more of the myocardial injury.", "The structured use of serial cardiac troponin has the potential to facilitate risk stratification, help make decisions about when to use imaging, and inform stage categorization and disease phenotyping among hospitalized COVID-19 patients."], "journal": "J Am Coll Cardiol", "publish_time": "2020", "aliases": []}
{"doc_id": 219970389, "title": "Cardiac Injury and COVID-19: A Systematic Review and Meta-Analysis", "abstract": ["BACKGROUND: During the current coronavirus disease 2019 (COVID-19) pandemic, a link between acute cardiac injury and COVID-19 infection has been observed.", "There is currently no consensus on the incidence of cardiac injury, its relationship to prognosis, or its possible cause.", "This article provides a comprehensive review and meta-analysis of the incidence, comorbidities, outcomes and possible mechanisms of acute cardiac injury in COVID-19 patients.", "METHODS: We searched PubMed and Embase for studies that evaluated cardiac injury in hospitalized COVID-19 patients.", "Demographic information, co-morbidities, and relevant laboratory values were extracted and a meta-analysis was performed.", "RESULTS: Sixteen studies from China, Italy and the US with 2224 patients were included in this meta-analysis.", "The incidence of cardiac injury was 24.4% (542/2224 patients) in hospitalized COVID-19 patients.", "The all-cause mortality in patients with cardiac injury was 72.6% (OR=17.32, 95% CI 9.21-32.57) compared to those without cardiac injury (14.5%).", "In subgroup analyses, factors associated with increased risk of developing cardiac injury were older age and history of hypertension (HTN), and chronic obstructive respiratory disease (COPD).", "CONCLUSION: Cardiac injury is common in hospitalized COVID-19 patients and is significantly associated with mortality.", "Patients who were older with HTN and COPD were prone to develop cardiac injury.", "Early screening, triage and cardiac monitoring are recommended for these patients."], "journal": "CJC Open", "publish_time": "2020-06-23", "aliases": []}
{"doc_id": 224817289, "title": "Cardiac injury prediction and lymphocyte immunity and inflammation analysis in hospitalized patients with coronavirus disease 2019 (COVID-19)", "abstract": ["BACKGROUND: Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic.", "The ability to predict cardiac injury and analyze lymphocyte immunity and inflammation of cardiac damage in patients with COVID-19 is limited.", "We aimed to determine the risk factors and predictive markers of cardiac injury in these patients.", "METHODS: Data from 124 consecutive hospitalized patients with confirmed COVID-19 were collected.", "We compared the proportion of cardiovascular disease history in moderate, severe, and critical cases.", "We obtained high-sensitivity cardiac troponin I (hs-cTn I) results from 68 patients.", "Patients were divided into two groups based on positive hs-cTn I result: those with cardiac injury (n = 19) and those without cardiac injury (n = 49).", "RESULTS: Compared with the group with moderate disease, hypertension, coronary heart disease, and smoking were more common in severe and critical cases.", "Diabetes mellitus was most common in the critical group.", "Age older than 65 years, presence of chronic kidney disease, and lower blood lymphocyte percentage were independent risk factors of cardiac injury.", "The total T- and B-lymphocyte counts and CD4+ and CD8+ T-cell counts were significantly lower in those with cardiac injury.", "A minimal lymphocyte percentage < 7.8% may predict cardiac injury.", "The interleukin (IL) 6 level in plasma was elevated in the group with cardiac injury.", "CONCLUSIONS: The lymphocyte percentage in blood may become a predictive marker of cardiac injury in COVID-19 patients.", "The total T and B cells and CD4+ and CD8+ cell counts decreased and the IL-6 level increased in COVID-19 patients with cardiac injury."], "journal": "Int. j. cardiol", "publish_time": "2020", "aliases": []}
{"doc_id": 225077754, "title": "Characteristics of Cardiac Injury in Critically Ill Patients With Coronavirus Disease 2019", "abstract": ["BACKGROUND: Cardiac injury has been reported in up to 30% of coronavirus disease 2019 (COVID-19) patients.", "However, cardiac injury is defined mainly by troponin elevation without description of associated structural abnormalities and its time course has not been studied.", "RESEARCH QUESTION: What are the ECG and echocardiographic abnormalities as well as their time course in critically ill COVID-19 patients?", "STUDY DESIGN AND METHODS: The cardiac function of 43 consecutive COVID-19 patients admitted to two ICUs was assessed prospectively and repeatedly, combining ECG, cardiac biomarker, and transthoracic echocardiographic analyses from ICU admission to ICU discharge or death or to a maximum follow-up of 14 days.", "Cardiac injury was defined by troponin elevation and newly diagnosed ECG or echocardiographic abnormalities, or both.", "RESULTS: At baseline, 49% of patients demonstrated a cardiac injury, and 70% of patients experienced cardiac injury within the first 14 days of ICU stay, with a median time of occurrence of 3 days (range, 0-7 days).", "The most frequent abnormalities were ECG or echocardiographic signs, or both, of left ventricular (LV) abnormalities (87% of patients with cardiac injury), right ventricular (RV) systolic dysfunction (47%), pericardial effusion (43%), new-onset atrial arrhythmias (33%), LV relaxation impairment (33%), and LV systolic dysfunction (13%).", "Between baseline and day 14, the incidence of pericardial effusion and of new-onset atrial arrhythmias increased and the incidence of ECG or echocardiographic signs, or both, of LV abnormalities as well as the incidence of LV relaxation impairment remained stable, whereas the incidence of RV and LV systolic dysfunction decreased.", "INTERPRETATION: Cardiac injury is common and early in critically ill COVID-19 patients.", "ECG or echocardiographic signs, or both, of LV abnormalities were the most frequent abnormalities, and patients with cardiac injury experienced more RV than LV systolic dysfunction."], "journal": "Chest", "publish_time": "2020", "aliases": []}
{"doc_id": 221276124, "title": "Cardiac Injury and Clinical Course of Patients With Coronavirus Disease 2019", "abstract": ["background: Cardiac injury is recognized as one of the most common critical complications during exacerbation of coronavirus disease 2019 (COVID-19) This study aimed to investigate the effect of cardiac injury on the clinical course of COVID-19 and to examine its potential mechanism and treatments methods and Results: A total of 222 hospitalized patients with COVID-19 from wuhan were selected for the study during February 10 to March 28, 2020 Demographic, laboratory, and clinical data on admission and during hospitalization were compared between patients with COVID-19 with or without cardiac injury.", "On admission, cardiac injury (n=29) was associated with advanced age, more underlying coronary artery disease, and a lower.", "Pao (2) Troponin levels were correlated with inflammatory markers (C-reactive protein: r=0 348, p & lt; 0 001; interleukin 6: r=0 558, p & lt; 0 001) andd-dimer levels (r=0 598, p & lt; 0 001) During hospitalization, another six patients suffered from cardiac injury and cardiac injury (n=35), resulting in higher rates of ventilation (invasive: 51 4 vs 1 6%, p & lt; 0 001; non-invasive: 31 4 vs 1 1%, p & lt; 0 001) and mortality (54 3 vs 1 1%, p & lt; 0 001) cardiac injury on admission was a predictive factor for mortality (adjusted hazard ratio=4 73, 95% confidence interval=1 35-16 63, P=0 015) Receiver operating characteristic curve analysis showed that, on admission, a troponin level of 36 35 pg/mL was predictive for mortality with a sensitivity of 73 7% and a specificity of 92 1% Conclusions: cardiac injury complicates the disease course and increases the mortality rate of COVID-19 Troponin levels should be checked at admission and during hospitalization for triage, better monitoring, and managing those with COVID-19, especially in the most severe patients.", "Condensed abstract: Cardiac injury is not uncommon in COVID-19 In a cohort of 222 patients with COVID-19, cardiac injury was found in 29 patients on admission and in another 6 patients during hospitalization.", "The admission level of troponin was well-correlated with inflammatory factors andd-dimer levels and strongly predicted mortality cardiac injury is a manifestation secondary to hypoxia and systemic infection, but which nevertheless further complicates the disease course and increases the mortality rate.", "Troponin levels should be checked at admission and during hospitalization for triage, better monitoring, and managing those with COVID-19, especially in the most severe patients."], "journal": "Frontiers in Cardiovascular Medicine", "publish_time": "2020", "aliases": []}
{"doc_id": 225071767, "title": "Coronavirus Disease 2019 and the Athletic Heart: Emerging Perspectives on Pathology, Risks, and Return to Play.", "abstract": ["Importance Cardiac injury with attendant negative prognostic implications is common among patients hospitalized with coronavirus disease 2019 (COVID-19) infection.", "Whether cardiac injury, including myocarditis, also occurs with asymptomatic or mild-severity COVID-19 infection is uncertain.", "There is an ongoing concern about COVID-19-associated cardiac pathology among athletes because myocarditis is an important cause of sudden cardiac death during exercise.", "Observations Prior to relaxation of stay-at-home orders in the US, the American College of Cardiology's Sports and Exercise Cardiology Section endorsed empirical consensus recommendations advising a conservative return-to-play approach, including cardiac risk stratification, for athletes in competitive sports who have recovered from COVID-19.", "Emerging observational data coupled with widely publicized reports of athletes in competitive sports with reported COVID-19-associated cardiac pathology suggest that myocardial injury may occur in cases of COVID-19 that are asymptomatic and of mild severity.", "In the absence of definitive data, there is ongoing uncertainty about the optimal approach to cardiovascular risk stratification of athletes in competitive sports following COVID-19 infection.", "Conclusions and Relevance This report was designed to address the most common questions regarding COVID-19 and cardiac pathology in athletes in competitive sports, including the extension of return-to-play considerations to discrete populations of athletes not addressed in prior recommendations.", "Multicenter registry data documenting cardiovascular outcomes among athletes in competitive sports who have recovered from COVID-19 are currently being collected to determine the prevalence, severity, and clinical relevance of COVID-19-associated cardiac pathology and efficacy of targeted cardiovascular risk stratification.", "While we await these critical data, early experiences in the clinical oversight of athletes following COVID-19 infection provide an opportunity to address key areas of uncertainty relevant to cardiology and sports medicine practitioners."], "journal": "JAMA cardiology", "publish_time": "2020-10-26", "aliases": []}
{"doc_id": 216555975, "title": "What should a cardiologist know about coronavirus disease 2019?", "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS\u00adCoV\u00ad2) is the cause of coronavirus disease 2019 (COVID\u00ad19).", "The most common symptoms of COVID\u00ad19 are: fever (81.8%-100%), cough (46.3%-86.2%), myalgia and fatigue (11%-50%), expectoration (4.4%-72%), and dyspnea (18.6%-59%).", "The most common laboratory abnormalities in COVID\u00ad19 include decreased lymphocyte count (35%-82.1%), thrombocytopenia (17%-36.2%), elevated serum C\u00adreactive protein (60.7%-93%), lactate dehydrogenase (41%-76%), and D\u00addimer concentrations (36%-46.4%).", "Among comorbidities in patients with COVID\u00ad19, cardiovascular disease is most commonly found.", "In addition, patients with concomitant cardiovascular diseases have worse prognosis and more often require admission to the intensive care unit (ICU), compared with patients without such comorbidities.", "It is estimated that about 20% of patients with COVID\u00ad19 develop cardiac injury.", "Cardiac injury is more prevalent among patients with COVID\u00ad19 who require ICU care.", "In a group of critically ill patients, 27.5% had an elevated N\u00adterminal pro-B\u00adtype natriuretic peptide concentration, and increased cardiac troponin level was found in 10% of patients.", "One of the life\u00adthreatening cardiac manifestations is coronavirus fulminant myocarditis, which may also occur without accompanying symptoms of pulmonary involvement.", "Early recognition and treatment is crucial in these cases.", "So far, data on the incidence of arrhythmias in patients with COVID\u00ad19 are limited.", "Coronavirus disease 2019 impacts patients with cardiovascular comorbidities and affects daily practice of cardiologists.", "Thus, it is important to know typical COVID\u00ad19 symptoms, possible clinical manifestations, complications, and recommended treatment."], "journal": "Kardiol Pol", "publish_time": "2020", "aliases": []}
{"doc_id": 231884757, "title": "Hyper-Inflammatory Response Involves in Cardiac Injury among Patients with Coronavirus Disease 2019", "abstract": ["BACKGROUND: Coronavirus disease 2019 (COVID-19) is still ongoing throughout the world and has resulted in considerable fatality.", "Inflammation and cardiac injury are commonly observed in these cases.", "However, the association between the hyper-inflammatory response and cardiac injury among patients with COVID-19 remains unknown.", "METHODS: The study was designed based on severe and critically ill patients with COVID-19.", "Information on demographics and baseline clinical characteristics as well as laboratory examinations were collected from the electronic medical records and analyzed.", "RESULTS: There were 32.4% (n\u00e2\u0080\u00af=\u00e2\u0080\u00af107) of patients presenting with cardiac injury.", "The median age was 67 years, and 48.8% (n\u00e2\u0080\u00af=\u00e2\u0080\u00af161) of patients were men.", "Hypertension was the most common in 161 (48.8%) patients, followed by diabetes (16.7%, n\u00e2\u0080\u00af=\u00e2\u0080\u00af55) and coronary heart disease (13.3%, n\u00e2\u0080\u00af=\u00e2\u0080\u00af44).", "Moreover, compared to cases without cardiac injury, those with cardiac injury were older, had higher proportions of coronary heart disease, had significantly elevated leukocyte counts and concentrations of N-terminal pro-B-Type natriuretic peptide, high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor (TNF)-&#945;, interleukin-2 receptor (IL-2R), IL-6, and IL-8, but lower lymphocyte counts.", "A significant positive correlation was observed between high-sensitivity troponin I and hs-CRP, TNF-&#945;, IL-2R, IL-6 and IL-8.", "Stepwise logistic regression analysis showed that hs-CRP, TNF-&#945; and IL-6 were independent risk factors for cardiac injury.", "CONCLUSIONS: Pro-inflammatory cytokines were associated with cardiac injury among severe and critically ill patients with COVID-19, suggesting that hyper-inflammatory response may involve in cardiac injury."], "journal": "Am. j. med. sci", "publish_time": "2021", "aliases": []}
{"doc_id": 232048637, "title": "Association of coagulation dysfunction with cardiac injury among hospitalized patients with COVID-19", "abstract": ["Cardiac injury is a common complication of the coronavirus disease 2019 (COVID-19), and is associated with adverse clinical outcomes.", "In this study, we aimed to reveal the association of cardiac injury with coagulation dysfunction.", "We enrolled 181 consecutive patients who were hospitalized with COVID-19, and studied the clinical characteristics and outcome of these patients.", "Cardiac biomarkers high-sensitivity troponin I (hs-cTnI), myohemoglobin and creatine kinase-myocardial band (CK-MB) were assessed in all patients.", "The clinical outcomes were defined as hospital discharge or death.", "The median age of the study cohort was 55 (IQR, 46\u201365) years, and 102 (56.4%) were males.", "Forty-two of the 181 patients (23.2%) had cardiac injury.", "Old age, high leukocyte count, and high levels of aspartate transaminase (AST), D-dimer and serum ferritin were significantly associated with cardiac injury.", "Multivariate regression analysis revealed old age and elevated D-dimer levels as being strong risk predictors of in-hospital mortality.", "Interleukin 6 (IL6) levels were comparable in patients with or without cardiac injury.", "Serial observations of coagulation parameters demonstrated highly synchronous alterations of D-dimer along with progression to cardiac injury.", "Cardiac injury is a common complication of COVID-19 and is an independent risk factor for in-hospital mortality.", "Old age, high leukocyte count, and high levels of AST, D-dimer and serum ferritin are significantly associated with cardiac injury, whereas IL6 are not.", "Therefore, the pathogenesis of cardiac injury in COVID-19 may be primarily due to coagulation dysfunction along with microvascular injury."], "journal": "Sci Rep", "publish_time": "2021-02-24", "aliases": []}
{"doc_id": 219948743, "title": "Cardiovascular manifestations in severe and critical patients with COVID-19", "abstract": ["BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could cause virulent infection leading to Corona Virus Disease 2019 (COVID-19)-related pneumonia as well as multiple organ injuries.", "HYPOTHESIS: COVID-19 infection may result in cardiovascular manifestations leading to worse clinical outcome.", "METHODS: Fifty four severe and critical patients with confirmed COVID-19 were enrolled.", "Risk factors predicting the severity of COVID-19 were analyzed.", "RESULTS: Of the 54 patients (56.1 \u00b1 13.5 years old, 66.7% male) with COVID-19, 39 were diagnosed as severe and 15 as critical cases.", "The occurrence of diabetes, the level of D-dimer, inflammatory and cardiac markers in critical cases were significantly higher.", "Troponin I (TnI) elevation occurred in 42.6% of all the severe and critical patients.", "Three patients experienced hypotension at admission and were all diagnosed as critical cases consequently.", "Hypotension was found in one severe case and seven critical cases during hospitalization.", "Sinus tachycardia is the most common type of arrythmia and was observed in 23 severe patients and all the critical patients.", "Atrioventricular block and ventricular tachycardia were observed in critical patients at end stage while bradycardia and atrial fibrillation were less common.", "Mild pericardial effusion was observed in one severe case and five critical cases.", "Three critical cases suffered new onset of heart failure.", "Hypotension during treatment, severe myocardial injury and pericardial effusion were independent risk factors predicting the critical status of COVID-19 infection.", "CONCLUSION: This study has systemically observed the impact of COVID-19 on cardiovascular system, including myocardial injury, blood pressure, arrythmia and cardiac function in severe and critical cases.", "Monitoring of vital signs and cardiac function of COVID-19 patients and applying potential interventions especially for those with hypotension during treatment, severe myocardial injury or pericardial effusion, is of vital importance."], "journal": "Clin Cardiol", "publish_time": "2020", "aliases": []}
{"doc_id": 231648989, "title": "Cardiac MRI and Myocardial Injury in COVID-19: Diagnosis, Risk Stratification and Prognosis", "abstract": ["Myocardial injury is a common complication of the COVID-19 illness and is associated with a worsened prognosis.", "Systemic hyperinflammation seen in the advanced stage of COVID-19 likely contributes to myocardial injury cardiac magnetic resonance imaging (cmr) is the preferred imaging modality for non-invasive evaluation in acute myocarditis, enabling risk stratification and prognostication.", "Modified scanning protocols in the pandemic setting reduce risk of exposure while providing critical data regarding cardiac tissue inflammation and fibrosis, chamber remodeling, and contractile function.", "The growing use of cmr in clinical practice to assess myocardial injury will improve understanding of the acute and chronic sequelae of myocardial inflammation from various pathological etiologies."], "journal": "Diagnostics", "publish_time": "2021", "aliases": []}
{"doc_id": 239887858, "title": "COVID-19 and Cardiac Arrhythmias", "abstract": ["Since the coronavirus disease (COVID-19) pandemic spread unrelentingly all over the world, millions of cases have been reported.", "Despite a high number of asymptomatic cases, the course of the disease can be serious or even fatal.", "The affection of the myocardium, called myocardial injury, is caused by multiple triggers.", "The occurrence of cardiac arrhythmias in COVID-19 patients with myocardial involvement and a critical course is common.", "In this review, potential mechanisms, incidence, and treatment options for cardiac arrhythmias in COVID-19 patients will be provided by performing a literature research in MESH database and the National Library of Medicine.", "Common cardiac arrhythmias in COVID-19 patients were sinus tachycardia, atrial fibrillation (AF), ventricular tachycardia (VT), ventricular fibrillation (VF), atrioventricular block, sinusoidal block or QTc prolongation.", "AF was the most common heart rhythm disorder.", "About 10% of COVID-19 patients develop new-onset AF and 23 to 33% showed recurrence of AF in patients with known AF.", "One retrospective trial revealed the incidence of VT or VF to be 5.9% in hospitalized patients.", "Both AF and VT are clearly associated with worse outcome.", "Several mechanisms such as hypoxia, myocarditis, myocardial ischemia, or abnormal host immune response, which induce cardiac arrhythmias, have been described.", "The effect of QT-prolonging drugs in inducing cardiac arrhythmias has become mitigated as these medications are no longer recommended.", "Acute management of cardiac arrhythmias in COVID-19 patients is affected by the reduction of exposure of health care personnel.", "More prospective data are desirable to better understand pathophysiology and consecutively adapt management."], "journal": "Hamostaseologie", "publish_time": "2021", "aliases": []}
{"doc_id": 231679838, "title": "Microthrombi As A Major Cause of Cardiac Injury in COVID-19: A Pathologic Study", "abstract": ["Background: Cardiac injury is common in hospitalized patients with COVID-19 and portends poorer prognosis.", "However, the mechanism and the type of myocardial damage associated with SARS-CoV-2 remain uncertain.", "Methods: We conducted a systematic pathologic analysis of 40 hearts from hospitalized patients dying of Coronavirus Disease 2019 (COVID-19) in Bergamo, Italy to determine the pathologic mechanisms of cardiac injury.", "We divided the hearts according to presence or absence of acute myocyte necrosis and then determined the underlying mechanisms of cardiac injury.", "Results: Of the 40 hearts examined, 14 (35%) had evidence of myocyte necrosis, predominantly of the left ventricle.", "As compared to subjects without necrosis, subjects with necrosis tended to be female, have chronic kidney disease, and shorter symptom onset to admission.", "The incidence of severe coronary artery disease (i.e., >75% cross sectional narrowing) was not significantly different between those with and without necrosis.", "3/14 (21 .4%) subjects with myocyte necrosis showed evidence of acute myocardial infarction defined as &#8805;1 cm2 area of necrosis while 11/14 (78.6%) showed evidence of focal (> 20 necrotic myocytes with an area of &#8805; 0.05 mm2 but <1 cm2) myocyte necrosis.", "Cardiac thrombi were present in 11/14 (78.6%) cases with necrosis, with 2/14 (14.2%) having epicardial coronary artery thrombi while 9/14 (64.3%) had microthrombi in myocardial capillaries, arterioles, and small muscular arteries.", "We compared cardiac microthrombi from COVID-19 positive autopsy cases to intramyocardial thromboemboli from COVID-19 cases as well as to aspirated thrombi obtained during primary percutaneous coronary intervention from uninfected and COVID-19 infected patients presenting with ST-segment elevation myocardial infarction (STEMI).", "Microthrombi had significantly greater fibrin and terminal complement C5b-9 immunostaining as compared to intramyocardial thromboemboli from COVID-19 negative subjects and to aspirated thrombi.", "There were no significant differences between the constituents of thrombi aspirated from COVID-19 positive and negative STEMI patients.", "Conclusions: The most common pathologic cause of myocyte necrosis was microthrombi.", "Microthrombi were different in composition as compared to intramyocardial thromboemboli from COVID-19 negative subjects and to coronary thrombi retrieved from COVID-19 positive and negative STEMI patients.", "Tailored anti-thrombotic strategies may be useful to counteract the cardiac effects of COVID-19 infection."], "journal": "Circulation", "publish_time": "2021", "aliases": []}
{"doc_id": 237455339, "title": "High-dose vitamin C ameliorates cardiac injury in COVID-19 pandemic: a retrospective cohort study", "abstract": ["Background: Cardiac injury is common and associated with poor clinical outcomes in COVID-19.", "Data are lacking whether high-dose intravenous vitamin C (HIVC) could help to ameliorate myocardial injury in the pandemic.", "Methods: The retrospective cohort study included consecutive severe and critically ill COVID-19 patients with cardiac injury receiving symptomatic supportive treatments alone or together with HIVC.", "Troponin I and inflammatory markers were collected at admission and day 21 during hospitalization from the electronic medical records.", "Results: The patients (n = 113) were categorized into the ameliorated cardiac injury (ACI) group (n = 70) and the non-ameliorated cardiac injury (NACI) group (n = 43).", "Overall, fifty-one (45.1%) patients were administered with HIVC, the percentages of patients with HIVC were higher in the ACI group than those in the NACI group.", "Logistic regression analysis revealed that HIVC was independently associated with the improvement of myocardial injury.", "Further analysis showed that inflammatory markers levels significantly decreased at day 21 during hospitalization in patients with HIVC therapy compared to those administered with symptomatic supportive treatments alone.", "Meanwhile, similar results were also observed regarding changes in inflammatory markers levels from baseline to day 21 during hospitalization in the patients treated with HIVC.", "Conclusions: HIVC can ameliorate cardiac injury through alleviating hyperinflammation in severe and critically ill patients with COVID-19."], "journal": "Aging (Albany NY)", "publish_time": "2021-09-09", "aliases": []}
{"doc_id": 232101045, "title": "Cardiac Injury in COVID-19: A Systematic Review", "abstract": ["Coronavirus 2019 (COVID-19) is responsible for the current pandemic which has already resulted in considerable mortality worldwide.", "This systematic review was conducted to summarize the results of the published articles assessing the incidence of heart diseases in patients infected with COVID-19.", "The electronic databases Scopus, Web of Science, Pubmed, Science Direct, and ProQuest were used to search for potentially relevant articles.", "Articles published from Dec 2019 to April 2020 were included.", "All cross-sectional, retrospective or prospective observational cohort and case-control studies were selected which reported the incidence or prevalence of myocardial injury, myocardial infarction, or cardiovascular disease in patients with confirmed COVID-19 infection.", "Based on the inclusion criteria, 12 articles were selected.", "The incidence of cardiac injury was reported in 8 articles and 8 articles focused on the cardiovascular outcomes of COVID-19 infection.", "The incidence of new cardiac injury was reported to be 7.2-77% in live and dead patients, respectively.", "The results showed that patients with cardiac injury had worse outcomes including higher mortality than those without cardiac injury.", "The most common cardiac injury outcomes were shock and malignant arrhythmias.", "The most common radiographic findings in patients with cardiac injury were multiple mottling and ground-glass opacities in the lungs (64.6%).", "A significant number of patients with cardiac injury required noninvasive mechanical ventilation (46.3%) or invasive mechanical ventilation (22.0%).", "Acute respiratory distress syndrome was seen in 58.5%, acute kidney injury in 8.5%, electrolyte disturbances in 15.9%, hypoproteinemia in 13.4%, and coagulation disorders in 7.3% of patients with cardiac injuries.", "In addition, survival days were negatively correlated with cardiac troponin I levels (r = -0.42, 95%, p = 0.005).", "The results of this review showed that myocardial injury in patients with COVID 19 has a poor prognosis.", "Hence, cardiac investigation and management in these patients are crucial."], "journal": "Adv Exp Med Biol", "publish_time": "2021", "aliases": []}
{"doc_id": 220379739, "title": "Early Diagnosis and Clinical Significance of Acute Cardiac Injury - Under the Iceberg: A Retrospective Cohort Study of 619 Non-critically Ill Hospitalized COVID-19 Pneumonia Patients", "abstract": ["Rationale: Coronavirus disease 2019 (COVID-19) can cause a viral pneumonia together with other extrapulmonary complications.", "Acute cardiac related injury (ACRI) is common in hospitalized COVID-19 patients.", "Objective: To explain the pathological mechanism of ACRI and improve the treatment strategy by retrospectively observing the factors associated with ACRI and factors affecting the prognosis of ACRI with COVID-19 at an early stage.", "Methods: 619 COVID-19 patients were from Tongji Hospital, Wuhan.", "T test was used for continuous variables while Chi-square test for categorical factors.", "Univariable and multivariable logistic regression models were applied to estimate odds ratio (OR) with 95% confidence interval (CI).", "Results: Among the 619 OOS Level-I hospitalized COVID-19 patients, 102 (16.5%) were defined as ACRI (stage-1: 59 cases, stage-2: 43 cases).", "50% of ACRI patients developed into severe cases and 25 patients died (CFR=24.5%), 42 times that of non-ACRI patients.", "Elderly (OR=2.83, P<0.001) , HTN (OR=2.09, P=0.005), {gamma}-globulin (OR=2.08, P=0.004), TCM (OR=0.55, P=0.017), PLT (OR=2.94, P<0.001) and NLR (OR=2.20, P=0.004) were independently correlated with ACRI.", "SBP[\u2265]140, dyspnea, DM, smoking history were correlated with ACRI-stage2 only.", "In the prognostic subgroup analysis of ACRI patients,{gamma}-globulin treatment could prolong LOS.", "TCM (OR=0.26, P=0.006), SBP[\u2265]160 (OR= 22.70, P=0.005), male (OR=2.66, P=0.044) were associated with severe illness while corticosteroids treatment (OR=3.34, P=0.033) and male (OR=4.303, P=0.008) with death.", "Surprisingly, we found the mortality of non-elderly patients is higher than elderly (32.4% VS 20.0%, P=0.164), and both IKF and RASI treatment were not correlated with any prognostic indicators including severe, death and LOS.", "Conclusion: This study observed that several non-traditional issues were associated with early cardiac injury in COVID-19 while many traditional cardiovascular risk factors were not.", "Besides elderly and male, hypertension was confirmed to be the most important risk factor."], "journal": "", "publish_time": "2020-07-07", "aliases": []}
{"doc_id": 220714792, "title": "Cardiac Injury Patterns and Inpatient Outcomes Among Patients Admitted with COVID-19", "abstract": ["Although certain risk factors have been associated with increased morbidity and mortality in patients admitted with Coronavirus Disease 2019 (COVID-19), the impact of cardiac injury and high-sensitivity troponin-I (hs-cTnI) concentrations are not well described.", "In this large retrospective longitudinal cohort study, we analyzed the cases of 1044 consecutively admitted patients with COVID-19 from March 9(th) until April 15(th).", "Cardiac injury was defined by a hs-cTnI concentration >99(th) percentile.", "Patient characteristics, laboratory data, and outcomes were described in patients with cardiac injury and different hs-cTnI cut-offs.", "The primary outcome was mortality, and the secondary outcomes were length of stay, need for intensive care unit care or mechanical ventilation, and their different composites.", "The final analyzed cohort included 1020 patients.", "The median age was 63 years, 50% of patients were female, and 40% were white.", "390 (38%) patients had cardiac injury on presentation.", "These patients were older (median age 70 years), had a higher cardiovascular disease burden, in addition to higher serum concentrations of inflammatory markers.", "They also exhibited an increased risk for our primary and secondary outcomes, with the risk increasing with higher hs-cTnI concentrations.", "Peak hs-cTnI concentrations continued to be significantly associated with mortality after a multivariate regression controlling for comorbid conditions, inflammatory markers, acute kidney injury, and acute respiratory distress syndrome.", "Within the same multivariate regression model, presenting hs-cTnI concentrations were not significantly associated with outcomes, and undetectable hs-cTnI concentrations on presentation did not completely rule out the risk for mechanical ventilation or death.", "In conclusion, cardiac injury was common in patients admitted with COVID-19.", "The extent of cardiac injury and peak hs-cTnI concentrations were associated with worse outcomes."], "journal": "Am J Cardiol", "publish_time": "2020-07-24", "aliases": []}
{"doc_id": 225069085, "title": "Myocardial Injury and Myocarditis in SARS-CoV-2 Patients", "abstract": ["myocarditis is one of the relatively common complications of respiratory infection with SARSCoV-2 As several patients confirmed with the new SARS-CoV-2 are known with cardiovascular disease (cvd) and data from the literature show negative prognosis and a higher risk of complications, this subgroup of subjects represents a particular situation.", "Therefore, an adequate understanding of the mechanisms involved in myocardial injury and interaction between COVID-19 and cvd is essential for optimal further management.", "Studies have proved that in COVID-19 patient myocarditis is determined via three pathological mechanisms of cardiomyocyte injury: direct viral cell entry and binding to ace2, vasculitis-mediated injury, and systemic inflammatory response leading to pro-inflammatory cytokine discharge.", "Studies show that the incidence of myocarditis in patients with SARS-CoV-2 is relatively low, 4 8%, but myocardial damage occurs in more than 25% of critical cases in the form of acute fulminant myocarditis with severe hemodynamic degradation, or develops when the severity of SARS-CoV-2 infection intensifies.", "The mortality rate in myocarditis from COVID-19 infection ranges between 50-70%, with poorer prognosis and a higher risk of complications in cvd patients.", "As in all of these cases increased troponin and natriuretic peptide levels proved to be a negative prognostic factor, for risk stratification and prompt treatment, cardiac biomarkers should be evaluated in all patients with COVID-19."], "journal": "Journal of Interdisciplinary Medicine", "publish_time": "2020", "aliases": []}
{"doc_id": 233389539, "title": "A pre- and during Pandemic Survey of Sars-Cov-2 Infection in Stray Colony and Shelter Cats from a High Endemic Area of Northern Italy", "abstract": ["Cats are susceptible to infection with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2).", "Whilst a number of studies have been performed worldwide on owned cats, limited data are available on stray, colony or shelter cats.", "We investigated SARS-CoV-2 infection in a stray cat population before and during human outbreaks of SARS-CoV-2 in cities in the Lombardy region in northern Italy, a high endemic region for SARS-CoV-2, using serological and molecular methods.", "A cohort of different samples were collected from 241 cats, including frozen archived serum samples from 136 cats collected before the 2019 coronavirus disease (COVID-19) pandemic and serum, pharyngeal and rectal swab samples from 105 cats collected during the SARS-CoV-2 outbreak.", "All pre-pandemic samples tested seronegative for antibodies against the nucleocapsid of SARS-CoV-2 using indirect enzyme linked immunosorbent assay (ELISA) test, while one serum sample collected during the pandemic was seropositive.", "No serological cross-reactivity was detected between SARS-CoV-2 antibodies and antibodies against feline enteric (FECV) and infectious peritonitis coronavirus (FIPC), Feline Immunodeficiency Virus (FIV), Feline Calicivirus (FCV), Feline Herpesvirus-1 (FHV-1), Feline Parvovirus (FPV), Leishmania infantum, Anaplasma phagocytophilum, Rickettsia spp., Toxoplasma gondii or Chlamydophila felis.", "No pharyngeal or rectal swab tested positive for SARS-CoV-2 RNA on real time reverse transcription-polymerase chain reaction (rRT-PCR).", "Our data show that SARS-CoV-2 did infect stray cats in Lombardy during the COVID-19 pandemic, but with lower prevalence than found in owned cats.", "This should alleviate public concerns about stray cats acting as SARS-CoV-2 carriers."], "journal": "Viruses", "publish_time": "2021-04-03", "aliases": []}
{"doc_id": 214807328, "title": "SARS-CoV-2 neutralizing serum antibodies in cats: a serological investigation", "abstract": ["Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China, and rapidly spread worldwide.", "Previous studies suggested cat could be a potential susceptible animal of SARS-CoV-2.", "Here, we investigated the infection of SARS-CoV-2 in cats by detecting specific serum antibodies.", "A cohort of serum samples were collected from cats in Wuhan, including 102 sampled after COVID-19 outbreak, and 39 prior to the outbreak.", "15 of 102 (14.7%) cat sera collected after the outbreak were positive for the receptor binding domain (RBD) of SARS-CoV-2 by indirect enzyme linked immunosorbent assay (ELISA).", "Among the positive samples, 11 had SARS-CoV-2 neutralizing antibodies with a titer ranging from 1/20 to 1/1080.", "No serological cross-reactivity was detected between the SARS-CoV-2 and type I or II feline infectious peritonitis virus (FIPV).", "Our data demonstrates that SARS-CoV-2 has infected cat population in Wuhan during the outbreak."], "journal": "bioRxiv", "publish_time": "2020-04-03", "aliases": []}
{"doc_id": 236320697, "title": "Do Dogs and Cats Passively Carry SARS-CoV-2 on Hair and Pads?", "abstract": ["The epidemiological role of domestic animals in the spread and transmission of SARS-CoV-2 to humans has been investigated in recent reports, but some aspects need to be further clarified.", "To date, only in rare cases have dogs and cats living with COVID-19 patients been found to harbour SARS-CoV-2, with no evidence of pet-to-human transmission.", "The aim of the present study was to verify whether dogs and cats act as passive mechanical carriers of SARS-CoV-2 when they live in close contact with COVID-19 patients.", "Cutaneous and interdigital swabs collected from 48 dogs and 15 cats owned by COVID-19 patients were tested for SARS-CoV-2 by qRT-PCR.", "The time elapsed between owner swab positivity and sample collection from pets ranged from 1 to 72 days, with a median time of 23 days for dogs and 39 days for cats.", "All samples tested negative, suggesting that pets do not passively carry SARS-CoV-2 on their hair and pads, and thus they likely do not play an important role in the virus transmission to humans.", "This data may contribute to confirming that the direct contact with the hair and pads of pets does not represent a route for the transmission of SARS-CoV-2."], "journal": "Viruses", "publish_time": "2021-07-13", "aliases": []}
{"doc_id": 232404985, "title": "SARS-CoV-2 Infection and Antibody Response in a Symptomatic Cat from Italy with Intestinal B-Cell Lymphoma", "abstract": ["Since the coronavirus disease (COVID-19) pandemic was first identified in early 2020, rare cases of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in pet cats have been reported worldwide.", "Some reports of cats with SARS-CoV-2 showed self-limiting respiratory or gastrointestinal disease after suspected human-to-feline transmission via close contact with humans with SARS-CoV-2.", "In the present study, we investigated a cat with SARS-CoV-2 that was presented to a private animal clinic in Northern Italy in May 2020 in a weak clinical condition due to an underlying intestinal B-cell lymphoma.", "The cat developed signs of respiratory tract disease, including a sneeze, a cough and ocular discharge, three days after an oropharyngeal swab tested positive for SARS-CoV-2 viral RNA using two real-time reverse transcriptase polymerase chain reaction (RT-qPCR) assays for the envelope (E) and RNA-dependent RNA polymerase (RdRp) gene.", "Thus, SARS-CoV-2 viral RNA was detectable prior to the onset of clinical signs.", "Five and six months after positive molecular results, the serological testing substantiated the presence of a SARS-CoV-2 infection in the cat with the detection of anti-SARS-CoV-2 receptor binding domain (RBD) immunoglobulin (IgG) antibodies and neutralizing activity in a surrogate virus neutralization assay (sVNT).", "To the best of our knowledge, this extends the known duration of seropositivity of SARS-CoV-2 in a cat.", "Our study provides further evidence that cats are susceptible to SARS-CoV-2 under natural conditions and strengthens the assumption that comorbidities may play a role in the development of clinical disease."], "journal": "Viruses", "publish_time": "2021", "aliases": []}
{"doc_id": 222216234, "title": "SARS-CoV-2 infection, disease and transmission in domestic cats", "abstract": ["Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the cause of Coronavirus Disease 2019 (COVID-19) and responsible for the current pandemic.", "Recent SARS-CoV-2 susceptibility studies in cats show that the virus can replicate in these companion animals and transmit to other cats.", "Here, we present an in-depth study of SARS-CoV-2 infection, disease and transmission in domestic cats.", "Cats were challenged with SARS-CoV-2 via intranasal and oral routes.", "One day post challenge (DPC), two sentinel cats were introduced.", "Animals were monitored for clinical signs, clinicopathological abnormalities and viral shedding.", "Postmortem examinations were performed at 4, 7 and 21 DPC.", "Viral RNA was not detected in blood but transiently in nasal, oropharyngeal and rectal swabs and bronchoalveolar lavage fluid as well as various tissues.", "Tracheobronchoadenitis of submucosal glands with the presence of viral RNA and antigen was observed in airways of the infected cats.", "Serology showed that both, principals and sentinels, developed antibodies to SARS-CoV-2.", "All animals were clinically asymptomatic during the course of the study and capable of transmitting SARS-CoV-2 to sentinels.", "The results of this study are critical for understanding the clinical course of SARS-CoV-2 in a naturally susceptible host species, and for risk assessment."], "journal": "Emerging microbes & infections", "publish_time": "2020-10-25", "aliases": [221096550]}
{"doc_id": 231964612, "title": "Susceptibility and Attenuated Transmissibility of SARS-CoV-2 in Domestic Cats", "abstract": ["Domestic cats, an important companion animal, can be infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).", "This has aroused concern regarding the ability of domestic cats to spread the virus that causes coronavirus disease 2019.", "We systematically demonstrated the pathogenesis and transmissibility of SARS-CoV-2 in cats.", "Serial passaging of the virus between cats dramatically attenuated the viral transmissibility, likely owing to variations of the amino acids in the receptor-binding domain sites of angiotensin-converting enzyme 2 between humans and cats.", "These findings provide insight into the transmissibility of SARS-CoV-2 in cats and information for protecting the health of humans and cats."], "journal": "J Infect Dis", "publish_time": "2021", "aliases": []}
{"doc_id": 232383967, "title": "Detection and Genome Sequencing of SARS-CoV-2 in a Domestic Cat with Respiratory Signs in Switzerland", "abstract": ["Since the emergence of coronavirus disease (COVID-19) in late 2019, domestic cats have been demonstrated to be susceptible to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) under natural and experimental conditions.", "As pet cats often live in very close contact with their owners, it is essential to investigate SARS-CoV-2 infections in cats in a One-Health context.", "This study reports the first SARS-CoV-2 infection in a cat in a COVID-19-affected household in Switzerland.", "The cat (Cat 1) demonstrated signs of an upper respiratory tract infection, including sneezing, inappetence, and apathy, while the cohabiting cat (Cat 2) remained asymptomatic.", "Nasal, oral, fecal, fur, and environmental swab samples were collected twice from both cats and analyzed by RT-qPCR for the presence of SARS-CoV-2 viral RNA.", "Both nasal swabs from Cat 1 tested positive.", "In addition, the first oral swab from Cat 2 and fur and bedding swabs from both cats were RT-qPCR positive.", "The fecal swabs tested negative.", "The infection of Cat 1 was confirmed by positive SARS-CoV-2 S1 receptor binding domain (RBD) antibody testing and neutralizing activity in a surrogate assay.", "The viral genome sequence from Cat 1, obtained by next generation sequencing, showed the closest relation to a human sequence from the B.1.1.39 lineage, with one single nucleotide polymorphism (SNP) difference.", "This study demonstrates not only SARS-CoV-2 infection of a cat from a COVID-19-affected household but also contamination of the cats\u2019 fur and bed with viral RNA.", "Our results are important to create awareness that SARS-CoV-2 infected people should observe hygienic measures to avoid infection and contamination of animal cohabitants."], "journal": "Viruses", "publish_time": "2021-03-17", "aliases": []}
{"doc_id": 238586365, "title": "Presence of Antibodies to SARS-CoV-2 in Domestic Cats in Istanbul, Turkey, Before and After COVID-19 Pandemic", "abstract": ["Recent studies demonstrated that domestic cats can be naturally and experimentally infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).", "This study was performed to investigate the presence of SARS-CoV-2-specific antibodies within the domestic cat population in Istanbul, Turkey, before the coronavirus disease 2019 (COVID-19) and during the COVID-19 pandemic.", "Overall, from 155 cat sera analyzed, 26.45% (41/155) tested positive in the spike protein-ELISA (S-ELISA), 28.38% (44/155) in the receptor-binding domain-ELISA (RBD-ELISA), and 21.9% (34/155) in both, the S- and RBD-ELISAs.", "Twenty-seven of those were also positive for the presence of antibodies to feline coronavirus (FCoV).", "Among the 34 SARS-CoV-2-positive sera, three of those were positive on serum neutralization assay.", "Six of the 30 cats before COVID-19 and 28 of the 125 cats during COVID-19 were found to be seropositive.", "About 20% of ELISA-positive cats exhibited mainly respiratory, gastrointestinal, and renal signs and skin lesions.", "Hematocrit, hemoglobin, white blood cells, lymphocyte, and platelet numbers were low in about 30% of ELISA-positive cats.", "The number of neutrophils and monocytes were above normal values in about 20% of ELISA-positive cats.", "The liver enzyme alanine aminotransferase levels were high in 23.5% ELISA-positive cats.", "In conclusion, this is the first report describing antibodies specific to SARS-CoV-2 antigens (S and RBD) in cats in Istanbul, Turkey, indicating the risk for domestic cats to contract SARS-CoV-2 from owners and/or household members with COVID-19.", "This study and others show that COVID-19-positive pet owners should limit their contact with companion animals and that pets with respiratory signs should be monitored for SARS-CoV-2 infections."], "journal": "Front Vet Sci", "publish_time": "2021-10-12", "aliases": []}
{"doc_id": 221952800, "title": "Respiratory disease in cats associated with human-to-cat transmission of SARS-CoV-2 in the UK", "abstract": ["Two cats from different COVID-19-infected households in the UK were found to be infected with SARS-CoV-2 from humans, demonstrated by immunofluorescence, in situ hybridisation, reverse transcriptase quantitative PCR and viral genome sequencing.", "Lung tissue collected post-mortem from cat 1 displayed pathological and histological findings consistent with viral pneumonia and tested positive for SARS-CoV-2 antigens and RNA.", "SARS-CoV-2 RNA was detected in an oropharyngeal swab collected from cat 2 that presented with rhinitis and conjunctivitis.", "High throughput sequencing of the virus from cat 2 revealed that the feline viral genome contained five single nucleotide polymorphisms (SNPs) compared to the nearest UK human SARS-CoV-2 sequence.", "An analysis of cat 2\u2019s viral genome together with nine other feline-derived SARS-CoV-2 sequences from around the world revealed no shared catspecific mutations.", "These findings indicate that human-to-cat transmission of SARS-CoV-2 occurred during the COVID-19 pandemic in the UK, with the infected cats developing mild or severe respiratory disease.", "Given the versatility of the new coronavirus, it will be important to monitor for human-to-cat, cat-to-cat and cat-to-human transmission."], "journal": "bioRxiv", "publish_time": "2020-09-23", "aliases": []}
{"doc_id": 245212608, "title": "The SARS-CoV-2 Reproduction Number R(0) in Cats", "abstract": ["Domestic cats are susceptible to SARS-CoV-2 virus infection and given that they are in close contact with people, assessing the potential risk cats represent for the transmission and maintenance of SARS-CoV-2 is important.", "Assessing this risk implies quantifying transmission from humans-to-cats, from cats-to-cats and from cats-to-humans.", "Here we quantified the risk of cat-to-cat transmission by reviewing published literature describing transmission either experimentally or under natural conditions in infected households.", "Data from these studies were collated to quantify the SARS-CoV-2 reproduction number R(0) among cats.", "The estimated R(0) was significantly higher than one, hence cats could play a role in the transmission and maintenance of SARS-CoV-2.", "Questions that remain to be addressed are the risk of transmission from humans-to-cats and cats-to-humans.", "Further data on household transmission and data on virus levels in both the environment around infected cats and their exhaled air could be a step towards assessing these risks"], "journal": "Viruses", "publish_time": "2021-12-10", "aliases": [236180017]}
{"doc_id": 235634239, "title": "Absence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in stray cats", "abstract": ["SARS-CoV-2 positive or seropositive owned cats have been reported worldwide.", "The detection of seropositive stray cats in the proximity of farms of infected minks, coupled with the demonstration of cat-to-cat transmission in experimental settings, raise the question whether stray cats may have an epidemiological role in the COVID-19 pandemic and may act as sentinel for the circulation of SARS-CoV-2.", "The aim of this study was to evaluate the presence of SARS-CoV-2 RNA and anti-SARS-CoV-2 antibodies in free roaming cats belonging to colonies located in an area highly affected by the COVID-19 pandemic and to correlate the results with the positivity rate in people sharing the same area.", "Interdigital, cutaneous, oropharyngeal, nasal and rectal swabs, as well as blood samples, were collected from 99 cats living in colonies and admitted to our hospital for neutering.", "This caseload corresponds to the 24.2% of the feline population living in the 25 sampled colonies and to the 5.6% of all the free-roaming registered cats.", "The presence of SARS-CoV-2 RNA in swabs was assessed using real time RT-PCR.", "Anti-SARS-CoV-2 serum antibodies were assessed using commercially available ELISA kits and confirmed by serum virus neutralization.", "In people, the SARS-CoV-2 positivity rate ranged from 3.0% to 5.1% (mean rate: 4.1%) and the seropositive rate from 12.1% to 16.3% (mean rate: 14.2%).", "Most of the colonies were in urban areas and resident cats had frequent contacts with external cats or people.", "A COVID-19 positive caretaker was found, whereas all the cats were negative for SARS-CoV-2 RNA and seronegative.", "Although the negative results cannot exclude previous infections followed by decrease of antibodies, this study suggests that colony cats do not have an important epidemiological role in SARS-CoV-2 transmission dynamics.", "Further studies on larger caseloads are warranted, also in the light of the emerging new viral variants, on a One Health perspective."], "journal": "Transbound. emerg. dis. (Internet)", "publish_time": "2021", "aliases": []}
{"doc_id": 237340843, "title": "Serological Screening for Antibodies against SARS-CoV-2 in Dutch Shelter Cats", "abstract": ["The COVID-19 pandemic raised concerns that companion animals might be infected with, and could become a reservoir of, SARS-CoV-2.", "As cats are popular pets and susceptible to Coronavirus, we investigated the seroprevalence of SARS-CoV-2 antibodies in shelter cats housed in Dutch animal shelters during the COVID-19 pandemic.", "In this large-scale cross-sectional study, serum samples of shelter cats were collected during the second wave of human COVID-19 infections in The Netherlands.", "Seroprevalence was determined by using an indirect protein-based ELISA validated for cats, and a Virus Neutralization Test (VNT) as confirmation.", "To screen for feline SARS-CoV-2 shedding, oropharyngeal and rectal swabs of cats positive for ELISA and/or VNT were analyzed using PCR tests.", "In 28 Dutch animal shelters, 240 shelter cats were convenience sampled.", "Two of these cats (0.8%; CI 95%: 0.1\u20133.0%) were seropositive, as evidenced by the presence of SARS-CoV-2 neutralizing antibodies.", "The seropositive animals tested PCR negative for SARS-CoV-2.", "Based on the results of this study, it is unlikely that shelter cats could be a reservoir of SARS-CoV-2 or pose a (significant) risk to public health."], "journal": "Viruses", "publish_time": "2021-08-18", "aliases": []}
{"doc_id": 235770477, "title": "First detection and molecular analysis of SARS-CoV-2 from a naturally infected cat from Argentina", "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of coronavirus disease 2019 (COVID-19), has rapidly spread worldwide.", "Studies of transmission of the virus carried out in animals have suggested that certain animals may be susceptible to infection with SARS-CoV-2.", "The aim of the present study was to investigate the infection of SARS-CoV-2 in pets (18 cats and 20 dogs) from owners previously confirmed as COVID-19-positive.", "Oropharyngeal and rectal swabs were taken and analyzed by real-time RT-PCR assays, while blood samples were taken for antibody detection.", "Of the total pets analyzed, one cat was found reactive to SARS-CoV-2 by real-time RT-PCR of an oropharyngeal and a rectal swab.", "This cat presented only sneezing as a clinical sign.", "Serological analysis confirmed the presence of antibodies in the serum sample from this cat, as well as in the serum from another cat non-reactive to real-time RT-PCR.", "Complete sequence and phylogenetic analysis allowed determining that the SARS-CoV-2 genome belonged to the B.1.499 lineage.", "This lineage has been reported in different provinces of Argentina, mainly in the Metropolitan Area of Buenos Aires.", "This study notifies the first detection of the natural infection and molecular analysis of SARS-CoV-2 in a cat from Argentina whose owner where COVID-19-positive.", "Although there is currently no evidence that cats can spread COVID-19, results suggest that health authorities should test pets with COVID-19-positive owners."], "journal": "Vet Microbiol", "publish_time": "2021-07-08", "aliases": []}
{"doc_id": 231713887, "title": "Experimental re-infected cats do not transmit SARS-CoV-2", "abstract": ["SARS-CoV-2 is the causative agent of COVID-19 and responsible for the current global pandemic.", "We and others have previously demonstrated that cats are susceptible to SARS-CoV-2 infection and can efficiently transmit the virus to na\u00efve cats.", "Here, we address whether cats previously exposed to SARS-CoV-2 can be re-infected with SARS-CoV-2.", "In two independent studies, SARS-CoV-2-infected cats were re-challenged with SARS-CoV-2 at 21 days post primary challenge (DPC) and necropsies performed at 4, 7 and 14 days post-secondary challenge (DP2C).", "Sentinels were co-mingled with the re-challenged cats at 1 DP2C.", "Clinical signs were recorded, and nasal, oropharyngeal, and rectal swabs, blood, and serum were collected and tissues examined for histologic lesions.", "Viral RNA was transiently shed via the nasal, oropharyngeal and rectal cavities of the re-challenged cats.", "Viral RNA was detected in various tissues of re-challenged cats euthanized at 4 DP2C, mainly in the upper respiratory tract and lymphoid tissues, but less frequently and at lower levels in the lower respiratory tract when compared to primary SARS-CoV-2 challenged cats at 4 DPC.", "Viral RNA and antigen detected in the respiratory tract of the primary SARS-CoV-2 infected cats at early DPCs were absent in the re-challenged cats.", "Na\u00efve sentinels co-housed with the re-challenged cats did not shed virus or seroconvert.", "Together, our results indicate that cats previously infected with SARS-CoV-2 can be experimentally re-infected with SARS-CoV-2; however, the levels of virus shed was insufficient for transmission to co-housed na\u00efve sentinels.", "We conclude that SARS-CoV-2 infection in cats induces immune responses that provide partial, non-sterilizing immune protection against re-infection."], "journal": "Emerg Microbes Infect", "publish_time": "2021", "aliases": [232197537]}
{"doc_id": 232158666, "title": "Serological evidence of SARS-CoV-2 and co-infections in stray cats in Spain", "abstract": ["A new coronavirus known as SARS-CoV-2 emerged in Wuhan in 2019 and spread rapidly to the rest of the world causing the pandemic disease named coronavirus disease of 2019 (COVID-19).", "Little information is known about the impact this virus can cause upon domestic and stray animals.", "The potential impact of SARS-CoV-2 has become of great interest in cats due to transmission among domestic cats and the severe phenotypes described recently in a domestic cat.", "In this context, there is a public health warning that needs to be investigated in relation with the epidemiological role of this virus in stray cats.", "Consequently, in order to know the impact of the possible transmission chain, blood samples were obtained from 114 stray cats in the city of Zaragoza (Spain) and tested for SARS-CoV-2 and other selected pathogens susceptible to immunosuppression including Toxoplasma gondii, Leishmania infantum, feline leukaemia virus (FeLV) and feline immunodeficiency virus (FIV) from January to October 2020.", "Four cats (3.51%), based on enzyme-linked immunosorbent assay (ELISA) using the receptor binding domain (RBD) of Spike antigen, were seroreactive to SARS-CoV-2.", "T. gondii, L. infantum, FeLV and FIV seroprevalence was 12.28%, 16.67%, 4.39% and 19.30%, respectively.", "Among seropositive cats to SARS-CoV-2, three cats were also seropositive to other pathogens including antibodies detected against T. gondii and FIV (n = 1); T. gondii (n = 1); and FIV and L. infantum (n = 1).", "The subjects giving positive for SARS-CoV-2 were captured in urban areas of the city in different months: January 2020 (2/4), February 2020 (1/4) and July 2020 (1/4).", "This study revealed, for the first time, the exposure of stray cats to SARS-CoV-2 in Spain and the existence of concomitant infections with other pathogens including T. gondii, L. infantum and FIV, suggesting that immunosuppressed animals might be especially susceptible to SARS-CoV-2 infection."], "journal": "Transbound. emerg. dis. (Internet)", "publish_time": "2021", "aliases": []}
{"doc_id": 221404373, "title": "A serological survey of SARS-CoV-2 in cat in Wuhan", "abstract": ["COVID-19 is a new respiratory illness caused by SARS-CoV-2, and has constituted a global public health emergency.", "Cat is susceptible to SARS-CoV-2.", "However, the prevalence of SARS-CoV-2 in cats remains largely unknown.", "Here, we investigated the infection of SARS-CoV-2 in cats during COVID-19 outbreak in Wuhan by serological detection methods.", "A cohort of serum samples were collected from cats in Wuhan, including 102 sampled after COVID-19 outbreak, and 39 prior to the outbreak.", "Fifteen sera collected after the outbreak were positive for the receptor binding domain (RBD) of SARS-CoV-2 by indirect enzyme linked immunosorbent assay (ELISA).", "Among them, 11 had SARS-CoV-2 neutralizing antibodies with a titer ranging from 1/20 to 1/1080.", "No serological cross-reactivity was detected between SARS-CoV-2 and type I or II feline infectious peritonitis virus (FIPV).", "In addition, we continuously monitored serum antibody dynamics of two positive cats every 10 days over 130 days.", "Their serum antibodies reached the peak at 10 days after first sampling, and declined to the limit of detection within 110 days.", "Our data demonstrated that SARS-CoV-2 has infected cats in Wuhan during the outbreak and described serum antibody dynamics in cats, providing an important reference for clinical treatment and prevention of COVID-19."], "journal": "Emerging microbes & infections", "publish_time": "2020-09-17", "aliases": []}
{"doc_id": 229178563, "title": "A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners", "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been detected in domestic and wild cats.", "However, little is known about natural viral infections of domestic cats, although their importance for modelling disease spread, informing strategies for managing positive human-animal relationships and disease prevention.", "Here, we describe the SARS-CoV-2 infection in a household of two human adults and sibling cats (one male and two females) using real-time RT\u2013PCR, an ELISA test, viral sequencing, and virus isolation.", "On May 5th, 2020, the cat-owners tested positive for SARS-CoV-2.", "Two days later, the male cat showed mild respiratory symptoms and tested positive.", "Four days after the male cat, the two female cats became positive, asymptomatically.", "Also, one human and one cat showed antibodies against SARS-CoV-2.", "All cats excreted detectable SARS-CoV-2 RNA for a shorter duration than humans and viral sequences analysis confirmed human-to-cat transmission.", "We could not determine if cat-to-cat transmission also occurred."], "journal": "Emerging microbes & infections", "publish_time": "2021-03-05", "aliases": [226238565]}
{"doc_id": 232412041, "title": "New detection of SARS-CoV-2 in two cats height months after COVID-19 outbreak appearance in France", "abstract": ["Although there are several reports in the literature of SARS-CoV-2 infection in cats, few SARS-CoV-2 sequences from infected cats have been published.", "In this report, SARS-CoV-2 infection was evaluated in two cats by clinical observation, molecular biology (qPCR and NGS), and serology (Microsphere immunoassay and seroneutralization).", "Following the observation of symptomatic SARS-CoV-2-infection in two cats, infection status was confirmed by RT-qPCR and, in one cat, serological analysis for antibodies against N-protein and S-protein, as well as neutralizing antibodies.", "Comparative analysis of five SARS-CoV-2 sequence-fragments obtained from one of the cats showed that this infection was not with one of the three recently emerged variants of SARS-CoV-2.", "This study provides additional information on the clinical, molecular, and serological aspects of SARS-CoV-2 infection in cats."], "journal": "bioRxiv", "publish_time": "2021-03-24", "aliases": []}
{"doc_id": 235233682, "title": "Evidence of neutralizing antibodies against SARS-CoV-2 in domestic cats living with owners with a history of COVID-19 in Lima \u2013 Peru", "abstract": ["SARS-CoV-2 can infect a variety of wild and domestic animals worldwide.", "Of these, domestic cats are highly susceptible species and potential viral reservoirs.", "As such, it is important to investigate disease exposure in areas with active community transmission and high disease prevalence.", "In this report we demonstrate the presence of serum neutralizing antibodies against the receptor binding-domain (RBD) of the SARS-CoV-2 in cats whose owners had been infected with SARS-CoV-2 in Lima, Peru, using a commercial competitive ELISA SARS-CoV-2 Surrogate Virus Neutralization Test.", "Out of 41 samples, 17.1% (7/41) and 31.7% (13/41) were positive, using the cut-off inhibition value of 30% and 20%, respectively.", "Not all cats living in a single house had detectable neutralizing antibodies showing that heterogenous exposure and immune among cohabiting animals.", "This is the first report of SARS-COV-2 exposure of domestic cats in Lima, Peru.", "Further studies are required to ascertain the prevalence of SARS-COV-2 exposure among domestic cats of Lima, Peru."], "journal": "bioRxiv", "publish_time": "2021-05-26", "aliases": [237308830]}
{"doc_id": 233370418, "title": "Detection of SARS\u2010CoV\u20102 in respiratory samples from cats in the UK associated with human\u2010to\u2010cat transmission", "abstract": ["Objectives: The aim of the study was to find evidence of SARS\u2010CoV\u20102 infection in UK cats.", "Design: Tissue samples were tested for SARS\u2010CoV\u20102 antigen using immunofluorescence and for viral RNA by in situ hybridisation.", "A set of 387 oropharyngeal swabs that had been submitted for routine respiratory pathogen testing was tested for SARS\u2010CoV\u20102 RNA using reverse transcriptase quantitative PCR.", "Results: Lung tissue collected post\u2010mortem from cat 1 tested positive for both SARS\u2010CoV\u20102 nucleocapsid antigen and RNA.", "SARS\u2010CoV\u20102 RNA was detected in an oropharyngeal swab collected from cat 2 that presented with rhinitis and conjunctivitis.", "High throughput sequencing of the viral genome revealed five single nucleotide polymorphisms (SNPs) compared to the nearest UK human SARS\u2010CoV\u20102 sequence, and this human virus contained eight SNPs compared to the original Wuhan\u2010Hu\u20101 reference sequence.", "An analysis of the viral genome of cat 2 together with nine other feline\u2010derived SARS\u2010CoV\u20102 sequences from around the world revealed no shared cat\u2010specific mutations.", "Conclusions: These findings indicate that human\u2010to\u2010cat transmission of SARS\u2010CoV\u20102 occurred during the COVID\u201019 pandemic in the UK, with the infected cats developing mild or severe respiratory disease.", "Given the ability of the new coronavirus to infect different species, it will be important to monitor for human\u2010to\u2010cat, cat\u2010to\u2010cat and cat\u2010to\u2010human transmission."], "journal": "Vet Rec", "publish_time": "2021-04-22", "aliases": []}
{"doc_id": 221858039, "title": "Pharmacological and cardiovascular perspectives on the treatment of COVID-19 with chloroquine derivatives", "abstract": ["The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19) and an ongoing severe pandemic.", "Curative drugs specific for COVID-19 are currently lacking.", "Chloroquine phosphate and its derivative hydroxychloroquine, which have been used in the treatment and prevention of malaria and autoimmune diseases for decades, were found to inhibit SARS-CoV-2 infection with high potency in vitro and have shown clinical and virologic benefits in COVID-19 patients.", "Therefore, chloroquine phosphate was first used in the treatment of COVID-19 in China.", "Later, under a limited emergency-use authorization from the FDA, hydroxychloroquine in combination with azithromycin was used to treat COVID-19 patients in the USA, although the mechanisms of the anti-COVID-19 effects remain unclear.", "Preliminary outcomes from clinical trials in several countries have generated controversial results.", "The desperation to control the pandemic overrode the concerns regarding the serious adverse effects of chloroquine derivatives and combination drugs, including lethal arrhythmias and cardiomyopathy.", "The risks of these treatments have become more complex as a result of findings that COVID-19 is actually a multisystem disease.", "While respiratory symptoms are the major clinical manifestations, cardiovascular abnormalities, including arrhythmias, myocarditis, heart failure, and ischemic stroke, have been reported in a significant number of COVID-19 patients.", "Patients with preexisting cardiovascular conditions (hypertension, arrhythmias, etc.)", "are at increased risk of severe COVID-19 and death.", "From pharmacological and cardiovascular perspectives, therefore, the treatment of COVID-19 with chloroquine and its derivatives should be systematically evaluated, and patients should be routinely monitored for cardiovascular conditions to prevent lethal adverse events."], "journal": "Acta Pharmacol Sin", "publish_time": "2020-09-23", "aliases": []}
{"doc_id": 226377989, "title": "Chloroquine and hydroxychloroquine in treatment of coronavirus disease-19", "abstract": ["At present, we are facing coronavirus disease (covid) -19 pandemic caused by the severe acute respiratory syndrome coronavirus-2 with several treatment choices and reports of different treatment outcomes chloroquine and hydroxychloroquine use for the management of severely ill patients started as a quite enthusiastic treatment option, following several small clinical trials, case series reports, public authorities, and media affirmation.", "However, the evidence we have so far is conflicting and some national societies and professional institutions implicate that we should wait for definite treatment recommendations until there are solid data for or against the use of these drugs.", "Until we have more powerful evidence in our hands, we should be aware of safety issues of the old drugs for the new application in the emergency state we are facing today with the COVID-19 pandemic.", "We performed a concise review of strengths, limitations, and awareness for chloroquine and hydroxychloroquine use for COVID-19 infection treatment based on the evidence the science has today."], "journal": "Open Access Macedonian Journal of Medical Sciences", "publish_time": "2020", "aliases": []}
{"doc_id": 221495706, "title": "Impact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin.", "abstract": ["Coronavirus disease 2019 (COVID-19), which is caused by a novel severe acute respiratory syndrome coronavirus (SARS-CoV-2), has recently emerged as a global health threat.", "To address this health emergency, various therapeutic approaches are currently under investigation.", "There is limited evidence on the effectiveness of hydroxychloroquine (HCQ) and chloroquine (CQ) as COVID-19 therapies, and thus World Health Organization (WHO) mentioned that \"Current data shows that this drug does not reduce deaths among hospitalized COVID-19 patients, nor help people with mild or moderate disease.\"", "CQ and HCQ are typically used for the treatment of malaria but have been recognized for certain beneficial effects in COVID-19 patients based on some clinical outcomes from the clinical treatment of COVID-19.", "A standard dose of HCQ has been proven effective and less toxic than CQ in COVID-19 patients; however, a comprehensive understanding of a patient's clinical condition is necessary.", "Based on several hospital findings, the Food and Drug Administration (FDA) has officially cancelled the emergency use authorization for HCQ and CQ for treating hospitalized COVID-19 patients on June 15, 2020.", "In this review, we highlight both pros and cons of the clinical use of CQ and HCQ in COVID-19 patients."], "journal": "Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research", "publish_time": "2020-09-01", "aliases": []}
{"doc_id": 220383607, "title": "Chloroquine for treatment of COVID-19 - a pig in a poke?", "abstract": ["Objective: Chloroquine has been frequently administered for treatment of coronavirus disease 2019 but there are serious concerns about its efficacy and cardiac safety.", "Our objective was to investigate the pharmacokinetics and safety of chloroquine in hospitalized COVID-19 patients.", "Design: A prospective observational study.", "Setting: Dutch hospitals Patients: Patients admitted to the hospital for treatment of COVID-19.", "Interventions: Pharmacokinetic sampling Measurements: The plasma concentrations of chloroquine and desethylchloroquine and QTc time.", "Main Results: A total of 83 patients were included.", "The median (IQR) plasma concentration chloroquine during treatment was 1.05 mol/L (0.63 - 1.55 mol/L).", "None of the patients reached exposure exceeding the concentration to inhibit SARS-CoV-2 replication by 90% (IC90) of 6.9 M. Furthermore, {Delta}QTc >60 milliseconds occurred after initiation of chloroquine treatment in 34% patients and during treatment QTc [\u2265]500 milliseconds was observed in 46% of patients.", "Conclusions: Recommended dose chloroquine treatment results in plasma concentrations that are unlikely to inhibit viral replication.", "Furthermore, the incidence of QTc prolongation was high.", "The preclinical promise of chloroquine as antiviral treatment in patients with COVID-19 is overshadowed by its cardiac toxicity and lack of effective exposure.", "It is unlikely that a positive clinical effect will be found with chloroquine for treatment of COVID-19."], "journal": "", "publish_time": "2020-07-08", "aliases": []}
{"doc_id": 231900725, "title": "Use of hydroxychloroquine and chloroquine in patients with COVID-19: a meta-analysis of randomized clinical trials", "abstract": ["COVID-19 has quickly become a public health problem worldwide, and treatment for this new disease is needed.", "Hydroxychloroquine is an antimalarial that in vitro studies have shown action against SARS-CoV-2, which is why it has been the target of clinical studies with conflicting results.", "Therefore, the aim of this systematic review was to assess the association of hydroxychloroquine use with the virological cure, clinical recovery, mortality, and development of adverse effects in patients with COVID-19.", "PubMed, Cochrane Library, and Lilacs were searched until 7 January 2021, for randomized clinical trials with COVID-19 patients treated with hydroxychloroquine or chloroquine.", "Of the 130 studies found, 12 met the inclusion criteria.", "Compared to the patient's control group, the risk ratio (RR) for the virological cure and clinical recovery with hydroxychloroquine or chloroquine use was 1.04 (95%CI 0.91-1.17) and 1.03 (95%CI 0.92-1.13), respectively.", "Hydroxychloroquine (with or without azithromycin) was also not associated with mortality (RR = 1.09, 95%CI 0.98-1.20).", "Treatment with hydroxychloroquine was associated with any adverse effects (RR = 1.50, 95%CI 1.18-1.81).", "Hydroxychloroquine or chloroquine use did not have a significant effect on virological cure, the time of clinical recovery, and improvement in survival in COVID-19 patients.", "However, patients who used hydroxychloroquine showed an increase in adverse effects."], "journal": "Pathog Glob Health", "publish_time": "2021", "aliases": []}
{"doc_id": 233611052, "title": "Chloroquine-induced prolonged QT interval in COVID-19 patients in Indonesia: Case series", "abstract": ["The treatment of coronavirus disease 2019 (COVID-19)remains in debate, and the use of chloroquine has not been validated by accurate clinical trials.The aim of this study was to provide the possible cardiotoxicity effect of chloroquine in patients with COVID-19.", "This study was a case-series of prolonged QT interval of COVID-19 patients treated with chloroquine in a hospital in Bali, Indonesia.", "There were two cases of COVID-19 with exhibited a prolonged QT interval after being administrated of chloroquine.The prolonged QT interval returned to normal after chloroquine was stopped.These cases alert us the cardiotoxicity effect of chloroquine and the need for serial electrocardiography monitoring before and during therapy.", "In conclusion, although antiviral and anti-inflammation properties of chloroquine on COVID-19 are promising, its cardiotoxicity effects should be monitored closely for less harm to the patients.", "\u00a9 2021 Oriental Scientific Publishing Company.", "All rights reserved."], "journal": "Biomedical and Pharmacology Journal", "publish_time": "2021", "aliases": []}
{"doc_id": 220941451, "title": "Brief Report: Retrospective Evaluation on the Efficacy of Lopinavir/Ritonavir and Chloroquine to Treat Nonsevere COVID-19 Patients", "abstract": ["BACKGROUND: The effectiveness of lopinavir/ritonavir (LPV/r) and chloroquine treatment for COVID-19 has not been verified.", "METHODS: We conducted a retrospective study to summarize the clinical practices of nonsevere patients with COVID-19 receiving the standard care, LPV/r or chloroquine in Beijing Ditan Hospital from January 20 to March 26, 2020.", "The main outcome measurements include the changes of cycle threshold values of open reading frame 1 ab (ORF1ab) and nucleocapsid (N) genes by reverse transcriptase-polymerase chain reaction assay from day 1 to 7 after admission for patients receiving standard care or after treatment being initiated for patients receiving either LPV/r or chloroquine.", "The proportion of developing severe illness, fever duration and the time from symptom onset to chest computer tomography improvement, and negative conversion of nucleic acid were compared.", "RESULTS: Of the 129 patients included in the study, 59 received the standard care, 51 received LPV/r, and 19 received chloroquine.", "The demographics and baseline characteristics were comparable among the 3 groups.", "The median duration of fever, median time from symptom onset to chest computer tomography improvement, and negative conversion of the nucleic acid were similar among the 3 groups.", "The median increase in cycle threshold values of N and ORF1ab gene for patients receiving LPV/r or chloroquine or the standard care during the treatment course was 7.0 and 8.5, 8.0, and 7.6, 5.0, and 4.0, respectively.", "These figures were not found significantly different among the 3 groups.", "CONCLUSIONS: Antiviral therapy using LPV/r or chloroquine seemed not to improve the prognosis or shorten the clinical course of COVID-19."], "journal": "J Acquir Immune Defic Syndr", "publish_time": "2020", "aliases": []}
{"doc_id": 245828200, "title": "Arrhythmia may contribute to neuropsychiatric symptoms in COVID-19 patients", "abstract": ["Forero-Pe\u00f1a et al.", "1 described immediate and long-term neuropsychiatric complications following the Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, and discussed the possible roles of (hydroxy)chloroquine and dexamethasone on these neuropsychiatric symptoms\u2026 However, arrhythmia may also contribute to neuropsychiatric symptoms in COVID-19 Patients and should not be neglected.", "Through literature search, we summarized abnormal electrocardiographic (ECG) findings in COVID-19 patients.", "Sinus tachycardia was the most common arrhythmia found in the patients, with frequencies of 16.9% - 70.4% (Table 1)\u2026 Thus, anti-arrhythmic drugs, such as amiodarone and metoprolol may be used for COVID-19 patients with ventricular arrhythmia to reduce the possible complication of neuropsychiatric disorders\u2026 Chloroquine and hydroxychloroquine have been widely used in COVID-19 treatments.", "However, there is compelling evidence that chloroquine and hydroxychloroquine induce significant QTc prolongation and potentially increase the risk of arrhythmia\u2026 Either psychiatric symptoms or arrhythmia in COVID-19 patients undergoing steroid treatments have not been well described in the literature.", "This article is protected by copyright.", "All rights reserved."], "journal": "J. med. virol", "publish_time": "2022", "aliases": []}
{"doc_id": 218759248, "title": "The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?", "abstract": ["The anti-malarial drugs chloroquine (CQ) and primarily the less toxic hydroxychloroquine (HCQ) are currently used to treat autoimmune diseases for their immunomodulatory and anti-thrombotic properties.", "They have also been proposed for the treatment of several viral infections, due to their anti-viral effects in cell cultures and animal models, and, currently, for the treatment of coronavirus disease 2019 (COVID-19), the pandemic severe acute respiratory syndrome caused by coronavirus 2 (Sars-Cov-2) infection that is spreading all over the world.", "Although in some recent studies a clinical improvement in COVID-19 patients has been observed, the clinical efficacy of CQ and HCQ in COVID-19 has yet to be proven with randomized controlled studies, many of which are currently ongoing, also considering pharmacokinetics, optimal dosing regimen, therapeutic level and duration of treatment and taking into account patients with different severity degrees of disease.", "Here we review what is currently known on the mechanisms of action of CQ and HCQ as anti-viral, anti-inflammatory and anti-thrombotic drugs and discuss the up-to-date experimental evidence on the potential mechanisms of action of CQ/HCQ in Sars-Cov2 infection and the current clinical knowledge on their efficacy in the treatment of COVID-19 patients.", "Given the role of iron in several human viral infections, we also propose a different insight into a number of CQ and HCQ pharmacological effects, suggesting a potential involvement of iron homeostasis in Sars-Cov-2 infection and COVID-19 clinical course."], "journal": "Pharmacological research", "publish_time": "2020-05-13", "aliases": [218596496]}
{"doc_id": 219736554, "title": "Chloroquine And Hydroxychloroquine For COVID-19 Treatment", "abstract": ["coronavirus disease 2019 (COVID-19) is an emerging disease caused bysevere acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that has been causing many people around the world affected.", "There is no approved treatment for COVID-19 Meanwhile, vaccine development still needs a long time before it becomes available to protect people from contracting COVID-19 Repurposing the available drugs is one of the fastest ways to get COVID-19 treatment.", "Studies have been conducted to discover for COVID-19 treatment that results in the finding of potential medication for COVID-19 Chloroquine and hydroxychloroquine are some of the available medication that shows potential for COVID-19 treatment.", "Preclinical study showed that the both drugs are active against SARS-CoV-2 in vitro A pilot clinical study also showed their efficacy in COVID-19 treatment.", "Many clinical trials are now being conducted to prove their safety and efficacy for the prevention and treatment of COVID-19 However, until now there are not enough data to support the use of these drugs in COVID-19 management.", "Under the pressure to treat COVID-19 patients with chloroquine or hydroxychloroquine, clinicians shouldnot use these drugs for COVID-19 without considering the available information regarding theiruse for COVID-19 This review summarized the evidence regarding the potential of chloroquine and hydroxychloroquine in COVID-19 management."], "journal": "Journal Of The Medical Sciences (Berkala Ilmu Kedokteran)", "publish_time": "2020", "aliases": []}
{"doc_id": 221541668, "title": "[Chloroquine phosphate: therapeutic drug for COVID-19]", "abstract": ["Since the outbreak of coronavirus disease 2019 (COVID-19) in the late 2019, a variety of antiviral drugs have been used in the first-line clinical trial.", "The diagnostic and treatment protocol for COVID-19 (trial.", "Version 6) in china recommends chloroquine phosphate for the first time as an anti-coronavirus trial drug.", "As a classic drug for treatment of malaria and rheumatism, chloroquine phosphate has been used clinically for more than 80 years, and has also shown good results in the treatment of various viral infections.", "As the plasma drug concentration varies greatly among different races and individuals and due to its narrow treatment window, chloroquine in likely to accumulate in the body to cause toxicity.", "Among the treatment regimens recommended for COVID-19, reports concerning the safety of a short-term high-dose chloroquine regimen remain scarce.", "In this review, the authors summarize the current research findings of chloroquine phosphate in the treatment of COVID-19, and examine the pharmacokinetic characteristics, antiviral therapy, the therapeutic mechanism and safety of chloroquine."], "journal": "Nan Fang Yi Ke Da Xue Xue Bao", "publish_time": "2020", "aliases": []}
{"doc_id": 220716128, "title": "Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2", "abstract": ["The coronavirus disease 2019 (COVID-19) pandemic, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been associated with more than 780,000 deaths worldwide (as of 20 August 2020).", "To develop antiviral interventions quickly, drugs used for the treatment of unrelated diseases are currently being repurposed to treat COVID-19.", "Chloroquine is an anti-malaria drug that is used for the treatment of COVID-19 as it inhibits the spread of SARS-CoV-2 in the African green monkey kidney-derived cell line Vero1-3.", "Here we show that engineered expression of TMPRSS2, a cellular protease that activates SARS-CoV-2 for entry into lung cells4, renders SARS-CoV-2 infection of Vero cells insensitive to chloroquine.", "Moreover, we report that chloroquine does not block infection with SARS-CoV-2 in the TMPRSS2-expressing human lung cell line Calu-3.", "These results indicate that chloroquine targets a pathway for viral activation that is not active in lung cells and is unlikely to protect against the spread of SARS-CoV-2 in and between patients."], "journal": "Nature", "publish_time": "2020", "aliases": []}
{"doc_id": 225317794, "title": "COVID-19: Chloroquine and hydroxychloroquine research, 6 April 2020", "abstract": ["In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic.", "Journals and public media.", "Although there are now ongoing clinical trials testing the efficacy and safety of several medicines for COVID-19, as of the date of this document, there is a lack of quality evidence to demonstrate chloroquine and/or hydroxychloroquine are effective in the treatment of COVID-19 Evidence is recently emerging via small studies with sub-optimal methodologies that are conflicting.", "In some countries in the americas, chloroquine or hydroxychloroquine is readily available, in some cases as an over-the-counter medicine national authorities should take measures to control the use of these medicines and prevent self-medication.", "The use of chloroquine and/or hydroxychloroquine outside of current guidelines and recommendations may result in adverse effects, including serious illness and death, and have a negative impact on other diseases where there is proven benefit.", "Public health authorities are urged to prioritize resources on those interventions that are currently recommended for standard of care."], "journal": "", "publish_time": "2020", "aliases": []}
{"doc_id": 220487801, "title": "Updates on the Pharmacology of Chloroquine against Coronavirus Disease 2019 (COVID-19): A Perspective on its Use in the General and Geriatric Population.", "abstract": ["BACKGROUND Chloroquine has been used to treat malaria for more than 70 years.", "Its safety profile and costeffectiveness are well-documented.", "Scientists have found that chloroquine has in vitro activity against novel coronavirus (SARS-CoV-2).", "Currently, chloroquine has been adopted in the Protocol for Managing Coronavirus Disease 2019 (COVID19) (Version 7) issued by China National Health Commission for clinically managing COVID-19.", "OBJECT This review will focus on the antiviral mechanism, effectiveness and safety, dosage and DDIs of chloroquine, for the purpose to provide evidence-based support for rational use of chloroquine in the treatment of COVID-19.", "Method\uff1aUse the search terms 'chloroquine' linked with 'effectiveness', 'safety', 'mechanism', 'drug-drug interaction (DDIs)' or other terms respectively to search relevant literature through PubMed.", "RESULT After searching, we found literature about antivirus mechanism, dosage, DDIs of chloroquine.", "However, studies of effectiveness and safety on chloroquine treatment of COVID-19 for the general and geriatric patients are not enough.", "CONCLUSION According to literature reports, chloroquine has been proved to have anti-SARS-CoV-2 effect in vitro and the potential mechanism of chloroquine in vivo.", "Pharmacokinetic characteristics and DDIs study are helpful to guide rational drug use in general and geriatric patients.", "Although there have been reports of successful clinical application of chloroquine in treatment COVID-19\uff0cmore clinical test data are still needed to prove its effectiveness and safety."], "journal": "Current drug metabolism", "publish_time": "2020-07-11", "aliases": []}
{"doc_id": 211213558, "title": "[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].", "abstract": ["At the end of December 2019, a novel coronavirus (COVID-19) caused an outbreak in Wuhan, and has quickly spread to all provinces in China and 26 other countries around the world, leading to a serious situation for epidemic prevention.", "So far, there is still no specific medicine.", "Previous studies have shown that chloroquine phosphate (chloroquine) had a wide range of antiviral effects, including anti-coronavirus.", "Here we found that treating the patients diagnosed as novel coronavirus pneumonia with chloroquine might improve the success rate of treatment, shorten hospital stay and improve patient outcome.", "In order to guide and regulate the use of chloroquine in patients with novel coronavirus pneumonia, the multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia developed this expert consensus after extensive discussion.", "It recommended chloroquine phosphate tablet, 500mg twice per day for 10 days for patients diagnosed as mild, moderate and severe cases of novel coronavirus pneumonia and without contraindications to chloroquine."], "journal": "Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases", "publish_time": "2020-02-20", "aliases": [212691691]}
{"doc_id": 218981523, "title": "Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review", "abstract": ["At this time of the COVID-19 pandemic, potentially effective treatments are currently under urgent investigation.", "Benefits of chloroquine and hydroxychloroquine for the treatment of COVID-19 infection have been proposed and clinical trials are underway.", "Chloroquine and hydroxychloroquine, typically used for the treatment of malaria and autoimmune diseases, have been considered for off-label use in several countries.", "In the literature, there are reports of ototoxic effects of the drugs causing damage to the inner ear structures, which then result in hearing loss, tinnitus, and/or imbalance.", "This mini-review represents a summary of the findings from a systematic search regarding ototoxicity of chloroquine and hydroxychloroquine in the published literature.", "The characteristics of sensorineural hearing loss and/or tinnitus after chloroquine or hydroxychloroquine treatment can be temporary but reports of persistent auditory and vestibular dysfunction exist.", "These are not frequent, but the impact can be substantial.", "Additionally, abnormal cochleovestibular development in the newborn was also reported after chloroquine treatment in pregnant women.", "The suggested dose of chloroquine for COVID-19 infection is considerably higher than the usual dosage for malaria treatment; therefore, it is plausible that the ototoxic effects will be greater.", "There are potential implications from this review for survivors of COVID-19 treated with chloroquine or hydroxychloroquine.", "Patient reports of hearing loss, tinnitus, or imbalance should be noted.", "Those with troublesome hearing loss, tinnitus and/or imbalance are encouraged to be referred for hearing evaluation and interventions once they are stable.", "Clinical trials of chloroquine or hydroxychloroquine should also consider including audiological monitoring in the protocol."], "journal": "Front. Public Health", "publish_time": "2020", "aliases": []}
{"doc_id": 226376846, "title": "Psychiatric side effects of chloroquine in covid-19 patients: Two case reports", "abstract": ["chloroquine and hydroxy chloroquine are widely use in africa and all over the world as anti-malarial drugs but also in the treatment of chronic inflammatory diseases.", "Since the outbreak of COVID-19 pandemic, morocco have included this medication in the COVID-19 treatment guidelines in association with azithromycine.", "Besides dermatologic problems, ocular impairments and gastro-intestinal effects, quinolines may also cause rarely described psychiatric adverse effects.", "To our knowledge, there has been no reports of psychiatric side effects of chloroquine or hydroxy chloroquine in the actual context of COVID-19 pandemic.", "Here, we present the description of two COVID-19 patients who showed psychiatric side effects after chloroquine treatment.", "One patient expressed psychotic symptoms and the other one experienced acute and intense anxiety.", "In both cases, and according to naranjo score, the association between chloroquine and psychiatric side effects was probable \u00a9 roukaya benjelloun et al."], "journal": "Pan African Medical Journal", "publish_time": "2020", "aliases": [231985404]}
{"doc_id": 218912798, "title": "Artesunate: could be an alternative drug to chloroquine in COVID-19 treatment?", "abstract": ["SARS (Severe Acute Respiratory Syndrome Coronavirus)-CV-2 (2019-nCov), which showed up in China in December 2019 and spread all over the world, has becomed a serious health problem.", "An effective, safe and proven treatment has not yet been found.", "Chloroquine has been recommended by some authors to be used for the treatment of patients infected with this virus however chloroquine may have side effects and drug resistance problems.", "Artesunate is a semisynthetic derivative of artemisinin, an antimalarial drug.", "Artesunate was thought to be an effective treatment for covid-19 because of its anti-inflammatory activity, NF-\u03baB (nuclear Factor kappa B)-coronavirus effect and chloroquine-like endocytosis inhibition mechanism."], "journal": "Chin Med", "publish_time": "2020-05-28", "aliases": []}
{"doc_id": 218518774, "title": "Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19", "abstract": ["OBJECTIVE: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also called COVID-19, has caused a pandemic which has swiftly involved the entire world and raised great public health concerns.", "The scientific community is actively exploring treatments that would potentially be effective in combating COVID-19.", "Hydroxychloroquine has been demonstrated to limit the replication of SARS-CoV-2 virus in vitro.", "In malarial pandemic countries, chloroquine is widely used to treat malaria.", "In malarial non-pandemic nations, chloroquine is not widely used.", "Chloroquine and hydroxychloroquine share similar chemical structures and mechanisms of action.", "The aim of this study was to indirectly investigate the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19 by determining the prevalence of COVID-19 in malaria pandemic and non-pandemic nations.", "We sought evidence to support or refute the hypothesis that these drugs could show efficacy in the treatment of COVID-19.", "MATERIALS AND METHODS: We reviewed in vitro studies, in vivo studies, original studies, clinical trials, and consensus reports, that were conducted to evaluate the antiviral activities of chloroquine and hydroxychloroquine.", "The studies on \"COVID-19 and its allied treatment were found from World Health Organization (WHO), ISI-Web of Science, PubMed, EMBASE, Scopus, Google Scholar, and clinical trial registries.", "The search was based on keywords: antiviral drugs, chloroquine, hydroxychloroquine, COVID-19, COVID-19 treatment modalities, and coronavirus.", "In addition, we analyzed the prevalence of COVID-19 in malaria pandemic and non-pandemic countries.", "The review and analyses were performed on March 28, 2020.", "RESULTS: For this study, we identified a total of 09 published articles: 03 clinical trials with sample size 150; 03 in vitro studies and 03 expert consensus reports.", "These studies were all suggestive that chloroquine and hydroxychloroquine can successfully treat COVID-19 infections.", "We found that COVID-19 infections are highly pandemic in countries where malaria is least pandemic and are least pandemic in nations where malaria is highly pandemic.", "CONCLUSIONS: Chloroquine and hydroxychloroquine have antiviral characteristics in vitro.", "The findings support the hypothesis that these drugs have efficacy in the treatment of COVID-19.", "People are currently using these drugs for malaria.", "It is reasonable, given the hypothetical benefit of these two drugs, that they are now being tested in clinical trials to assess their effectiveness to combat this global health crisis."], "journal": "Eur Rev Med Pharmacol Sci", "publish_time": "2020", "aliases": [233474010, 218521873]}
{"doc_id": 215801024, "title": "The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19", "abstract": ["The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has posed the world at a pandemic risk.", "Coronavirus-19 disease (COVID-19) is an infectious disease caused by SARS-CoV-2, which causes pneumonia, requires intensive care unit hospitalization in about 10% of cases and can lead to a fatal outcome.", "Several efforts are currently made to find a treatment for COVID-19 patients.", "So far, several anti-viral and immunosuppressive or immunomodulating drugs have demonstrated some efficacy on COVID-19 both in vitro and in animal models as well as in cases series.", "In COVID-19 patients a pro-inflammatory status with high levels of interleukin (IL)-1B, IL-1 receptor (R)A and tumor necrosis factor (TNF)-&#945; has been demonstrated.", "Moreover, high levels of IL-6 and TNF-&#945; have been observed in patients requiring intensive-care-unit hospitalization.", "This provided rationale for the use of anti-rheumatic drugs as potential treatments for this severe viral infection.", "Other agents, such as hydroxychloroquine and chloroquine might have a direct anti-viral effect.", "The anti-viral aspect of immunosuppressants towards a variety of viruses has been known since long time and it is herein discussed in the view of searching for a potential treatment for SARS-CoV-2 infection."], "journal": "J Autoimmun", "publish_time": "2020", "aliases": []}
{"doc_id": 246476453, "title": "Virucidal activity and mechanism of action of cetylpyridinium chloride against SARS-CoV-2", "abstract": ["Objective Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen causing the coronavirus disease 2019 (COVID-19) global pandemic.", "Recent studies have shown the importance of the throat and salivary glands as sites of virus replication and transmission.", "The viral host receptor, angiotensin-converting enzyme 2 (ACE2), is broadly enriched in epithelial cells of the salivary glands and oral mucosae.", "Oral care products containing cetylpyridinium chloride (CPC) as a bactericidal ingredient are known to exhibit antiviral activity against SARS-CoV-2 in vitro.", "However, the exact mechanism of action remains unknown.", "Methods This study examined the antiviral activity of CPC against SARS-CoV-2 and its inhibitory effect on the interaction between the viral spike (S) protein and ACE2 using an enzyme-linked immunosorbent assay.", "Results CPC (0.05%, 0.1% and 0.3%) effectively inactivated SARS-CoV-2 within the contact times (20 and 60 s) in directions for use of oral care products in vitro.", "The binding ability of both the S protein and ACE2 were reduced by CPC.", "Conclusions Our results suggest that CPC inhibits the interaction between S protein and ACE2, and thus, reduces infectivity of SARS-CoV-2 and suppresses viral adsorption."], "journal": "bioRxiv", "publish_time": "2022-01-31", "aliases": []}
{"doc_id": 235699781, "title": "Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues", "abstract": ["In this study, a series of 10 quinoline analogues was evaluated for their in vitro antiviral activity against a panel of alpha- and beta-coronaviruses, including the severe acute respiratory syndrome coronaviruses 1 and 2 (SARS-CoV-1 and SARS-CoV-2), as well as the human coronaviruses (HCoV) 229E and OC43.", "Chloroquine and hydroxychloroquine were the most potent with antiviral EC(50) values in the range of 0.12\u201312 \u03bcM.", "Chloroquine displayed the most favorable selectivity index (i.e.", "ratio cytotoxic versus antiviral concentration), being 165 for HCoV-OC43 in HEL cells.", "Potent anti-coronavirus activity was also observed with amodiaquine, ferroquine and mefloquine, although this was associated with substantial cytotoxicity for mefloquine.", "Primaquine, quinidine, quinine and tafenoquine only blocked coronaviruses replication at higher concentrations, while piperaquine completely lacked antiviral and cytotoxic effect.", "A time-of-addition experiment in HCoV-229E-infected HEL cells revealed that chloroquine interferes with viral entry at a post-attachment stage.", "Using confocal microscopy, no viral RNA synthesis could be detected upon treatment of SARS-CoV-2-infected cells with chloroquine.", "The inhibition of SARS-CoV-2 replication by chloroquine and hydroxychloroquine coincided with an inhibitory effect on the autophagy pathway as visualized by a dose-dependent increase in LC3-positive puncta.", "The latter effect was less pronounced or even absent with the other quinolines.", "In summary, we showed that several quinoline analogues, including chloroquine, hydroxychloroquine, amodiaquine, ferroquine and mefloquine, exhibit broad anti-coronavirus activity in vitro."], "journal": "Antiviral Res", "publish_time": "2021-07-01", "aliases": []}
{"doc_id": 234471816, "title": "Computational and experimental insights on the interaction of artemisinin, dihydroartemisinin and chloroquine with SARS-CoV-2 spike protein receptor-binding domain (RBD)", "abstract": ["The mechanism of host cell invasion of severe acute respiratory syndrome coronavirus-2 SARS-CoV-2 is connected with the interaction of spike protein (S) with angiotensin-converting enzyme 2 (ACE2) through receptor-binding domain (RBD).", "Small molecules targeting this assembly are being investigated as drug candidates to contrast SARS-CoV-2.", "In this context, chloroquine, an antimalarial agent proposed as a repurposed drug to treat coronavirus disease-19 (COVID-19), was hypothesized to bind RBD among its other mechanisms.", "Similarly, artemisinin and its derivatives are being studied as potential antiviral agents.", "In this work, we investigated the interaction of artemisinin, its metabolite dihydroartemisinin and chloroquine with RBD by means of computational tools and in vitro.", "Docking studies showed that the compounds interfere with the same region of the protein and molecular dynamics (MD) simulations demonstrated the stability of the predicted complexes.", "Bio-layer interferometry showed that chloroquine dose-dependently binds RBD (KD = 35.9 \u00b5M) more efficiently than artemisinins."], "journal": "Natural product research", "publish_time": "2021-05-12", "aliases": []}
{"doc_id": 221258252, "title": "Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2", "abstract": ["PURPOSE OF REVIEW: The rapid spread of virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has turned out to be a global emergency.", "Symptoms of this viral infection, coronavirus disease 2019 (COVID-19), include mild infections of the upper respiratory tract, viral pneumonia, respiratory failure, multiple organ failure and death.", "Till date, no drugs have been discovered to treat COVID-19 patients, and therefore, a considerable amount of interest has been shown in repurposing the existing drugs.", "RECENT FINDINGS: Out of these drugs, chloroquine (CQ) and hydroxychloroquine (HCQ) have demonstrated positive results indicating a potential antiviral role against SARS-CoV-2.", "Its mechanism of action (MOA) includes the interference in the endocytic pathway, blockade of sialic acid receptors, restriction of pH mediated spike (S) protein cleavage at the angiotensin-converting enzyme 2 (ACE2) binding site and prevention of cytokine storm.", "Unfortunately, its adverse effects like gastrointestinal complications, retinopathy and QT interval prolongation are evident in treated COVID-19 patients.", "Yet, multiple clinical trials have been employed in several countries to evaluate its ability in turning into a needed drug in this pandemic.", "SUMMARY: This review attempts to summarize the MOA of CQ/HCQ and its side effects.", "The existing literature hints that till date, the role of CQ/HCQ in COVID-19 may be sceptical, and further studies are warranted for obtaining a therapeutic option that could be effectively used across the world to rise out from this pandemic."], "journal": "Curr Pharmacol Rep", "publish_time": "2020-08-24", "aliases": []}
{"doc_id": 235808384, "title": "Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors", "abstract": ["Many viruses utilize the host endo-lysosomal network for infection.", "Tracing the endocytic itinerary of SARS-CoV-2 can provide insights into viral trafficking and aid in designing new therapeutic strategies.", "Here, we demonstrate that the receptor binding domain (RBD) of SARS-CoV-2 spike protein is internalized via the pH-dependent CLIC/GEEC (CG) endocytic pathway in human gastric-adenocarcinoma (AGS) cells expressing undetectable levels of ACE2.", "Ectopic expression of ACE2 (AGS-ACE2) results in RBD traffic via both CG and clathrin-mediated endocytosis.", "Endosomal acidification inhibitors like BafilomycinA1 and NH(4)Cl, which inhibit the CG pathway, reduce the uptake of RBD and impede Spike-pseudoviral infection in both AGS and AGS-ACE2 cells.", "The inhibition by BafilomycinA1 was found to be distinct from Chloroquine which neither affects RBD uptake nor alters endosomal pH, yet attenuates Spike-pseudovirus entry.", "By screening a subset of FDA-approved inhibitors for functionality similar to BafilomycinA1, we identified Niclosamide as a SARS-CoV-2 entry inhibitor.", "Further validation using a clinical isolate of SARS-CoV-2 in AGS-ACE2 and Vero cells confirmed its antiviral effect.", "We propose that Niclosamide, and other drugs which neutralize endosomal pH as well as inhibit the endocytic uptake, could provide broader applicability in subverting infection of viruses entering host cells via a pH-dependent endocytic pathway."], "journal": "PLoS Pathog", "publish_time": "2021-07-12", "aliases": []}
{"doc_id": 229524687, "title": "Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2", "abstract": ["Up to date, effective antivirals have not been widely available for treating COVID-19 In this study, we identify a dual-functional cross-linking peptide 8P9R which can inhibit the two entry pathways (endocytic pathway and TMPRSS2-mediated surface pathway) of SARS-CoV-2 in cells.", "The endosomal acidification inhibitors (8P9R and chloroquine) can synergistically enhance the activity of arbidol, a spike-ACE2 fusion inhibitor, against SARS-CoV-2 and SARS-CoV in cells.", "In vivo studies indicate that 8P9R or the combination of repurposed drugs (umifenovir also known as arbidol, chloroquine and camostat which is a tmprss2 inhibitor), simultaneously interfering with the two entry pathways of coronaviruses, can significantly suppress SARS-CoV-2 replication in hamsters and SARS-CoV in mice.", "Here, we use drug combination (arbidol, chloroquine, and camostat) and a dual-functional 8P9R to demonstrate that blocking the two entry pathways of coronavirus can be a promising and achievable approach for inhibiting SARS-CoV-2 replication in vivo.", "Cocktail therapy of these drug combinations should be considered in treatment trials for COVID-19 Until today effective antivirals for COVID-19 treatment are not widely available.", "Here, zhao et al characterize a dual-functional cross-linking peptide, 8P9R, that can inhibit SARS-CoV-2 virus entry in vitro and suppresses viral replication in vivo in golden syrian hamster."], "journal": "Nature Communications", "publish_time": "2021", "aliases": []}
{"doc_id": 229723597, "title": "Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine", "abstract": ["INTRODUCTION: Urgent action is needed to fight the ongoing COVID-19 pandemic by reducing the number of infected people along with the infection contagiousness and severity.", "Chlorpromazine (CPZ), the prototype of typical antipsychotics from the phenothiazine group, is known to inhibit clathrin-mediated endocytosis and acts as an antiviral, in particular against SARS-CoV-1 and MERS-CoV.", "The aim of this in vitro study was to test CPZ against a SARS-CoV-2 isolate in monkey and human cells.", "MATERIAL AND METHODS: Monkey VeroE6 cells and human alveolar basal epithelial A549-ACE2 cells were infected with SARS-CoV-2 in presence of different concentrations of CPZ.", "Supernatants were harvested at day 2 and analysed by RT-qPCR for the presence of SARS-CoV-2 RNA.", "Cell viability was assessed on non-infected cells.", "RESULTS: We evidenced an antiviral activity of CPZ against SARS-CoV-2 in monkey VeroE6 cells with an IC50 of 8.2 \u00b5M, a CC50 of 13.5\u00b5M and a SI of 1.65.", "In human A549-ACE2 cells, CPZ was also associated with an anti-SARS-CoV-2 activity, with an IC50 of 11.3 \u00b5M, a CC50 of 23.1 \u00b5M and a SI of 2.04.", "DISCUSSION: Even though the measured SI are low, such IC50 measured in vitro may translate to CPZ dosage used in clinical routine because of CPZ high biodistribution in lungs and in saliva.", "Also, CPZ brain distribution could be of high interest for treating or preventing the neurological and psychiatric forms of COVID-19.", "CONCLUSIONS: These preclinical findings support clinical investigation of the repurposing of CPZ, a largely used drug with mild side effects, in COVID-19 treatment."], "journal": "Int J Antimicrob Agents", "publish_time": "2020-12-30", "aliases": [218571851]}
{"doc_id": 220837359, "title": "Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2", "abstract": ["Hydroxychloroquine, used to treat malaria and some autoimmune disorders, potently inhibits viral infection of SARS coronavirus (SARS-CoV-1) and SARS-CoV-2 in cell-culture studies.", "However, human clinical trials of hydroxychloroquine failed to establish its usefulness as treatment for COVID-19.", "This compound is known to interfere with endosomal acidification necessary to the proteolytic activity of cathepsins.", "Following receptor binding and endocytosis, cathepsin L can cleave the SARS-CoV-1 and SARS-CoV-2 spike (S) proteins, thereby activating membrane fusion for cell entry.", "The plasma membrane-associated protease TMPRSS2 can similarly cleave these S proteins and activate viral entry at the cell surface.", "Here we show that the SARS-CoV-2 entry process is more dependent than that of SARS-CoV-1 on TMPRSS2 expression.", "This difference can be reversed when the furin-cleavage site of the SARS-CoV-2 S protein is ablated.", "We also show that hydroxychloroquine efficiently blocks viral entry mediated by cathepsin L, but not by TMPRSS2, and that a combination of hydroxychloroquine and a clinically-tested TMPRSS2 inhibitor prevents SARS-CoV-2 infection more potently than either drug alone.", "These studies identify functional differences between SARS-CoV-1 and -2 entry processes, and provide a mechanistic explanation for the limited in vivo utility of hydroxychloroquine as a treatment for COVID-19.", "Author SummaryThe novel pathogenic coronavirus SARS-CoV-2 causes COVID-19 and remains a threat to global public health.", "Chloroquine and hydroxychloroquine have been shown to prevent viral infection in cell-culture systems, but human clinical trials did not observe a significant improvement in COVID-19 patients treated with these compounds.", "Here we show that hydroxychloroquine interferes with only one of two somewhat redundant pathways by which the SARS-CoV-2 spike (S) protein is activated to mediate infection.", "The first pathway is dependent on the endosomal protease cathepsin L and sensitive to hydroxychloroquine, whereas the second pathway is dependent on TMPRSS2, which is unaffected by this compound.", "We further show that SARS-CoV-2 is more reliant than SARS coronavirus (SARS-CoV-1) on the TMPRSS2 pathway, and that this difference is due to a furin cleavage site present in the SARS-CoV-2 S protein.", "Finally, we show that combinations of hydroxychloroquine and a clinically tested TMPRSS2 inhibitor work together to effectively inhibit SARS-CoV-2 entry.", "Thus TMPRSS2 expression on physiologically relevant SARS-CoV-2 target cells may bypass the antiviral activities of hydroxychloroquine, and explain its lack of in vivo efficacy."], "journal": "bioRxiv", "publish_time": "2020-07-22", "aliases": []}
{"doc_id": 220281843, "title": "Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine", "abstract": ["As the world is severely affected by COVID-19 pandemic, the use of chloroquine and hydroxychloroquine in prevention or for the treatment of patients is allowed in multiple countries but remained at the center of much controversy in recent days.", "This review describes the properties of chloroquine and hydroxychloroquine, and highlights not only their anti-viral effects but also their important immune-modulatory properties and their well-known use in autoimmune diseases, including systemic lupus and arthritis.", "Chloroquine appears to inhibit in vitro SARS virus' replication and to interfere with SARS-CoV2 receptor (ACE2).", "Chloroquine and hydroxychloroquine impede lysosomal activity and autophagy, leading to a decrease of antigen processing and presentation.", "They are also known to interfere with endosomal Toll-like receptors signaling and cytosolic sensors of nucleic acids, which result in a decreased cellular activation and thereby a lower type I interferons and inflammatory cytokine secretion.", "Given the antiviral and anti-inflammatory properties of chloroquine and hydroxychloroquine, there is a rational to use them against SARS-CoV2 infection.", "However, the anti-interferon properties of these molecules might be detrimental, and impaired host immune responses against the virus.", "This duality could explain the discrepancy with the recently published studies on CQ/HCQ treatment efficacy in COVID-19 patients.", "Moreover, although these treatments could be an interesting potential strategy to limit progression toward uncontrolled inflammation, they do not appear per se sufficiently potent to control the whole inflammatory process in COVID-19, and more targeted and/or potent therapies should be required at least in add-on."], "journal": "Front Immunol", "publish_time": "2020-07-02", "aliases": []}
{"doc_id": 220846638, "title": "In silico Study of Azithromycin, Chloroquine and Hydroxychloroquine and their Potential Mechanisms of Action against SARS-CoV-2 Infection", "abstract": ["The coronavirus disease 19 (COVID-19) is a highly transmissible viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).", "Clinical trials have reported an improved outcome resulting from effective reduction or absence of viral load when patients were treated with chloroquine or hydroxychloroquine.", "In addition, these drugs had their effects improved by simultaneous azithromycin administration.", "The Receptor-Binding Domain of SARS-CoV Spike Protein (RBD of S Protein) binds to the cell surface angiotensin-converting enzyme 2 (ACE2) receptors allowing viral entry and replication into the host cells.", "The viral Main Protease (Mpro) and the Cathepsin L (CTSL) are among the proteolytic systems involved in S Protein activation by SARS-CoV-2.", "Hence, molecular docking studies were performed to test the binding performance of these three drugs against four targets.", "Our finding showed azithromycin affinity scores (\u2206G) with strong interactions with ACE2, CTSL, Mpro and RBD.", "Chloroquine affinity scores showed 3 low energy results (less negative) with ACE2, CTSL and RBD; and a firm bond score with Mpro.", "With hydroxychloroquine, two results (ACE2 and Mpro) were firmly bound to the receptors; however, CTSL and RBD showed low interaction energies.", "The differences in better interactions and affinity between hydroxychloroquine and chloroquine with ACE2 and Mpro were probably due to structural differences between the drugs.", "Azithromycin, on other hand, not only showed more negative (better) values in affinity, but also in the number of interactions in all targets.", "Nevertheless, further studies are needed to investigate the antiviral properties of these drugs against SARS-CoV-2."], "journal": "Int J Antimicrob Agents", "publish_time": "2020-07-30", "aliases": []}
{"doc_id": 226015489, "title": "Uncontrolled mass use of hydroxychloroquine", "abstract": ["Hydroxychloroquine (HCQ) has previously been shown to inhibit coronavirus replication in vitro.", "But antiviral properties mechanisms are not well known, HCQ is a weak base that accumulates in lysosomes, modifies their pH, and interferes with some enzymes.", "In the lack of confirmed efficacy, the initial potential risk is not to expose patients to adverse effects.", "However, results from preliminary clinical studies have drawn inconclusive results regarding the efficacy of HCQ in coronavirus disease 2019 (COVID-19), due to sev-eral important weaknesses in research methodologies.", "Hypokalemia often occurs in patients infected with severe acute respiratory syndrome coron-avirus 2 (SARS-CoV-2), possibly due to the particular tropism of SARS-CoV-2 with regard to Angiotensin-converting enzyme 2 (ACE2).", "The wide use of HCQ, even against medical advice, will show an impact on ongoing clinical trials.", "It is important that we can recruite COVID-19 patients in these research studies to generate appropriate data regarding drugs that show promising efficacy against COVID-19.", "Currently, only doctors should be allowed to prescribe HCQ, and treatment should be confined to hospital settings, with proper car-diac and therapeutic drug monitoring."], "journal": "Int. J. Res. Pharm. Sci.", "publish_time": "2020", "aliases": []}
{"doc_id": 233206003, "title": "Repurposing Chloroquine Against Multiple Diseases With Special Attention to SARS-CoV-2 and Associated Toxicity", "abstract": ["chloroquine and its derivatives have been used since ages to treat malaria and have also been approved by the fda to treat autoimmune diseases.", "The drug employs pH-dependent inhibition of functioning and signalling of the endosome, lysosome and trans-Golgi network, immunomodulatory actions, inhibition of autophagy and interference with receptor binding to treat cancer and many viral diseases.", "The ongoing pandemic of COVID-19 has brought the whole world on the knees, seeking an urgent hunt for an anti-SARS-CoV-2 drug chloroquine has shown to inhibit receptor binding of the viral particles, interferes with their replication and inhibits `` cytokine storm '' Though multiple modes of actions have been employed by chloroquine against multiple diseases, viral diseases can provide an added advantage to establish the anti-SARS-CoV-2 mechanism, the in vitro and in vivo trials against SARS-CoV-2 have yielded mixed results.", "The toxicological effects and dosage optimization of chloroquine have been studied for many diseases, though it needs a proper evaluation again as chloroquine is also associated with several toxicities.", "Moreover, the drug is inexpensive and is readily available in many countries.", "Though much of the hope has been created by chloroquine and its derivatives against multiple diseases, repurposing it against SARS-CoV-2 requires large scale, collaborative, randomized and unbiased clinical trials to avoid false promises.", "This review summarizes the use and the mechanism of chloroquine against multiple diseases, its side-effects, mechanisms and the different clinical trials ongoing against `` COVID-19 ''."], "journal": "Frontiers in Pharmacology", "publish_time": "2021", "aliases": []}
{"doc_id": 218585710, "title": "Chloroquine als mogelijke behandeling van COVID-19./ [Chloroquine as a possible treatment for COVID-19]", "abstract": ["Since the outbreak of COVID-19, chloroquine has been mentioned as a possible treatment.", "In vitro studies have shown anti-viral activity of chloroquine against SARS-CoV-2.", "Recently, the Dutch National Institute for Public Health and the Environment published treatment options for antiviral treatment for COVID-19 where chloroquine was suggested as first choice for off-label treatment, beside remdesivir en lopinavir/ritonavir.", "In this commentary, we provide a background and history of chloroquine, the evidence for antiviral efficacy of chloroquine and the arguments for off-label use of chloroquine in COVID-19."], "journal": "Ned. tijdschr. geneeskd", "publish_time": "2020", "aliases": []}
{"doc_id": 235202954, "title": "Integrative web-based analysis of omics data for study of drugs against SARS-CoV-2", "abstract": ["Research on drugs against SARS-CoV-2 (cause of COVID-19) has been one of the major world concerns at present.", "There have been abundant research data and findings in this field.", "The interference of drugs on gene expression in cell lines, drug-target, protein-virus receptor networks, and immune cell infiltration of the host may provide useful information for anti-SARS-CoV-2 drug research.", "To simplify the complex bioinformatics analysis and facilitate the evaluation of the latest research data, we developed OmiczViz ( http://medcode.link/omicsviz ), a web tool that has integrated drug-cell line interference data, virus-host protein-protein interactions, and drug-target interactions.", "To demonstrate the usages of OmiczViz, we analyzed the gene expression data from cell lines treated with chloroquine and ruxolitinib, the drug-target protein networks of 48 anti-coronavirus drugs and drugs bound with ACE2, and the profiles of immune cell infiltration between different COVID-19 patient groups.", "Our research shows that chloroquine had a regulatory role of the immune response in renal cell line but not in lung cell line.", "The anti-coronavirus drug-target network analysis suggested that antihistamine of promethaziney and dietary supplement of Zinc might be beneficial when used jointly with antiviral drugs.", "The immune infiltration analysis indicated that both the COVID-19 patients admitted to the ICU and the elderly with infection showed immune exhaustion status, yet with different molecular mechanisms.", "The interactive graphic interface of OmiczViz also makes it easier to analyze newly discovered and user-uploaded data, leading to an in-depth understanding of existing findings and an expansion of existing knowledge of SARS-CoV-2.", "Collectively, OmicsViz is web program that promotes the research on medical agents against SARS-CoV-2 and supports the evaluation of the latest research findings."], "journal": "Sci Rep", "publish_time": "2021", "aliases": []}
{"doc_id": 221510259, "title": "Methylene Blue Inhibits In Vitro the SARS-CoV-2 Spike \u2013 ACE2 Protein-Protein Interaction \u2013 A Mechanism That Can Contribute to Its Antiviral Activity Against COVID-19", "abstract": ["Due to our interest in the chemical space of organic dyes to identify potential small-molecule inhibitors (SMIs) for protein-protein interactions (PPIs), we initiated a screen of such compounds to assess their inhibitory activity against the interaction between SARS-CoV-2 spike protein and its cognate receptor ACE2, which is the first critical step initiating the viral attachment and entry of this coronavirus responsible for the ongoing COVID-19 pandemic.", "As part of this, we found that methylene blue, a tricyclic phenothiazine compound approved by the FDA for the treatment of methemoglobinemia and used for other medical applications (including the inactivation of viruses in blood products prior to transfusion when activated by light), inhibits this interaction.", "We confirmed that it does so in a concentration-dependent manner with a low micromolar half-maximal inhibitory concentration (IC50 = 3 \u03bcM) in our protein-based ELISA-type setup, while chloroquine, siramesine, and suramin showed no inhibitory activity in this assay.", "Erythrosine B, which we have shown before to be a promiscuous SMI of PPIs, also inhibited this interaction with an activity similar, possibly slightly higher, than those found for it for other PPIs.", "This PPI inhibitory activity of methylene blue could contribute to its antiviral activity against SARS-CoV-2 even in the absence of light by blocking its attachment to ACE2-expressing cells and making this inexpensive and widely available drug potentially useful in the prevention and treatment of COVID-19 as an oral or inhaled medication."], "journal": "bioRxiv", "publish_time": "2020-08-31", "aliases": []}
{"doc_id": 232120804, "title": "Polyunsaturated \u03c9-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry", "abstract": ["The strain SARS-CoV-2, newly emerged in late 2019, has been identified as the cause of COVID-19 and the pandemic declared by WHO in early 2020.", "Although lipids have been shown to possess antiviral efficacy, little is currently known about lipid compounds with anti-SARS-CoV-2 binding and entry properties.", "To address this issue, we screened, overall, 17 polyunsaturated fatty acids, monounsaturated fatty acids and saturated fatty acids, as wells as lipid-soluble vitamins.", "In performing target-based ligand screening utilizing the RBD-SARS-CoV-2 sequence, we observed that polyunsaturated fatty acids most effectively interfere with binding to hACE2, the receptor for SARS-CoV-2.", "Using a spike protein pseudo-virus, we also found that linolenic acid and eicosapentaenoic acid significantly block the entry of SARS-CoV-2.", "In addition, eicosapentaenoic acid showed higher efficacy than linolenic acid in reducing activity of TMPRSS2 and cathepsin L proteases, but neither of the fatty acids affected their expression at the protein level.", "Also, neither reduction of hACE2 activity nor binding to the hACE2 receptor upon treatment with these two fatty acids was observed.", "Although further in vivo experiments are warranted to validate the current findings, our study provides a new insight into the role of lipids as antiviral compounds against the SARS-CoV-2 strain."], "journal": "Sci Rep", "publish_time": "2021-03-04", "aliases": [230649298]}
{"doc_id": 238001599, "title": "Computational Modeling of ACE2 Inhibitors for Development of Drugs Against Coronaviruses", "abstract": ["Despite the declaration of SARS-CoV-2 infection as a pandemic on March 11, 2020 by the World Health Organization, till date, no effective treatment has been approved to combat the severity of this pandemic.", "Few antiviral and antimalarial drugs have been used for symptomatic treatment of COVID-19 infection, but none of the treatment strategies has provided promising results against this infection.", "As the journey of a vaccine is also very long, there is a need to repurpose the already approved drugs against this pandemic.", "The urge of studying the structural association of human ACE2, an entry receptor of the virus in the human body with the SARS-CoV-2, may lead to the invention of a new promising prophylactic as well as curative treatment options for the COVID-19 pandemic.", "This chapter covers the importance of human ACE2 receptors in pathophysiology of COVID-19 infection.", "Finally, the results of various computational studies have been elaborated in this chapter.", "The role of different classes of already approved drugs which have shown promise against SARS-CoV-2 infection in in silico docking and computational modeling experiments is summarized for their future prospects in the treatment of COVID-19 infection.", "They were chosen on the basis of their free binding energies and relative ligand scoring scales.", "Molecular docking tools like molecule operating environment (MOE), Glide, AutoDock Vina, and Swiss dock were used in many in silico experiments.", "Some of the potential treatment modalities found in literature survey were ACE inhibitors, antibiotics, anti-inflammatory, antineoplastic, phosphodiesterase inhibitors, hydroxychloroquine and chloroquine, and so on, which have been proved to be efficacious treatment options for SARS-CoV-2 infection by computational modeling of human ACE2 receptors."], "journal": "Methods Pharmacol. Toxicol..", "publish_time": "2021", "aliases": []}
{"doc_id": 239018701, "title": "Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern", "abstract": ["[Image: see text] The antimicrobial medication malarone (atovaquone/proguanil) is used as a fixed-dose combination for treating children and adults with uncomplicated malaria or as chemoprophylaxis for preventing malaria in travelers.", "It is an inexpensive, efficacious, and safe drug frequently prescribed around the world.", "Following anecdotal evidence from 17 patients in the provinces of Quebec and Ontario, Canada, suggesting that malarone/atovaquone may present some benefits in protecting against COVID-19, we sought to examine its antiviral potential in limiting the replication of SARS-CoV-2 in cellular models of infection.", "In VeroE6 expressing human TMPRSS2 and human lung Calu-3 epithelial cells, we show that the active compound atovaquone at micromolar concentrations potently inhibits the replication of SARS-CoV-2 and other variants of concern including the alpha, beta, and delta variants.", "Importantly, atovaquone retained its full antiviral activity in a primary human airway epithelium cell culture model.", "Mechanistically, we demonstrate that the atovaquone antiviral activity against SARS-CoV-2 is partially dependent on the expression of TMPRSS2 and that the drug can disrupt the interaction of the spike protein with the viral receptor, ACE2.", "Additionally, spike-mediated membrane fusion was also reduced in the presence of atovaquone.", "In the United States, two clinical trials of atovaquone administered alone or in combination with azithromycin were initiated in 2020.", "While we await the results of these trials, our findings in cellular infection models demonstrate that atovaquone is a potent antiviral FDA-approved drug against SARS-CoV-2 and other variants of concern in vitro."], "journal": "ACS Infect Dis", "publish_time": "2021-10-18", "aliases": []}
{"doc_id": 245335858, "title": "ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2", "abstract": ["SARS-CoV-2, the etiologic agent of COVID-19, uses ACE2 as a cell entry receptor.", "Soluble ACE2 has been shown to have neutralizing antiviral activity but has a short half-life and no active transport mechanism from the circulation into the alveolar spaces of the lung.", "To overcome this, we constructed an ACE2-human IgG1 fusion protein with mutations in the catalytic domain of ACE2.", "A mutation in the catalytic domain of ACE2, MDR504, significantly increased binding to SARS-CoV-2 spike protein, as well as to a spike variant, in vitro with more potent viral neutralization in plaque assays.", "Parental administration of the protein showed stable serum concentrations with excellent bioavailability in the epithelial lining fluid of the lung, and ameliorated lung SARS-CoV-2 infection in vivo.", "These data support that the MDR504 hACE2-Fc is an excellent candidate for treatment or prophylaxis of COVID-19 and potentially emerging variants."], "journal": "iScience", "publish_time": "2021-12-20", "aliases": []}
{"doc_id": 227905268, "title": "Protoporphyrin IX and verteporfin potently inhibit SARS-CoV-2 infection in vitro and in a mouse model expressing human ACE2", "abstract": ["The SARS-CoV-2 infection is spreading rapidly worldwide.", "Efficacious antiviral therapeutics against SARS-CoV-2 is urgently needed.", "Here, we discovered that protoporphyrin IX (PpIX) and verteporfin, two FDA-approved drugs, completely inhibited the cytopathic effect produced by SARS-CoV-2 infection at 1.25 \u00b5mol/Land 0.31 \u00b5mol/L respectively, and their EC50 values of reduction of viral RNA were at nanomolar concentrations.", "The selectivity indices of PpIX and verteporfin were 952.74 and 368.93, respectively, suggesting broad margin of safety.", "Importantly, PpIX and verteporfin prevented SARS-CoV-2 infection in mice adenovirally transduced with human ACE2.", "The compounds, sharing a porphyrin ring structure, were shown to bind viral receptor ACE2 and interfere with the interaction between ACE2 and the receptor-binding domain of viral S protein.", "Our study suggests that PpIX and verteporfin are potent antiviral agents against SARS-CoV-2 infection and sheds new light on developing novel chemoprophylaxis and chemotherapy against SARS-CoV-2."], "journal": "", "publish_time": "2020", "aliases": [220922196]}
{"doc_id": 237592292, "title": "Risk versus Benefit of Using Hydroxychloroquine to Treat Patients with COVID-19", "abstract": ["Hydroxychloroquine (HCQ), also known by its trade name Plaquenil\u00ae, has been used for over 50 years as a treatment for malaria, systemic lupus erythematosus, and rheumatoid arthritis.", "As the COVID-19 pandemic emerged in the United States and globally in early 2020, HCQ began to garner attention as a potential treatment and as prophylaxis against COVID-19.", "Preliminary data indicated that HCQ as well as chloroquine (CQ) possessed in vitro antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).", "Early clinical data from China and France reported that HCQ and CQ were associated with viral load reduction and clinical improvement in patients with COVID-19 compared to control groups; however, an overwhelming number of randomized controlled trials, meta-analyses, and systematic reviews have since concluded that HCQ used alone, or in combination with azithromycin (AZ), provides no mortality or time-to-recovery benefit in hospitalized patients with COVID-19.", "Additionally, these same trials reported adverse events including cardiac, neuropsychiatric, hematologic, and hepatobiliary manifestations in patients with COVID-19 whom had been treated with HCQ.", "This review article summarizes the available data pertaining to the adverse events associated with HCQ use, alone or in combination with azithromycin, in patients with COVID-19 in order to fully assess the risk versus benefit of treating COVID-19 patients with these agents.", "The results of this review lead us to conclude that the risks of adverse events associated with HCQ use (with or without AZ) outweigh the potential clinical benefits and thus recommend against its use in the treatment or prevention of COVID-19."], "journal": "Can J Infect Dis Med Microbiol", "publish_time": "2021-09-15", "aliases": []}
{"doc_id": 232228147, "title": "Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin", "abstract": ["Azithromycin and chloroquine/hydroxychloroquine are being used internationally off-label to treat patients with coronavirus disease 2019 (COVID-19) based on in vitro and weak studies involving humans.", "However, the evidence about the benefit of these drugs is very uncertain and on the other hand, information regarding possible harms is on the rise.", "There are increasing reports associating chloroquine/hydroxychloroquine with/without azithromycin with prolonged QT and ventricular arrhythmias (monomorphic or polymorphic ventricular tachycardia) in COVID-19 patients.", "We present the case of a severe acute respiratory syndrome coronavirus 2-infected kidney transplant patient for which he received treatment with chloroquine plus azithromycin and on Day 4 of therapy, the patient suddenly developed a wide complex tachycardia.", "Because of the increasing reports of adverse effects related to these drugs, their use should be avoided until further evidence of clinical benefit is available."], "journal": "Oxf Med Case Reports", "publish_time": "2021-01-23", "aliases": []}
{"doc_id": 219560450, "title": "Macrolides and viral infections: focus on azithromycin in COVID-19 pathology", "abstract": ["The emergence of the new COVID-19 virus is proving to be a challenge in seeking effective therapies.", "Since the most severe clinical manifestation of COVID-19 appears to be a severe acute respiratory syndrome, azithromycin has been proposed as a potential treatment.", "Azithromycin is known to have immunomodulating and antiviral properties.", "In vitro studies have demonstrated the capacity of azithromycin in reducing production of pro-inflammatory cytokines such as IL-8, IL-6, TNF alpha, reduce oxidative stress, and modulate T-helper functions.", "At the same time there are multiple clinical evidences of the role of azithromycin in acute respiratory distress syndrome and against Middle East Respiratory syndrome (MERS).", "Some preliminary evidence has demonstrated controversial results regarding efficacy of azithromycin in combination with hydroxychloroquine in COVID-19.", "First, a French trial demonstrated 100% virological negativizing of six patients treated with azithromycin plus hydroxychloroquine vs. 57.1% of patients treated with only hydroxychloroquine and 12.5% of the control group (P < 0.05).", "On the other hand, another case series revealed no efficacy at all on 11 patients treated with the same combination and doses.", "Furthermore, there are some concerns regarding the association of azithromycin and hydroxychloroquine because of potential QT prolongation.", "In fact, both drugs have this as a potential side effect and evidence regarding the safe use of this combination is controversial.", "Despite the necessity to quickly find solutions for COVID-19, extreme caution must be used in evaluating the risk-benefit balance.", "However, based on preclinical and clinical evidence and some preliminary results in COVID-19, azithromycin could have potential in the fight against this new disease."], "journal": "Int J Antimicrob Agents", "publish_time": "2020", "aliases": []}
{"doc_id": 221843528, "title": "Cardiotoxicity induced by the combination therapy of chloroquine and azithromycin in human embryonic stem cell-derived cardiomyocytes", "abstract": ["Combination therapy using chloroquine (CQ) and azithromycin (AZM) has drawn great attention due to its potential anti-viral activity against SARS-CoV-2.", "However, clinical trials have revealed that the co-administration of CQ and AZM resulted in severe side effects, including cardiac arrhythmia, in patients with COVID-19.", "To elucidate the cardiotoxicity induced by CQ and AZM, we examined the effects of these drugs based on the electrophysiological properties of human embryonic stem cellderived cardiomyocytes (hESC-CMs) using multi-electrode arrays.", "CQ treatment significantly increased the field potential duration, which corresponds to prolongation of the QT interval, and decreased the spike amplitude, spike slope, and conduction velocity of hESC-CMs.", "AZM had no significant effect on the field potentials of hESC-CMs.", "However, CQ in combination with AZM greatly increased the field potential duration and decreased the beat period and spike slope of hESC-CMs when compared with CQ monotherapy.", "In support of the clinical data suggesting the cardiovascular side effects of the combination therapy of CQ and AZM, our results suggest that AZM reinforces the cardiotoxicity induced by CQ in hESC-CMs.", "[BMB Reports 2020; 53(10): 545-550]."], "journal": "BMB Rep", "publish_time": "2020", "aliases": []}
{"doc_id": 235213481, "title": "Effect of Hydroxychloroquine on QTc in Patients Diagnosed with COVID-19: A Systematic Review and Meta-Analysis", "abstract": ["Background: Hydroxychloroquine or chloroquine with or without the concomitant use of azithromycin have been widely used to treat patients with SARS-CoV-2 infection, based on early in vitro studies, despite their potential to prolong the QTc interval of patients.", "Objective: This is a systematic review and metanalysis designed to assess the effect of hydroxychloroquine with or without the addition of azithromycin on the QTc of hospitalized patients with COVID-19.", "Materials and methods: PubMed, Scopus, Cochrane and MedRxiv databases were reviewed.", "A random effect model meta-analysis was used, and I-square was used to assess the heterogeneity.", "The prespecified endpoints were \u0394QTc, QTc prolongation > 500 ms and \u0394QTc > 60 ms.", "Results: A total of 18 studies and 7179 patients met the inclusion criteria and were included in this systematic review and meta-analysis.", "The use of hydroxychloroquine with or without the addition of azithromycin was associated with increased QTc when used as part of the management of patients with SARS-CoV-2 infection.", "The combination therapy with hydroxychloroquine plus azithromycin was also associated with statistically significant increases in QTc.", "Moreover, the use of hydroxychloroquine alone, azithromycin alone, or the combination of the two was associated with increased numbers of patients that developed QTc prolongation > 500 ms.", "Conclusion: This systematic review and metanalysis revealed that the use of hydroxychloroquine alone or in conjunction with azithromycin was linked to an increase in the QTc interval of hospitalized patients with SARS-CoV-2 infection that received these agents."], "journal": "J Cardiovasc Dev Dis", "publish_time": "2021-05-13", "aliases": []}
{"doc_id": 220656784, "title": "Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines", "abstract": ["The global COVID-19 pandemic has led to a race to find medications that can improve the prognosis of the disease.", "Azithromycin, in association with hydroxychloroquine or chloroquine, has been proposed as one such medication.", "The aim of this review is to describe the pharmacological mechanism, clinical evidence and prescribing guidelines concerning azithromycin in COVID-19 patients.", "There is weak evidence on the antiviral and immunomodulating effects of azithromycin, which in addition is not based on results from COVID-19 patients specifically.", "Therefore, this antibacterial should be considered only as empirical treatment of community-acquired pneumonia (CAP), although not all current treatment guidelines are in agreement.", "After the initial expectations raised by a small trial, more recent evidence has raised serious safety concerns on the use of hydroxychloroquine or chloroquine with azithromycin to treat COVID-19 patients, as all these drugs have arrhythmogenic potential.", "The World Health Organization has not made recommendations suggesting the use of azithromycin with hydroxychloroquine or chloroquine as treatment for COVID-19, but some national organisations have taken a different position, recommending this as first-line treatment.", "Several scientific societies, including the American College of Cardiology, have cautioned about the risks of this treatment in view of the lack of evidence concerning its benefits."], "journal": "Drug Saf", "publish_time": "2020-07-21", "aliases": []}
{"doc_id": 239531995, "title": "The impact of hydroxychloroquine and azithromycin on the corrected qt interval in patients with the novel Coronavirus disease 2019.", "abstract": ["OBJECTIVE With the coronavirus disease 2019 (COVID-19) continuing to spread all over the world, although there is no specific treatment until now, hydroxychloroquine and azithromycin have been reported to be effective in recent studies.", "Although long-term use of hydroxychloroquine and azithromycin has been reported to cause QT prolongation and malign arrhythmia, there is not enough data about the effect of short-term use on arrhythmia.", "Therefore, this study aims to assess the effect of hydroxychloroquine alone and hydroxychloroquine + azithromycin on corrected QT (QTc).", "METHODS A baseline electrocardiogram and on-treatment baseline electrocardiogram were retrospectively collected in COVID-19 patients who received hydroxychloroquine and/or azithromycin.", "The QTc interval was calculated, and the baseline and peak QTc intervals were compared.", "In addition, the peak QTc intervals of monotherapy and combination therapy were compared.", "RESULTS Of the 155 patients included, 102 (65.8%) patients were using hydroxychloroquine, and 53 (34.2%) patients were using hydroxychloroquine + azithromycin combination.", "The use of both hydroxychloroquine alone and hydroxychloroquine + azithromycin combined therapy significantly prolonged the QTc, and the QTc interval was significantly longer in patients receiving combination therapy.", "QTc prolongation caused early termination in both groups, 5 (4.9%) patients in the monotherapy group and 6 (11.3%) patients in the combination therapy group.", "CONCLUSION In this study, patients who received hydroxychloroquine for the treatment of COVID-19 were at high risk of QTc prolongation, and concurrent treatment with azithromycin was associated with greater changes in QTc."], "journal": "Revista da Associacao Medica Brasileira", "publish_time": "2021-07-01", "aliases": []}
{"doc_id": 220970821, "title": "Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review", "abstract": ["The predicament arising from the coronavirus disease 2019 (COVID-19) pandemic has become one of the most significant modern public health challenges.", "Despite uncertainties in the viral determinants and pathogenesis, it is crucial to accurately inspect all available evidence to construct accurate clinical guidelines for optimised patient care.", "This study aims to discuss the available evidence for the use of chloroquine (CQ) and hydroxychloroquine (HCQ) against COVID-19.", "Early in vitro studies of CQ/HCQ against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are convincing.", "But contradictory evidence exists on the clinical use of CQ/HCQ, either alone or in combination with azithromycin.", "As of now, there is no compelling clinical evidence on CQ, HCQ, and azithromycin in COVID-19 and the available evidence is limited to methodologically inferior non-randomised studies.", "Studies have also shown detrimental drug reactions to CQ and \u2018HCQ plus azithromycin\u2019, mainly cardiac side effects in hospitalised patients with coexisting cardiovascular comorbidities.", "Therefore, we recommend that physicians avoid high doses and exercise extreme caution in the compassionate use of CQ/HCQ, either alone or in combination with other antiviral drugs."], "journal": "Ther Adv Infect Dis", "publish_time": "2020-08-04", "aliases": []}
{"doc_id": 236959681, "title": "Effect of azithromycin and hydroxychloroquine in patients hospitalized with COVID\u201019: Network meta\u2010analysis of randomized controlled trials", "abstract": ["Chloroquine or its derivative hydroxychloroquine (HCQ) combined with or without azithromycin (AZ) have been widely investigated in observational studies as a treatment option for coronavirus 2019 (COVID\u201019) infection.", "The network meta\u2010analysis aims to summarize evidence from randomized controlled trials (RCTs) to determine if AZ or HCQ is associated with improved clinical outcomes.", "PubMed and Embase were searched from inception to March 7, 2021.", "We included published RCTs that investigated the efficacy of AZ, HCQ, or its combination among hospitalized patients with COVID\u201019 infection.", "The outcomes of interest were all\u2010cause mortality and the use of mechanical ventilation.", "The pooled odds ratio was calculated using a random\u2010effect model.", "A total of 10 RCTs were analyzed.", "Participant's mean age ranged from 40.4 to 66.5 years.", "There was no significant effect on mortality associated with AZ plus HCQ (odds ratio [OR] = 0.562 [95% confidence interval {CI}: 0.168\u20131.887]), AZ alone (OR = 0.965 [95% CI: 0.865\u20131.077]), or HCQ alone (OR = 1.122 [95% CI: 0.995\u20131.266]; p = 0.06).", "Similarly, based on pooled effect sizes derived from direct and indirect evidence, none of the treatments had a significant benefit in decreasing the use of mechanical ventilation.", "No heterogeneity was identified (Cochran's Q = 1.68; p = 0.95; \u03c4 (2) = 0; I (2) = 0% [95% CI: 0%\u20130%]).", "Evidence from RCTs suggests that AZ with or without HCQ was not associated with a significant effect on the mortality or mechanical ventilation rates in hospitalized patients with COVID\u201019.", "More research is needed to explore therapeutics agents that can effectively reduce the mortality or severity of COVID\u201019."], "journal": "J Med Virol", "publish_time": "2021-08-17", "aliases": []}
{"doc_id": 239031185, "title": "A Systematic Review on the Therapeutic Relevance of Hydroxychloroquine/Chloroquine in the Management of COVID-19", "abstract": ["BACKGROUND: The coronavirus disease-2019 (COVID-19) pandemic is coming to the fore and has surfaced as a public health emergency of international concern.", "The lack of vaccines or an effective treatment has led to the global hunt for potential pharmaceuticals in adequately managing this disease.", "This systematic review highlights the efficacy of chloroquine and its derivative hydroxychloroquine in the treatment of COVID-19 and also explores the safety profile of these drugs.", "METHODS: EMBASE, COCHRANE, and PubMed databases were searched for studies on the use of hydroxychloroquine or chloroquine in the treatment of COVID-19.", "RESULTS: Twenty articles were selected including expert opinions, National Guidelines, three small randomized controlled trials, and one prospective study.", "Both hydroxychloroquine and chloroquine have shown promising results including reduction in hospital length of stay and overall mortality.", "Moreover, concomitant use with azithromycin seems to reduce viral load to a greater extent.", "CONCLUSIONS: Considering the known safety profile of these drugs in the treatment of other diseases, their availability and affordability, chloroquine and hydroxychloroquine are potential antiviral agents in the treatment of COVID-19.", "However, reported side effects of these drugs when used in conjunction with azithromycin in patients with comorbidities have raised significant safety concerns.", "High-quality randomized clinical trials are warranted to provide more comprehensive evidence of the safety of these drugs in patients infected with COVID-19."], "journal": "Indian J Community Med", "publish_time": "2021-10-13", "aliases": []}
{"doc_id": 221589723, "title": "Safety assessment of drug combinations used in COVID-19 treatment: in silico toxicogenomic data-mining approach", "abstract": ["Improvement of COVID-19 clinical condition was seen in studies where combination of antiretroviral drugs, lopinavir and ritonavir, as well as immunomodulant antimalaric, chloroquine/hydroxychloroquine together with the macrolide-type antibiotic, azithromycin, was used for patient's treatment.", "Although these drugs are \u201cold\u201d, their pharmacological and toxicological profile in SARS-CoV-2 \u2013 infected patients are still unknown.", "Thus, by using in silico toxicogenomic data-mining approach, we aimed to assess both risks and benefits of the COVID-19 treatment with the most promising candidate drugs combinations: lopinavir/ritonavir and chloroquine/hydroxychloroquine + azithromycin.", "The Comparative Toxicogenomics Database (CTD; http://CTD.mdibl.org), Cytoscape software (https://cytoscape.org) and ToppGene Suite portal (https://toppgene.cchmc.org) served as a foundation in our research.", "Our results have demonstrated that lopinavir/ritonavir increased the expression of the genes involved in immune response and lipid metabolism (IL6, ICAM1, CCL2, TNF, APOA1, etc.).", "Chloroquine/hydroxychloroquine + azithromycin interacted with 6 genes (CCL2, CTSB, CXCL8, IL1B, IL6 and TNF), whereas chloroquine and azithromycin affected two additional genes (BCL2L1 and CYP3A4), which might be a reason behind a greater number of consequential diseases.", "In contrast to lopinavir/ritonavir, chloroquine/hydroxychloroquine + azithromycin downregulated the expression of TNF and IL6.", "As expected, inflammation, cardiotoxicity, and dyslipidaemias were revealed as the main risks of lopinavir/ritonavir treatment, while chloroquine/hydroxychloroquine + azithromycin therapy was additionally linked to gastrointestinal and skin diseases.", "According to our results, these drug combinations should be administrated with caution to patients suffering from cardiovascular problems, autoimmune diseases, or acquired and hereditary lipid disorders."], "journal": "Toxicol Appl Pharmacol", "publish_time": "2020-09-11", "aliases": []}
{"doc_id": 221405788, "title": "Treatment Options for Severe Acute Respiratory Syndrome, Middle East Respiratory Syndrome, and Coronavirus Disease 2019: a Review of Clinical Evidence", "abstract": ["Coronaviruses have caused serious Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus Disease 2019 (COVID-19) outbreaks, and only remdesivir has been recently indicated for the treatment of COVID-19.", "In the line of therapeutic options for SARS and MERS, this study aims to summarize the current clinical evidence of treatment options for COVID-19.", "In general, the combination of antibiotics, ribavirin, and corticosteroids was considered as a standard treatment for patients with SARS.", "The addition of this conventional treatment with lopinavir/ritonavir, interferon, and convalescent plasma showed potential clinical improvement.", "For patients with MERS, ribavirin, lopinavir/ritonavir, interferon, and convalescent plasma were continuously recommended.", "However, a high-dose of corticosteroid was suggested for severe cases only.", "The use of lopinavir/ritonavir and convalescent plasma was commonly reported.", "There was limited evidence for the effect of corticosteroids, other antiviral drugs like ribavirin, and favipiravir.", "Monoclonal antibody of tocilizumab and antimalarial agents of chloroquine and hydroxychloroquine were also introduced.", "Among antibiotics for infection therapy, azithromycin was suggested.", "In conclusion, this study showed the up-to-date evidence of treatment options for COVID-19 that is helpful for the therapy selection and the development of further guidelines and recommendations.", "Updates of on-going clinical trials and observational studies may confirm the current findings."], "journal": "Infect Chemother", "publish_time": "2020-09-16", "aliases": []}
{"doc_id": 219300087, "title": "Hydroxychloroquine/ chloroquine as a treatment choice or prophylaxis for Covid-19 at the primary care level in developing countries: A Primum non Nocere dilemma", "abstract": ["The Food and Drug Administration (FDA) warned against the use of Hydroxychloroquine or chloroquine for Covid-19 outside of a hospital or a clinical trial setting due to the risk of QT interval prolongation, ventricular tachycardia and the increased risk of these complications when combined with some antibiotics such as azithromycin.", "Several studies have reported no benefit of Hydroxychloroquine or chloroquine, when used alone or with a macrolide in COVID-19 hospitalized patients.", "Despite these warnings, in several developing countries the official guidelines for treatment of Covid-19 patients at the primary care level recommend Hydroxychloroquine and azithromycin, among other treatments, as the first-choice for mild symptomatic Covid-19 patients, asymptomatic contacts or for prophylaxis.", "In our opinion there is a primum non nocere dilemma during this Covid-19 pandemic.", "In order to solve this bioethical problem, we strongly recommend that a randomized controlled trial in a primary care setting be carried out as a matter of urgency in these areas of the world."], "journal": "J Neurol Sci", "publish_time": "2020", "aliases": []}
{"doc_id": 226658281, "title": "Hydroxychloroquine and chloroquine in prophylaxis and treatment of COVID-19: What is known?", "abstract": ["The corona virus disease-19 (COVID-19) pandemic has affected the entire world causing huge economic losses and considerable morbidity and mortality.", "Considering the explosive growth of the pandemic repurposing existing medicines may be cost-effective and may be approved for use in COVID-19 faster.", "Researchers and medical practitioners worldwide have explored the use of chloroquine and hydroxychloroquine, in few occasions combined with the macrolide antibiotic azithromycin, for COVID-19 treatment.", "These two drugs are economic and easily available, and hence gained attention as a potential option for COVID-19 management.", "As per the available evidence, the outcomes of treatments with these medications are conflicting from both the efficacy and safety (predominantly cardiac related) perspectives currently, multiple studies are underway to test the safety and efficacy of these medications and more results are expected in the near future.", "The retina, the endocrine system (with risk of hypoglycemia), the musculoskeletal system, the hematological system, and the neurological system may also be affected.", "The use of these drugs is contraindicated in patients with arrhythmias, known hypersensitivity, and in patients on amiodarone.", "In addition to the published literature, personal communication with doctors treating COVID-19 patients seems to suggest the drugs may be effective in reducing symptoms and hastening clinical recovery.", "The literature evidence is still equivocal and further results are awaited.", "There has been recent controversy including retraction of articles published in prestigious journals about these medicines.", "Their low cost, long history of use, and easy availability are positive factors with regard to use of these drugs in COVID-19 \u00a9 2021 Wolters.", "Kluwer.", "Medknow.", "Publications.", "All rights reserved."], "journal": "Journal of Pharmacy and Bioallied Sciences", "publish_time": "2021", "aliases": []}
{"doc_id": 238713932, "title": "An Umbrella Review of Clinical Efficacy and Adverse Cardiac Events Associated with Hydroxychloroquine or Chloroquine with or Without Azithromycin in Patients with COVID-19", "abstract": ["CONTEXT: The safety and efficacy of several repurposed drugs, including hydroxychloroquine and chloroquine, with or without azithromycin, were presumed to be miraculous in treating patients with COVID-19.", "However, as it later transpired, these therapeutic agents seem to be associated with critical adverse cardiac events.", "OBJECTIVES: Given the skepticism around the advantages and disadvantages of the aforementioned treatment strategies, the present study aimed to investigate the clinical efficacy and cardiac toxicity of hydroxychloroquine or chloroquine with or without azithromycin in the setting of COVID-19 infection.", "METHOD: This was an umbrella review conducted on patients with COVID-19 who received hydroxychloroquine or chloroquine with or without azithromycin from January 2020 to November 2020.", "We systematically searched PubMed, Scopus, Cochrane, ProQuest, Web of Science, and Embase databases.", "RESULTS: Three studies (systematic review and meta-analysis) were analyzed to evaluate the arrhythmogenic potential of hydroxychloroquine or chloroquine with or without azithromycin in patients with COVID-19 and identify the clinical efficacy of such a combination.", "CONCLUSIONS: We found no benefit for patients with COVID-19 who received hydroxychloroquine or chloroquine alone or in combination with azithromycin.", "Moreover, it is noteworthy that these medications, particularly when considering co-administration, could result in both statistically and clinically elevated risks of notorious arrhythmias, such as TdP."], "journal": "Anesth Pain Med", "publish_time": "2021-08-15", "aliases": []}
{"doc_id": 227159320, "title": "Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine", "abstract": ["The ongoing pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has drawn the attention of researchers and clinicians from several disciplines and sectors who are trying to find durable solutions both at preventive and treatment levels.", "To date, there is no approved effective treatment or vaccine available to control the coronavirus disease-2019 (COVID-19).", "The preliminary in vitro studies on viral infection models showed potential antiviral activities of type I and III interferons (IFNs), chloroquine (CQ)/hydroxychloroquine (HCQ), and azithromycin (AZM); however, the clinical studies on COVID-19 patients treated with CQ/HCQ and AZM led to controversies in different regions due to their adverse side effects, as well as their combined treatment could prolong the QT interval.", "Interestingly, the treatment with type I IFNs showed encouraging results.", "Moreover, the different preliminary reports of COVID-19 candidate vaccines showcase promising results by inducing the production of a high level of neutralizing antibodies (NAbs) and specific T cell-mediated immune response in almost all participants.", "The present review aims to summarize and analyze the recent progress evidence concerning the use of IFNs, CQ/HCQ, and AZM for the treatment of COVID-19.", "The available data on immunization options to prevent the COVID-19 are also analyzed with the aim to present the promising options which could be investigated in future for sustainable control of the pandemic."], "journal": "Biomed Pharmacother", "publish_time": "2020-11-11", "aliases": []}
{"doc_id": 216642707, "title": "An evaluation of co-use of chloroquine or hydroxychloroquine plus azithromycin on cardiac outcomes: A pharmacoepidemiological study to inform use during the COVID19 pandemic", "abstract": ["BACKGROUND: Chloroquine or hydroxychloroquine (chloroquine) plus azithromycin is considered as therapy for COVID-19.", "With benefit evaluations underway, safety concerns due to potential additive effects on QTc prolongation should be addressed.", "OBJECTIVE: We compared risk of cardiac adverse events between combinations of chloroquine and azithromycin and chloroquine and amoxicillin.", "METHODS: We conducted a retrospective cohort study using the IBM MarketScan Commercial Claims and Medicare Supplemental Databases, 2005\u20132018.", "We included autoimmune disease patients aged \u226518 years initiating azithromycin or amoxicillin for \u22655 days during chloroquine treatment.", "Patients had continuous insurance coverage \u22656 months before combination use until 5 days thereafter or inpatient death.", "Two outcomes were sudden cardiac arrest/ventricular arrhythmias (SCA/VA) and cardiac symptoms.", "We followed patients for up to 5 days to estimate hazard ratios (HR).", "Covariates were adjusted using stabilized inverse probability treatment weighting.", "RESULTS: We identified two SVC/VA events among >145,000 combination users.", "The adjusted incidence of cardiac symptoms among azithromycin and amoxicillin users was 276 vs 254 per 10,000 person-years with an adjusted HR of 1.10 (95%CI, 0.62\u20131.95).", "CONCLUSION: Combination use of chloroquine and azithromycin at routine doses did not show pronounced increases in arrhythmias in this real-world population, though small sample size and outcome rates limit conclusions."], "journal": "Res Social Adm Pharm", "publish_time": "2020-04-30", "aliases": []}
{"doc_id": 220672273, "title": "Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID\u201019 Infection", "abstract": ["Chloroquine and hydroxychloroquine are quinoline derivatives used to treat malaria.", "To date, these medications are not approved for the treatment of viral infections and there are no well\u2010controlled, prospective, randomized clinical studies or evidence to support their use in patients with Coronavirus Infectious Disease\u20102019 (COVID\u201019).", "Nevertheless, chloroquine and hydroxychloroquine are being studied alone or in combination with other agents to assess their effectiveness in the treatment or prophylaxis for COVID\u201019.", "The effective use of any medication involves an understanding of its pharmacokinetics (PK), safety and mechanism of action.", "This work provides basic clinical pharmacology information relevant for planning and initiating COVID\u201019 clinical studies with chloroquine or hydroxychloroquine, summarizes safety data from healthy volunteer studies, and summarizes safety data from Phase 2 and Phase 2/3 clinical studies in patients with uncomplicated malaria, including a Phase 2/3 study in pediatric patients following administration of azithromycin and chloroquine in combination.", "In addition, this work presents data describing the proposed mechanisms of action against the severe acute respiratory distress syndrome (ARDS) coronavirus\u20132 (SARS\u2010CoV\u20102) and summarizes clinical efficacy to date."], "journal": "Clin Pharmacol Ther", "publish_time": "2020-07-20", "aliases": []}
{"doc_id": 243964110, "title": "Clinical Efficacy of Hydroxychloroquine or Chloroquine in Patients with COVID-19: An Umbrella Review", "abstract": ["[...]8 studies were included.", "Glucocorticoids, Azithromycin, Remdesivir, Ropinavir/ritonavir combination therapy, Chloroquine (CQ), Hydroxychloroquine (HCQ), Interferon beta, IL-6 inhibitor (Tocilizumab), and Favipiravir are some of the drugs being recently used for patients with COVID-19.", "Results To evaluate the clinical efficacy of CQ and HCQ on the treatment of COVID-19-induced pneumonia and their effect on mortality and disease progression in this group of patients, eight studies (including five systematic reviews and three systematic reviews with meta-analysis) were included.", "[...]its clinical use must either adhere to the Monitored Emergency Use of Unregistered and Investigational Interventions (MEURI) framework or be ethically approved by the World Health Organization as a validated test.", "2- Patil et at.2 announced the results of 100 studies, including 590368 cases, as follows: HCQ and CQ are effective in several studies (in vitro and clinical studies) in the treatment of mild to severe pneumonia"], "journal": "Pharmaceutical Sciences", "publish_time": "2021", "aliases": []}
{"doc_id": 221858042, "title": "Characteristics of patients with diabetes hospitalised for COVID-19 infection-a brief case series report", "abstract": ["OBJECTIVES: Diabetes has been shown to be a risk factor for corona virus disease-2019 (COVID-19) infection.", "The characteristics of patients with diabetes vulnerable to this infection are less specified.", "We aim to present the characteristics of patients with diabetes admitted to hospital with COVID-19.", "DESIGN: A retrospective case series.", "SETTING: A single clinical centre in the UK.", "METHODS: We have retrospectively collected the demographics, medical characteristics and outcome of all patients with diabetes admitted to hospital over two-week period with COVID-19 infection.", "All cases were diagnosed by a reverse transcription polymerase chain reaction (RT-PCR) of pharyngeal and nasal swabs.", "RESULTS: A total of 71 COVID-19 patients were admitted during the study period of whom 16 (22.5%) patients had diabetes and were included in this case series.", "There was no significant difference between patients with compared to those without diabetes regarding age, gender or clinical presentation.", "However, comorbidities were more common in patients with diabetes specially hypertension {75% v 36.4%, a difference of 38.6%, 95% confidence interval (CI) 6.5-58.3} and chronic kidney disease (37.5 v 5.5, a difference of 32% (1.6-51.6).", "Patients with diabetes were significantly more obese than those without diabetes (56.2% v 21.8% a difference of 34.4%, 95% CI 7.7-61.1).", "About one third (31.3%) of patients with diabetes were frail.", "Mean {standard deviation (SD)} duration of diabetes was 10 (2.8) years and mean (SD) HbA1c was 60.3 (15.6) mmol/mol.", "The use of angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs) and non-steroidal anti-inflammatory drugs (NSAIDs) was common (37.5%, 25% and 18.8% respectively).", "There was no significant difference in the outcomes between patients with compared to those without diabetes.", "CONCLUSION: Patients with diabetes hospitalised for COVID-19 were significantly more obese and had high prevalence of comorbidities than those without diabetes.", "Other features of patients with diabetes and COVID-19 infection included long duration of diabetes, less tight glycaemic control and common use of ACE inhibitors, ARBs and NSAIDs."], "journal": "Diabetes Res Clin Pract", "publish_time": "2020", "aliases": []}
{"doc_id": 225547972, "title": "Diabetes in COVID-19 pandemic-prevalence, patient characteristics and adverse outcomes", "abstract": ["BACKGROUND: Current literature on COVID-19 pandemic has identified diabetes as a common comorbidity in patients affected.", "However, the evidence that diabetes increases the risk of infection, effect of diabetes on outcomes and characteristics of patients at risk is not clear.", "OBJECTIVES: To explore the prevalence of diabetes in COVID-19 pandemic, effect of diabetes on clinical outcomes and to characterise the patients with diabetes affected by COVID-19.", "METHODS: A literature review of articles published in English language and reported outcomes on prevalence and effect of diabetes on outcomes and patients' characteristics.", "RESULTS: The prevalence of diabetes in COVID-19 patients appears similar to that in the general population.", "The evidence of diabetes increasing the risk of severe infection and adverse outcomes is substantial.", "The progression of the disease into acute respiratory distress syndrome, the requirement for intensive care admission or mechanical ventilation and mortality all have been increased by the presence of diabetes.", "Patients with diabetes at risk of COVID-19 appear to be obese, of older age, have uncontrolled glycaemia and have coexisting comorbidities especially cardiovascular disease and hypertension.", "Tight glycaemic control on admission to hospital using insulin infusion has shown some beneficial effects; however, the role of hypoglycaemic medications in the management of these patients is not yet clear.", "CONCLUSION: High risk group should be identified and prioritised in future vaccination programmes.", "Future research is required to optimise management of patients with diabetes and develop new ways to manage them via technological developments such as telecare."], "journal": "Int J Clin Pract", "publish_time": "2021", "aliases": [232049477]}
{"doc_id": 225080814, "title": "Multidimensional Analysis of Risk Factors for the Severity and Mortality of Patients with COVID-19 and Diabetes", "abstract": ["INTRODUCTION: Diabetes is one of the most common comorbidities of COVID-19.", "We aimed to conduct a multidimensional analysis of risk factors associated with the severity and mortality of patients with COVID-19 and diabetes.", "METHODS: In this retrospective study involving 1443 patients with COVID-19, we analyzed the clinical and laboratory characteristics and risk factors associated with disease severity in patients with COVID-19 with and without diabetes.", "Binary logistic regression analyses were performed to identify the risk factors associated with mortality in patients with COVID-19 and diabetes.", "The 84-day survival duration for critical patients with COVID-19 and diabetes who had different levels of leukocytes and neutrophils, or treated with immunoglobulin or not, was conducted using Kaplan-Meier survival curves.", "RESULTS: Of the 1443 patients with COVID-19, 256 (17.7%) had diabetes, had a median age of 66.0 [IQR 58.0-73.8] years, and were more likely to develop severe (41.8% vs. 35.6%) and critical disease (34.0% vs. 14.9%), followed by higher mortality (21.1% vs. 7.0%), than those without diabetes.", "Higher levels of leukocytes (> 5.37 \u00d7 109/L), older age, and comorbid cerebrovascular disease and chronic renal disease independently contributed to in-hospital death of patients with COVID-19 and diabetes.", "Leukocytes > 5.37 \u00d7 109/L and the application of immunoglobulin were associated with shorter survival duration and lower mortality, respectively, in critical patients with COVID-19 and diabetes.", "CONCLUSIONS: More attention should be paid to patients with COVID-19 and diabetes, especially when they have high leukocyte counts (> 5.37 \u00d7 109/L).", "Timely and adequate intravenous immunoglobulin (IVIG) use may reduce the mortality of critical patients with COVID-19 and diabetes."], "journal": "Infect Dis Ther", "publish_time": "2020", "aliases": []}
{"doc_id": 237011446, "title": "Clinical presentation and mortality risk factors for COVID-19 among diabetic patients in a tertiary care center in South India", "abstract": ["BACKGROUND: Non-communicable diseases (NCD) like hypertension, diabetes, cardiovascular and cerebrovascular diseases are the most common comorbidities among COVID-19 patients.", "The clinical presentation and mortality pattern of COVID-19 are different for patients with comorbidities and without comorbidities.", "OBJECTIVE: To determine the clinical presentation of COVID-19 and risk factors for COVID-19 mortality among diabetic patients in a tertiary care hospital in South India.", "METHODS: A record-based longitudinal study was conducted by reviewing the case records of COVID-19 patients admitted for treatment from June 2020 to September 2020 in a tertiary care centre in South India.", "Potential risk factors for COVID-19 mortality were analysed using univariate binomial logistic regression, generalized linear models (GLM) with the Poisson distribution.", "Survival curves were made using the Kaplan-Meier method.", "RESULTS: Out of 200 COVID-19 patients with diabetes with a mean (SD) age of 56.1 (11.8) years, 61% were men.", "The median survival time was slightly lesser in male COVID-19 patients (15 days) as compared to female patients (16 days).", "The risk of mortality among COVID-19 patients with diabetes is increased for patients who presented with breathlessness (aRR=4.5 (95% CI: 2.3-8.8)), had positive history of smoking (aRR=1.9 (95% CI: 1.1-3.8)), who had CKD (aRR=1.8 (95% CI: 1.1-2.8)) and who had cardiac illness (aRR=1.6 (95% CI: 0.9-2.7)).", "CONCLUSION: Diabetes patients with COVID-19 need to be given additional care and monitoring especially if they present with breathlessness, positive history of smoking, cardiac illness and, CKD.", "Public health campaigns and health education activities to control smoking is needed to reduce the COVID-19 mortality in diabetes patients."], "journal": "Indian J Tuberc", "publish_time": "2021-08-14", "aliases": []}
{"doc_id": 222081108, "title": "Relation of D-dimer levels of COVID-19 patients with diabetes mellitus", "abstract": ["BACKGROUND AND AIMS: Diabetes is a frequent comorbidity in patients with Severe COVID-19 infection associated with a worse prognosis.", "Hypercoagulability with elevation in D-dimer levels has been demonstrated in patients with COVID-19.", "This study aims to study D-dimer levels in people with diabetes compared to those without diabetes among patients with COVID-19 infection.", "METHODS: In this observational study 98 moderate and severely ill patients with COVID-19 infection were included at a dedicated COVID hospital.", "The study group was divided into patients with diabetes and without diabetes.", "Peak D-dimer was measured in both the groups and compared using appropriate statistical tests.", "RESULTS: In our study peak D-dimer levels were 1509 \u00b1 2420 ng/mL (Mean \u00b1 SD) in people with diabetes and 515 \u00b1 624 ng/mL (Mean \u00b1 SD) in patients without diabetes.", "Patients with diabetes had higher D-dimer levels which were statistically significant.", "CONCLUSIONS: This study shows COVID-19 patients with diabetes had significantly higher D-dimer levels.", "Therefore, it is possible that COVID-19 infection with diabetes is more likely to cause hypercoagulable state with a worse prognosis.", "However clinical implications of these findings will need to be seen in further studies."], "journal": "Diabetes Metab Syndr", "publish_time": "2020-10-01", "aliases": []}
{"doc_id": 245220976, "title": "Comorbidities and mortality in COVID-19 patients()", "abstract": ["BACKGROUND: The high mortality rate in Coronavirus Disease (COVID-19) patients is associated with their comorbid conditions.", "Therefore, it is important to identify risk factors associated with poor outcomes among COVID-19 patients.", "The aims of this study were to find out the comorbidities in case of death due to COVID-19.", "METHODS: The design of this study was a retrospective descriptive method with a confirmed COVID-19 patient on hospitalized at Dr. Wahidin Sudirohusodo Hospital from March to September 2020.", "Ethics Council recommendation number: 357/UN4.6.4.5.31/PP36/2020.", "RESULTS: A total of 454 patients were included of this study.", "78 (17.18%) patients death due to COVID-19, consisting of 52 (66.67%) male and 26 (33.33%) female.", "Range of ages between 18 and 85 years.", "The highest mortality rate occurred in the age group \u226560 years (35; 51.47%), followed by the age group of 45\u201359 years (33; 48.53%), and the age group of <45 years (10; 12%).", "The prevalent comorbidity was hypertension (42.31%), cardiovascular disease (30.77%), diabetes (28.21%), chronic kidney disease (23.08%), malignancy (15.38%), obesity (15.38%), chronic liver disease (7.69%), chronic respiratory disease (6.41%), immune related disease (3.85%), and non-traumatic cerebral infarction (3.85%).", "41 (52.56%) patients reported having two or more comorbidities, and 37 (47.44%) only has one comorbidity.", "Elevated neutrophil-to-lymphocyte ratio (NLR) \u22653.13 was seen in the majority of patients (68; 87.18%).", "The mean value of NLR was 20.94.", "CONCLUSIONS: Hypertension, cardiovascular disease, and diabetes were the most common comorbidity in patients death due to COVID-19.", "More than half of the patients had two or more comorbidities."], "journal": "Gac Sanit", "publish_time": "2021-12-17", "aliases": []}
{"doc_id": 220287360, "title": "Chronic heart diseases as the most prevalent comorbidities among deaths by COVID-19 in Brazil", "abstract": ["Age, sex and presence of comorbidities are risk factors associated with COVID-19.", "Hypertension, diabetes and heart disease are the most common comorbidities in patients with COVID-19.", "The objective of this study was to estimate the prevalence of patients with comorbidities who died of COVID-19 in Brazil.", "Searches of data were carried out on the official pages of the 26 State health departments and the federal district.", "The random-effect method was used to calculate the prevalence of patients with comorbidities who died.", "From the beginning of the pandemic in Brazil until May 20, 2020, 276,703 cases of COVID-19 were notified in Brazil, 6.4% died, 58.6% of whom were male.", "The prevalence of comorbidities among deaths was 83% (95% CI: 79 - 87), with heart disease and diabetes being the most prevalent.", "To our knowledge, this study represents the first large analysis of cases of patients with confirmed COVID-19 in Brazil.", "There is a high prevalence of comorbidities (83%) among patients who died from COVID-19 in Brazil, with heart disease being the most prevalent.", "This is important considering the possible secondary effects produced by drugs such as hydroxychloroquine."], "journal": "Rev Inst Med Trop Sao Paulo", "publish_time": "2020", "aliases": []}
{"doc_id": 238997555, "title": "Diabetes and covid-19 in congolese patients", "abstract": ["Background: The global pandemic Coronavirus Disease 2019 (COVID-19) due to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is reported to be potentially severe in patients with morbid conditions.", "One common reported comorbidities is diabetes.", "We aimed in this study to precise the clinical characteristics and outcomes in a series of congolese diabetic patients affected by COVID-19 infection.", "Patients and methods: We retrospectely studied from 256 COVID-19 patients, a cohort of 30 persons with previously known diabetes.", "The glycaemia controls have been obtained by plasma glucose assay.", "All patients have been tested positive to SARS-CoV-2 by RT-PCR method.", "Results: The COVID-19 diabetic patients represented 11,7% of all COVID-19 patients with confidence interval of 95% [7,77-15,65].", "Older individuals and male sex were predominent.", "Dyspnea and sauration of oxygen < 90 were significatives and added risk factors were noted in 63.3% of patients, particulary hyperglycaemia with hypertension or obesity.", "The mortality rate at the percentage of 36.7% was more prevalent in patients with added comorbidities (30%) versus without comorbidities (6.7%).", "Conclusion: Congolese COVID-19 diabetic patients of male sex and older age exhibiting arterial hypertension and obesity are the most exposed to severe COVID-19 and increasead mortality rate."], "journal": "African Health Sciences", "publish_time": "2021", "aliases": []}
{"doc_id": 220304662, "title": "Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events", "abstract": ["BACKGROUND AND AIMS: Currently there is limited knowledge on medical comorbidities and COVID-19; we conducted a systematic review and meta-analysis to evaluate the impact of various morbidities on serious events in COVID 19.", "METHODS: PubMed, Cochrane Central Register of Clinical Trials were searched on April 28, 2020, to extract published articles that reported the outcomes of COVID-19 patients.", "The search terms were \"coronavirus\" and \"clinical characteristics\".", "ICU admission, mechanical ventilation, ARDS, Pneumonia, death was considered serious events.", "The comorbidities assessed in the study were Hypertension (HTN), Diabetes mellitus (DM), Cardiovascular diseases (CVD), Chronic obstructive pulmonary disease (COPD) and Chronic Kidney disease (CKD).", "Subsequently, comparisons between comorbidity patient group and the non-comorbidity patient groups, in terms of serious events were made using the pooled estimates of odd's ratio (OR) RESULTS: We identified 688 published results and 16 studies with 3994 patients were included in the systematic review.", "Serious events were seen in 526(13.16%) patients.", "Presence of hypertension with OR 2.95, diabetes mellitus with OR 3.07, Cardio vascular disease with OR 4.58, COPD with OR 6.66 and Chronic kidney disease with OR 5.32 had significant association in patients with COVID 19 on having serious events.", "Presence of diabetes mellitus (OR 2.78)) had a significant impact on death in COVID 19 patients with a p-value 0.004.", "CONCLUSIONS: Presence of medical comorbidities in COVID-19 leads to higher risk of developing serious events i.e.", "ICU admission, mechanical intubation and mortality.", "The presence of Diabetes mellitus has a significant impact on mortality rate in COVID-19 patients."], "journal": "Diabetes Metab Syndr", "publish_time": "2020", "aliases": []}
{"doc_id": 236784305, "title": "The presentation of clinical characteristics, comorbidities, and outcomes among covid-19 confirmed patients in banda aceh, Indonesia", "abstract": ["Introduction: Coronavirus disease 2019 (COVID-19) is a highly contagious disease with an increasing number of infections in Indonesia.", "However, hypertension and diabetes are chronic diseases with high incidence in Aceh, there is still limited information regarding the demographics and clinical data of COVID-19 patients.", "This study aims to explain the clinical characteristics, comorbidities, and outcomes of COVID-19 patients.", "Methods: A retrospective method was used to locate data from the medical record of COVID-19 patients that were admitted to the hospital between March-June 2020.", "The characteristics demographics, clinical data on admission, and outcomes were extracted from the medical record.", "In order to determine the comorbid relationship, the chi-square test was used for the laboratory tests and clinical outcomes.", "Results: A total of 240 patients were included, and more than one-third were male 141 (58.8%) with 20-40 years of age at most (47.5%).", "Most of the patients had comorbid hypertension (14%) and diabetes mellitus (13.", "Furthermore, most COVID-19 was mild and very severe degrees respectively, 141 (58.8%) and 31 (12.9%).", "The patients with recovery are 209 (87.1%) and only 31 (12.9%) died.", "Lymphopenia, neutropenia, and Degree of severity had a significant relationship with the clinical outcome of COVID-19 (p <0.05).", "The comorbid and clinical outcome did not show a significant relationship (p> 0.05).", "Conclusion: Hypertension and diabetes mellitus are the most common comorbid reported in the COVID-19 patients.", "The Inflammation markers, such as lymphocytes and neutrophils can be used as an early warning to increase awareness in the treatment of the patients.", "\u00a9 2021, Sanglah General Hospital.", "All rights reserved."], "journal": "Bali Medical Journal", "publish_time": "2021", "aliases": []}
{"doc_id": 241581523, "title": "Diabetes patients with comorbidities had unfavorable outcomes following COVID-19: A retrospective study", "abstract": ["BACKGROUND: Previous studies have shown that diabetes mellitus is a common comorbidity of coronavirus disease 2019 (COVID-19), but the effects of diabetes or anti-diabetic medication on the mortality of COVID-19 have not been well described.", "AIM: To investigate the outcome of different statuses (with or without comorbidity) and anti-diabetic medication use before admission of diabetic after COVID-19.", "METHODS: In this multicenter and retrospective study, we enrolled 1422 consecutive hospitalized patients from January 21, 2020, to March 25, 2020, at six hospitals in Hubei Province, China.", "The primary endpoint was in-hospital mortality.", "Epidemiological material, demographic information, clinical data, laboratory parameters, radiographic characteristics, treatment and outcome were extracted from electronic medical records using a standardized data collection form.", "Most of the laboratory data except fasting plasma glucose (FPG) were obtained in first hospitalization, and FPG was collected in the next day morning.", "Major clinical symptoms, vital signs at admission and comorbidities were collected.", "The treatment data included not only COVID-19 but also diabetes mellitus.", "The duration from the onset of symptoms to admission, illness severity, intensive care unit (ICU) admission, and length of hospital stay were also recorded.", "All data were checked by a team of sophisticated physicians.", "RESULTS: Patients with diabetes were 10 years older than non-diabetic patients [(39 - 64) vs (56 - 70), P < 0.001] and had a higher prevalence of comorbidities such as hypertension (55.5% vs 21.4%, P < 0.001), coronary heart disease (CHD) (9.9% vs 3.5%, P < 0.001), cerebrovascular disease (CVD) (3% vs 2.2%, P < 0.001), and chronic kidney disease (CKD) (4.7% vs 1.5%, P = 0.007).", "Mortality (13.6% vs 7.2%, P = 0.003) was more prevalent among the diabetes group.", "Further analysis revealed that patients with diabetes who took acarbose had a lower mortality rate (2.2% vs 26.1, P < 0.01).", "Multivariable Cox regression showed that male sex [hazard ratio (HR) 2.59 (1.68 - 3.99), P < 0.001], hypertension [HR 1.75 (1.18 - 2.60), P = 0.006), CKD [HR 4.55 (2.52-8.20), P < 0.001], CVD [HR 2.35 (1.27 - 4.33), P = 0.006], and age were risk factors for the COVID-19 mortality.", "Higher HRs were noted in those aged \u2265 65 (HR 11.8 [4.6 - 30.2], P < 0.001) vs 50-64 years (HR 5.86 [2.27 - 15.12], P < 0.001).", "The survival curve revealed that, compared with the diabetes only group, the mortality was increased in the diabetes with comorbidities group (P = 0.009) but was not significantly different from the non-comorbidity group (P = 0.59).", "CONCLUSION: Patients with diabetes had worse outcomes when suffering from COVID-19; however, the outcome was not associated with diabetes itself but with comorbidities.", "Furthermore, acarbose could reduce the mortality in diabetic."], "journal": "World J Diabetes", "publish_time": "2021-10-15", "aliases": []}
{"doc_id": 232243179, "title": "Outcomes of COVID-19 patients with comorbidities in southwest Nigeria", "abstract": ["BACKGROUND: Data on the comorbidities that result in negative outcomes for people with COVID-19 are currently scarce for African populations.", "This study identifies comorbidities that predict death among a large sample of COVID-19 patients from Nigeria.", "METHODS: This was a retrospective analysis of medical records for 2184 laboratory confirmed cases of COVID-19 in Lagos, southwest Nigeria.", "Extracted data included age, sex, severity of condition at presentation and self-reported comorbidities.", "The outcomes of interest were death or discharge from facility.", "RESULTS: Most of the cases were male (65.8%) and the median age was 43 years (IQR: 33\u201355).", "Four hundred and ninety-two patients (22.5%) had at least one comorbidity and the most common amongst them were hypertension (74.2%) and diabetes (30.3%).", "The mortality rate was 3.3% and a significantly higher proportion of patients with comorbidities died compared to those with none.", "The comorbidities that predicted death were hypertension (OR: 2.21, 95%CI: 1.22\u20134.01), diabetes (OR: 3.69, 95% CI: 1.99\u20136.85), renal disease (OR: 12.53, 95%CI: 1.97\u201379.56), cancer (OR: 14.12, 95% CI: 2.03\u201398.19) and HIV (OR: 1.77\u201384.15].", "CONCLUSION: Comorbidities are prevalent and the associated risk of death is high among COVID-19 patients in Lagos, Nigeria.", "Public enlightenment, early identification and targeted care for COVID-19 cases with comorbidities are recommended as the pandemic evolves."], "journal": "PLoS One", "publish_time": "2021-03-15", "aliases": []}
{"doc_id": 236147154, "title": "Clinico-demographic, hematological, and comorbidity profile of COVID-19 patients admitted at tertiary care center", "abstract": ["Introduction: Severe acute respiratory syndrome coronavirus 2 has caused a worldwide pandemic.", "This study was aimed to describe the clinico-demographic, hematological, and comorbidity profile in a group of coronavirus disease 2019 (COVID-19) patients at a tertiary care center in north India.", "Materials and Methods: We conducted a prospective, single-center collection of data regarding clinico-epidemiological, hematological parameters, and comorbidity profile of COVID-19 patients admitted at a tertiary care facility.", "Results: Data from 200 patients with COVID-19 were collected and analyzed.", "The median age of the patients was 48 years, with 63% males, and 78% patients were from urban area.", "Ten patients were smokers while 11 patients were alcoholic.", "The occupation of 20.6% of patients was related directly or indirectly with medical or allied professions.", "The most common mode of transmission of COVID-19 was direct close contact with microbiologically confirmed patients.", "Fever (n = 93;46.5%) was the most common presenting symptom and the median duration of onset of symptoms before admission were 3.5 days (range 2-6 days).", "In hematological profile, lymphopenia (n = 48;24%) had been the most common documented finding.", "Comorbidities were present in 39 (19.5%) patients, of which diabetes mellitus (n = 25;12.5%) was the most common.", "Furthermore, the case fatality rate in our study was 1.5%.", "Conclusion: Among all patients of COVID-19 at our center, the characteristic findings included high proportion of male patients with younger to middle-age group, diabetes as most common comorbidity and people who were directly or indirectly in contact with the health-care system were more prone for developing the disease."], "journal": "Indian Journal of Respiratory Care", "publish_time": "2021", "aliases": []}
{"doc_id": 220670124, "title": "Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort", "abstract": ["BACKGROUND: Hospitalized COVID-19 patients tend to be older and frequently have hypertension, diabetes, or coronary heart disease, but whether these comorbidities are true risk factors (ie, more common than in the general older population) is unclear.", "We estimated associations between preexisting diagnoses and hospitalized COVID-19 alone or with mortality, in a large community cohort.", "METHODS: UK Biobank (England) participants with baseline assessment 2006-2010, followed in hospital discharge records to 2017 and death records to 2020.", "Demographic and preexisting common diagnoses association tested with hospitalized laboratory-confirmed COVID-19 (March 16 to April 26, 2020), alone or with mortality, in logistic models.", "RESULTS: Of 269 070 participants aged older than 65, 507 (0.2%) became COVID-19 hospital inpatients, of which 141 (27.8%) died.", "Common comorbidities in hospitalized inpatients were hypertension (59.6%), history of fall or fragility fractures (29.4%), coronary heart disease (21.5%), type 2 diabetes (type 2, 19.", "9%), and asthma (17.6%).", "However, in models adjusted for comorbidities, age group, sex, ethnicity, and education, preexisting diagnoses of dementia, type 2 diabetes, chronic obstructive pulmonary disease, pneumonia, depression, atrial fibrillation, and hypertension emerged as independent risk factors for COVID-19 hospitalization, the first 5 remaining statistically significant for related mortality.", "Chronic kidney disease and asthma were risk factors for COVID-19 hospitalization in women but not men.", "CONCLUSIONS: There are specific high-risk preexisting comorbidities for COVID-19 hospitalization and related deaths in community-based older men and women.", "These results do not support simple age-based targeting of the older population to prevent severe COVID-19 infections."], "journal": "J Gerontol A Biol Sci Med Sci", "publish_time": "2020", "aliases": []}
{"doc_id": 220797339, "title": "Hypertension is a risk factor for adverse outcomes in patients with coronavirus disease 2019: a cohort study.", "abstract": ["Background: Comorbidities are commonly seen in patients with coronavirus disease 2019 (COVID-19), but the clinical implication is not yet well-delineated.", "We aim to characterize the prevalence and clinical implications of comorbidities in patients with COVID-19.Methods: This is a retrospective multi-center study involving patients admitted between January 16th and March 10th 2020.The composite endpoint was defined as the presence of at least one of the following, intensive care unit (ICU) admission, or the need for mechanical ventilation, or death.Results: Atotal of472 consecutive cases admitted to 51 certified COVID-19 tertiary care hospitals were enrolled(median age was 43 [32-53.5] years and 53.0% were male).There were101 (21.4%) patients presented with comorbidities, including hypertension (15.0%), diabetes mellitus (7.8%), coronary artery disease (2.6%), chronic obstructive pulmonary disease (1.3%) and cerebrovascular disease (1.9%).The composite endpoint occurred in 65 (13.8%) patients.Multivariate stepwise logistic regression analysis indicated that older age(odds ratio [OR] 1.39, 95% confidence interval (CI) 1.05-1.85, per 10 -year increment),antecedent hypertension(OR 2.82, 95% CI 1.09-7.29), neutrophil counts (OR 1.33, 95% CI 1.14-1.56)and lactate dehydrogenase level (OR 1.01, 95% CI 1.00-1.01)were independently associated with the presence of composite endpoint.Hypertensive patients, compared with controls, had a greater chance of experiencing the composite endpoint (P < 0.001) and each individual endpoint,i.e.ICU admission (P < 0.001), mechanical ventilation (P < 0.001) and death (P = 0.012).In the stepwise regression analysis ofanti-hypertensive medications, none of the therapy predicted the composite endpoint.Conclusions: Hypertension is a common comorbidity in patients with COVID-19 and associated with adverse outcomes.", "Key messagesHypertension was identified as the comorbidity associated with the prognosis of COVID-19in this retrospective cohort.Patients with hypertension could experience an increased risk of thecomposite endpoint.Anti-hypertensive therapy did not affect patient outcomes."], "journal": "Annals of medicine", "publish_time": "2020-07-27", "aliases": []}
{"doc_id": 222277996, "title": "Clinical Outcomes in Diabetic Vs Non-diabetic Patients with Severe Covid-19", "abstract": ["session TITLE: critical care posters SESSION TYPE: Original.", "Investigation.", "Posters PRESENTED ON: October 18-21, 2020 PURPOSE: Diabetes has been shown in recent studies to be highly prevalent in critically ill patients with severe coronavirus disease 2019 (COVID-19) However, data comparing clinical outcomes in diabetic and non-diabetic patients remained limited.", "We aim to compare characteristics and clinical outcomes of diabetic and non-diabetic critically ill patients with severe COVID-19 methods: Following institutional review board approval, we identified 115 patients who were admitted to the intensive care unit (icu) for severe COVID-19 De-identified patient data was retrospectively collected and analyzed using stata version 15 1 (statcorp) data reported here are those which are available through April 28 2020 RESULTS: We identified 115 patients who were admitted to the icu for severe COVID-19 The population had a mean age of 63 44 years, 67% were male, the mean bmi was 33 30 The mean duration of symptoms prior to hospitalization was 6 35 days.", "Comorbidities were common, 68 patients had a Charlson comorbidities index equal to or above 3 The most common comorbidities included hypertension (65%), diabetes (41%) and hyperlipidemia (35%) The most common symptoms were dyspnea (81%), cough (75%) and fever (68%) When comparing the 47 diabetic and the 68 non-diabetic patients in our study, there was a similar number of patients requiring invasive (65% diabetic; 51% non-diabetic) and non-invasive mechanical ventilation (36% diabetic; 48% non-diabetic) There were no significant differences in their clinical management.", "Both populations had similar rates of shock requiring vasopressors (57% diabetic; 48% non-diabetic) and renal failure requiring renal replacement therapy (27% diabetic; 25% non-diabetic) There were no significant differences in the rate of acute kidney injury (61% diabetics; 40% non-diabetics) and acute hepatic injury between both groups (27% diabetics; 22% non-diabetics) diabetic patients had significantly higher rates of troponin elevation (89% diabetics; 70% non-diabetic) After propensity score matching, diabetics were more likely to experience in hospital mortality (OR 2 94 CI 1 32; 6 52, p-value 0 008) and were less likely to be discharged from the hospital (OR 0 38 CI 0 17; 0 83, p-value 0 02) when compared with non-diabetics CONCLUSIONS: Diabetics experience higher rates of mortality and are less likely to be discharged when compared with non-diabetic patients clinical IMPLICATIONS: Further studies to evaluate management strategies in diabetic patients with severe COVID-19 may be useful given the increased risk for mortality in this population DISCLOSURES: No relevant relationships by yasmin herrera, source=Web.", "Response.", "No relevant relationships by kam sing ho, source=Web.", "Response.", "No relevant relationships by raymonde jean, source=Web.", "Response.", "No relevant relationships by joseph poon, source=Web.", "Response."], "journal": "Chest", "publish_time": "2020", "aliases": []}
{"doc_id": 222351753, "title": "Impact of comorbidities on clinical prognosis in 1280 patients with different types of COVID-19", "abstract": ["The study aimed to compare the clinical characteristics and outcomes of patients with different types (ordinary, severe, and critical) of COVID-19.", "A total of 1280 patients diagnosed with COVID-19 were retrospectively studied, including 793 ordinary patients, 363 severe patients and 124 critical patients.", "The impact of comorbidities on prognosis in ordinary, severe, and critical patients were compared and analyzed.", "The most common comorbidities were hypertension (33.0%), followed by diabetes (14.4%).", "The length of hospital stay and time from the onset to discharge were significantly longer in ordinary patients with comorbidities compared with those without comorbidities.", "Critical patients with comorbidities had significantly lower cure rate (19.3% vs 38.9%, p<0.05) and significantly higher mortality rate (53.4% vs 33.3%, p<0.05) compared with those without comorbidities.", "The time from onset to discharge was significantly longer in ordinary patients with hypertension compared with those without hypertension.", "The mortality rate of critical patients with diabetes was higher than that of patients without diabetes (71.4% vs 42.7%, p<0.05).", "Men had a significantly increased risk of death than women (OR=4.395, 95% CI 1.896 to 10.185, p<0.05); patients with diabetes had higher risk of death (OR=3.542, 95% CI 1.167 to 10.750, p<0.05).", "Comorbidities prolonged treatment time in ordinary patients, increased the mortality rate and reduced the cure rate of critical patients; hypertension and diabetes may be important factors affecting the clinical course and prognosis of ordinary and critical patients, respectively."], "journal": "J Investig Med", "publish_time": "2020-10-13", "aliases": []}
{"doc_id": 229349815, "title": "Death due to COVID\u201019 in a patient with diabetes, epilepsy, and gout comorbidities", "abstract": ["There is evidence of increased incidence, rapid progression, and poor prognosis of COVID\u201019 in patients with underlying comorbidities such as diabetes and epilepsy.", "Developing effective treatment regimens for COVID\u201019 patients with multiple comorbidities is crucial, as patients' past medical history is an essential contributor to possible organ injuries in COVID\u201019 patients.", "Herein, we report a confirmed case of COVID\u201019 patient with a history of multiple underlying diseases, including diabetes, epilepsy, and gout.", "The patient developed multiple organ failure and died a week after intensive care unit (ICU) admission.", "Multiple organ failure is the most common cause of death in COVID\u201019 patients."], "journal": "Clin Case Rep", "publish_time": "2020-11-25", "aliases": [229011168]}
{"doc_id": 234794679, "title": "Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India", "abstract": ["BACKGROUND AND AIMS: There are increasing case reports of rhino-orbital mucormycosis in people with coronavirus disease 2019 (COVID-19), especially from India.", "Diabetes mellitus (DM) is an independent risk factor for both severe COVID-19 and mucormycosis.", "We aim to conduct a systematic review of literature to find out the patient's characteristics having mucormycosis and COVID-19.", "METHODS: We searched the electronic database of PubMed and Google Scholar from inception until May 13, 2021 using keywords.", "We retrieved all the granular details of case reports/series of patients with mucormycosis, and COVID-19 reported world-wide.", "Subsequently we analyzed the patient characteristics, associated comorbidities, location of mucormycosis, use of steroids and its outcome in people with COVID-19.", "RESULTS: Overall, 101 cases of mucormycosis in people with COVID-19 have been reported, of which 82 cases were from India and 19 from the rest of the world.", "Mucormycosis was predominantly seen in males (78.9%), both in people who were active (59.4%) or recovered (40.6%) from COVID-19.", "Pre-existing diabetes mellitus (DM) was present in 80% of cases, while concomitant diabetic ketoacidosis (DKA) was present in 14.9%.", "Corticosteroid intake for the treatment of COVID-19 was recorded in 76.3% of cases.", "Mucormycosis involving nose and sinuses (88.9%) was most common followed by rhino-orbital (56.7%).", "Mortality was noted in 30.7% of the cases.", "CONCLUSION: An unholy trinity of diabetes, rampant use of corticosteroid in a background of COVID-19 appears to increase mucormycosis.", "All efforts should be made to maintain optimal glucose and only judicious use of corticosteroids in patients with COVID-19."], "journal": "Diabetes Metab Syndr", "publish_time": "2021", "aliases": []}
{"doc_id": 235233310, "title": "Preadmission Predictors of Severe COVID-19 in Patients with Diabetes Mellitus", "abstract": ["OBJECTIVE: To explore predictors of severe COVID-19 disease in patients with diabetes hospitalized for COVID-19.", "METHODS: This is a retrospective observational study of adults with diabetes admitted for COVID-19.", "Bivariate tests and multivariable Cox regression were used to identify risk factors for severe COVID-19, defined as a composite endpoint of intensive care unit admission/ intubation or in-hospital death.", "RESULTS: In 1134 patients with diabetes admitted for COVID-19, more severe disease was associated with older age (HR 1.02, p<0.001), male sex (HR 1.28, p=0.017), Asian race (HR 1.34, p=0.029 [reference: white]), and greater obesity (moderate obesity HR 1.59, p=0.015; severe obesity HR 2.07, p=0.002 [reference: normal body mass index]).", "Outpatient diabetes medications were not associated with outcomes.", "CONCLUSIONS: Age, male sex, Asian race, and obesity were associated with increased risk of severe COVID-19 disease in adults with type 2 diabetes hospitalized for COVID-19.", "SUMMARY: In patients with type 2 diabetes hospitalized for COVID-19 disease, we observed that age, male sex, Asian race, and obesity predicted severe COVID-19 outcomes of intensive care unit admission, intubation, or in-hospital death.", "The risk conferred by obesity increased with worsening obesity.", "Outpatient diabetes medications were not observed to be significant predictors of study outcomes."], "journal": "J Diabetes Complications", "publish_time": "2021-05-28", "aliases": []}
{"doc_id": 235334420, "title": "Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study", "abstract": ["Objective: Male sex is one of the determinants of severe coronavirus diseas-e-2019 (COVID-19).", "We aimed to characterize sex differences in severe outcomes in adults with diabetes hospitalized for COVID-19.", "Methods: We performed a sex-stratified analysis of clinical and biological features and outcomes (i.e.", "invasive mechanical ventilation (IMV), death, intensive care unit (ICU) admission and home discharge at day 7 (D7) or day 28 (D28)) in 2380 patients with diabetes hospitalized for COVID-19 and included in the nationwide CORONADO observational study (NCT04324736).", "Results: The study population was predominantly male (63.5%).", "After multiple adjustments, female sex was negatively associated with the primary outcome (IMV and/or death, OR: 0.66 (0.49-0.88)), death (OR: 0.49 (0.30-0.79)) and ICU admission (OR: 0.57 (0.43-0.77)) at D7 but only with ICU admission (OR: 0.58 (0.43-0.77)) at D28.", "Older age and a history of microvascular complications were predictors of death at D28 in both sexes, while chronic obstructive pulmonary disease (COPD) was predictive of death in women only.", "At admission, C-reactive protein (CRP), aspartate amino transferase (AST) and estimated glomerular filtration rate (eGFR), according to the CKD-EPI formula predicted death in both sexes.", "Lymphocytopenia was an independent predictor of death in women only, while thrombocytopenia and elevated plasma glucose concentration were predictors of death in men only.", "Conclusions: In patients with diabetes admitted for COVID-19, female sex was associated with lower incidence of early severe outcomes, but did not influence the overall in-hospital mortality, suggesting that diabetes mitigates the female protection from COVID-19 severity.", "Sex-associated biological determinants may be useful to optimize COVID-19 prevention and management in women and men."], "journal": "Eur J Endocrinol", "publish_time": "2021", "aliases": []}
{"doc_id": 219589389, "title": "Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19", "abstract": ["A possible association could exist between type 2 diabetes mellitus (T2DM) and Coronavirus-19 (Covid-19) infection.", "Indeed, patients with T2DM show high prevalence, severity of disease and mortality during Covid-19 infection.", "However, the rates of severe disease are significantly higher in patients with diabetes compared with non-diabetes (34.6% vs. 14.2%; p < 0.001).", "Similarly, T2DM patients have higher rates of need for Intensive Care Unit (ICU, 37.0% vs. 26.7%; p = 0.028).", "Thus, about the pneumonia of Covid-19, we might speculate that the complicated alveolar-capillary network of lungs could be targeted by T2DM micro-vascular damage.", "Therefore, T2DM patients frequently report respiratory symptoms and are at increased risk of several pulmonary diseases.", "In addition, pro-inflammatory pathways as that involving interleukin 6 (IL-6), could be a severity predictor of lung diseases.", "Therefore, it looks intuitive to speculate that this condition could explain the growing trend of cases, hospitalization and mortality for patients with T2DM during Covid-19 infection.", "To date, an ongoing experimental therapy with monoclonal antibody against the IL-6 receptor in Italy seems to have beneficial effects on severe lung disease and prognosis in patients with Covid-19 infection.", "Therefore, should patients with T2DM be treated with more attention to glycemic control and monoclonal antibody against the IL-6 receptor during the Covid-19 infection?"], "journal": "Cardiovasc Diabetol", "publish_time": "2020-06-11", "aliases": []}
{"doc_id": 221406959, "title": "ASSOCIATION OF HYPERGLYCEMIA WITH HOSPITAL MORTALITY IN COVID-19 PATIENTS WITHOUT DIABETES: A COHORT STUDY", "abstract": ["Objective: Diabetes is a known risk factor for mortality in Coronavirus disease 2019 (COVID-19) patients.", "Our objective was to identify prevalence of hyperglycemia in COVID-19 patients with and without diabetes and quantify its association with COVID-19 disease course.", "Research Design and Methods: In this observational cohort study, all consecutive COVID-19 patients admitted to John H Stroger Jr. Hospital, Chicago, IL from March 15, 2020 to May 15, 2020 were included.", "The primary outcome was hospital mortality and the main predictor was hyperglycemia (any blood glucose [\u2265]7.78 mmol/L during hospitalization).", "Results: Of 403 COVID-19 patients studied, 228 (57%) developed hyperglycemia.", "Of these, 83 (21%) had hyperglycemia without diabetes.", "A total of 51 (12.7%) patients died.", "Compared to the reference group no-diabetes/no-hyperglycemia patients the no-diabetes/hyperglycemia patients showed higher mortality (1.8% versus 20.5%, adjusted odds ratio 21.94 (95% confidence interval 4.04-119.0), p < 0.001); improved prediction of death (p=0.0162) and faster progression to death (p=0.0051).", "Hyperglycemia within the first 24 and 48 hours was also significantly associated with mortality (odds ratio 2.15 and 3.31, respectively).", "Further, compared to the same reference group, no-diabetes/hyperglycemia patients had higher risk of ICU admission (p<0.001), mechanical ventilation (p<0.001) and acute respiratory distress syndrome (p<0.001) and a longer hospital stay in survivors (p<0.001).", "Conclusions: Hyperglycemia in the absence of diabetes was common (21% of hospitalized COVID-19 patients) and was associated with an increased risk of and faster progression to death.", "Development of hyperglycemia in COVID-19 patients who do not have diabetes is an early indicator of poor prognosis."], "journal": "", "publish_time": "2020-09-02", "aliases": [232358033]}
{"doc_id": 240090042, "title": "Mortality and Clinical Outcomes among Patients with COVID-19 and Diabetes", "abstract": ["Background Diabetes mellitus (DM) is a decisive risk factor for severe illness in coronavirus disease 2019 (COVID-19).", "India is home to a large number of people with DM, and many of them were infected with COVID-19.", "It is critical to understand the impact of DM on mortality and other clinical outcomes of COVID-19 infection from this region.", "Aims The primary objective of our study was to analyze the mortality rate in people with DM infected with COVID-19.", "The secondary objectives were to assess the effect of various comorbidities on mortality and study the impact of DM on other clinical outcomes.", "Methods This is a retrospective study of COVID-19 infected patients admitted to a tertiary care hospital in north India in the early phase of the pandemic.", "Results Of the 1211 cases admitted, 19 were excluded because of incomplete data, and 1192 cases were finally considered for analysis.", "DM constituted 26.8% of total patients.", "The overall mortality rate was 6.1%, and the rate was 10.7% in the presence of diabetes (p < 0.01, OR 2.55).", "In univariate analysis, increased age, chronic kidney disease (CKD), coronary artery disease (CAD), stroke, and cancer were associated with mortality.", "On multiple logistic regression, the independent predictors of mortality were CAD, CKD, and cancer.", "Breathlessness and low SpO(2) at presentation, extensive involvement in CXR, and elevated ANC/ALC ratio were also significantly associated with mortality.", "Conclusions The presence of comorbidities such as DM, hypertension, CAD, CKD, and cancer strongly predict the risk of mortality in COVID-19 infection.", "Early triaging and aggressive therapy of patients with these comorbidities can optimize clinical outcomes."], "journal": "Med Sci (Basel)", "publish_time": "2021-10-26", "aliases": []}
{"doc_id": 245616022, "title": "Increased Risk of Poor Clinical Outcome in COVID-19 Patients with Diabetes Mellitus and in-hospital Mortality Predictors: A Retrospective Cohort from a Tertiary Hospital in Indonesia", "abstract": ["Abstract Aim: To determine association between diabetes in confirmed cases of COVID-19 and intensive care admission and in-hospital mortality, evaluate several laboratory parameters as mortality predictor, and develop predictors of in-hospital mortality among diabetics with COVID-19.", "Methods: This retrospective cohort recruited all cases of COVID-19 hospitalized in Fatmawati General Hospital during March to October 2020.", "Inclusion criteria was RT-PCR confirmed cases of COVID-19 who aged 18 years and older while exclusion criteria were incomplete medical record or cannot be found and pregnant women.", "Results: We enrolled 506 participants to this study with median age of 51 years (IQR:22), female (56.32%), and diabetes (28.46%).", "Diabetes increased intensive care admission (adjusted OR:6.07;95%CI:3.52-10,43) and in-hospital mortality (adjusted OR:50;95%CI:1.61-3.89).", "In predicting in-hospital mortality, ferritin and lactate dehydrogenase offered an acceptable discrimination, AUC:0.71 (95%CI: 0.62-0.79) and AUC:0.70 (95%CI: 0.61-0.78), respectively.", "The optimal cut-off of predicting mortality for ferritin was 786 g/mL and for LDH was 514.94 u/L.", "Factors include age above 70 years old, RBGs level on admission above 250 mg/dL or below 140 mg/dL, ferritin level above 786 ng/mL, and presence of ARDS increased the odds of mortality among individuals with diabetes.", "Conclusions: Diabetes increases risk intensive care admission and in hospital mortality in COVID-19.", "Multivariate analysis showed that older age, RBG on admission, high ferritin level, presence of ARDS increased the odds of mortality among individuals with diabetes."], "journal": "", "publish_time": "2022-01-01", "aliases": []}
{"doc_id": 235786097, "title": "Diabetes and COVID-19: Population Impact 18 Months Into the Pandemic.", "abstract": ["Eighteen months into the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease 2019 [COVID-19]) pandemic, epidemiologic studies indicate that diabetes is a central contributor to severe COVID-19 morbidity, and, conversely, COVID-19 has had a devastating effect on the population with diabetes.", "In this literature synthesis, we summarize the relationship of diabetes to COVID-19-related morbidity and mortality, discuss the predictors of severe adverse outcomes and implications of the overall pandemic, and critique the current status of and identify needs for epidemiologic studies for the next phase of the pandemic.", "Case series show that \u223c30-40% of people with COVID-19-related hospitalization, severe morbidity requiring intensive care, and/or death have type 2 or type 1 diabetes.", "Among hospitalized individuals with diabetes, \u223c21-43% required intensive care and case fatality is \u223c25%.", "Risk of severe morbidity and mortality is 100-250% higher among people with diabetes than those without, even after adjustment for sociodemographic factors and comorbid conditions.", "Impact on the general population with diabetes has been similarly dire, as overall mortality rates were 50% higher than historical trends, a net increase more than twice that of the general population.", "Of the excess deaths, \u223c75-80% are not officially attributed to COVID-19, which raises unanswered questions about missed attribution or collateral impact.", "Many predictors of poor outcomes have been identified, particularly comorbid conditions (chronic kidney disease, coronary heart disease, and heart failure), concurrent obesity, and acute and chronic poor HbA1c control, that point to the potential to reduce severe morbidity and mortality in its next stages.", "However, response to the continuing pandemic will benefit from population-wide studies with broader examination of the risks of exposure, infection, and hospitalization, for which few data currently exist.", "The indirect impact of the pandemic's effects on health services, health behaviors, disease management, care, control, and complications has not been well quantified; determining this impact will be essential to lessen the future impact.", "Expanding epidemiologic studies of the relationship of diabetes to COVID-19 beyond few high-income countries will also be essential to limit the burden in low- and middle-income countries where 80% of individuals with diabetes reside and where the COVID-19 pandemic has been so damaging."], "journal": "Diabetes care", "publish_time": "2021-07-09", "aliases": []}
{"doc_id": 229719014, "title": "Diabetic patients with COVID-19 need more attention and better glycemic control", "abstract": ["BACKGROUND: coronavirus disease 2019 (COVID-19) is a pandemic disease spreading all over the world and has aroused global concerns.", "The increasing mortality has revealed its severity.", "It is important to distinguish severe patients and provide appropriate treatment and care to prevent damages diabetes is reported to be a common comorbidity in COVID-19 patients and associated with higher mortality.", "We attempted to clarify the relationship between diabetes and COVID-19 patients' severity AIM: To determine the role of type 2 diabetes in COVID-19 patients methods: To study the relationship between diabetes and COVID-19, we retrospectively collected 61 patients' data from a tertiary medical center in wuhan.", "All the patients were diagnosed with laboratory-confirmed COVID-19 and admitted to the center from February 13 to March 1, 2020 patients' age, sex, laboratory tests, chest computed tomography findings, capillary blood glucose (BG), and treatments were collected and analyzed fisher exact test was used for categorical data univariate and multivariate logistic regressions were used to explore the relationship between clinical characteristics and patients' severity RESULTS: In the 61 patients, the comorbidity of type 2 diabetes, hypertension, and heart diseases were 24 6% (15 out of 61), 37 7% (23 out of 61), and 11 5% (7 out of 61), respectively.", "The diabetic group was related to more invasive treatments (p = 0 02) and severe status (p = 0 003) In univariate logistic regression, histories of diabetes (or = 7 13, p = 0 003), hypertension (or = 3 41, p = 0 039), and hepatic dysfunction (or = 7 69, p = 0 002) were predictors of patients' severity while heart disease (or = 4 21, p = 0 083) and large lung involvement (or = 2 70, p = 0 093) also slightly exacerbated patients' conditions.", "In the multivariate analysis, diabetes (or = 6 29, p = 0 016) and hepatic dysfunction (or = 5 88, p = 0 018) were risk factors for severe patients diabetic patients showed elevated BG in 61 7% of preprandial tests and 33 3% of postprandial tests, revealing the limited control of glycemia in COVID-19 patients CONCLUSION: A history of type 2 diabetes is correlated with invasive treatments and severe status suboptimal glycemic control and hepatic dysfunction have negative effects on severity status and may lead to the exacerbation of COVID-19 patients."], "journal": "World J Diabetes", "publish_time": "2020", "aliases": []}
{"doc_id": 235348549, "title": "Predictors of Severe COVID-19 in Patients With Diabetes: A Multicenter Review", "abstract": ["OBJECTIVE: Diabetes is an independent risk factor for severe SARS-CoV-2 infections.", "This study aims to elucidate the risk factors predictive of more severe outcomes in patients with diabetes by comparing the clinical characteristics of those requiring inpatient admissions with those who remain outpatient.", "METHODS: A retrospective review identified 832 patients-631 inpatients and 201 outpatients-with diabetes and a positive SARS-CoV-2 test result between March 1 and June 15, 2020.", "Comparisons between the outpatient and inpatient cohorts were conducted to identify risk factors associated with severity of disease determined by admission rate and mortality.", "Previous dipeptidyl peptidase 4 inhibitor use and disease outcomes were analyzed.", "RESULTS: Risk factors for increased admission included older age (odds ratio [OR], 1.04 [95% CI, 1.01-1.06]; P = .003), the presence of chronic kidney disease (OR, 2.32 [1.26-4.28]; P = .007), and a higher hemoglobin A1c at the time of admission (OR, 1.25 [1.12-1.39]; P < .001).", "Lower admission rates were seen in those with commercial insurance.", "Increased mortality was seen in individuals with older age (OR, 1.09 [1.07-1.11]; P < .001), higher body mass index number (OR, 1.04 [1.01-1.07]; P = .003), and higher hemoglobin A1c value at the time of diagnosis of COVID-19 (OR, 1.12 [1.01-1.24]; P = .028) and patients requiring hospitalization.", "Lower mortality was seen in those with hyperlipidemia.", "Dipeptidyl peptidase 4 inhibitor use prior to COVID-19 infection was not associated with a decreased hospitalization rate.", "CONCLUSION: This retrospective review offers the first analysis of outpatient predictors for admission rate and mortality of COVID-19 in patients with diabetes."], "journal": "Endocr. pract", "publish_time": "2021", "aliases": []}
{"doc_id": 220350670, "title": "Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease", "abstract": ["Background: Diabetes mellitus (DM) and cardiovascular disease (CVD) are present in a large number of patients with novel Coronavirus disease 2019 (COVID-19).", "We aimed to determine the risk and predictors of in-hospital mortality from COVID-19 in patients with DM and CVD.", "Methods: This retrospective cohort study included hospitalized patients aged \u2265 18 years with confirmed COVID-19 in Alborz province, Iran, from 20 February 2020 to 25 March 2020.", "Data on demographic, clinical and outcome (in-hospital mortality) data were obtained from electronic medical records.", "Self-reported comorbidities were classified into the following groups: \"DM\"(having DM with or without other comorbidities), \"only DM\"(having DM without other comorbidities), \"CVD\"(having CVD with or without other comorbidities), \"only CVD\"(having CVD without other comorbidities), and \"having any comorbidity\".", "Multivariate logistic regression models were fitted to quantify the risk and predictors of in-hospital mortality from COVID-19 in patients with these comorbidities.", "Results: Among 2957 patients with COVID-19, 2656 were discharged as cured, and 301 died.", "In multivariate model, DM (OR: 1.62 (95% CI 1.14-2.30)) and only DM (1.69 (1.05-2.74)) increased the risk of death from COVID-19; but, both CVD and only CVD showed non-significant associations (p &gt; 0.05).", "Moreover, \"having any comorbidities\"increased the risk of in-hospital mortality from COVID-19 (OR: 2.66 (95% CI 2.09-3.40)).", "Significant predictors of mortality from COVID-19 in patients with DM were lymphocyte count, creatinine and C-reactive protein (CRP) level (all P-values &lt; 0.05).", "Conclusions: Our findings suggest that diabetic patients have an increased risk of in-hospital mortality following COVID-19; also, lymphocyte count, creatinine and CRP concentrations could be considered as significant predictors for the death of COVID-19 in these patients."], "journal": "Diabetol. Metab. Syndr.", "publish_time": "2020", "aliases": []}
{"doc_id": 231702136, "title": "Predictors of Mortality in a Multi-Racial Urban Cohort of Persons with Type 2 Diabetes and Novel Coronavirus 19", "abstract": ["OBJECTIVE: Diabetes has been identified as a risk factor for intubation and mortality in patients with SARS Co-V 2 (COVID-19).", "We seek to examine the impact of clinical variables such as Hemoglobin A1c (HbA1c) on mortality and need for intubation, as well as demographic variables such as age, sex and race on persons with type 2 diabetes and COVID-19.", "RESEARCH DESIGN AND METHODS: Analyses were conducted on 4413 patients with an ICD-10 diagnosis of type 2 diabetes and COVID-19.", "Survival analysis was conducted using Kaplan- Meier curves and the log-rank test to compare subgroup analyses.", "RESULTS: In this multi-variate analyses, male gender, older age and hyperglycemia at admission were associated with increased mortality and intubation, but this was not seen for race, ethnicity, insurance type or HbA1c.", "Based on Kaplan-Meier analysis, having comorbid conditions such as hypertension, chronic kidney disease and coronary artery disease were associated with a statistically significant increased risk of mortality.", "CONCLUSIONS: Glycemic levels at admission have a greater impact on health outcomes than HbA1c.", "Older men and those with comorbid disease are also at greater risk for mortality.", "Further longitudinal studies need to be done to evaluate the impact of COVID-19 on type 2 diabetes."], "journal": "J. diabetes (Online)", "publish_time": "2021", "aliases": []}
{"doc_id": 235480541, "title": "Predictors of severity and mortality among patients hospitalized with COVID-19 in Rhode Island", "abstract": ["BACKGROUND: In order for healthcare systems to prepare for future waves of COVID-19, an in-depth understanding of clinical predictors is essential for efficient triage of hospitalized patients.", "METHODS: We performed a retrospective cohort study of 259 patients admitted to our hospitals in Rhode Island to examine differences in baseline characteristics (demographics and comorbidities) as well as presenting symptoms, signs, labs, and imaging findings that predicted disease progression and in-hospital mortality.", "RESULTS: Patients with severe COVID-19 were more likely to be older (p = 0.02), Black (47.2% vs. 32.0%, p = 0.04), admitted from a nursing facility (33.0% vs. 17.9%, p = 0.006), have diabetes (53.9% vs. 30.4%, p<0.001), or have COPD (15.4% vs. 6.6%, p = 0.02).", "In multivariate regression, Black race (adjusted odds ratio [aOR] 2.0, 95% confidence interval [CI]: 1.1-3.9) and diabetes (aOR 2.2, 95%CI: 1.3-3.9) were independent predictors of severe disease, while older age (aOR 1.04, 95% CI: 1.01-1.07), admission from a nursing facility (aOR 2.7, 95% CI 1.1-6.7), and hematological co-morbidities predicted mortality (aOR 3.4, 95% CI 1.1-10.0).", "In the first 24 hours, respiratory symptoms (aOR 7.0, 95% CI: 1.4-34.1), hypoxia (aOR 19.9, 95% CI: 2.6-152.5), and hypotension (aOR 2.7, 95% CI) predicted progression to severe disease, while tachypnea (aOR 8.7, 95% CI: 1.1-71.7) and hypotension (aOR 9.0, 95% CI: 3.1-26.1) were associated with increased in-hospital mortality.", "CONCLUSIONS: Certain patient characteristics and clinical features can help clinicians with early identification and triage of high-risk patients during subsequent waves of COVID-19."], "journal": "PLoS One", "publish_time": "2021", "aliases": []}
{"doc_id": 221327955, "title": "Fasting Plasma Glucose Level Independently Predicts the Mortality of Patients with Coronavirus Disease 2019 Infection: A Multicenter, Retrospective Cohort Study", "abstract": ["BACKGROUND: Coronavirus disease 2019 (COVID-19) has become a global pandemic, which prompts a consensus for the necessity to seek risk factors for this critical disease.", "Risk factors affecting mortality of the disease remain elusive.", "Diabetes and hyperglycemia are known to negatively affect a host\u2019s antiviral immunity.", "We evaluated the relationship between a history of diabetes, fasting plasma glucose (FPG) levels and mortality among severely ill patients with COVID-19.", "METHODS: This was a retrospective cohort study that assessed 106 adult inpatients (aged \u226518 years) from two tertiary hospitals in Daegu, South Korea.", "The participants were transferred to tertiary hospitals because their medical condition required immediate intensive care.", "The demographic and laboratory data were compared between COVID-19 patients who survived and those who did not.", "RESULTS: Compared with the survivor group, age, and the proportions of diabetes, chronic lung disease and FPG were significantly higher in the deceased group.", "In the Cox proportional hazards regression model for survival analysis, FPG level and age were identified as significant predictors of mortality (P<0.05).", "The threshold values for predicting high mortality were age >68 years and FPG of 168 mg/dL, respectively.", "Among those without diabetes, high FPG remained a significant predictor of mortality (P<0.04).", "CONCLUSION: High FPG levels significantly predicted mortality in COVID-19, regardless of a known history of diabetes.", "These results suggest intensive monitoring should be provided to COVID-19 patients who have a high FPG level."], "journal": "Endocrinol Metab (Seoul)", "publish_time": "2020-08-26", "aliases": []}
{"doc_id": 222233582, "title": "Factors associated with the poor outcomes in diabetic patients with COVID-19", "abstract": ["PURPOSE: Diabetic\u2019s patients are supposed to experience higher rates of COVID-19 related poor outcomes.", "We aimed to determine factors predicting poor outcomes in hospitalized diabetic patients with COVID-19.", "METHODS: This retrospective cohort study included all adult diabetic patients with radiological or laboratory confirmed COVID-19 who hospitalized between 20 February 2020 and 27 April 2020 in Alborz province, Iran.", "Data on demographic, medical history, and laboratory test at presentation were obtained from electronic medical records.", "Diagnosis of diabetes mellitus was self-reported.", "Comorbidities including cancer, rheumatism, immunodeficiency, or chronic diseases of respiratory, liver, and blood were classified as \u201cother comorbidities\u201d due to low frequency.", "The assessed poor outcomes were in-hospital mortality, need to ICU care, and receiving invasive mechanical ventilation.", "Self-reported.", "Multivariate logistic regression models were fitted to quantify the predictors of in-hospital mortality from COVID-19 in patients with DM.", "RESULTS: Of 455 included patients, 98(21.5%) received ICU care, 65(14.3%) required invasive mechanical ventilation, and 79 (17.4%) dead.", "In the multivariate model, significant predictors of \u201cdeath of COVID-19\u201d were age 65 years or older (OR (95% CI): 2.0 (1.16\u20133.44), chronic kidney disease (CKD) (2.05 (1.16\u20133.62), presence of \u201cother comorbidities\u201d (2.20 (1.04\u20134.63)), neutrophil count \u22658.0 \u00d7 10(9)/L)6.62 (3.73\u201311.7 ((, Hb level < 12.5 g/dl (2.05 (1.13\u20133.72) (, and creatinine level \u2265 1.36 mg/dl (3.10 (1.38\u20136.98)).", "(All p \u2013values <0.05).", "Some of these factors were also associated with other assessed poor outcomes, e.g., need to ICU care or invasive mechanical ventilation.", "CONCLUSION: Diabetic patients with age 65 years or older, comorbidity CKD, \u201cother comorbidities\u201d, as well as neutrophil count \u22658.0 \u00d7 10(9)/L, Hb level < 12.5 g/dl, and creatinine level \u2265 1.36 mg/dl, were more likely to dead after COVID-19.", "Presence of hypertension and cardiovascular disease were associated with none of the poor outcomes."], "journal": "J Diabetes Metab Disord", "publish_time": "2020-10-09", "aliases": []}
{"doc_id": 235562632, "title": "Clinical, laboratory and radiological predictors of unfavorable hospital admission course for diabetic patients with covid-19", "abstract": ["Background: Patients with diabetes mellitus infected with the new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are at risk of high morbidity and mortality.", "Objective: Our study aimed to address the clinical, laboratory and radiological predictors of hospital admission course for patients with diabetes mellitus with COVID19 infection at the time of admission.", "Patients and Methods: This was a single center, retrospective study of patients with diabetes mellitus (DM) admitted with COVID-19 infection.", "Patients with unfavorable admission course were compared with those of favorable course regarding patient characteristics, clinical presentation, results of laboratory investigations and chest CT severity score.", "Univariate and multivariate analysis associated with the unfavorable course was performed.", "Results: Among 141 patients with DM admitted with COVID19, 44 patients had unfavorable course.", "Those with the favorable course were significantly younger (53.3\u00b116.4) vs (67.3 \u00b115.8) in the unfavorable course group, multivariate analysis revealed that age more than 65, presence of hypertension, CT severity scoring, high HBA1c, AST, IL6, oxygen saturation less than 93% and low lymphocyte count were the independent predictors of the unfavorable hospital admission course.", "Conclusions: Our finding suggests that old age, presence of hypertension, hypoxia at presentation, in addition to high HBA1c, AST, IL6, CT severity scoring and low lymphocyte count were significant predictors of unfavorable admission course in COVID19 patients with diabetes.", "\u00a9 2021, Ain Shams University Faculty of Medicine.", "All rights reserved."], "journal": "Egyptian Journal of Hospital Medicine", "publish_time": "2021", "aliases": []}
{"doc_id": 222352828, "title": "The Neutrophil-to-Monocyte Ratio and Lymphocyte-to-Neutrophil Ratio at Admission Predict In-Hospital Mortality in Mexican Patients with Severe SARS-CoV-2 Infection (Covid-19)", "abstract": ["There is a deep need for mortality predictors that allow clinicians to quickly triage patients with severe coronavirus disease 2019 (Covid-19) into intensive care units at the time of hospital admission.", "Thus, we examined the efficacy of the lymphocyte-to-neutrophil ratio (LNR) and neutrophil-to-monocyte ratio (NMR) as predictors of in-hospital death at admission in patients with severe Covid-19.", "A total of 54 Mexican adult patients with Covid-19 that met hospitalization criteria were retrospectively enrolled, followed-up daily until hospital discharge or death, and then assigned to survival or non-survival groups.", "Clinical, demographic, and laboratory parameters were recorded at admission.", "A total of 20 patients with severe Covid-19 died, and 75% of them were men older than 62.90 \u00b1 14.18 years on average.", "Type 2 diabetes, hypertension, and coronary heart disease were more prevalent in non-survivors.", "As compared to survivors, LNR was significantly fourfold decreased while NMR was twofold increased.", "LNR \u2264 0.088 predicted in-hospital mortality with a sensitivity of 85.00% and a specificity of 74.19%.", "NMR \u2265 17.75 was a better independent risk factor for mortality with a sensitivity of 89.47% and a specificity of 80.00%.", "This study demonstrates for the first time that NMR and LNR are accurate predictors of in-hospital mortality at admission in patients with severe Covid-19."], "journal": "Microorganisms", "publish_time": "2020-10-10", "aliases": []}
{"doc_id": 222832455, "title": "Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry", "abstract": ["BACKGROUND: Hyperglycaemia has emerged as an important risk factor for death in coronavirus disease 2019 (COVID-19).", "The aim of this study was to evaluate the association between blood glucose (BG) levels and in-hospital mortality in non-critically patients hospitalized with COVID-19.", "METHODS: This is a retrospective multi-centre study involving patients hospitalized in Spain.", "Patients were categorized into three groups according to admission BG levels: <140 mg/dL, 140-180 mg/dL and >180 mg/dL.", "The primary endpoint was all-cause in-hospital mortality.", "RESULTS: Of the 11,312 patients, only 2128 (18.9%) had diabetes and 2289 (20.4%) died during hospitalization.", "The in-hospital mortality rates were 15.7% (<140 mg/dL), 33.7% (140-180 mg) and 41.1% (>180 mg/dL), p<.001.", "The cumulative probability of mortality was significantly higher in patients with hyperglycaemia compared to patients with normoglycaemia (log rank, p<.001), independently of pre-existing diabetes.", "Hyperglycaemia (after adjusting for age, diabetes, hypertension and other confounding factors) was an independent risk factor of mortality (BG >180 mg/dL: HR 1.50; 95% confidence interval (CI): 1.31-1.73) (BG 140-180 mg/dL; HR 1.48; 95%CI: 1.29-1.70).", "Hyperglycaemia was also associated with requirement for mechanical ventilation, intensive care unit (ICU) admission and mortality.", "CONCLUSIONS: Admission hyperglycaemia is a strong predictor of all-cause mortality in non-critically hospitalized COVID-19 patients regardless of prior history of diabetes.", "KEY MESSAGE Admission hyperglycaemia is a stronger and independent risk factor for mortality in COVID-19.", "Screening for hyperglycaemia, in patients without diabetes, and early treatment of hyperglycaemia should be mandatory in the management of patients hospitalized with COVID-19.", "Admission hyperglycaemia should not be overlooked in all patients regardless prior history of diabetes."], "journal": "Ann Med", "publish_time": "2021", "aliases": []}
{"doc_id": 235647972, "title": "Hypertension is the major predictor of poor outcomes among inpatients with COVID-19 infection in the UK: a retrospective cohort study", "abstract": ["OBJECTIVE: To assess the impact of diabetes, hypertension and cardiovascular diseases on inpatient mortality from COVID-19, and its relationship to ethnicity and social deprivation.", "DESIGN: Retrospective, single-centre observational study SETTING: Birmingham, UK.", "PARTICIPANTS: 907 hospitalised patients with laboratory-confirmed COVID-19 from a multi-ethnic community, admitted between 1 March 2020 and 31 May 2020.", "MAIN OUTCOME MEASURES: The primary analysis was an evaluation of cardiovascular conditions and diabetes in relation to ethnicity and social deprivation, with the end-point of inpatient death or death within 30 days of discharge.", "A multivariable logistic regression model was used to calculate HRs while adjusting for confounders.", "RESULTS: 361/907 (39.8%) died in hospital or within 30 days of discharge.", "The presence of diabetes and hypertension together appears to confer the greatest mortality risk (OR 2.75; 95% CI 1.80 to 4.21; p<0.001) compared with either condition alone.", "Age >65 years (OR 3.32; 95% CI 2.15 to 5.11), male sex (OR 2.04; 95% CI 1.47 to 2.82), hypertension (OR 1.69; 95% CI 1.10 to 2.61) and cerebrovascular disease (OR 1.87; 95% CI 1.31 to 2.68) were independently associated with increased risk of death.", "The mortality risk did not differ between the quintiles of deprivation.", "High-sensitivity troponin I was the best predictor of mortality among biomarkers (OR 4.43; 95% CI 3.10 to 7.10).", "Angiotensin-receptor blockers (OR 0.57; 95% CI 0.33 to 0.96) and ACE inhibitors (OR 0.65; 95% CI 0.43 to 0.97) were not associated with adverse outcome.", "The Charlson Index of Comorbidity scores were significantly higher in non-survivors.", "CONCLUSIONS: The combined prevalence of hypertension and diabetes appears to confer the greatest risk, where diabetes may have a modulating effect.", "Hypertension and cerebrovascular disease had a significant impact on inpatient mortality.", "Social deprivation and ethnicity did not have any effect once the patient was in hospital."], "journal": "BMJ Open", "publish_time": "2021", "aliases": []}
{"doc_id": 221370517, "title": "Machine Learning and Meta-Analysis Approach to Identify Patient Comorbidities and Symptoms that Increased Risk of Mortality in COVID-19", "abstract": ["Background: Providing appropriate care for people suffering from COVID-19, the disease caused by the pandemic SARS-CoV-2 virus is a significant global challenge.", "Many individuals who become infected have pre-existing conditions that may interact with COVID-19 to increase symptom severity and mortality risk.", "COVID-19 patient comorbidities are likely to be informative about individual risk of severe illness and mortality.", "Accurately determining how comorbidities are associated with severe symptoms and mortality would thus greatly assist in COVID-19 care planning and provision.", "Methods: To assess the interaction of patient comorbidities with COVID-19 severity and mortality we performed a meta-analysis of the published global literature, and machine learning predictive analysis using an aggregated COVID-19 global dataset.", "Results: Our meta-analysis identified chronic obstructive pulmonary disease (COPD), cerebrovascular disease (CEVD), cardiovascular disease (CVD), type 2 diabetes, malignancy, and hypertension as most significantly associated with COVID-19 severity in the current published literature.", "Machine learning classification using novel aggregated cohort data similarly found COPD, CVD, CKD, type 2 diabetes, malignancy and hypertension, as well as asthma, as the most significant features for classifying those deceased versus those who survived COVID-19.", "While age and gender were the most significant predictor of mortality, in terms of symptom-comorbidity combinations, it was observed that Pneumonia-Hypertension, Pneumonia-Diabetes and Acute Respiratory Distress Syndrome (ARDS)-Hypertension showed the most significant effects on COVID-19 mortality.", "Conclusions: These results highlight patient cohorts most at risk of COVID-19 related severe morbidity and mortality which have implications for prioritization of hospital resources."], "journal": "", "publish_time": "2020-08-21", "aliases": [237323542]}
{"doc_id": 236391156, "title": "Cardiovascular disease, hypertension, diabetes and cystatin c jointly predict covid-19 mortality alongside age, male sex and black ethnicity", "abstract": ["Introduction: Studies of risk factors for severe/fatal COVID-19 to date may not have identified the optimal set of informative predictors.", "Hypothesis: Use of penalized regression with stability analysis may identify new, sparse sets of risk factors jointly associated with COVID-19 mortality.", "Methods: We investigated demographic, social, lifestyle, biological (lipids, cystatin C, vitamin D), medical (comorbidities, medications) and air pollution data from UK Biobank (N=473,574) in relation to linked COVID-19 mortality, and compared with non-COVID-19 mortality.", "We used penalized regression models (LASSO) with stability analysis (80% selection threshold from 1,000 models with 80% subsampling) to identify a sparse set of variables associated with COVID-19 mortality.", "Results: Among 43 variables considered by LASSO stability selection, cardiovascular disease, hypertension, diabetes, cystatin C, age, male sex and Black ethnicity were jointly predictive of COVID-19 mortality risk at 80% selection threshold (Figure).", "Of these, Black ethnicity and hypertension contributed to COVID-19 but not non-COVID-19 mortality.", "Conclusions: Use of LASSO stability selection identified a sparse set of predictors for COVID-19mortality including cardiovascular disease, hypertension, diabetes and cystatin C, a marker of renalfunction that has also been implicated in atherogenesis and inflammation.", "These results indicate theimportance of cardiometabolic comorbidities as predisposing factors for COVID-19 mortality.Hypertension was differentially highly selected for risk of COVID-19 mortality, suggesting the need for continued vigilance with good blood pressure control during the pandemic."], "journal": "Circulation", "publish_time": "2021", "aliases": []}
{"doc_id": 237945338, "title": "From stress to stigma \u2013 Mental health considerations of health care workers involved in COVID19 management", "abstract": ["BACKGROUND: Healthcare workers (HCWs) involved in administration and patient management during COVID-19 pandemic are at high risk of developing psychological problems related to fear and stress of contacting COVID infection.", "This is augmented by the stigma faced at home and society, owing to the nature of their job.", "AIM: To assess the mental health issues and stigma amongst health care workers involved in COVID care.", "METHODOLOGY: We conducted a hospital based cross sectional study where 150 health care workers involved in the care of COVID-19 patients, directly and indirectly, were selected using systematic random sampling.", "They were assessed using Depression, Anxiety and Stress Scale (DASS-21) Hindi Version, The Impact of Event Scale - Revised scale and a Modified Stigma scale.", "RESULTS: Significant psychological stress, anxiety, depression and high risk for developing post-traumatic stress disorder was found in more than half of the healthcare workers, albeit more in those having direct contact with COVID patients (p < 0.05).", "Stigma was significantly reported in most HCWs, especially with concerns regarding public attitude and disclosure of their work profile.", "CONCLUSION: Healthcare Workers are at a higher risk for developing psychological disorders and post-traumatic stress disorder because of the immensely stressful work-related conditions and stigma related to working with COVID patients.", "This may lead to long lasting psychosocial consequences which may affect more severely than the infection itself.", "Early identification of psychological issues of HCWs and timely intervention is the key."], "journal": "Indian J Tuberc", "publish_time": "2021-09-27", "aliases": []}
{"doc_id": 222307207, "title": "Physical health complaints among healthcare workers engaged in the care of critically ill COVID-19 patients: A single tertiary-care center prospective study from Japan", "abstract": ["Background: Healthcare workers (HCWs) who care for patients with the novel coronavirus infectious disease (COVID-19) are at an increased risk and fear contracting the infection themselves.", "HCWs are chronically exposed to very intense stress, both and physically and mentally.", "Hospitals must reduce both the physical and mental burden of HCWs on the front lines and ensure their safety.", "No prospective study has focused on the physical health complaints among HCWs engaged in the care of critically ill COVID-19 patients.", "This study aimed to investigate the occupational risk among HCWs of experiencing physical symptoms during the current COVID-19 pandemic.", "Methods: A twice-weekly questionnaire targeting HCWs who care for COVID-19 patients was performed at Osaka City University Hospital from April 30 to May 31, 2020 using a shareable Research Electronic Data Capture tool.", "The demographic characteristics of the participants, frequency of exposure to at-risk care, and physical complaints were evaluated.", "Results: A total of 35 doctors, 88 nurses, and 35 technicians were engaged in the care of these critically ill COVID-19 patients.", "76 HCWs participated in this study, of whom 24 (31.6%) were doctors, 43 (56.6%) were nurses, and 9 (11.8%) were technicians.", "The frequency of experiencing any physical symptom was 25.0% among HCWs.", "Exposure to at-risk care was significantly higher among nurses than among doctors (p < 0.001); likewise, the frequency of experiencing physical symptoms was higher among nurses than among doctors (p < 0.01).", "The multivariate analysis revealed that nurses (odds ratio 8.29; p = 0.01) might be independently at risk of experiencing physical symptoms.", "Conclusions: Our results indicate that occupational health care at hospitals must be allocated to HCWs who are highly exposed to at-risk care, particularly nurses engaged in the care of COVID-19 patients."], "journal": "", "publish_time": "2020-10-12", "aliases": []}
{"doc_id": 245772676, "title": "The mental health of NHS staff during the COVID-19 pandemic: two-wave Scottish cohort study", "abstract": ["BACKGROUND: Health and social care workers (HSCWs) are at risk of experiencing adverse mental health outcomes (e.g.", "higher levels of anxiety and depression) because of the COVID-19 pandemic.", "This can have a detrimental effect on quality of care, the national response to the pandemic and its aftermath.", "AIMS: A longitudinal design provided follow-up evidence on the mental health (changes in prevalence of disease over time) of NHS staff working at a remote health board in Scotland during the COVID-19 pandemic, and investigated the determinants of mental health outcomes over time.", "METHOD: A two-wave longitudinal study was conducted from July to September 2020.", "Participants self-reported levels of depression (Patient Health Questionnaire-9), anxiety (Generalised Anxiety Disorder-7) and mental well-being (Warwick-Edinburgh Mental Well-being Scale) at baseline and 1.5 months later.", "RESULTS: The analytic sample of 169 participants, working in community (43%) and hospital (44%) settings, reported substantial levels of depression and anxiety, and low mental well-being at baseline (depression, 30.8%; anxiety, 20.1%; well-being, 31.9%).", "Although mental health remained mostly constant over time, the proportion of participants meeting the threshold for anxiety increased to 27.2% at follow-up.", "Multivariable modelling indicated that working with, and disruption because of, COVID-19 were associated with adverse mental health changes over time.", "CONCLUSIONS: HSCWs working in a remote area with low COVID-19 prevalence reported substantial levels of anxiety and depression, similar to those working in areas with high COVID-19 prevalence.", "Efforts to support HSCW mental health must remain a priority, and should minimise the adverse effects of working with, and disruption caused by, the COVID-19 pandemic."], "journal": "BJPsych Open", "publish_time": "2022-01-07", "aliases": []}
{"doc_id": 235464316, "title": "Psychological impact of COVID-19 pandemic on frontline health care workers in Bangladesh: A cross-sectional study", "abstract": ["AIMS: Frontline health care workers exposed to COVID-19 patients could be at increased risk of developing psychological issues.", "The study aimed to estimate the prevalence of mental health-related problems, specifically depression, anxiety, post-traumatic stress disorder (PTSD), and insomnia among health care professionals during the COVID-19 pandemic in Bangladesh and to compare these between medical and allied health care professionals.", "METHOD: This cross-sectional survey was conducted using Google Form then subsequent telephone interview between June and August 2020.", "Using random sampling, a total of 479 health care professionals participated in the study.", "We collected data on demographics.", "Anxiety and depression were measured using 4 items Patient Health Questionnaire-4 (PHQ-4), PTSD was measured using 4 items Primary Care (PC)-PTSD-Screen, and insomnia was measured by using a 7-item Insomnia Severity Index (ISI).", "A multivariable logistic regression analysis was performed to assess risk factors associated with mental health symptoms.", "RESULT: Overall, 17.6% of frontline health workers had symptoms of anxiety, 15.5% had depression symptoms, 7.6% had PTSD symptoms and 5.9% had symptoms of insomnia.", "Compared to allied health professionals (n = 113, 24%), doctors (n = 366, 76%) had significantly higher prevalence of anxiety: 21.1% vs 06%, (OR = 4.19; 95% CI = 1.88\u20139.35; p-value <0.001); depression: 18% vs 6.8%, (OR = 2.99; 95% CI = 1.40\u20136.42; p-value 0.005); PTSD: 9.4% vs 1.7%, (OR = 5.96; 95% CI = 1.41\u201325.11; p-value 0.015) and insomnia: 7.4% vs 0.9%, (OR = 9.22; 95% CI = 1.24\u201368.4; p-value 0.03).", "Logistic regression analysis showed that pre-existing medical illness has significantly more risks of developing symptoms of anxiety (adjusted OR = 2.85; 95% CI = 1.71\u20134.76; p-value <0.001) and depression (OR = 2.29; 95% CI = 1.39\u20133.77; p-value 0.001).", "Having a postgraduate degree (adjusted OR = 6.13; 95% CI = 1.28\u201329.28; p-value 0.023) and working in secondary care setting (adjusted OR = 3.08; 95% CI = 1.18\u20138.02; p value 0.021) have significant predictors of developing anxiety symptoms among health workers.", "Those who had worked more than 6 weeks in COVID-19 dedicated hospitals had risk of developing symptoms of PSTD (OR = 2.83; 95% CI = 1.35\u20135.93; p value 0.006) and insomnia (OR = 2.63; 95% CI = 1.15\u20136.02; p value 0.022).", "CONCLUSION: Our study demonstrated a high prevalence of symptoms of depression, anxiety, PTSD, and insomnia among Bangladeshi frontline health workers (particularly among doctors) during the COVID-19 pandemic.", "There is an urgent need to address the mental health needs of frontline health workers.", "Funding: Medical Research Council, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh."], "journal": "BJPsych Open", "publish_time": "2021-06-18", "aliases": [235464316]}
{"doc_id": 244859257, "title": "Symptoms of Depression, Anxiety, Post-Traumatic Stress Disorder, and Suicidal Ideation Among State, Tribal, Local, and Territorial Public Health Workers During the COVID-19 Pandemic \u2014 United States, March\u2013April 2021", "abstract": ["Increases in mental health conditions have been documented among the general population and health care workers since the start of the COVID-19 pandemic (1-3).", "Public health workers might be at similar risk for negative mental health consequences because of the prolonged demand for responding to the pandemic and for implementing an unprecedented vaccination campaign.", "The extent of mental health conditions among public health workers during the COVID-19 pandemic, however, is uncertain.", "A 2014 survey estimated that there were nearly 250,000 state and local public health workers in the United States (4).", "To evaluate mental health conditions among these workers, a nonprobability-based online survey was conducted during March 29-April 16, 2021, to assess symptoms of depression, anxiety, post-traumatic stress disorder (PTSD), and suicidal ideation among public health workers in state, tribal, local, and territorial public health departments.", "Among 26,174 respondents, 52.8% reported symptoms of at least one mental health condition in the preceding 2 weeks, including depression (30.8%), anxiety (30.3%), PTSD (36.8%), or suicidal ideation (8.4%).", "The highest prevalence of symptoms of a mental health condition was among respondents aged \u226429 years (range = 13.6%-47.4%) and transgender or nonbinary persons (i.e., those who identified as neither male nor female) of all ages (range = 30.4%-65.5%).", "Public health workers who reported being unable to take time off from work were more likely to report adverse mental health symptoms.", "Severity of symptoms increased with increasing weekly work hours and percentage of work time dedicated to COVID-19 response activities.", "Implementing prevention and control practices that eliminate, reduce, and manage factors that cause or contribute to public health workers' poor mental health might improve mental health outcomes during emergencies."], "journal": "MMWR Morb Mortal Wkly Rep", "publish_time": "2021-12-03", "aliases": [235713267]}
{"doc_id": 239012720, "title": "Supporting Health-Care Workers and Patients in Quarantine Wards: Evidence From a Survey of Frontline Health-Care Workers and Inpatients With COVID-19 in Wuhan, China", "abstract": ["Objective: Frontline health-care workers and patients with COVID-19 have been identified as high-risk groups for psychological problems.", "Experience of working or staying in quarantine wards generated psychological stressors for health-care workers and patients with COVID-19.", "The present study aimed to investigate the psychological symptoms of hospitalized patients with COVID-19 and the health-care workers treating them during the outbreak period, examine the effects of psychological stressors on mental health in both populations and perceived coping resources for both sides.", "Methods: Three hundred and eleven health-care workers working in a COVID-19 designated hospital in Wuhan, China, and 148 hospitalized patients with COVID-19 in the same hospital participated in this cross-sectional survey conducted in February 2020.", "Psychological symptoms, psychological stressors, and perceived coping resources were reported by both groups.", "Results: Thirty-three percent of health-care workers and 35.2% of patients with COVID-19 had significant psychological symptoms that were indicative of a high risk for psychological disorders.", "Pandemic-related psychological stressors contributed to psychological symptoms for both populations.", "Concern about patients was one aspect of psychological stressors of frontline health-care workers and both groups perceived support from the opposite side as an important external coping resource.", "Conclusion: The results shed light on the need to provide psychological support to both frontline health-care workers and patients with COVID-19 and suggest enhancing the treatment alliance might be effective to improve mental health for both populations during the crisis."], "journal": "Front Public Health", "publish_time": "2021-10-18", "aliases": []}
{"doc_id": 236163076, "title": "Mental Disorders Among Health Care Workers at the Early Phase of COVID-19 Pandemic in Kenya; Findings of an Online Descriptive Survey", "abstract": ["Background: Healthcare workers responding to the Corona Virus Pandemic (COVID-19) are at risk of mental illness.", "Data is scanty on the burden of mental disorders among Kenyan healthcare workers responding to the pandemic that can inform mental health and psychosocial support.", "The purpose of this study was to establish the frequency and associated factors of worry, generalized anxiety disorder, depression, posttraumatic stress disorder and poor quality of sleep among Kenyan health care workers at the beginning of COVID-19 pandemic.", "Methods: We conducted an online survey among 1,259 health care workers in Kenya.", "A researcher developed social demographic questionnaire and several standardized tools were used for data collection.", "Standardized tools were programmed into Redcap, (Research Electronic Data Capture) and data analysis was performed using R Core Team.", "In all analysis a p-value < 0.05 was considered significant.", "Results: 66% of the participants reported experiencing worry related to COVID-19.", "32.1% had depression, 36% had generalized anxiety, 24.2% had insomnia and 64.7% scored positively for probable Post Traumatic Stress Disorder (PTSD).", "Depression was higher among females compared to men (36.5 vs. 26.9%, p = 0.003), workers <35 years old compared to older ones (38.1 vs. 26.4%, p < 0.001), and those who were not married compared to those who were married (40.6 vs. 27.6%, p < 0.001).", "Generalized anxiety was commoner among workers aged <35 years (43.5 vs. 29.3%, p < 0.001), females (41.7 vs. 29.2%, p < 0.001), those who mere not married compared to the married (45.2 vs. 31.2%, p < 0.001) and those with <10 years working experience (41.6 to 20.5%, p < 0.001).", "Younger health care professional had a higher proportion of insomnia compared to the older ones (30.3 vs. 18.6%, p < 0.001).", "Insomnia was higher among those with <10 years' experience compared to those with more than 20 years' experience(27.3 vs. 17.6%, p = 0.043) Conclusion: Many Kenyan healthcare workers in the early phase of COVID-19 pandemic suffered from various common mental disorders with young, female professionals who are not married bearing the bigger burden.", "This data is useful in informing interventions to promote mental and psychosocial wellbeing among Kenyan healthcare workers responding to the pandemic."], "journal": "Front Psychiatry", "publish_time": "2021-07-22", "aliases": []}
{"doc_id": 237326362, "title": "Moral Distress and Perceived Community Views Are Associated with Mental Health Symptoms in Frontline Health Workers during the COVID-19 Pandemic", "abstract": ["Background: Sudden changes in clinical practice and the altered ability to care for patients due to the COVID-19 pandemic have been associated with moral distress and mental health concerns in healthcare workers internationally.", "This study aimed to investigate the severity, prevalence, and predictors of moral distress experienced by Australian healthcare workers during the COVID-19 pandemic.", "Methods: A nationwide, voluntary, anonymous, single time-point, online survey of self-identified frontline healthcare workers was conducted between 27th August and 23rd October 2020.", "Participants were recruited through health organisations, professional associations, or colleges, universities, government contacts, and national media.", "Results: 7846 complete responses were received from nurses (39.4%), doctors (31.1%), allied health staff (16.7%), or other roles (6.7%).", "Many participants reported moral distress related to resource scarcity (58.3%), wearing PPE (31.7%) limiting their ability to care for patients, exclusion of family going against their values (60.2%), and fear of letting co-workers down if they were infected (55.0%).", "Many personal and workplace predictors of moral distress were identified, with those working in certain frontline areas, metropolitan locations, and with prior mental health diagnoses at particular risk of distress.", "Moral distress was associated with increased risk of anxiety, depression, post-traumatic stress disorder, and burnout.", "Conversely, feeling appreciated by the community protected against these risks in healthcare workers.", "Conclusions: Safeguarding healthcare workforces during crises is important for both patient safety and workforce longevity.", "Targeted interventions are required to prevent or minimise moral distress and associated mental health concerns in healthcare workers during COVID-19 and other crises."], "journal": "Int J Environ Res Public Health", "publish_time": "2021-08-18", "aliases": []}
{"doc_id": 232245941, "title": "COVID-19 and Long-Term Care Healthcare Worker Mental Health in Rhode Island", "abstract": ["Introduction.", "Healthcare workers in long-term care settings and group homes for the disabled are at signi? cant risk of contracting COVID-19 and subsequently infecting the residents, fellow co-workers, and their family.", "In addition, lower paying long-term care healthcare workers maybe working multiple jobs which increases the risk of exposure.", "In.", "April 2020, 27% of all deaths in the population was among residents in long-term care.", "The elderly population has the greatest risk for mortality from covid-19 (liu et al 2020) and are disproportionality a? ected by social distance and self-isolation.", "Most long-term care settings have implemented lockdowns preventing families from visiting and limiting interactions among residents social isolation of the elderly is considered a serious public health concern social disconnection is a risk factor for increased depression and anxiety among the elderly.", "It is hypothesized that elderly persons are at high risk for poor mental health outcomes from the COVID-19 pandemic.", "The alzheimer's disease.", "International suggest that those with dementia \u201c may become more anxious, angry, stressed, agitated, and withdrawn during the outbreak \u201d These factors potentially may increase stress on healthcare workers in long-term care settings beyond the fears of exposure and transmitting COVID-19 to their families.", "There are few studies to date that examine the mental health impact of COVID-19 on healthcare workers in long-term care.", "The united nations has highlighted the mental health risk to workers in long-term care \u201c First responders and front line workers, particularly workers in health and long-term care play a crucial role in? ghting the outbreak and saving lives.", "However, they are under exceptional stress, being faced with extreme workloads, di? cult decisions, risks of becoming infected and spreading infection to families and communities, and witnessing deaths of patients \u201d methods healthcare workers in long-term care facilities, and assisted living facilities in rhode island were given questionnaires to complete that examined mental health and risk factors associated with COVID-19 The questionnaire includes items on the healthcare worker's experience with COVID-19 Resilience is measured using.", "The.", "Brief.", "Resilience.", "Scale assessing the individual's ability to bounce back or recover from stress.", "Subjective incompetence is de? ned as the perceived incapacity to perform tasks and express feelings deemed appropriate in a stressful situation.", "Increasing distress and subjective incompetence may convert a normal reaction to stress into mental disorder requiring intervention.", "Demoralization is measured using the demoralization.", "Scale-II Depression and anxiety is measured using two of the most commonly used screens in clinical care, the PHQ-9 for depression and the GAD-7 for generalized anxiety family functioning during and before the COVID-19 pandemic is measured using the three-item.", "Brief.", "Assessment of family functioning social support is measured during and before the COVID-19 pandemic using the emotional-informational support subscale of the Brief.", "Social.", "Support scale derived from the medical outcomes study social support.", "Survey.", "Coronavirus.", "Anxiety.", "Scale is a mental health screener designed to aid in the identi? cation of probable cases of dysfunctional anxiety associated with the COVID-19 pandemic.", "The fear of Coronavirus-19 scale was used to measure this construct.", "The? ve-item.", "Primary.", "Care PTSD screen was adapted to COVID-19 as a traumatic event.", "Items measuring healthcare worker workplace stress was developed based on a items from a number of existing scales A 15-item health care workers attitudes toward the management of COVID-19 in the long-term care facility was developed by the research team that focuses on training of sta?, safety, and resident care results.", "Preliminary data will be presented data collection is currently underway.", "There are 65 assisted living facilities and 85 nursing homes in rhode island.", "Approximately 10% of the facilities are currently participating with the aim to recruit nearly all facilities in the state.", "Conclusions.", "The hypotheses to be tested is that healthcare workers in long-term care settings have mental health issues including demoralization, depression and anxiety due to the COVID-19 pandemic disaster.", "That those who are in facilities with COVID-19 residents have increased stress.", "Those facilities that have placed increased demands on healthcare workers will have employees that are having more difficulty in dealing with the COVID-19 pandemic.", "This study examines how healthcare workers in long-term care facilities have coped during the COVID-19 pandemic and the impact on their mental health; factors that protect or place the healthcare worker at risk for poorer mental health outcomes (depression, anxiety, demoralization, post-traumatic stress); and factors during COVID-19 that place the healthcare worker for poorer mental health outcomes during COVID-19 pandemic funding department of psychiatry of psychiatry and human behavior, warren alpert medical school of brown university, lifespan."], "journal": "The American Journal of Geriatric Psychiatry", "publish_time": "2021", "aliases": []}
{"doc_id": 232039438, "title": "Frontline Health Care Workers' Mental Workload During the COVID-19 Pandemic: A Cross-Sectional Study", "abstract": ["Workload is an essential factor affecting the performance of health care workers (HCWs).", "High level of mental workload increased their risks of insomnia, anxiety, and depression.", "This study committed to investigate frontline HCWs' mental workload and analyze its influencing factors during the novel coronavirus disease 2019 (COVID-19) pandemic.", "A total of 802 frontline HCWs completed the online questionnaires.", "Their total mental workload score was 69.7 \u00b1 16.4.", "Frontline HCWs were satisfied with their performance (4.0 \u00b1 3.3) and showed a low level of frustration (8.3 \u00b1 5.7).", "The most important dimensions of mental workload were \"effort\" (16.4 \u00b1 13.7), \"physical demand\" (15.7 \u00b1 4.7), and \"mental demand\" (12.9 \u00b1 5.2).", "Frontline nurses and HCWs who have higher education level, longer working years, and higher professional title perceived higher mental workload scores (P < .05).", "In conclusion, frontline HCWs' mental workload was not high as seen during the COVID-19 pandemic in China.", "They have made tremendous efforts and dedication to caring for COVID-19 patients.", "Job-related factors, some of which can be eliminated by proper management skills, increased frontline HCWs mental workload."], "journal": "Asia Pac J Public Health", "publish_time": "2021", "aliases": []}
{"doc_id": 232133118, "title": "Factors affecting mental illness and social stress in hospital workers treating COVID-19: Paradoxical distress during pandemic era", "abstract": ["BACKGROUND: The coronavirus disease 2019 (COVID-19) has affected all countries in the world.", "Hospital workers are at high risk of mental illness, such as anxiety and depression.", "Furthermore, they also face many social stresses, such as deterioration of human relations and income reduction.", "Apart from mental illness, these social stresses can reduce motivation and lead to voluntary absenteeism, which contribute to a collapse of medical systems.", "Thus, for maintaining medical systems, it is crucial to clarify risk factors for both mental illness and increased social stress among hospital workers.", "However, little attention has been paid to factors affecting social stress, and thus, we aimed to address this gap.", "METHODS: In this cross-sectional survey of 588 hospital workers, the levels of anxiety, depression, and social stress were assessed using the 7-item Generalized Anxiety Disorder scale (GAD-7), 9-item Patient Health Questionnaire (PHQ-9), and Tokyo Metropolitan Distress Scale for Pandemic (TMDP).", "Multiple regression analyses were conducted to identify the demographic variables affecting these problems.", "RESULTS: Older age and female sex were common risk factors for anxiety, depression, and social stress.", "Moreover, occupational exposure to COVID-19 and hospital staff other than doctors/fewer non-work days were risk factors for increased anxiety and depression, respectively.", "Furthermore, living with families/others was a risk factor for increased social stress during this pandemic.", "CONCLUSION: Our findings could be useful for developing policies and practices to minimize the risk of mental illness and increased social stress among hospital workers, highlighting that attention should be paid to social factors, such as an individual's household situation."], "journal": "J Psychiatr Res", "publish_time": "2021", "aliases": []}
{"doc_id": 245829344, "title": "Worry from contracting COVID-19 infection and its stigma among Egyptian health care providers", "abstract": ["BACKGROUNDS: Healthcare providers (HCPs) in COVID-19 epidemic face stressful workload of disease management, shortage of protective equipment and high risk of infection and mortality.", "These stressors affect greatly their mental health.", "The aim is to identify working conditions among Egyptian HCPs during COVID-19 epidemic as well as stigma and worry perceptions from contracting COVID-19 infection and their predictors.", "METHODS: A cross-sectional study was conducted among 565 HCPs.", "Data was collected through Google online self-administered questionnaire comprised seven parts: demographics characteristics, knowledge and attitude of COVID-19, working condition, worry of contracting COVID-19 at work, discrimination intention at work for COVID-19 patients, stigma assessment using impact stigma, and internalized shame scales.", "RESULTS: The vast majority of HCPs (94.7%) were worried from contracting COVID-19 at work.", "Risk factors for perceiving severe worry from contracting COVID-19 were expecting infection as a severe illness, believing that infection will not be successfully controlled, improbability to continue working during the pandemic even if in a well/fit health, high discrimination intention and impact stigma scales.", "Significantly high impact stigma scores were detected among those aged < 30 years, females, workers primarily in sites susceptible for contracting COVID-19 infection, those had severe worry from contracting infection at work, and high internalized shame scale.", "The risk factors for perceiving higher internalized shame scores were not having a previous experience in working during a pandemic, high discrimination intention towards COVID-19 patients and high impact stigma scale.", "CONCLUSIONS: Considerable levels of worry and stigma were detected among Egyptian HCPs during COVID-19 outbreak.", "The psychological aspect of health care providers should not be overlooked during epidemic; appropriate institutional mental health support should be provided especially for young HCPs, those without previous work experience in epidemic and those who work in high-risk units.", "Raising the community awareness about contribution of HCPs in fighting the epidemic might decrease stigmatization action toward HCPs."], "journal": "J Egypt Public Health Assoc", "publish_time": "2022-01-10", "aliases": []}
{"doc_id": 234494477, "title": "Magnitude and determinants of the psychological impact of COVID-19 among health care workers: A systematic review", "abstract": ["Introduction: The mental health of the health care professionals is more likely to be affected by the coronavirus disease-19 compared to the general population.", "Accordingly, the current study aimed to summarize the magnitudes and determinants of the psychological impact of coronavirus among health care professionals.", "Methods: The studies from Medline via PubMed, Science Direct, and Google Scholar were searched from 5 September to 19 October 2020.", "The review was conducted as per PRISMA-2009 (Preferred Reporting Items for Systematic Reviews and Meta-analyses).", "Result: Initially, 6316 articles were searched from three databases (PubMed, Science Direct, and Google Scholar).", "Finally, 20 articles were filtered to be included in our review.", "Among different types of psychological impact, stress was reported that lies within the range from 5.2% to 100%, anxiety was reported from 11.1% to 100%, depression was from 10.6% to 58%, and insomnia was from 28.75% to 34%.", "Several factors were related to the negative psychological state of health care workers due to coronavirus disease-19 like educational level, occupation, gender, age, working environment, work experience, legal status, ethnicity, psychological comorbidity, social support, personal/family exposure, and feeling of health care providers.", "Conclusion: The most common psychological impacts among health care workers were anxiety and stress.", "Besides different sociodemographic factors that determine the psychological impacts, front-line health care workers and participants having psychological comorbidity have a high risk of negative psychological state impacts as compared to their counterparts.", "Therefore, special attention should tend to health care workers directly involved in the prevention and management of coronavirus disease-19 and having a different risk of mental health condition."], "journal": "SAGE Open Medicine", "publish_time": "2021", "aliases": []}
{"doc_id": 230989014, "title": "Mental health of health-care workers during the COVID-19 pandemic", "abstract": ["Besides its effects on physical health, the coronavirus disease 2019 (COVID-19) pandemic has resulted in adverse consequences on mental health of health-care workers.", "Several factors such as safety concerns and fear of infecting self or family members, social isolation measures, strict infection control procedures, lack of protective measures, exhaustion due to increased duration of working, and seeing patients die or colleagues infected can contribute to the development of mental health problems in health-care workers during the current COVID-19 pandemic.", "Some health-care staff including nurses, advanced practice providers, frontline health-care workers, and health-care workers who have children are more vulnerable to these mental health problems.", "Prevention of infection and staff burnout in health-care workers, provision of a timely mental health care, and social support are among the most important measures to provide a mental health care for health-care workers during the current COVID-19 pandemic."], "journal": "Ibnosina Journal of Medicine and Biomedical Sciences", "publish_time": "2020", "aliases": [219888751]}
{"doc_id": 232116537, "title": "Depressive and Anxiety Symptoms of Healthcare Workers in Intensive Care Unit Under the COVID-19 Epidemic: An Online Cross-Sectional Study in China", "abstract": ["Background: Since the coronavirus disease-2019 (COVID-19) outbreak, intensive care unit (ICU) healthcare workers were responsible for the critical infected patients.", "However, few studies focused on the mental health of ICU healthcare workers.", "This study aimed to investigate the psychological impact of COVID-19 on ICU healthcare workers in China.", "Methods: We distributed the nine-item Patient Health Questionnaire (PHQ-9) and seven-item General Anxiety Disorder questionnaire (GAD-7) online to ICU healthcare workers in China.", "Respondents were divided into frontline and second-line according to whether they have contact with COVID-19 patients.", "Depressive and anxiety symptoms of all respondents were evaluated based on their questionnaire scores.", "Results: There were 731 ICU healthcare workers finally enrolled in our study, including 303 (41.5%) male, 383 (52.4%) doctors, and 617 (84.4%) aged 26-45 years.", "All in all, 482 (65.9%) ICU healthcare workers reported symptoms of depression, while 429 (58.7%) reported anxiety.", "There was no significant difference between frontline (n = 325) and second-line (n = 406) respondents in depression (P = 0.15) and anxiety severity (P = 0.56).", "Logistic regression analysis showed that being female, ICU work time >5 years, and night duty number &#8805;10 were risk factors of developing depressive and anxiety symptoms.", "Income reduction was separately identified as risk of anxiety.", "Additionally, ICU work time >5 years was also identified as risk of developing moderate-severe depressive and anxiety symptoms.", "Conclusions: Frontline ICU work was not associated with higher risk of depressive and anxiety symptoms during COVID-19 pandemic remission period in China.", "Actions like controlling night duty number, ensuring vacation, and increasing income should be taken to relieve mental health problem.", "Furthermore, we should pay close attention to those who had worked long years in ICU."], "journal": "Front Public Health", "publish_time": "2021", "aliases": []}
{"doc_id": 245357472, "title": "The Sustained Psychological Impact of the COVID-19 Pandemic on Health Care Workers One Year after the Outbreak\u2014A Repeated Cross-Sectional Survey in a Tertiary Hospital of North-East Italy", "abstract": ["This study aimed to evaluate the mental health outcomes of health care workers (HCWs) of the Verona academic hospital trust (Italy) one year after the outbreak of COVID-19 and to identify predicted risk factors.", "A web-based survey was conducted from mid-April to mid-May 2021 on hospital workers one year after the first evaluation performed during the lock-down phase of the COVID-19 pandemic.", "Post-traumatic stress, general anxiety, depression, and burnout were assessed by using, respectively, the impact of event scale (IES-R), the self-rating anxiety scale (SAS), the patient health questionnaire (PHQ-9) and the Maslach burnout inventory-general survey (MBI-GS).", "Multivariate logistic regression analysis was performed to identify factors associated with each of the four mental health outcomes one year after the COVID-19 outbreak.", "A total of 1033 HCWs participated.", "The percentage of HCWs scoring above the cut-off increased from 2020 to 2021 in all of the outcome domains (anxiety, 50.1% vs. 55.7, p < 0.05; depression, 26.6% vs. 40.6%, p < 0.001; burnout, 28.6% vs. 40.6%, p < 0.001; chi-square test), with the exception of post-traumatic distress.", "There was also an increase when stratifying by occupation and workplace, with a greater increase for depression and burnout.", "Multivariate analysis revealed that, one year after the COVID-19 outbreak, nurses were at the greatest risk of anxiety and depression, whereas residents were at the greatest risk of burnout (in terms of low professional efficacy).", "Working in intensive care units was associated with an increased risk of developing severe emotional exhaustion and a cynical attitude towards work."], "journal": "Int J Environ Res Public Health", "publish_time": "2021-12-19", "aliases": []}
{"doc_id": 245125081, "title": "Mental Health During COVID-19: A Qualitative Study with Ethnically Diverse Healthcare Workers in the United Kingdom", "abstract": ["Introduction: Healthcare workers are experiencing deterioration in their mental health due to COVID-19.", "Ethnic minority populations in the United Kingdom are disproportionately affected by COVID-19, with a higher death rate and poorer physical and mental health outcomes.", "It is important that healthcare organisations consider the specific context and mental, as well as physical, health needs of an ethnically diverse healthcare workforce in order to better support them during, and after, the COVID-19 pandemic.", "Methods: We undertook a qualitative work package as part of the United Kingdom Research study into Ethnicity and COVID-19 outcomes among healthcare workers (UK-REACH).", "As part of the qualitative research, we conducted focus group discussions with healthcare workers between December 2020 and July 2021, and covered topics such as their experiences, fears and concerns, and perceptions about safety and protection, while working during the pandemic.", "The purposive sample included ancillary health workers, doctors, nurses, midwives and allied health professionals from diverse ethnic backgrounds.", "We conducted discussions using Microsoft Teams.", "Recordings were transcribed and thematically analysed.", "Findings: We carried out 16 focus groups with a total of 61 participants.", "Several factors were identified which contributed to, and potentially exacerbated, the poor mental health of ethnic minority healthcare workers during this period including anxiety (due to inconsistent protocols and policy); fear (of infection); trauma (due to increased exposure to severe illness and death); guilt (of potentially infecting loved ones); and stress (due to longer working hours and increased workload).", "Conclusion: COVID-19 has affected the mental health of healthcare workers.", "We identified a number of factors which may be contributing to a deterioration in mental health across diverse ethnic groups.", "Healthcare organisations should consider developing strategies to counter the negative impact of these factors.", "This paper will help employers of healthcare workers and other relevant policy makers better understand the wider implications and potential risks of COVID-19 and assist in developing strategies to safeguard the mental health of these healthcare workers going forward, and reduce ethnic disparities."], "journal": "", "publish_time": "2021-12-14", "aliases": []}
{"doc_id": 230507823, "title": "Mental Health Outcomes in Healthcare Workers in COVID-19 and Non-COVID-19 Care Units: A Cross-Sectional Survey in Belgium", "abstract": ["BACKGROUND: The literature shows the negative psychological impact of the coronavirus disease 2019 (COVID-19) outbreak on frontline healthcare workers.", "However, few are known about the mental health of physicians and nurses working in general hospitals during the outbreak, caring for patients with COVID-19 or not.", "OBJECTIVES: This survey assessed differences in mental health in physicians and nurses working in COVID-19 or non-COVID-19 medical care units.", "DESIGN: A cross-sectional mixed-mode survey was used to assess burnout, insomnia, depression, anxiety, and stress.", "SETTING: A total of 1,244 physicians and nurses from five general hospitals in Belgium, working in COVID-19 care units (CCU), non-COVID-19 care units (NCCU), or both (CCU + NCCU) were informed of the study.", "PARTICIPANTS: Six hundred forty-seven healthcare workers participated in the survey (response rate = 52%).", "MEASUREMENTS: Validated instruments were used to assess the outcomes: the PFI (burnout/professional fulfillment), the ISI (insomnia), and the DASS-21 (depression, anxiety, and stress).", "RESULTS: Results showed high prevalence of burnout, insomnia, depression, and anxiety among participants.", "After adjusting for confounders, multivariate analysis of variance showed no differences between CCU, NCCU, and CCU + NCCU workers.", "Univariate general linear models showed higher level of burnout, insomnia, and anxiety among nurses in comparison to physicians.", "Being a nurse, young, isolated, with an increased workload were risk factors for worse mental health outcomes.", "LIMITATIONS: The mental health of the tested sample, before the outbreak, is unknown.", "Moreover, this cross-sectional design provides no information on the evolution of the mental health outcomes over time.", "CONCLUSION: Directly caring for patients with COVID-19 is not associated with worse mental health outcomes among healthcare workers in general hospitals.", "High prevalence of burnout, insomnia, depression, and anxiety among physicians and nurses requires special attention, and specific interventions need to be implemented.", "PROTOCOL REGISTRATION: ClinicalTrials.gov, identifier NCT04344145."], "journal": "Front Psychol", "publish_time": "2021-01-05", "aliases": []}
{"doc_id": 235072268, "title": "Prevalence of mental health symptoms and its effect on insomnia among healthcare workers who attended hospitals during COVID-19 pandemic: A survey in Dhaka city", "abstract": ["abstract: Background.", "During the COVID-19 pandemic, the high workload, risk of infection, and safety issues for family members may pose a threat to the mental health of healthcare workers (hcws) working in hospital settings.", "The study aimed to find out the prevalence of anxiety, depression, and insomnia symptoms were among hcws, as well as the factors related to these mental health issues.", "Methods.", "We conducted an online survey of hcws employed in dhaka city from June 6 to July 6, 2020 Symptoms of anxiety, depression, and insomnia were measured using the generalized anxiety disorder, the depression module of the patient health questionnaire, and the insomnia.", "Severity.", "Index, respectively.", "The related factors of anxiety, depression, and insomnia symptoms were identified using three regression models.", "Results.", "This research included responses from 294 HCWs (mean\u00b1 standard deviation age: 28 86\u00b15 5 years; 43 5% were female) anxiety, depression, and insomnia symptoms were found in 20 7%, 26 5%, and 44 2% of hcws, respectively.", "The variable financial difficulties was commonly found as an associated factor for anxiety, depression, and insomnia symptoms female hcws were more prone to mental health symptoms and insomnia compared to male hcws (adjusted odds ratio- AOR=2 20, 95% CI=1 27 \u2013 3 79) The depression symptoms among hcws were found to be a factor for insomnia (AOR=6 321, 95% CI= 3 158 \u2013 12 650) Conclusion.", "In the current pandemic, the high prevalence of mental health symptoms among hcws indicates that this occupational group being associated with increased mental distress.", "Increasing financial support for hcws and providing support to female workers in care facilities could help to alleviate the burden of mental illness.", "Supportive, training, and educational strategies, particularly through knowledge and communication platforms, could be recommended to the care facilities, which can reduce the burden of mental health symptoms among hcws."], "journal": "Heliyon", "publish_time": "2021", "aliases": []}
{"doc_id": 237468994, "title": "Occupational Disruptions during the COVID-19 Pandemic and Their Association with Healthcare Workers\u2019 Mental Health", "abstract": ["Background: The COVID-19 crisis has caused prolonged and extreme demands on healthcare services.", "This study investigates the types and prevalence of occupational disruptions, and associated symptoms of mental illness, among Australian frontline healthcare workers during the COVID-19 pandemic.", "Methods: A national cross-sectional online survey was conducted between 27 August and 23 October 2020.", "Frontline healthcare workers were invited to participate via dissemination from major health organisations, professional associations or colleges, universities, government contacts, and national media.", "Data were collected on demographics, home and work situations, and validated scales of anxiety, depression, PTSD, and burnout.", "Results: Complete responses were received from 7846 healthcare workers (82.4%).", "Most respondents were female (80.9%) and resided in the Australian state of Victoria (85.2%).", "Changes to working conditions were common, with 48.5% reporting altered paid or unpaid hours, and many redeployed (16.8%) or changing work roles (27.3%).", "Nearly a third (30.8%) had experienced a reduction in household income during the pandemic.", "Symptoms of mental illness were common, being present in 62.1% of participants.", "Many respondents felt well supported by their workplaces (68.3%) and believed that workplace communication was timely and useful (74.4%).", "Participants who felt well supported by their organisation had approximately half the risk of experiencing moderate to severe anxiety, depression, burnout, and PTSD.", "Half (50.4%) of respondents indicated a need for additional training in using personal protective equipment and/or caring for patients with COVID-19.", "Conclusions: Occupational disruptions during the COVID-19 pandemic occurred commonly in health organisations and were associated with worse mental health outcomes in the Australian health workforce.", "Feeling well supported was associated with significantly fewer adverse mental health outcomes.", "Crisis preparedness focusing on the provision of timely and useful communication and support is essential in current and future crises."], "journal": "Int J Environ Res Public Health", "publish_time": "2021-09-02", "aliases": []}
{"doc_id": 246493094, "title": "Characterising within-hospitalSARS-CoV-2 transmission events using epidemiological and viral genomic data across two pandemic waves.", "abstract": ["Hospital outbreaks of COVID19 result in considerable mortality and disruption to healthcare services and yet little is known about transmission within this setting.", "We characterise within hospital transmission by combining viral genomic and epidemiological data using Bayesian modelling amongst 2181 patients and healthcare workers from a large UK NHS Trust.", "Transmission events were compared between Wave 1 (1st March to 25th J'uly 2020) and Wave 2 (30th November 2020 to 24th January 2021).", "We show that staff-to-staff transmissions reduced from 31.6% to 12.9% of all infections.", "Patient-to-patient transmissions increased from 27.1% to 52.1%.", "40%-50% of hospital-onset patient cases resulted in onward transmission compared to 4% of community-acquired cases.", "Control measures introduced during the pandemic likely reduced transmissions between healthcare workers but were insufficient to prevent increasing numbers of patient-to-patient transmissions.", "As hospital-acquired cases drive most onward transmission, earlier identification of nosocomial cases will be required to break hospital transmission chains."], "journal": "Nature communications", "publish_time": "2022-02-03", "aliases": []}
{"doc_id": 236039069, "title": "Characterising within-hospital SARS-CoV-2 transmission events: a retrospective analysis integrating epidemiological and viral genomic data from a UK tertiary care setting across two pandemic waves", "abstract": ["Structured abstractO_ST_ABSObjectivesC_ST_ABSTo characterise within-hospital SARS-CoV-2 transmission across two waves of the COVID-19 pandemic.", "DesignA retrospective Bayesian modelling study to reconstruct transmission chains amongst 2181 patients and healthcare workers using combined viral genomic and epidemiological data.", "SettingA large UK NHS Trust with over 1400 beds and employing approximately 17,000 staff.", "Participants780 patients and 522 staff testing SARS-CoV-2 positive between 1st March 2020 and 25th July 2020 (Wave 1); and 580 patients and 299 staff testing SARS-CoV-2 positive between 30th November 2020 and 24th January 2021 (Wave 2).", "Main outcome measuresTransmission pairs including who-infected-whom; location of transmission events in hospital; number of secondary cases from each individual, including differences in onward transmission from community and hospital onset patient cases.", "ResultsStaff-to-staff transmission was estimated to be the most frequent transmission type during Wave 1 (31.6% of observed hospital-acquired infections; 95% CI 26.9 to 35.8%), decreasing to 12.9% (95% CI 9.5 to 15.9%) in Wave 2.", "Patient-to-patient transmissions increased from 27.1% in Wave 1 (95% CI 23.3 to 31.4%) to 52.1% (95% CI 48.0 to 57.1%) in Wave 2, to become the predominant transmission type.", "Over 50% of hospital-acquired infections were concentrated in 8/120 locations in Wave 1 and 10/93 locations in Wave 2.", "Approximately 40% to 50% of hospital-onset patient cases resulted in onward transmission compared to less than 4% of definite community-acquired cases.", "ConclusionsPrevention and control measures that evolved during the COVID-19 pandemic may have had a significant impact on reducing infections between healthcare workers, but were insufficient during the second wave to prevent a high number of patient-to-patient transmissions.", "As hospital-acquired cases appeared to drive most onward transmissions, more frequent and rapid identification and isolation of these cases will be required to break hospital transmission chains in subsequent pandemic waves."], "journal": "", "publish_time": "2021", "aliases": []}
{"doc_id": 215782271, "title": "Work-related Covid-19 transmission", "abstract": ["Importance: Our study helps fill the knowledge gap related to work-related transmission in the emerging coronaviral pandemic.", "Objective: To demonstrate high-risk occupations for early coronavirus disease 2019 (Covid-19) local transmission.", "Methods: In this observational study, we extracted confirmed Covid-19 cases from governmental investigation reports in Hong Kong, Japan, Singapore, Taiwan, Thailand, and Vietnam.", "We followed each country/area for 40 days after its first locally transmitted case, and excluded all imported cases.", "We defined a possible work-related case as a worker with evidence of close contact with another confirmed case due to work, or an unknown contact history but likely to be infected in the working environment (e.g.", "an airport taxi driver).", "We calculated the case number for each occupation, and illustrated the temporal distribution of all possible work-related cases and healthcare worker (HCW) cases.", "The temporal distribution was further defined as early outbreak (the earliest 10 days of the following period) and late outbreak (11th to 40th days of the following period).", "Results: We identified 103 possible work-related cases (14.9%) among a total of 690 local transmissions.", "The five occupation groups with the most cases were healthcare workers (HCWs) (22%), drivers and transport workers (18%), services and sales workers (18%), cleaning and domestic workers (9%) and public safety workers (7%).", "Possible work-related transmission played a substantial role in early outbreak (47.7% of early cases).", "Occupations at risk varied from early outbreak (predominantly services and sales workers, drivers, construction laborers, and religious professionals) to late outbreak (predominantly HCWs, drivers, cleaning and domestic workers, police officers, and religious professionals).", "Conclusions: Work-related transmission is considerable in early Covid-19 outbreaks, and the elevated risk of infection was not limited to HCW.", "Implementing preventive/surveillance strategies for high-risk working populations is warranted."], "journal": "", "publish_time": "2020-04-11", "aliases": []}
{"doc_id": 218758822, "title": "Work-related COVID-19 transmission in six Asian countries/areas: A follow-up study", "abstract": ["OBJECTIVE: There is limited evidence of work-related transmission in the emerging coronaviral pandemic.", "We aimed to identify high-risk occupations for early coronavirus disease 2019 (COVID-19) local transmission.", "METHODS: In this observational study, we extracted confirmed COVID-19 cases from governmental investigation reports in Hong Kong, Japan, Singapore, Taiwan, Thailand, and Vietnam.", "We followed each country/area for 40 days after its first locally transmitted case, and excluded all imported cases.", "We defined a possible work-related case as a worker with evidence of close contact with another confirmed case due to work, or an unknown contact history but likely to be infected in the working environment (e.g.", "an airport taxi driver).", "We calculated the case number for each occupation, and illustrated the temporal distribution of all possible work-related cases and healthcare worker (HCW) cases.", "The temporal distribution was further defined as early outbreak (the earliest 10 days of the following period) and late outbreak (11th to 40th days of the following period).", "RESULTS: We identified 103 possible work-related cases (14.9%) among a total of 690 local transmissions.", "The five occupation groups with the most cases were healthcare workers (HCWs) (22%), drivers and transport workers (18%), services and sales workers (18%), cleaning and domestic workers (9%) and public safety workers (7%).", "Possible work-related transmission played a substantial role in early outbreak (47.7% of early cases).", "Occupations at risk varied from early outbreak (predominantly services and sales workers, drivers, construction laborers, and religious professionals) to late outbreak (predominantly HCWs, drivers, cleaning and domestic workers, police officers, and religious professionals).", "CONCLUSIONS: Work-related transmission is considerable in early COVID-19 outbreaks, and the elevated risk of infection was not limited to HCW.", "Implementing preventive/surveillance strategies for high-risk working populations is warranted."], "journal": "PLoS One", "publish_time": "2020", "aliases": []}
{"doc_id": 221115352, "title": "Social Network Analysis of COVID-19 Transmission in Karnataka, India", "abstract": ["We used social network analysis (SNA) to study the novel coronavirus (COVID-19) outbreak in Karnataka, India, and assess the potential of SNA as a tool for outbreak monitoring and control.", "We analyzed contact tracing data of 1147 Covid-19 positive cases (mean age 34.91 years, 61.99% aged 11-40, 742 males), anonymized and made public by the government.", "We used software tools Cytoscape and Gephi to create SNA graphics and determine network attributes of nodes (cases) and edges (directed links, determined by contact tracing, from source to target patients).", "Outdegree was 1-47 for 199 (17.35%) nodes, and betweenness 0.5-87 for 89 (7.76%) nodes.", "Men had higher mean outdegree and women, higher betweenness.", "Delhi was the exogenous source of 17.44% cases.", "Bangalore city had the highest caseload in the state (229, 20%), but comparatively low cluster formation.", "Thirty-four (2.96%) super-spreaders (outdegree[\u00e2\u0089\u00a5]5) caused 60% of the transmissions.", "Real-time social network visualization can allow healthcare administrators to flag evolving hotspots and pinpoint key actors in transmission.", "Prioritizing these areas and individuals for rigorous containment could help minimize resource outlay and potentially achieve a significant reduction in COVID-19 transmission."], "journal": "", "publish_time": "2020-08-14", "aliases": [221916388]}
{"doc_id": 245386715, "title": "Transmission from vaccinated individuals in a large SARS-CoV-2 Delta variant outbreak", "abstract": ["An outbreak of over one thousand COVID-19 cases in Provincetown, Massachusetts, in July 2021\u2014the first large outbreak mostly in vaccinated individuals in the US\u2014prompted a comprehensive public health response, motivating changes to national masking recommendations and raising questions about infection and transmission among vaccinated individuals.", "To address these questions, we combined genomic and epidemiological data from 467 individuals, including 40% of known outbreak-associated cases.", "The Delta variant accounted for 99% of outbreak-associated cases in this dataset; it was introduced from at least 40 sources, but 83% of cases derived from a single source, likely through transmission across multiple settings over a short time rather than a single event.", "Genomic and epidemiological data supported multiple transmissions of Delta from and between fully vaccinated individuals.", "However, despite its magnitude, the outbreak had limited onward impact in MA and the US, likely due to high vaccination rates and a robust public health response."], "journal": "Cell", "publish_time": "2021-12-23", "aliases": []}
{"doc_id": 216528400, "title": "COVID-19: Modelling Local Transmission and Morbidity effects to provide an estimate of overall Relative Healthcare Resource Impact by General Practice Granularity", "abstract": ["IntroductionSevere Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the name given to the 2019 novel coronavirus.", "COVID-19 is the name given to the disease associated with the virus.", "SARS-CoV-2 is a new strain of coronavirus that has not been previously identified in humans.", "MethodsTwo key factors were analysed which when multiplied together would give an estimate of relative demand on healthcare utilisation.", "These factors were case incidence and case morbidity.", "GP Practice data was used as this provided the most geographically granular source of published public population data.", "To analyse case incidence, the latest values for indicators that could be associated with infection transmission rates were collected from the Office of National Statistics (ONS) and Quality Outcome Framework (QOF) sources.", "These included population density, % age >16 at fulltime work/education, % age over 60, % BME ethnicity, social deprivation as IMD 2019, Location as latitude/longitude, and patient engagement as % self-confident in their own long term condition management.", "Average case morbidity was calculated by applying the international mortality Odds Ratio to the local population relevant age and disease prevalences and then summing and dividing by the equivalent national figure.", "To provide a comparative measure of overall healthcare resource impact, individual GP practice impact scores were compared against the median practice.", "ResultsThe case incidence regression is a dynamic situation with the significance of specific factors moderating over time as the balance between external infection, community transmission and impact of mitigation measures feeds through to the number of cases.", "It showed that currently Urban, % Working and age >60 were the strongest determinants of case incidence.", "The local population comorbidity remains unchanged.", "The range of relative HC impact was wide with 80% of practices falling between 20%-250% of the national median.", "Once practice population numbers were included it showed that the top 33% of GP practices supporting 45% of the patient population would require 68% of COVID-19 healthcare resources.", "The model provides useful information about the relative impact of Covid-19 on healthcare workload at GP practice granularity in all parts of England.", "ConclusionCovid-19 is impacting on the utilisation of health and social care resources across the country.", "This model provides a method for predicting relative local levels of disease burden based on defined criteria and thereby providing a method for targeting limited (and perhaps soon to be scarce) care resources to optimise national, regional and local responses to the COVID-19 outbreak.."], "journal": "", "publish_time": "2020-03-23", "aliases": [218598099]}
{"doc_id": 244545081, "title": "Prevalence and Associated Risk Factors of COVID-19 Infection Among Healthcare Workers in a Pandemic Hospital", "abstract": ["Introduction: This study aimed to investigate the prevalence of Coronavirus disease-2019 (COVID-19) infection among healthcare workers in our hospital with the risk factors affecting the transmission and course of the disease and to determine the control measures.", "Methods: Medical records of healthcare workers diagnosed with COVID-19, confirmed by polymerase chain reaction (PCR) between 11 March and 30 April 2020, were retrospectively analyzed in our hospital in the center of \u00cdstanbul, the city with the highest number of cases in our country.", "Real-time PCR detection was used to verify the diagnosis of the healthcare workers.", "A rapid diagnostic test kit for COVID-19 immunoglobulin M (IgM) and IgG antibodies was used in seroconversion analysis.", "Results: In our hospital, 4,177 COVID-19 cases confirmed by the laboratory between March 11 and April 30 2020 were followed.", "Of the 4177 cases, 165 (3.95%) were healthcare workers.", "The majority of healthcare workers with positive test results were nurses (36.3%), and 118 (71.5%) of the healthcare workers worked 40 h or more per week.", "Thoracic tomography examinations were performed in all infected healthcare workers, and 69 (41.8%) were diagnosed with pneumonia by the detection of ground patchy lesions.", "Conclusion: During the epidemic, early training of healthcare workers on the disease, use of personal protective equipment, and infection control are extremely important to reduce the risk of infection among healthcare workers.", "Periodic screening of asymptomatic healthcare workers can also help protect patients and hospital staff and prevent loss of workforce.", "(English) [ FROM AUTHOR] Ama\u00e7: Bu \u00e7al\u0131\u015fmada, hastanemizde g\u00f6rev yapan sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131n\u0131n Koronavir\u00fcs hastal\u0131\u011f\u0131-2019 (COVID-19) enfeksiyonu prevalans\u0131 ile hastal\u0131\u011f\u0131n bula\u015f\u0131n\u0131 ve seyrini etkileyen risk fakt\u00f6rlerinin ara\u015ft\u0131r\u0131lmas\u0131 ve kontrol \u00f6nlemlerinin belirlenmesi ama\u00e7lanm\u0131\u015ft\u0131r.", "Y\u00f6ntemler: \u00dclkemizde olgular\u0131n en fazla oldu\u011fu \u015fehir olan \u00cdstanbul'un merkezinde olan hastanemizde 11 Mart-30 Nisan 2020 tarihleri aras\u0131nda polimeraz zincir reaksiyon (PCR) ile konfirme edilmi\u015f COVID-19 tan\u0131s\u0131 alan sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131n\u0131n t\u0131bbi kay\u0131tlar\u0131 retrospektif olarak incelenmi\u015ftir.", "Sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131n\u0131n tan\u0131lar\u0131 ger\u00e7ek zamanl\u0131 PCR tespit y\u00f6ntemi ile konulmu\u015ftur.", "Serokonversiyon incelemesi i\u00e7in h\u0131zl\u0131 test tan\u0131 kiti COVID-19 imm\u00fcnoglobulin M (IgM) ve IgG kullan\u0131lm\u0131\u015ft\u0131r.", "Bulgular: Hastanemizde 11 Mart-30 Nisan 2020 tarihleri aras\u0131nda laboratuvar taraf\u0131ndan konfirme edilmi\u015f 4.177 COVID-19 olgusu takip edilmi\u015ftir.", "Toplam 165'i (%3,95) sa\u011fl\u0131k \u00e7al\u0131\u015fan\u0131yd\u0131.", "Pozitif olanlar\u0131n \u00e7o\u011funlu\u011funu hem\u015fireler (%36,3) olu\u015fturmakta ve sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131n 118'i (%71,5) haftada 40 saat ve \u00fczerinde \u00e7al\u0131\u015fmaktad\u0131r.", "Enfekte sa\u011fl\u0131k \u00e7al\u0131\u015fan\u0131n t\u00fcm\u00fcne toraks tomografisi \u00e7ekilmi\u015f olup 69'unda (%41,8) yamasal lezyonlar saptanarak pn\u00f6moni tan\u0131s\u0131 konulmu\u015ftur.", "Sonu\u00e7: Salg\u0131n s\u0131ras\u0131nda sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131n\u0131n hastal\u0131kla ilgili bilgilendirilme, ki\u015fisel koruyucu ekipman kullan\u0131m\u0131 ve enfeksiyon kontrol\u00fc ile ilgili e\u011fitimlerinin erken d\u00f6nemde yap\u0131lmas\u0131 sa\u011fl\u0131k \u00e7al\u0131\u015fmalar\u0131nda enfeksiyon riskini azaltma a\u00e7\u0131s\u0131ndan son derece \u00f6nemlidir.", "Asemptomatik sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131n\u0131n da d\u00fczenli aral\u0131klarla taranmas\u0131n\u0131n hastalar\u0131n ve hastane personelinin korunmas\u0131 a\u00e7\u0131s\u0131ndan faydal\u0131 olaca\u011f\u0131 ayr\u0131ca i\u015f g\u00fcc\u00fc kayb\u0131n\u0131n da \u00f6n\u00fcne ge\u00e7ilece\u011fi a\u00e7\u0131kt\u0131r.", "(Turkish) [ FROM AUTHOR] Copyright of Istanbul Medical Journal is the property of Galenos Yayinevi Tic.", "LTD. STI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission.", "However, users may print, download, or email articles for individual use.", "This may be abridged.", "No warranty is given about the accuracy of the copy.", "Users should refer to the original published version of the material for the full .", "(Copyright applies to all s.)"], "journal": "Pandemi Hastanesinde \u00c7al\u0131\u015fan Sa\u011fl\u0131k \u00c7al\u0131\u015fanlar\u0131nda COVID-19 Enfeksiyonunun Yayg\u0131nl\u0131\u011f\u0131 ve &Iacute;li\u015fkili Risk Fakt\u00f6rleri.", "publish_time": "2021", "aliases": []}
{"doc_id": 239047482, "title": "Evidence of transmission from fully vaccinated individuals in a large outbreak of the SARS-CoV-2 Delta variant in Provincetown, Massachusetts", "abstract": ["Multiple summer events, including large indoor gatherings, in Provincetown, Massachusetts (MA), in July 2021 contributed to an outbreak of over one thousand COVID-19 cases among residents and visitors.", "Most cases were fully vaccinated, many of whom were also symptomatic, prompting a comprehensive public health response, motivating changes to national masking recommendations, and raising questions about infection and transmission among vaccinated individuals.", "To characterize the outbreak and the viral population underlying it, we combined genomic and epidemiological data from 467 individuals, including 40% of known outbreak-associated cases.", "The Delta variant accounted for 99% of sequenced outbreak-associated cases.", "Phylogenetic analysis suggests over 40 sources of Delta in the dataset, with one responsible for a single cluster containing 83% of outbreak-associated genomes.", "This cluster was likely not the result of extensive spread at a single site, but rather transmission from a common source across multiple settings over a short time.", "Genomic and epidemiological data combined provide strong support for 25 transmission events from, including many between, fully vaccinated individuals; genomic data alone provides evidence for an additional 64.", "Together, genomic epidemiology provides a high-resolution picture of the Provincetown outbreak, revealing multiple cases of transmission of Delta from fully vaccinated individuals.", "However, despite its magnitude, the outbreak was restricted in its onward impact in MA and the US, likely due to high vaccination rates and a robust public health response."], "journal": "medRxiv", "publish_time": "2021-10-20", "aliases": []}
{"doc_id": 238180775, "title": "Epidemic process of COVID-19 in the Russian Federation: Interim results. 2nd report", "abstract": ["Objective.", "To perform an interim analysis of epidemiological parameters of COVID-19 related to contacts and secondary cases of infection in the Russian Federation.", "Materials and methods.", "We analyzed 190,856 primary COVID-19 cases and 146,996 people who had been in contact with them.", "We used some data of monitoring performed by the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing in January\u2013June 2020.", "We characterized the foci of infection and people who had contacts with primary COVID-19 cases and secondary cases of infection.", "Results.", "Just over half (50.02%) of study participants who had contacts with COVID-19 contacted with primary patients with mild disease, whereas 45.40% of individuals contacted with patients with moderate disease and 4.58% of individuals had contacts with patients with severe disease.", "Patients with mild COVID-19 interacted with more people, which resulted in a greater number of secondary cases of infection.", "The highest proportion of both primary COVID-19 patients and people who had contact with COVID- 19 was observed in the age group of 41\u201364 years (44.42% and 44.51%, respectively).", "Approximately one third of COVID-19 patients and people who had contact with COVID-19 were 18 to 40 years old (30.20% and 34.21% respectively).", "The proportions of children aged 0\u20136 years and 7\u201317 years among COVID-19 patients were 2.70% and 4.02%, respectively;the same proportions among those who had contact with COVID-19 cases were 1.94 and 3.13%, respectively.", "Household contacts were the most common ways of COVID-19 transmission in all age groups.", "Patients aged between 40 and 64 years played the most significant role in the transmission of this infection in different foci.", "Individuals from this age group comprised 42.02% of patients infected in social institutions, 43.40% of those who had household contacts, and 47.70% of those infected at work.", "Conclusion.", "Patients with mild and moderate disease aged 18 to 64 years had the highest number of contacts and, therefore, caused the highest number of secondary cases of infection.", "Household contacts played the most important role in COVID-19 transmission in all age groups.", "Among people aged 18 to 64 years, COVID-19 transmission at work was also important.", "In all foci of infection, the majority of patients were in the age group of 40\u201364 years.", "Our findings can be used to optimize the preventive measures for COVID-19.", "\u00a9 2021, Dynasty Publishing House.", "All rights reserved."], "journal": "Infektsionnye Bolezni", "publish_time": "2021", "aliases": []}
{"doc_id": 233393643, "title": "Detection of SARS-CoV-2 infection by saliva and nasopharyngeal sampling in frontline healthcare workers: an observational cohort study.", "abstract": ["Background The SARS-CoV-2 pandemic has caused an unprecedented strain on healthcare systems worldwide, including the UK National Health Service (NHS).", "During the first wave of SARS-CoV-2 transmission in UK, SARS-CoV-2 NHS diagnostic test availability was limited to self-isolating symptomatic staff.", "The burden of symptomatic and asymptomatic infection in healthcare workers (HCW) attending work was unknown.", "Methods We conducted an observational cohort study of SARS-CoV-2 infection in HCW working in an acute NHS Trust during the first wave of the COVID-19 pandemic, using serial self-collected saliva and nasopharyngeal (NP) samples.", "We also collected self-assessed symptom profiles and isolation behaviours.", "We retrospectively compared SARS-CoV-2 detection by RT-PCR from saliva (weekly) and NP swabs (twice weekly) from 85 individuals in this cohort and evaluated the association with symptoms.", "Findings Over a 12-week period from 30th March 2020, 40% (n=34/85, CI95% 31.3-51.8%) HCWs had evidence of SARS-CoV-2 infection by surveillance NP swab and/or saliva RT-qPCR.", "Agreement between paired saliva and NP swabs was poor (28.6%, CI95% 13.2-48.7%) with both methods detecting symptomatic and asymptomatic infections.", "Symptoms were reported by 47.1% (n=40) and self-isolation by 25.9% participants (n=22).", "Only 41.2% (n=14/34) participants with SARS-CoV-2 infection reported any symptoms within 14 days of the infection.", "Interpretation HCWs are a potential source of SARS-CoV-2 transmission in hospitals and symptom screening will identify the minority of infections in HCW.", "Saliva is an easily accessible fluid sample for screening for SARS-CoV-2 infection and in addition to NP swab, facilitated ascertainment of symptomatic and asymptomatic cases in this setting.", "Combined saliva and NP testing would improve detection of SARS-CoV-2 for surveillance.", "Better understanding of transmissibility from asymptomatic staff using transmission-based infection precautions, is required to inform policy."], "journal": "", "publish_time": "2021-04-26", "aliases": []}
{"doc_id": 233351544, "title": "[Evaluation of Healthcare Professionals in Contact with Patients Diagnosed with COVID-19 Detected Outside of the Pandemic Service in our Hospital].", "abstract": ["The \"Coronavirus Disease 19 (COVID-19)\" caused by \"Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)\" is still active all over the world as a pandemia.", "It is reported that at least 7000 health care workers (HCW) had lost their lives due to COVID-19 from the beginning of the pandemia till September 2020 in the world.", "In our country between the dates, March 11, 2020 which the first case was reported, and September 1, 2020, the date which our study has been finalized, 7428 HCW were infected by SARS-CoV-2, and 52 of them were deceased.", "In this study, it was aimed to evaluate the contact and illness of healthcare workers working outside of the pandemic clinics in our hospital and to examine the possible transmission routes and disease prognoses.", "Healthcare workers who were working outside the pandemic service between March 11, 2020 and September 1, 2020 and who had a definite diagnosis of COVID-19 and all hospital staff who had contacted with these people, and HCW who had contact with patients diagnosed with COVID-19 while receiving inpatient treatment in services other than the pandemic service was evaluated and classified as low, medium and high risk according to the risk scoring defined in the published \"Ministry of Health COVID-19 Guidelines\".", "Healthcare workers who were evaluated as contacted were questioned in detail regarding the use of personal protective equipment (PPE) at the time of contact, especially suitability of the masks, contact time and shape and all the data were recorded.", "A total of 53 index cases (40 HCW and 13 inpatients diagnosed as COVID-19) were detected during the study period.", "The number of HCW contacted with these index cases was 672.", "In our study, we examined the data of 40 index cases and 672 contacted HCW (total of 712 HCW).", "Only 3 of 40 index cases (7.5%) had hospital-acquired COVID-19 infection, the other 37 cases were infected by community sources.", "COVID-19 was not detected in 94.2% of the contacted HCW during the follow-up while 5.8% of them had positive PCR test results.", "Considering the possible way of contamination among the contacted HCW who developed COVID-19 during the follow-up period, it was determined that 13.1% of the cases were a result of taken care of patients, 86.9% of the cases were a result of being in hospital social environments (drinking tea, smoking, eating, chatting in the same room without personal precautions) and in the days after the contact, it was in the form of contact with healthcare personnel diagnosed with COVID-19.", "When the contacted HCW were questioned about using proper masks at the time of contact, we determined that 93.3% of them used masks during patient caring procedures, however, only 48.9% used masks when they were in social areas (p<0.001).", "Healthcare workers face an unprecedented risk of occupational disease and death due to the COVID-19 pandemic.", "However, it is also observed that prolonged pandemia period caused health workers to disregard rigorous infection control precautions in social areas of hospitals which they follow inpatient care although this has shown to be the most common way of contamination.", "Commonly performed in-service training and causing awareness in all areas of the hospital about following infection control precautions and PPE usage and checking the process regularly are the most important ways to prevent HCW from being affected by COVID-19."], "journal": "Mikrobiyoloji bulteni", "publish_time": "2021-04-01", "aliases": []}
{"doc_id": 215782614, "title": "Modeling Covid-19 dynamics for real-time estimates and projections: an application to Albanian data", "abstract": ["The SARS-CoV-2 epidemic is one of the biggest challenges healthcare systems worldwide have ever had to face.", "To curb transmission many countries have adopted social distancing measures and travel restrictions.", "Estimating the effect of these measures in each context is challenging and requires mathematical models of the transmission dynamics.", "Projections for the future course of the epidemic strongly rely on model predictions and accurate representation of real-time data as they accumulate.", "Here I develop an SEIR modeling framework for Covid-19, to evaluate reported cases and fatalities, and to enable forecasting using evidence-based Bayesian parameter estimation.", "This Bayesian framework offers a tool to parametrize real-time dynamics of Covid-19 cases, and explore the effect of control as it unfolds in any setting.", "I apply the model to Covid-19 data from Albania, where drastic control measures were put in place already on the day of the first confirmed case.", "Evaluating the dynamics of reported cases 9-31 March 2020, I estimate parameters and make preliminary projections.", "Three weeks into the measures, Albanian data already indicate a strong signature of more than 40% transmission reduction, and lend support to a progressively increasing effect of control measures rather than a static one.", "In the Albanian setting, the model and data match well, projecting the peak of the outbreak may be around 5-15 April, and be contained within 300 active confirmed cases if control continues with the same trend.", "This framework can be used to understand the quantitative effects of different control measures in real-time, and inform adaptive intervention for success in other settings."], "journal": "", "publish_time": "2020-03-23", "aliases": []}
{"doc_id": 235709922, "title": "COVID-19 Community Transmission among Healthcare Workers at a Tertiary Care Cardiac Center", "abstract": ["Aim: To determine the frequency, mode of transmission, and outcome of Coronavirus Disease 2019 (COVID-19) among healthcare workers (HCWs) in a tertiary care cardiac center in the Kingdom of Saudi Arabia (KSA).", "Methods: This is a retrospective study of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infected HCWs and was conducted from 2 March to 31 December 2020.", "Data related to the presence of COVID-19 symptoms, mode of transmission, hospitalization, and mortality were collected from the patients\u2019 medical records.", "Results: Of the 4462 patients tested for COVID-19 by real-time reverse transcriptase polymerase chain reaction (RT-PCR), 203 (4.5%) HCWs were positive; of these, 125 (61.6%) were males, and the most common age group was <40 years.", "The most commonly encountered health professionals were nurses (74, 36.4%), followed by therapists/technicians (48, 23.6%), housekeepers (25, 12.3%), and physicians (21, 10.4%).", "The majority (184, 90.6%) of the HCWs contracted COVID-19 in the community, and only 19 (9.4%) were healthcare-associated infections.", "Of the infected HCWs, 169 (83.3%) had mild symptoms and were managed in home isolation.", "The most common symptoms were fever (128, 63.1%), body ache (124, 61.8%), headache (113, 55.7%), dry cough (123, 60.6%), sore throat (97, 47.8%), body weakness (97, 47.8%), and fatigue (94, 46.3%).", "Comparing males and females, there was a significantly higher number of female nurses; in contrast, there was a higher number of male physicians, housekeepers, therapists/technicians, and other specialty HCWs.", "A significantly lower number of nurses, therapists/technicians were infected in the \u226540 years age group compared to <40 years.", "Furthermore, a significantly higher difference was observed among non-Saudi nurses compared to Saudi nurses.", "No mortality was documented among the included HCWs.", "Conclusions: In the largest tertiary cardiac center in KSA, most HCWs who contracted COVID-19 developed mild symptoms; nurses and those aged <40 years were most commonly infected, and most infections were acquired in the community.", "HCWs\u2019 adherence to mitigation measures outside of the workplace is vital to curb the current pandemic and decrease nosocomial transmission risk."], "journal": "Med Sci (Basel)", "publish_time": "2021-06-30", "aliases": []}
{"doc_id": 221820602, "title": "Clinical characteristics and humoral immune response in Healthcare Workers with COVID-19 in a Teaching Hospital in Belgium", "abstract": ["BACKGROUND: Healthcare workers (hcws) are at high risk of acquiring COVID-19 and could play a role in nosocomial transmission.", "Since.", "February 4, 2020, belgian.", "Health authorities reported more than 90568 cases, of which 8 3% were hcws data on clinical characteristics, sources of infection and humoral immune response of hcws with COVID-19 remain scarce AIM: Analyse the clinical characteristics, humoral immune response, sources of contamination, and outcomes among hcws with COVID-19 METHODS: This retrospective study includes 176 HCWs with laboratory-confirmed COVID-19 in a teaching hospital in belgium.", "Between.", "March 1 (st), and May 31 (th) 2020, all HCWs with symptoms suspect of COVID-19 were tested through a RT-PCR on a nasopharyngeal swab serological testing was performed between 55 and 137 days after the onset of symptoms FINDINGS: median age was 40 8 years and 75% were female median delay between onset of symptoms and diagnosis was 4 39 days.", "Most frequent symptoms were cough and headache (75% respectively) fever accounted for 68 7% Most represented professions were nurses (42%) hcws were mainly infected by patient contact (32 9%) 7 6% required hospitalization and 1 7% were admitted in intensive care unit.", "Unfortunately, one hcw died (0 5%) total antibodies were positive in 109/126 (86 5%) CONCLUSIONS: clinical presentation of COVID-19 in hcws does not differ from the general population.", "However outcomes were more favourable with a mortality rate lower than that reported in belgian COVID-19 patients in general (16%) The main source of infection was the hospital settings.", "Our positive antibodies rate was high but lower than what was reported."], "journal": "J Hosp Infect", "publish_time": "2020", "aliases": []}
{"doc_id": 224966547, "title": "Healthcare professionals\u2019 knowledge, perception and practice towards COVID-19: A cross-sectional web-survey", "abstract": ["Abstract Objective COVID-19 is a highly contagious disease Healthcare professionals (HCPs) are increasingly facing suspected and confirmed cases of COVID-19 To evaluate Iraqi HCPs (physicians, dentists and pharmacists) knowledge, perception and practice towards COVID-19 Methods This was a cross-sectional, anonymised web-survey, using an electronic application (Surveyheart?)", "The web-survey link was posted via the closed groups of physicians, dentists and pharmacists in Iraq on Facebook and Twitter The questionnaire was self-administered and data was collected between, 10th?25th of March 2020 Key findings Three hundred seventy two HCPs participated in the study The majority of Iraqi HCPs have a good knowledge about the origin, incubation period, the mode of transmission, the common signs and symptoms and the groups of patients who were at higher risk of COVID-19 HCPs identified internet, social media as the main source of information about the disease The lowest rate of correct answers was found in items related to the virus which is responsible for the development of COVID-19 disease (44 6%) and the types of face mask that protect against COVID-19 (40 6%) Physicians were found to have higher score of knowledge compared to dentists and pharmacists Iraqi HCPs requested more strict preventive measure to be applied to prevent the spread of the disease Iraqi HCPs expressed their inclination to use the international guidelines to treat confirmed cases Conclusions Iraqi HCPs have an overall good knowledge towards COVID-19 More information should be published from reputable and authentic sources to HCPs The Ministry of Health in Iraq could take its responsibility to inform the health providers with updated and confirmed information about COVID-19 prevention and management"], "journal": "Journal of Pharmaceutical Health Services Research", "publish_time": "2020", "aliases": []}
{"doc_id": 227224342, "title": "The impact of vaccination on COVID-19 outbreaks in the United States", "abstract": ["Background: Global vaccine development efforts have been accelerated in response to the devastating COVID-19 pandemic.", "We evaluated the impact of a 2-dose COVID-19 vaccination campaign on reducing incidence, hospitalizations, and deaths in the United States (US).", "Methods: We developed an agent-based model of SARS-CoV-2 transmission and parameterized it with US demographics and age-specific COVID-19 outcomes.", "Healthcare workers and high-risk individuals were prioritized for vaccination, while children under 18 years of age were not vaccinated.", "We considered a vaccine efficacy of 90% against infection following 2 doses administered 28 days apart achieving 40% vaccine coverage of the overall population.", "We specified 10% pre-existing population immunity for the base-case scenario and calibrated to an effective reproduction number of 1.5, accounting for current COVID-19 interventions in the US.", "Results: Vaccination reduced the overall attack rate to 1.6% (95% CI: 1.3% - 1.8%) from 7.1% (95% CI: 6.3% - 7.9%) across the same period without vaccination.", "The highest relative reduction (83-90%) was observed among individuals aged 65 and older.", "Vaccination markedly reduced adverse outcomes, with non-ICU, ICU hospitalizations, and deaths decreasing by 85.2% (95% CI: 82.3% - 87.6%), 85.3% (95% CI: 82.3% - 87.8%), and 87.8% (95% CI: 85.1% - 90.1%), respectively.", "Conclusions: Our results indicate that vaccination can have a substantial impact on reducing disease transmission and adverse clinical outcomes.", "However, with uptake of 40% or less in the population, vaccination is unlikely to completely eliminate the need for non-pharmaceutical interventions."], "journal": "", "publish_time": "2020", "aliases": []}
{"doc_id": 239944132, "title": "Experience of a COVID-19 outbreak response in a general hospital in Gyeonggi Province, Korea.", "abstract": ["OBJECTIVES Coronavirus disease 2019 (COVID-19) outbreaks in general hospitals are particularly risky because they not only overburden the regional healthcare delivery system, but also increase the possibility of community transmission.", "This study shares an experience of a COVID-19 outbreak response in a general hospital in Gyeonggi Province, Korea.", "METHODS Since the first COVID-19 confirmed case was recognized in Hospital A on March 29, 2020, the Immediate Response Team of Gyeonggi Province and Korea Disease Control and Prevention Agency devised a plan to conduct an epidemiological investigation and minimize the paralysis of hospital functions.", "Apart from the epidemiological investigation, a risk assessment of the hospital and management of contacts, including patients and workers, were also undertaken.", "RESULTS In total, 72 confirmed cases were identified, including 26 hospitalized patients, 16 healthcare personnel, 7 visitors, and 22 cases identified externally.", "The majority of the confirmed cases were exposed in Ward B or were contacts of people exposed in Ward A (58.3% of 72 cases).", "Among healthcare personnel, caregivers were found to be the most vulnerable to COVID-19 in this outbreak.", "CONCLUSIONS Preparation for all possible situations in medical facilities is important because it is difficult to find alternative resources.", "The findings of this study provide information on controlling the further transmission of COVID-19 and furnish evidence of the importance of ordinary management skills to be prepared for COVID-19."], "journal": "Epidemiology and health", "publish_time": "2021", "aliases": []}
{"doc_id": 231987885, "title": "Characteristics and Transmission Dynamics of COVID-19 in Healthcare Workers in a Pediatric COVID-Care Hospital in Mumbai", "abstract": ["OBJECTIVE: To evaluate if Healthcare workers (HCWs) at the frontline of COVID-19 response in a pediatric hospital are at an increased risk of acquiring SARS-CoV-2.", "METHODS: The Hospital Infection Control Committee (HICC) and virology testing records were combined to identify SARS-CoV-2 positive HCWs and study the transmission dynamics of COVID-19 over 6 months.", "RESULTS: COVID-19 cases in our HCWs cohort rose and declined parallel to community cases.", "Forty two out of 534 HCWs (8%) were SARS-CoV-2 positive with no fatalities.", "No clinical staff in the special COVID ward or ICU was positive.", "Significant proportion of non-clinical staff (30%) were SARS-CoV-2 positive.", "About 70% of SARS-CoV-2 positive staff had likely community acquisition, with a significant proportion having travelled by public transport or having a contact history with a positive case in the community.", "Twenty four percent of positive staff were asymptomatic and detected positive on re-joining test.", "CONCLUSIONS: Sustained transmission of SARS-CoV-2 did not occur in our cohort beyond community transmission.", "Appropriate PPE use, strict and constantly improving infection control measures and testing of both clinical and non-clinical staff were essential methods for restricting transmission amongst HCWs."], "journal": "Indian Pediatrics", "publish_time": "2021", "aliases": []}
{"doc_id": 244957760, "title": "Propagation of a hospital-associated cluster of COVID-19 in Malaysia", "abstract": ["BACKGROUND: Hospitals are vulnerable to COVID-19 outbreaks.", "Intrahospital transmission of the disease is a threat to the healthcare systems as it increases morbidity and mortality among patients.", "It is imperative to deepen our understanding of transmission events in hospital-associated cases of COVID-19 for timely implementation of infection prevention and control measures in the hospital in avoiding future outbreaks.", "We examined the use of epidemiological case investigation combined with whole genome sequencing of cases to investigate and manage a hospital-associated cluster of COVID-19 cases.", "METHODS: An epidemiological investigation was conducted in a University Hospital in Malaysia from 23 March to 22 April 2020.", "Contact tracing, risk assessment, testing, symptom surveillance, and outbreak management were conducted following the diagnosis of a healthcare worker with SARS-CoV-2 by real-time PCR.", "These findings were complemented by whole genome sequencing analysis of a subset of positive cases.", "RESULTS: The index case was symptomatic but did not fulfill the initial epidemiological criteria for routine screening.", "Contact tracing suggested epidemiological linkages of 38 cases with COVID-19.", "Phylogenetic analysis excluded four of these cases.", "This cluster included 34 cases comprising ten healthcare worker-cases, nine patient-cases, and 15 community-cases.", "The epidemic curve demonstrated initial intrahospital transmission that propagated into the community.", "The estimated median incubation period was 4.7 days (95% CI: 3.5\u20136.4), and the serial interval was 5.3 days (95% CI: 4.3\u20136.5).", "CONCLUSION: The study demonstrated the contribution of integrating epidemiological investigation and whole genome sequencing in understanding disease transmission in the hospital setting.", "Contact tracing, risk assessment, testing, and symptom surveillance remain imperative in resource-limited settings to identify and isolate cases, thereby controlling COVID-19 outbreaks.", "The use of whole genome sequencing complements field investigation findings in clarifying transmission networks.", "The safety of a hospital population during this COVID-19 pandemic may be secured with a multidisciplinary approach, good infection control measures, effective preparedness and response plan, and individual-level compliance among the hospital population.", "SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06894-y."], "journal": "BMC Infect Dis", "publish_time": "2021-12-09", "aliases": []}
{"doc_id": 236136564, "title": "Clinical and epidemiological characteristics and outcomes of Coronavirus disease-19 patients in a large longitudinal study", "abstract": ["Objective: This study aimed to determine the clinical and epidemiological characteristics and outcomes of Coronavirus disease (COVID)-19 patients.", "Methods: In this large cohort study, 15,409 confirmed patients with the COVID-19 of different severities were followed-up from three specialized COVID-19 hospitals between March 18 and October 11, 2020 in Iraqi Kurdistan.", "The predictors of mortality and severity were examined in binary logistic regression analysis.", "Results: The incidence rate of severe/critical status was 12.3% with a median age of 36.0 and case fatality rate (CFR) of 1.98%.", "The incidence rate of severe/critical conditions and CFR rose with increased age groups;except for 0\u201314 years (11.9%).", "The incidence rate of severe/critical patients and CFR was 8.3% and 0.5%, 21.1% and 4.0%, and 23.7% and 8.7% in 15\u201349 years, 50\u201364 years, and 65 and older age groups, respectively.", "The severity of the disease and CFR was associated with coexisting chronic diseases such as cardiovascular diseases (18.2% and 3.1%) and diabetes mellitus (19.8% and 3.4%).", "The asymptomatic patients (8400 and 54.5%) had statistically higher CFR;2.3% versus 1.6% (P = 0.006).", "The most common symptoms on diagnosis were fever (31.9%), cough (23.5%), loss of smell/taste (16.3%), sore throat (15.7%), shortness of breath (9.8%), and headache (9.5%).", "The results showed that being older was the only predictor of mortality and severity in COVID-19 patients.", "Conclusions: This region has a low incidence of severe-critic status and CFR.", "The patients with coexisting medical conditions are more likely to have severe conditions and die of COVID-19.", "The older age predicts severe/critic status and higher CFR.", "[ABSTRACT FROM AUTHOR] Copyright of Journal of Health Sciences (Qassim University) is the property of Journal of Health Sciences and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission.", "However, users may print, download, or email articles for individual use.", "This abstract may be abridged.", "No warranty is given about the accuracy of the copy.", "Users should refer to the original published version of the material for the full abstract.", "(Copyright applies to all Abstracts.)"], "journal": "Journal of Health Sciences (Qassim University)", "publish_time": "2021", "aliases": []}
{"doc_id": 237935756, "title": "Examining the Clinical Prognosis of Critically Ill Patients with COVID-19 Admitted to Intensive Care Units: A Nationwide Saudi Study", "abstract": ["Backgroundand Objectives: COVID-19 is a novel infectious disease caused by a single-stranded RNA coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).", "We aimed to conduct a nationwide multicenter study to determine the characteristics and the clinical prognostic outcome of critically ill COVID-19 patients admitted to intensive care units (ICUs).", "Materials and Methods: This is a nationwide cohort retrospective study conducted in twenty Saudi hospitals.", "Results: An analysis of 1470 critically ill COVID-19 patients demonstrated that the majority of patients were male with a mean age of 55.9 \u00b1 15.1 years.", "Most of our patients presented with a shortness of breath (SOB) (81.3%), followed by a fever (73.7%) and a cough (65.1%).", "Diabetes and hypertension were the most common comorbidities in the study (52.4% and 46.0%, respectively).", "Multiple complications were observed substantially more among non-survivors.", "The length and frequency of mechanical ventilation use were significantly greater (83%) in the non-survivors compared with the survivors (31%).", "The mean Sequential Organ Failure Assessment (SOFA) score was 6 \u00b1 5.", "The overall mortality rate of the cohort associated with patients that had diabetes, hypertension and ischemic heart disease was 41.8%.", "Conclusion: Age; a pre-existing medical history of hypertension, diabetes and ischemic heart disease; smoking cigarettes; a BMI \u2265 29; a long mechanical ventilation and ICU stay; the need of ventilatory support; a high SOFA score; fungal co-infections and extracorporeal membrane oxygenation (ECMO) use were key clinical characteristics that predicted a high mortality in our population."], "journal": "Medicina (Kaunas)", "publish_time": "2021-08-26", "aliases": []}
{"doc_id": 243762366, "title": "Risk Factors of COVID-19 Critical Outcomes in the Eastern Mediterranean Region: A Multicountry Retrospective Study", "abstract": ["BACKGROUND: The establishment of empirical evidence in the Eastern Mediterranean Region (EMR) necessitates the implementation of wide-scale studies to describe the demographic, clinical features, and severity profile of COVID-19 patients.", "OBJECTIVE: This study aimed to assess the patterns of COVID-19 severity and mortality in seven countries and to determine the risk factors of COVID-19 severity and mortality.", "METHODS: This multi-country study was based on a retrospective review of medical records of hospitalized patients confirmed to have COVID-19.", "This study included data from Iraq, Pakistan, Sudan, Somalia, Morocco, Egypt, and Yemen.", "All demographic and clinical data were extracted from hospital records (paper files) by trained data collectors.", "RESULTS: A total of 4141 patients were included in this study from seven countries.", "Comorbidities were reported by nearly half of the patients, with hypertension (HT) (24.7%) and diabetes (22.7%) being the most common.", "Older age, diabetes mellitus, hypertension, and heart diseases were significantly associated with COVID-19 severity and mortality.", "Ever smoking and renal diseases were significantly associated with severity but not mortality, while male gender, respiratory diseases, and malignancy were significantly associated with mortality but not severity.", "CONCLUSIONS: The study confirmed the role of comorbidities and demographic features on the severity and mortality of COVID-19.", "Understanding the contributing factors ensures attentive care and informs clinical management of patients with poorer prognoses in the early stages of diseases."], "journal": "JMIR public health and surveillance", "publish_time": "2021", "aliases": []}
{"doc_id": 227950410, "title": "Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients", "abstract": ["INTRODUCTION: Progression of COVID-19 to severe disease and death is insufficiently understood.", "OBJECTIVE: Summarize the prevalence of risk factors and adverse outcomes and determine their associations in COVID-19 patients who were hospitalized.", "METHODS: We searched Medline, Embase and Web of Science for case-series and observational studies of hospitalized COVID-19 patients through August 31, 2020.", "Data were analyzed by fixed-effects meta-analysis using Shore's adjusted confidence intervals to address heterogeneity.", "RESULTS: Seventy-seven studies comprising 38906 hospitalized patients met inclusion criteria; 21468 from the US-Europe and 9740 from China.", "Overall prevalence of death [% (95% CI)] from COVID-19 was 20% (18-23%); 23% (19-27%) in the US and Europe and 11% (7-16%) for China.", "Of those that died, 85% were aged&#8805;60 years, 66% were males, and 66%, 44%, 39%, 37%, and 27% had hypertension, smoking history, diabetes, heart disease, and chronic kidney disease (CKD), respectively.", "The case fatality risk [%(95% CI)] were 52% (46-60) for heart disease, 51% (43-59) for COPD, 48% (37-63) for chronic kidney disease (CKD), 39% for chronic liver disease (CLD), 28% (23-36%) for hypertension, and 24% (17-33%) for diabetes.", "Summary relative risk (sRR) of death were higher for age&#8805;60 years [sRR = 3.6; 95% CI: 3.0-4.4], males [1.3; 1.2-1.4], smoking history [1.3; 1.1-1.6], COPD [1.7; 1.4-2.0], hypertension [1.8; 1.6-2.0], diabetes [1.5; 1.4-1.7], heart disease [2.1; 1.8-2.4], CKD [2.5; 2.1-3.0].", "The prevalence of hypertension (55%), diabetes (33%), smoking history (23%) and heart disease (17%) among the COVID-19 hospitalized patients in the US were substantially higher than that of the general US population, suggesting increased susceptibility to infection or disease progression for the individuals with comorbidities.", "CONCLUSIONS: Public health screening for COVID-19 can be prioritized based on risk-groups.", "Appropriately addressing the modifiable risk factors such as smoking, hypertension, and diabetes could reduce morbidity and mortality due to COVID-19; public messaging can be accordingly adapted."], "journal": "PLoS One", "publish_time": "2020", "aliases": []}
{"doc_id": 244809640, "title": "A Population-Based Registry Analysis on Hospitalized COVID-19 Patients with Previous Cardiovascular Disease: Clinical Profile, Treatment, and Predictors of Death", "abstract": ["A high percentage of patients with COVID-19 (coronavirus disease 2019) have previous cardiovascular disease (CVD).", "The findings presented here came from an epidemiological population-based registry study (real-world data) that enrolled all in-hospital COVID-19 patients with previous CVD from 1 March to 31 May 2020.", "Death, other comorbidities, hospital stay variables, ventilation type, and main clinical outcomes were evaluated.", "In Castile and Leon, 35.83% of the 7307 in-hospital COVID-19 patients who participated in this study had previous CVD, particularly arrhythmias (48.97%), cerebrovascular disease (25.02%), ischemic heart disease (22.8%), and chronic heart failure (20.82%).", "Of the patients, 21.36% were men and more than 90% were over 65 years of age, and the mortality rate achieved 32.93%.", "The most used medicines were antibiotics (91.41%), antimalarials (73.3%), steroids (46.64%), and antivirals (43.16%).", "The main predictors of death were age over 65 years (OR: 5), ventilation needs (OR: 2.81), treatment with anti-SIRS (systemic inflammatory response syndrome) medicines (OR: 1.97), antivirals (OR: 1.74) or steroids (OR: 1.68), SIRS (OR: 5.75), SARS (severe acute respiratory syndrome) (OR: 2.44), or AKI (acute kidney injury) (OR: 1.63) occurrence.", "Chronic heart failure and cerebrovascular disease were associated with a worse clinical course of COVID-19, especially in men older than 65 years with diabetes who developed SIRS, SARS, or AKI."], "journal": "J Cardiovasc Dev Dis", "publish_time": "2021-11-29", "aliases": []}
{"doc_id": 236529755, "title": "Epidemiological and Clinical Characteristics of Deceased COVID-19 Patients", "abstract": ["OBJECTIVE: Fatalities due to coronavirus disease 2019 (COVID-19) continue to increase, and information on the epidemiological and clinical characteristics of deceased patients who were hospitalized with COVID-19 is limited in the Arab region.", "The current study aimed to address this gap.", "METHODS: Three hundred and four Saudi patients in Jazan Region, Saudi Arabia, who died after being hospitalized with COVID-19 between July 1, 2020, and December 31, 2020, were analyzed in this retrospective cohort study.", "RESULTS: A greater proportion of male patients (59%), compared to female patients (41%), died due to COVID-19.", "Just over half (55%) of the deaths due to COVID-19 affected patients aged \u226565 years.", "More than two-thirds of the deceased COVID-19 patients had diabetes (70%) and hypertension (69%); other comorbidities were obesity (30%), heart disease (30%), and chronic kidney disease (14%).", "Dyspnea (91%), cough (80%), and fever (70%) were the most frequently reported clinical symptoms.", "Eighty-five per cent of COVID-19 deaths occurred in patients admitted to the intensive care unit (ICU), and 90% of the patients required mechanical ventilation.", "Typically, lymphopenia, and neutrophilia were observed on admission and 24 hours prior to death.", "Creatinine and serum ferritin levels and erythrocyte sedimentation rate and D-dimer plasma levels increased significantly following infection with COVID-19.", "Lung infiltrates and pulmonary opacity (83%) were the most common findings on chest X-ray.", "Respiratory failure (70%) and acute respiratory distress syndrome (52%) were the leading complications to death.", "Logistic and Cox regression revealed that a higher age, smoking, high creatinine and aspartate transaminase levels, and respiratory failure were significantly associated with the risk of mortality during the early stay in hospitals.", "CONCLUSION: The proportion of comorbidities was high in deceased patients who were hospitalized with COVID-19 in Jazan region, Saudi Arabia.", "A higher age, smoking, and respiratory failure were significant predictors of mortality during the early stay in hospitals."], "journal": "Int J Gen Med", "publish_time": "2021-07-24", "aliases": []}
{"doc_id": 237387021, "title": "Clinical Characteristics and Early Outcomes of Hospitalized COVID-19 Patients with End-Stage Kidney Disease in Saudi Arabia", "abstract": ["BACKGROUND: The prognosis of the novel coronavirus disease 2019 (COVID-19) may be poor in patients with end-stage kidney disease (ESKD).", "Limited information is available on the clinical characteristics and outcomes of such patients in Arab countries.", "The present study aimed to address this gap.", "METHODS: This retrospective cohort study included 101 patients with ESKD who were hospitalized for COVID-19 between May 1, 2020 and December 31, 2020 at King Fahad Central Hospital (single center), Jazan Province, Saudi Arabia.", "Chi-square test, independent samples t-test, Mann\u2013Whitney U-test, and Cox regression were performed in the statistical analysis.", "RESULTS: Of the 101 hospitalized COVID-19 patients with ESKD, 20 patients died (19.8%).", "Patients aged \u2265 65 years had a significant mortality risk.", "Mortality was higher in male patients (70%) than in female patients (30%).", "The most common comorbidities were hypertension (88%), diabetes mellitus (47%), and heart disease (17%).", "The presence of diabetes and cardiovascular diseases along with ESKD increased the mortality risk [relative risk (RR) = 6.5 and RR = 3.8, respectively].", "The most frequently reported clinical symptoms were fever (50%), shortness of breath (41%), and cough (35%).", "In total, 17% of the patients were admitted to the intensive care unit and required mechanical ventilation.", "Most patients had bilateral lung infiltrates (88%).", "Hemoglobin levels and platelet counts were significantly lower in the deceased patients than in the surviving ones.", "Moreover, compared with the surviving patients, higher degree of lymphocytopenia, neutrophilia, ferritin, D-dimer, blood urea nitrogen, and aspartate transaminase were detected in the deceased patients.", "Septic shock (20%) and respiratory failure (19%) were the most prevalent complications resulting in death.", "CONCLUSION: COVID-19 patients with ESKD have an increased risk of poor outcomes and mortality.", "The mortality risk increases with an increase in age and the presence of other comorbidities, such as diabetes and cardiovascular disease.", "Elevated levels of inflammatory markers correlate with disease severity and are associated with in-hospital mortality in this population."], "journal": "Int J Gen Med", "publish_time": "2021-08-26", "aliases": []}
{"doc_id": 243988375, "title": "Presentation and outcomes of chronic kidney disease patients with COVID-19", "abstract": ["INTRODUCTION: COVID-19 is currently a global health issue and an important cause of mortality.", "Chronic kidney disease (CKD) is one of the risk factors for infection, morbidity and mortality by SARS-CoV-2.", "In our study, we aimed to evaluate the clinical presentation and outcomes of CKD patients with COVID-19, as well as identify predictors of mortality.", "METHODS: This was a retrospective study of CKD patients admitted in a tertiary-care Portuguese hospital between March and August of 2020.", "Variables were submitted to univariate and multivariate analysis to determine factors predictive of in-hospital mortality.", "RESULTS: 130 CKD patients were analyzed (median age 73.9 years, male 60.0%).", "Hypertension (81.5%), cardiovascular disease (36.2%), and diabetes (54.6%) were frequent conditions.", "Cough, dyspnea, fever and respiratory failure were also common.", "Almost 60% had anemia, 50% hypoalbuminemia, 13.8% hyperlactacidemia and 17% acidemia.", "Mean serum ferritin was 1531 microg/L, mean CRP 8.3 mg/dL and mean LDH 336.9 U/L.", "Most patients were treated with lopinavir/ritonavir, hydroxychloroquine or corticosteroids and only 2 with remdesivir.", "Eighty percent had acute kidney injury and 16.2% required intensive care unit admission.", "The 34 patients who died were older and more likely to have heart failure.", "They had higher neutrophils/lymphocytes ratio, ferritin, lactate, and LDH levels.", "Multivariate analysis identified an association between older age [OR 1.1 (CI 1.01-1.24), p=0.027], higher ferritin [OR 1.0 (CI 1.00-1.00), p=0.009] and higher LDH levels [OR 1.0 (CI 1.00-1.01), p=0.014] and mortality.", "CONCLUSION: In our cohort of CKD patients with COVID-19, older age, higher ferritin, and higher LDH levels were independent risk factors for mortality."], "journal": "Jornal Brasileiro de Nefrologia", "publish_time": "2021", "aliases": []}
{"doc_id": 232199221, "title": "Prediction of COVID-19 mortality among hospitalized patients in Sudan", "abstract": ["Background: COVID-19 was primarily reported in China.", "The mortality rate across countries had ranged from 1% up to more than 10% and it is underestimated in some countries.", "Advanced age is the most frequently reported factor associated to mortality.", "Other factors were the presence of comorbidities such as diabetes mellitus, hypertension and obesity.", "Several models for mortality prediction had been developed to assist in improving the prognosis.", "The aim of our study was to assess the factors related to mortality among COVID-19 patients and develop a prediction model based on these factors.", "Methods: A retrospective cohort study assessed the factors related to the mortality among COVID-19 patients who attended Imperial Hospital isolation centre on November- December, 2020, Khartoum, Sudan.", "Statistical tests performed were chi-square test, odds ratio and regression to develop the prediction model.", "Tests were considered statistically significant when p < 0.05.", "Results: 105 patients were studied.", "29% of the patients were deceased, while, 71% were discharged alive.", "A statistically significant association was found between the age and severity with regards to mortality rate (p=0.034, 0.018 respectively).", "The model equation for mortality prediction: Mortality = -14.724+ (1.387* Age) + (-0.323* Gender) + (1.814* Admission) + ( 0.193* Ischemic Heart Disease) + ( -0.369* Fever) + ( 1.595* Cough) + ( 1.953* Complications) + ( 0.149* Duration of hospitalization) + ( 0.999* Enoxaparin dose).", "Conclusions: Age, admission ward, cough and enoxaparin dose were statistically significant predictors for COVID-19 mortality ( p= 0.014, 0.011, 0.015, 0.006 respectively)."], "journal": "", "publish_time": "2021-03-11", "aliases": []}
{"doc_id": 242433896, "title": "Management of covid-19 in 55 hemodialysis patients: Experience from eastern Turkey", "abstract": ["Aim: The novel coronavirus causes acute severe respiratory syndrome (SARS COV 2), and the disease is named COVID-19.", "The virus spreads easily, and CO-VID-19 may be asymptomatic or cause severe pneumonia and ARDS.", "Hemodialysis patients are affected by COVID-19 because of the immunosuppression caused by uremia, comorbid diseases and the risk of cross-contamination during dialysis.", "In this study, we aimed to examine the clinical features and outcomes of 55 hemodialysis patients diagnosed with COVID-19.", "Material and Methods: Fifty-five hemodialysis patients who met the COVID-19 probable case definition were included in the study.", "Clinical and laboratory features were recorded from patient files and electronic data retrospectively.", "Results: The study included 55 patients, the average age was 59.6 \u00b1 13.2 years, 49% (n = 27) were female.", "Hypertension, Diabetes Mellitus, coronary heart diseases were the most common comorbid diseases.", "Comparing survivors and non-survivors, it was seen that the non-survivors were older (p=0.010).", "Logistic regression analyses revealed that age, SO2, lactate, WBC, neutrophil count, CRP, LDH, CK, ALT, AST, albumin, total protein, ferritin and D-Dimer were associated with the risk of mortality Discussion: Myalgia, cough, and shortness of breath are the most common symptoms of COVID-19 infection in HD patients, with no apparent fever.", "Age, SO2, WBC count, neutrophil count, CRP, LDH, CK, ALT, AST, albumin, total protein, ferritin and D-Dimer were found to be associated with mortality.", "Close monitoring of these parameters during the follow-up and treatment of patients may provide additional benefits in terms of survival."], "journal": "Annals of Clinical and Analytical Medicine", "publish_time": "2021", "aliases": []}
{"doc_id": 220047935, "title": "Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis", "abstract": ["The new coronavirus, COVID-19 was declared a pandemic by the world.", "Health.", "Organization on March 11, 2020 Risk factors associated with this disease are age, sex, and the presence of comorbidities, the most common being hypertension, diabetes, and heart disease.", "The aim of this meta-analysis was to calculate the prevalence and geographical distribution of comorbidities in all patients admitted to intensive care units (icus), and the mortality rate of COVID-19 We selected studies based upon epidemiological and clinical descriptions of the patients and mortality from the disease to determine the pooled prevalence of comorbidities in all patients and in mortality cases due to COVID-19 The pooled prevalence was estimated using the random effects model, and odds ratios were used to measure the probability of death for a patient with a comorbidity.", "The total prevalence of comorbidities in patients with COVID-19 was 42% (95% CI: 25-60), 61% (95% CI: 42-80) in those admitted to the icu, and 77% (95% CI: 68-86) among death cases; males were the most affected.", "Hypertension was the most prevalent comorbidity in all three groups studied, accounting for 32%, 26%, and 35%, respectively.", "The odds ratio of death for a patient with a comorbidity compared to one with no comorbidity was 2 4 (P & lt; 0 0001) The higher the prevalence of comorbidities the higher the odds that the COVID-19 patient will need intensive care or will die, especially if the pre-existing disease is hypertension, heart disease, or diabetes."], "journal": "Revista do Instituto de Medicina Tropical de Sao Paulo", "publish_time": "2020", "aliases": []}
{"doc_id": 239067501, "title": "Hematologic and coagulopathy parameter as a survival predictor among moderate to severe COVID-19 patients in non- ICU ward: A single-center study at the main referral hospital in Surabaya, East Java, Indonesia", "abstract": ["Background : This research aimed to examine and analyze risk factors for death, hematologic parameters and coagulation in COVID-19 patients at RSUD Dr. Soetomo Surabaya, one of the referral centers for probable COVID-19 patient cases in East Java.", "Method : This was a retrospective analytical study by taking secondary data on patients with probable COVID-19 cases who were treated in hospital isolation rooms from May to September, 2020.", "Result : Of 538 probable COVID-19 patients, 217 tested positive, with an average age of 52.11\u00b113.12 years, and there were 38 death cases.", "Hematologic parameters, such as white blood cell, neutrophil and lymphocyte counts, were significantly different in the deceased group.", "On the other hand, coagulation parameters, consisting of D-dimer, CRP, PT, and aPTT showed significantly similar value in the deceased group.", "Univatiate analysis concluded that chronic kidney disease, diabetes mellitus, coronary heart disease, WBC, NLR, and PPT counts could predict the mortality, while multivariate analysis revealed that coronary heart disease was the only significant independent predictor of mortality.", "Conclusion : This research shows that hematologic and coagulation parameters were increased in the majority of COVID-19 patients and the deceased group.", "While the number of neutrophils and WBC increases, the number of lymphocytes decreases significantly with increasing disease severity.", "Coronary heart disease is an independent predictor of mortality.", "\u00a9 2021 Bintoro SUY et al."], "journal": "", "publish_time": "2021", "aliases": [244755707]}
{"doc_id": 221896198, "title": "On the Analysis of Mortality Risk Factors for Hospitalized COVID-19 Patients: a Data-driven Study Using the Major Brazilian Database", "abstract": ["Background: Brazil became the epicenter of the COVID-19 epidemic in a brief period of a few months after the first officially registered case.", "The knowledge of the epidemiological/clinical profile and the risk factors of Brazilian COVID-19 patients can assist in the decision making of physicians in the implementation of early and most appropriate measures for poor prognosis patients.", "However, these reports are missing.", "Here we present a comprehensive study that addresses this demand.", "Methods: This data-driven study was based on the Brazilian Ministry of Health Database (SIVEP-Gripe, 2020) regarding notified cases of hospitalized COVID-19 patients during the period from February 26 to August 10, 2020.", "Demographic data, clinical symptoms, comorbidities and other additional information of patients were analyzed.", "Results: The hospitalization rate was higher for male gender (56.56%) and for older age patients of both sexes.", "Overall, the mortality rate was quite high (41.28%) among hospitalized patients, especially those over 60 years of age.", "Most prevalent symptoms were cough, dyspnoea, fever, low oxygen saturation and respiratory distress.", "Heart disease, diabetes, obesity, kidney disease, neurological disease, and pneumopathy were the most prevalent comorbidities.", "A high prevalence of hospitalized COVID-19 patients with heart disease (65.7%) and diabetes (53.55%) and with a high mortality rate of around 50% was observed.", "The ICU admission rate was 39.37% and of these 62.4% died.", "24.4% of patients required invasive mechanical ventilation (IMV), with high mortality among them (82.98%).", "The main mortality risk predictors were older age and IMV requirement.", "In addition, socioeconomic conditions have been shown to significantly influence the disease outcome, regardless of age and comorbidities.", "Conclusion: Our study provides a comprehensive overview of the hospitalized Brazilian COVID-19 patients profile and the mortality risk factors.", "The analysis also evidenced that the disease outcome is influenced by multiple factors, as unequally affects different segments of population."], "journal": "", "publish_time": "2020-09-25", "aliases": []}
{"doc_id": 232074269, "title": "What is the effect of lockdown upon hospitalisation due to COVID-19 amongst patients from a heart failure registry?", "abstract": ["Introduction: Coronavirus disease 2019 (COVID-19) is associated with a high risk of mortality especially in patients with cardiovascular conditions such as heart failure.", "The UK government announced a national lockdown last year to curb the spread of the virus.", "We conducted this study primarily to ascertain the impact of lockdown upon the incidence of COVID-19 hospitalisation amongst patients with a known diagnosis of heart failure (HF) Methods: This was a retrospective cohort study of 1097 patients from our HF registry who had presented with acute decompensated HF in 2018 and 2019.", "Incidence and outcomes of hospitalisation due to COVID-19 were analysed in this cohort both during the 1st UK lockdown as well as after the lockdown period.", "Co-morbidities, frailty index, clinical features, blood results, and heart failure treatments were compared between the 2 groups (COVID versus no-COVID) and between the group of patients who died versus survivors.", "Results: 50 out of 801 surviving (6.2%) HF patients required hospitalisation due to COVID-19 from March to November 2020; 24 patients (3.1%) during the first lockdown and 26 (3.5%) in the post-lockdown period; p=0.7.", "In comparison to patients not hospitalised with COVID-19 (no-COVID group), there was a significantly higher prevalence of co-morbidities amongst HF patients who were hospitalised with COVID-19, such as hypertension (p<0.001), diabetes (p=0.005), ischaemic heart disease (p=0.01) and increased body mass index.", "30 day mortality amongst HF patients hospitalised due to COVID-19 was 52%.", "Rockwood Frailty Score [\u2265]6 (OR 6.530695 % CI:1.8958 to 22.4961; p=0.003) and diabetes (OR 3.82;95% CI 1.13 to 12.95; p=0.03) were independent predictors of 30 day mortality.", "Conclusion: Our data suggests that the incidence of hospitalisation due to COVID-19 was similar both during as well as post lockdown amongst patients from our HF registry.", "HF patients with cardiovascular co-morbidities such as obesity, hypertension, diabetes and ischaemic heart disease have a higher risk of hospitalisation due to COVID-19.", "Diabetes and Rockwood Frailty score are independent predictors of short term mortality.", "Co-morbidity and frailty scores should be incorporated during initial assessment to help risk-prediction."], "journal": "", "publish_time": "2021-03-01", "aliases": []}
{"doc_id": 229231661, "title": "Liver injury at hospital admission as predictor for in-hospital mortality in patients with COVID-19", "abstract": ["background: Liver test abnormalities are common in patient hospitalized with COVID-19 infection and correlate with adverse outcomes.", "Predictors of liver injury in patients with COVID-19 infection have not been adequately studied.", "Our study assessed the association of baseline covariates with severe liver injury and in-hospital mortality in a large cohort of COVID-19 patients.", "Methods: We reviewed electronic medical records of 10,856 COVID-19 patients who were admitted to our health system from March 1 to April 30, 2020 We correlated baseline characteristics on hospital admission of these patients with degrees of liver injury (without, mild to moderate, and severe) We performed univariate and multivariate logistic regression analysis to assess predictors of severity of liver injury.", "We analyzed in-hospital mortality based on severity of liver injury and presence of comorbidities using.", "Kaplan-Meir analysis and Cox-Proportional hazard model.", "Results: There were 28 5% patients with no liver injury, 63 9% patients with mild to moderate liver injury, and 7 6% patients with severe liver injury.", "Younger patients, hispanic or latino, males, patients with chronic liver disease and those without hypertension, coronary artery disease, heart failure, or diabetes mellitus were more likely to present with severe liver injury in unadjusted analysis.", "These risks of severe liver injury remained high after adjusted for demographic and co-morbid factors.", "The risks of in-hospital mortality were incremental with increasing severity of the liver injury.", "Increasing severity of liver injury in older patients (& gt; 60 yrs), male, patients with hypertension or diabetes mellitus was associated with incrementally poor survival.", "Conclusion: Severe liver injury on hospital admission is associated with increased in-hospital mortality in COVID-19 patients.", "Increasing severity of liver injury was associated with higher risk for poor outcome in older patients, male, and patients with hypertension or diabetes."], "journal": "Hepatology", "publish_time": "2020", "aliases": []}
{"doc_id": 235822577, "title": "Heart Disease, Advanced Age, Minority Race, and Hispanic Ethnicity Are Associated With Mortality in COVID-19 Patients", "abstract": ["BACKGROUND: The objective of this study was to determine the associations between heart disease, obesity, and demographic factors and increased COVID-19 mortality.", "METHODS: We extracted deidentified patient-level data from the Froedtert Health System and Children's Hospital of Wisconsin and used descriptive statistics and multivariable logistic regression to characterize relationships between heart disease, obesity, age group, sex, race and ethnicity and mortality following COVID-19 diagnosis.", "RESULTS: We found heart disease (adjusted odds ratio [AOR] 2.85;95% CI, 2.11-8.83) and other demographic factors are significant predictors of increased mortality in COVID-19 patients.", "However, obesity was not a significant predictor of mortality (AOR 1.04;95% CI, 0.53- 3.10).", "DISCUSSION: These unique results indicate some comorbid conditions and patient demographics contribute more strongly to mortality in COVID-19 patients."], "journal": "Wmj", "publish_time": "2021", "aliases": []}
{"doc_id": 236961620, "title": "Predictive factors of mortality related to COVID-19: A retrospective cohort study of 600 cases in the intensive care unit of the university hospital of Oujda", "abstract": ["INTRODUCTION: Although the corona virus is responsible in the majority of cases for mild symptoms, there are sometimes severe and even lethal forms of this disease.", "Our study aimed to identify clinical and para-clinical predictors of mortality related to COVID-19.", "MATERIALS AND METHODS: This is a single-center retrospective cohort study conducted from March 2020 to December 2020 at intensive care unit department of Mohamed VI University Hospital Oujda, Morocco including 600 patients with COVID-19.", "RESULTS: We included 600 patients, the mortality rate was 32.50%, the predictors of mortality identified in our study were: associated heart disease (RR: 1.826; CI: [1.081\u20133.084]; p:0.024), high D-dimer level at admission (RR:1.027; CI: [1.011\u20131.047]; p:0.001), need for mechanical ventilation (RR: 4.158; CI: [2.648\u20136.530]; p: <0.0001).", "CONCLUSION: Based on these results, we were able to identify 3 predictors of COVID 19 mortality (associated heart failure, high D-dimer level on admission, and need for mechanical ventilation).", "These predictors could help clinicians to identify early patients with high risk of lethality in order to reduce mortality related to corona virus."], "journal": "Ann Med Surg (Lond)", "publish_time": "2021-08-10", "aliases": []}
{"doc_id": 237273667, "title": "Urban Tertiary Care Centre Experience of Characteristics of Severe COVID-19 Pneumonia", "abstract": ["Introduction: The global pandemic of novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in Wuhan, China, in December 2019, and has since spread worldwide.", "[1] This study attempts to summarize current evidence regarding major inflammatory markers, severity predictors and its impact on outcome, which provide current clinical experience and treatment guidance for this novel coronavirus.", "Methods: This is a retrospective observational study done at an urban teaching covid-19 designated hospital.", "Hospital data were analysed with aim of studying inflammatory markers, predictors and outcome.", "Patients were classified in Mild, Moderate, Severe & Critical categories of COVID cases.", "Their clinical parameters, laboratory investigations, radiological findings & Outcome measures were studied.", "Strength of association & correlation of those parameters with severity and in-hospital mortality were studied.", "Results: A total 204 (N) patients were clinically classified into different severity groups, as per MOHFW and qCSI(quick Covid Severity Index) guidelines, as Mild (34), Moderate (56), Severe (39) and Critical (75).", "The mean(SD) age of the cohort was 55.1+13.2 years; 74.02% were male.", "Severe COVID-19 illness is seen more in patients more than 50 years of age.", "COVID-19 patients having IHD develop worse disease with excess early in-hospital mortality.", "Respiratory rate & Heart Rate on admission are correlated with severe and stormy disease.", "Among Inflammatory markers, on admission LDH, D-Dimer and CRP are related with severity and excess in-hospital death rate.", "Conclusion: Advanced age, male gender, IHD, Respiratory Rate & Heart Rate on admission were associated with severe covid-19 illness.", "S. Lactate Dehydrogenase & D-dimer was associated with severe covid-19 illness and early in-hospital death."], "journal": "", "publish_time": "2021-08-24", "aliases": []}
{"doc_id": 232282763, "title": "Mortality Predictors in COVID-19 Patients with Cardiogenic Shock", "abstract": ["purpose novel coronavirus SARS-CoV2 disease (COVID-19) primarily affects the respiratory system; however, severe cases have been reported that have resulted in cardiogenic shock (CS) While it is known that COVID-19 is more severe in those cardiovascular disease, the predictors of mortality of CS with COVID-19 has yet to be explored in depth.", "Utilizing a large hospital research database, we explored the predictors of death in these patients methods subjects with diagnosis codes \u201c COVID-19 \u201d and \u201c cardiogenic shock \u201d or \u201c acute dilated cardiomyopathy \u201d were identified in an institutional registry of patients 72 patients met the diagnostic criteria clinical variables studied included disease history, biomarkers, and imaging were included.", "Descriptive statistics and logistic regression modeling were performed using STATA/ SE 15 1 Results.", "Of the 72 patients diagnosed with cs with COVID-19, 29 died.", "History of heart failure (HF) was associated with a higher risk of death (OR 4 06, p=0 012) as was diuretic use (likely a proxy for hf (OR 2 71, p=0 05)) Age, sex, and other clinical variables (see table) were not associated with death.", "In a multivariable model including age and sex, prior HF diagnosis remained significantly associated with death (OR 4 27 p=0 015) Conclusion.", "In CS with COVID-19, a history of cardiac disease and/or HF strongly predicted mortality.", "Other markers presumed to be associated with mortality such as age, sex and biomarkers were not significantly associated with death in this population.", "Given these findings, hf patients should be strongly encouraged to reduce their risk of exposure to infection."], "journal": "The Journal of Heart and Lung Transplantation", "publish_time": "2021", "aliases": []}
{"doc_id": 238202647, "title": "Delayed admissions and efficacy of steroid use in patients with critical and severe COVID-19: an apprehensive approach", "abstract": ["BACKGROUND: Inadvertent delays in access to appropriate therapeutic interventions in high-risk group coronavirus disease 2019 (COVID-19) patients contribute to mortality in patients with severe/critical disease presentation.", "OBJECTIVES: The aim of this study was to determine the effect of timely admission to the hospital on mortality of patients with severe/critical COVID-19.", "Another secondary aspect of this study was to observe the efficacy of time-dependent use of corticosteroids on mortality of critical/severe COVID-19 patients.", "METHODS: Clinical data of 659 patients with severe/critical COVID-19, admitted to four major tertiary care hospitals from the Islamabad-Rawalpindi region of Pakistan was retrospectively collected from a period February\u2013August 2020.", "Multivariate logistic regression analysis was carried out to determine the predictors of mortality in severe/critical COVID-19 patients.", "RESULTS: Out of a total of 659 patients, 469 (71.2%) patients died.", "Age > 60 years, presence of hypertension, heart disease and kidney disease along with late admission (>5 days) were significant predictors of mortality in patients with severe/critical COVID-19.", "CONCLUSIONS: The study highlights the importance of well-timed provision of appropriate medical interventions control COVID-19-associated mortality."], "journal": "J Public Health (Oxf)", "publish_time": "2021-09-27", "aliases": []}
{"doc_id": 238989081, "title": "COVID-19-associated Coagulopathy and Thromboembolism: Determination of their Patterns and Risk Factors as Predictors of Mortality Among Severe COVID-19 Patients", "abstract": ["BACKGROUND: Corona virus disease 2019 (COVID-19) is associated with coagulopathy (CAC) and venous thromboembolism (VTE).", "These are well-reported complications of COVID-19 infection.", "Earlier publications have shown that CAC and thromboembolism are predictors of mortality among COVID-19 patients with severe disease.", "MATERIAL AND METHODS: A prospective study was conducted in the Intensive Care Unit (ICU) where all confirmed COVID-19 patients were enrolled and followed until death or ICU discharge.", "CAC, VTE, along with all comorbidities were recorded.", "Predictors of mortality were determined by univariate and multivariate regression.", "RESULTS: Among 261 patients with COVID-19, 48.3% survived and 51.7% died.", "CAC was present in 53.2% and 76.3% of the survivors and non-survivors, respectively (p<0.001); 89 patients (31.4%) had VTE (p=0.36) and 11 patients (4.2%) had arterial thrombosis (p=0.76) among survivors and non-survivors.", "Age between 71-80 years (p=0.009), male gender (p=0.045), CAC (p<0.001), comorbidities like chronic kidney disease (CKD, p=0.013), chronic obstructive pulmonary disease (COPD, p=0.001) and asthma (p=0.046), were significant predictors of mortality.", "CONCLUSION: A severe complication of COVID-19 is CAC, such as sepsis-induced coagulopathy, overt disseminated-coagulopathy and VTE.", "Old age, various comorbidities (e.g.", "COPD, CKD or asthma), CAC, VTE (pulmonary embolism) and coagulation parameters with critical severity score (D-dimers, platelets, prothrombin time) and the SOFA (Sequential Organ Failure Assessment) score were significant predictors of mortality among COVID-19 patients."], "journal": "Current vascular pharmacology (Online)", "publish_time": "2021", "aliases": []}
{"doc_id": 235582958, "title": "Predictors of mortality in COVID 19 associated respiratory failure among predominantly African American patients", "abstract": ["Rationale:Patients with COVID-19 frequently develop severe respiratory disease and may require invasive mechanical ventilation.", "A study of primarily white patients intubated for COVID-19 associated respiratory failure found predictors of 28-day mortality to be respiratory system compliance, age, tidal volume, arterial pH and heart rate.", "Little is known about the outcomes of minority populations with severe COVID-19 pneumonia.", "Therefore, we present an analysis of the predictors of mortality in a group of primarily African American patients with COVID-19 associated respiratory failure.", "Methods:All adult patients admitted to the University of Chicago COVID-19 intensive care unit receiving invasive mechanical ventilation between March 1st and June 31st, 2020 were identified.", "Patients were included in the study if they had at least one recorded measure of plateau airway pressure while receiving volume-controlled ventilation allowing determination of driving pressure and lung compliance.", "Univariable analysis was conducted comparing survivors with those who died in-hospital followed by construction of a multivariable logistic regression model predicting in-hospital mortality based on significant factors from univariable analysis, excluding colinear variables.", "Results:Eighty-five patients were included in this retrospective study.", "Patients were primarily African American (n=73, 86%).", "Among all study patients, median tidal volume was 6.0 cc/kg ideal body weight (IQR 5.8-6.2), PEEP was 8 cm H2O (IQR 5.0-10), and driving pressure was 14 cm H2O (IQR 11-16).", "Median respiratory system compliance was 27 ml/cm H2O (IQR 21-34).", "Salvage therapies for refractory hypoxemia in the cohort included prone positioning (27%), paralysis (27%), inhaled pulmonary vasodilators (19%), and extracorporeal membrane oxygenation (1%).", "In the multivariable logistic regression model, age (OR 1.077, 95% CI 1.031 to 1.125, p=0.001) and driving pressure (OR 1.174, 95% CI 1.009 to 1.366, p=0.038) were found to be independent predictors of mortality.", "Conclusions:In a predominantly African American patient population with COVID-19 pneumonia requiring invasive mechanical ventilation, higher driving pressure was predictive of overall mortality.", "These finding are consistent with the work of Botta et al (2020), who demonstrated reduced lung compliance was predictive of mortality among a largely white group of patients with severe COVID-19 pneumonia.", "While minority populations infected with COVID-19 have been found worse outcomes, early lung mechanics appear to be comparable to white patients.", "These findings support that higher driving pressures and low lung compliance are indicative of serious lung injury which may lead to death."], "journal": "American Journal of Respiratory and Critical Care Medicine", "publish_time": "2021", "aliases": []}
{"doc_id": 235709211, "title": "Predictors of Clinical Outcomes in Adult COVID-19 Patients Admitted to a Tertiary Care Hospital in India: an analytical cross-sectional study", "abstract": ["BACKGROUND: The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has resulted in exponential rise in the number of patients getting hospitalised with corona virus disease 2019 (COVID-19).", "There is a paucity of data from South East Asian Region related to the predictors of clinical outcomes in these patients.", "This formed the basis of conducting our study.", "METHODS: This was an analytical cross-sectional study.", "Demographic, clinical, radiological and laboratory data of 125 patients was collected on admission.", "The study outcome was death or discharge after recovery.", "For univariate analysis, unpaired t-test, Chi-square and Fisher\u2019s Exact test were used.", "Receiver operating characteristic (ROC) curves were plotted for Sequential Organ Failure Assessment (SOFA) score and few laboratory parameters.", "Logistic regression was applied for multivariate analysis.", "RESULTS: Elderly age, ischemic heart disease and smoking were significantly associated with mortality.", "Elevated levels of D-dimer and lactate dehydrogenase (LDH) and reduced lymphocyte counts were the predictors of mortality.", "The ROCs for SOFA score curve showed a cut-off value \u2265 3.5 (sensitivity- 91.7% and specificity- 87.5%), for IL-6 the cut-off value was \u2265 37.9 (sensitivity- 96% and specificity- 78%) and for lymphocyte counts, a cut off was calculated to be less than and equal to 1.46 x 10(9) per litre (sensitivity- 75.2% and specificity- 83.3%).", "CONCLUSION: Old age, smoking history, ischemic heart disease and laboratory parameters including elevated D-dimer, raised LDH and low lymphocyte counts at baseline are associated with COVID-19 mortality.", "A higher SOFA score at admission is a poor prognosticator in COVID-19 patients.", "(www.actabiomedica.it)"], "journal": "Acta Biomed", "publish_time": "2021-07-01", "aliases": []}
{"doc_id": 232361746, "title": "Vascular Comorbidities Worsen Prognosis of Patients with Heart Failure Hospitalized with COVID-19", "abstract": ["Background: Prior diagnosis of heart failure (HF) is associated with increased length of hospital stay (LOS) and mortality from Coronavirus disease-2019 (COVID-19).", "Associations between substance use, venous thromboembolism (VTE), or peripheral arterial disease (PAD) and its effects on LOS or mortality in patients with HF hospitalized with COVID-19 remains unknown.", "Objective: This study identified risk factors associated with poor in-hospital outcomes among patients with HF hospitalized with COVID-19.", "Methods: Case control study was conducted of patients with prior diagnosis of HF hospitalized with COVID-19 at an academic tertiary care center from January 1, 2020 to February 28, 2021.", "Patients with HF hospitalized with COVID-19 with risk factors were compared with those without risk factors for clinical characteristics, length of stay (LOS), and mortality.", "Multivariate regression was conducted to identify multiple predictors of increased LOS and in-hospital mortality in patients with HF hospitalized with COVID-19.", "Results: Total of 211 HF patients were hospitalized with COVID-19.", "Females had longer LOS than males (9 days vs. 7 days; p < 0.001).", "Compared with patients without peripheral arterial disease (PAD) or ischemic stroke, patients with PAD or ischemic stroke had longer LOS (7 days vs. 9 days; p = 0.012 and 7 days vs. 11 days, p < 0.001; respectively).", "Older patients (aged 65 and above) had increased in-hospital mortality compared to younger patients (Adjusted OR: 1.04; 95% CI: 1.00-1.07; p = 0.036).", "VTE increased mortality more than three-fold in patients with HF hospitalized with COVID-19 (Adjusted OR: 3.33; 95% CI: 1.29-8.43; p = 0.011).", "Conclusion: Vascular diseases increase LOS and mortality in patients with HF hospitalized with COVID-19."], "journal": "", "publish_time": "2021-03-26", "aliases": []}
{"doc_id": 236961974, "title": "COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae", "abstract": ["A close and intriguing relationship has been suggested between heart failure (HF) and coronavirus disease 2019 (COVID-19).", "First, COVID-19 pandemic represented a global public health emergency in the last year and had a catastrophic impact on health systems worldwide.", "Several studies showed a reduction in HF hospitalizations, ranging from 30 to 66% in different countries and leading to a subsequent increase in HF mortality.", "Second, pre-existing HF is a risk factor for a more severe clinical course of COVID-19 and an independent predictor of in-hospital mortality.", "Third, patients hospitalized for COVID-19 may develop both an acute decompensation of chronic HF and de-novo HF as a consequence of myocardial injury and cardiovascular (CV) complications.", "Myocardial injury occurred in at least 10% of unselected COVID-19 cases and up to 41% in critically ill patients or in those with concomitant CV comorbidities.", "Few cases of COVID-19-related acute myocarditis, presenting with severe reduction in the left ventricular (LV) ejection fraction and peculiar histopathological findings, were described.", "However, recent data suggested that COVID-19 may be associated with both systolic and diastolic LV dysfunction, with LV diastolic impairment, pulmonary hypertension, and right ventricular dysfunction representing the most frequent findings in echocardiographic studies.", "An overview of available data and the potential mechanisms behind myocardial injury, possibly leading to HF, will be presented in this review.", "Beyond the acute phase, HF as a possible long-term consequence of cardiac involvement in COVID-19 patients has been supposed and need to be investigated yet."], "journal": "Front Cardiovasc Med", "publish_time": "2021-08-10", "aliases": []}
{"doc_id": 233220281, "title": "Predicting Severity and Intrahospital Mortality in COVID-19: The Place and Role of Oxidative Stress", "abstract": ["SARS-CoV-2 virus causes infection which led to a global pandemic in 2020 with the development of severe acute respiratory syndrome.", "Therefore, this study was aimed at examining its possible role in predicting severity and intrahospital mortality of COVID-19, alongside with other laboratory and biochemical procedures, clinical signs, symptoms, and comorbidity.", "This study, approved by the Ethical Committee of Clinical Center Kragujevac, was designed as an observational prospective cross-sectional clinical study which was conducted on 127 patients with diagnosed respiratory COVID-19 viral infection from April to August 2020.", "The primary goals were to determine the predictors of COVID-19 severity and to determine the predictors of the negative outcome of COVID-19 infection.", "All patients were divided into three categories: patients with a mild form, moderate form, and severe form of COVID-19 infection.", "All biochemical and laboratory procedures were done on the first day of the hospital admission.", "Respiratory (p < 0.001) and heart (p = 0.002) rates at admission were significantly higher in patients with a severe form of COVID-19.", "From all observed hematological and inflammatory markers, only white blood cell count (9.43 \u00b1 4.62, p = 0.001) and LDH (643.13 \u00b1 313.3, p = 0.002) were significantly higher in the severe COVID-19 group.", "We have observed that in the severe form of SARS-CoV-2, the levels of superoxide anion radicals were substantially higher than those in two other groups (11.3 \u00b1 5.66, p < 0.001) and the nitric oxide level was significantly lower in patients with the severe disease (2.66 \u00b1 0.45, p < 0.001).", "Using a linear regression model, TA, anosmia, ageusia, O(2)(\u2212), and the duration at the ICU are estimated as predictors of severity of SARS-CoV-2 disease.", "The presence of dyspnea and a higher heart rate were confirmed as predictors of a negative, fatal outcome.", "Results from our study show that presence of hypertension, anosmia, and ageusia, as well as the duration of ICU stay, and serum levels of O(2)(\u2212) are predictors of COVID-19 severity, while the presence of dyspnea and an increased heart rate on admission were predictors of COVID-19 mortality."], "journal": "Oxid Med Cell Longev", "publish_time": "2021-03-26", "aliases": []}
{"doc_id": 221127286, "title": "Clinical Characteristics and Prognosis of 244 Cardiovascular Patients Suffering From Coronavirus Disease in Wuhan, China", "abstract": ["Background The coronavirus disease 2019 (COVID-19) has developed into a global outbreak.", "Patients with cardiovascular disease (CVD) with COVID-19 have different clinical characteristics and prognostic outcomes.", "This study aimed to summarize the clinical characteristics and laboratory indicators of patients with COVID-19 with CVD, especially the critically ill patients.", "Methods and Results This study included 244 patients diagnosed with COVID-19 and CVD (hypertension, coronary heart disease, or heart failure).", "The patients were categorized into critical (n=36) and noncritical (n=208) groups according to the interim guidance of China's National Health Commission.", "Clinical, laboratory, and outcome data were collected from the patients' medical records and compared between the 2 groups.", "The average body mass index of patients was significantly higher in the critical group than in the noncritical group.", "Neutrophil/lymphocyte ratio, and C-reactive protein, procalcitonin, and fibrinogen, and d-dimer levels at admission were significantly increased in the critical group.", "The all-cause mortality rate among cases of COVID-19 combined with CVD was 19.26%; the proportion of coronary heart disease and heart failure was significantly higher in deceased patients than in recovered patients.", "High body mass index, previous history of coronary heart disease, lactic acid accumulation, and a decrease in the partial pressure of oxygen were associated with death.", "Conclusions All-cause mortality in patients with COVID-19 with CVD in hospitals is high.", "The high neutrophil/lymphocyte ratio may be a predictor of critical patients.", "Overweight/obesity combined with coronary heart disease, severe hypoxia, and lactic acid accumulation resulting from respiratory failure are related to poor outcomes.", "Registration URL: https://www.chictr.org.cn; Unique identifier: ChiCTR2000029865."], "journal": "J Am Heart Assoc", "publish_time": "2020", "aliases": []}
{"doc_id": 237863744, "title": "Critical care in cardiac surgery patients with COVID-19: International and own experience", "abstract": ["The widespread occurrence of coronavirus disease 2019 (COVID-19) in the world has led to a sharp decrease in the number of cardiac surgery interventions and had a negative impact on treatment outcomes.", "We present an overview of the available literature on the effects of COVID-19 on cardiac surgery at this time.", "The lack of randomized studies and guidelines on the tactics of perioperative management of patients with cardiovascular pathology encourages to rely on isolated clinical cases presented in the literature.", "The presence of cardiovascular disease in COVID-19 patients has been identified as a risk factor associated with high morbidity and mortality from the first days of the pandemic.", "In addition to older age, chronic comorbidities increase the risk of severe COVID-19 infection as well as its lethal outcome.", "Among the predictors of 30-day mortality in COVID-19 patients in the postoperative period the following were underlined: male sex (p\u02c20.001), high risk class according to the American Society of Anesthesiologists (ASA) (p\u02c20.001), age over 70 years (p\u02c20.001), emergency surgery (p = 0.026), oncological surgery (p = 0.046).", "To date, there are no studies on the perioperative management of cardiac surgery patients with acquired heart disease with persistent post-COVID-19 lung disease.", "We present the results of our own experience of perioperative management of a cardiac surgery patient with COVID-associated outpatient bilateral polysegmental pneumonia.", "Patients with cardiac surgery after COVID-19 required intensive preoperative preparation.", "Appointment of the proposed scheme of antibacterial therapy in combination with corticosteroids has reduced the intensity of inflammatory changes in lung tissue.", "Surgical improvement of intracardiac hemodynamics under cardiopulmonary bypass led to complete reduction of lung parenchyma injury and restoration of the respiratory system.", "Results.", "In patients with acquired heart disease, respiratory failure can be caused not only by post-COVID-19 lung injury, but also by impaired intracardiac hemodynamics with increased pulmonary artery pressure due to the initial heart disorders.", "Restoration of adequate gas exchange function in the group of post-COVID-19 patients is ineffective without timely cardiac surgery.", "\u00a9 2021 The Authors.", "Published by Professional Edition Eastern Europe."], "journal": "Ukrainskyi Zhurnal Sertsevo-sudynnoi Khirurhii", "publish_time": "2021", "aliases": []}
{"doc_id": 242947285, "title": "Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries.", "abstract": ["AIMS Patients with cardiac disease are considered high risk for poor outcomes following hospitalization with COVID-19.", "The primary aim of this study was to evaluate heterogeneity in associations between various heart disease subtypes and in-hospital mortality.", "METHODS AND RESULTS We used data from the CAPACITY-COVID registry and LEOSS study.", "Multivariable Poisson regression models were fitted to assess the association between different types of pre-existing heart disease and in-hospital mortality.", "A total of 16 511 patients with COVID-19 were included (21.1% aged 66-75 years; 40.2% female) and 31.5% had a history of heart disease.", "Patients with heart disease were older, predominantly male, and often had other comorbid conditions when compared with those without.", "Mortality was higher in patients with cardiac disease (29.7%; n = 1545 vs. 15.9%; n = 1797).", "However, following multivariable adjustment, this difference was not significant [adjusted risk ratio (aRR) 1.08, 95% confidence interval (CI) 1.02-1.15; P = 0.12 (corrected for multiple testing)].", "Associations with in-hospital mortality by heart disease subtypes differed considerably, with the strongest association for heart failure (aRR 1.19, 95% CI 1.10-1.30; P < 0.018) particularly for severe (New York Heart Association class III/IV) heart failure (aRR 1.41, 95% CI 1.20-1.64; P < 0.018).", "None of the other heart disease subtypes, including ischaemic heart disease, remained significant after multivariable adjustment.", "Serious cardiac complications were diagnosed in <1% of patients.", "CONCLUSION Considerable heterogeneity exists in the strength of association between heart disease subtypes and in-hospital mortality.", "Of all patients with heart disease, those with heart failure are at greatest risk of death when hospitalized with COVID-19.", "Serious cardiac complications are rare during hospitalization."], "journal": "European heart journal", "publish_time": "2021-11-04", "aliases": [232204195]}
{"doc_id": 240254777, "title": "Frequency and Impact of Preadmission Digestive Symptoms on Outcome in Severe COVID-19: A Prospective Observational Cohort Study", "abstract": ["BACKGROUND: Coronavirus disease-2019 (COVID-19) commonly presents with respiratory symptoms.", "However, symptoms involving the digestive system may be present, significance of which is not well studied in the Indian scenario.", "METHODS: This prospective observational cohort study included consecutive patients with severe COVID-19 admitted to intensive care unit of our tertiary care hospital from September 9, 2020, to March 14, 2021.", "We evaluated the frequency of preadmission digestive symptoms and compared the demographic, clinical, laboratory parameters, and organ failure at admission and during intensive care along with mortality between those with and without digestive symptoms.", "In the digestive group, we sought to find predictors of mortality.", "RESULTS: Digestive symptoms were present in 76/234 (32.4%) with severe COVID-19 infection.", "In comparison to nondigestive group, digestive patients had higher need for noninvasive ventilation (p 0.028), invasive lines (68%, p 0.003), vasopressors (64%, p 0.01), blood product transfusion (21.1%, p <0.001), and heart failure (55.4%, p 0.041).", "Confounding factors of alcohol abuse, smoking, sedentary lifestyle as a causative agent for heart failure could not be ruled out.", "Proportional mortality rate is higher in the digestive group (65.8%, p = 0.015).", "Mortality is multifactorial with preadmission abdominal pathologies (HR 4.3) or central nervous system (CNS)-related comorbidities (HR 2.829), presentation with multiple digestive symptoms (HR 6.9), higher sequential organ failure assessment score (SOFA) score at admission (HR 1.258) and discharge (HR 1.162), and presence of acute kidney injury (AKI) Grade 3 (HR 2.95) as predictors of mortality.", "After adjusting for all confounders, need for vasopressor was observed to be associated with 11.58 times higher risk of mortality.", "CONCLUSION: Preadmission digestive symptoms may be associated with a turbulent illness with invasive interventions, heart failure, and greater proportional mortality in severe COVID-19.", "AKI Grade 3 is identified as a preventable risk factor predicting mortality.", "CTRI/2021/03/032325.", "HOW TO CITE THIS ARTICLE: Karna ST, Singh P, Revadi G, Khurana A, Shivhare A, Saigal S, et al.", "Frequency and Impact of Preadmission Digestive Symptoms on Outcome in Severe COVID-19: A Prospective Observational Cohort Study.", "Indian J Crit Care Med 2021;25(11):1247\u20131257."], "journal": "Indian J Crit Care Med", "publish_time": "2021-11-11", "aliases": []}
{"doc_id": 233291846, "title": "Prevalence and predictors of in-hospital mortality of patients hospitalized with COVID-19 infection", "abstract": ["BACKGROUND: The severity and mortality from COVID-19 infection vary among populations.", "The aim of this study was to determine the prevalence and predictors of mortality among patients hospitalized with COVID-19 infection in a tertiary care hospital in Oman.", "METHODS: We conducted a retrospective study using database that included: demographic, clinical characteristics, laboratory parameters, medications and clinical outcomes of all patients hospitalized in Royal Hospital, Muscat, Oman, between March 12, 2020 and December 1st 2020.", "Univariate and multivariate logistic regression was performed to investigate the relationship between each variable and the risk of death of COVID-19 infected patients.", "RESULTS: In total,1002 patients with COVID-19 infection with mean age of the cohort was 54\u00b116 years (65% (n=650) male) were included, with an overall and intensive care unit (ICU) mortalities of 26% (n=257) and 42% (n=199/473), respectively.", "The prevalence of ICU admission was 47% (n=473) and the need for mechanical ventilation was 41% (n=413).", "The overall length of stay in the ICU was 13 (9-21) days.", "Adjusting for other factors in the model, the multivariable logistic regression demonstrated that in-hospital mortality in admitted COVID-19 patients was associated with old age (p<0.001), heart diseases (adjusted odds ratio (aOR), 1.84; 95% confidence interval (CI): 1.11-3.03; p=0.018), liver diseases (aOR, 4.48; 95% CI: 1.04-19.3; p=0.044), those with higher ferritin levels (aOR, 1.00; 95% CI: 1.00-1.00; p=0.006), acute respiratory distress syndrome (ARDS) (aOR, 3.20; 95% CI: 1.65-6.18; p=0.001), sepsis (aOR, 1.77; 95% CI: 1.12-2.80; p=0.022), and those that had ICU admission (aOR, 2.22; 95% CI: 1.12-4.38; p=0.022).", "CONCLUSION: In this cohort, mortality in hospitalized COVID-19 patients was high and was associated with advanced age, heart diseases, liver disease, high ferritin, ARDS, sepsis and ICU admission.", "These high-risk groups should be prioritized for COVID-19 vaccinations."], "journal": "J Infect Public Health", "publish_time": "2021", "aliases": []}
{"doc_id": 233232893, "title": "Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses", "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is pandemic.", "Prevention and control strategies require an improved understanding of SARS-CoV-2 dynamics.", "We did a rapid review of the literature on SARS-CoV-2 viral dynamics with a focus on infective dose.", "We sought comparisons of SARS-CoV-2 with other respiratory viruses including SARS-CoV-1 and Middle East respiratory syndrome coronavirus.", "We examined laboratory animal and human studies.", "The literature on infective dose, transmission and routes of exposure was limited specially in humans, and varying endpoints were used for measurement of infection.", "Despite variability in animal studies, there was some evidence that increased dose at exposure correlated with higher viral load clinically, and severe symptoms.", "Higher viral load measures did not reflect coronavirus disease 2019 severity.", "Aerosol transmission seemed to raise the risk of more severe respiratory complications in animals.", "An accurate quantitative estimate of the infective dose of SARS-CoV-2 in humans is not currently feasible and needs further research.", "Our review suggests that it is small, perhaps about 100 particles.", "Further work is also required on the relationship between routes of transmission, infective dose, co-infection and outcomes."], "journal": "Epidemiol Infect", "publish_time": "2021-04-14", "aliases": []}
{"doc_id": 230484097, "title": "Association between upper respiratory tract viral load, comorbidities, disease severity and outcome of patients with SARS-CoV-2 infection", "abstract": ["BACKGROUND: There is limited information on the association between upper respiratory tract (URT) viral loads, host factors, and disease severity in SARS-CoV-2 infected patients.", "METHODS: We studied 1,122 patients (mean age: 46 years) diagnosed by PCR.", "URT viral load, measured by PCR cycle threshold, was categorized as high, moderate or low.", "RESULTS: There were 336 (29.9%) patients with comorbidities; 309 patients (27.5%) had high, 316 (28.2%) moderate, and 497 (44.3%) low viral load.", "In univariate analyses, compared to patients with moderate or low viral load, patients with high viral load were older, had more often comorbidities, developed symptomatic disease, were intubated and died; in addition, patients with high viral load had longer stay in intensive care unit and longer intubation compared to patients with low viral load (p-values <0.05 for all).", "Patients with chronic cardiovascular disease, hypertension, chronic pulmonary disease, immunosuppression, obesity and chronic neurological disease had more often high viral load (p-value<0.05 for all).", "Multivariate analysis found that a high viral load was associated with COVID-19.", "The level of viral load was not associated with any other outcome.", "CONCLUSIONS: URT viral load could be used to identify patients at higher risk for morbidity or severe outcome."], "journal": "J. infect. dis", "publish_time": "2021", "aliases": []}
{"doc_id": 220304265, "title": "ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS", "abstract": ["The dynamics of viral load (VL) of the 2019 novel coronavirus (SARS-CoV-2) and its association with different clinical parameters remain poorly characterized in the United States patient population.", "Herein we investigate associations between VL and parameters such as severity of symptoms, disposition (admission vs direct discharge), length of hospitalization, and admission to the intensive care unit, length of need for oxygen support and overall survival in a cohort of 205 patients from a tertiary care center in New York City.", "VL was determined using q-PCR and Log10 transformed for normalization.", "Univariate and multivariate regression models were used to test these associations.", "We found that diagnostic viral load is significantly lower in hospitalized patients than in patients not hospitalized (log10 VL = 3.3 vs.4.0; p=0.018) after adjusting for age, sex, race, BMI, and comorbidities.", "Higher VL was associated with shorter duration of the symptoms in all patients and hospitalized patients only and shorter hospital stay (coefficient =-2.02,-2.61, -2.18; p<0.001, p=0.002, p=0.013, respectively).", "No significant association was noted between VL, admission to ICU, length of oxygen support, and overall survival.", "Our findings suggest a higher shedding risk in less symptomatic patients; an important consideration for containment strategies in SARS-CoV-2.", "Furthermore, we identify a novel association between viral load and history of cancer.", "Larger studies are warranted to validate our findings."], "journal": "Am J Pathol", "publish_time": "2020-07-03", "aliases": [220483844]}
{"doc_id": 235126219, "title": "Clinical, immunological and genomic characterization of asymptomatic and symptomatic cases with SARS-CoV-2 infection, India", "abstract": ["Background: The current global pandemic of Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2 led to the investigation with clinical, biochemical, immunological and genomic information of the patients to understand the pathophysiology of this viral infection.", "Methods: Samples were collected from six asymptomatic and six symptomatic SARS-CoV-2 confirmed hospitalized patients in Bhubaneswar, Odisha, India.", "Clinical details, biochemical parameters, treatment regime were collected from hospital, viral load was determined by RT-PCR, levels of cytokines and circulating antibodies in plasma were assessed by Bioplex and isotyping respectively.", "In addition, the whole genome sequencing of viral strains and mutational analysis were carried out.", "Findings Analysis of the biochemical parameters highlighted the increased levels of C-Reactive protein (CRP), lactate dehydrogenase (LDH), serum SGPT, serum SGOT and ferritin in symptomatic patients indicating that patients with higher levels of few biochemical parameters might experience severe pathophysiological complications after SARS-CoV-2 infection.", "This was also observed that symptomatic patients were mostly with one or more comorbidities, especially diabetes (66.6%).", "Surprisingly the virological estimation revealed that there was no significant difference in viral load of oropharyngeal (OP) samples between the two groups.", "This suggests that the viral load in OP sample does not correlate with disease severity and both asymptomatic and symptomatic patients are equally capable of transmitting the virus.", "Whereas, viral load was higher in plasma and serum samples of symptomatic patients suggesting that the development of clinical complications is mostly associated to high viral load in plasma and serum.", "This also demonstrated that the patients with high viral load in plasma and serum samples were found to develop sufficient amounts of antibodies (IgG, IgM and IgA).", "Interestingly, the levels of 7 cytokines (IL-6, IL-1@, IP-10, IL-8, IL-10, IFN-@2, IL-15) were found to be highly elevated in symptomatic patients, while three cytokines (soluble CD40L, GRO and MDC) were remarkably higher in asymptomatic patients.", "Therefore, this data suggest that cytokines and chemokines may serve as predictive indicator of SARS-CoV-2 infection and contribute to understand the pathogenesis of COVID-19.", "The whole genome sequence analysis revealed that the current isolates were clustered with 19B, 20A and 20B clades, however acquired 11 additional changes in Orf1ab, spike, Orf3a, Orf8 and nucleocapsid proteins.", "The data also confirmed that the D614G mutation in spike protein is mostly linked with severe SARS-CoV-2 infection as two patients with this mutation passes away.", "Interpretation This is the first comprehensive study of SARS CoV-2 patients from India.", "This will contribute to a better understanding of the pathophysiology of SARS-CoV-2 infection and advance in the implementation of effective disease control strategies."], "journal": "", "publish_time": "2021-05-23", "aliases": []}
{"doc_id": 244912651, "title": "1192. Correlation Between SARS CoV 2 Viral Load and Clinical Evolution of Patients Under 15 Years of Age with COVID 19 in a General Hospital in the Province of Buenos Aires, Argentina", "abstract": ["BACKGROUND: SARS CoV2 infection produces clinical manifestations of different severity.", "The pediatric population represents less than 10% of cases, with a mortality of less than 1%.", "The severity of the condition and mortality are mainly associated with comorbidities.", "There is controversy about the correlation between the viral load of SARS CoV2 in respiratory samples and the evolution and severity of the clinical picture.", "The CT (cycle threshold) in the detection of the SARS CoV 2 genome in respiratory samples can be used as an indirect indicator of the viral load in the analyzed samples.", "GOALS: to determine the correlation between the SARS CoV 2 CT values in the detection of the viral genome with the severity of the clinical picture.", "Describe the clinical, epidemiological, and laboratory characteristics of patients with PCR-confirmed SARS CoV2 infection in respiratory samples.", "METHODS: A retrospective, observational and analytical study that included patients under 15 years of age with confirmed SARS CoV2 infection by PCR of respiratory samples treated at the Hospital Isidoro Iriarte in the city of Quilmes between March 1 2020 and April 30, 2021.", "RESULTS: 485 patients (n) were included.", "The distribution by severity of the clinical picture was mild (84%, n = 408), moderate (12%, n = 59) and severe (4%, n = 18).", "Comorbidities were more frequent among patients with moderate and severe symptoms.", "Viral load was associated with severity of clinical manifestations.", "Patients with moderate and severe COVID19 required hospital admission more frequently for a longer time, the use of supplemental oxygen and antibiotics were more frequent in patients with moderate and severe symptoms.", "Symptoms of lower respiratory tract infection such as cough and respiratory distress were more frequent in patients with moderate and severe symptoms.", "No patient required admission to the ICU or mechanical ventilation.", "No patient died.", "CONCLUSION: In this study, patients with moderate and severe COVID19 infection had a higher viral load in respiratory samples, a higher frequency of comorbidities, a higher frequency of hospitalization and a longer hospital stay.", "Lower respiratory symptoms were associated with moderate and severe symptoms, while odynophagia, vomiting, and diarrhea were associated with mild clinical symptoms.", "DISCLOSURES: All Authors: No reported disclosures"], "journal": "Open Forum Infect Dis", "publish_time": "2021-12-04", "aliases": []}
{"doc_id": 229349887, "title": "Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study", "abstract": ["Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread rapidly around the world, posing a major threat to human health and the economy.", "Currently, long-term data on viral shedding and the serum antibody responses in COVID-19 patients are still limited.", "Herein, we report the clinical features, viral RNA loads, and serum antibody levels in a cohort of 112 COVID-19 patients admitted to the Honghu People\u2019s Hospital, Hubei Province, China.", "Overall, 5.36% (6/112) of patients showed persistent viral RNA shedding (> 45 days).", "The peak viral load was higher in the severe disease group than in the mild group (median cycle threshold value, 36.4 versus 31.5; P = 0.002).", "For most patients the disappearance of IgM antibodies occurred approximately 4\u20136 weeks after symptoms onset, while IgG persisted for over 194 days after the onset of symptoms, although patients showed a 46% reduction in antibodies titres against SARS-CoV-2 nucleocapsid protein compared with the acute phase.", "We also studied 18 asymptomatic individuals with RT-qPCR confirmed SARS-CoV-2 infection together with 17 symptomatic patients, and the asymptomatic individuals were the close contacts of these symptomatic cases.", "Delayed IgG seroconversion and lower IgM seropositive rates were observed in asymptomatic individuals.", "These data indicate that higher viral loads and stronger antibody responses are related to more severe disease status in patients with SARS-CoV-2 infection, and the antibodies persisted in the recovered patient for more than 6 months so that the vaccine may provide protection against SARS-CoV-2 infection.", "ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12250-020-00329-9) contains supplementary material, which is available to authorized users."], "journal": "Virol Sin", "publish_time": "2020-12-22", "aliases": []}
{"doc_id": 227236245, "title": "IgG Antibodies, SARS-CoV-2 Load, and Prognostic Indicators in Patients with Severe and Mild COVID-19 in Japan", "abstract": ["We assessed the association of severity of coronavirus disease 2019 (COVID-19) with acute respiratory syndrome coronavirus 2 (SARS-CoV-2) load, IgG antibody level, and prognostic indicators.Twenty-one patients hospitalized with COVID-19 were classified as having severe or mild disease on the basis of average respiratory rate during hospitalization (severe: \u226522 breaths/min; mild: <22 breaths/min).", "Viral load in nasopharyngeal samples, blood levels of C-reactive protein (CRP), lymphocytes, and D-dimer on admission and plasma immunoglobulin G (IgG) index on Day 7\u00b12 after symptom onset were compared in relation to disease severity.", "Seven patients had severe disease and 14 had mild disease.", "Those with severe disease had a significantly higher IgG index (median: 3.75 vs 0.56, p=0.01) and CRP (median: 8.6 vs 1.0 mg/dL, p<0.001) and D-dimer levels (median: 1.65 vs 0.75 \u00b5g/mL; p=0.002) and a significantly lower lymphocyte count (median: 1,176 vs 666 cells/\u00b5L, p=0.005) and viral load (median: 8.7\u00d7106 vs 2.3\u00d7104 copies/mL, p=0.005).", "Furthermore, time from symptom onset to virus disappearance was significantly longer in severe patients (median: 24 vs 17 days, p=0.03).", "A high IgG index in the early phase of the disease was associated with severe disease and might serve as a prognostic indicator."], "journal": "J Nippon Med Sch", "publish_time": "2021", "aliases": []}
{"doc_id": 238741012, "title": "SARS-CoV-2 viral load as a predictor for disease severity in outpatients and hospitalised patients with COVID-19: A prospective cohort study", "abstract": ["INTRODUCTION: We aimed to examine if severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) cycle quantification (C(q)) value, as a surrogate for SARS-CoV-2 viral load, could predict hospitalisation and disease severity in adult patients with coronavirus disease 2019 (COVID-19).", "METHODS: We performed a prospective cohort study of adult patients with PCR positive SARS-CoV-2 airway samples including all out-patients registered at the Department of Infectious Diseases, Odense University Hospital (OUH) March 9-March 17 2020, and all hospitalised patients at OUH March 10-April 21 2020.", "To identify associations between C(q)-values and a) hospital admission and b) a severe outcome, logistic regression analyses were used to compute odds ratios (OR) and 95% Confidence Intervals (CI), adjusting for confounding factors (aOR).", "RESULTS: We included 87 non-hospitalised and 82 hospitalised patients.", "The median baseline C(q)-value was 25.5 (interquartile range 22.3\u201329.0).", "We found a significant association between increasing C(q)-value and hospital-admission in univariate analysis (OR 1.11, 95% CI 1.04\u20131.19).", "However, this was due to an association between time from symptom onset to testing and C(q)-values, and no association was found in the adjusted analysis (aOR 1.08, 95% CI 0.94\u20131.23).", "In hospitalised patients, a significant association between lower C(q)-values and higher risk of severe disease was found (aOR 0.89, 95% CI 0.81\u20130.98), independent of timing of testing.", "CONCLUSIONS: SARS-CoV-2 PCR C(q)-values in outpatients correlated with time after symptom onset, but was not a predictor of hospitalisation.", "However, in hospitalised patients lower C(q)-values were associated with higher risk of severe disease."], "journal": "PLoS One", "publish_time": "2021-10-12", "aliases": []}
{"doc_id": 226217584, "title": "SARS-CoV-2 viral load is associated with increased disease severity and mortality", "abstract": ["The relationship between SARS-CoV-2 viral load and risk of disease progression remains largely undefined in coronavirus disease 2019 (COVID-19).", "Here, we quantify SARS-CoV-2 viral load from participants with a diverse range of COVID-19 disease severity, including those requiring hospitalization, outpatients with mild disease, and individuals with resolved infection.", "We detected SARS-CoV-2 plasma RNA in 27% of hospitalized participants, and 13% of outpatients diagnosed with COVID-19.", "Amongst the participants hospitalized with COVID-19, we report that a higher prevalence of detectable SARS-CoV-2 plasma viral load is associated with worse respiratory disease severity, lower absolute lymphocyte counts, and increased markers of inflammation, including C-reactive protein and IL-6.", "SARS-CoV-2 viral loads, especially plasma viremia, are associated with increased risk of mortality.", "Our data show that SARS-CoV-2 viral loads may aid in the risk stratification of patients with COVID-19, and therefore its role in disease pathogenesis should be further explored."], "journal": "Nat Commun", "publish_time": "2020-10-30", "aliases": [220548381]}
{"doc_id": 228631502, "title": "Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19", "abstract": ["BACKGROUND: COVID-19 can course with respiratory and extrapulmonary disease.", "SARS-CoV-2 RNA is detected in respiratory samples but also in blood, stool and urine.", "Severe COVID-19 is characterized by a dysregulated host response to this virus.", "We studied whether viral RNAemia or viral RNA load in plasma is associated with severe COVID-19 and also to this dysregulated response.", "METHODS: A total of 250 patients with COVID-19 were recruited (50 outpatients, 100 hospitalized ward patients and 100 critically ill).", "Viral RNA detection and quantification in plasma was performed using droplet digital PCR, targeting the N1 and N2 regions of the SARS-CoV-2 nucleoprotein gene.", "The association between SARS-CoV-2 RNAemia and viral RNA load in plasma with severity was evaluated by multivariate logistic regression.", "Correlations between viral RNA load and biomarkers evidencing dysregulation of host response were evaluated by calculating the Spearman correlation coefficients.", "RESULTS: The frequency of viral RNAemia was higher in the critically ill patients (78%) compared to ward patients (27%) and outpatients (2%) (p < 0.001).", "Critical patients had higher viral RNA loads in plasma than non-critically ill patients, with non-survivors showing the highest values.", "When outpatients and ward patients were compared, viral RNAemia did not show significant associations in the multivariate analysis.", "In contrast, when ward patients were compared with ICU patients, both viral RNAemia and viral RNA load in plasma were associated with critical illness (OR [CI 95%], p): RNAemia (3.92 [1.183-12.968], 0.025), viral RNA load (N1) (1.962 [1.244-3.096], 0.004); viral RNA load (N2) (2.229 [1.382-3.595], 0.001).", "Viral RNA load in plasma correlated with higher levels of chemokines (CXCL10, CCL2), biomarkers indicative of a systemic inflammatory response (IL-6, CRP, ferritin), activation of NK cells (IL-15), endothelial dysfunction (VCAM-1, angiopoietin-2, ICAM-1), coagulation activation (D-Dimer and INR), tissue damage (LDH, GPT), neutrophil response (neutrophils counts, myeloperoxidase, GM-CSF) and immunodepression (PD-L1, IL-10, lymphopenia and monocytopenia).", "CONCLUSIONS: SARS-CoV-2 RNAemia and viral RNA load in plasma are associated with critical illness in COVID-19.", "Viral RNA load in plasma correlates with key signatures of dysregulated host responses, suggesting a major role of uncontrolled viral replication in the pathogenesis of this disease."], "journal": "Crit Care", "publish_time": "2020", "aliases": []}
{"doc_id": 242062408, "title": "Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1\u03b2, Early Predictors of Severe COVID-19", "abstract": ["Viral and host immune kinetics during acute COVID-19 and after remission of acute symptoms need better characterization.", "SARS-CoV-2 RNA, anti-SARS-CoV-2 IgA, IgM, and IgG antibodies, and proinflammatory cytokines were measured in sequential samples from hospitalized COVID-19 patients during acute infection and six months following diagnosis.", "Twenty four laboratory confirmed COVID-19 patients with mild/moderate and severe COVID-19 were included.", "Most were males (83%) with a median age of 61 years.", "Twenty one percent were admitted to the intensive care unit (ICU) and eight of them (33.3%) met the criteria for severe COVID-19 disease.", "A delay in SARS-CoV-2 levels\u2019 decline during the first six days of follow up, and viral load persistence until month 3 were related to severe COVID-19, but not viral load levels at the diagnosis.", "Higher levels of anti-SARS-CoV-2 IgA, IgM, IgG and the cytokines IL-6, IL-8 and MIP-1\u03b2 at the diagnosis time were related to the severe COVID-19 outcome.", "Higher levels of MIP-1\u03b2, IL-1\u03b2, MIP-1\u03b1 and IFN-\u03b3 were observed at month 1 and 3 during mild/moderate disease, compared to severe COVID-19.", "IgG persisted at low levels after six months of diagnosis.", "In conclusion, higher concentrations of IgA, IgM, and IgG, and IL-6, IL-8 and MIP-1\u03b2 are identified as early predictors of COVID-19 severity, whereas no significant association is found between baseline SARS-COV-2 viral load and COVID-19 severity."], "journal": "Microorganisms", "publish_time": "2021-10-29", "aliases": []}
{"doc_id": 232138756, "title": "Inflammatory but not respiratory symptoms associated with ongoing upper airway viral replication in outpatients with uncomplicated COVID-19", "abstract": ["Background: The vast majority of SARS-CoV-2 infections are uncomplicated and do not require hospitalization, but contribute to ongoing transmission.", "Our understanding of the clinical course of uncomplicated COVID-19 remains limited.", "Methods: We detailed the natural history of uncomplicated COVID-19 among 120 outpatients enrolled in a randomized clinical trial of Peginterferon Lambda.", "We characterized symptom trajectory and clusters using exploratory factor analysis, assessed predictors of symptom resolution and cessation of oropharyngeal viral shedding using Cox proportional hazard models, and evaluated associations between symptoms and viral shedding using mixed effects linear models.", "Results: Headache, myalgias and chills peaked at day 4 after symptom onset; cough peaked on day 9.", "Two distinct symptom cluster trajectories were identified; one with mild, upper respiratory symptoms, and the other with more severe and prolonged inflammatory symptoms.", "The median time to symptom resolution from earliest symptom onset was 17 days (95% CI 14-18).", "Neither enrollment SARS-CoV-2 IgG levels (Hazard ratio [HR] 1.88, 95% CI 0.84-4.20) nor oropharyngeal viral load at enrollment (HR 1.01, 95% CI 0.98-1.05) were significantly associated with the time to symptom resolution.", "The median time to cessation of viral shedding was 10 days (95% CI 8-12), with higher SARS-CoV-2 IgG levels at enrollment associated with hastened resolution of viral shedding (HR 3.12, 95% CI 1.4-6.9, p=0.005).", "Myalgia, joint pains, and chills were associated with a significantly greater odds of oropharyngeal SARS-CoV-2 RNA detection.", "Conclusions: In this outpatient cohort, inflammatory symptoms peaked early and were associated with ongoing SARS-CoV-2 replication.", "SARS-CoV-2 antibody levels were associated with more rapid viral shedding cessation, but not with time to symptom resolution.", "These findings have important implications for COVID-19 screening approaches and clinical trial design."], "journal": "", "publish_time": "2021-03-08", "aliases": []}
{"doc_id": 237456023, "title": "Baseline SARS-CoV-2 Viral Load is Associated With COVID-19 Disease Severity and Clinical Outcomes: Post-Hoc Analyses of a Phase 2/3 Trial", "abstract": ["BACKGROUND: Elucidating the relationship between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load and clinical outcomes is critical for understanding COVID-19.", "METHODS: SARS-CoV-2 levels were analyzed by quantitative real-time polymerase chain reaction (RT-qPCR) of nasopharyngeal or oropharyngeal swab specimens collected at baseline and clinical outcomes were recorded over 60 days from 1362 COVID-19 hospitalized patients enrolled in a multicenter, randomized, placebo-controlled phase 2/3 trial of sarilumab for COVID-19 (NCT04315298).", "RESULTS: In post-hoc analyses, higher baseline viral load, measured by both RT-qPCR cycle threshold (Ct) and log(10) copies/mL, was associated with greater supplemental oxygenation requirements and disease severity at study entry.", "Higher baseline viral load was associated with higher mortality, lower likelihood of improvement in clinical status and supplemental oxygenation requirements, and lower rates of hospital discharge.", "Viral load was not impacted by sarilumab treatment over time versus placebo.", "CONCLUSIONS: These data support viral load as an important determinant of clinical outcomes in hospitalized patients with COVID-19 requiring supplemental oxygen or assisted ventilation."], "journal": "J Infect Dis", "publish_time": "2021-09-08", "aliases": []}
{"doc_id": 231955285, "title": "Pretest Symptom Duration and Cycle Threshold Values for Severe Acute Respiratory Syndrome Coronavirus 2 Reverse-Transcription Polymerase Chain Reaction Predict Coronavirus Disease 2019 Mortality", "abstract": ["BACKGROUND: The relationship between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load and patient symptom duration in both in- and outpatients, and the impact of these factors on patient outcomes, are currently unknown.", "Understanding these associations is important to clinicians caring for patients with coronavirus disease 2019 (COVID-19) methods: We conducted an observational study between March 10 and May 30, 2020 at a large quaternary academic medical center in new york city.", "Patient characteristics, laboratory values, and clinical outcomes were abstracted from the electronic medical records.", "Of all patients tested for SARS-CoV-2 during this time (N = 16 384), there were 5467 patients with positive tests, 4254 of which had available cycle threshold (Ct) values and were included in further analysis univariable and multivariable logistic regression models were used to test associations between Ct values, duration of symptoms before testing, patient characteristics, and mortality.", "The primary outcome is defined as death or discharge to hospice RESULTS: Lower.", "Ct values at diagnosis (ie, higher viral load) were associated with significantly higher mortality among both in- and outpatients.", "It is interesting to note that patients with a shorter time since the onset of symptoms to testing had a worse prognosis, with those presenting less than 3 days from symptom onset having 2-fold increased odds of death.", "After adjusting for time since symptom onset and other clinical covariates, ct values remained a strong predictor of mortality CONCLUSIONS: Severe acute respiratory syndrome coronavirus 2 reverse-transcription polymerase chain reaction.", "Ct value and duration of symptoms are strongly associated with mortality.", "These 2 factors add useful information for clinicians to risk stratify patients presenting with COVID-19."], "journal": "Open Forum Infect Dis", "publish_time": "2021", "aliases": []}
{"doc_id": 229687954, "title": "Quantitative Detection of SARS-CoV-2 RNA in nasopharyngeal samples from infected patients with mild disease.", "abstract": ["Diagnosis of SARS-COV-2 cases is based on the count of real-time RT-PCR positive people.", "Viral load by real-time RT-PCR has been suggested as a biomarker of the SARS-CoV-2 infection.", "However, the association of viral load and severity of the disease is not yet resolved.", "Nasopharyngeal samples from 458 patients were tested by RT-PCR for SARS-CoV-2 diagnosis.", "Relative quantitation was made by the comparative threshold cycle (\u0394\u0394CT) formula between ORF1ab viral and RNase P housekeeping genes.", "Absolute viral load was calculate using a reference positive control.", "Most prevalent clinical signs were cough (75.8%), myalgia (66.7%) and fever (48.5%).", "Hypertension (18.2%), neurological diseases (15.1%), and asthma and hypothyroidism (12.1%) were most frequent comorbidities.", "Fever, either as an exclusive symptom or combined with others, was associated with high viral loads (2\u0394\u0394Ct range 35.65-155.16; 4.25-4.89 log10 RNA copies/test]).", "During the first week after onset of symptoms in mild patients up to 60 years-old was detected the peak of viral load.", "Children under 10 years-old have a high viral load (313.84; 2.50) in the first two days post-infection with a sharp decline thereafter.", "Cases between 10 and 49 years-old mostly showed low and moderate viral load during the first two days post-infection (range 0.03-17.24; -1.50-1.24).", "Patients over 60 years-old have high viral load up to the second week after the onset of symptoms (range 25.32-155.42; 1.40-2.19), indicating the longer presence of the virus in them.", "These findings suggest the viral load in nasopharyngeal swabs would help to monitor the SARS-CoV-2 infection in mild COVID-19 cases.", "This article is protected by copyright.", "All rights reserved."], "journal": "Journal of medical virology", "publish_time": "2020-12-26", "aliases": []}
{"doc_id": 236914431, "title": "Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patients", "abstract": ["Key elements for viral pathogenesis include viral strains, viral load, co-infection, and host responses.", "Several studies analyzing these factors in the function of disease severity of have been published; however, no studies have shown how all of these factors interplay within a defined cohort.", "To address this important question, we sought to understand how these four key components interplay in a cohort of COVID-19 patients.", "We determined the viral loads and gene expression using high throughput sequencing and various virological methods.", "We found that viral loads in the upper respiratory tract in COVID-19 patients at an early phase of infection vary widely.", "While the majority of nasopharyngeal (NP) samples have a viral load lower than the limit of detection of infectious viruses, there are samples with an extraordinary amount of SARS-CoV-2 RNA and a high viral titer.", "No specific viral factors were identified that are associated with high viral loads.", "Host gene expression analysis showed that viral loads were strongly correlated with cellular antiviral responses.", "Interestingly, however, COVID-19 patients who experience mild symptoms have a higher viral load than those with severe complications, indicating that naso-pharyngeal viral load may not be a key factor of the clinical outcomes of COVID-19.", "The metagenomics analysis revealed that the microflora in the upper respiratory tract of COVID-19 patients with high viral loads were dominated by SARS-CoV-2, with a high degree of dysbiosis.", "Finally, we found a strong inverse correlation between upregulation of interferon responses and disease severity.", "Overall our study suggests that a high viral load in the upper respiratory tract may not be a critical factor for severe symptoms; rather, dampened antiviral responses may be a critical factor for a severe outcome from the infection."], "journal": "Sci Rep", "publish_time": "2021-08-03", "aliases": []}
{"doc_id": 229313526, "title": "SARS-CoV-2 RNAemia with higher nasopharyngeal viral load is strongly associated with severity and mortality in patients with COVID-19", "abstract": ["Objective: This study aimed to determine the frequency of SARS-CoV-2 RNA in serum and its association with the clinical severity of COVID-19.", "Methods: An analytical cross-sectional study was performed in a single tertiary care hospital and included consecutive patients with confirmed COVID-19.", "The prevalence of SARS-CoV-2 RNAemia and the strength of its association with clinical severity variables, including required oxygen supplementation, ICU admission, invasive mechanical ventilation, and in-hospital mortality, were examined.", "Results: Fifty-six patients were included in the study.", "The median age was 54.5 years, and individuals with RNAemia were older than those without detectable SARS-CoV-2 RNA in serum (78 vs. 50 years; P = .0013).", "RNAemia was detected in 19.6% of patients (11/56) and in 1.0% (1/25), 50.0% (6/12), and 100.0% (4/4) of moderate, severe, and critically ill cases, respectively.", "Patients with RNAemia required more frequent oxygen supplementation (90.0% vs. 13.3%; P < .0001) and ICU admission (81.8% vs. 6.7%; P < .0001) and required invasive mechanical ventilation (27.3% vs. 0.0%; P < .0001).", "Among patients with RNAemia, the median viral loads of NP swabs that were collected around the same time as the serum were significantly higher in critically ill cases (5.4 Log10 copies/L [IQR: 4.2-6.3]) than in moderate-severe cases (2.6 Log10 copies/L [1.1-4.5]; P =.030) and were significantly higher in nonsurvivor cases (6.2 Log10 copies/L [IQR: 6.0-6.5]) than in survivor cases (3.9 Log10 copies/L [1.6-4.6]; P =.045).", "Conclusions: This study demonstrated a relatively high proportion of SARS-CoV-2 RNAemia and an association between RNAemia and clinical severity.", "Moreover, among the patients with RNAemia, the viral loads of NP swabs were correlated with severity and mortality, thus suggesting the potential utility of combining serum testing with NP tests as a prognostic indicator for COVID-19 with a higher quality than each separate test."], "journal": "", "publish_time": "2020-12-18", "aliases": [237243513]}
{"doc_id": 230800259, "title": "413. Association of SARS-CoV-2 Genomic Load in Nasopharyngeal Samples with Adverse COVID-19 Patient Outcomes: A Retrospective Analysis from an Academic Hospital Center in New York City", "abstract": ["BACKGROUND: SARS-CoV-2, the cause of COVID-19 pneumonia, is associated with heterogenous presentations ranging from asymptomatic infection to severe respiratory failure.", "We explored the association of SARS-CoV-2 genomic load as a risk factor for adverse patient outcomes.", "METHODS: We included adult patients admitted to the hospital with clinical and radiographic findings of pneumonia and a confirmatory polymerase chain reaction (PCR) test of SARS-CoV-2 within 24 hours of admission.", "We segregated patients into 3 genomic load status groups: low (Cycle threshold (Ct) \u226535) intermediate (25< Ct< 35) and high (Ct \u226425) using real-time PCR.", "The primary outcome was a composite outcome of death, intubation and/or use of extracorporeal membrane oxygenation.", "Secondary outcomes included severity of pneumonia on admission, as measured by the Pneumonia Severity Index (PSI).", "Sensitivity analyses were performed to include Acute Respiratory Distress Syndrome (ARDS) in the composite outcome and varying Ct classification breakpoints.", "RESULTS: Of 457 patients positive for SARS-CoV-2 assay from March 31(st) to April 10(th) 2020, 316 met inclusion criteria and were included in the final analysis.", "Included patients were followed for a median of 25 days (IQR 21\u201328).", "High genomic load at presentation was associated with higher Charlson Comorbidity Index scores (p=0.005), transplant recipient status (p< 0.001) and duration of illness less than 7 days (p=0.005).", "Importantly, patients with high genomic load were more likely to reach the primary endpoint (p=0.001), and had higher PSI scores on admission (p=0.03).", "In multivariate analysis, high genomic load remained an independent predictor of primary outcome.", "Results remained significant in sensitivity analyses.", "Flow Chart [Image: see text] Prediction of Outcomes Based on Genomic Load [Image: see text] Prediction of Outcomes Based on Genomic Load and Pneumonia Severity Index [Image: see text] CONCLUSION: High genomic load of SARS-CoV-2 in nasopharyngeal samples at the time of admission is independently associated with mortality and intubation.", "This finding should prompt further research on the role of viral load as a clinical predictor and possible modifiable risk factor for adverse outcomes as treatment strategies evolve in this global pandemic.", "DISCLOSURES: All Authors: No reported disclosures"], "journal": "Open Forum Infect Dis", "publish_time": "2020-12-31", "aliases": []}
{"doc_id": 227099878, "title": "Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters", "abstract": ["BACKGROUND: Clinical outcomes of the interaction between the co-circulating pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and seasonal influenza viruses are unknown.", "METHODS: We established a golden Syrian hamster model co-infected by SARS-CoV-2 and mouse-adapted A(H1N1)pdm09 simultaneously or sequentially.", "The weight loss, clinical scores, histopathological changes, viral load and titer, and serum neutralizing antibody titre were compared with hamsters challenged by either virus.", "RESULTS: Co-infected hamsters had more weight loss, more severe lung inflammatory damage and tissue cytokine/chemokine expression.", "Lung viral load, infectious virus titers and virus antigen expression suggested that hamsters were generally more susceptible to SARS-CoV-2 than A(H1N1)pdm09.", "Sequential co-infection with A(H1N1)pdm09 one day prior to SARS-CoV-2 exposure resulted in a lower lung SARS-CoV-2 titer and viral load than with SARS-CoV-2 infection alone, but a higher lung A(H1N1)pdm09 viral load.", "Co-infection also increased intestinal inflammation with more SARS-CoV-2 nucleoprotein expression in enterocytes.", "Simultaneous co-infection was associated with delay in resolution of lung damages, lower serum SARS-CoV-2 neutralizing antibody and longer SARS-CoV-2 shedding in oral swabs compared to that of SARS-CoV-2 infection alone.", "CONCLUSIONS: Simultaneous or sequential co-infection by SARS-CoV-2 and A(H1N1)pdm09 caused more severe disease than infection by either virus in hamsters.", "Prior A(H1N1)pdm09 infection lowered SARS-CoV-2 pulmonary viral loads but enhanced lung damage.", "Whole-population influenza vaccination for prevention of co-infection, and multiplex molecular diagnostics for both viruses to achieve early initiation of antiviral treatment for improvement of clinical outcome should be considered."], "journal": "Clin Infect Dis", "publish_time": "2021", "aliases": []}
{"doc_id": 236484018, "title": "Correlation of SARS-CoV-2 Viral Load in Different Population Subsets: A Study from a Tertiary Care North Indian Hospital", "abstract": ["BACKGROUND: The correlation of SARS-CoV-2 viral load with disease severity in different population subsets is still elusive.", "There is a scarcity of literature regarding this aspect in Indian Population.", "AIM: To study retrospectively the risk factors and the role of viral load with disease severity among different age groups of North Indian population.", "METHODS: Here we quantified the viral load of 239 positive participants and collected data retrospectively from April 2020 to May 2020 and categorised the patients as per disease severity and population subsets.", "RESULTS: Asymptomatic patients were found to have higher viral load than the symptomatic patients, though the difference was not found to be statistically significant.", "The logistic regression analysis showed that contact with laboratory confirmed cases, SARI and ILI were independent risk factors for acquiring COVID-19 infection.", "CONCLUSION: SARS-CoV-2 viral load is not significantly associated with disease severity among different population subsets.", "However, there is a need to carry out more studies with a larger number of patients to validate and confirm the above findings."], "journal": "Int J Appl Basic Med Res", "publish_time": "2021-07-19", "aliases": []}
{"doc_id": 227297483, "title": "Angiotensin converting enzyme inhibitors, a risk factor of poor outcome in diabetic patients with COVID-19 infection", "abstract": ["Introduction: Diabetes mellitus and hypertension are described as the most common comorbidities among COVID-19 patients.", "We investigated the adverse effect of aceis in diabetic and nondiabetic patients with COVID-19."], "journal": "Iranian Journal of Kidney Diseases", "publish_time": "2020", "aliases": []}
{"doc_id": 237279346, "title": "Clinical Characteristics and Outcomes of Hypertensive Patients Infected with COVID-19: A Retrospective Study", "abstract": ["BACKGROUND: Hypertension has been reported as the most prevalent comorbidity in patients with coronavirus disease 2019 (COVID-19).", "This retrospective study aims to compare the clinical characteristics and outcomes in COVID-19 patients with or without hypertension.", "METHODS: A total of 944 hospitalized patients with laboratory-confirmed COVID-19 were included from January to March 2020.", "Information from the medical record, including clinical features, radiographic and laboratory results, complications, treatments, and clinical outcomes, were extracted for the analysis.", "RESULTS: A total of 311 (32.94%) patients had comorbidity with hypertension.", "In COVID-19 patients with hypertension, the coexistence of type 2 diabetes (56.06% vs 43.94%), coronary heart disease (65.71% vs 34.29%), poststroke syndrome (68.75% vs 31.25%) and chronic kidney diseases (77.78% vs 22.22%) was significantly higher, while the coexistence of hepatitis B infection (13.04% vs 86.96%) was significantly lower than in COVID-19 patients without hypertension.", "Computed tomography (CT) chest scans show that COVID-19 patients with hypertension have higher rates of pleural effusion than those without hypertension (56.60% vs 43.40%).", "In addition, the levels of blood glucose [5.80 (IQR, 5.05\u20137.50) vs 5.39 (IQR, 4.81\u20136.60)], erythrocyte sedimentation rate (ESR) [28 (IQR, 17.1\u201355.6) vs 21.8 (IQR, 11.5\u201344.1), P=0.008], C-reactive protein (CRP) [17.92 (IQR, 3.11\u201346.6) vs 3.15 (IQR, 3.11\u201323.4), P=0.013] and serum amyloid A (SAA) [99.28 (IQR, 8.85\u2013300) vs 15.97 (IQR, 5.97\u2013236.1), P=0.005] in COVID-19 patients with hypertension were significantly higher than in patients without hypertension.", "CONCLUSION: It is common for patients with COVID-19 to have the coexistence of hypertension, type 2 diabetes, coronary heart disease and so on, which may exacerbate the severity of COVID-19.", "Therefore, optimal management of hypertension and other comorbidities is essential for better clinical outcomes."], "journal": "Int J Gen Med", "publish_time": "2021-08-17", "aliases": []}
{"doc_id": 231615877, "title": "Should all patients with hypertension be worried about developing severe coronavirus disease 2019 (COVID-19)?", "abstract": ["BACKGROUND: Hypertension, the most common comorbidity among coronavirus disease 2019 (COVID-19) patients, is accompanied by worse clinical outcomes, but there is lack of evidence about prognostic factors among COVID-19 patients with hypertension.", "We have come up with some prognostic factors to predict the severity of COVID-19 among hypertensive patients.", "In addition, epidemiologic, clinical and laboratory differences among COVID-19 patients with and without underlying hypertension were evaluated.", "METHODS: Medical profiles of 598 COVID-19 cases were analyzed.", "Patients were divided into two comparative groups according to their positive or negative history of hypertension.", "Then, epidemiologic, clinical, laboratory and radiological features and also clinical outcomes were compared.", "RESULTS: 176 (29.4%) patients had underlying hypertension.", "Diabetes was significantly higher in hypertensive group [72 (40.9%) vs 76 (18%)] (P-value: 0.001).", "Cardiovascular and renal disorders were significantly higher in hypertensive patients.", "(P-value: 0.001 and 0.013 respectively).", "In COVID-19 patients with hypertension, severe/critical types were significantly higher.", "[42(23.8%) vs. 41(9.7%)], (P-value: 0.012).", "In the logistic regression model, Body mass index > 25 (OR(Adj): 1.8, 95% CI: 1.2 to 2.42; P-value: 0.027), age over 60 (OR(Adj): 1.26, 95% CI: 1.08 to 1.42; P-value: 0.021), increased hospitalization period (OR(Adj): 2.1, 95% CI: 1.24 to 2.97; P-value: 0.013), type 2 diabetes (OR(Adj): 2.22, 95% CI: 1.15 to 3.31; P-value: 0.001) and chronic kidney disease (OR(Adj): 1.83, 95% CI: 1.19 to 2.21; P-value: 0.013) were related with progression of COVID-19.", "CONCLUSION: Hypertensive patients with Age > 60-year-old, BMI > 25 Kg/m(2), CVD, diabetes and chronic kidney disease are associated with poor outcomes in those with COVID-19 infection."], "journal": "Clin Hypertens", "publish_time": "2021-01-15", "aliases": []}
{"doc_id": 235706925, "title": "Clinical characteristics, gastrointestinal manifestations and outcomes of COVID-19 patients in Iran; does the location matters?", "abstract": ["BACKGROUND: Coronavirus disease 2019 (COVID-19) started in Asia, and Iran was one of its first epicenters.", "AIM: To study the gastrointestinal (GI) symptoms and comorbidities associated with this pandemic in four different regions of Iran.", "METHODS: We analyzed data from severe acute respiratory syndrome coronavirus 2 positive patients evaluated at four hospitals of Iran (n = 91), including South (Shiraz), Southeast (Dezful), Rasht (North), and Northwest (Mashhad) between April and September 2020.", "Demographics, comorbidities and clinical findings including GI symptoms were collected.", "Statistical descriptive analysis and correlation analyses of symptoms, comorbidities, and mortality were performed.", "RESULTS: The average age of COVID-19 patients was 51.1 years, and 56% were male.", "Mortality rate was 17%.", "Cough with 84.6%, shortness of breath with 71.4%, fever with 52.7%, and loss of appetite with 43.9% were the main symptoms.", "Overall cardiac disease was the most common comorbidity with an average of 28.5% followed by hypertension (28.5%) and diabetes (25.2%).", "The highest comorbidity in North (Rasht) was diabetes (30%) and in South (Dezful) hypertension (37%).", "Shiraz leads cardiac disease with 43.4%.", "The most reported GI symptoms included nausea, diarrhea, vomiting, and abdominal pain, with 42.8%, 31.8%, 26.8%, and 12% prevalence, respectively.", "In addition, albumin, alkaline phosphatase, aspartate aminotransferase, and alanine aminotransferase were elevated in 26.3%.", "CONCLUSION: Our results show hypertension and diabetes as the most common comorbidities, but their distribution was different in COVID-19 patients in the four studied regions of Iran.", "Nausea, diarrhea, and elevated liver enzymes were the most common GI symptoms.", "There was also a high mortality rate that was associated with high infection rates in Iran at the beginning of the pandemic."], "journal": "World J Clin Cases", "publish_time": "2021-06-26", "aliases": []}
{"doc_id": 220045842, "title": "Why obesity, hypertension, diabetes, and ethnicities are common risk factors for COVID\u201019 and H1N1 influenza infections", "abstract": ["Obesity, hypertension, diabetes, and specific ethnicities (Black and Hispanic) have been reported to be common comorbidities and possible risk factors for the severity of both COVID-19 and H1N1 influenza infections.", "Thus, it is important to understand why these four risk factors are common to both COVID-19 and H1N1 influenza infections, and whether a common mechanism exists.", "Respiratory failure is the most important pathology that contributes to the severity of both COVID-19 and H1N1 influenza infections.", "Additionally, obesity has been reported to be a risk factor for the development of acute respiratory distress syndrome (ARDS), which is a serious clinical manifestation of both COVID-19 and H1N1 infections.", "Obesity is a risk factor for hypertension.", "Most of the previous studies showing hypertension as a risk factor for the severity of COVID-19 and H1N1 infections were either not based on multiple logistic regression analyses or did not include obesity or BMI as an explanatory variable in their multiple logistic regression models.", "Moreover, similar attention is needed when specifying patients with diabetes or of specific ethnicities (Black and Hispanic) as potentially more vulnerable to either infection, because obesity also correlates with diabetes, and is more prevalent in these ethnicities.", "Notably, a retrospective cohort study has shown that obesity or high BMI are predictive risk factors for severe COVID-19 outcomes, independent of age, diabetes, and hypertension.", "Associations between hypertension, diabetes, ethnicities and severity of COVID-19 and H1N1 infections may be confounded by obesity to a considerable extent.", "This article is protected by copyright.", "All rights reserved."], "journal": "J Med Virol", "publish_time": "2020-06-29", "aliases": []}
{"doc_id": 236478920, "title": "Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study", "abstract": ["BACKGROUND: The current pandemic of coronavirus disease (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has shown epidemiological and clinical characteristics that appear worsened in hypertensive patients.", "The morbidity and mortality of the disease among hypertensive patients in Africa have yet to be well described.", "METHODS: In this retrospective cohort study all confirmed COVID-19 adult patients (\u226518 years of age) in Lagos between February 27 to July 62,020 were included.", "Demographic, clinical and outcome data were extracted from electronic medical records of patients admitted at the COVID-19 isolation centers in Lagos.", "Outcomes included dying, being discharged after recovery or being evacuated/transferred.", "Descriptive statistics considered proportions, means and medians.", "The Chi-square and Fisher\u2019s exact tests were used in determining associations between variables.", "Kaplan\u2013Meier survival analysis and Cox regression were performed to quantify the risk of worse outcomes among hypertensives with COVID-19 and adjust for confounders.", "P-value \u22640.05 was considered statistically significant.", "RESULTS: A total of 2075 adults with COVID-19 were included in this study.", "The prevalence of hypertension, the most common comorbidity, was 17.8% followed by diabetes (7.2%) and asthma (2.0%).", "Overall mortality was 4.2% while mortality among the hypertensives was 13.7%.", "Severe symptoms and mortality were significantly higher among the hypertensives and survival rates were significantly lowered by the presence of additional comorbidity to 50% from 91% for those with hypertension alone and from 98% for all other patients (P < 0.001).", "After adjustment for confounders (age and sex), severe COVID-19and death were higher for hypertensives {severe/critical illness: HR = 2.41, P = 0.001, 95%CI = 1.4\u20134.0, death: HR = 2.30, P = 0.001, 95%CI = 1.2\u20134.6, for those with hypertension only} {severe/critical illness: HR = 3.76, P = 0.001, 95%CI = 2.1\u20136.4, death: crude HR = 6.63, P = 0.001, 95%CI = 3.4\u20131.6, for those with additional comorbidities}.", "Hypertension posed an increased risk of severe morbidity (approx.", "4-fold) and death (approx.", "7-fold) from COVID-19 in the presence of multiple comorbidities.", "CONCLUSION: The potential morbidity and mortality risks of hypertension especially with other comorbidities in COVID-19 could help direct efforts towards prevention and prognostication.", "This provides the rationale for improving preventive caution for people with hypertension and other comorbidities and prioritizing them for future antiviral interventions.", "SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41256-021-00210-6."], "journal": "Glob Health Res Policy", "publish_time": "2021-07-29", "aliases": []}
{"doc_id": 218647627, "title": "Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study", "abstract": ["OBJECTIVE: Diabetes is common in COVID-19 patients and associated with unfavorable outcomes.", "We aimed to describe the characteristics and outcomes and to analyze the risk factors for in-hospital mortality of COVID-19 patients with diabetes.", "RESEARCH DESIGN AND METHODS: This two-center retrospective study was performed at two tertiary hospitals in Wuhan, China.", "Confirmed COVID-19 patients with diabetes (N = 153) who were discharged or died from 1 January 2020 to 8 March 2020 were identified.", "One sex- and age-matched COVID-19 patient without diabetes was randomly selected for each patient with diabetes.", "Demographic, clinical, and laboratory data were abstracted.", "Cox proportional hazards regression analyses were performed to identify the risk factors associated with the mortality in these patients.", "RESULTS: Of 1,561 COVID-19 patients, 153 (9.8%) had diabetes, with a median age of 64.0 (interquartile range 56.0-72.0) years.", "A higher proportion of intensive care unit admission (17.6% vs. 7.8%, P = 0.01) and more fatal cases (20.3% vs. 10.5%, P = 0.017) were identified in COVID-19 patients with diabetes than in the matched patients.", "Multivariable Cox regression analyses of these 306 patients showed that hypertension (hazard ratio [HR] 2.50, 95% CI 1.30-4.78), cardiovascular disease (HR 2.24, 95% CI 1.19-4.23), and chronic pulmonary disease (HR 2.51, 95% CI 1.07-5.90) were independently associated with in-hospital death.", "Diabetes (HR 1.58, 95% CI 0.84-2.99) was not statistically significantly associated with in-hospital death after adjustment.", "Among patients with diabetes, nonsurvivors were older (76.0 vs. 63.0 years), most were male (71.0% vs. 29.0%), and they were more likely to have underlying hypertension (83.9% vs. 50.0%) and cardiovascular disease (45.2% vs. 14.8%) (all P values <0.05).", "Age &#8805;70 years (HR 2.39, 95% CI 1.03-5.56) and hypertension (HR 3.10, 95% CI 1.14-8.44) were independent risk factors for in-hospital death of patients with diabetes.", "CONCLUSIONS: COVID-19 patients with diabetes had worse outcomes compared with the sex- and age-matched patients without diabetes.", "Older age and comorbid hypertension independently contributed to in-hospital death of patients with diabetes."], "journal": "Diabetes Care", "publish_time": "2020", "aliases": []}
{"doc_id": 231910910, "title": "COVID-19 patients with hypertension are at potential risk of worsened organ injury", "abstract": ["In less than 6 months, COVID-19 spread rapidly around the world and became a global health concern.", "Hypertension is the most common chronic disease in COVID-19 patients, but its impact on these patients has not been well described.", "In this retrospective study, 82 patients diagnosed with COVID-19 were enrolled, and epidemiological, demographic, clinical, laboratory, radiological and therapy-related data were analyzed and compared between COVID-19 patients with (29 cases) or without (53 cases) hypertension.", "The median age of the included patients was 60.5 years, and the cohort included 49 women (59.8%) and 33 (40.2%) men.", "Hypertension (31 [28.2%]) was the most common chronic illness, followed by diabetes (16 [19.5%]) and cardiovascular disease (15 [18.3%]).", "The most common symptoms were fatigue (55 [67.1%]), dry cough (46 [56.1%]) and fever &#8805; 37.3 \u00b0C (46 [56.1%]).", "The median time from illness onset to positive RT-PCR test was 13.0 days (range 3-25 days).", "There were 6 deaths (20.7%) in the hypertension group and 5 deaths (9.4%) in the nonhypertension group, and more hypertensive patients with COVID-19 (8 [27.6%]) than nonhypertensive patients (2 [3.8%]) (P = 0.002) had at least one comorbid disease.", "Compared with nonhypertensive patients, hypertensive patients exhibited higher neutrophil counts, serum amyloid A, C-reactive protein, and NT-proBNP and lower lymphocyte counts and eGFR.", "Dynamic observations indicated more severe disease and poorer outcomes after hospital admission in the hypertension group.", "COVID-19 patients with hypertension have increased risks of severe inflammatory reactions, serious internal organ injury, and disease progression and deterioration."], "journal": "Sci Rep", "publish_time": "2021", "aliases": []}
{"doc_id": 236475708, "title": "Clinical characteristics and risk factors of patients with severe COVID-19 in Riyadh, Saudi Arabia: A retrospective study", "abstract": ["BACKGROUND: COVID-19 is newly emerging infectious disease that spread globally at unpredictable and unique pattern to the extent that the World Health Organization announced COVID-19 as a pandemic in the first couple months of 2020.", "This study aims to describe clinical and demographic features of COVID-19 patients and the influence of various risk factors on the severity of disease.", "METHODS: This research is a retrospective study based on Saudi Arabia's ministry of health\u2019s Covid-19 data.", "The analysis relies on data of all COVID-19 patients recorded in Riyadh between 1st, March 2020 and 30th, July 2020.", "Statistical analyses were performed to investigate the effect of demographic characteristic, clinical presentation, and comorbidities on infection severity.", "RESULTS: A total number of 1026 COVID-19 patients were identified based on the demographic data as follows: 709 cases (69% of cases) were males and 559 cases (54% of cases) were Saudi.", "Most of patients were diagnosed with mild signs and symptoms 697 (68% of cases), while 164 patient (16% of cases) demonstrated moderate signs and symptoms, and 103 cases (10%) were severe and 62 (6%) had critical febrile illness.", "Fever, cough, sore throat, and shortness of breath were the most common symptoms among patients with COVID-19.", "Among studied comorbidities in COVID-19 patients, diabetes mellitus and hypertension were the most prevalent.", "The results from the bivariate logistic regression analysis revealed that older age, diabetes mellitus, asthma, smoking, and fever are associated with severe or critically ill cases.", "CONCLUSION: The findings of this study show that old age, fever, and comorbidities involving diabetes mellitus, asthma, and smoking were significantly associated with infection severity."], "journal": "J Infect Public Health", "publish_time": "2021-07-28", "aliases": []}
{"doc_id": 230823066, "title": "The Clinical Characteristics and Risk Factors of Severe COVID-19", "abstract": ["OBJECTIVE: We aim to investigate the clinical characteristics and risk factors for the severe cases of coronavirus disease 2019 (COVID-19) in comparison with the non-severe patients.", "METHODS: We searched PubMed, EMBASE, Web of Science, and CNKI to collect all relevant studies published before July 26, 2020, and a total of 30 papers were included in this meta-analysis.", "RESULTS: In the severe COVID-19 patients, 60% (95% CI = 56\u201364%) were male, 25% (95% CI = 21\u201329%) were over 65 years old, 34% (95% CI = 24\u201344%) were obese, and 55% (95% CI = 41\u201370%) had comorbidities.", "The most prevalent comorbidities were hypertension (34%, 95% CI = 25\u201344%), diabetes (20%, 95% CI = 15\u201325%), and cardiovascular disease (CVD; 12%, 95% CI = 9\u201316%).", "The most common blood test abnormalities were elevated C-reactive protein (CRP; 87%, 82\u201392%), decreased lymphocyte count (68%, 58\u201377%), and increased lactate dehydrogenase (69%, 95% CI = 57\u201381%).", "In addition, abnormal laboratory findings revealing organ dysfunctions were frequently observed in the severe cases, including decrease in albumin (43%, 95% CI = 24\u201363%) and increase in aspartate aminotransferase (47%, 95% CI = 38\u201356%), alanine aminotransferase (28%, 95% CI = 16\u201339%), troponin I/troponin T (TnI/TnT; 29%, 95% CI = 13\u201345%), and serum Cr (SCr; 10%, 95% CI = 5\u201315%).", "CONCLUSION: The male, elderly and obese patients and those with any comorbidities, especially with hypertension, diabetes, and CVD, were more likely to develop into severe cases.", "But the association between hypertension, diabetes, CVD, and severity of COVID-19 was declined by the increase of age.", "A significant elevation in cardiac TnI/TnT, the hepatic enzymes, and SCr and the reduction in lymphocytes with elevated CRPs are important markers for the severity.", "Specific attention should be given to the elderly male and obese patients and those with indications of severe immune injury in combination with bacterial infection and indication of multi-organ dysfunction or damages."], "journal": "Gerontology", "publish_time": "2021-01-06", "aliases": []}
{"doc_id": 220502472, "title": "Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients", "abstract": ["Hypertension is one of the most common comorbidities in patients with coronavirus disease 2019 (COVID-19).", "This study aimed to clarify the impact of hypertension on COVID-19 and investigate whether the prior use of renin-angiotensin-aldosterone system (RAAS) inhibitors affects the prognosis of COVID-19.", "A total of 996 patients with COVID-19 were enrolled, including 282 patients with hypertension and 714 patients without hypertension.", "Propensity score-matched analysis (1:1 matching) was used to adjust the imbalanced baseline variables between the 2 groups.", "Patients with hypertension were further divided into the RAAS inhibitor group (n=41) and non-RAAS inhibitor group (n=241) according to their medication history.", "The results showed that COVID-19 patients with hypertension had more severe secondary infections, cardiac and renal dysfunction, and depletion of CD8+ cells on admission.", "Patients with hypertension were more likely to have comorbidities and complications and were more likely to be classified as critically ill than those without hypertension.", "Cox regression analysis revealed that hypertension (hazard ratio, 95% CI, unmatched cohort [1.80, 1.20-2.70]; matched cohort [2.24, 1.36-3.70]) was independently associated with all-cause mortality in patients with COVID-19.", "In addition, hypertensive patients with a history of RAAS inhibitor treatment had lower levels of C-reactive protein and higher levels of CD4+ cells.", "The mortality of patients in the RAAS inhibitor group (9.8% versus 26.1%) was significantly lower than that of patients in the non-RAAS inhibitor group.", "In conclusion, hypertension may be an independent risk factor for all-cause mortality in patients with COVID-19.", "Patients who previously used RAAS inhibitors may have a better prognosis."], "journal": "Hypertension", "publish_time": "2020", "aliases": []}
{"doc_id": 230662974, "title": "The influence of pre-existing hypertension on coronavirus disease 2019 patients", "abstract": ["Hypertension represents one of the most common pre-existing conditions and comorbidities in Coronavirus disease 2019 (COVID-19) patients.", "To explore whether hypertension serves as a risk factor for disease severity, a multi-centre, retrospective study was conducted in COVID-19 patients.", "A total of 498 consecutively hospitalised patients with lab-confirmed COVID-19 in China were enrolled in this cohort.", "Using logistic regression, we assessed the association between hypertension and the likelihood of severe illness with adjustment for confounders.", "We observed that more than 16% of the enrolled patients exhibited pre-existing hypertension on admission.", "More severe COVID-19 cases occurred in individuals with hypertension than those without hypertension (21% vs. 10%, P = 0.007).", "Hypertension associated with the increased risk of severe illness, which was not modified by other demographic factors, such as age, sex, hospital geological location and blood pressure levels on admission.", "More attention and treatment should be offered to patients with underlying hypertension, who usually are older, have more comorbidities and more susceptible to cardiac complications."], "journal": "Epidemiol Infect", "publish_time": "2021-01-05", "aliases": []}
{"doc_id": 236331998, "title": "Associated risk of death from COVID-19 infection in patients with hypertensive co-morbidities", "abstract": ["Background: The COVID-19 pandemic caused by the SARS-CoV-2 virus has left infected patients with comorbidities in severe and deadly conditions.", "Hypertension is a non-communicable disease (NCD) and is one of the most common comorbidities observed in COVID-19 patients.", "Purpose: This study aims to understand the relationship between hypertension and the risk of death through COVID-19.", "Method: The study employed a systematic review of journals.", "Journals and articles related to hypertension and COVID-19 were collected and analyzed.", "The inclusion criteria was COVID-19 articles pertaining to hypertensive patients, and the exclusion criteria was articles that did not use English as well as those that did not display full text.", "Result: Hypertension is a multifactorial disease.", "The presence of hypertension is often not realized by the sufferer.", "A COVID-19 infection can worsen the condition of the person and can cause damage to vital organs.", "The use of antihypertensive drugs of the angiotensin-converting enzyme inhibitor (ACEI) and the angiotensin receptor blocker (ARB) groups can be continued to be administered to hypertensive patients.", "There should be no cause for concern for these patients to develop COVID-19 infections by taking these drugs."], "journal": "Jurnal Berkala Epidemiologi / Periodic Epidemiology Journal", "publish_time": "2021", "aliases": []}
{"doc_id": 231939550, "title": "Hypertension and COVID-19: Ongoing Controversies", "abstract": ["coronavirus disease 2019 (COVID-19) has become a worldwide pandemic responsible for millions of deaths around the world.", "Hypertension has been identified as one of the most common comorbidities and risk factors for severity and adverse outcome in these patients.", "Recent investigations have raised the question whether hypertension represents a predictor of outcome in COVID-19 patients independently of other common comorbidities such as diabetes, obesity, other cardiovascular diseases, chronic kidney, liver, and pulmonary diseases.", "However, the impact of chronic and newly diagnosed hypertension in COVID-19 patients has been insufficiently investigated.", "The same is true for the relationship between blood pressure levels and outcomes in COVID-19 patients.", "It seems that the long discussion about the impact of angiotensin-converting enzyme inhibitors (acei) and blockers of angiotensin I receptors (arb) on severity and outcome in COVID-19 is approaching an end because the large number of original studies and meta-analyses discarded the initial findings about higher prevalence of ACEI/ARB use in patients with unfavorable outcomes.", "Nevertheless, there are many controversies in the relationship between hypertension and COVID-19 The aim of this review article is to provide a clinical overview of the currently available evidence regarding the predictive value of hypertension, the effect of blood pressure levels, the impact of previously known and newly diagnosed hypertension, and the effect of antihypertensive therapy on the severity and outcomes in COVID-19 patients."], "journal": "Frontiers in Cardiovascular Medicine", "publish_time": "2021", "aliases": []}
{"doc_id": 238412163, "title": "Hypertension as an independent risk factor for severity and mortality in patients with COVID-19: a retrospective study", "abstract": ["PURPOSE OF THE STUDY: Hypertension is one of the most common comorbidities in COVID-19 pneumonia.", "However, whether it is an independent factor on the severity and mortality of COVID-19 has not been studied.", "STUDY DESIGN: In this study, 736 patients with a PCR-confirmed diagnosis of COVID-19 were included from 12 January 2020 to 25 March 2020.", "All patients were divided into two groups according to whether or not they were hypertensive.", "After propensity score matching (PSM) to remove the interference of mismatches in the baseline data, the clinical characteristics and outcomes of angiotensin II receptor blocker (ARB)/ACE inhibitors application were analysed.", "RESULTS: A total of 220 (29.9%) patients were hypertensive, and 516 (70.1%) patients were not hypertensive.", "PSM eliminated demographic and comorbidity differences between the two groups.", "Of all participants, 32 patients died (4.3% mortality), including 17 out of 220 in the hypertension group (7.7%) and 15 out of 516 in the non-hypertension group (2.9%).", "The incidence of intensive care unit (ICU) stay in the hypertension group (12.8%) was higher than in the non-hypertension group (5.3%) (p<0.05).", "Logistic regression analysis showed that hypertension was an independent risk factor for death, not other comorbidities.", "Kaplan-Meier analysis showed that mortality was higher in the hypertension group than in the non-hypertension group before and after PSM (p<0.05).", "There was no statistically significant difference in ICU therapy, mortality and hospitalisation time between hypertensive patients with or without ARBs/ACE inhibitors (p>0.05).", "CONCLUSION: Hypertension was an independent risk factor for the severity and mortality of patients with COVID-19.", "ARBs/ACE inhibitors should not be discontinued in hypertensive patients with COVID-19."], "journal": "Postgrad Med J", "publish_time": "2021-10-05", "aliases": []}
{"doc_id": 245773217, "title": "Not Only High Number and Specific Comorbidities but Also Age Are Closely Related to Progression and Poor Prognosis in Patients With COVID-19", "abstract": ["Background: Some patients with comorbidities and rapid disease progression have a poor prognosis.", "Aim: We aimed to investigate the characteristics of comorbidities and their relationship with disease progression and outcomes of COVID-19 patients.", "Methods: A total of 718 COVID-19 patients were divided into five clinical type groups and eight age-interval groups.", "The characteristics of comorbidities were compared between the different clinical type groups and between the different age-interval groups, and their relationships with disease progression and outcomes of COVID-19 patients were assessed.", "Results: Approximately 91.23% (655/718) of COVID-19 patients were younger than 60 years old.", "Approximately 64.76% (465/718) had one or more comorbidities, and common comorbidities included non-alcoholic fatty liver disease (NAFLD), hyperlipidaemia, hypertension, diabetes mellitus (DM), chronic hepatitis B (CHB), hyperuricaemia, and gout.", "COVID-19 patients with comorbidities were older, especially those with chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD).", "Hypertension, DM, COPD, chronic kidney disease (CKD) and CVD were mainly found in severe COVID-19 patients.", "According to spearman correlation analysis the number of comorbidities was correlated positively with disease severity, the number of comorbidities and NAFLD were correlated positively with virus negative conversion time, hypertension, CKD and CVD were primarily associated with those who died, and the above-mentioned correlation existed independently of age.", "Risk factors included age, the number of comorbidities and hyperlipidaemia for disease severity, the number of comorbidities, hyperlipidaemia, NAFLD and COPD for the virus negative conversion time, and the number of comorbidities and CKD for prognosis.", "Number of comorbidities and age played a predictive role in disease progression and outcomes.", "Conclusion: Not only high number and specific comorbidities but also age are closely related to progression and poor prognosis in patients with COVID-19.", "These findings provide a reference for clinicians to focus on not only the number and specific comorbidities but also age in COVID-19 patients to predict disease progression and prognosis.", "Clinical Trial Registry: Chinese Clinical Trial Register ChiCTR2000034563."], "journal": "Front Med (Lausanne)", "publish_time": "2022-01-07", "aliases": []}
{"doc_id": 238358911, "title": "Impact of metabolic and cardiovascular disease on COVID-19 mortality: A systematic review and meta-analysis", "abstract": ["BACKGROUND AND AIMS: This meta-analysis aims to highlight the impact of cardio-metabolic comorbidities on COVID-19 severity and mortality.", "METHODS: A thorough search on major online databases was done for studies describing the clinical outcomes of COVID-19 patients.", "We used random-effects model to compute pooled estimates for critical or fatal disease.", "RESULTS: A total of 20,475 patients from 33 eligible studies were included.", "Maximum risk of development of critical or fatal COVID-19 disease was seen in patients with underlying cardiovascular disease [OR: 3.44, 95% CI: 2.65\u20134.48] followed by chronic lung disease, hypertension and diabetes mellitus.", "Of the total cases, 64% had one of the four comorbidities with the most prevalent being hypertension with a pooled prevalence of 27%.", "CONCLUSIONS: Presence of comorbidities like cardiovascular disease, chronic lung disease, hypertension and diabetes mellitus led to a higher risk of development of critical or fatal COVID-19 disease, with maximum risk seen with underlying cardiovascular disease."], "journal": "Diabetes Metab Syndr", "publish_time": "2021-10-06", "aliases": []}
{"doc_id": 236618581, "title": "Hypertension with covid 19 infection at the hospital of the christian university of indonesia, jakarta period may to october 2020", "abstract": ["Background: This study discussed patients with cofi d infection 19 who were admitted to Indonesian Christian university hospital with comorbid hypertension.", "On December 31, 2019, China reported a case of mysterious pneumonia with no known cause.", "Within 3 days, the number of patients with these cases was 44 patients and continues to increase until now there are thousands of cases.", "Initially epidemiological data showed 66% of patients were related or exposed to a seafood market or live market in Wuhan, Hubei Province, China.", "(2019-nCoV) .2 On February 11, 2020, the World Health Organization named the new virus Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and the name of the disease as Coronavirus Disease 2019 (COVID-19).", "Hypertension is one of the most common comorbids in Covid-19 patients.", "Hypertension is also widely available in Covid-19 patients who experience ARDS.", "It is currently unclear whether uncontrolled hypertension is a risk factor for contracting Covid-19, but controlling blood pressure is still considered important to reduce the burden of disease.", "SARS-CoV-2, the virus that causes Covid-19, binds to ACE2 in the lungs to enter cells, resulting in the use of angiotensin converting enzymes (ACE inhibitors) and angiotensin receptor blockers (ARBs), 2 classes of drugs that are frequently used in controlling hypertension, questionable benefi t or harm.", "Objective: Studying patients with covid 19 and their accompanying comorbids who were treated at the Hospital of the Faculty of Medicine of the Indonesian Christian University, Jakarta.", "Method:This type of research is observational research.", "This study only observed patients.", "Study design of all treated patients with COVID-19.", "Research Location: General Hospital of the Christian University of Indonesia, Research Time: May to October 2020.", "Result:It showed 50 people entered the inclusion criteria, hypertension with the most covid 19, 26 people (52%), type 2 diabetes mellitus with covid 19, 22 people (44%), CKD on hemodialysis with covid 19, 4 people (8%), CKD Non HD with covid 19, 3 people (6%).", "There were 2 patients with heart failure with covid 19 (4%), 2 people with hyperthyroidism with covid 19 (4%).", "Meanwhile, the ages of 61-70 years (40%) have a lot of Covid 19 in the period that date.", "Conclusion:Covid 19 patients with comorbid hypertension and type 2 diabetes mellitus were mostly found with ages between 61-70 years."], "journal": "Journal of Hypertension", "publish_time": "2021", "aliases": []}
{"doc_id": 235197384, "title": "Clinico-radiological profile of COVID-19 in Kashmiri population: A descriptive study", "abstract": ["AIM: The purpose of our study was to assess the presentation of COVID-19 disease in terms of clinical and radiological features in our population.", "METHODS: 64 RT-PCR documented COVID-19 patients were included in the study.", "Clinical, biochemical, and radiological data were collected and analyzed retrospectively from last week of March to 30(th) April 2020.", "RESULTS: Out of the 64 patients, 38 (59.4%) were males, 44 (68.7%) had a history of contact with COVID-19 positive patient.", "26.6%patients were in the age group of 21\u201330 years.", "53.1% patients were asymptomatic while as cough and fever were the most common symptoms in 21.8 and 20.3% patients, respectively.", "Anosmia was present in four patients.", "Hypertension and hypothyroidism were the most common comorbid illnesses among the study population in 9.4% patients each.", "Lymphopenia was present in 38% of patients CRP was increased in 83% patients, LDH in 90.2%, and ferritin in 51.5% of patients.", "17 (26.6%) patients had bilateral disease in CT. RUL was the most common lobe involved in 18 (28.1%) patients.", "GGO and consolidation were seen in 22 (34.45) and 13 (20.3%) patients, respectively.", "Vessel enlargement was observed in 11 (17.2%) patients.", "All five lobes were involved in 9 (14.1%) patients.", "Five patients developed severe disease with respiratory comprise; two of them eventually died.", "CONCLUSION: The clinical and radiological characteristics of COVID-19 patients vary among different populations.", "Although there are no radiological features which seems to be characteristic of COVID-19, but CT helps in evaluation of the patients as many asymptomatic ones have some radiological findings suggestive of viral pneumonia."], "journal": "J Family Med Prim Care", "publish_time": "2021-04-08", "aliases": []}
{"doc_id": 222144330, "title": "Altered mental status in 71 deaths due to COVID-19", "abstract": ["OBJECTIVE: The purpose of this study was to investigate the occurrence of neurologic symptoms with a focus on altered mental status in a sample of deaths due to COVID-19.", "METHODS: We reviewed neurologic symptoms in 71 deaths due to COVID-19 at the first US hospital with reported cases, of which 66 (93%) had medical comorbidities, 47 (66%) came from assisted living facilities or nursing homes and 35 (49%) had baseline dementia.", "RESULTS: Sixty-one patients (86%) demonstrated neurologic symptoms at hospital admission.", "Altered mental status was seen in 47 patients (66%) and represented the most common neurologic symptom.", "Seven patients (10%) were comatose at hospital admission and 5 (7%) presented with altered mental status without respiratory symptoms.", "Three patients had seizures and two had strokes.", "Hypertension (61%), cardiovascular disease (59%), and dementia (49%) were the most common comorbidities associated with death due to COVID-19 in our sample.", "CONCLUSIONS: Neurologic symptoms, particularly altered mental status, are very common in COVID-19 patients with high risk of mortality.", "In a small subset of patients, altered mental status is the defining feature of disease presentation.", "A mental status examination should be incorporated in the medical assessment of COVID-19."], "journal": "Int J Neurosci", "publish_time": "2020", "aliases": []}
{"doc_id": 216596612, "title": "Elevated interleukin\u20106 and severe COVID\u201019: A meta\u2010analysis", "abstract": ["Interleukin-6 is an important marker of inflammation.", "We performed a systematic review and meta-analysis to demonstrate the association of elevated IL-6 with severe Coronavirus disease-2019 (COVID-19).", "A total of 9 studies were included in the systematic review and meta-analysis.", "Patients with severe COVID-19 had a significantly higher serum IL-6 levels compared to non-severe patients (mean difference (MD): 38.6 pg/mL, 95% CI: 24.3 - 52.9 pg/mL, p <0.001, I2 = 98.5%).", "On meta-regression, increasing mean IL-6 level was associated with increased mortality in patients (Coefficient (Q): 0.01, 95% CI: 0.01-0.03, p = 0.03).", "Given the association of elevated IL-6 with severe COVID-19 and mortality, clinicians should use this as a potential marker to recognize severe disease.", "IL-6 should be incorporated in a scoring system along with other inflammatory markers to risk stratify the patients for early recognition of severe disease.", "Our study should encourage researchers to conduct trial evaluating Anti IL-6 antibodies such as Tocilizumab to assess the efficacy in patients with severe COVID-19.", "This article is protected by copyright.", "All rights reserved."], "journal": "J Med Virol", "publish_time": "2020-06-02", "aliases": []}
{"doc_id": 235373195, "title": "Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients", "abstract": ["A disruption of the crosstalk between the gut and the lung has been implicated as a driver of severity during respiratory-related diseases.", "Lung injury causes systemic inflammation, which disrupts gut barrier integrity, increasing the permeability to gut microbes and their products.", "This exacerbates inflammation, resulting in positive feedback.", "We aimed to test whether severe Coronavirus disease 2019 (COVID-19) is associated with markers of disrupted gut permeability.", "We applied a multi-omic systems biology approach to analyze plasma samples from COVID-19 patients with varying disease severity and SARS-CoV-2 negative controls.", "We investigated the potential links between plasma markers of gut barrier integrity, microbial translocation, systemic inflammation, metabolome, lipidome, and glycome, and COVID-19 severity.", "We found that severe COVID-19 is associated with high levels of markers of tight junction permeability and translocation of bacterial and fungal products into the blood.", "These markers of disrupted intestinal barrier integrity and microbial translocation correlate strongly with higher levels of markers of systemic inflammation and immune activation, lower levels of markers of intestinal function, disrupted plasma metabolome and glycome, and higher mortality rate.", "Our study highlights an underappreciated factor with significant clinical implications, disruption in gut functions, as a potential force that may contribute to COVID-19 severity."], "journal": "Front Immunol", "publish_time": "2021-06-09", "aliases": []}
{"doc_id": 221201717, "title": "Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes", "abstract": ["Early in the COVID-19 pandemic, type 2 diabetes (T2D) was marked as a risk factor for severe disease and mortality.", "Inflammation is central to the aetiology of both conditions where variations in immune responses can mitigate or aggravate disease course.", "Identifying at-risk groups based on immunoinflammatory signatures is valuable in directing personalised care and developing potential targets for precision therapy.", "This observational study characterised immunophenotypic variation associated with COVID-19 severity in T2D.", "Broad-spectrum immunophenotyping quantified 15 leucocyte populations in peripheral circulation from a cohort of 45 hospitalised COVID-19 patients with and without T2D.", "Lymphocytopenia and specific loss of cytotoxic CD8+ lymphocytes were associated with severe COVID-19 and requirement for intensive care in both non-diabetic and T2D patients.", "A morphological anomaly of increased monocyte size and monocytopenia restricted to classical CD14Hi CD16- monocytes was specifically associated with severe COVID-19 in patients with T2D requiring intensive care.", "Increased expression of inflammatory markers reminiscent of the type 1 interferon pathway (IL6, IL8, CCL2, INFB1) underlaid the immunophenotype associated with T2D.", "These immunophenotypic and hyperinflammatory changes may contribute to increased voracity of COVID-19 in T2D.", "These findings allow precise identification of T2D patients with severe COVID-19 as well as provide evidence that the type 1 interferon pathway may be an actionable therapeutic target for future studies."], "journal": "EMBO Mol Med", "publish_time": "2020", "aliases": []}
{"doc_id": 221910525, "title": "Inflammatory markers in gynecologic oncology patients hospitalized with covid-19", "abstract": ["Introduction.", "Elevated inflammatory markers in COVID-19 infection are predictive of disease severity and mortality.", "It is unclear if these markers are associated with severe disease in patients with cancer due to underlying tumor related inflammation.", "We sought to further understand the inflammatory response related to COVID-19 in gynecologic cancer patients methods patients with history of gynecologic cancer hospitalized for COVID-19 infection with available laboratory data were identified laboratory values at the time of hospital admission and clinical outcomes were abstracted from electronic medical records.", "Severe infection was defined as infection requiring icu admission or resulting in death.", "Results 86 patients with gynecologic cancer were hospitalized with COVID-19 infection with median age of 68 5 years (interquartile range (iqr), 59 0 to 74 8 years) Of the 86 patients, 29 (33 7%) patients required icu admission and 25 (29 1%) patients died of COVID-19 complications.", "There were 36 (41 9%) patients in remission and 50 (58 1%) had active disease.", "Patients with severe infection had significantly higher ferritin (median 1163 0, iqr 640 0-1967 0) and creactive protein (crp) (median 142 0, iqr 62 5-217 1) levels than those with non-severe disease (median 624 0, iqr 269 7-954 0, P=0 01; median 62 3, iqr 13 0-159 1, P=0 02 respectively) (table 1) white blood cell count, absolute neutrophil count, and lactate were also associated with severe disease.", "Procalcitonin and D-Dimer levels were not significantly associated with severe disease (P=0 2; P=0 7 respectively) Conclusion/Implications.", "Inflammatory markers (ferritin and crp) in gynecologic cancer patients are associated with COVID-19 severity and can be used as prognostic markers at the time of admission."], "journal": "International Journal of Gynecological Cancer", "publish_time": "2020", "aliases": []}
{"doc_id": 221220588, "title": "Predicting Disease Severity and Outcome in COVID-19 Patients: A Review of Multiple Biomarkers.", "abstract": ["CONTEXT An abundance of clinical reports focused on specific laboratory parameters have been reported on COVID-19, but a systematic analysis synthesizing these findings has not been performed.", "OBJECTIVE To review and summarize the current available literature on the predictive role of various biomarkers in COVID-19 patients.", "DATA SOURCES A literature search was performed using databases including PubMed, medRxiv, and bioRxiv.", "A total of 72 papers were reviewed including 54 peer reviewed papers and 18 non-peer reviewed preprints.", "CONCLUSIONS While non-specific, acute phase reactants including CRP, ferritin, SAA, and procalcitonin were reported as sensitive markers of acute COVID-19 disease.", "Significantly elevated WBC count, marked lymphopenia, decreased CD3, CD4 or CD8 T-lymphocyte counts, high neutrophil count, thrombocytopenia, and markedly elevated inflammatory biomarkers were associated with severe disease and the risk of developing sepsis with rapid progression.", "Trends observed by serial laboratory measurements during hospitalization including progressive decrease of lymphocyte count, thrombocytopenia, elevated CRP, procalcitonin, increased liver enzymes, decreased renal function, and coagulation derangements were more common in critically ill patient groups and associated with a high incidence of clinical complications.", "Elevated IL-6 level and markedly increased SAA were most often reported in severely and critically ill patients.", "Indicators of systemic inflammation such as neutrophil-lymphocyte ratio (NLR), systemic immune-inflammation (SII) index or COVID-19 Severity Score may be utilized to predict disease severity, outcome, and mortality.", "Interpretation of the data reported in the studies reviewed here is limited due to study design (mostly retrospective), limited sample size, and a lack of defined clinical criteria."], "journal": "Archives of pathology & laboratory medicine", "publish_time": "2020-08-20", "aliases": []}
{"doc_id": 244799930, "title": "Binding of phosphatidylserine\u2010positive microparticles by PBMCs classifies disease severity in COVID\u201019 patients", "abstract": ["Infection with SARS\u2010CoV\u20102 is associated with thromboinflammation, involving thrombotic and inflammatory responses, in many COVID\u201019 patients.", "In addition, immune dysfunction occurs in patients characterised by T cell exhaustion and severe lymphopenia.", "We investigated the distribution of phosphatidylserine (PS), a marker of dying cells, activated platelets and platelet\u2010derived microparticles (PMP), during the clinical course of COVID\u201019.", "We found an unexpectedly high amount of blood cells loaded with PS(+) PMPs for weeks after the initial COVID\u201019 diagnosis.", "Elevated frequencies of PS(+)PMP(+) PBMCs correlated strongly with increasing disease severity.", "As a marker, PS outperformed established laboratory markers for inflammation, leucocyte composition and coagulation, currently used for COVID\u201019 clinical scoring.", "PS(+) PMPs preferentially bound to CD8(+) T cells with gene expression signatures of proliferating effector rather than memory T cells.", "As PS(+) PMPs carried programmed death\u2010ligand 1 (PD\u2010L1), they may affect T cell expansion or function.", "Our data provide a novel marker for disease severity and show that PS, which can trigger the blood coagulation cascade, the complement system, and inflammation, resides on activated immune cells.", "Therefore, PS may serve as a beacon to attract thromboinflammatory processes towards lymphocytes and cause immune dysfunction in COVID\u201019."], "journal": "J Extracell Vesicles", "publish_time": "2021-12-01", "aliases": [235649858]}
{"doc_id": 239476765, "title": "COVID-19 associated coagulopathy is correlated with increased age and markers of inflammation response", "abstract": ["Background: The severe manifestations of the coronavirus disease 2019 (COVID-19) are linked to viral hyper-inflammation, cytokine release syndrome and subsequent coagulation disturbances.", "The most common coagulation abnormality observed in COM-19 patients is the elevation of the plasma levels of D-dimers.", "The aim of this study was to evaluate the characteristics of COVID-19-associated inflammatory syndrome and coagulopathy, in correlation with disease severity.", "Methods: We performed a cross-sectional study, enrolling all consecutive COVID-19 patients treated in the Adulti 3 Department of the Prof Dr. Matei Bals National Institute of Infectious Diseases, Bucharest, Romania, between 1st march and 30th September 2020.", "We recorded clinical and epidemiological characteristics, inflammatory markers, coagulation abnormalities and lymphocyte count.", "The severity of lung involvement was assessed using native Computed Tomography examination.", "Results: We included 106 patients with SARS-COV2 infection, 50 males (47.2%) and 56 females (52.8%), age range 14-91 years.", "All markers of inflammation were increased in our study in patients with severe disease, as were lactate dehydrogenase, monocyte distribution width, and neutrophil-to-lymphocyte ratio.", "An elevated level of serum D-dimers was observed in approximately half of our subjects and was associated with disease severity.", "Our best linear regression model for predicting COVID-19 coagulopathy (manifested as abnormal D-dimer levels) included age, fibrinogen, and lymphocyte count.", "Conclusion: Our findings emphasize the association between COVID-19 coagulopathy and the presence of systemic inflammation.", "A significant proportion of patients with moderate and severe disease had coagulation abnormalities and these were linked with the presence of inflammation and older age.."], "journal": "Revista Romana De Medicina De Laborator", "publish_time": "2021", "aliases": []}
{"doc_id": 245335872, "title": "Low Transferrin Levels Predict Heightened Inflammation in COVID-19 Patients: New Insights", "abstract": ["Objectives : Mounting evidence links hyper-inflammation in gravely ill patients to low serum iron levels and hyper-ferritinemia.", "However, little attention was given to other iron-associated markers such as transferrin.", "The aim of this study is to investigate the association of different iron parameters in severe COVID-19 disease and their relation to disease severity.", "Subjects and methods : This study involved 73 hospitalized patients positive for SARS-CoV-2.", "Patients were classified into two groups according to symptom severity as mild and severe.", "Blood levels of anti-SARS-CoV2 antibodies, IL-6, CRP and iron-related biomarkers were measured.", "Results : The results revealed a significant increase in IL-6, CRP and ferritin levels and decreased transferrin and iron levels in severe COVID-19 disease.", "Transferrin negatively predicted variations in IgM and IgG levels (P< 0.001), as well as 34.4% and 36.6% increase in IL-6 and CRP levels respectively (P< 0.005).", "Importantly, transferrin was the main negative predictor of ferritin levels, determining 22.7% of serum variations (P< 0.001).", "Conclusion : Reduced serum transferrin and iron levels, along with the increased CRP and high ferritin, were strongly associated with the heightened inflammatory and immune state in COVID-19 disease.", "Transferrin can be used as valuable predictors of increased severity and progression of disease."], "journal": "Int J Infect Dis", "publish_time": "2021-12-21", "aliases": []}
{"doc_id": 235947972, "title": "CLOT STIFFNESS MEASURED BY SEER SONORHEOMETRY AS A MARKER OF POOR PROGNOSIS IN HOSPITALIZED COVID-19 PATIENTS", "abstract": ["Background: High incidence of life-threatening thrombotic complications is observed in severely ill COVID-19 patients.", "D-dimer may help evaluate disease severity and predict outcomes at hospital admission.", "However, its non-specificity and long analysis times strongly constrain its clinical value.", "Viscoelastic tests (VET) are widely available rapid point-of-care devices that have been shown to detect a hypercoagulable state (increased clot stiffness and fibrinolysis shutdown) as major contributors of the thrombotic complication in COVID-19.", "Nevertheless, based on the data obtained so far, definitive conclusions have not been drawn.", "Objectives: We aim to evaluate the association between VET parameters, standard coagulation tests and inflammation markers assessed in COVID-19 patients at hospital admission with disease severity and outcomes.", "Patients/Methods: A total of 69 COVID-19 patients requiring hospitalization were included in the study.", "The pro-inflammatory and pro-thrombotic state was analyzed by a panel of inflammation markers (IL-6, CRP, LDH, ferritin), routine coagulation tests (PT, aPTT, platelet count, fibrinogen, D-dimer) and a SEER sonorheometry VET profile (Quantra System).", "Results: Inflammatory markers IL-6, CRP, LDH and ferritin were elevated in a high percentage of patients (73.6%, 89.2%, 57.1% and 52.4%), as were coagulation-related parameters such as fibrinogen (81.4%) and D-dimer levels (66.2%).", "Quantra analysis revealed increased clot stiffness (CS) in 34.8%, particularly due to increased fibrinogen contribution (FCS) in 63.7%.", "Increased clot stability to lysis (CSL) was observed in 32.4%.", "Age > 65 years, elevated values of fibrinogen, D-dimer, LDH, increased clot stiffness and resistance to clot lysis were significantly associated with worsening disease.", "The Quantra FCS parameter showed a particularly high prognostic value in distinguishing patients with severe symptomatology.", "Conclusion: The global study of hemostasis by the whole blood point-of-care Quantra VET system may be a powerful tool for identifying poor prognosis in COVID-19 patients at hospital admission.", "In particular, FCS measured by Quantra could be established as a plausible prognostic marker to aid the clinical management of COVID-19 patients."], "journal": "", "publish_time": "2021-07-16", "aliases": []}
{"doc_id": 232342117, "title": "Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection", "abstract": ["Objectives: Uncontrolled thromboinflammation plays an important role in the pathogenesis of coronavirus disease (COVID-19) caused by SARS-CoV-2 virus.", "Complement was implicated as key contributor to this process, therefore we hypothesized that markers of the complement profile, indicative for the activation state of the system, may be related to the severity and mortality of COVID-19.", "Methods: In this prospective cohort study samples of 102 hospitalized and 26 outpatients with PCR-confirmed COVID-19 were analyzed.", "Primary outcome was in-hospital, COVID-19 related mortality, and secondary outcome was COVID-19 severity as assessed by the WHO ordinal scale.", "Complement activity of alternative and classical pathways, its factors, regulators, and activation products were measured by hemolytic titration, turbidimetry, or enzyme-immunoassays.", "Clinical covariates and markers of inflammation were extracted from hospital records.", "Results: Increased complement activation was characteristic for hospitalized COVID-19 patients.", "Complement activation was significantly associated with markers of inflammation, such as interleukin-6, C-reactive protein, and ferritin.", "Twenty-five patients died during hospital stay due to COVID-19 related illness.", "Patients with uncontrolled complement activation leading to consumption of C3 and decrease of complement activity were more likely to die, than those who had complement activation without consumption.", "Cox models identified anaphylatoxin C3a, and C3 overactivation and consumption (ratio of C3a/C3) as predictors of in-hospital mortality [HR of 3.63 (1.55-8.45, 95% CI) and 6.1 (2.1-17.8), respectively].", "Conclusion: Increased complement activation is associated with advanced disease severity of COVID-19.", "Patients with SARS-CoV-2 infection are more likely to die when the disease is accompanied by overactivation and consumption of C3.", "These results may provide observational evidence and further support to studies on complement inhibitory drugs for the treatment of COVID-19."], "journal": "Front Immunol", "publish_time": "2021", "aliases": []}
{"doc_id": 236282357, "title": "LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes", "abstract": ["Diabetes is a known risk factor for severe coronavirus disease 2019 (COVID-19), the disease caused by the new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).", "However, there is a lack of knowledge about the mechanisms involved in the evolution of COVID-19 in individuals with diabetes.", "We aimed to evaluate whether the chronic low-grade inflammation of diabetes could play a role in the development of severe COVID-19.", "We collected clinical data and blood samples of patients with and without diabetes hospitalized for COVID-19.", "Plasma samples were used to measure inflammatory mediators and peripheral blood mononuclear cells, for gene expression analysis of the SARS-CoV-2 main receptor system (ACE2/TMPRSS2), and for the main molecule of the leukotriene B4 (LTB4) pathway (ALOX5).", "We found that diabetes activates the LTB4 pathway and that during COVID-19 it increases ACE2/TMPRSS2 as well as ALOX5 expression.", "Diabetes was also associated with COVID-19-related disorders, such as reduced oxygen saturation as measured by pulse oximetry/fraction of inspired oxygen (FiO2) and arterial partial pressure of oxygen/FiO2 levels, and increased disease duration.", "In addition, the expressions of ACE2 and ALOX5 are positively correlated, with increased expression in patients with diabetes and COVID-19 requiring intensive care assistance.", "We confirmed these molecular results at the protein level, where plasma LTB4 is significantly increased in individuals with diabetes.", "In addition, IL-6 serum levels are increased only in individuals with diabetes requiring intensive care assistance.", "Together, these results indicate that LTB4 and IL-6 systemic levels, as well as ACE2/ALOX5 blood expression, could be early markers of severe COVID-19 in individuals with diabetes."], "journal": "Diabetes", "publish_time": "2021", "aliases": []}
{"doc_id": 245219651, "title": "The Diagnostic and Predictive Roles of Neutrophil-Lymphocyte Ratio for Severity of Disease in COVID-19 Patients", "abstract": ["BACKGROUND: Neutrophil-lymphocyte ratio (NLR), lymphocyte-monocyte ratio (LMR), and platelet-lymphocyte ratio (PLR) are inflammation markers in inflammatory, cardiovascular, and malignant diseases and are important to assess prognosis.", "The aim of the study is to show the correlation between the inflammation markers of NLR, LMR, and PLR identified in total blood count of patients with Coronavirus disease 2019 (COVID-19) with the disease severity.", "METHODS: A total of 409 patients attending hospital with clinical symptoms of COVID-19 and with positive quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) test were divided into two groups as 61 severe patients and 348 non-severe patients.", "The levels of inflammation markers NLR, LMR, PLR, and c-reactive protein (CRP) were assessed.", "RESULTS: The mean age of 409 patients was 49.9 \u00b1 18.3 years and 48.7% of all patients were female.", "In the severe patient group, NLR 8.94 \u00b1 13.24, LMR 2.24 \u00b1 1.46, and PLR 248 \u00b1 254 were identified.", "NLR exhibited the largest area under the curve at 0.698, with the highest specificity (67%) and sensitivity (67.3%) among the other inflammation markers such as LMR and PLR.", "Consistent with the severity of disease in severe COVID-19 patients, NLR, PLR, CRP and other inflammation markers increase, while LMR is observed to reduce.", "CONCLUSIONS: NLR and PLR, calculated with the simple, cheap, and easily accessible hemogram test requested for diagnosis and follow-up of COVID-19 disease, were correlated with the total score for radiological findings and duration of hospitalization, and we observed NLR and LMR may predict disease severity."], "journal": "Clin. lab", "publish_time": "2021", "aliases": []}
{"doc_id": 226490552, "title": "Increased inflammatory markers correlate with liver damage and predict severe COVID-19: a systematic review and meta-analysis.", "abstract": ["Aim This study aimed to determine whether patients with elevated CRP, TNF\u03b1, and IL-6 levels may be at increased risk for severe infection and liver damage of COVID-19.", "Background The COVID-19 outbreak is a serious health problem to human beings.", "The evidence suggests that inflammatory markers related to liver damage increase in severe forms of COVID-19 compared to mild cases.", "Methods The electronic databases ISI Web of Science, EMBASE, and Cochrane Library were comprehensively searched for articles published up to May, 2020.", "Data from each identified study was combined using the random effects model to estimate standardized mean difference (SMD) and 95% confidence intervals (95% CIs).", "Sensitivity and publication bias were also calculated.", "Results Totally, 23 studies were included in this meta-analysis comprising 4313 patients with COVID-19.", "The random effects results demonstrated that patients with severe COVID-19 had significantly higher levels of CRP [SMD = 3.26 mg/L; (95% CI 2.5, 3.9); p<0.05; I2 = 98.02%; PHeterogeneity = 0.00], TNF\u03b1 [SMD = 1.78 ng/mL; (95% CI 0.39, 3.1); p=0.012; I2 = 98.2%; PHeterogeneity = 0.00], and IL-6 [ SMD = 3.67 ng/mL; (95% CI 2.4, 4.8); p<0.05; I2 = 97.8%; PHeterogeneity = 0.00] compared with those with the mild form of the disease.", "Significant heterogeneity was present.", "No significant publication bias was observed in the meta-analysis.", "Sensitivity analyses showed a similar effect size while reducing the heterogeneity.", "Conclusion The data suggests that enhanced inflammation may be associated with COVID-19-related liver damage, possibly involving inflammatory marker-related mechanisms."], "journal": "Gastroenterology and hepatology from bed to bench", "publish_time": "2020", "aliases": []}
{"doc_id": 224812909, "title": "Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients\u2019 performance: a prospective observational cohort study", "abstract": ["BACKGROUND: Severe coronavirus disease 2019 (COVID-19) is frequently associated with hyperinflammation and hyperferritinemia.", "The latter is related to increased mortality in COVID-19.", "Still, it is not clear if iron dysmetabolism is mechanistically linked to COVID-19 pathobiology.", "METHODS: We herein present data from the ongoing prospective, multicentre, observational CovILD cohort study (ClinicalTrials.gov number, NCT04416100), which systematically follows up patients after COVID-19.", "109 participants were evaluated 60 days after onset of first COVID-19 symptoms including clinical examination, chest computed tomography and laboratory testing.", "RESULTS: We investigated subjects with mild to critical COVID-19, of which the majority received hospital treatment.", "60 days after disease onset, 30% of subjects still presented with iron deficiency and 9% had anemia, mostly categorized as anemia of inflammation.", "Anemic patients had increased levels of inflammation markers such as interleukin-6 and C-reactive protein and survived a more severe course of COVID-19.", "Hyperferritinemia was still present in 38% of all individuals and was more frequent in subjects with preceding severe or critical COVID-19.", "Analysis of the mRNA expression of peripheral blood mononuclear cells demonstrated a correlation of increased ferritin and cytokine mRNA expression in these patients.", "Finally, persisting hyperferritinemia was significantly associated with severe lung pathologies in computed tomography scans and a decreased performance status as compared to patients without hyperferritinemia.", "DISCUSSION: Alterations of iron homeostasis can persist for at least two months after the onset of COVID-19 and are closely associated with non-resolving lung pathologies and impaired physical performance.", "Determination of serum iron parameters may thus be a easy to access measure to monitor the resolution of COVID-19.", "TRIAL REGISTRATION: ClinicalTrials.gov number: NCT04416100."], "journal": "Respir Res", "publish_time": "2020-10-21", "aliases": []}
{"doc_id": 230484222, "title": "The role of obesity in inflammatory markers in COVID-19 patients", "abstract": ["Obesity has emerged as a significant risk factor for severe COVID-19 worldwide.", "Given both COVID-19 infection and obesity have been associated with increased systemic inflammation, we evaluated inflammatory markers in obese and non-obese individuals hospitalized for COVID-19 at Massachusetts General Hospital.", "We hypothesized that obese patients would have a more exuberant inflammatory response as evidenced by higher initial and peak inflammatory markers along with worse clinical outcomes.", "Of the 781 patients, 349 were obese (45%).", "Obese individuals had higher initial and peak levels of CRP and ESR as well as higher peak d-dimer (P < 0.01 for all) in comparison to non-obese individuals, while.", "IL-6 and ferritin were similar.", "In addition, obese individuals had a higher odds of requiring vasopressor use (OR 1.54, 95% CI 1.00-2.38, P = 0.05), developing hypoxemic respiratory failure (OR 1.58, 95% CI 1.04-2.40, P = 0.03) and death (OR 2.20, 95% CI 1.31-3.70, P = 0.003) within 28 days of presentation to care.", "Finally, higher baseline levels of CRP and D-dimer were associated with worse clinical outcomes even after adjustment for BMI.", "Our findings suggest greater disease severity in obese individuals is characterized by more exuberant inflammation."], "journal": "Obes Res Clin Pract", "publish_time": "2021", "aliases": []}
{"doc_id": 226963222, "title": "Severe COVID-19 is fueled by disrupted gut barrier integrity", "abstract": ["Background: A disruption of the crosstalk between gut and lung has been implicated as a driver of severity during several respiratory-related diseases.", "Lung injury causes systemic inflammation, which disrupts gut barrier integrity, increasing the permeability to gut microbes and their products.", "This exacerbates inflammation, resulting in positive feedback.", "We applied a multi-omic systems biology approach to investigate the potential link between loss of gut barrier integrity and Coronavirus disease 2019 (COVID-19) severity.", "Methods: We analyzed plasma samples from age and gender-matched COVID-19 patients (n=60) with varying disease severity (mild, moderate, and severe) and 20 SARS-CoV2 negative controls.", "We measured markers and drivers of tight junction permeability and microbial translocation using ELISA;inflammation and immune activation markers using ELISA and multiplex cytokine arrays;untargeted metabolomic and lipidomic analyses using mass spectrometry;and plasma glycomes using capillary electrophoresis and lectin microarray.", "False discovery rate (FDR) was calculated to account for multiple comparisons.", "Results: Our data indicate, first, that severe COVID-19 is associated with a dramatic increase in the level of zonulin (FDR&lt;0.00001), the only known physiological driver of intestinal tight junction permeability.", "This increased permeability associated with translocation of both bacterial (LPS binding protein (LBP) levels) and fungal (\u03b2-glucan levels) products into blood (FDR&lt;0.01).", "The degree of intestinal permeability and microbial translocation strongly correlated with increased systemic inflammation (correlations with IL-6 and other inflammatory cytokines and markers) (FDR&gt;0.05).", "Second, levels of metabolomic and lipidomic markers of gut and gut microbiota functionality including citrulline (a marker of healthy gut;decreased), succinic acid, and tryptophan catabolism metabolites (markers of microbial dysbiosis;increased) were disrupted during severe COVID-19 (FDR&lt;0.05).", "Finally, the gut microbiome is known to release enzymes that degrade plasma glycans, which regulate inflammation and complement activation.", "Indeed, severe COVID-19 was associated with loss of the anti-complement activation galactosylated glycans from plasma and IgG glycoproteins (FDR&lt;0.05).", "Conclusion: Our data provide multiple layers of evidence that a previously unappreciated factor with significant clinical implications, disruption in gut barrier integrity, is a potential force that contributes to COVID-19 severity."], "journal": "Topics in Antiviral Medicine", "publish_time": "2021", "aliases": []}
{"doc_id": 222132610, "title": "Comparing biomarkers for COVID-19 disease with commonly associated preexisting conditions and complications.", "abstract": ["Severe coronavirus disease 2019 (COVID-19) has been associated with certain preexisting health conditions and can cause respiratory failure along with other multi-organ injuries.", "However, the mechanism of these relationships is unclear, and prognostic biomarkers for the disease and its systemic complications are lacking.", "This study aims to examine the plasma protein profile of COVID-19 patients and evaluate overlapping protein modules with biomarkers of common comorbidities.", "Blood samples were collected from COVID-19 cases (n=307) and negative controls (n=78) among patients with acute respiratory distress.", "Proteins were measured by proximity extension assay utilizing next-generation sequencing technology.", "Its associations to COVID-19 disease characteristics were compared to that of preexisting conditions and established biomarkers for myocardial infarction (MI), stroke, hypertension, diabetes, smoking, and chronic kidney disease.", "Several proteins were differentially expressed in COVID-19, including multiple pro-inflammatory cytokines such as IFN-gamma, CXCL10, and CCL7/MCP-3.", "Elevated IL-6 was associated with increased severity, while baseline IL1RL1/ST2 levels were associated with a worse prognosis.", "Network analysis identified several protein modules associated with COVID-19 disease characteristics overlapping with processes of preexisting hypertension and impaired kidney function.", "BNP and NTpro-BNP, markers for MI and stroke, increased with disease progression and were positively associated with severity.", "MMP12 was similarly elevated and has been previously linked to smoking and inflammation in emphysema, along with increased cardiovascular disease risk.", "In conclusion, this study provides an overview of the systemic effects of COVID-19 and candidate biomarkers for clinical assessment of disease progression and the risk of systemic complications."], "journal": "", "publish_time": "2020-10-05", "aliases": []}
{"doc_id": 237206432, "title": "Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19", "abstract": ["BACKGROUND: COVID-19 pathology is associated with exuberant inflammation, vascular damage, and activation of coagulation.", "In addition, complement activation has been described and is linked to disease pathology.", "However, few studies have been conducted in cancer patients.", "OBJECTIVE: This study examined complement activation in response to COVID-19 in the setting of cancer associated thromboinflammation.", "METHODS: Markers of complement activation (C3a, C5a, sC5b-9) and complement inhibitors (Factor H, C1-Inhibitor) were evaluated in plasma of cancer patients with (n=43) and without (n=43) COVID-19 and stratified based on elevated plasma D-dimer levels (>1.0 \u03bcg/ml FEU).", "Markers of vascular endothelial cell dysfunction and platelet activation (ICAM-1, thrombomodulin, P-selectin) as well as systemic inflammation (pentraxin-3, serum amyloid A, soluble urokinase plasminogen activator receptor) were analyzed to further evaluate the inflammatory response.", "RESULTS: Increases in circulating markers of endothelial cell dysfunction, platelet activation, and systemic inflammation were noted in cancer patients with COVID-19.", "In contrast, complement activation increased in cancer patients with COVID-19 and elevated D-dimers.", "This was accompanied by decreased C1-Inhibitor levels in patients with D-dimers > 5 ug/ml FEU.", "CONCLUSION: Complement activation in cancer patients with COVID-19 is significantly increased in the setting of thromboinflammation.", "These findings support a link between coagulation and complement cascades in the setting of inflammation."], "journal": "Front Immunol", "publish_time": "2021-08-18", "aliases": []}
{"doc_id": 235211047, "title": "Markers of brain and endothelial Injury and inflammation are acutely and sex specifically regulated in SARS-CoV-2 infection", "abstract": ["Objective: To investigate brain injury markers (BIM), endothelial injury markers (EIM) and cytokine/chemokine (CC) markers of systemic inflammation in coronavirus disease 2019 (COVID-19) and across sex.", "Methods: Plasma samples from 57 subjects at <48 hours of COVID 19 hospitalization, 14 subjects at 3 months of COVID 19 hospitalization and 20 matched controls were interrogated for the levels of six BIMs, including GFAP, S100B, Syndecan1, UCHLI, MAP2 and NSE, two EIMs, including sICAM1 and sVCAM1 and thirty eight CCs.", "Statistical and bioinformatics methods were used to measure differences in the marker profiles across (a) COVID 19 vs controls and (b) men vs women.", "Results: Three BIMs: MAP2, NSE and S100B, two EIMs: sICAM1 and sVCAM1 and seven CCs: GRO IL10, sCD40L, IP10, IL1Ra, MCP1 and TNFa; were significantly (p<0.05) elevated in the COVID 19 cohort compared to controls.", "Two CCs: MDC and MIP1a; were significantly lower in the COVID-19 cohort.", "Bioinformatics analysis reveal a stronger positive association between BIM/CC/EIMs in the COVID-19 cohort.", "Analysis across sex revealed that several BIMs and CCs including NSE, IL10, IL15 and IL8 were significantly (p<0.05) higher in men compared to women.", "Men also expressed a more robust BIM/ EIM/CC association profile compared to women.", "At 3 months, BIMs and CCs were not significantly different in the COVID-19 cohort compared to controls.", "Conclusion: The acute elevation of BIMs, CCs, and EIMs and the robust associations among them at COVID-19 hospitalization suggest that brain injury is mediated by endotheliopathy and inflammation.", "Higher BIM and inflammatory markers in men additionally suggest that men are more susceptible to the risk compared to women."], "journal": "", "publish_time": "2021-05-27", "aliases": []}
{"doc_id": 227260847, "title": "Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19", "abstract": ["OBJECTIVE: The full spectrum of coronavirus disease 2019 (COVID-19) infection ranges from asymptomatic to acute respiratory distress syndrome, characterized by hyperinflammation and thrombotic microangiopathy.", "The pathogenic mechanisms are poorly understood, but emerging evidence suggest that excessive neutrophil extracellular trap (NET) formation plays a key role in COVID-19 disease progression.", "Here, we evaluate if circulating markers of NETs are associated with COVID-19 disease severity and clinical outcome, as well as to markers of inflammation and in vivo coagulation and fibrinolysis.", "Approach and Results: One hundred six patients with COVID-19 with moderate to severe disease were enrolled shortly after hospital admission and followed for 4 months.", "Acute and convalescent plasma samples as well as plasma samples from 30 healthy individuals were assessed for markers of NET formation: citrullinated histone H3, cell-free DNA, NE (neutrophil elastase).", "We found that plasma levels of NET markers were all elevated in patients with COVID-19 relative to healthy controls, were associated with respiratory support requirement and short-term mortality, and declined to those found in healthy individuals 4 months post-infection.", "Levels of the NET markers also correlated with white blood cells, neutrophils, inflammatory cytokines, and C-reactive protein, as well as to markers of in vivo coagulation, fibrinolysis, and endothelial damage.", "CONCLUSIONS: Our findings suggest a role of NETs in COVID-19 disease progression, implicating their contribution to an immunothrombotic state.", "Further, we observed an association between circulating markers of NET formation and clinical outcome, demonstrating a potential role of NET markers in clinical decision-making, as well as for NETs as targets for novel therapeutic interventions in COVID-19.", "REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04402944, NCT04541979, NCT04445285, NCT04432987, NCT04402970."], "journal": "Arterioscler Thromb Vasc Biol", "publish_time": "2020", "aliases": []}
{"doc_id": 233326912, "title": "Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19", "abstract": ["Coronavirus disease 2019 (COVID-19) experienced an outbreak that expanded worldwide.", "Lopinavir/ritonavir (LPV/r), which is used effectively for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronavirus infections, was applied for COVID-19 treatment given similarities in the molecular structures of these viruses.", "We performed a systematic review and meta-analysis to evaluate the efficacy and safety of lopinavir/ritonavir antiviral treatment in patients with SARS, MERS, and COVID-19.", "After registration with INPLASY, a search was conducted in PubMed, Embase, China National Knowledge Infrastructure (CNKI), Cochrane Library, WanFang Data, China Biomedical Literature Database (CBM) and other databases for all relevant literature on lopinavir/ritonavir treatment of SARS, MERS and COVID-19.", "The Cochrane Collaboration\u2019s bias risk assessment tool and the Newcastle-Ottawa Scale (NOS) were used to evaluate the quality of the literature, and RevMan 5.3 software was used to evaluate the relevant outcome indicators of the efficacy and safety of lopinavir/ritonavir in the treatment of COVID-19.", "A total of 18 eligible studies (including randomized controlled studies, cohort studies, and case-control studies) were retrieved and included with a total of 2273 patients.", "The lopinavir/ritonavir group exhibited an increased nucleic acid conversion rate (P=0.004), higher virus clearance rate (P<0.0001), lower mortality rate (P=0.002), and reduced incidence of acute respiratory distress syndrome (ARDS) (P=0.02) compared with the control group.", "No significant benefit in the improvement rate of chest CT (P=0.08) or incidence of adverse events (P=0.45) was noted.", "The lopinavir/ritonavir group had a lower incidence of acute respiratory distress syndrome (P=0.02).", "According to the clinical prognostic results, the incidence of adverse events between the two groups was not statistically significant (P<0.0001).", "The efficacy of lopinavir/ritonavir in the treatment of patients with SARS, MERS and COVID-19 was significantly better than that of the control.", "Furthermore, the incidence of adverse events did not significantly increase.", "Lopinavir/ritonavir is effective in the treatment of COVID-19, and this combination should be further assessed in RCT studies.", "In addition, when we analyzed the differences in age and sex, we found that the differences were statistically significant in the safety and effectiveness of lopinavir/ritonavir in patients with COVID-19, and both of these factors played a significant role in the trial."], "journal": "Aging (Albany NY)", "publish_time": "2021-04-20", "aliases": []}
{"doc_id": 221182438, "title": "Efficacy of various treatment modalities for nCOV\u20102019: a systematic review and meta\u2010analysis", "abstract": ["BACKGROUND: Several therapeutic agents have been investigated for treatment of novel Coronavirus\u20102019 (nCOV\u20102019).", "We conducted a systematic review and meta\u2010analysis to assess the efficacy of various treatment modalities in nCOV\u20102019 patients.", "METHODS: A literature search was conducted before 29 June 2020 in PubMed, Google Scholar, Cochrane library databases.", "A fixed\u2010effect model was applied if I(2) <50%, else results were combined using random\u2010effect model.", "Risk Ratio (RR) or Standardized Mean Difference (SMD) along\u2010with 95% Confidence Interval (95%CI) were used to pool the results.", "Between\u2010study heterogeneity was explored using influence and sensitivity analyses and publication bias was assessed using funnel plots.", "Entire statistical analysis was conducted in R version 3.6.2.", "RESULTS: Fifty studies involving 15 in\u2010vitro and 35 clinical studies including 9170 nCOV\u20102019 patients were included.", "Lopinavir\u2010Ritonavir was significantly associated with shorter mean time to clinical recovery (SMD \u20100.32; 95%CI \u20100.57 to \u20100.06), Remdesivir was significantly associated with better overall clinical recovery (RR 1.17; 95%CI 1.07 to 1.29) and Tocilizumab was associated with less all\u2010cause mortality (RR 0.38; 95%CI 0.16 to 0.93).", "Hydroxychloroquine was associated with longer time to clinical recovery and less overall clinical recovery.", "It additionally had higher all\u2010cause mortality and more total adverse events.", "CONCLUSION: Our meta\u2010analysis suggests that except in vitro studies, no treatment has shown overall favorable outcomes in nCOV\u20102019 patients.", "Lopinavir\u2010Ritonavir, Remdesivir and Tocilizumab may have some benefits while Hydroxychloroquine administration may cause harm in nCOV\u20102019 patients.", "Results from upcoming large clinical trials may further clarify role of these drugs."], "journal": "Eur J Clin Invest", "publish_time": "2020-08-18", "aliases": []}
{"doc_id": 219700906, "title": "Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019", "abstract": ["BACKGROUND/AIMS: The efficacies of lopinavir-ritonavir or hydroxychloroquine remain to be determined in patients with coronavirus disease 2019 (COVID-19).", "To compare the virological and clinical responses to lopinavir-ritonavir and hydroxychloroquine treatment in COVID-19 patients.", "METHODS: This retrospective cohort study included patients with COVID-19 treated with lopinavir-ritonavir or hydroxychloroquine at a single center in Korea from February 17 to March 31, 2020.", "Patients treated with lopinavir-ritonavir and hydroxychloroquine concurrently and those treated with lopinavir-ritonavir or hydroxychloroquine for less than 7 days were excluded.", "Time to negative conversion of viral RNA, time to clinical improvement, and safety outcomes were assessed after 6 weeks of follow-up.", "RESULTS: Of 65 patients (mean age, 64.3 years; 25 men [38.5%]), 31 were treated with lopinavir-ritonavir and 34 were treated with hydroxychloroquine.", "The median duration of symptoms before treatment was 7 days and 26 patients (40%) required oxygen support at baseline.", "Patients treated with lopinavir-ritonavir had a significantly shorter time to negative conversion of viral RNA than those treated with hydroxychloroquine (median, 21 days vs. 28 days).", "Treatment with lopinavir-ritonavir (adjusted hazard ratio [aHR], 2.28; 95% confidence interval [CI], 1.24 to 4.21) and younger age (aHR, 2.64; 95% CI 1.43 to 4.87) was associated with negative conversion of viral RNA.", "There was no significant difference in time to clinical improvement between lopinavir-ritonavir- and hydroxychloroquine-treated patients (median, 18 days vs. 21 days).", "Lymphopenia and hyperbilirubinemia were more frequent in lopinavir-ritonavir-treated patients compared with hydroxychloroquine-treated patients.", "CONCLUSIONS: Lopinavir-ritonavir was associated with more rapid viral clearance than hydroxychloroquine in mild to moderate COVID-19, despite comparable clinical responses.", "These findings should be confirmed in randomized, controlled trials."], "journal": "Korean J Intern Med", "publish_time": "2020-06-16", "aliases": []}
{"doc_id": 229080306, "title": "Various Combination of Antiviral Treatment of COVID-19 Pneumonia;A Preliminary Observational Study", "abstract": ["background: coronavirus disease 2019 (COVID-19) has emerged serious medical crisis worldwide.", "No regimen has been approved as gold standard of treatment.", "There were no report of other combinations of antiviral cocktail therapy.", "Methods: We compared time to recovery of COVID-19 pneumonia patients who were treated with various combinations of lopinavir/ritonavir, darunavir /ritonavir, favipiravir, hydroxychloroquine, or no antiviral treatment with lopinavir/ritonavir plus high-dose oseltamivir.", "Results: Lopinavir/ritonavir plus high-dose oseltamivir had the best efficacy in terms of time to recovery compared to no antiviral treatment (P=0 003) and darunavir/ritonavir plus hydroxychloroquine and favipiravir (p =0 02) Lopinavir/ritonavir plus favipiravir had the borderline efficacy in terms of time to recovery compared to no antiviral treatment (P=0 05) There was no superior efficacy in terms of time to recovery of the combinations of darunavir/ritonavir plus hydroxychloroquine with or without favipiravir compared with no antiviral treatment (P0 05) Darunavir/ritonavir plus hydroxychloroquine with or without favipiravir had similar efficacy to Lopinavir/ritonavir plus favipiravir (P0 05) The patients who were treated with hydroxychloroquine 400-1200 mg/day had a significantly increased risk of death (P=0 04) Conclusions: The combination of lopinavir/ritonavir plus high-dose oseltamivir exhibited a trend of superiority compared to the combination of darunavir/ritonavir plus hydroxychloroquine and favipiravir and no antiviral treatment.", "However, the efficacy of the combinations of antiviral cocktail treatment of COVID-19 pneumonia should be further investigated in a randomized control study registerd as nct04303299 trial.", "Registration: NCT04303299."], "journal": "", "publish_time": "2020", "aliases": []}
{"doc_id": 40409310, "title": "Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.", "abstract": ["BACKGROUND The clinical response of patients with severe acute respiratory syndrome (SARS) to a combination of lopinavir/ritonavir and ribavirin was examined after establishing the in vitro antiviral susceptibility of the SARS associated coronavirus to a panel of antiviral agents.", "METHODS The in vitro susceptibility of the prototype of SARS associated coronavirus to a panel of nucleoside analogues and protease inhibitors currently licensed for clinical use was studied.", "Forty one patients with SARS followed for 3 weeks were treated with a combination of lopinavir/ritonavir and ribavirin.", "The clinical progress and virological outcomes were monitored and compared with 111 patients treated with ribavirin only who served as historical controls.", "RESULTS In vitro antiviral activity against SARS associated coronavirus was demonstrated for lopinavir and ribavirin at concentrations of 4 micro g/ml and 50 micro g/ml, respectively, only at 48 hours.", "The adverse clinical outcome (ARDS or death) was significantly lower in the treatment group than in the historical controls (2.4% v 28.8%, p<0.001) at day 21 after the onset of symptoms.", "The adverse outcome remained significantly lower in the treatment group than in the controls-both those diagnosed early (p<0.001) and those diagnosed later in the course of the epidemic (p = 0.002)-but there was no significant difference in adverse outcome rates between the two time periods (p = 0.548).", "No time related difference in outcome was observed in the control groups.", "A reduction in steroid usage and nosocomial infections was seen in patients initially treated with lopinavir/ritonavir, and these patients had a decreasing viral load and rising peripheral lymphocyte count.", "Multivariate analysis showed that age, hepatitis B carrier status, and lack of treatment with this antiviral combination were independent predictors of an adverse outcome.", "Lopinavir/ritonavir treatment was associated with a better outcome even when adjusted for baseline lactate dehydrogenase level.", "CONCLUSIONS The apparent favourable clinical response with lopinavir/ritonavir and ribavirin supports further randomised placebo controlled trials in patients with SARS."], "journal": "Thorax", "publish_time": "2004", "aliases": []}
{"doc_id": 220627941, "title": "Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients", "abstract": ["Interferons (IFNs) are widely used in treating coronavirus disease 2019 (COVID-19) patients.", "However, a recent report of ACE2, the host factor mediating SARS-Cov-2 infection, identifying it as interferon-stimulated raised considerable safety concern.", "To examine the association between the use and timing of IFN-&#945;2b and clinical outcomes, we analyzed in a retrospective multicenter cohort study of 446 COVID-19 patients in Hubei, China.", "Regression models estimated that early administration (&#8804;5 days after admission) of IFN-&#945;2b was associated with reduced in-hospital mortality in comparison with no admission of IFN-&#945;2b, whereas late administration of IFN-&#945;2b was associated with increased mortality.", "Among survivors, early IFN-&#945;2b was not associated with hospital discharge or computed tomography (CT) scan improvement, whereas late IFN-&#945;2b was associated with delayed recovery.", "Additionally, early IFN-&#945;2b and umifenovir alone or together were associated with reduced mortality and accelerated recovery in comparison with treatment with lopinavir/ritonavir (LPV/r) alone.", "We concluded that administration of IFN-&#945;2b during the early stage of COVID-19 could induce favorable clinical responses."], "journal": "", "publish_time": "2020", "aliases": []}
{"doc_id": 227253267, "title": "Efficacy and Safety of Lopinavir/Ritonavir for Treatment of COVID-19: A Systematic Review and Meta-Analysis", "abstract": ["(Background) Lopinavir-ritonavir (LPV/RTV) is a human immunodeficiency virus (HIV) antiviral combination that has been considered for the treatment of COVID-19 disease.", "(Aim) This systematic review aimed to assess the efficacy and safety of LPV/RTV in COVID-19 patients in the published research.", "(Methods) A protocol was developed based on the Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) statement.", "Articles were selected for review from 8 electronic databases.", "This review evaluated the effects of LPV/RTV alone or in combination with standard care \u00b1 interferons/antiviral treatments compared to other therapies, regarding duration of hospital stay, risk of progressing to invasive mechanical, time to virological cure and body temperature normalization, cough relief, radiological progression, mortality and safety.", "(Results) A consensus was reached to select 32 articles for full-text screening; only 14 articles comprising 9036 patients were included in this study; and eight of these were included for meta-analysis.", "Most of these studies did not report positive clinical outcomes with LPV/RTV treatment.", "In terms of virological cure, three studies reported less time in days to achieve a virological cure for LPV/RTV arm relative to no antiviral treatment (\u22120.81 day; 95% confidence interval (CI), \u22124.44 to 2.81; p = 0.007, I(2) = 80%).", "However, the overall effect was not significant (p = 0.66).", "When comparing the LPV/RTV arm to umifenovir arm, a favorable affect was observed for umifenovir arm, but not statically significant (p = 0.09).", "In terms of time to body normalization and cough relief, no favorable effects of LPV/RTV versus umifenovir were observed.", "The largest trials (RECOVERY and SOLIDARITY) have shown that LPV/RTV failed to reduce mortality, initiation of invasive mechanical ventilation or hospitalization duration.", "Adverse events were reported most frequently for LPV/RTV (n = 84) relative to other antivirals and no antiviral treatments.", "(Conclusions) This review did not reveal any significant advantage in efficacy of LPV/RTV for the treatment of COVID-19 over standard care, no antivirals or other antiviral treatments.", "This result might not reflect the actual evidence."], "journal": "Trop Med Infect Dis", "publish_time": "2020-11-28", "aliases": [219872448]}
{"doc_id": 244509601, "title": "Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review", "abstract": ["BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel strain that causes acute respiratory illnesses known as coronavirus disease 2019 (COVID-19).", "Currently, there is limited information regarding the therapeutic management for this disease.", "Several studies have stated that antivirals drugs such as remdesivir, favipiravir, and lopinavir/ritonavir may potentially inhibit the virus from spreading to the host.", "OBJECTIVE: The aim of this systematic review was to summarize the clinical effectiveness and safety of remdesivir, favipiravir, and lopinavir/ritonavir on COVID-19.", "METHODS: The PubMed and Cochrane Library databases were searched up to July 2021 to identify eligible experimental randomized controlled trials on remdesivir, favipiravir, and lopinavir/ritonavir for COVID-19 patients.", "This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline.", "RESULTS: From 158 references, 15 studies were included in the review.", "The results showed that remdesivir has some potential benefits for hospitalized COVID-19 patients, as seen from clinical improvements such as faster recovery time, less duration of hospitalization, and fewer respiratory side effects among COVID-19 patients.", "However, the impact of remdesivir in reducing mortality remains uncertain.", "Treatment with favipiravir has shown promising improvement in the clinical status of COVID-19 patients, although the results suggested no significant differences in some clinical parameters such as length of hospitalizations and clinical recovery.", "A combination of favipiravir with other supportive therapy showed more favorable outcomes for COVID-19 patients.", "Furthermore, the use of lopinavir/ritonavir in COVID-19 patients reported no significant clinical improvement compared to standard care with notable adverse effect reactions.", "CONCLUSION: This study provides an overview of the evidence-based role of remdesivir, favipiravir, and lopinavir/ritonavir in the management of COVID-19.", "A thorough assessment of the benefit-risk profile in COVID-19 patients is urgently needed.", "The current review was based on very limited available data; therefore, further well-designed clinical trials are required."], "journal": "Int J Gen Med", "publish_time": "2021-11-23", "aliases": []}
{"doc_id": 235796436, "title": "Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial", "abstract": ["PURPOSE: To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19).", "METHODS: Critically ill adults with COVID-19 were randomized to receive lopinavir-ritonavir, hydroxychloroquine, combination therapy of lopinavir-ritonavir and hydroxychloroquine or no antiviral therapy (control).", "The primary endpoint was an ordinal scale of organ support-free days.", "Analyses used a Bayesian cumulative logistic model and expressed treatment effects as an adjusted odds ratio (OR) where an OR > 1 is favorable.", "RESULTS: We randomized 694 patients to receive lopinavir-ritonavir (n = 255), hydroxychloroquine (n = 50), combination therapy (n = 27) or control (n = 362).", "The median organ support-free days among patients in lopinavir-ritonavir, hydroxychloroquine, and combination therapy groups was 4 (\u2013 1 to 15), 0 (\u2013 1 to 9) and\u20141 (\u2013 1 to 7), respectively, compared to 6 (\u2013 1 to 16) in the control group with in-hospital mortality of 88/249 (35%), 17/49 (35%), 13/26 (50%), respectively, compared to 106/353 (30%) in the control group.", "The three interventions decreased organ support-free days compared to control (OR [95% credible interval]: 0.73 [0.55, 0.99], 0.57 [0.35, 0.83] 0.41 [0.24, 0.72]), yielding posterior probabilities that reached the threshold futility (\u2265 99.0%), and high probabilities of harm (98.0%, 99.9% and > 99.9%, respectively).", "The three interventions reduced hospital survival compared with control (OR [95% CrI]: 0.65 [0.45, 0.95], 0.56 [0.30, 0.89], and 0.36 [0.17, 0.73]), yielding high probabilities of harm (98.5% and 99.4% and 99.8%, respectively).", "CONCLUSION: Among critically ill patients with COVID-19, lopinavir-ritonavir, hydroxychloroquine, or combination therapy worsened outcomes compared to no antiviral therapy.", "SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00134-021-06448-5."], "journal": "Intensive Care Med", "publish_time": "2021-07-12", "aliases": []}
{"doc_id": 220526145, "title": "Systematic and Statistical Review of Coronavirus Disease 19 Treatment Trials", "abstract": ["The following systematic review and meta-analysis compile the current data regarding human controlled COVID-19 treatment trials.", "An electronic search of the literature compiled studies pertaining to human controlled treatment trials with COVID-19.", "Medications assessed included lopinavir/ritonavir, arbidol, hydroxychloroquine, tocilizumab, favipiravir, heparin, and dexamethasone.", "Statistical analyses were performed for common viral clearance endpoints whenever possible.", "Lopinavir/ritonavir showed no significant effect on viral clearance for COVID-19 cases (OR 0.95 [95% CI 0.50-1.83]).", "Hydroxychloroquine also showed no significant effect on COVID-19 viral clearance rates (OR 2.16 [95% CI 0.80-5.84]).", "Arbidol showed no 7-day (OR 1.63 [95% CI 0.76-3.50]) or 14-day viral (OR 5.37 [95% CI 0.35-83.30]) clearance difference compared to lopinavir/ritonavir.", "Review of literature showed no significant clinical improvement with lopinavir/ritonavir, arbidol, hydroxychloroquine, or remdesivir.", "Tocilizumab showed mixed results regarding survival.", "Favipiravir showed quicker symptom improvement compared to lopinavir/ritonavir and arbidol.", "Heparin and dexamethasone showed improvement with severe COVID-19 cases requiring supplemental oxygenation.", "Current medications do not show significant effect on COVID-19 viral clearance rates.", "Tocilizumab showed mixed results regarding survival.", "Favipiravir shows favorable results compared to other tested medications.", "Heparin and dexamethasone show benefit especially for severe COVID-19 cases."], "journal": "SN Compr Clin Med", "publish_time": "2020", "aliases": [218685725]}
{"doc_id": 216642796, "title": "Lopinavir-ritonavir alone or combined with arbidol in the treatment of 73 hospitalized patients with COVID-19: a pilot retrospective study", "abstract": ["Objectives: This study aimed to evaluate the antiviral efficacy of lopinavir/ritonavir alone or combined with arbidol in the treatment of hospitalized patients with common coronavirus disease-19 (COVID-19).", "Methods: In this retrospective observational study, COVID-19 hospitalized patients were identified and divided into two groups based on the antiviral agents used during their hospitalization.", "Group-LR patients were treated with single antiviral drug of lopinavir-ritonavir.", "Group-LR+Ar patients were treated with lopinavir-ritonavir combined with arbidol for antiviral therapy at least 3 days.", "Patients were assessed for different clinical outcomes.", "Results: A total of 34 and 39 patients were identified for Group-LR and Group-LR+Ar, respectively.", "Treatment with lopinavir-ritonavir alone was not difference from lopinavir-ritonavir combined with arbidol in overall cure rate of COVID-19 hospitalized patients (92.3% and 97.1%, respectively).", "In a modified intention-to-treat analysis, lopinavir-ritonavir combined with abidol led to a median time of hospital stay that was shorter by 1.5 days than group-LR (12.5 days vs. 14 days).", "The percentages of COVID-19 RNA clearance was 92.3 in group-LR and 97.1 in group-LR+Ar.", "The mean time of virus turning negative was 11.5 plus-or-minus sign 9.0 days in group-LR+Ar that were longer than group-LR.", "Treatment of lopinavir-ritonavir combined with arbidol did not significantly accelerate main symptoms improvement and promote the image absorption of pulmonary inflammation.", "Conclusion: No benefit was observed in the anti-virus effect of lopinavir-ritonavir combined with arbidol compared with lopinavir-ritonavir alone in the hospitalized patients with COVID-19.", "More clinical observations in COVID-19 patients may help to confirm or exclude the effect of antiviral agents."], "journal": "", "publish_time": "2020-04-29", "aliases": []}
{"doc_id": 226206001, "title": "Efficacy of Lopinavir/Ritonavir Compared With Standard Care for Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review", "abstract": ["BACKGROUND: Coronavirus disease 2019 (COVID-19) is a newly discovered multi-organ disease caused by the novel coronavirus SARS-CoV-2.", "Currently, there are no official guidelines on the pharmacological treatment of COVID-19.", "Lopinavir/ritonavir is a licensed antiviral treatment against HIV and has shown activity against other coronaviruses.", "OBJECTIVE: In this study, we review the evidence of the use of lopinavir/ritonavir as a potential treatment candidate against COVID-19.", "METHOD: This systematic review has been registered in PROSPERO (CRD42020182067).", "A systematic search of the literature for the observational and randomized controlled trial was conducted in PubMed, PubMed Central, and Google Scholar through May 2nd, 2020.", "Two reviewers independently searched and selected.", "The risk of bias was evaluated using the Jadad scale, Newcastle-Ottawa Quality assessment tool, and National Institute of Health quality assessment tool.", "RESULTS: A total of 1,965 articles were screened from which 6 articles were selected.", "Of 6 articles that were included in this study, 4 reported no significant benefit in clinical improvement with lopinavir/ritonavir when compared to standard care of treatment, while 2 studies reported otherwise.", "Lopinavir/ritonavir was also not associated with a reduction of 28-day mortality rate as reported by 1 included study.", "Most included studies reported gastrointestinal symptoms as side effects from lopinavir/ritonavir therapy.", "CONCLUSION: There is not yet enough evidence to support the regular use of lopinavir/ritonavir in the treatment of COVID19.", "Further clinical trials are needed to evaluate lopinavir/ritonavir's efficacy in treatment."], "journal": "Infectious disorders. Drug targets (Online)", "publish_time": "2020", "aliases": []}
{"doc_id": 219318596, "title": "Viral kinetics and factors associated with rapid viral clearance during lopinavir/ritonavir-based combination therapy in non-severe COVID-19 patients", "abstract": ["OBJECTIVE: Lopinavir/ritonavir has modest antiviral activity against severe acute respiratory syndrome coronavirus 2.", "The aim was to investigate the viral kinetics and factors associated with viral clearance during lopinavir/ritonavir-based combination treatment in non-severe patients.", "PATIENTS AND METHODS: Sixty-four patients were retrospectively enrolled.", "Viral RNA was detected by real-time RT-PCR assay from sputum or throat swab samples at different time points.", "The patterns of viral kinetics were characterized, and factors associated with rapid viral clearance, which was defined as viral RNA undetectable within two weeks, were analyzed using multivariate logistic regression analyses.", "RESULTS: All patients achieved viral RNA negativity and were discharged from the hospital.", "Furthermore, 48 (75%) and 16 (25%) patients achieved rapid and delayed viral clearance, respectively.", "The lymphocyte counts of rapid viral clearance patients (1.40 [1.20-1.80] \u00d7 109/L) were higher, when compared to delayed viral clearance patients (1.00 [0.70-1.47] \u00d7 109/L) (p=0.024).", "The multivariate logistic analysis revealed that high lymphocyte count (&#8805;1.3\u00d7109/L) is an independent factor associated with rapid viral clearance (OR=7.62, 95% CI=1.15-50.34, p=0.035).", "CONCLUSIONS: The viral shedding exhibited different patterns during treatment.", "Immune insufficiency is responsible for the delayed viral clearance, suggesting that an immunomodulator should be considered to promote viral clearance in patients with low lymphocyte counts."], "journal": "Eur Rev Med Pharmacol Sci", "publish_time": "2020", "aliases": []}
{"doc_id": 214695931, "title": "The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients", "abstract": ["OBJECTIVE: This study aims to evaluate the correlation between viral clearance and blood biochemical index of 94 discharged patients with COVID-19 infection in Shenzhen Third People\u2019s Hospital, enrolled from Jan 5 to Feb 13, 2020.", "METHODS: The clinical and laboratory findings were extracted from the electronic medical records of the patients.", "The data were analysed and reviewed by a trained team of physicians.", "Information on clinical signs and symptoms, medical treatment, virus clearance, and laboratory parameters including interleukin 6 (IL-6) and C-reactive protein were collected.", "RESULTS: COVID-19 mRNA clearance ratio was identified significantly correlated with the decline of serum creatine kinase (CK) and lactate dehydrogenase (LDH) levels.", "Furthermore, COVID-19 mRNA clearance time was positively correlated with the length of hospital stay in patients treated with either IFN-\u03b1 + lopinavir/ritonavir or IFN-\u03b1 + lopinavir/ritonavir + ribavirin.", "CONCLUSIONS: Therapeutic regimens of IFN-\u03b1 + lopinavir/ritonavir and IFN-\u03b1 + lopinavir/ritonavir + ribavirin might be beneficial for treatment of COVID-19.", "Serum LDH or CK decline may predict a favorable response to treatment of COVID-19 infection."], "journal": "Inflamm Res", "publish_time": "2020-03-29", "aliases": []}
{"doc_id": 221523486, "title": "Lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review.", "abstract": ["OBJECTIVE Lopinavir/ritonavir has been used for the treatment of Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) coronavirus infections.", "It has been suggested that, based on this experience, this drug should also be studied in SARS-CoV2 infection.", "MATERIALS AND METHODS We performed a systematic review of the literature regarding the use of lopinavir/ritonavir for the treatment of these three infections.", "We systematically searched the PubMed database from inception to April 30th, 2020, to identify in-vitro and animal studies and any reports of human use of lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19.", "We also searched the Clinicatrial.gov to identify ongoing trials.", "RESULTS Five in-vitro studies evaluated the effect of lopinavir/ritonavir in SARS.", "Three additional in-vitro studies reported the EC50 of the antiviral activity of lopinavir/ritonavir in MERS.", "We identified no in vitro studies evaluating the effect of lopinavir/ritonavir on the novel coronavirus.", "Two retrospective matched-cohort studies reported the use of lopinavir/ritonavir in combination with ribavirin for SARS patients.", "Three case reports and one retrospective study described the use of lopinavir/ritonavir in MERS.", "Twenty-two papers describe the use of lopinavir/ritonavir in adult patients with COVID-19.", "CONCLUSIONS The existing literature does not suffice for assessing whether Lopinavir/ritonavir has any benefit in SARS, MERS or COVID-19."], "journal": "European review for medical and pharmacological sciences", "publish_time": "2020-08-01", "aliases": []}
{"doc_id": 239727655, "title": "Research progress on the clinical application of lopinavir/ritonavir for the treatment of coronavirus infection", "abstract": ["In the face of the sudden outbreak of novel coronavirus pneumonia (coronavirusdisease-19, COVID-19), the research and development of new antiviral drugs requires a certain amount of time and cost, and it is urgent to find safe and effective antiviral drugs that can be used clinically.", "Lopinavir/ritonavir (lopinavir/ritonavir, LPV/r) is a commonly used antiviral drug against adult or child human immunodeficiency virus (humanimmunodeficiency, HIV) infections.", "Past animal trials and clinical experience suggest It is expected to have a certain anti-viral efficacy against the new coronavirus in the fight against severe acute respiratory syndrome (Severe acute respiratory syndrome, SARS) and Middle East respiratory syndrome (Midle East respiratory syndrome, MERS).", "drug.", "Especially for patients with mild infections, the combination of drugs seems to be expected to exert a better effect, but it is necessary to pay attention to the issue of drug safety and use drugs with caution.", "This article aims to review the clinical research progress of LPV/r anti-coronavirus infection treatment for clinical reference."], "journal": "Chinese Journal of Viral Diseases", "publish_time": "2021", "aliases": []}
{"doc_id": 220078123, "title": "SARS-CoV-2 and HIV protease inhibitors: why lopinavir/ritonavir will not work for COVID-19 infection.", "abstract": ["Since the beginning of the outbreak of severe acute respiratory syndrome (SARS) coronavirus (CoV) 2 lopinavir/ritonavir was selected for treatment.", "The recent publication of Cao et al in the NEJM[1] showed that lopinavir/ritonavir treatment did not accelerate clinical improvement compared with standard of care.", "This raised the question if we in retrospect could have known this.", "The aim of this paper is to gather all the available evidence and to comprehensively discuss this issue."], "journal": "Antiviral therapy", "publish_time": "2020-06-26", "aliases": []}
{"doc_id": 235242556, "title": "Lopinavir/Ritonavir for COVID-19: a Systematic Review and Meta-Analysis", "abstract": ["PURPOSE: To provide the latest evidence on the efficacy and safety of lopinavir/ritonavir compared to other treatment options for COVID-19.", "METHODS: We searched PubMed, Cochran Library, Embase, Scopus, and Web of Science for the relevant records up to April 2021.", "Moreover, we scanned MedRxiv, Google Scholar, and clinical registry databases to identify additional records.", "We have used the Newcastle-Ottawa Scale and Cochrane risk of bias tools to assess the quality of studies.", "This Meta-analysis was conducted using RevMan software (version 5.3).", "RESULTS: Fourteen studies were included.", "No significant difference was observed between lopinavir/ritonavir and non-antiviral treatment groups in terms of negative rate of PCR (polymerase chain reaction) on day 7 (risk ratio [RR]: 0.83; 95% CI: 0.63 to 1.09; P=0.17), and day 14 (RR: 0.93; 95% CI: 0.81 to 1.05; P=0.25), PCR negative conversion time (mean difference [MD]: 1.09; 95% CI: -0.10 to 2.29; P=0.07), secondary outcomes, and adverse events (P>0.05).", "There was no significant difference between lopinavir/ritonavir and chloroquine as well as lopinavir/ritonavir and hydroxychloroquine regarding the efficacy outcomes (P>0.05).", "However, lopinavir/ritonavir showed better efficacy than arbidol for the same outcomes (P<0.05).", "Lopinavir/ritonavir plus arbidol was effective compared to arbidol alone in terms of the negative rate of PCR on day 7 (P=0.02).", "However, this difference was not significant regarding other efficacy outcomes (P>0.05).", "CONCLUSION: Lopinavir/ritonavir has no more treatment effects than other therapeutic agents used herein in COVID-19 patients."], "journal": "J Pharm Pharm Sci", "publish_time": "2021", "aliases": []}
{"doc_id": 235188816, "title": "An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-\u00df-1a and hydroxychloroquine in hospitalized patients with COVID-19", "abstract": ["OBJECTIVES: We evaluated the clinical, virological and safety outcomes of lopinavir/ritonavir, lopinavir/ritonavir-interferon (IFN)-\u00df-1a, hydroxychloroquine or remdesivir in comparison to standard of care (control) in coronavirus 2019 disease (COVID-19) inpatients requiring oxygen and/or ventilatory support.", "METHODS: We conducted a phase III multicentre, open-label, randomized 1:1:1:1:1, adaptive, controlled trial (DisCoVeRy), an add-on to the Solidarity trial (NCT04315948, EudraCT2020-000936-23).", "The primary outcome was the clinical status at day 15, measured by the WHO seven-point ordinal scale.", "Secondary outcomes included quantification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in respiratory specimens and pharmacokinetic and safety analyses.", "We report the results for the lopinavir/ritonavir-containing arms and for the hydroxychloroquine arm, trials of which were stopped prematurely.", "RESULTS: The intention-to-treat population included 583 participants-lopinavir/ritonavir (n = 145), lopinavir/ritonavir-IFN-\u00df-1a (n = 145), hydroxychloroquine (n = 145), control (n = 148)-among whom 418 (71.7%) were male, the median age was 63 years (IQR 54-71), and 211 (36.2%) had a severe disease.", "The day-15 clinical status was not improved with the investigational treatments: lopinavir/ritonavir versus control, adjusted odds ratio (aOR) 0.83, (95% confidence interval (CI) 0.55-1.26, p 0.39), lopinavir/ritonavir-IFN-\u00df-1a versus control, aOR 0.69 (95%CI 0.45-1.04, p 0.08), and hydroxychloroquine versus control, aOR 0.93 (95%CI 0.62-1.41, p 0.75).", "No significant effect of investigational treatment was observed on SARS-CoV-2 clearance.", "Trough plasma concentrations of lopinavir and ritonavir were higher than those expected, while those of hydroxychloroquine were those expected with the dosing regimen.", "The occurrence of serious adverse events was significantly higher in participants allocated to the lopinavir/ritonavir-containing arms.", "CONCLUSION: In adults hospitalized for COVID-19, lopinavir/ritonavir, lopinavir/ritonavir-IFN-\u00df-1a and hydroxychloroquine improved neither the clinical status at day 15 nor SARS-CoV-2 clearance in respiratory tract specimens."], "journal": "Clin. microbiol. infect", "publish_time": "2021", "aliases": []}
{"doc_id": 243943687, "title": "Herb-Drug Interaction Between Xiyanping Injection and Lopinavir/Ritonavir, Two Agents Used in COVID-19 Pharmacotherapy", "abstract": ["The global epidemic outbreak of the coronavirus disease 2019 (COVID-19), which exhibits high infectivity, resulted in thousands of deaths due to the lack of specific drugs.", "Certain traditional Chinese medicines (TCMs), such as Xiyanping injection (XYPI), have exhibited remarkable benefits against COVID-19.", "Although TCM combined with Western medicine is considered an effective approach for the treatment of COVID-19, the combination may result in potential herb-drug interactions in the clinical setting.", "The present study aims to verify the effect of XYPI on the oral pharmacokinetics of lopinavir (LPV)/ritonavir (RTV) using an in vivo rat model and in vitro incubation model of human liver microsomes.", "After being pretreated with an intravenous dose of XYPI (52.5 mg/kg) for one day and for seven consecutive days, the rats received an oral dose of LPV/RTV (42:10.5 mg/kg).", "Except for the t(1/2) of LPV is significantly prolonged from 4.66 to 7.18 h (p < 0.05) after seven consecutive days pretreatment, the pretreatment resulted in only a slight change in the other pharmacokinetic parameters of LPV.", "However, the pharmacokinetic parameters of RTV were significantly changed after pretreatment with XYPI, particularly in treatment for seven consecutive days, the AUC(0-\u221e) of RTV was significantly shifted from 0.69 to 2.72 h \u03bcg/mL (p < 0.05) and the CL exhibited a tendency to decrease from 2.71 L/h to 0.94 L/h (p < 0.05), and the t(1/2) of RTV prolonged from 3.70 to 5.51 h (p < 0.05), in comparison with the corresponding parameters in untreated rats.", "After administration of XYPI, the expression of Cyp3a1 protein was no significant changed in rats.", "The in vitro incubation study showed XYPI noncompetitively inhibited human CYP3A4 with an apparent Ki value of 0.54 mg/ml in a time-dependent manner.", "Our study demonstrated that XYPI affects the pharmacokinetics of LPV/RTV by inhibiting CYP3A4 activity.", "On the basis of this data, patients and clinicians can take precautions to avoid potential drug-interaction risks in COVID-19 treatment."], "journal": "Front Pharmacol", "publish_time": "2021-11-11", "aliases": []}
{"doc_id": 235348866, "title": "CD4+ T cell lymphopenia and dysfunction in severe COVID-19 disease is autocrine TNF-\u03b1/TNFRI-dependent", "abstract": ["Lymphopenia is common in severe COVID-19 disease, yet the mechanisms are poorly understood.", "In 148 patients with severe COVID-19, we found lymphopenia was associated with worse survival.", "CD4+ lymphopenia predominated, with lower CD4+/CD8+ ratios in severe COVID-19 compared to recovered, mild disease (p<0.0001).", "In severe disease, immunodominant CD4+ T cell responses to Spike-1(S1) produced increased in vitro TNF-\u03b1, but impaired proliferation and increased susceptibility to activation-induced cell death (AICD).", "CD4+TNF-\u03b1+ T cell responses inversely correlated with absolute CD4+ counts from severe COVID-19 patients (n=76; R=-0.744, P<0.0001).", "TNF-\u03b1 blockade including infliximab or anti-TNFRI antibodies strikingly rescued S1-specific CD4+ proliferation and abrogated S1-AICD in severe COVID-19 patients (P<0.001).", "Single-cell RNAseq demonstrated downregulation of Type-1 cytokines and NF\u03baB signaling in S1-stimulated CD4+ cells with infliximab treatment.", "Lung CD4+ T cells in severe COVID-19 were reduced and produced higher TNF-\u03b1 versus PBMC.", "Together, our findings show COVID-19-associated CD4+ lymphopenia and dysfunction is autocrine TNF-\u03b1/TNFRI-dependent and therapies targeting TNF-\u03b1 may be beneficial in severe COVID-19.", "One Sentence Summary Autocrine TNF-\u03b1/TNFRI regulates CD4+ T cell lymphopenia and dysfunction in severe COVID-19 disease."], "journal": "bioRxiv", "publish_time": "2021-06-03", "aliases": []}
{"doc_id": 229300284, "title": "Apoptosis-induced T-cell lymphopenia is related to COVID-19 severity", "abstract": ["Increased levels of acute-phase reactants and lymphopenia are predictors of disease severity in coronavirus disease 2019 (COVID-19).", "This study aimed to investigate the role of apoptosis in the etiology of lymphopenia in patients with COVID-19.", "This multicentered, prospective, and case-control study was conducted with polymerase chain reaction (+) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients, and an age-gender-matched control group.", "Samples were taken at the time of diagnosis and analyzed via flow cytometry within 24 h. The participants' demographic data and initial laboratory tests were also recorded.", "In total, 33 patients with COVID-19 (mean age = 45.4 \u00b1 17.2) and 25 controls (mean age = 43.4 \u00b1 17.4) participated in the study.", "All patients were identified as having mild (16), moderate (5), or severe (12) disease severity.", "Both early and late apoptotic cells in B and T lymphocytes were increased in all patients with COVID-19 (p < .05).", "Early apoptotic (EA) B and T lymphocytes were also higher in severe cases compared to mild cases (p = .026).", "There was no significant difference between lymphopenia and apoptosis in patients with COVID-19.", "However, patients with lymphopenia (n = 14) and severe COVID-19 (p = .013) had increased EA T lymphocytes.", "This study's results show that B and T lymphocytes' apoptosis increases in patients with COVID-19.", "In addition, enhanced T lymphocyte apoptosis is associated with disease severity in lymphopenic patients with COVID-19."], "journal": "J Med Virol", "publish_time": "2021", "aliases": []}
{"doc_id": 231789002, "title": "Lymphopenia as a Biological Predictor of Outcomes in COVID-19 Patients: A Nationwide Cohort Study", "abstract": ["We aimed to identify whether lymphopenia is a reliable prognostic marker for COVID-19 Using data derived from a korean nationwide longitudinal cohort of 5628 COVID-19 patients, we identified propensity-matched cohorts (n = 770) with group I of severe lymphopenia (absolute lymphocyte counts [ alc ]: & lt; 500/mm3, n = 110), group II of mild-to-moderate lymphopenia (alc: & ge; 500 & ndash; & lt; 1000/mm3, n = 330), and group iii, no lymphopenia (alc: & ge; 1000/mm3, n = 330) A significantly higher mortality rate was associated with lymphopenia severity: 40% in group I, 22 7% in group II, and 13 0% in group iii (p & lt; 0 001) At 28 days, the estimated inferior overall survival associated with intensified lymphopenia: 62 7% in group I, 79 9% in group II, and 89 0% in group iii (p & lt; 0 001) lymphopenia contributed significantly toward a greater need for interventions in all groups but at varying degrees: requirements of invasive ventilation, intensive oxygen supply, or adequate oxygen supply, respectively (p & lt; 0 001) The lymphopenia intensity was independently associated with higher COVID-19 mortality in multivariable analysis; adjusted odds ratios of 5 63 (95% CI, 3 0 & ndash; 10 72), and 2 47 (95% CI, 1 5 & ndash; 4 13) for group I and group II, respectively lymphopenia and its severity levels may serve as reliable predictive factors for COVID-19 clinical outcomes; thus, lymphopenia may provide the prognostic granularity required for clinical use in the management of patients with COVID-19."], "journal": "Cancers", "publish_time": "2021", "aliases": []}
{"doc_id": 221672881, "title": "Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis", "abstract": ["BACKGROUND: There is a compelling need to identify clinical and laboratory predictors of unfavorable clinical course and death in patients with coronavirus disease (COVID-19).", "A trend towards low lymphocyte count and high neutrophil counts in patients with poor outcomes has been reported by earlier studies.", "We aim to synthesize existing data evaluating the relationship between clinical outcomes and abnormal neutrophil and lymphocyte counts at admission in COVID-19 patients.", "METHODS: An electronic search was carried out in PubMed, China National Knowledge Infrastructure (CNKI) and Cochrane Central Register of Controlled Trials (CENTRAL) to identify eligible studies reporting frequency data on neutrophilia and lymphopenia at admission in hospitalization in COVID-19 patients.", "Pooled odds ratios of clinical outcomes for each parameter were calculated using Comprehensive Meta-Analysis.", "RESULTS: A total of 22 studies (4,969 patients) were included in this meta-analysis.", "Lymphopenia at admission was found to be significantly associated with increased odd of progression to severe disease (odds ratio [OR], 4.20; 95% confidence interval [95CI%], 3.46-5.09) and death (OR, 3.71; 95%CI, 1.63-8.44).", "Neutrophilia at admission was also found to be significantly associated with increased odd of progression to severe disease (OR, 7.99; 95%CI, 1.77-36.14) and death (OR, 7.87; 95%CI, 1.75-35.35).", "Subgroup analysis revealed that COVID-19 patients with severe lymphopenia (<0.5 x10\u00d7(9)/L) had 12-fold increased odds of in-hospital mortality.", "CONCLUSION: Admission lymphopenia and neutrophilia are associated with poor outcomes in patients with COVID-19.", "Regular monitoring and early and even more aggressive intervention shall hence be advisable in patients with low lymphocyte and high neutrophil counts.", "These variables may be useful in risk stratification models.", "(www.actabiomedica.it)"], "journal": "Acta Biomed", "publish_time": "2020-09-07", "aliases": []}
{"doc_id": 215417838, "title": "Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study", "abstract": ["Background: Coronavirus disease-2019 (COVID-19) is a rapidly escalating epidemic caused by SARS-CoV-2.", "Identification of a simple and effective indicator to assess disease severity and outcome is urgently needed.", "Methods: This study retrospectively analyzed dynamic changes of lymphocyte percentage (LYM%) in 15 death cases, 15 severe cases as well as 40 moderate cases of COVID-19 patients.", "Next, prognostic role of lymphopenia in COVID-19 were verified in 92 hospitalized cases.", "Results: Our results from death and severe cases showed that LYM% in blood test were inversely associated with the progression and severity of COVID-19.", "LYM% in patients with moderate COVID-19 remained higher than 20% 10-12 days after symptom onset.", "In contrast, LYM% was lower than 20% in severe cases.", "However, LYM% in severe cases was higher than 5% 17-19 days after the onset of the disease, while it fell below 5% in death cases.", "Therefore, we established a reliable Time from symptom onset-LYM% model (TLM), which could be used to evaluate disease severity and predict the outcomes of hospitalized patients with COVID-19.", "Conclusion: Lymphopenia can be used to indicate clinical course, treatment effect and outcomes of COVID-19 patients."], "journal": "", "publish_time": "2020-03-03", "aliases": []}
{"doc_id": 233742290, "title": "Lymphopenia and lung complications in patients with coronavirus disease-2019 (COVID-19): A retrospective study based on clinical data", "abstract": ["A rapid outbreak of novel coronavirus, coronavirus disease-2019 (COVID-19), has made it a global pandemic.", "This study focused on the possible association between lymphopenia and computed tomography (CT) scan features and COVID-19 patient mortality.", "The clinical data of 596 COVID-19 patients were collected from February 2020 to September 2020.", "The patients' serological survey and CT scan features were retrospectively explored.", "The median age of the patients was 56.7 \u00b1 16.4 years old.", "Lung involvement was more than 50% in 214 COVID-19 patients (35.9%).", "The average blood lymphocyte percentage was 20.35 \u00b1 10.16 (normal range, 20%-50%).", "Although the levels of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were high in more than 80% of COVID-19 patients; CRP, ESR, and platelet-to-lymphocyte ratio (PLR) may not indicate the in-hospital mortality of COVID-19.", "Patients with severe lung involvement and lymphopenia were found to be significantly associated with increased odds of death (odds ratio, 9.24; 95% confidence interval, 4.32-19.78).", "These results indicated that lymphopenia < 20% along with pulmonary involvement >50% impose a multiplicative effect on the risk of mortality.", "The in-hospital mortality rate of this group was significantly higher than other COVID-19 hospitalized cases.", "Furthermore, they meaningfully experienced a prolonged stay in the hospital (p = .00).", "Lymphocyte count less than 20% and chest CT scan findings with more than 50% involvement might be related to the patient's mortality.", "These could act as laboratory and clinical indicators of disease severity, mortality, and outcome."], "journal": "J Med Virol", "publish_time": "2021", "aliases": []}
{"doc_id": 244148228, "title": "Lymphopenia is Associated with Severe Coronavirus Disease 2019 (COVID-19) Infections", "abstract": ["Background: Covid-19 is a very contagious and quickly spreading viral infection, caused by a corona virus SARS-COV-2 which was originally reported in China on December 5, 2019.", "It was confirmed as pandemic by WHO on March 11, 2020.", "This disease is yet under research.", "It has variable severity which includes no symptoms to pneumonia.", "This can cause death of the patient.", "Aim: To evaluate the association of Lymphopenia with severity of COVID 19 in COVID-19 patients Methods: It was a retrospective observational study conducted in COVID wards of Ghurki hospital Lahore.", "Record of 100 COVID-19 patients that were admitted between March and July 2021 fulfilling the inclusion criteria was included in the study.", "A pre-structured pro forma was filled to collect the data.", "Results: Out of 100 patients, 30 patients were included in Non-severe group while severe group had 70 patients.", "The mean age of study population was 52.5\u00b110.38 with 60% male and 40% female.", "70% patients in severe group had some co-existent comorbidity.", "The most commonly reported symptoms were fever and cough in both groups while shortness of breath was more commonly reported in severe group.", "Conclusion: Lymphopenia is associated with severe Coronavirus disease 2019 (COVID-19) infections.", "Lymphocytes count can be used to assess the severity of COVID 19."], "journal": "Pakistan Journal of Medical and Health Sciences", "publish_time": "2021", "aliases": []}
{"doc_id": 237436652, "title": "Lymphopenia in Covid-19: A single center retrospective study of 589 cases", "abstract": ["BACKGROUND: Lymphopenia is one of features that helps identify patients with severe Covid-19.", "This retrospectively study analyzed the association of lymphopenia with the severity of COVID-19 infection, determinate the predictive factors of lymphopenia and the significance of mortality in patient with lymphopenia.", "METHODS: This retrospective study included patients diagnosed with Covid-19 and admitted to intensive care unit of our university hospital center From Mars 1st 2020, to December 31st(,) 2020.", "RESULTS: In this study, 589 patients were included, a group had lymphopenia with 357 cases (60.06%) and the non-lymphopenia group with 232 cases (39.4%).", "The median age of our patients having lymphopenia was 65 years (56\u201376).", "Hypertension and diabetes were noted in the majority of patients with lymphopenia than in the non-lymphopenia group.", "Lymphopenia was strongly correlated to the inflammatory biomarkers of COVID-19 and were significant.", "A significant correlation was found between lymphopenia group and CT scan.", "Lymphopenia was observed as an indicator of prolonged duration of hospitalization but was not significant.", "CONCLUSION: Analytical data from this retrospective study shows the importance in the association between lymphopenia and the severity of COVID-19 infection, hence the need for dynamic monitoring of the number of lymphocytes on admission and during hospitalization of these patients."], "journal": "Ann Med Surg (Lond)", "publish_time": "2021-09-08", "aliases": []}
{"doc_id": 235188212, "title": "High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections", "abstract": ["Severe COVID-19 disease is associated with an increase in pro-inflammatory markers, such as IL-1, IL-6, and tumor necrosis alpha, less cd4 interferon-gamma expression, and fewer cd4 and cd8 cells, which increase the susceptibility to bacterial and fungal infections.", "One such opportunistic fungal infection is mucormycosis.", "Initially, it was debated whether a person taking immunosuppressants, such as corticosteroids, and monoclonal antibodies will be at higher risk for COVID-19 or whether the immunosuppresive state would cause a more severe COVID-19 disease.", "However, immunosuppressants are currently continued unless the patients are at greater risk of severe COVID-19 infection or are on high-dose corticosteroids therapy.", "As understood so far, COVID-19 infection may induce significant and persistent lymphopenia, which in turn increases the risk of opportunistic infections.", "It is also noted that 85% of the COVID-19 patients' laboratory findings showed lymphopenia.", "This means that patients with severe COVID-19 have markedly lower absolute number of T lymphocytes, CD4+T and CD8+ T cells and, since the lymphocytes play a major role in maintaining the immune homeostasis, the patients with COVID-19 are highly susceptible to fungal co-infections.", "This report is intended to raise awareness of the importance of early detection and treatment of mucormycosis and other fungal diseases, such as candidiasis, SARS-CoV-2-associated pulmonary aspergillosis, pneumocystis pneumonia and cryptococcal disease, in COVID-19 patients, to reduce the risk of mortality."], "journal": "Discoveries", "publish_time": "2021", "aliases": []}
{"doc_id": 233981897, "title": "Abnormal Thyroid Function Is Associated With Lymphopenia in Bacterial Sepsis and COVID-19", "abstract": ["Background: Lymphopenia is a key feature of immune dysfunction in bacterial sepsis and COVID-19 patients and is associated with poor clinical outcomes, but the cause is largely unknown.", "These severely ill patients may also present with thyroid function abnormalities, so-called non-thyroidal illness syndrome (NTIS), and several studies have suggested that TSH, thyroxin (T4) and triiodothyronine (T3) play a crucial role in the homeostatic regulation and function of lymphocyte populations.", "Aim: The purpose of this study was to test the hypothesis that abnormal thyroid function correlates with lymphopenia in severly ill patients with bacterial sepsis or COVID-19.", "Methods: Retrospective analysis of absolute lymphocyte counts and circulating TSH, T4, FT4, T3, albumin and inflammatory biomarkers was performed in two independent cohorts of bacterial sepsis (n=224) and hospitalized COVID-19 patients (n=35).", "Results: Only T3 correlated (rho=0.252, p-value: <0.001) with lymphocyte counts in the bacterial sepsis population and lower concentrations were found in severe lymphopenic compared to non-lympopenic patients (p-value: <0.001; n=56 per group).", "Severe lymphopenic COVID-19 patients (n=17) showed significantly lower plasma concentrations of TSH, T4, FT4 and T3 (p-value: 0.026, <0.001, 0.001, <0.001, respectively) compared to patients withouth lymphopenia (n=18), and demonstrated significantly increased values of the inflammatory parameters IL-6, C-reactive protein and ferritin (p-value: <0.001, 0.023, and 0.008, respectively).", "Remarkable, after one week follow-up, the majority of (12/15) COVID-19 patients showed quantitative recovery of their lymphocyte numbers, while TSH and thyroid hormones remained mainly disturbed.", "Conclusions: Abnormal thyroid function correlates with low lymphocyte counts in severe sepsis and COVID-19 patients, but future studies need to establish whether a causal relationship is involved."], "journal": "J Endocr Soc", "publish_time": "2021-05-03", "aliases": []}
{"doc_id": 237278234, "title": "Lymphopenia and IgG2 subclass deficiency in patients with severe COVID-19 pneumonia", "abstract": ["BACKGROUND: COVID-19 caused by the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) manifests with a range of disease severities.", "A small proportion of COVID-19 patients are severely ill; however, a significant proportion of these patients are critically ill, and require admission and mechanical ventilation, which is associated with a high mortality.", "OBJECTIVE: To identify factors that may predispose patients with COVID-19 to severe disease that requires mechanical ventilation (MV).", "METHODS: We performed a retrospective audit of patients admitted with COVID-19 pneumonia to the intensive care unit (ICU) and medical wards to evaluate the potential associations between comorbid conditions, lymphopenia and IgG subclass deficiency with a need for MV.", "RESULTS: A total of 51 patients were included in the study.", "Almost half of the patients (47%; n=24) were documented to have IgG2 deficiency, 43% (n=22) had lymphopenia and 37% (n=19) had combined lymphopenia and IgG2 subclass deficiency.", "Of the 24 patients who required MV, 75% had IgG2 subclass deficiency, 73% had lymphopenia and 50% had both.", "The relative risk for requiring MV was 2.64, 3.38 and 2.81 for lymphopenia, IgG2 subclass deficiency and both, respectively.", "CONCLUSION: These findings suggest that lymphopenia, low IgG2 concentrations or the combination of both may be used to identify patients with severe COVID-19 that are at increased risk for MV.", "This may facilitate earlier identification of patients at high risk, who may benefit from more intensive therapy."], "journal": "Afr J Thorac Crit Care Med", "publish_time": "2021-03-30", "aliases": []}
{"doc_id": 244932939, "title": "Haematological profile of COVID-19 patients from a centre in Singapore", "abstract": ["BACKGROUND: Haematological markers such as absolute lymphopenia have been associated with severe COVID-19 infection.", "However, in the literature to date, the cohorts described have typically included patients who were moderate to severely unwell with pneumonia and who required intensive care stay.", "It is uncertain if these markers apply to a population with less severe illness.", "We sought to describe the haematological profile of patients with mild disease with COVID-19 admitted to a single centre in Singapore.", "METHODS: We examined 554 consecutive PCR positive SARS-COV-2 patients admitted to a single tertiary healthcare institution from Feb 2020 to April 2020.", "In all patients a full blood count was obtained within 24\u00e2\u0080 h of presentation.", "RESULTS: Patients with pneumonia had higher neutrophil percentages (66.5 \u00b1 11.6 vs 55.2 \u00b1 12.6%, p < 0.001), lower absolute lymphocyte count (1.5 \u00b1 1.1 vs 1.9 \u00b1 2.1 x109/L, p < 0.011) and absolute eosinophil count (0.2 \u00b1 0.9 vs 0.7 \u00b1 1.8 \u00d7 109/L, p = 0.002).", "Platelet counts (210 \u00b1 56 vs 230 \u00b1 61, p = 0.020) were slightly lower in the group with pneumonia.", "We did not demonstrate significant differences in the neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio and platelet-lymphocyte ratio in patients with or without pneumonia.", "Sixty-eight patients (12.3%) had peripheral eosinophilia.", "This was more common in migrant workers living in dormitories.", "CONCLUSION: Neutrophilia and lymphopenia were found to be markers associated with severe COVID-19 illness.", "We did not find that combined haematological parameters: neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio and platelet-lymphocyte ratio, had any association with disease severity in our cohort of patients with mild-moderate disease.", "Migrant workers living in dormitories had eosinophilia which may reflect concurrent chronic parasitic infection."], "journal": "Hematology", "publish_time": "2021", "aliases": []}
{"doc_id": 225376927, "title": "Lymphopenia-induced T cell proliferation is a hallmark of severe COVID-19", "abstract": ["Coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has a broad clinical presentation ranging from asymptomatic infection to fatal disease.", "Different features associated with the immune response to SARS-CoV-2, such as hyperinflammation and reduction of peripheral CD8+ T cell counts are strongly associated with severe disease.", "Here, we confirm the reduction in peripheral CD8+ T cells both in relative and absolute terms and identify T cell apoptosis and migration into inflamed tissues as possible mechanisms driving peripheral T cell lymphopenia.", "Furthermore, we find evidence of elevated serum interleukin-7, thus indicating systemic T cell paucity and signs of increased T cell proliferation in patients with severe lymphopenia.", "Following T cell lymphopenia in our pseudo-longitudinal time course, we observed expansion and recovery of poly-specific antiviral T cells, thus arguing for lymphopenia-induced T cell proliferation.", "In summary, this study suggests that extensive T cell loss and subsequent T cell proliferation are characteristic of severe COVID-19."], "journal": "bioRxiv", "publish_time": "2020-08-04", "aliases": []}
{"doc_id": 235233760, "title": "Association of Clinical and Immunological Characteristics With Disease Severity and Outcomes in 211 Patients With COVID-19 in Wuhan, China", "abstract": ["BACKGROUND: Coronavirus disease 2019 (COVID-19) has posed a great threat to global public health.", "There remains an urgent need to address the clinical significance of laboratory finding changes in predicting disease progression in COVID-19 patients.", "We aimed to analyze the clinical and immunological features of severe and critically severe patients with COVID-19 in comparison with non-severe patients and identify risk factors for disease severity and clinical outcome in COVID-19 patients.", "METHODS: The consecutive records of 211 patients with COVID-19 who were admitted to Zhongnan Hospital of Wuhan University from December 2019 to February 2020 were retrospectively reviewed.", "RESULTS: Of the 211 patients with COVID-19 recruited, 111 patients were classified as non-severe, 59 as severe, and 41 as critically severe cases.", "The median age was obviously higher in severe and critically severe cases than in non-severe cases.", "Severe and critically severe patients showed more underlying comorbidities than non-severe patients.", "Fever was the predominant presenting symptom in COVID-19 patients, and the duration of fever was longer in critically severe patients.", "Moreover, patients with increased levels of serum aminotransferases and creatinine (CREA) were at a higher risk for severe and critical COVID-19 presentations.", "The serum levels of IL-6 in severe and critically severe patients were remarkably higher than in non-severe patients.", "Lymphopenia was more pronounced in severe and critically severe patients compared with non-severe patients.", "Lymphocyte subset analysis indicated that severe and critically severe patients had significantly decreased count of lymphocyte subpopulations, such as CD4+ T cells, CD8+ T cells and B cells.", "A multivariate logistic analysis indicated that older age, male sex, the length of hospital stay, body temperature before admission, comorbidities, higher white blood cell (WBC) counts, lower lymphocyte counts, and increased levels of IL-6 were significantly associated with predicting the progression to severe stage of COVID-19.", "CONCLUSION: Older age, male sex, underlying illness, sustained fever status, abnormal liver and renal functions, excessive expression of IL-6, lymphopenia, and selective loss of peripheral lymphocyte subsets were related to disease deterioration and clinical outcome in COVID-19 patients.", "This study would provide clinicians with valuable information for risk evaluation and effective interventions for COVID-19."], "journal": "Front Cell Infect Microbiol", "publish_time": "2021-05-28", "aliases": []}
{"doc_id": 227056280, "title": "Lymphopenia predicted illness severity and recovery in patients with COVID-19: A single-center, retrospective study", "abstract": ["The outbreak of SARS-CoV-2 began in December 2019 and rapidly became a pandemic.", "The present study investigated the significance of lymphopenia on disease severity.", "A total of 115 patients with confirmed COVID-19 from a tertiary hospital in Changsha, China, were enrolled.", "Clinical, laboratory, treatment and outcome data were gathered and compared between patients with and without lymphopenia.", "The median age was 42 years (1-75).", "Fifty-four patients (47.0%) of the 115 patients had lymphopenia on admission.", "More patients in the lymphopenia group had hypertension (30.8% vs. 10.0%, P = 0.006) and coronary heart disease (3.6% vs. 0%, P = 0.029) than in the nonlymphopenia group, and more patients with leukopenia (48.1% vs 14.8%, P<0.001) and eosinopenia (92.6% vs 54.1%, P<0.001) were observed.", "Lymphopenia was also correlated with severity grades of pneumonia (P<0.001) and C-reactive protein (CRP) level (P = 0.0014).", "Lymphopenia was associated with a prolonged duration of hospitalization (17.0 days vs. 14.0 days, P = 0.002).", "Lymphocyte recovery appeared the earliest, prior to CRP and chest radiographs, in severe cases, which suggests its predictive value for disease improvement.", "Our results demonstrated the clinical significance of lymphopenia for predicting the severity of and recovery from COVID-19, which emphasizes the need to dynamically monitor lymphocyte count."], "journal": "PLoS One", "publish_time": "2020", "aliases": []}
{"doc_id": 233351290, "title": "Profound dysregulation of T cell homeostasis and function in patients with severe COVID\u201019", "abstract": ["BACKGROUND: Coronavirus disease 2019 (COVID\u201019) is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102) and shows a broad clinical presentation ranging from asymptomatic infection to fatal disease.", "A very prominent feature associated with severe COVID\u201019 is T cell lymphopenia.", "However, homeostatic and functional properties of T cells are ill\u2010defined in COVID\u201019.", "METHODS: We prospectively enrolled individuals with mild and severe COVID\u201019 into our multicenter cohort and performed a cross\u2010sectional analysis of phenotypic and functional characteristics of T cells using 40\u2010parameter mass cytometry, flow cytometry, targeted proteomics, and functional assays.", "RESULTS: Compared with mild disease, we observed strong perturbations of peripheral T cell homeostasis and function in severe COVID\u201019.", "Individuals with severe COVID\u201019 showed T cell lymphopenia and redistribution of T cell populations, including loss of na\u00efve T cells, skewing toward CD4(+)T follicular helper cells and cytotoxic CD4(+) T cells, and expansion of activated and exhausted T cells.", "Extensive T cell apoptosis was particularly evident with severe disease and T cell lymphopenia, which in turn was accompanied by impaired T cell responses to several common viral antigens.", "Patients with severe disease showed elevated interleukin\u20107 and increased T cell proliferation.", "Furthermore, patients sampled at late time points after symptom onset had higher T cell counts and improved antiviral T cell responses.", "CONCLUSION: Our study suggests that severe COVID\u201019 is characterized by extensive T cell dysfunction and T cell apoptosis, which is associated with signs of homeostatic T cell proliferation and T cell recovery."], "journal": "Allergy", "publish_time": "2021-06-30", "aliases": []}
{"doc_id": 234746390, "title": "Radiologically Undetectable Latent Pulmonary Lymphocyte Infiltration Suggesting the Need for Early Glucocorticoid Therapy: An Autopsy Case of Rapidly Progressive COVID-19 Pneumonia with Lymphopenia", "abstract": ["We herein report a fatal case of coronavirus disease 2019 (COVID-19) pneumonia with rapid progression of respiratory failure and lymphopenia.", "Excessive recruitment and sequestration of lymphocytes in the lung were suggested as the pathophysiology underlying COVID-19-associated lymphopenia.", "Interestingly, the autopsy in this case revealed lymphocytic infiltration in the lungs even at sites that appeared normal on autopsy imaging.", "These findings suggest that in COVID-19 cases with risk factors of severe exacerbation, early glucocorticoid administration should be considered, especially if lymphopenia is present, even if the imaging findings show only mild abnormalities."], "journal": "Intern Med", "publish_time": "2021", "aliases": []}
{"doc_id": 233278221, "title": "Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome", "abstract": ["BACKGROUND: Coronavirus disease 2019 (COVID-19) is a serious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in severe cases associated with acute respiratory distress syndrome (ARDS).", "OBJECTIVE: To describe the clinical characteristics of patients with ARDS-COVID-19.", "MATERIALS AND METHODS: This study involved 197 male Egyptian participants, among them111 COVID-19 patients presented with ARDS, 60 COVID-19 patients presented with non-ARDS, and 26 Non-COVID-19 patients.", "We reported the analysis results of clinical and laboratory information, including blood routine tests, blood biochemistry parameters [aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatinine and C-reactive protein (CRP)], thrombotic activity (D-dimer) and serum ferritin and lactate dehydrogenase (LDH).", "RESULTS: The levels of hemoglobin, AST, creatinine, monocyte count, monocyte %, RBC count, TLC, and platelet count were not significantly different among the groups.", "The lymphopenia and increased CRP, ALT, D-dimer, ferritin, and LDH were observed in patients with ARDS-COVID-19.", "CONCLUSION: COVID-19 patients with ARDS presented with lymphopenia, increased thrombotic activity, increased CRP, LDH, and ferritin levels.", "The results revealed that CRP, D-dimer, LDH levels, and lymphopenia have a significant association with the COVID-19 severity and can be used as biomarkers to predict the disease severity."], "journal": "PLoS One", "publish_time": "2021", "aliases": []}
{"doc_id": 220123346, "title": "Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19).", "abstract": ["Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory disease, which can evolve into multi-organ failure (MOF), leading to death.", "Several biochemical alterations have been described in COVID-19 patients.", "To date, many biomarkers reflecting the main pathophysiological characteristics of the disease have been identified and associated with the risk of developing severe disease.", "Lymphopenia represents the hallmark of the disease, and it can be detected since the early stage of infection.", "Increased levels of several inflammatory biomarkers, including c-reactive protein, have been found in COVID-19 patients and associated with an increased risk of severe disease, which is characterised by the so-called \"cytokine storm\".", "Also, the increase of cardiac and liver dysfunction biomarkers has been associated with poor outcome.", "In this review, we provide an overview of the main biochemical characteristics of COVID-19 and the associated biomarkers alterations."], "journal": "Diagnosis", "publish_time": "2020-06-24", "aliases": []}
{"doc_id": 222119163, "title": "A Mechanism for Severity of Disease in Older Patients with COVID-19: The Nexus between Telomere Length and Lymphopenia", "abstract": ["Background: Lymphopenia due to a plummeting T-cell count is a major feature of severe COVID-19.", "T-cell proliferation is telomere length (TL)-dependent and TL shortens with age.", "Older persons are disproportionally affected by severe COVID-19, and we hypothesized that those with short TL have less capacity to mount an adequate T-cell proliferative response to SARS-CoV-2.", "This hypothesis predicts that among older patients with COVID-19, shorter telomeres of peripheral blood mononuclear cells (PBMCs) will be associated with a lower lymphocyte count.", "Methods: Our sample comprised 17 COVID-19 and 21 non-COVID-19 patients, aged 87(8) (mean(SD)) and 87 (9) years, respectively.", "We measured TL by the Telomere Shortest Length Assay, a novel method that measures and tallies the short telomeres directly relevant to telomere-mediated biological processes.", "The primary analysis quantified TL as the proportion of telomeres shorter than 2 kilobases.", "For comparison, we also quantified TL by Southern blotting, which measures the mean length of telomeres.", "Results: Lymphocyte count (109/L) was 0.91 (0.42) in COVID-19 patients and 1.50(0.50) in non-COVID-19 patients (P < 0.001).", "In COVID-19 patients, but not in non-COVID-19 patients, lymphocyte count was inversely correlated with the proportion of telomeres shorter than 2 kilobases (P = 0.005) and positively correlated with the mean of telomeres measured by TeSLA (P = 0.03).", "Lymphocyte counts showed no statistically significant correlations with Southern blotting results in COVID-19 or non-COVID-19 patients.", "Conclusions: These results support the hypothesis that a compromised TL-dependent T-cell proliferative response contributes to lymphopenia and the resulting disproportionate severity of COVID-19 among old adults.", "We infer that infection with SARS-CoV-2 uncovers the limits of the TL reserves of older persons."], "journal": "medRxiv : the preprint server for health sciences", "publish_time": "2020-10-04", "aliases": []}
{"doc_id": 221979837, "title": "High-Quality Masks Reduce COVID-19 Infections and Deaths in the US", "abstract": ["OBJECTIVES: To evaluate the effectiveness of widespread adoption of masks or face coverings to reduce community transmission of the SARS-CoV-2 virus that causes COVID-19.", "METHODS: We created an agent-based stochastic network simulation using a variant of the standard SEIR dynamic infectious disease model.", "We considered a mask order that was initiated 3.5 months after the first confirmed COVID-19 case.", "We varied the likelihood of individuals wearing masks from 0\u2013100% in steps of 20% (mask adherence) and considered 25% to 90% mask-related reduction in viral transmission (mask efficacy).", "Sensitivity analyses assessed early (by week 13) versus late (by week 42) adoption of masks and geographic differences in adherence (highest in urban and lowest in rural areas).", "RESULTS: Introduction of mask use with 50% efficacy worn by 50% of individuals reduces the cumulative infection attack rate (IAR) by 27%, the peak prevalence by 49%, and population-wide mortality by 29%.", "If 90% of individuals wear 50% efficacious masks, this decreases IAR by 54%, peak prevalence by 75%, and population-wide mortality by 55%; similar improvements hold if 70% of individuals wear 75% efficacious masks.", "Late adoption reduces IAR and deaths by 18% or more compared to no adoption.", "Lower adoption in rural areas than urban would lead to rural areas having the highest IAR.", "CONCLUSIONS: Even after community transmission of SARS-CoV-2 has been established, adoption of mask-wearing by a majority of community-dwelling individuals can meaningfully reduce the number and outcome of COVID-19 infections over and above physical distancing interventions."], "journal": "medRxiv", "publish_time": "2021-01-28", "aliases": []}
{"doc_id": 233875372, "title": "Reply to Zhang et al.: Slowing the rate of spread of COVID-19", "abstract": ["Zhang et al.", "(2020) reported that mandating face coverings in public is necessary to decrease the rate of new COVID-19 infections.", "We present a counterexample that disproves this finding.", "We agree with Zhang et al.", "that masks can be an important element in reducing virus transmission and that widespread use may be essential for returning to full activity.", "However, their analysis neglects the potential importance of physical distancing for limiting COVID-19 transmission by misattributing its effect to mask requirements.", "A full suite of epidemiological tools is necessary in these challenging times."], "journal": "", "publish_time": "2020-07-01", "aliases": []}
{"doc_id": 216055370, "title": "Impact of population mask wearing on Covid-19 post lockdown", "abstract": ["COVID-19, caused by SARS-CoV2 is a rapidly spreading global pandemic.", "Although precise transmission routes and dynamics are unknown, SARS-CoV2 is thought primarily to spread via contagious respiratory droplets.", "Unlike with SARS-CoV, maximal viral shedding occurs in the early phase of illness, and this is supported by models that suggest 40-80% of transmission events occur from pre- and asymptomatic individuals.", "One widely-discussed strategy to limit transmission of SARS-CoV2, particularly from presymptomatic individuals, has been population-level wearing of masks.", "Modelling for pandemic influenza suggests some benefit in reducing total numbers infected with even 50% mask-use.", "COVID-19 has a higher hospitalization and mortality rate than influenza, and the impacts on these parameters, and critically, at what point in the pandemic trajectory mask-use might exert maximal benefit are completely unknown.", "We derived a simplified SIR model to investigate the effects of near-universal mask-use on COVID-19 assuming 8 or 16% mask efficacy.", "We decided to model, in particular, the impact of masks on numbers of critically-ill patients and cumulative mortality, since these are parameters that are likely to have the most severe consequences in the COVID-19 pandemic.", "Whereas mask use had a relatively minor benefit on critical-care and mortality rates when transmissibility (Reff) was high, the reduction on deaths was dramatic as the effective R approached 1, as might be expected after aggressive social-distancing measures such as wide-spread lockdowns.", "One major concern with COVID-19 is its potential to overwhelm healthcare infrastructures, even in resource-rich settings, with one third of hospitalized patients requiring critical-care.", "We incorporated this into our model, increasing death rates for when critical-care resources have been exhausted.", "Our simple model shows that modest efficacy of masks could avert substantial mortality in this scenario.", "Importantly, the effects on mortality became hyper-sensitive to mask-wearing as the effective R approaches 1, i.e.", "near the tipping point of when the infection trajectory is expected to revert to exponential growth, as would be expected after effective lockdown.", "Our model suggests that mask-wearing might exert maximal benefit as nations plan their post-lockdown strategies and suggests that mask-wearing should be included in further more sophisticated models of the current pandemic."], "journal": "", "publish_time": "2020-04-16", "aliases": []}
{"doc_id": 232209777, "title": "Association of state-issued mask mandates and allowing on-premises restaurant dining with county-level COVID-19 case and death growth rates - United States, March 1-December 31, 2020", "abstract": ["What is already known about this topic?", "Universal masking and avoiding nonessential indoor spaces are recommended to mitigate the spread of COVID-19.", "What is added by this report?", "Mandating masks was associated with a decrease in daily COVID-19 case and death growth rates within 20 days of implementation.", "Allowing on-premises restaurant dining was associated with an increase in daily COVID-19 case growth rates 41-100 days after implementation and an increase in daily death growth rates 61-100 days after implementation.", "What are the implications for public health practice?", "Mask mandates and restricting any on-premises dining at restaurants can help limit community transmission of COVID-19 and reduce case and death growth rates.", "These findings can inform public policies to reduce community spread of COVID-19."], "journal": "Morbidity and Mortality Weekly Report", "publish_time": "2021", "aliases": []}
{"doc_id": 237271297, "title": "Rationale for Mass Masking in Controlling the COVID-19 Pandemic", "abstract": ["The rapid spread of the coronavirus disease 2019 (COVID-19) into a global pandemic caught the world unprepared.", "Previously effective measures for containing disease outbreaks were overwhelmed, necessitating strict controls such as lockdowns or curfews.", "Among the disease control interventions, community mass masking was one of the highly controversial issues with differing opinions on its indications or effectiveness from different health authorities around the world.", "Regions where community mass masking was timely introduced were associated with lower transmission rates, and more effective disease control.", "In this article, we discuss the evidence on the effectiveness, and rationale for community mass masking to prevent the COVID-19 transmission.", "Areas for further research to define the role of mass masking in light of the COVID-19 pandemic will be suggested.", "This would help policy makers in formulating mass masking policies."], "journal": "Front Public Health", "publish_time": "2021-08-24", "aliases": []}
{"doc_id": 231901169, "title": "Decline in COVID-19 Hospitalization Growth Rates Associated with Statewide Mask Mandates - 10 States, March-October 2020", "abstract": ["SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is transmitted predominantly by respiratory droplets generated when infected persons cough, sneeze, spit, sing, talk, or breathe.", "CDC recommends community use of face masks to prevent transmission of SARS-CoV-2 (1).", "As of October 22, 2020, statewide mask mandates were in effect in 33 states and the District of Columbia (2).", "This study examined whether implementation of statewide mask mandates was associated with COVID-19-associated hospitalization growth rates among different age groups in 10 sites participating in the COVID-19-Associated Hospitalization Surveillance Network (COVID-NET) in states that issued statewide mask mandates during March 1-October 17, 2020.", "Regression analysis demonstrated that weekly hospitalization growth rates declined by 2.9 percentage points (95% confidence interval [CI] = 0.3-5.5) among adults aged 40-64 years during the first 2 weeks after implementing statewide mask mandates.", "After mask mandates had been implemented for &#8805;3 weeks, hospitalization growth rates declined by 5.5 percentage points among persons aged 18-39 years (95% CI = 0.6-10.4) and those aged 40-64 years (95% CI = 0.8-10.2).", "Statewide mask mandates might be associated with reductions in SARS-CoV-2 transmission and might contribute to reductions in COVID-19 hospitalization growth rates, compared with growth rates during <4 weeks before implementation of the mandate and the implementation week.", "Mask-wearing is a component of a multipronged strategy to decrease exposure to and transmission of SARS-CoV-2 and reduce strain on the health care system, with likely direct effects on COVID-19 morbidity and associated mortality."], "journal": "MMWR Morb Mortal Wkly Rep", "publish_time": "2021", "aliases": []}
{"doc_id": 236415106, "title": "Mask-Ematics: Modeling the Effects of Masks in COVID-19 Transmission in High-Risk Environments", "abstract": ["The COVID-19 pandemic has placed an unprecedented burden on public health and strained the worldwide economy.", "The rapid spread of COVID-19 has been predominantly driven by aerosol transmission, and scientific research supports the use of face masks to reduce transmission.", "However, a systematic and quantitative understanding of how face masks reduce disease transmission is still lacking.", "We used epidemic data from the Diamond Princess cruise ship to calibrate a transmission model in a high-risk setting and derive the reproductive number for the model.", "We explain how the terms in the reproductive number reflect the contributions of the different infectious states to the spread of the infection.", "We used that model to compare the infection spread within a homogeneously mixed population for different types of masks, the timing of mask policy, and compliance of wearing masks.", "Our results suggest substantial reductions in epidemic size and mortality rate provided by at least 75% of people wearing masks (robust for different mask types).", "We also evaluated the timing of the mask implementation.", "We illustrate how ample compliance with moderate-quality masks at the start of an epidemic attained similar mortality reductions to less compliance and the use of high-quality masks after the epidemic took off.", "We observed that a critical mass of 84% of the population wearing masks can completely stop the spread of the disease.", "These results highlight the significance of a large fraction of the population needing to wear face masks to effectively reduce the spread of the epidemic.", "The simulations show that early implementation of mask policy using moderate-quality masks is more effective than a later implementation with high-quality masks.", "These findings may inform public health mask-use policies for an infectious respiratory disease outbreak (such as one of COVID-19) in high-risk settings."], "journal": "Epidemiologia", "publish_time": "2021", "aliases": []}
{"doc_id": 235180899, "title": "Mask mandate and use efficacy in state-level COVID-19 containment", "abstract": ["Background: Containment of the COVID-19 pandemic requires evidence-based strategies to reduce transmission.", "Because COVID-19 can spread via respired droplets, many states have mandated mask use in public settings.", "Randomized control trials have not clearly demonstrated mask efficacy against respiratory viruses, but observational studies suggest greater mask compliance may be associated with lower infection rates.", "We hypothesized that statewide mask mandates and mask use are associated with lower COVID-19 case growth rates in the United States.", "Methods: We calculated total COVID-19 case growth and mask use for the continental United States with data from the Centers for Disease Control and Prevention and Institute for Health Metrics and Evaluation.", "We estimated post-mask mandate case growth in non-mandate states using median issuance dates of neighboring states with mandates.", "Results: Case growth was not significantly different between mandate and non-mandate states at low or high transmission rates, and surges were equivocal.", "Mask use predicted lower case growth at low, but not high transmission rates.", "Growth rates were comparable between states in the top and bottom mask use quintiles adjusted for normalized total cases early in the pandemic and unadjusted after peak Fall-Winter infections.", "Mask use did not predict Summer 2020 case growth for non-Northeast states or Fall-Winter 2020 growth for all states.", "Conclusions: Mask mandates and use are not associated with slower state-level COVID-19 spread during COVID-19 growth surges.", "COVID-19 containment requires future research and implementation of existing efficacious strategies."], "journal": "", "publish_time": "2021-05-25", "aliases": []}
{"doc_id": 237471805, "title": "A Direct Observation Video Method for Describing COVID-19 Transmission Factors on a Micro-Geographical Scale: Viral Transmission (VT)-Scan", "abstract": ["The COVID-19 pandemic severely affected many aspects of human life.", "While most health agencies agree mask wearing and physical distancing reduce viral transmission, efforts to improve the assessment of these behaviors are lacking.", "This study aimed to develop a direct observation video method [Viral Transmission (VT)-Scan] for assessing COVID-19 transmission behaviors and related factors (e.g., environmental setting).", "A wearable video device (WVD) was used to obtain videos of outdoor, public areas.", "The videos were examined to extract relevant information.", "All outcomes displayed good to excellent intra- and inter-reliability with intra-class correlation coefficients ranging from 0.836 to 0.997.", "The majority of people had a mask (60.8%) but 22.1% of them wore it improperly, 45.4% were not physical distancing, and 27.6% were simultaneously mask and physical distancing non-compliant.", "Transmission behaviors varied by demographics with white, obese males least likely to be mask-compliant and white, obese females least likely to physical distance.", "Certain environments (e.g., crosswalks) were identified as \u201chot spots\u201d where higher rates of adverse transmission behaviors occurred.", "This study introduces a reliable method for obtaining objective data on COVID-19 transmission behaviors and related factors which may be useful for agent-based modeling and policy formation."], "journal": "Int J Environ Res Public Health", "publish_time": "2021-09-03", "aliases": []}
{"doc_id": 221188334, "title": "Mask or no mask for COVID-19: A public health and market study", "abstract": ["Efficient strategies to contain the coronavirus disease 2019 (COVID-19) pandemic are peremptory to relieve the negatively impacted public health and global economy, with the full scope yet to unfold.", "In the absence of highly effective drugs, vaccines, and abundant medical resources, many measures are used to manage the infection rate and avoid exhausting limited hospital resources.", "Wearing masks is among the non-pharmaceutical intervention (NPI) measures that could be effectively implemented at a minimum cost and without dramatically disrupting social practices.", "The mask-wearing guidelines vary significantly across countries.", "Regardless of the debates in the medical community and the global mask production shortage, more countries and regions are moving forward with recommendations or mandates to wear masks in public.", "Our study combines mathematical modeling and existing scientific evidence to evaluate the potential impact of the utilization of normal medical masks in public to combat the COVID-19 pandemic.", "We consider three key factors that contribute to the effectiveness of wearing a quality mask in reducing the transmission risk, including the mask aerosol reduction rate, mask population coverage, and mask availability.", "We first simulate the impact of these three factors on the virus reproduction number and infection attack rate in a general population.", "Using the intervened viral transmission route by wearing a mask, we further model the impact of mask-wearing on the epidemic curve with increasing mask awareness and availability.", "Our study indicates that wearing a face mask can be effectively combined with social distancing to flatten the epidemic curve.", "Wearing a mask presents a rational way to implement as an NPI to combat COVID-19.", "We recognize our study provides a projection based only on currently available data and estimates potential probabilities.", "As such, our model warrants further validation studies."], "journal": "PLoS One", "publish_time": "2020", "aliases": []}
{"doc_id": 222213226, "title": "The impact of mask-wearing and shelter-in-place on COVID-19 outbreaks in the United States", "abstract": ["OBJECTIVES: A hasty reopening has led to a resurgence of the novel coronavirus disease 2019 (COVID-19) in the United States (US).", "We aimed to quantify the impact of several public health measures including non-medical mask-wearing, shelter-in-place, and detection of silent infections to help inform COVID-19 mitigation strategies.", "METHODS: We extended a previously established agent-based disease transmission model and parameterized it with estimates of COVID-19 characteristics and US population demographics.", "We implemented non-medical mask-wearing, shelter-in-place, and case isolation as control measures, and quantified their impact on reducing the attack rate and adverse clinical outcomes.", "RESULTS: We found that non-medical mask-wearing by 75% of the population reduced infections, hospitalizations, and deaths by 37.7% (interquartile range (IQR): 36.1-39.4%), 44.2% (IQR: 42.9-45.8%), and 47.2% (IQR: 45.5-48.7%), respectively, in the absence of a shelter-in-place strategy.", "Sheltering individuals aged 50 to 64 years of age was the most efficient strategy, decreasing attack rate, hospitalizations, and deaths by over 82% when combined with mask-wearing.", "Outbreak control was achieved in the simulated scenarios and the attack rate was reduced to below 1% when at least 33% of silent pre-symptomatic and asymptomatic infections were identified and isolated.", "CONCLUSIONS: Mask-wearing, even with the use of non-medical masks, has a substantial impact on outbreak control.", "A judicious implementation of shelter-in-place strategies remains an important public health intervention amid ongoing outbreaks."], "journal": "Int J Infect Dis", "publish_time": "2020", "aliases": []}
{"doc_id": 235479894, "title": "Association of social distancing and face mask use with risk of COVID-19", "abstract": ["Given the continued burden of COVID-19 worldwide, there is a high unmet need for data on the effect of social distancing and face mask use to mitigate the risk of COVID-19.", "We examined the association of community-level social distancing measures and individual face mask use with risk of predicted COVID-19 in a large prospective U.S. cohort study of 198,077 participants.", "Individuals living in communities with the greatest social distancing had a 31% lower risk of predicted COVID-19 compared with those living in communities with poor social distancing.", "Self-reported 'always' use of face mask was associated with a 62% reduced risk of predicted COVID-19 even among individuals living in a community with poor social distancing.", "These findings provide support for the efficacy of mask-wearing even in settings of poor social distancing in reducing COVID-19 transmission.", "Despite mass vaccination campaigns in many parts of the world, continued efforts at social distancing and face mask use remain critically important in reducing the spread of COVID-19."], "journal": "Nat Commun", "publish_time": "2021", "aliases": []}
{"doc_id": 215238818, "title": "To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic", "abstract": ["Face mask use by the general public for limiting the spread of the COVID-19 pandemic is controversial, though increasingly recommended, and the potential of this intervention is not well understood.", "We develop a compartmental model for assessing the community-wide impact of mask use by the general, asymptomatic public, a portion of which may be asymptomatically infectious.", "Model simulations, using data relevant to COVID-19 dynamics in the US states of New York and Washington, suggest that broad adoption of even relatively ineffective face masks may meaningfully reduce community transmission of COVID-19 and decrease peak hospitalizations and deaths.", "Moreover, mask use decreases the effective transmission rate in nearly linear proportion to the product of mask effectiveness (as a fraction of potentially infectious contacts blocked) and coverage rate (as a fraction of the general population), while the impact on epidemiologic outcomes (death, hospitalizations) is highly nonlinear, indicating masks could synergize with other non-pharmaceutical measures.", "Notably, masks are found to be useful with respect to both preventing illness in healthy persons and preventing asymptomatic transmission.", "Hypothetical mask adoption scenarios, for Washington and New York state, suggest that immediate near universal (80%) adoption of moderately (50%) effective masks could prevent on the order of 17\u201345% of projected deaths over two months in New York, while decreasing the peak daily death rate by 34\u201358%, absent other changes in epidemic dynamics.", "Even very weak masks (20% effective) can still be useful if the underlying transmission rate is relatively low or decreasing: In Washington, where baseline transmission is much less intense, 80% adoption of such masks could reduce mortality by 24\u201365% (and peak deaths 15\u201369%), compared to 2\u20139% mortality reduction in New York (peak death reduction 9\u201318%).", "Our results suggest use of face masks by the general public is potentially of high value in curtailing community transmission and the burden of the pandemic.", "The community-wide benefits are likely to be greatest when face masks are used in conjunction with other non-pharmaceutical practices (such as social-distancing), and when adoption is nearly universal (nation-wide) and compliance is high."], "journal": "Infect Dis Model", "publish_time": "2020-04-21", "aliases": []}
{"doc_id": 221635154, "title": "Mask-Wearing During the COVID-19 Pandemic", "abstract": ["Background Masks have been widely recommended as a precaution against COVID-19 transmission.", "Several studies have shown the efficacy of masks at curbing droplet dispersion in lab settings.", "Using individual response data from the Imperial College London-YouGov personal measures survey, this study investigates reported mask use and its association with the spread of COVID-19.", "Methods We examine the association of reported mask-wearing in a population within a country with the growth rate of active cases COVID-19 cases.", "The analysis uses country-wide data from weekly surveys of individuals mask-wearing behavior in public places, as well as other concurrently implemented nonpharmaceutical interventions, mobility changes, new cases of COVID-19 data and other control variables.", "The mask-wearing data were obtained from the Imperial College-YouGov multi-country survey of peoples personal habits before and during COVID-19.", "Because mask-wearing showed substantial variation across countries and over time, we use a reduced form econometric model to relate population-wide changes in mask-wearing to the growth rate in COVID-19.", "Results The results indicate that reported mask-wearing could play an important role in mitigating the growth of COVID-19.", "Widespread mask-wearing within a country associates with an expected 7% (95% CI: 3.94%-9.99%) decline in the growth rate of daily active cases of COVID-19 in the country.", "This daily decline equates to an expected 88.5% drop in the growth of daily active cases over a 30-day period when compared to zero percent mask-wearing, all else held equal.", "The decline in daily growth rate due to the combined effect of reported mask-wearing, reduced social mobility, and non-pharmaceutical interventions averages 28.1% (95% CI: 24.2%-32%).", "These estimates remain robust across multiple sensitivity analyses.", "Conclusions Face mask usage as a preventative measure against the transmission of COVID-19 varies widely across countries.", "This observational study uses data from 24 countries and finds that reported face mask usage associates with a decline in new COVID-19 cases.", "Even though the model controls for a large variety of variables that affect spread, and we run a number of robustness checks, it remains possible that some of the decline associated with face masks is related to confounding variables not included in the model.", "In summary, due to the confounding variables and the variations in the type of mask and its usage, randomized control trials of mask usage in populations are needed to determine the true effect of mask wearing on mitigating the transmission of infectious respiratory diseases."], "journal": "", "publish_time": "2020-09-13", "aliases": []}
{"doc_id": 232017436, "title": "Effectiveness of non-pharmaceutical interventions to contain COVID-19: a case study of the 2020 spring pandemic wave in New York City", "abstract": ["As COVID-19 continues to pose significant public health threats, quantifying the effectiveness of different public health interventions is crucial to inform intervention strategies.", "Using detailed epidemiological and mobility data available for New York City and comprehensive modelling accounting for under-detection, we reconstruct the COVID-19 transmission dynamics therein during the 2020 spring pandemic wave and estimate the effectiveness of two major non-pharmaceutical interventions\u2014lockdown-like measures that reduce contact rates and universal masking.", "Lockdown-like measures were associated with greater than 50% transmission reduction for all age groups.", "Universal masking was associated with an approximately 7% transmission reduction overall and up to 20% reduction for 65+ year olds during the first month of implementation.", "This result suggests that face covering can substantially reduce transmission when lockdown-like measures are lifted but by itself may be insufficient to control SARS-CoV-2 transmission.", "Overall, findings support the need to implement multiple interventions simultaneously to effectively mitigate COVID-19 spread before the majority of population can be protected through mass-vaccination."], "journal": "Journal of the Royal Society, Interface", "publish_time": "2021-02-23", "aliases": []}
{"doc_id": 230350152, "title": "Strategies to minimize SARS-CoV-2 transmission in classroom settings: Combined impacts of ventilation and mask effective filtration efficiency", "abstract": ["The impact of the COVID-19 pandemic continues to be significant and global.", "As the global community learns more about the novel coronavirus SARS-CoV-2, there is strong evidence that a significant modality of transmission is via the long-range airborne route, referred to here as aerosol transmission.", "In this paper, we evaluate the efficacy of ventilation, mask effective filtration efficiency, and the combined effect of the two on the reduction of aerosol infection probability for COVID-19 in a classroom setting.", "The Wells-Riley equation is used to predict the conditional probability of infection for three distinct airborne exposure scenarios: (1) an infectious instructor exposing susceptible students; (2) an infectious student exposing other susceptible students; and (3) an infectious student exposing a susceptible instructor.", "Field measurements were performed in a classroom using a polydisperse neutralized salt (NaCl) aerosol, generated in a size range consistent with human-generated SARS-CoV-2 containing bioaerosols, as a safe surrogate.", "Measurements included time-resolved and size-resolved NaCl aerosol concentration distributions and size-resolved effective filtration efficiency of different masks with and without mask fitters.", "The measurements were used to validate assumptions and inputs for the Wells-Riley model.", "Aerosol dynamics and distribution measurements confirmed that the majority of the classroom space is uniform in aerosol concentration within a factor of 2 or better for distances > 2 m from the aerosol source.", "Mask effective filtration efficiency measurements show that most masks fit poorly with estimated leakage rates typically > 50%, resulting in significantly reduced effective filtration efficiency.", "However, effective filtration efficiencies approaching the mask material filtration efficiency were achievable using simple mask fitters.", "Wells-Riley model results for the different scenarios suggest that ventilation of the classroom alone is not able to achieve infection probabilities less than 0.01 (1%) for air exchanges rates up to 10 1/h and an event duration of one hour.", "The use of moderate to high effective filtration efficiency masks by all individuals present, on the other hand, was able to significantly reduce infection probability and could achieve reductions in infection probability by 5x, 10x, or even >100x dependent on the mask used and use of a mask fitter.", "This enables conditional infection probabilities <0.001 (0.1%) or even < 0.0001 (0.01%) to be reached with the use of masks and mask fitters alone.", "Finally, the results demonstrate that the reductions provided by ventilation and masks are synergistic and multiplicative.", "The results reinforce the use of properly donned masks to achieve reduced aerosol transmission of SARS-CoV-2 and other infectious diseases transmitted via respiratory aerosol indoors and provide new motivation to further improve the effective filtration efficiency of common face coverings through improved design, and/or the use of mask fitters."], "journal": "", "publish_time": "2021-01-04", "aliases": []}
{"doc_id": 221553898, "title": "COVID-19 Transmission Dynamics and Effectiveness of Public Health Interventions in New York City during the 2020 Spring Pandemic Wave", "abstract": ["New York City experienced a large COVID-19 pandemic wave during March - May 2020.", "We model the transmission dynamics of COVID-19 in the city during the pandemic and estimate the effectiveness of public health interventions (overall and for each major intervention separately) for the entire population and by age group.", "We estimate that the overall effective reproductive number was 2.99 at the beginning of the pandemic wave and reduced to 0.93 one week after the stay-at-home mandate.", "Most age groups experienced similar reductions in transmission.", "Interventions reducing contact rates were associated with a 70.7% (95% CI: 65.0 - 76.4%) reduction of transmission overall and >50% for all age groups during the pandemic.", "Face covering was associated with a 6.6% (95% CI: 0.8 - 12.4%) reduction of transmission overall and up to 20% for 65+ year-olds during the first month of implementation.", "Accounting for the amount of time masks are in use (i.e.", "mainly outside homes), these findings indicate universal masking could reduce transmission by up to 28-32% when lockdown-like measures are lifted, if the high effectiveness estimated for older adults were achieved for all ages.", "These estimates are verified by out-of-fit projections and support the need for implementing multiple interventions simultaneously in order to effectively mitigate the spread of COVID-19."], "journal": "", "publish_time": "2020-09-09", "aliases": []}
{"doc_id": 239050637, "title": "SARS-CoV-2 transmission during an indoor professional sporting event", "abstract": ["Sporting events with spectators can present a risk during the COVID-19 pandemic of becoming potential superspreader events that can result in mass-infection amongst participants\u2014both sportspeople and spectators alike.", "In order to prevent disease transmission, many professional sporting bodies have implemented detailed hygiene regulations.", "This report analyzes SARS-CoV-2 transmission during a professional sports event (2nd division professional basketball in Germany).", "Whilst social distancing in this context is not always possible, the rate of infection was significantly reduced by wearing face masks that cover the mouth and nose.", "There was no infection amongst individuals who continuously wore medical particle filter masks (Category KN95/FFP2 or higher) during this sporting event."], "journal": "Sci Rep", "publish_time": "2021-10-20", "aliases": []}
{"doc_id": 227037240, "title": "Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers: A Randomized Controlled Trial", "abstract": ["BACKGROUND: Observational evidence suggests that mask wearing mitigates transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).", "It is uncertain if this observed association arises through protection of uninfected wearers (protective effect), via reduced transmission from infected mask wearers (source control), or both.", "OBJECTIVE: To assess whether recommending surgical mask use outside the home reduces wearers' risk for SARS-CoV-2 infection in a setting where masks were uncommon and not among recommended public health measures.", "DESIGN: Randomized controlled trial (DANMASK-19 [Danish Study to Assess Face Masks for the Protection Against COVID-19 Infection]).", "(ClinicalTrials.gov: NCT04337541) SETTING: Denmark, April and May 2020.", "PARTICIPANTS: Adults spending more than 3 hours per day outside the home without occupational mask use.", "INTERVENTION: Encouragement to follow social distancing measures for coronavirus disease 2019, plus either no mask recommendation or a recommendation to wear a mask when outside the home among other persons together with a supply of 50 surgical masks and instructions for proper use.", "MEASUREMENTS: The primary outcome was SARS-CoV-2 infection in the mask wearer at 1 month by antibody testing, polymerase chain reaction (PCR), or hospital diagnosis.", "The secondary outcome was PCR positivity for other respiratory viruses.", "RESULTS: A total of 3030 participants were randomly assigned to the recommendation to wear masks, and 2994 were assigned to control; 4862 completed the study.", "Infection with SARS-CoV-2 occurred in 42 participants recommended masks (1.8%) and 53 control participants (2.1%).", "The between-group difference was \u22120.3 percentage point (95% CI, \u22121.2 to 0.4 percentage point; P = 0.38) (odds ratio, 0.82 [CI, 0.54 to 1.23]; P = 0.33).", "Multiple imputation accounting for loss to follow-up yielded similar results.", "Although the difference observed was not statistically significant, the 95% CIs are compatible with a 46% reduction to a 23% increase in infection.", "LIMITATION: Inconclusive results, missing data, variable adherence, patient-reported findings on home tests, no blinding, and no assessment of whether masks could decrease disease transmission from mask wearers to others.", "CONCLUSION: The recommendation to wear surgical masks to supplement other public health measures did not reduce the SARS-CoV-2 infection rate among wearers by more than 50% in a community with modest infection rates, some degree of social distancing, and uncommon general mask use.", "The data were compatible with lesser degrees of self-protection.", "PRIMARY FUNDING SOURCE: The Salling Foundations."], "journal": "Ann Intern Med", "publish_time": "2020-11-18", "aliases": []}
{"doc_id": 235217679, "title": "Effectiveness of Face Masks in Reducing the Spread of COVID-19: A Model-Based Analysis.", "abstract": ["BACKGROUND The World Health Organization and US Centers for Disease Control and Prevention recommend that both infected and susceptible people wear face masks to protect against COVID-19.", "METHODS We develop a dynamic disease model to assess the effectiveness of face masks in reducing the spread of COVID-19, during an initial outbreak and a later resurgence, as a function of mask effectiveness, coverage, intervention timing, and time horizon.", "We instantiate the model for the COVID-19 outbreak in New York, with sensitivity analyses on key natural history parameters.", "RESULTS During the initial epidemic outbreak, with no social distancing, only 100% coverage of masks with high effectiveness can reduce the effective reproductive number Re below 1.", "During a resurgence, with lowered transmission rates due to social distancing measures, masks with medium effectiveness at 80% coverage can reduce Re below 1 but cannot do so if individuals relax social distancing efforts.", "Full mask coverage could significantly improve outcomes during a resurgence: with social distancing, masks with at least medium effectiveness could reduce Re below 1 and avert almost all infections, even with intervention fatigue.", "For coverage levels below 100%, prioritizing masks that reduce the risk of an infected individual from spreading the infection rather than the risk of a susceptible individual from getting infected yields the greatest benefit.", "LIMITATIONS Data regarding COVID-19 transmission are uncertain, and empirical evidence on mask effectiveness is limited.", "Our analyses assume homogeneous mixing, providing an upper bound on mask effectiveness.", "CONCLUSIONS Even moderately effective face masks can play a role in reducing the spread of COVID-19, particularly with full coverage, but should be combined with social distancing measures to reduce Re below 1.", "[Box: see text]."], "journal": "Medical decision making : an international journal of the Society for Medical Decision Making", "publish_time": "2021-05-27", "aliases": []}
{"doc_id": 226449531, "title": "Potential insights into COVID-19 disparitiesfrom the science of cancer health disparities", "abstract": ["Older age as well as health comorbidities that include metabolic syndrome, cardiovascular disease, hypertension, asthma, and chronic kidney disease are listed by the centers for diseases control and Prevention (cdc) as strongrisk factors for severe disease and mortality from COVID-19 Since the outbreak began throughout the world and theUnited.", "States, both gender and race/ethnicity have additionally become associated with infection and severeCOVID-10 disease and mortality.", "While all humans lacked immunity at its onset to the new SARS-CoV-2 virus, thecause of COVID-19, older-age individuals are likely more susceptible due to age-weakened immune systems, thepresence of health comorbidities, and are the most likely group to be housed within skilled nursing facilities (snfs) where outbreaks and death from COVID-19 have been frequent snfs often lacked isolation protocols, initial viraltesting, and lacked personalized protection equipment (ppe) that was prioritized to hospitals.", "People with healthcomorbidities regardless of age are more susceptible to severe COVID-19 likely because of weakened health andimmunity.", "Indeed, patients on immunosuppression for medical conditions were among the first susceptible to severeinfection when the outbreak began.", "The association of severe COVID-19 and race/ethnicity shows the strongestrationale with socioeconomic inequalities.", "Those from minority-population backgrounds are often in more urbancrowded areas where mitigating factors of social distancing and opportunities to avoid virus exposure are lessrealized.", "Many minority populations, as a result of socioeconomic inequality, have more difficult access to healthcare, hold lower-paying jobs, reside in lower-income neighborhoods with grocery store deserts, have higher use oftobacco and alcohol and demonstrate lower physical activity, and have lower use of preventive medicine.", "This inturn has the physiologic consequences of alteration of the gut microbiome, increased localized inflammation, andcompromised immunity, leading to higher frequencies of health comorbidities, the exact conditions that have beenshown to place an individual at much higher risk for mortality from COVID-19 Other COVID-19 risk factors such asblood group type A and the use of angiotensin-converting enzyme (ace) inhibitors for the high prevalence ofessential hypertension and cardiovascular disease in racial populations appear not to play a role.", "Specific spikeprotein variants that have proved to be more virulent have not been evaluated among racial groups.", "The use ofhydroxychloroquine might play a role in sudden death if used for treatment or prophylaxis of COVID-19 in someafrican americans because of the common presence of a cardiac sodium channel polymorphism.", "The higher risk formen over women for severe COVID-19 disease is intriguing; the SARS-CoV-2 virus requires the use of cell ACE2receptors and the cell serine protease tmprss2, both regulated by androgens for expression.", "Differences inexpression levels as well as trials of antiandrogen therapy are both being explored to assess if these permissive cellfactors are the cause for gender differences."], "journal": "Clinical Cancer Research", "publish_time": "2020", "aliases": []}
{"doc_id": 221400916, "title": "Racial, Economic, and Health Inequality and COVID-19 Infection in the United States", "abstract": ["OBJECTIVES: There is preliminary evidence of racial and social economic disparities in the population infected by and dying from COVID-19.", "The goal of this study is to report the associations of COVID-19 with respect to race, health, and economic inequality in the United States.", "METHODS: We performed an ecological study of the associations between infection and mortality rate of COVID-19 and demographic, socioeconomic, and mobility variables from 369 counties (total population, 102,178,117 [median, 73,447; IQR, 30,761\u2013256,098]) from the seven most affected states (Michigan, New York, New Jersey, Pennsylvania, California, Louisiana, Massachusetts).", "RESULTS: The risk factors for infection and mortality are different.", "Our analysis shows that counties with more diverse demographics, higher population, education, income levels, and lower disability rates were at a higher risk of COVID-19 infection.", "However, counties with higher proportion with disability and poverty rates had a higher death rate.", "African Americans were more vulnerable to COVID-19 than other ethnic groups (1981 African American infected cases versus 658 Whites per million).", "Data on mobility changes corroborate the impact of social distancing.", "CONCLUSION: Our study provides evidence of racial, economic, and health inequality in the population infected by and dying from COVID-19.", "These observations might be due to the workforce of essential services, poverty, and access to care.", "Counties in more urban areas are probably better equipped at providing care.", "The lower rate of infection, but a higher death rate in counties with higher poverty and disability could be due to lower levels of mobility, but a higher rate of comorbidities and health care access.", "ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40615-020-00833-4) contains supplementary material, which is available to authorized users."], "journal": "J Racial Ethn Health Disparities", "publish_time": "2020-09-01", "aliases": [217311524]}
{"doc_id": 220746967, "title": "Population-based Estimates for High Risk of Severe COVID-19 Disease due to Age and Underlying Health Conditions", "abstract": ["INTRODUCTION: COVID-19 is a viral respiratory disease, which became a global threat to public health.", "Specific subsets of the population are more vulnerable, namely those with chronic diseases.", "We aimed to estimate the share of the Portuguese population at the highest risk for complications following COVID-19 infection due to both old age and specific comorbidities.", "MATERIAL AND METHODS: Our sample included all people aged 65 years and above (2215 men and 3486 women) who participated in the fifth Portuguese National Health Interview Survey, conducted in 2014.", "In order to project the potential population at highest risk for COVID-19, we used the latest available official demographic estimates from the National Institute of Statistics - INE 2018.", "We used a more restrictive definition of risk combining old age criteria and the following chronic conditions as potential risk factors for COVID-19 according to the available literature: hypertension, diabetes, chronic obstructive pulmonary disease, cardio- and cerebrovascular disease.", "RESULTS: We estimated that 15.5% (n = 1 560 667) of the Portuguese population might be at increased risk for complications from COVID-19 because of old age and existing chronic conditions.", "Such estimates vary across the country (from 1.7% in Azores to 33.7% in Northern Portugal).", "Northern Portugal not only has the highest prevalence of selected morbidity (72.8%) within mainland Portugal, but also has the largest population at risk for COVID-19 (n = 526 607).", "This was followed by the Lisbon and Tagus Valley region (n = 408 564) and Central Portugal (n = 388 867).", "DISCUSSION: Our results should encourage authorities to continue protecting those more vulnerable to the pandemic threat, particularly on those areas of the country which are more likely to be further affected.", "CONCLUSION: We projected a considerable number of Portuguese people at the highest risk for severe COVID-19 disease due to both old age and pre-existing chronic conditions.", "Such estimates vary across the country."], "journal": "Acta Med Port", "publish_time": "2020", "aliases": []}
{"doc_id": 221885993, "title": "Intersectionality and inequalities in medical risk for severe COVID-19 in the Canadian Longitudinal Study on Aging", "abstract": ["BACKGROUND AND OBJECTIVES: Older populations with underlying medical conditions are at higher risk of COVID-19 severity and mortality once infected.", "Intersectional gerontology considers the compounding effects of multiple forms of social inequity.", "This study explores how racial-nativity status, family income, education level and the intersecting profile of these three social standings stratify differential patterns of chronic conditions among Canadians aged 45 years and older.", "RESEARCH DESIGN AND METHODS: Using the baseline Canadian Longitudinal Study on Aging (n = 29,748), multinomial logistic regression analyses were conducted to estimate multivariable-adjusted odds of having one and/or two (&#8804; 2) or multiple (&#8805;3) medical conditions (i.e., diabetes, asthma, cancer, previous heart attack, cardiovascular disease, kidney disease, hypertension, chronic obstructive pulmonary disease, and obesity) based on socio-demographic characteristics.", "RESULTS: There were significant racial-nativity disparities and social-class gradients in multimorbidity.", "The odds of having &#8805;3 medical conditions were greater for Black immigrants (OR=1.79, 95% CI=1.13, 2.82), South Asian immigrants (OR=1.49, 95% CI=1.02, 2.19) and close to double for Aboriginal Canadians (OR=1.96, 95% CI=1.37, 2.80) relative to Canadian-born Whites.", "Black, South Asian and Aboriginal populations from disadvantaged socioeconomic backgrounds had the highest odds of having &#8805;3 medical conditions (OR=3.50, 95% CI=1.41, 8.70).", "DISCUSSION AND IMPLICATIONS: Despite a universal health system, marginalized older Canadians who are racialized foreign-born, less educated, and/or low-income have a higher prevalence of multimorbidity that are associated with COVID-19 severe illness and mortality.", "Upstream health policy and social care tackling intersecting structural inequities should be undertaken to prevent increasing multimorbidity among underserved aging populations."], "journal": "GerontologistGerontologist", "publish_time": "2020", "aliases": []}
{"doc_id": 234345284, "title": "10 IMPACT OF CHRONIC LIVER DISEASE ON THE COVID-19 HOSPITAL ADMITTED PATIENTS", "abstract": ["Introduction: Patient with chronic liver disease (CLD) can have adverse outcomes in setting of COVID-19 infection.", "Our goal is to determine the prevalence of liver disease in COVID-19 infection and outcomes as compared to individuals without CLD.", "Methods: We conducted a retrospective review of the patients admitted for COVID-19 infection from March 1st, 2020 till May 31st, 2020.", "The patients who had chronic liver disease were identified based on imaging interpretation and chronically elevated liver enzymes.", "Chart review was done for 332 patients, the one with missing data were excluded (n=16).", "We included 316 patients in the analysis.", "Of them 12.0% patients had underlying chronic liver disease.", "Results: Of total 43.7% were female and 48.4% were Caucasians.", "The patients with liver disease were older (64.6 \u00b1 15.3 vs 57.6 \u00b1 17.4, p=0.02) as compared to non-CLD.", "The CLD patients had higher number of coronary artery disease (47.4% vs 18.9%, p<0.001).", "The other comorbid conditions including chronic obstructive pulmonary disease, asthma, cancer, chronic kidney disease, diabetes mellitus, hypertension, obesity, obstructive sleep apnea and smoking were similar in both groups.", "The CLD patients had higher mortality (aOR: 3.3, 95% CI: 1.37-8.05), thromboembolism (aOR: 3.77, 95% CI: 1.33-10.71), acute respiratory distress syndrome (aOR:2.25, 95% CI: 1.04-4.85) and trend of severe COVID-19 infection (aOR:1.90, 95% CI:0.91-3.98) whereas the 3 month readmission was similar in both groups.", "The Kaplan Meier survival curve suggest that COVID-19 patients with CLD died early during the study period.", "Conclusion: The presence of chronic liver disease in inpatient COVID-19 infections is associated with three fold higher mortality.", "The CLD patients had higher incidence of severe infection.", "$\u03a6gure"], "journal": "Gastroenterology", "publish_time": "2021-05-31", "aliases": []}
{"doc_id": 233308918, "title": "COVID-19 in patients with hepatobiliary and pancreatic diseases: a single-centre cross-sectional study in East London", "abstract": ["OBJECTIVE: To explore risk factors associated with COVID-19 susceptibility and survival in patients with pre-existing hepato-pancreato-biliary (HPB) conditions.", "DESIGN: Cross-sectional study.", "SETTING: East London Pancreatic Cancer Epidemiology (EL-PaC-Epidem) Study at Barts Health National Health Service Trust, UK.", "Linked electronic health records were interrogated on a cohort of participants (age &#8805;18 years), reported with HPB conditions between 1 April 2008 and 6 March 2020.", "PARTICIPANTS: EL-PaC-Epidem Study participants, alive on 12 February 2020, and living in East London within the previous 6 months (n=15 440).", "The cohort represents a multi-ethnic population with 51.7% belonging to the non-White background.", "MAIN OUTCOME MEASURE: COVID-19 incidence and mortality.", "RESULTS: Some 226 (1.5%) participants had confirmed COVID-19 diagnosis between 12 February and 12 June 2020, with increased odds for men (OR 1.56; 95% CI 1.2 to 2.04) and Black ethnicity (2.04; 1.39 to 2.95) as well as patients with moderate to severe liver disease (2.2; 1.35 to 3.59).", "Each additional comorbidity increased the odds of infection by 62%.", "Substance misusers were at more risk of infection, so were patients on vitamin D treatment.", "The higher ORs in patients with chronic pancreatic or mild liver conditions, age >70, and a history of smoking or obesity were due to coexisting comorbidities.", "Increased odds of death were observed for men (3.54; 1.68 to 7.85) and Black ethnicity (3.77; 1.38 to 10.7).", "Patients having respiratory complications from COVID-19 without a history of chronic respiratory disease also had higher odds of death (5.77; 1.75 to 19).", "CONCLUSIONS: In this large population-based study of patients with HPB conditions, men, Black ethnicity, pre-existing moderate to severe liver conditions, six common medical multimorbidities, substance misuse and a history of vitamin D treatment independently posed higher odds of acquiring COVID-19 compared with their respective counterparts.", "The odds of death were significantly high for men and Black people."], "journal": "BMJ Open", "publish_time": "2021", "aliases": []}
{"doc_id": 216035390, "title": "Estimated inequities in COVID-19 infection fatality rates by ethnicity for Aotearoa New Zealand", "abstract": ["AIMS: There is limited evidence as to how clinical outcomes of COVID-19 including fatality rates may vary by ethnicity.", "We aim to estimate inequities in infection fatality rates (IFR) in New Zealand by ethnicity.", "METHODS: We combine existing demographic and health data for ethnic groups in New Zealand with international data on COVID-19 IFR for different age groups.", "We adjust age-specific IFRs for differences in unmet healthcare need, and comorbidities by ethnicity.", "We also adjust for life expectancy reflecting evidence that COVID-19 amplifies the existing mortality risk of different groups.", "RESULTS: The IFR for Maori is estimated to be 50% higher than that of non-Maori, and could be even higher depending on the relative contributions of age and underlying health conditions to mortality risk.", "CONCLUSIONS: There are likely to be significant inequities in the health burden from COVID-19 in New Zealand by ethnicity.", "These will be exacerbated by racism within the healthcare system and other inequities not reflected in official data.", "Highest risk communities include those with elderly populations, and Maori and Pacific communities.", "These factors should be included in future disease incidence and impact modelling."], "journal": "N Z Med J", "publish_time": "2020", "aliases": []}
{"doc_id": 226222838, "title": "COVID-19 disparity among racial and ethnic minorities in the US: A cross sectional analysis", "abstract": ["AIM: To analyze racial disparities in Coronavirus disease (COVID-19) cases in the United States of America and discuss possible reasons behind this inequality.", "SUBJECT AND METHODS: We obtained estimated case counts of African-American, Caucasian, Native American, Asian and Hispanic individuals with coronavirus disease (COVID-19)infection through May 5, 2020, from publicly available data on state departments of health websites.", "We calculated race-specific fractions as the percentage of the total population and analyzed the reasons behind this disparity.", "RESULTS: The incident rates of COVID-19 were higher among African Americans and among Latinos disproportionately higher than their representation in 14 states and 9 states, respectively.", "A similar observation was also reported for New York city.", "The percentage of deaths reported among African Americans was disproportionately higher than their represented share in the population in 23 out of 35 states.", "It was reported that 22.4% of COVID-19 deaths in the USA were African American, even though black people make up 13.4% of the USA population.", "CONCLUSIONS: The analysis shows the disparity of coronavirus disease outcomes by ethnicity and race.", "Additional research is needed to determine the factors behind this inequality."], "journal": "Travel Med Infect Dis", "publish_time": "2020-11-01", "aliases": []}
{"doc_id": 221367583, "title": "[Social Inequalities and COVID-19: Social-Epidemiological Perspectives on the Pandemic].", "abstract": ["The new Coronavirus Disease (COVID-19) hits specific population groups harder than others.", "However, social-epidemiological patterns of the pandemic which go beyond differences by age and gender have hardly been addressed in Germany.", "First reports from other western industrialised countries indicate that people living in socioeconomically deprived areas and people of color have an increased risk of severe COVID-19 progression and mortality.", "Social inequalities in the risk of infection due to different living and working conditions, and social inequalities in the susceptibility and risk factors for severe COVID-19, particularly in pre-existing medical conditions, might play an important role in explaining those findings.", "Such inequalities are well established for Germany, as well.", "It can therefore be assumed that also in Germany people with a lower socioeconomic status might be more affected during the further course of the pandemic.", "In addition, the interventions to contain the pandemic might have unequal social, economic and psychological impacts on different social groups.", "Hence, the COVID-19 pandemic has the overall potential to increase social and health inequalities.", "Social-epidemiological research into COVID-19 is therefore needed to advance measures of health protection and infection control in an evidence-based, targeted and socially equitable manner."], "journal": "Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))", "publish_time": "2020-08-28", "aliases": []}
{"doc_id": 218485655, "title": "Population vulnerability to COVID-19 in Europe: a burden of disease analysis", "abstract": ["Background: Evidence has emerged showing that elderly people and those with pre-existing chronic health conditions may be at higher risk of developing severe health consequences from COVID-19.", "In Europe, this is of particular relevance with ageing populations living with non-communicable diseases, multi-morbidity and frailty.", "Published estimates of Years Lived with Disability (YLD) from the Global Burden of Disease (GBD) study help to characterise the extent of these effects.", "Our aim was to identify the countries across Europe that have populations at highest risk from COVID-19 by using estimates of population age structure and YLD for health conditions linked to severe illness from COVID-19.", "Methods: Population and YLD estimates from GBD 2017 were extracted for 45 countries in Europe.", "YLD was restricted to a list of specific health conditions associated with being at risk of developing severe consequences from COVID-19 based on guidance from the United Kingdom Government.", "This guidance also identified individuals aged 70 years and above as being at higher risk of developing severe health consequences.", "Study outcomes were defined as: (i) proportion of population aged 70 years and above; and (ii) rate of YLD for COVID-19 for vulnerable health conditions across all ages.", "Bivariate groupings were established for each outcome and combined to establish overall population-level vulnerability.", "Results: Countries with the highest proportions of elderly residents were Italy, Greece, Germany, Portugal and Finland.", "When assessments of population-level YLD rates for COVID-19 vulnerable health conditions were made the highest rates were observed for Bulgaria, Czech Republic, Croatia, Hungary and Bosnia and Herzegovina.", "A bivariate analysis indicated that the countries at high-risk across both measures of vulnerability were: Bulgaria; Portugal; Latvia; Lithuania; Greece; Germany; Estonia; and Sweden.", "Conclusion: Routine estimates of population structures and non-fatal burden of disease measures can be usefully combined to create composite indicators of vulnerability for rapid assessments, in this case to severe health consequences from COVID-19.", "Countries with available results for sub-national regions within their country, or national burden of disease studies that also use sub-national levels for burden quantifications, should consider using non-fatal burden of disease estimates to estimate geographical vulnerability to COVID-19."], "journal": "", "publish_time": "2020-05-04", "aliases": [218978781]}
{"doc_id": 228084735, "title": "Convergence of COVID-19 and chronic air pollution risks: Racial/ethnic and socioeconomic inequities in the U.S", "abstract": ["Recent research suggests greater COVID-19 prevalence in areas burdened with higher exposure to chronic air pollution, but previous studies have not examined if socially disadvantaged populations are more likely to reside in communities located at the convergence of both COVID-19 and air pollution health risks.", "This article presents a national scale U.S. study that investigates whether racial/ethnic minorities, socioeconomically deprived residents, and other vulnerable groups are significantly overrepresented in counties where significantly higher COVID-19 incidence spatially coincides with higher respiratory health risks from outdoor exposure to hazardous air pollutants (HAPs).", "COVID-19 data from the Johns Hopkins Center for Systems Science and Engineering database are linked to respiratory risk estimates from the U.S. Environmental Protection Agency's National Air Toxics Assessment and variables from the 2018 American Community Survey.", "Bivariate local measures of spatial association are implemented to identify county clusters representing relationships between COVID-19 incidence rate and respiratory risk from HAP exposure.", "Socio-demographic characteristics of these clusters are compared using bivariate statistical tests and multivariable generalized estimating equations.", "Counties where greater COVID-19 incidence coincides significantly with higher HAP respiratory risk contain disproportionately higher percentages of non-Hispanic Black, socioeconomically deprived, and uninsured residents than all other U.S. counties, after controlling for spatial clustering, population density, older age, and other contextual factors.", "These significant socio-demographic inequities represent an important starting point for more detailed investigations of places facing the double burden of elevated COVID-19 prevalence and air pollution exposure, and also emphasize the urgent need to develop mitigation strategies for addressing both COVID-19 and chronic air pollution in socially vulnerable communities."], "journal": "Environ Res", "publish_time": "2021", "aliases": []}
{"doc_id": 237217853, "title": "LB771 Racial and Ethnic Disparities in COVID-19-Related Infection in Patients with Psoriasis: A Cross-Sectional Study", "abstract": ["Psoriasis severity may vary due to demographics and geography, yet data on the risk, racial disparities, and outcomes for COVID-19 in patients with psoriasis is limited.", "We evaluated rates of COVID-19 infection, hospitalization, and mortality among psoriasis patients in a California-based population through a cross-sectional study utilizing the University of California COVID Research Data Set (UC CORDS).", "Psoriasis diagnosis, COVID-19 testing, demographics, hospitalizations, and mortality were collected.", "Specific biologic (adalimumab, ustekinumab, secukinumab, guselkumab, and etanercept) and systemic (cyclosporine and methotrexate) treatment for at least 30 days prior to COVID-19 testing were identified.", "Data from 290,838 patients is included in UC CORDS with a 3.59% positive COVID-19 test rate.", "Of these, 3,566 patients had a diagnosis of psoriasis, with a 2.44% positive infection rate;lower than the 3.56% infection rate for those without psoriasis (p=0.00021).", "There were no significant differences in hospitalization or mortality rate for COVID-19-positive psoriasis patients compared to those without psoriasis (p=0.5523, p=0.1152, respectively).", "Lastly, no significant difference in infection rate for psoriasis patients on systemic (2.92%, p=0.579) or biologic agents (2.46%, p=0.986) in comparison to psoriasis patients not on these treatments.", "UC CORDS data showed higher COVID-19 infection rates in non-white (3.05%) and Hispanic (8.35%) patients compared to non-Hispanic Caucasians (1.95%, p<0.00001).", "No significant differences were seen in infection, hospitalization, or mortality rates between non-Hispanic races (Caucasian, African American, and Asian).", "Overall, psoriasis patients did not have increased risk for COVID-19 infection, hospitalization, or mortality, regardless of treatment modality."], "journal": "Journal of Investigative Dermatology", "publish_time": "2021-09-30", "aliases": []}
{"doc_id": 222159684, "title": "Outcomes in Hispanics With COVID\u201019 Are Similar to Those of Caucasian Patients in Suburban New York", "abstract": ["BACKGROUND: Despite reported higher rates and worse outcomes due to COVID\u201019 in certain racial and ethnic groups, much remains unknown.", "We explored the association between Hispanic ethnicity and outcomes in COVID\u201019 patients in Long Island, New York.", "METHODS: We conducted a retrospective cohort study of 2,039 Hispanic and non\u2010Hispanic Caucasian patients testing positive for SARS\u2010CoV\u20102 between March 7 and May 23, 2020, at a large suburban academic tertiary care hospital near New York City.", "We explored the association of ethnicity with need for intensive care unit (ICU), invasive mechanical ventilation (IMV), and mortality.", "RESULTS: Of all patients, 1,079 (53%) were non\u2010Hispanic Caucasians and 960 (47%) were Hispanic.", "Hispanic patients presented in higher numbers than expected for our catchment area.", "Compared with Caucasians, Hispanics were younger (45 years vs. 59 years), had fewer comorbidities (66% with no comorbidities vs. 40%), were less likely to have commercial insurance (35% vs. 59%), or were less likely to come from a nursing home (2% vs. 10%).", "In univariate comparisons, Hispanics were less likely to be admitted (37% vs. 59%) or to die (3% vs. 10%).", "Age, shortness of breath, congestive heart failure (CHF), coronary artery disease (CAD), hypoxemia, and presentation from nursing homes were associated with admission.", "Male sex and hypoxemia were associated with ICU admission.", "Male sex, chronic obstructive pulmonary disease, and hypoxemia were associated with IMV.", "Male sex, CHF, CAD, and hypoxemia were associated with mortality.", "After other factors were adjusted for, Hispanics were less likely to be admitted (odds ratio = 0.62, 95% confidence interval = 0.52 to 0.92) but Hispanic ethnicity was not associated with ICU admission, IMV, or mortality.", "CONCLUSIONS: Hispanics presented at higher rates than average for our population but outcomes among Hispanic patients with COVID\u201019 were similar to those of Caucasian patients."], "journal": "Acad Emerg Med", "publish_time": "2020-10-30", "aliases": []}
{"doc_id": 237007706, "title": "The Role of the Health Coach in a Global Pandemic", "abstract": ["BACKGROUND: While medical teams were perplexed about the novel SARS-CoV-2 infection, transmission and impairment of organ systems and immune function, viral infections spread worldwide.", "Complex intersectional issues of co-morbidities coupled with marginalized, diverse ethnic/racial populations emerged as significant risks to contracting severe COVID-19.", "OBJECTIVE: Since a healthy lifestyle is fundamental for lowering risk to chronic diseases, public health initiatives to manage this and future pandemics should include strategies that assist individuals to improve health status through targeted behavior changes.", "This conceptual paper builds a case for certified professional health coaches as primary actors in future preventive strategies, with expanded skills in addressing social determinants of health and \u201cnext generational\u201d cultural competencies.", "METHODS: This concept paper primarily synthesizes fast-tracked research in 2020 regarding the demographic impact of COVID-19, specifically those groups suffering the highest morbidity and mortality rates.", "Exploring these intersectional issues through a conceptual lens provides strategies for certified health coaches to contribute their expertise in behavioral change within the larger contextual settings of racial/ethnic disparities and social inequities.", "RESULTS: As the co-morbidities and other chronic conditions related to COVID-19 among individuals and families in low-income communities are worsened by dual forces (lifestyle/behavioral choices and ingrained structural inequities), adding the support of certified health coaches to build trust, provide more convenient access to address vaccine hesitancy, and dispell falsehoods, is an effective means for advancing health and wellbeing.", "Group coaching and one-on-one coaching can work in tandem with public health initiatives for reducing chronic disease burden and addressing social determinants of health (SDoH).", "Skills are identified in coaching SDoH with expanded cultural competencies for health coaches.", "CONCLUSION: Certified professional health coaches can make a positive impact on general risk reduction of chronic diseases within ethnic/racial minorities, thereby supporting population health in facing future contagions with greater health resilience."], "journal": "Glob Adv Health Med", "publish_time": "2021-08-09", "aliases": []}
{"doc_id": 235729572, "title": "Factors Associated With Severe COVID-19 Infection Among Persons of Different Ages Living in a Defined Midwestern US Population", "abstract": ["Objective To identify risk factors associated with severe COVID-19 infection in a defined, Midwestern, U.S. population overall and within different age groups.", "Patients and Methods We used the Rochester Epidemiology Project research infrastructure to identify persons residing in a defined 27-county Midwestern region who had a positive PCR test for COVID-19 between 3/1/2020 and 09/30/2020 (N=9,928).", "Age, sex, race, ethnicity, body mass index, smoking status, and 44 chronic disease categories were considered as possible risk factors for severe infection.", "Severe infection was defined as hospitalization or death due to COVID-19.", "Associations between risk factors and severe infection were estimated using Cox proportional hazard models overall and within 3 age groups (0-44, 45-64, and 65+ years).", "Results Overall, 474 (4.8%) persons developed severe COVID-19 infection.", "Older age, male sex, non-white race, Hispanic ethnicity, obesity, and a higher number of chronic conditions were associated with increased risk of severe infection.", "After adjustment, 36 chronic disease categories were significantly associated with severe infection.", "The risk of severe infection varied significantly across age groups.", "In particular, persons 0-44 years with cancer, chronic neurologic disorders, hematologic disorders, ischemic heart disease, and other endocrine disorders had a greater than 3-fold increased risk of severe infection compared to persons of the same age without those conditions.", "Associations were attenuated in older age groups.", "Conclusion Older persons are more likely to experience severe infections; however, severe cases occur in younger persons as well.", "Our data provide insight regarding younger persons at especially high risk of severe COVID-19 infection."], "journal": "Mayo Clin Proc", "publish_time": "2021-07-05", "aliases": []}
{"doc_id": 232173279, "title": "UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records", "abstract": ["BACKGROUND: Characterising the size and distribution of the population at risk of severe COVID-19 is vital for effective policy and planning.", "Older age, and underlying health conditions, are associated with higher risk of death from COVID-19.", "This study aimed to describe the population at risk of severe COVID-19 due to underlying health conditions across the United Kingdom.", "METHODS: We used anonymised electronic health records from the Clinical Practice Research Datalink GOLD to estimate the point prevalence on 5 March 2019 of the at-risk population following national guidance.", "Prevalence for any risk condition and for each individual condition is given overall and stratified by age and region with binomial exact confidence intervals.", "We repeated the analysis on 5 March 2014 for full regional representation and to describe prevalence of underlying health conditions in pregnancy.", "We additionally described the population of cancer survivors, and assessed the value of linked secondary care records for ascertaining COVID-19 at-risk status.", "RESULTS: On 5 March 2019, 24.4% of the UK population were at risk due to a record of at least one underlying health condition, including 8.3% of school-aged children, 19.6% of working-aged adults, and 66.2% of individuals aged 70 years or more.", "7.1% of the population had multimorbidity.", "The size of the at-risk population was stable over time comparing 2014 to 2019, despite increases in chronic liver disease and diabetes and decreases in chronic kidney disease and current asthma.", "Separately, 1.6% of the population had a new diagnosis of cancer in the past 5 y.", "CONCLUSIONS: The population at risk of severe COVID-19 (defined as either aged \u226570 years, or younger with an underlying health condition) comprises 18.5 million individuals in the UK, including a considerable proportion of school-aged and working-aged individuals.", "Our national estimates broadly support the use of Global Burden of Disease modelled estimates in other countries.", "We provide age- and region- stratified prevalence for each condition to support effective modelling of public health interventions and planning of vaccine resource allocation.", "The high prevalence of health conditions among older age groups suggests that age-targeted vaccination strategies may efficiently target individuals at higher risk of severe COVID-19.", "SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-021-10427-2."], "journal": "BMC Public Health", "publish_time": "2021-03-11", "aliases": [221298514]}
{"doc_id": 218873233, "title": "Overdose and risk factors for coronavirus disease 2019", "abstract": ["BACKGROUND: There have been significant efforts to respond to the two public health emergencies of coronavirus disease 2019 (COVID-19) and overdose in British Columbia (BC), Canada.", "The purpose of this study was to quantify the prevalence of known risk factors associated with mortality due to COVID-19 for persons who have had a non-fatal overdose during 2015-2017 in comparison to persons who have not had an overdose.", "METHODS: Data were extracted from the BC Provincial Overdose Cohort which includes a 20 % random sample of BC residents and persons who have had a non-fatal overdose in BC from January 2015 to December 2017.", "Chi-square tests and logistic regression were used to compare risk factors by overdose history.", "RESULTS: Persons who had a non-fatal overdose were significantly more likely to have three (chronic pulmonary disease, diabetes, coronary heart disease) of the four known chronic conditions associated with the development of severe illness due to COVID-19 compared to persons who did not have a previous non-fatal overdose event.", "CONCLUSION: Persons who had an overdose were more likely to have several chronic conditions associated with the development of severe illness due to COVID-19.", "The increased likelihood of having these risk factors is reflective of the social and health inequities experienced by persons who have a history of overdose."], "journal": "Drug Alcohol Depend", "publish_time": "2020", "aliases": []}
{"doc_id": 245193778, "title": "Assessment of a Hotel-Based Protective Housing Program for Incidence of SARS-CoV-2 Infection and Management of Chronic Illness Among Persons Experiencing Homelessness", "abstract": ["IMPORTANCE: Persons experiencing homelessness (PEH) are at higher risk for SARS-CoV-2 infection and severe illness due to COVID-19 because of a limited ability to physically distance and a higher burden of underlying health conditions.", "OBJECTIVE: To describe and assess a hotel-based protective housing intervention to reduce incidence of SARS-CoV-2 infection among PEH in Chicago, Illinois, with increased risk of severe illness due to COVID-19.", "DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study analyzed PEH who were provided protective housing in individual hotel rooms in downtown Chicago during the COVID-19 pandemic from April 2 through September 3, 2020.", "Participants were PEH at increased risk for severe COVID-19, defined as (1) aged at least 60 years regardless of health conditions, (2) aged at least 55 years with any underlying health condition posing increased risk, or (3) aged less than 55 years with any underlying health condition posing substantially increased risk (eg, HIV/AIDS).", "EXPOSURES: Participants were housed in individual hotel rooms to reduce the risk of SARS-CoV-2 infection; on-site health care workers provided daily symptom monitoring, regular SARS-CoV-2 testing, and care for chronic health conditions.", "Additional on-site services included treatment of mental health and substance use disorders and social services.", "MAIN OUTCOMES AND MEASURES: The main outcome measured was SARS-CoV-2 incidence, with SARS-Cov2 infection defined as a positive upper respiratory specimen using any polymerase chain reaction diagnostic assay authorized for emergency use by the Food and Drug Administration.", "Secondary outcomes were blood pressure control, glycemic control as measured by hemoglobin A(1c), and housing placements at departure.", "RESULTS: Of 259 participants from 16 homeless shelters in Chicago, 104 (40.2%) were aged at least 65 years, 190 (73.4%) were male, 185 (71.4%) were non-Hispanic Black, and 49 (18.9%) were non-Hispanic White.", "There was an observed reduction in SARS-CoV-2 incidence during the study period among the protective housing cohort (54.7 per 1000 people [95% CI, 22.4-87.1 per 1000 people]) compared with citywide rates for PEH residing in shelters (137.1 per 1000 people [95% CI, 125.1-149.1 per 1000 people]; P = .001).", "There was also an adjusted change in systolic blood pressure at a rate of \u22125.7 mm Hg (95% CI, \u22129.3 to \u22122.1 mm Hg) and hemoglobin A(1c) at a rate of \u22121.4% (95% CI, \u22122.4% to \u22120.4%) compared with baseline.", "More than half of participants (51% [n = 132]) departed from the intervention to housing of some kind (eg, supportive housing).", "CONCLUSIONS AND RELEVANCE: This cohort study found that protective housing was associated with a reduction in SARS-CoV-2 infection among high-risk PEH during the first wave of the COVID-19 pandemic in Chicago.", "These findings suggest that with appropriate wraparound supports (ie, multisector services to address complex needs), such housing interventions may reduce the risk of SARS-CoV-2 infection, improve noncommunicable disease control, and provide a pathway to permanent housing."], "journal": "JAMA Netw Open", "publish_time": "2021-12-13", "aliases": []}
{"doc_id": 233461595, "title": "The Collateral Damage of the COVID-19 Outbreak on Mental Health and Psychiatry", "abstract": ["The potential consequences of the COVID-19 outbreak are multifarious and remain largely unknown.", "Deaths as a direct result of the condition are already in the millions, and the number of indirect deaths is likely to be even higher.", "Pre-existing historical inequalities are compounded by the virus, driving increased rates of infection and deaths amongst people who use drugs and alcohol, those belonging to racial-ethnic minority groups, poorer communities, LBGTQ+ populations, healthcare workers, and other members of the care economy; all of whom are already at increased risk of adverse mental health effects.", "In this paper we suggest that a central role of mental health practitioners is advocacy: both for people who use psychiatric services and for those who, due to the effects of the pandemic, are at an increased risk of needing to do so."], "journal": "Int. j. environ. res. public health (Online)", "publish_time": "2021", "aliases": []}
{"doc_id": 220651205, "title": "Impact of Social Determinants of Health on the Emerging COVID-19 Pandemic in the United States", "abstract": ["A novel coronavirus (2019-nCoV) caused a global pandemic in the months following the first four cases reported in wuhan, china, on December 29, 2019 The elderly, immunocompromised, and those with preexisting conditions-such as asthma, cardiovascular disease (cvd), hypertension, chronic kidney disease (ckd), or obesity-experience higher risk of becoming severely ill if infected with the virus.", "Systemic social inequality and discrepancies in socioeconomic status (ses) contribute to higher incidence of asthma, cvd, hypertension, ckd, and obesity in segments of the general population.", "Such preexisting conditions bring heightened risk of complications for individuals who contract the coronavirus disease (COVID-19) from the virus (2019-nCoV) -also known as `` severe acute respiratory syndrome coronavirus 2 '' (SARS-CoV-2) In order to help vulnerable groups during times of a health emergency, focus must be placed at the root of the problem.", "Studying the social determinants of health (sdoh), and how they impact disadvantaged populations during times of crisis, will help governments to better manage health emergencies so that every individual has equal opportunity to staying healthy.", "This review summarizes the impact of social determinants of health (sdoh) during the COVID-19 pandemic."], "journal": "Frontiers in public health", "publish_time": "2020", "aliases": []}
{"doc_id": 245018543, "title": "Leukocyte albumin ratio as an early predictor of mortality in critical COVID-19 patients", "abstract": ["Aim: The aim of this study is to analyze the effectiveness of the leukocyte albumin ratio (LAR) in predicting mortality in critical COVID-19 patients.", "Material and Methods: In this retrospectively-designed study, we evaluated a total of 98 critical patients who were hospitalized in the intensive care unit.", "Patients were divided into two groups according to hospital mortality as survivors (n=43) and non-survivors (n=55).", "Results: The non-survivors group was statistically significantly older (67.3 +/- 9.7 versus 62.5 +/- 10.9;p=0.023).", "HT and DM were detected more in the non-survivors group than in the survivors group (p=0.031, p=0.018, respectively).", "Mean LAR values were significantly higher in non-survivors than in survivors (5.9 +/- 3.5 versus 3.3 +/- 1.4;p<0.001).", "LAR values was positively correlated with urea (r=0.43, p<0.001), LDH (r=0.35, p<0.001), ferritin (r=0.25, p=0.015), procalcitonin (r=0.34, p<0.001), and pro-BNP (r=0.24, p=0.015) levels.", "A cut-off value of 3.71 ng/mL for LAR predicted mortality with a sensitivity of 76% and a specificity of 70% (AUC:0.779 95% Cl:0.689-0.870;p<0.001).", "Multivariable logistic regression analysis revealed that older age (OR:1.114, 95% CI:1.020-1.218;p=0.017) and increased ferritin (OR:1.003, 95% CI:1.001-1.004;p=0.002) and LAR (OR:1.583, 95% CI:1.073-2.337;p=0.021) values were independent predictors of mortality in patients with critical COVID-19.", "Discussion: LAR can be a useful and prognostic marker that can be used to predict mortality in COVID-19 patients admitted to the intensive care unit."], "journal": "Annals of Clinical and Analytical Medicine", "publish_time": "2021", "aliases": []}
{"doc_id": 222177857, "title": "Clinical characteristics and manifestations in older patients with COVID-19", "abstract": ["BACKGROUND: To investigate the clinical characteristics and manifestations of older patients with coronavirus disease 2019 (COVID-19).", "METHODS: In this retrospective study, 566 patients with confirmed COVID-19 were enrolled and the clinical characteristics, laboratory findings, complications and outcome data were collected and analyzed.", "RESULTS: Among the 566 patients (median age, 61.5 years) with COVID-19, 267 (47.2%) patients were male and 307 (54.2%) were elderly.", "Compared with younger patients, older patients had more underlying comorbidities and laboratory abnormalities.", "A higher rate of acute respiratory distress syndrome (ARDS), acute cardiac injury and heart failure was observed in the older group as compared with younger and middle-aged groups, particularly those oldest-old patients had more multi-organ damage.", "Older patients with COVID-19 were more likely to suffer from acute cardiac injury in cases with preexistenting cardiovascular diseases, while there was no difference among the three groups when patients had no history of cardiovascular diseases.", "Older patients presented more severe with the mortality of 18.6%, which was higher than that in younger and middle-aged patients (P < 0.05).", "Multivariable analysis showed that age, lymphopenia, ARDS, acute cardiac injury, heart failure and skeletal muscle injury were associated with death in older patients, while glucocorticoids might be harmful.", "CONCLUSIONS: Older patients, especially the oldest-old patients were more likely to exhibit significant systemic inflammation, pulmonary and extrapulmonary organ damage and a higher mortality.", "Advanced age, lymphopenia, ARDS, acute cardiac injury, heart failure and skeletal muscle injury were independent predictors of death in older patients with COVID-19 and glucocorticoids should be carefully administered in older patients."], "journal": "BMC Geriatr", "publish_time": "2020-10-08", "aliases": []}
{"doc_id": 235423416, "title": "Association of Frailty with Adverse Outcomes in Patients with Suspected COVID-19 Infection", "abstract": ["Older age and frailty are predictors of adverse outcomes in patients with COVID-19.", "In emergency medicine, patients do not present with the diagnosis, but with suspicion of COVID-19.", "The aim of this study was to assess the association of frailty and age with death or admission to intensive care in patients with suspected COVID-19.", "This single-centre prospective cohort study was performed in the Emergency Department of a tertiary care hospital.", "Patients, 65 years and older, with suspected COVID-19 presenting to the Emergency Department during the first wave of the pandemic were consecutively enrolled.", "All patients underwent nasopharyngeal SARS-CoV-2 PCR swab tests.", "Patients with a Clinical Frailty Scale (CFS) &gt;4, were considered to be frail.", "Associations between age, gender, frailty, and COVID-19 status with the composite adverse outcome of 30-day-intensive-care-admission and/or 30-day-mortality were tested.", "In the 372 patients analysed, the median age was 77 years, 154 (41.4%) were women, 44 (11.8%) were COVID-19-positive, and 125 (33.6%) were frail.", "The worst outcome was seen in frail COVID-19-patients with six (66.7%) adverse outcomes.", "Frailty (CFS &gt;4) and COVID-19-positivity were associated with an adverse outcome after adjustment for age and gender (frailty: OR 5.01, CI 2.56\u201310.17, p &lt;0.001;COVID-19: OR 3.47, CI 1.48\u20137.89, p = 0.003).", "Frailty was strongly associated with adverse outcomes and outperformed age as a predictor in emergency patients with suspected COVID-19."], "journal": "Journal of Clinical Medicine", "publish_time": "2021", "aliases": []}
{"doc_id": 226537299, "title": "Predictors of mortality in COVID-19 patients at Kinshasa University Hospital, Democratic Republic of the Congo (from March to June 2020)", "abstract": ["Introduction: since the 1st case of coronavirus disease 2019 (COVID-19) in kinshasa on March 10th 2020, mortality risk factors have not yet been reported.", "The objectives of the present study were to assess survival and to identify predictors of mortality in COVID-19 patients at kinshasa university hospital methods: a retrospective cohort study was conducted, 141 COVID-19 patients admitted at the kinshasa university hospital from March 23 to June 15, 2020 were included in the study kaplan meier & # 039; s method was used to described survival.", "Predictors of mortality were identified by cox regression models.", "Results: of the 141 patients admitted with COVID-19, 67 4% were men (sex ratio 2H:1F); their average age was 49 6\u00b116 5 years.", "The mortality rate in hospitalized patients with COVID-19 was 29% during the study period with 70% deceased within 24 hours of admission survival was decreased with the presence of hypertension, diabetes mellitus, low blood oxygen saturation (bos), severe or critical stage disease.", "In multivariate analysis, age between 40 and 59 years [ adjusted hazard ratio (ahr): 4 07; 95% CI: 1 16- 8 30 ], age at least 60 years (ahr: 6 65; 95% CI: 1 48-8 88), severe or critical COVID-19 (ahr: 14 05; 95% CI: 6 3-15 67) and presence of dyspnea (ahr: 5 67; 95% CI: 1 46-21 98) were independently and significantly associated with the risk of death.", "Conclusion: older age, severe or critical COVID-19 and dyspnea on admission were potential predictors of mortality in patients with COVID-19 These predictors may help clinicians identify patients with a poor prognosis."], "journal": "Pan African Medical Journal", "publish_time": "2020", "aliases": []}
{"doc_id": 222415522, "title": "Older age and frailty are the chief predictors of mortality in COVID-19 patients admitted to an acute medical unit in a secondary care setting- a cohort study", "abstract": ["BACKGROUND: There is a need for more observational studies across different clinical settings to better understand the epidemiology of the novel COVID-19 infection.", "Evidence on clinical characteristics of COVID-19 infection is scarce in secondary care settings in Western populations.", "METHODS: We describe the clinical characteristics of all consecutive COVID-19 positive patients (n = 215) admitted to the acute medical unit at Fairfield General Hospital (secondary care setting) between 23 March 2020 and 30 April 2020 based on the outcome at discharge (group 1: alive or group 2: deceased).", "We investigated the risk factors that were associated with mortality using binary logistic regression analysis.", "Kaplan-Meir (KM) curves were generated by following the outcome in all patients until 12 May 2020.", "RESULTS: The median age of our cohort was 74 years with a predominance of Caucasians (87.4%) and males (62%).", "Of the 215 patients, 86 (40%) died.", "A higher proportion of patients who died were frail (group 2: 63 vs group 1: 37%, p < 0.001), with a higher prevalence of cardiovascular disease (group 2: 58 vs group 1: 33%, p < 0.001) and respiratory diseases (group 2: 38 vs group 1: 25%, p = 0.03).", "In the multivariate logistic regression models, older age (odds ratio (OR) 1.03; p = 0.03), frailty (OR 5.1; p < 0.001) and lower estimated glomerular filtration rate (eGFR) on admission (OR 0.98; p = 0.01) were significant predictors of inpatient mortality.", "KM curves showed a significantly shorter survival time in the frail older patients.", "CONCLUSION: Older age and frailty are chief risk factors associated with mortality in COVID-19 patients hospitalised to an acute medical unit at secondary care level.", "A holistic approach by incorporating these factors is warranted in the management of patients with COVID-19 infection."], "journal": "BMC Geriatr", "publish_time": "2020-10-16", "aliases": []}
{"doc_id": 227182390, "title": "At the peak of Covid-19 age and disease severity but not comorbidities are predictors of mortality. Covid-19 burden in Bergamo, Italy", "abstract": ["BACKGROUND: Findings from February, 2020, indicate that the clinical spectrum of Covid-19 can be heterogeneous, probably due to the infectious dose and viral load of SARS-CoV-2 within the first weeks of the outbreak.", "The aim of this study was to investigate predictors of overall 28-day mortality at the peak of the italian outbreak methods: Retrospective observational study of all Covid-19 patients admitted to the main hospital of bergamo, from February 23 to march, 14, 2020 RESULTS: 508 patients were hospitalized, predominantly male (72 4%), mean age of 66\u00b115 years; 49 2% were older than 70 years.", "Most of patients presented with severe respiratory failure (median value [ IQR ] of PaO2/FiO2 233 [ 149-281 ]) Mortality rate at 28 days resulted of 33 7% (N=171) 39 0% of patients were treated with continuous positive airway pressure (cpap), 9 5% with non-invasive ventilation (niv) and 13 6% with endotracheal intubation 9 5% were admitted to semi-intensive respiratory care unit, and 18 9% to icu risk factors independently associated with 28-day mortality were advanced age (\u226578 years: odds ratio, or, 95% confidence interval [ CI ] 38 91 [ 10 67-141 93 ], p & lt; 0 001; 70-77 years: 17 30 [ 5 40-55 38 ], p & lt; 0 001; 60-69 years: 3 20 [ 1 00-10 20 ], p=0 049), PaO2/FiO2 & lt; 200 at presentation (3 50 [ 1 70-7 20 ], p=0 001), need for CPAP/NIV in the first 24 hours (8 38 [ 3 63-19 35 ], p & lt; 0 001), and blood urea value at admission (1 01 [ 1 00-1 02 ], p=0 015) CONCLUSIONS: At the peak of the outbreak, with a probable high infectious dose and viral load, older age, the severity of respiratory failure and renal impairment at presentation, but not comorbidities, are predictors of 28-day mortality in Covid-19."], "journal": "Panminerva Med", "publish_time": "2020", "aliases": []}
{"doc_id": 226988182, "title": "Clinical profile and predictors of in-hospital mortality among older patients admitted for COVID-19", "abstract": ["BACKGROUND: The coronavirus disease 2019 (COVID-19) is characterized by poor outcomes and mortality, particularly in older patients.", "METHODS: Post-hoc analysis of the international, multicentre, \"real-world\" HOPE COVID-19 registry.", "All patients aged &#8805;65 years hospitalised for COVID-19 were selected.", "Epidemiological, clinical, analytical and outcome data were obtained.", "A comparative study between two age subgroups, 65-74 and &#8805;75 years, was performed.", "The primary endpoint was all cause in-hospital mortality.", "RESULTS: 1,520 patients aged &#8805;65 years (60.3% male, median age of 76 [IQR 71-83] years) were included.", "Comorbidities such as hypertension (69.2%), dyslipidemia (48.6%), cardiovascular diseases (any chronic heart disease in 38.4% and cerebrovascular disease in 12.5%), and chronic lung disease (25.3%) were prevalent, and 49.6% were on ACEI/ARBs.", "Patients aged 75 years and older suffered more in-hospital complications (respiratory failure, heart failure, renal failure, sepsis) and a significantly higher mortality (18.4 vs. 48.2%, P < 0.001), but fewer admissions to intensive care units (11.2 vs. 4.8%).", "In the overall cohort, multivariable analysis demonstrated age &#8805;75 (OR 3.54), chronic kidney disease (OR 3.36), dementia (OR 8,06), peripheral oxygen saturation at admission <92% (OR 5.85), severe lymphopenia (<500/mm3) (OR 3.36) and qSOFA (Quick Sequential Organ Failure Assessment Score) >1 (OR 8.31) to be independent predictors of mortality.", "CONCLUSION: Patients aged &#8805;65 years hospitalised for COVID-19 had high rates of in-hospital complications and mortality, especially among patients 75 years or older.", "Age &#8805;75 years, dementia, peripheral oxygen saturation <92%, severe lymphopenia and qSOFA scale >1 were independent predictors of mortality in this population."], "journal": "Age ageing", "publish_time": "2020", "aliases": []}
{"doc_id": 219331890, "title": "Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States", "abstract": ["INTRODUCTION: Higher comorbidity and older age have been reported as correlates of poor outcomes in COVID-19 patients worldwide; however, US data are scarce.", "We evaluated mortality predictors of COVID-19 in a large cohort of hospitalized patients in the United States.", "DESIGN: Retrospective, multicenter cohort of inpatients diagnosed with COVID-19 by RT-PCR from 1 March to 17 April 2020 was performed, and outcome data evaluated from 1 March to 17 April 2020.", "Measures included demographics, comorbidities, clinical presentation, laboratory values and imaging on admission.", "Primary outcome was mortality.", "Secondary outcomes included length of stay, time to death and development of acute kidney injury in the first 48-h.", "RESULTS: The 1305 patients were hospitalized during the evaluation period.", "Mean age was 61.0 \u00b1 16.3, 53.8% were male and 66.1% African American.", "Mean BMI was 33.2 \u00b1 8.8 kg m-2 .", "Median Charlson Comorbidity Index (CCI) was 2 (1-4), and 72.6% of patients had at least one comorbidity, with hypertension (56.2%) and diabetes mellitus (30.1%) being the most prevalent.", "ACE-I/ARB use and NSAIDs use were widely prevalent (43.3% and 35.7%, respectively).", "Mortality occurred in 200 (15.3%) of patients with median time of 10 (6-14) days.", "Age > 60 (aOR: 1.93, 95% CI: 1.26-2.94) and CCI > 3 (aOR: 2.71, 95% CI: 1.85-3.97) were independently associated with mortality by multivariate analyses.", "NSAIDs and ACE-I/ARB use had no significant effects on renal failure in the first 48 h. CONCLUSION: Advanced age and an increasing number of comorbidities are independent predictors of in-hospital mortality for COVID-19 patients.", "NSAIDs and ACE-I/ARB use prior to admission is not associated with renal failure or increased mortality."], "journal": "J Intern Med", "publish_time": "2020", "aliases": []}
{"doc_id": 236210856, "title": "Impact of Chronic RAAS Use in Elderly COVID-19 Patients: A Retrospective Analysis", "abstract": ["Corona Virus Disease-19 (COVID-19) recently emerged as a global pandemic.", "Advanced age is the most important risk factor for increased virus susceptibility and worse outcomes.", "Many older adults are currently treated with renin\u2013angiotensin\u2013aldosterone system (RAAS) inhibitors and there is concern that these medications might increase the risk of mortality by COVID-19.", "This is a retrospective cohort of 346 patients older than 65 years with COVID-19, at the Department of Medicine of the Centro Hospitalar Universit\u00e1rio Lisboa Norte, in Portugal, hospitalized between March 2020 and August 2020.", "Mean age was 80.9 \u00b1 8.7 years old.", "Most patients had arterial hypertension (n = 279, 80.6%), almost half (n = 161, 46.5%) had cardiovascular disease and approximately one-third of patients had heart failure (n = 127, 36.7%) or diabetes Mellitus (n = 113, 32.7%).", "Ninety-eight patients (28.3%) had chronic kidney disease and almost half of the patients (49.4%) were chronically under renin\u2013angiotensin\u2013aldosterone system (RAAS) inhibitors.", "Twenty percent of patients died during hospitalization.", "In a multivariate analysis, older age (OR 1.11, 95% CI 1.04, 1.18, p = 0.002), absence of baseline medication with RAAS inhibitors (OR 0.27, 95% CI 0.10, 0.75, p = 0.011), higher serum ferritin (OR 1.00, 95% CI 1.00, 1.00, p = 0.003) and higher lactate levels (OR 1.08, 95% CI 1.02, 1.14, p = 0.006) were independent predictors of mortality.", "Older age, higher serum ferritin and lactate levels at admission were found to be independent predictors of mortality and might act as early predictors of worsening disease in clinical practice.", "Chronic treatment with RAAS inhibitors appeared to be protective, supporting guidelines in not discontinuing such drugs."], "journal": "J Clin Med", "publish_time": "2021-07-16", "aliases": []}
{"doc_id": 235774995, "title": "COVID-19 and aging: Identifying measures of severity", "abstract": ["INTRODUCTION: We aimed to compare clinical features of older age group and young and middle-aged patients with COVID-19 and analyze mortality predictors.", "METHODS: Retrospective analysis of ongoing collection of prespecified data, on a single institution, including patients hospitalized consecutively due to COVID-19 infection, from March to June 2020.", "RESULTS: Of 195 patients, 56.9% were \u2a7e65 years (older age group).", "Older age group had multimorbidity (p < 0.001).", "At admission Early Warning Score-2 (p < 0.001), C-reactive protein, D-dimer, creatinine, anemia and lymphopenia were higher in older age group, as well as median time of hospitalization (14 vs 10 days, p = 0.004).", "Complications were more common in older age group, but there were no significant differences in admission to intensive care.", "There were 18 deaths, 16 in older age group.", "Modified Early Warning Score at admission (odds ratio = 1.60, 95% confidence interval = 1.07\u20131.37, p = 0.021) and C-reactive protein >5 mg/dL (odds ratio = 2.12, 95% confidence interval = 1.13\u201326.26, p = 0.034) were independent predictors of inhospital mortality in older age group but not in young and middle-aged.", "CONCLUSION: Older age group was at higher risk for complications and inhospital mortality.", "Identification of specific scores of severity for this population is essential to ensure that best care is provided."], "journal": "SAGE Open Med", "publish_time": "2021-06-24", "aliases": []}
{"doc_id": 236175314, "title": "Spatial epidemiological study of the distribution, clustering, and risk factors associated with early COVID-19 mortality in Mexico", "abstract": ["COVID-19 is a respiratory disease caused by SARS-CoV-2, which has significantly impacted economic and public healthcare systems worldwide.", "SARS-CoV-2 is highly lethal in older adults (>65 years old) and in cases with underlying medical conditions, including chronic respiratory diseases, immunosuppression, and cardio-metabolic diseases, including severe obesity, diabetes, and hypertension.", "The course of the COVID-19 pandemic in Mexico has led to many fatal cases in younger patients attributable to cardio-metabolic conditions.", "Thus, in the present study, we aimed to perform an early spatial epidemiological analysis for the COVID-19 outbreak in Mexico.", "Firstly, to evaluate how mortality risk from COVID-19 among tested individuals (MRt) is geographically distributed and secondly, to analyze the association of spatial predictors of MRt across different states in Mexico, controlling for the severity of the disease.", "Among health-related variables, diabetes and obesity were positively associated with COVID-19 fatality.", "When analyzing Mexico as a whole, we identified that both the percentages of external and internal migration had positive associations with early COVID-19 mortality risk with external migration having the second-highest positive association.", "As an indirect measure of urbanicity, population density, and overcrowding in households, the physicians-to-population ratio has the highest positive association with MRt.", "In contrast, the percentage of individuals in the age group between 10 to 39 years had a negative association with MRt.", "Geographically, Quintana Roo, Baja California, Chihuahua, and Tabasco (until April 2020) had higher MRt and standardized mortality ratios, suggesting that risks in these states were above what was nationally expected.", "Additionally, the strength of the association between some spatial predictors and the COVID-19 fatality risk varied by zone."], "journal": "PLoS One", "publish_time": "2021-07-21", "aliases": []}
{"doc_id": 235396498, "title": "Clinical characteristics and predictors of mortality among COVID-19 patients in Saudi Arabia", "abstract": ["BACKGROUND: The new coronavirus disease (COVID-19) has caused more than 1.8 million deaths, with a fatality rate of 2.5% in more than 200 countries as of January 4, 2021.", "Analysis of COVID-19 clinical features can help predict disease severity and risk of mortality, early identification of high-risk patients, and provide knowledge to inform clinical interventions.", "OBJECTIVE: The purpose of this study is to investigate the clinical characteristics and possible predictors associated with mortality in patients with COVID-19 admitted to King Fahad (KFH), Ohood, and Miqat hospitals in Madina, Saudi Arabia.", "METHODS: This retrospective observational study to investigate the clinical characteristic and possible predictors associated with mortality for those 119 mild, moderate, or critically ill patients confirmed by laboratory results to have COVID-19 who were admitted to three hospitals in Madina, Saudi Arabia, from March 25, 2020, to July 30, 2020.", "Data were collected from December 1, 2020, to December 14, 2020.", "RESULTS: Of the 119 patients included in the study, the mean age was 54.2 (\u00b115.7) years, with 78.2% survivors and 21.8% non-survivors.", "The demographic analysis indicated that the likelihood of mortality for patients in the older age group (i.e., &#8805;65 years) was five times higher than those in the younger age group (OR = 5.34, 95% CI 1.71-16.68, p = 0.004).", "The results also indicated those patients who admitted to the intensive care unit (ICU) was approximately seven times higher odds of mortality compare with those who were not admitted (OR = 6.48, 95% CI 2.52-16.63, p < 0.001).", "In addition, six laboratory parameters were positively associated with the odds of mortality: white blood cell count (OR = 1.11, 95% CI 1.02-1.21, p = 0.018), neutrophil (OR = 1.11, 95% CI 1.02-1.22, p = 0.020), creatine kinase myocardial band (OR = 1.02, 95% CI 1.00-1.03, p = 0.030), C-reactive protein (OR = 1.01, 95% CI 1.00-1.01, p = 0.002), urea (OR = 1.06, 95% CI 1.01-1.11, p = 0.026), and lactate dehydrogenase (OR = 1.00, 95% CI 1.00-1.01, p = 0.020).", "CONCLUSIONS: In this cohort, COVID-19 patients within the older age group (&#8805;65 years) admitted to the ICU with increased C-reactive protein levels in particular, were associated with increased odds of mortality.", "Further clinical observations are warranted to support these findings and enhance the mapping and control of this pandemic."], "journal": "J Infect Public Health", "publish_time": "2021", "aliases": []}
{"doc_id": 238749755, "title": "Geriatrics-focused indicators predict mortality more than age in older adults hospitalized with COVID-19", "abstract": ["BACKGROUND: Age has been implicated as the main risk factor for COVID-19-related mortality.", "Our objective was to utilize administrative data to build an explanatory model accounting for geriatrics-focused indicators to predict mortality in hospitalized older adults with COVID-19.", "METHODS: Retrospective cohort study of adults age 65 and older (N = 4783) hospitalized with COVID-19 in the greater New York metropolitan area between 3/1/20-4/20/20.", "Data included patient demographics and clinical presentation.", "Stepwise logistic regression with Akaike Information Criterion minimization was used.", "RESULTS: The average age was 77.4 (SD = 8.4), 55.9% were male, 20.3% were African American, and 15.0% were Hispanic.", "In multivariable analysis, male sex (adjusted odds ration (adjOR) = 1.06, 95% CI:1.03-1.09); Asian race (adjOR = 1.08, CI:1.03-1.13); history of chronic kidney disease (adjOR = 1.05, CI:1.01-1.09) and interstitial lung disease (adjOR = 1.35, CI:1.28-1.42); low or normal body mass index (adjOR:1.03, CI:1.00-1.07); higher comorbidity index (adjOR = 1.01, CI:1.01-1.02); admission from a facility (adjOR = 1.14, CI:1.09-1.20); and mechanical ventilation (adjOR = 1.52, CI:1.43-1.62) were associated with mortality.", "While age was not an independent predictor of mortality, increasing age (centered at 65) interacted with hypertension (adjOR = 1.02, CI:0.98-1.07, reducing by a factor of 0.96 every 10 years); early Do-Not-Resuscitate (DNR, life-sustaining treatment preferences) (adjOR = 1.38, CI:1.22-1.57, reducing by a factor of 0.92 every 10 years); and severe illness on admission (at 65, adjOR = 1.47, CI:1.40-1.54, reducing by a factor of 0.96 every 10 years).", "CONCLUSION: Our findings highlight that residence prior to admission, early DNR, and acute illness severity are important predictors of mortality in hospitalized older adults with COVID-19.", "Readily available administrative geriatrics-focused indicators that go beyond age can be utilized when considering prognosis.", "SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-021-02527-w."], "journal": "BMC Geriatr", "publish_time": "2021-10-14", "aliases": []}
{"doc_id": 229337488, "title": "Age Does Not Predict Mortality in Hospitalized COVID-19+ Older Adults: Rethinking Resource Allocation Based on Age", "abstract": ["Older adults are disproportionately affected by the coronavirus (COVID-19) pandemic.", "While age has been used to guide resource allocation based on studies implicating age as the main risk factor for COVID-19-related mortality, most did not account for critical factors such as baseline functional and cognitive status, or life-sustaining treatment preferences.", "The objective of this study was to determine whether age is independently associated with mortality in older adults hospitalized with COVID-19.", "We conducted a retrospective cohort study of adults age 65+ with confirmed COVID-19 hospitalized in the greater NY metropolitan area between 3/1/20-4/20/20.", "Primary outcome was in-hospital mortality, with age as the primary predictor.", "Multivariate logistic regression was used to evaluate association between age and in-hospital mortality after controlling for demographics, severity of acute illness, comorbidities, and baseline function, cognition, and life-sustaining treatment preferences.", "4,969 patients were included, average age 77.3, 56.0% male, 46.8% White, 20.8% African American, 15.1% Hispanic.", "Common comorbidities included hypertension (61.1%), and diabetes (36.8%); average number of comorbidities was 3.4 (SD 2.8) and 13.0% had dementia.", "20.8% arrived from a facility and 5.7% had early do-not-resuscitate orders.", "On arrival, the Modified Early Warning System score was 4.2 (SD 1.7) and 79.6% required oxygen therapy.", "35.3% of patients expired.", "In multivariate analysis, age was not independently associated with mortality (p = .173).", "Functional status, multi-morbidity, life-sustaining treatment preferences, and illness severity, not age, were associated with mortality among older adults hospitalized with COVID-19, suggesting age should not be used as the main indicator to guide resource allocation."], "journal": "Innov Aging", "publish_time": "2020-12-16", "aliases": [229337488]}
{"doc_id": 226051062, "title": "Inverse Association between Serotonin 2A Receptor Antagonist Medication Use and Mortality in Severe COVID-19 Infection", "abstract": ["advanced age and medical co-morbidity are strong predictors of mortality in COVID-19 infection.", "Yet few studies (to date) have specifically addressed risk factors associated with COVID-19 mortality in a high-risk subgroup of older us adults having one or more chronic diseases.", "Our hypothesis is that medications having 'off-target' anti-inflammatory effects may play a role in modulating the immune response in COVID-19 infection.", "We analyzed baseline risk factors associated with respiratory failure or death in 55 older adult us military veterans hospitalized for COVID-19 infection during (March-June 2020) the peak of the pandemic in new jersey.", "Fifty-three percent (29/55) of patients experienced respiratory failure and thirty-one percent (17/55) died.", "In adjusted logistic regression analysis, baseline neutrophil to lymphocyte ratio (nlr) (P=0 0035) and body mass index (P=0 03) were significant predictors of the risk for respiratory failure.", "Age (P=0 05) and non-use (vs use) of psychotropic medications having serotonin 2A receptor antagonist properties (odds ratio 5 06; 95% confidence intervals 1 18-21 7; P= 0 029) was each a significant predictor of an increased risk of death.", "There was a significant interaction effect of age and non-use (vs use) of psychotropic serotonin 2A receptor antagonist medications on the odds ratio (OR) for death (P=0 011) In selected, ventilator-dependent COVID-19 pneumonia patients treated with psychotropic serotonin 2A receptor antagonist medications to control agitation and icu delirium, there was an apparent positive association between medication use and significant rise in the absolute lymphocyte count and decrease in the neutrophil: lymphocyte ratio taken together, these data are the first to suggest that certain psychotropic medications used in the treatment of chronic psychiatric illness and/or for acute delirium are inversely associated with mortality in severe COVID-19 infection by unknown mechanism which may involve (in part) immunomodulatory effects."], "journal": "Endocrinol Diabetes Metab J", "publish_time": "2020", "aliases": []}
{"doc_id": 235723570, "title": "Predictors of survival in older adults hospitalized with COVID-19", "abstract": ["OBJECTIVE: This study was designed to investigate clinical characteristics associated with mortality and predictors of survival in older adults hospitalized with COVID-19 with a focus on neurological comorbidities and presenting neurological manifestations.", "METHODS: We compared clinical characteristics in an age- and gender-matched sample of 75 deceased and 75 recovered patients (M(Age) = 78) hospitalized with COVID-19 and developed a logistic regression to predict likelihood of survival.", "RESULTS: Deceased patients were more like to have dementia, altered mental status (AMS), acute respiratory distress syndrome (ARDS), sepsis, mechanical ventilation, and balance difficulties; higher heart rate, respiratory rate, blood urea nitrogen, creatinine, and absolute neutrophils; lower oxygen saturation and absolute lymphocytes; and shorter length of hospitalization.", "Logistic regression based on three mortality predictors (ARDS, AMS, and length of hospitalization) correctly predicted 87% of the outcome (89% sensitivity at 85% specificity).", "CONCLUSIONS: Dementia and AMS were strong predictors of death in older adults hospitalized with COVID-19.", "Our findings add to the rapidly growing neurology of COVID-19 literature and underscore the importance of early recognition and the incorporation of a mental status examination into the medical assessment of COVID-19."], "journal": "Neurol Sci", "publish_time": "2021-07-03", "aliases": []}
{"doc_id": 245126210, "title": "Clinical features and predictors of mortality among hospitalized patients with COVID-19 in Niger", "abstract": ["INTRODUCTION: COVID-19 has spread across the African continent, including Niger.", "Yet very little is known about the phenotype of people who tested positive for COVID-19.", "In this humanitarian crises region, we aimed at characterizing variation in clinical features among hospitalized patients with COVID-19-like syndrome and to determine predictors associated with COVID-19 mortality among those with confirmed COVID-19.", "METHODS: The study was a retrospective nationwide cohort of hospitalized patients isolated for COVID-19 infection, using the health data of the National Health Information System from 19 March 2020 (onset of the pandemic) to 17 November 2020.", "All hospitalized patients with COVID-19-like syndrome at admission were included.", "A Cox-proportional regression model was built to identify predictors of in-hospital death among patients with confirmed COVID-19.", "RESULTS: Sixty-five percent (472/729) of patients hospitalized with COVID-19 like syndrome tested positive for SARS-CoV-2 among which, 70 (15%) died.", "Among the patients with confirmed COVID-19 infection, age was significantly associated with increased odds of reporting cough (adjusted odds ratio [aOR] 1.02; 95% confidence interval [CI] 1.01\u20131.03) and fever/chills (aOR 1.02; 95% CI 1.02\u20131.04).", "Comorbidity was associated with increased odds of presenting with cough (aOR 1.59; 95% CI 1.03\u20132.45) and shortness of breath (aOR 2.03; 95% CI 1.27\u20133.26) at admission.", "In addition, comorbidity (adjusted hazards ratio [aHR] 2.04; 95% CI 2.38\u20136.35), shortness of breath at baseline (aHR 2.04; 95% CI 2.38\u20136.35) and being 60 years or older (aHR 5.34; 95% CI 3.25\u20138.75) increased the risk of COVID-19 mortality two to five folds.", "CONCLUSION: Comorbidity, shortness of breath on admission, and being aged 60 years or older are associated with a higher risk of death among patients hospitalized with COVID-19 in a humanitarian crisis setting.", "While robust prospective data are needed to guide evidence, our data might aid intensive care resource allocation in Niger."], "journal": "Confl Health", "publish_time": "2021-12-14", "aliases": []}
{"doc_id": 223517969, "title": "Predictors of mortality in patients with COVID-19 - a systematic review", "abstract": ["Introduction: In the current COVID-19 pandemic, disease diagnosis is essential for optimal management and timely isolation of infected cases in order to prevent further spread.", "The aim of this study was to systematically review the assessment of risk and model the predictors of mortality in COVID-19 patients.", "Methods: A systematic search was conducted of PubMed, Scopus, Embase, Google Scholar, and Web of Science databases.", "Variables associated with hospital mortality using bivariate analysis were included as potential independent predictors associated with mortality at the p <0.05levels.", "Results: We included 114 studies accounting for 310,494 patients from various parts of the world.", "For the purpose of this analysis, we set a cutoff point of 10% for the mortality percentages.", "High mortality rates were defined as higher than 10% of confirmed positive cases and were given a score of two, while low mortality percentage (<10%) was assigned to the score of one.", "We then analyzed the associations between 72 variables and the observed mortality rates.", "These variables included a large range of related conditions such as demographics, signs and symptoms and related morbidities, vital signs, laboratory findings, imaging studies, underlying diseases, and the status of countries' income based on United Nation's classifications.", "Conclusion: Findings suggest that older age, hypertension, and diabetes mellitus conferred a significant increased risk of mortality among patients with COVID-19.", "In the multivariate analysis, only diabetes mellitus demonstrated an independent relationship with increased mortality.", "Further studies are needed to ascertain the relationship between possible risk factors with COVID-19 mortality."], "journal": "Eur J Integr Med", "publish_time": "2020", "aliases": []}
{"doc_id": 235632933, "title": "Model of End-Stage Liver Disease (MELD) Score as a Predictor of In-Hospital Mortality in Patients with COVID-19: A Novel Approach to a Classic Scoring System", "abstract": ["Background Limited data is available for reliable and accurate predictors of in-hospital mortality in patients diagnosed with COVID-19.", "Methods This scientific study is a retrospective cohort study of patients without a known history of liver diseases who were hospitalized with COVID-19 viral infection.", "Patients were stratified into low score groups (Model of End-Stage Liver Disease [MELD] score <10) and high score groups (MELD \u226510).", "Clinical outcomes were evaluated, including in-hospital mortality, hospital length of stay, and intensive care unit length of stay (ICU LOS).", "Results Our cohort of 186 COVID-19 positive patients included 88 (47%) women with a mean age of 60 years in the low score group and mean age of 73 years in the high score group.", "Patients in the high score group were older in age (p<0.0001) and more likely to have history of diabetes mellitus (p=0.0020), stage 3 chronic kidney disease (CKD) (p=0.0013), hypertension (p<0.0001), stroke/transient ischemic attack (TIA) (p=0.0163), asthma (p=0.0356), dementia (p<0.0001), and chronic heart failure (p=0.0055).", "The in-hospital mortality or discharge to hospice rate was significantly higher in the high-score group as opposed to the low-score group (p=0.0014).", "Conversely, there was no significant difference among both groups in the hospital length of stay (LOS) and ICU LOS (p=0.6929 and p=0.7689, respectively).", "Conclusion Patients hospitalized with COVID-19 infection and found to have a MELD score greater than or equal to 10 were found to have a higher mortality as compared to their counterparts.", "Conversely a low MELD score is a very strong indicator of a more favorable prognosis, indicating hospital survival.", "We propose using the MELD score as an adjunct for risk stratifying patients diagnosed with COVID-19 without prior history of liver dysfunction."], "journal": "Cureus", "publish_time": "2021-05-22", "aliases": []}
{"doc_id": 221712128, "title": "Predictors of In-Hospital Mortality in Older Patients With COVID-19: The COVIDAge Study", "abstract": ["OBJECTIVE: To determine predictors of in-hospital mortality related to COVID-19 in older patients.", "DESIGN: Retrospective cohort study.", "SETTING AND PARTICIPANTS: Patients aged 65 years and older hospitalized for a diagnosis of COVID-19.", "METHODS: Data from hospital admission were collected from the electronic medical records.", "Logistic regression and Cox proportional hazard models were used to predict mortality, our primary outcome.", "Variables at hospital admission were categorized according to the following domains: demographics, clinical history, comorbidities, previous treatment, clinical status, vital signs, clinical scales and scores, routine laboratory analysis, and imaging results.", "RESULTS: Of a total of 235 Caucasian patients, 43% were male, with a mean age of 86 \u00b1 6.5 years.", "Seventy-six patients (32%) died.", "Nonsurvivors had a shorter number of days from initial symptoms to hospitalization (P = .007) and the length of stay in acute wards than survivors (P < .001).", "Similarly, they had a higher prevalence of heart failure (P = .044), peripheral artery disease (P = .009), crackles at clinical status (P < .001), respiratory rate (P = .005), oxygen support needs (P < .001), C-reactive protein (P < .001), bilateral and peripheral infiltrates on chest radiographs (P = .001), and a lower prevalence of headache (P = .009).", "Furthermore, nonsurvivors were more often frail (P < .001), with worse functional status (P < .001), higher comorbidity burden (P < .001), and delirium at admission (P = .007).", "A multivariable Cox model showed that male sex (HR 4.00, 95% CI 2.08-7.71, P < .001), increased fraction of inspired oxygen (HR 1.06, 95% CI 1.03-1.09, P < .001), and crackles (HR 2.42, 95% CI 1.15-6.06, P = .019) were the best predictors of mortality, while better functional status was protective (HR 0.98, 95% CI 0.97-0.99, P = .001).", "CONCLUSIONS AND IMPLICATIONS: In older patients hospitalized for COVID-19, male sex, crackles, a higher fraction of inspired oxygen, and functionality were independent risk factors of mortality.", "These routine parameters, and not differences in age, should be used to evaluate prognosis in older patients."], "journal": "J Am Med Dir Assoc", "publish_time": "2020", "aliases": []}
{"doc_id": 220120970, "title": "Safety, Tolerability, and Pharmacokinetics of Remdesivir, an Antiviral for Treatment of COVID\u201019, in Healthy Subjects", "abstract": ["Remdesivir (RDV), a single diastereomeric monophosphoroamidate prodrug that inhibits viral RNA polymerases, has potent in vitro antiviral activity against SARS\u2010CoV2.", "RDV received FDA\u2019s emergency use authorization in United States and approval in Japan for treatment of severe COVID\u201019 patients.", "This report describes two phase 1 studies that evaluated the safety and pharmacokinetics (PK) of single escalating and multiple intravenous (IV) doses of RDV (solution or lyophilized formulation) in healthy subjects.", "Lyophilized formulation was evaluated for potential future use in clinical trials due to its storage stability in resource\u2010limited settings.", "All adverse events were Grade 1 or 2 in severity.", "Overall, RDV exhibited a linear profile following single\u2010dose IV administration over 2 hours of RDV solution formulation across the dose range of 3 to 225mg.", "Both lyophilized and solution formulations provided comparable PK parameters.", "High intracellular concentrations of the active triphosphate (approximately 220 to 370\u2010 fold higher than the in vitro EC50 against SARS\u2010CoV\u20102 clinical isolate) were achieved following infusion of 75 mg or 150 mg lyophilized formulation over 30 minutes or 2 hours.", "Following multiple\u2010doses of RDV 150mg once daily for 7 or 14 days, RDV exhibited a PK profile similar to single\u2010dose administration.", "Metabolite GS\u2010441524 accumulated approximately 1.9\u2010fold after daily dosing.", "Overall, RDV exhibited favorable safety and PK profiles that supported once\u2010daily dosing."], "journal": "Clin Transl Sci", "publish_time": "2020-06-26", "aliases": []}
{"doc_id": 222344564, "title": "Clofazimine is a broad-spectrum coronavirus inhibitor that antagonizes SARS-CoV-2 replication in primary human cell culture and hamsters", "abstract": ["COVID-19 pandemic is the third zoonotic coronavirus (CoV) outbreak of the century after severe acute respiratory syndrome (SARS) in 2003 and Middle East respiratory syndrome (MERS) since 2012.", "Treatment options for CoVs are largely lacking.", "Here, we show that clofazimine, an anti-leprosy drug with a favorable safety and pharmacokinetics profile, possesses pan-coronaviral inhibitory activity, and can antagonize SARS-CoV-2 replication in multiple in vitro systems, including the human embryonic stem cell-derived cardiomyocytes and ex vivo lung cultures.", "The FDA-approved molecule was found to inhibit multiple steps of viral replication, suggesting multiple underlying antiviral mechanisms.", "In a hamster model of SARS-CoV-2 pathogenesis, prophylactic or therapeutic administration of clofazimine significantly reduced viral load in the lung and fecal viral shedding, and also prevented cytokine storm associated with viral infection.", "Additionally, clofazimine exhibited synergy when administered with remdesivir.", "Since clofazimine is orally bioavailable and has a comparatively low manufacturing cost, it is an attractive clinical candidate for outpatient treatment and remdesivir-based combinatorial therapy for hospitalized COVID-19 patients, particularly in developing countries.", "Taken together, our data provide evidence that clofazimine may have a role in the control of the current pandemic SARS-CoV-2, endemic MERS-CoV in the Middle East, and, possibly most importantly, emerging CoVs of the future."], "journal": "Res Sq", "publish_time": "2020-10-07", "aliases": []}
{"doc_id": 221505145, "title": "Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis", "abstract": ["Objectives: The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, also known as COVID-19 pandemic has caused an alarming situation worldwide.", "Since the first detection, in December 2019, there have been no effective drug therapy options for treating the SARS-CoV-2 pandemic.", "However, healthcare professionals are using chloroquine, hydroxychloroquine, remdesivir, convalescent plasma and some other options of treatments.", "This study aims to compare the biological, molecular, pharmacological, and clinical characteristics of these three treatment modalities for SARS-COV-2 infections, Chloroquine and Hydroxychloroquine, Convalescent Plasma, and Remdesivir.", "Methods: A search was conducted in the \"Institute of Science Information (ISI)-Web of Science, PubMed, EMBASE, ClinicalTrials.gov, Cochrane Library databases, Scopus, and Google Scholar\" for peer reviewed, published studies and clinical trials through July 30, 2020.", "The search was based on keywords \"COVID-19\" SARS-COV-2, chloroquine, hydroxychloroquine, convalescent plasma, remdesivir and treatment modalities.", "Results: As of July 30, 2020, a total of 36,640 relevant documents were published.", "From them 672 peer reviewed, published articles, and clinical trials were screened.", "We selected 17 relevant published original articles and clinical trials: 05 for chloroquine and/or hydroxychloroquine with total sample size (n\u00e2\u0080\u00af=\u00e2\u0080\u00af220), 05 for Remdesivir (n\u00e2\u0080\u00af=\u00e2\u0080\u00af1,781), and 07 for Convalescent Plasma therapy (n\u00e2\u0080\u00af=\u00e2\u0080\u00af398), with a combined total sample size (n\u00e2\u0080\u00af=\u00e2\u0080\u00af2,399).", "Based on the available data, convalescent plasma therapy showed clinical advantages in SARS-COV-2 patients.", "Conclusions: All three treatment modalities have both favorable and unfavorable characteristics, but none showed clear evidence of benefit for early outpatient disease or prophylaxis.", "Based on the current available data, convalescent plasma therapy appears to show clinical advantages for inpatient use.", "In the future, ongoing large sample size randomized controlled clinical trials may further clarify the comparative efficacy and safety of these three treatment classes, to conclusively determine whom to treat with which drug and when to treat them."], "journal": "", "publish_time": "2020", "aliases": []}
{"doc_id": 246412955, "title": "Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials", "abstract": ["BACKGROUND: Coronavirus disease 2019 (COVID-19) continues to pose a significant threat to public health worldwide.", "The purpose of this study was to review current evidence obtained from randomized clinical trials on the efficacy of antivirals for COVID-19 treatment.", "METHODS: A systematic literature search was performed using PubMed to identify randomized controlled trials published up to September 4, 2021 that examined the efficacy of antivirals for COVID-19 treatment.", "Studies that were not randomized controlled trials or that did not include treatment of COVID-19 with approved antivirals were excluded.", "Risk of bias was assessed using the Scottish Intercollegiate Guidelines Network (SIGN) method.", "Due to study heterogeneity, inferential statistics were not performed and data were expressed as descriptive statistics.", "RESULTS: Of the 2,284 articles retrieved, 31 (12,440 patients) articles were included.", "Overall, antivirals were more effective when administered early in the disease course.", "No antiviral treatment demonstrated efficacy at reducing COVID-19 mortality.", "Sofosbuvir/daclatasvir results suggested clinical improvement, although statistical power was low.", "Remdesivir exhibited efficacy in reducing time to recovery, but results were inconsistent across trials.", "CONCLUSIONS: Although select antivirals have exhibited efficacy to improve clinical outcomes in COVID-19 patients, none demonstrated efficacy in reducing mortality.", "Larger RCTs are needed to conclusively establish efficacy.", "SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07068-0."], "journal": "BMC Infect Dis", "publish_time": "2022-01-31", "aliases": []}
{"doc_id": 245179238, "title": "Modeling the Structure\u2013Activity Relationship of Arbidol Derivatives and Other SARS-CoV-2 Fusion Inhibitors Targeting the S2 Segment of the Spike Protein", "abstract": ["[Image: see text] Umifenovir (Arbidol) has been reported to exhibit some degree of efficacy in multiple clinical trials for the treatment of COVID-19 as a monotherapy.", "It has also demonstrated synergistic inhibition of SARS-CoV-2 with other direct-acting antivirals such as Remdesivir.", "A computational approach was used to identify the most favorable binding site to the SARS-CoV-2 Spike S2 segment and to perform virtual screening.", "Compounds selected from modeling were evaluated in a live SARS-CoV-2 infection assay.", "An Arbidol (ARB) derivative with substitutions at both the C-4 and C-6 positions was found to exhibit a modest improvement in activity and solubility properties in comparison to ARB.", "However, all of the derivatives were found to only be partial inhibitors, rather than full inhibitors in a virus-induced cytopathic effect-based assay.", "The binding mode is also corroborated by parallel modeling of a series of oleanolic acid trisaccharide saponin fusion inhibitors shown to bind to the S2 segment.", "Recently determined experimental structures of the Spike protein allowed atomic resolution modeling of fusion inhibitor binding as a function of pH, and the implications for the molecular mechanism of direct-acting fusion inhibitors targeting the S2 segment are discussed."], "journal": "J Chem Inf Model", "publish_time": "2021-12-13", "aliases": []}
{"doc_id": 238748317, "title": "Whole-Lung Low-Dose Radiation Therapy (LD-RT) for Non-Intubated Oxygen-Dependent Patients with COVID-19-Related Pneumonia Receiving Dexamethasone and/or Remdesevir", "abstract": ["Background Low-dose radiotherapy (LD-RT) has produced anti-inflammatory effects in both animal models and early human trials of COVID-19-related pneumonia.", "The role of whole-lung LD-RT within existing treatment paradigms merits further study.", "Methods A phase II prospective trial studied the addition of LD-RT to standard drug treatments.", "Hospitalized and oxygen-dependent patients receiving dexamethasone and/or remdesevir were treated with 1.5 Gy whole-lung LD-RT and compared to a blindly-matched contemporaneous control cohort.", "Results Of 40 patients evaluated, 20 received drug therapy combined with whole-lung LD-RT and 20 without LD-RT.", "Intubation rates were 14% with LD-RT compared to 32% without (p=0.09).", "Intubation-free survival was 77% vs. 68% (p=0.17).", "Biomarkers of inflammation (C-reactive protein, p=0.02) and cardiac injury (creatine kinase, p<0.01) declined following LD-RT compared to controls.", "Mean time febrile was 1.4 vs 3.3 days, respectively (p=0.14).", "Significant differences in clinical recovery (7.5 vs. 7 days, p=0.37) and radiographic improvement (p=0.72) were not detected.", "On subset analysis, CRP decline following LD-RT was predictive of recovery without intubation compared to controls (0% vs. 31%, p=0.04), freedom from prolonged hospitalizations (21+ days) (0% vs. 31%, p=0.04), and decline in oxygenation burden (56% reduction, p=0.06).", "CRP decline following 1st drug therapy was not similarly predictive of outcome in controls (p=0.36).", "Conclusions Adding LD-RT to standard drug treatments reduced biomarkers of inflammation and cardiac injury in COVID-19 patients and may have reduced intubation.", "Durable CRP decline following LD-RT predicted especially favorable recovery, freedom from intubation, reduction in prolonged hospitalization, and reduced oxygenation burden.", "A confirmatory randomized trial is now ongoing.", "Clinical Trial Registration: NCT04366791.", "Funding: None"], "journal": "Radiother Oncol", "publish_time": "2021-10-13", "aliases": []}
{"doc_id": 218658621, "title": "Hyperbaric oxygen therapy in preventing mechanical ventilation in COVID-19 patients: a retrospective case series.", "abstract": ["OBJECTIVE A pandemic afflicts the entire world.", "The highly contagious SARS-CoV-2 virus originated in Wuhan, China in late 2019 and rapidly spread across the entire globe.", "According to the World Health Organization (WHO), the novel Coronavirus (COVID-19)has infected more than two million people worldwide, causing over 160,000 deaths.", "Patients with COVID-19 disease present with a wide array of symptoms, ranging from mild flu-like complaints to life threatening pulmonary and cardiac complications.", "Older people and patients with underlying disease have an increased risk of developing severe acute respiratory syndrome (SARS) requiring mechanical ventilation.", "Once intubated, mortality increases exponentially.", "A number of pharmacologic regimens, including hydroxychloroquine-azithromycin, antiviral therapy (eg, remdesevir), and anti-IL-6 agents (e.g., toclizumab), have been highlighted by investigators over the course of the pandemic, based on the therapy's potential to interrupt the viral life-cycle of SARS-CoV-2 or preventing cytokine storm.", "At present, there have been no conclusive series of reproducible randomised clinical trials demonstrating the efficacy of any one drug or therapy for COVID-19.", "CASES COVID-19 positive patients (n=5) at a single institution received hyperbaric oxygen therapy (HBOT) between 13 and 20 April 2020.", "All the patients had tachypnoea and low oxygen saturation despite receiving high FiO2.", "HBOT was added to prevent the need for mechanical ventilation.", "A standard dive profile of 2.0ATA for 90 minutes was employed.", "Patients received between one and six treatments in one of two dedicated monoplace hyperbaric chambers.", "RESULTS All the patients recovered without the need for mechanical ventilation.", "Following HBOT, oxygen saturation increased, tachypnoea resolved and inflammatory markers fell.", "At the time of writing, three of the five patients have been discharged from the hospital and two remain in stable condition.", "CONCLUSION This small sample of patients exhibited dramatic improvement with HBOT.", "Most importantly, HBOT potentially prevented the need for mechanical ventilation.", "Larger studies are likely to define the role of HBOT in the treatment of this novel disease."], "journal": "Journal of wound care", "publish_time": "2020-05-01", "aliases": []}
{"doc_id": 219429421, "title": "Randomization amid a pandemic - a critical appraisal regarding convalescent plasma therapy clinical trials for COVID-19 patients", "abstract": ["Abstract.", "The novel coronavirus disease (COVID-19) is spreading rapidly, a pandemic that has already affected millions of people across the world.", "Currently there are no vaccines or drugs approved for COVID-19 Initial data which are coming from large clinical trials using hydroxychloroquine, Lopinavir/Ritonavir, remdesevir, and Favipiravir are not satisfactory against COVID-19 till now and we are in the midst of a worldwide public health threat.", "In this context human convalescent plasma is considered as an option for treatment of COVID-19 disease.", "Convalescent plasma therapy is a classic adaptive immunotherapy which involves the administration of antibodies against COVID-19 to a COVID-19 patient for the purpose of treating the viral disease.", "Over the last two decades, convalescent plasma therapy was used for the treatment of 2003 SARS-CoV-1 epidemic, 2009-2010 H1N1 influenza virus pandemic, the 2012 middle east.", "Respiratory.", "Syndrome (mers) -CoV epidemic and 2014-2016 Ebola epidemic."], "journal": "ISBT Science Series", "publish_time": "2020", "aliases": []}
{"doc_id": 225072057, "title": "Effectiveness of steroid treatment for SARS-CoV-2 pneumonia with COP-like reaction: a case report", "abstract": ["Several studies on the treatment of coronavirus disease (COVID-19) are being conducted, and various drugs are being tried; however, the results have not been uniform.", "Steroids have been widely used in the treatment of COVID-19, but their effects are controversial.", "As immunosuppressive and anti-inflammatory agents, steroids are considered to reduce lung damage by regulating various inflammatory responses.", "We report a case of severe acute respiratory syndrome coronavirus-2 pneumonia manifesting as a cryptogenic organizing pneumonia-like reaction and discuss its treatment, clinical course, and favorable outcomes after steroid administration."], "journal": "Disaster Med Public Health Prep", "publish_time": "2020", "aliases": []}
{"doc_id": 226283340, "title": "Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi-Organ Failure", "abstract": ["background: New treatment platforms that can prevent acute respiratory distress syndrome (ards) or reduce its mortality rate in high-risk coronavirus disease 2019 (COVID-19) patients, such as those with an underlying cancer, are urgently needed rejuveinix (rjx) is an intravenous formulation of anti-oxidants and anti-inflammatory agents.", "Its active ingredients include ascorbic acid, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate RJX is being developed as an anti-inflammatory and anti-oxidant treatment platform for patients with sepsis, including COVID-19 patients with viral sepsis and ards here, we report its clinical safety profile in a phase 1 clinical study (clinicaltrials gov identifier: NCT03680105) and its potent protective activity in the lipopolysaccharide galactosamine (LPS-GalN) mouse model of ards methods: A phase 1, double-blind, placebo-controlled, randomized, two-part, ascending dose-escalation study was performed in participating 76 healthy volunteer human subjects in compliance with the ich (E6) good clinical practice guidelines to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of rjx (protocol no RPI003; clinicaltrials gov identifier: NCT03680105) The ability of rjx to prevent fatal shock, ards, and multi-organ failure was examined in the well-established LPS-GalN mouse model of sepsis and ards standard methods were employed for the statistical analysis of data in both studies.", "Findings: In the phase 1 clinical study, no participant developed serious adverse events (saes) or Grade 3-Grade 4 adverse events (aes) or prematurely discontinued participation in the study.", "In the non-clinical study, rjx exhibited potent and dose-dependent protective activity, decreased the inflammatory cytokine responses (interleukin-6, tumor necrosis factor alpha, transforming growth factor beta), and improved survival in the LPS-GalN mouse model of sepsis and ards histopathological examinations showed that rjx attenuated the LPS-GalN induced acute lung injury (ali) and pulmonary edema as well as liver damage.", "Conclusion: RJX showed a very favorable safety profile and tolerability in human subjects.", "It shows potential to favorably affect the clinical course of high-risk COVID-19 by preventing ards and its complications."], "journal": "Front Pharmacol", "publish_time": "2020", "aliases": []}
{"doc_id": 216322884, "title": "Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China", "abstract": ["Background With evidence of sustained transmission in more than 190 countries, coronavirus disease 2019 (COVID-19) has been declared a global pandemic.", "As such, data are urgently needed about risk factors associated with clinical outcomes.", "Methods A retrospective chart review of 323 hospitalized patients with COVID-19 in Wuhan was conducted.", "Patients were classified into three disease severity groups (non-severe, severe, and critical), based on their initial clinical presentation.", "Clinical outcomes were designated as favorable and unfavorable, based on disease progression and response to treatments.", "Logistic regression models were performed to identify factors associated with clinical outcomes, and logrank test was conducted for the association with clinical progression.", "Results Current standard treatments did not show significant improvement on patient outcomes in the study.", "By univariate logistic regression model, 27 risk factors were significantly associated with clinical outcomes.", "Further, multivariate regression indicated that age over 65 years, smoking, critical disease status, diabetes, high hypersensitive troponin I (>0.04 pg/mL), leukocytosis (>10 x 109/L) and neutrophilia (>75 x 109/L) predicted unfavorable clinical outcomes.", "By contrast, the use of hypnotics was significantly associated with favorable outcomes.", "Survival analysis also confirmed that patients receiving hypnotics had significantly better survival.", "Conclusions To our knowledge, this is the first indication that hypnotics could be an effective ancillary treatment for COVID-19.", "We also found that novel risk factors, such as higher hypersensitive troponin I, predicted poor clinical outcomes.", "Overall, our study provides useful data to guide early clinical decision making to reduce mortality and improve clinical outcomes of COVID-19."], "journal": "", "publish_time": "2020-03-26", "aliases": [218491227]}
{"doc_id": 220253769, "title": "Clinical trials for the prevention and treatment of COVID\u201019: current state of play", "abstract": ["Since coronavirus disease 2019 (COVID\u201019) emerged in Wuhan, China in December 2019 and spread around the world, over 1100 clinical studies have been registered globally on clinical trials registries, including over 500 randomised controlled trials.", "Such rapid development and launch of clinical trials is impressive but presents challenges, including the potential for duplication and competition.", "There is currently no known effective treatment for COVID\u201019.", "In order to focus on those studies most likely to influence clinical practice, we summarise the 31 currently registered randomised trials with a target sample size of at least 1000 participants.", "We have grouped these trials into four categories: prophylaxis; treatment of outpatients with mild COVID\u201019; treatment of hospitalised patients with moderate COVID\u201019; and treatment of hospitalised patients with moderate or severe disease.", "The most common therapeutic agent being trialled currently is hydroxychloroquine (24 trials with potential sample size of over 25 000 participants), followed by lopinavir\u2013ritonavir (seven trials) and remdesevir (five trials).", "There are many candidate drugs in pre\u2010clinical and early phase development, and these form a pipeline for future large clinical trials if current candidate therapies prove ineffective or unsafe."], "journal": "Med J Aust", "publish_time": "2020-06-27", "aliases": []}
{"doc_id": 226853486, "title": "Association between early treatment with Qingfei Paidu decoction and favorable clinical outcomes in patients with COVID-19: A retrospective multicenter cohort study", "abstract": ["The coronavirus disease 2019 (COVID-19) epidemic has been almost controlled in China under a series of policies, including \"early diagnosis and early treatment\".", "This study aimed to explore the association between early treatment with Qingfei Paidu decoction (QFPDD) and favorable clinical outcomes.", "In this retrospective multicenter study, we included 782 patients (males, 56 %; median age 46) with confirmed COVID-19 from 54 hospitals in nine provinces of China, who were divided into four groups according to the treatment initiation time from the first date of onset of symptoms to the date of starting treatment with QFPDD.", "The primary outcome was time to recovery; days of viral shedding, duration of hospital stay, and course of the disease were also analyzed.", "Compared with treatment initiated after 3 weeks, early treatment with QFPDD after less than 1 week, 1-2 weeks, or 2-3 weeks had a higher likelihood of recovery, with adjusted hazard ratio (HR) (95 % confidence interval [CI]) of 3.81 (2.65-5.48), 2.63 (1.86-3.73), and 1.92 (1.34-2.75), respectively.", "The median course of the disease decreased from 34 days to 24 days, 21 days, and 18 days when treatment was administered early by a week (P < 0.0001).", "Treatment within a week was related to a decrease by 1-4 days in the median duration of hospital stay compared with late treatment (P<0.0001).", "In conclusion, early treatment with QFPDD may serve as an effective strategy in controlling the epidemic, as early treatment with QFPDD was associated with favorable outcomes, including faster recovery, shorter time to viral shedding, and a shorter duration of hospital stay.", "However, further multicenter, prospective studies with a larger sample size should be conducted to confirm the benefits of early treatment with QFPDD."], "journal": "Pharmacol Res", "publish_time": "2020", "aliases": []}
{"doc_id": 221997330, "title": "Screening of FDA Approved Drugs Against SARS-CoV-2 Main Protease: Coronavirus Disease", "abstract": ["At the end of December 2019, a new strain of coronavirus was identified in the Wuhan city of Hubei province in China.", "Within a shorter period of time, an unprecedented outbreak of this strain was witnessed over the entire Wuhan city.", "This novel coronavirus strain was later officially renamed as COVID-19 (Coronavirus disease 2019) by the World Health Organization.", "The mode of transmission was human-to-human contact and hence resulted in a rapid surge across the globe where more than 24 million people have been infected with COVID-19.", "In the current scenario, finding potent drug candidates for the treatment of COVID-19 has emerged as the most challenging task for clinicians and researchers worldwide.", "Identification of new drugs and vaccine development may take from a few months to years based on the clinical trial processes.", "To overcome the several limitations involved in identifying and bringing out potent drug candidates for treating COVID-19, in the present study attempts were made to screen the FDA approved drugs using High Throughput Virtual Screening (HTVS).", "The COVID-19 main protease (COVID-19 Mpro) was chosen as the drug target for which the FDA approved drugs were initially screened with HTVS.", "The drug candidates that exhibited favorable docking score, energy, and emodel calculations were further taken for performing Induced Fit Docking (IFD) using Schrodinger's GLIDE.", "From the flexible docking results, the following four FDA approved drugs Sincalide, Pentagastrin, Ritonavir, and Phytonadione were identified.", "In particular, Sincalide and Pentagastrin can be considered potential key players for the treatment of COVID-19 disease."], "journal": "Int J Pept Res Ther", "publish_time": "2020", "aliases": []}
{"doc_id": 234488043, "title": "Broad Anti-Viral Capacities of Lian-Hua-Qing-Wen Capsule and Jin-Hua-Qing-Gan Granule and Rational use Against COVID-19 Based on Literature Mining", "abstract": ["The novel coronavirus disease 2019 (COVID-19) has become a matter of international concern as the disease is spreading exponentially statistics showed that infected patients in china who received combined treatment of traditional chinese medicine and modern medicine exhibited lower fatality rate and relatively better clinical outcomes.", "Both.", "Lian-Hua-Qing-Wen.", "Capsule (lhqwc) and Jin-Hua-Qing-Gan.", "Granule (jhqgg) have been recommended by china food and drug administration for the treatment of COVID-19 and have played a vital role in the prevention of a variety of viral infections.", "Here, we desired to analyze the broad-spectrum anti-viral capacities of lhqwc and jhqgg, and to compare their pharmacological functions for rational clinical applications.", "Based on literature mining, we found that both lhqwc and jhqgg were endowed with multiple antiviral activities by both targeting viral life cycle and regulating host immune responses and inflammation.", "In addition, from literature analyzed, jhqgg is more potent in modulating viral life cycle, whereas lhqwc exhibits better efficacies in regulating host anti-viral responses.", "When translating into clinical applications, oral administration of lhqwc could be more beneficial for patients with insufficient immune functions or for patients with alleviated symptoms after treatment with jhqgg."], "journal": "Front Pharmacol", "publish_time": "2021", "aliases": []}
{"doc_id": 236147017, "title": "Early use of tocilizumab in patients with severe pneumonia secondary to severe acute respiratory syndrome coronavirus 2 infection and poor prognostic criteria: Impact on mortality rate and intensive care unit admission", "abstract": ["The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2, keeps spreading globally.", "Evidence suggests that a subgroup of patients with severe symptomatology might have cytokine storms, which increases mortality.", "The use of interleukin-6 (IL-6) inhibitors may help in controlling the pathological immune response to the virus.", "Tocilizumab, a monoclonal antibody against IL-6, stands as an optional treatment for COVID-19 patients presenting this inflammatory hyper-response.", "We conducted a retrospective, observational, cohort study including 50 patients affected by COVID-19 with severe pneumonia and poor prognosis criteria, who have also undergone standard treatment; 36 of these patients additionally received tocilizumab in an early stage.", "The need for intensive care unit (ICU) admission, mortality, recovery of respiratory function, and improvement of biochemical and hematological parameters were compared between cohorts.", "Most patients were men, non-smokers and the most frequently reported comorbidities were hypertension and diabetes.", "Recurrent symptoms were fever, cough, and dyspnoea.", "54.8% of patients from the tocilizumab group needed intubation, while in the control group 85.7% needed it.", "Treatment with tocilizumab significatively increased IL-6 levels, (554.45; CI 95% 186.69, 1032.93; P < .05) while C-reactive protein mean levels were reduced (\u2013108.19; CI 95% \u2013140.15, \u201375.33; P < .05), but no significant difference was found between cohorts.", "In comparison with the controls, tocilizumab reduced mortality (25.0% vs 42.9%, P = .021) and the number of ICU admissions (63.9% vs 100.0%, P = .021).", "44.1% of patients treated with tocilizumab showed favorable radiological evolution, when compared with 15.4% of patients from the control group.", "Tocilizumab may improve clinical symptoms and mitigate deterioration observed in severe COVID-19 patients, and could be considered as an effective therapeutic option in subjects experiencing a significant inflammatory response to the disease."], "journal": "Medicine (Baltimore)", "publish_time": "2021-07-23", "aliases": []}
{"doc_id": 221686786, "title": "Safety and Efficacy of the combined use of ivermectin, dexamethasone, enoxaparin and aspirin against COVID-19", "abstract": ["From the first outbreak in Wuhan (China) in December 2019, until today the number of deaths worldwide due to the coronavirus pandemic exceeds eight hundred thousand people and the number of infected people arises to more than 25 million.", "No treatment tested worldwide has shown unquestionable efficacy in the fight against COVID 19, according to NICE reports.", "We have designed an experimental treatment called IDEA based on four affordable drugs already available on the market in Argentina, based on the following rationale: -Ivermectin solution at a relatively high dose to lower the viral load in all stages of COVID 19 -Dexamethasone 4-mg injection, as anti-inflammatory drug to treat hyperinflammatory reaction to COVID-infection -Enoxaparin injection as anticoagulant to treat hypercoagulation in severe cases.", "-Aspirin 250-mg tablets to prevent hypercoagulation in mild and moderate cases Except for Ivermection oral solution, which was used in a higher dose than approved for parasitosis, all other drugs were used in the already approved dose and indication.", "Regarding Ivermectin safety, several oral studies have shown it to be safe even when used at daily doses much higher than those approved already.", "A clinical study has been conducted on COVID-19 patients at Eurnekian Hospital in the Province of Buenos Aires, Argentina.", "The study protocol and its final outcomes are described in this article.", "Results were compared with published data and data from patients admitted to the hospital receiving other treatments.", "None of the patient presenting mild symptoms needed to be hospitalized.", "Only one patient died (0.59 % of all included patients vs. 2.1 % overall mortality for the disease in Argentina today; 3.1 % of hospitalized patients vs. 26.8 % mortality in published data).", "IDEA protocol appears to be a useful alternative to prevent disease progression of COVID-19 when applied to mild cases and to decrease mortality in patients at all stages of the disease with a favorable risk-benefit ratio."], "journal": "", "publish_time": "2020-09-15", "aliases": []}
{"doc_id": 226089516, "title": "Pharmacological interventions for the treatment of Coronavirus Disease (COVID-19)/ Intervenciones farmacol\u00f3gicas para el tratamiento de la Enfermedad por Coronavirus (COVID-19)", "abstract": ["Several drugs have been proposed as therapeutic alternatives for COVID-19.", "An electronic systematic search of MEDLINE (via PubMed) was carried out until March 20th 2020, in order to identify the available evidence on pharmacological interventions for specific treatment of COVID-19.", "The quality of the evidence from clinical trials was evaluated according to the GRADE methodology.", "947 publications were identified and 15 studies were selected: 3 clinical trials, 5 case series and 7 case reports.", "The existing evidence for hydroxychloroquine, favipiravir and lopinavir/ritonavir comes from clinical trials reporting favorable results for the first two drugs, while no benefit was observed when lopinavir/ritonavir was added to standard treatment.", "However, due to methodological issues, the evidence for hydroxychloroquine is very low.", "For favipiravir and lopinavir/ritonavir the evidence is low.", "Regarding the use of arbidol interferon, or the combined use of these with lopinavir/ritonavir, the evidence is limited since it derives from case series or case report with non-determining results.", "No studies were identified that reliably demonstrate the efficacy and safety of any pharmacological intervention against COVID-19."], "journal": "An. Facult. Med.", "publish_time": "2020", "aliases": []}
{"doc_id": 235775520, "title": "Case Report: Coronavirus Disease 2019-associated Rhinosinusitis Mucormycosis Caused by Rhizopus arrhizus: A Rare but Potentially Fatal Infection Occurring After Treatment with Corticosteroids", "abstract": ["Coronavirus disease 2019 (COVID-19) first emerged in Wuhan, China, in December 2019.", "Since that time, the frequency of bacterial and fungal coinfections has been continuously increasing.", "Although invasive pulmonary aspergillosis is being increasingly recognized in association with COVID-19, there is limited information regarding COVID-19-associated mucormycosis.", "We describe a 50-year-old woman with uncontrolled diabetes who received systemic corticosteroids and remdesevir during her admission for COVID-19.", "A few days after discharge, the patient was readmitted because of facial swelling and numbness, and a diagnosis of COVID-19-associated rhinosinusitis mucormycosis caused by Rhizopus arrhizus (formerly called Rhizopus oryzae) was confirmed with sequencing of the internal transcribed spacer region of the ribosomal DNA.", "This report aimed to address the importance of short-term follow-up for COVID-19 patients who have received systemic corticosteroids, particularly those with predisposing conditions, because early detection and prompt, aggressive treatment are essential for the management of invasive fungal infections."], "journal": "Am. j. trop. med. hyg", "publish_time": "2021", "aliases": []}
{"doc_id": 218759443, "title": "Rescue therapy for severe COVID-19-associated acute respiratory distress syndrome with tissue plasminogen activator: A case series", "abstract": ["The coronavirus disease 2019 (COVID-19) pandemic has led to unprecedented stresses on modern medical systems, overwhelming the resource infrastructure in numerous countries while presenting a unique series of pathophysiologic clinical findings.", "Thrombotic coagulopathy is common in critically ill patients suffering from COVID-19, with associated high rates of respiratory failure requiring prolonged periods of mechanical ventilation.", "Here, we report a case series of five patients suffering from profound, medically refractory COVID-19-associated respiratory failure who were treated with fibrinolytic therapy using tissue plasminogen activator (tPA; alteplase).", "All five patients appeared to have an improved respiratory status following tPA administration: one patient had an initial marked improvement that partially regressed after several hours, one patient had transient improvements that were not sustained, and three patients had sustained clinical improvements following tPA administration.", "LEVEL OF EVIDENCE: Therapeutic, Level V."], "journal": "J Trauma Acute Care Surg", "publish_time": "2020", "aliases": []}
{"doc_id": 237516193, "title": "COVID-19 Critical Illness: A Data-Driven Review", "abstract": ["The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges in critical care medicine, including extreme demand for intensive care unit (ICU) resources and rapidly evolving understanding of a novel disease.", "Up to one-third of hospitalized patients with COVID-19 experience critical illness.", "The most common form of organ failure in COVID-19 critical illness is acute hypoxemic respiratory failure, which clinically presents as acute respiratory distress syndrome (ARDS) in three-quarters of ICU patients.", "Noninvasive respiratory support modalities are being used with increasing frequency given their potential to reduce the need for intubation.", "Determining optimal patient selection for and timing of intubation remains a challenge.", "Management of mechanically ventilated patients with COVID-19 largely mirrors that of non-COVID-19 ARDS.", "Organ failure is common and portends a poor prognosis.", "Mortality rates have improved over the course of the pandemic, likely owing to increasing disease familiarity, data-driven pharmacologics, and improved adherence to evidence-based critical care.", "Expected final online publication date for the Annual Review of Medicine, Volume 73 is January 2022.", "Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates."], "journal": "Ann. rev. med", "publish_time": "2021", "aliases": []}
{"doc_id": 226975381, "title": "Central and peripheral nervous system complications of COVID-19: A prospective tertiary center cohort with 3-month follow-up", "abstract": ["Objective: To systematically describe CNS and PNS complications in hospitalized COVID-19 patients.", "Methods: We conducted a prospective, consecutive, observational study of adult patients from a tertiary referral center with confirmed COVID-19.", "All patients were screened daily for neurological and neuropsychiatric symptoms during admission, at discharge and at 3-month follow-up.", "We classified complications as caused by SARS-CoV-2 neurotropism, immune-mediated or critical illness-related.", "Results: From April-September 2020, we enrolled 61 consecutively admitted COVID-19 patients, 35 (57%) of whom were referred to ICU for respiratory failure.", "Evaluation revealed a higher frequency of CNS/PNS symptoms in ICU patients compared to non-ICU patients.", "The most common CNS complication was encephalopathy (n=22, 36.1%), which was severe in 13 patients (GCS[\u2264]12), including 8 with akinetic mutism.", "Length of ICU admission was an independent predictor of encephalopathy (OR=1.23).", "Other CNS complications included ischemic stroke, a biopsy-proven acute necrotizing encephalitis, and transverse myelitis.", "The most common PNS complication was critical illness polyneuromyopathy (13.1%), with prolonged ICU stay as independent predictor (OR=1.14).", "Treatment-related PNS complications included meralgia paresthetica.", "Of 41 complications in total, 3 were classified as para/post-infectious.", "The remainder included cases secondary to critical illness or other causes (n=34) or without sufficient investigations (n=4).", "Cerebrospinal fluid was negative for SARS-CoV-2 RNA in all 5 patients investigated.", "Conclusions: CNS/PNS complications were common in hospitalized COVID-19 patients, particularly in ICU patients, and often attributable to critical illness.", "In cases with COVID-19 as the primary cause for neurological disease, there were no signs of viral neurotropism, but laboratory changes suggested autoimmune-mediated mechanisms."], "journal": "", "publish_time": "2020-11-17", "aliases": []}
{"doc_id": 215733257, "title": "Fatal outcome in a liver transplant recipient with COVID\u201019", "abstract": ["Liver injury is common in patients with COVID\u201019, but little is known about its clinical presentation and severity in the context of liver transplant.", "We describe a case of COVID\u201019 in a patient who underwent transplant 3 years ago for hepatocellular carcinoma.", "The patient came to clinic with symptoms of respiratory disease; pharyngeal swabs for severe acute respiratory syndrome coronavirus 2 were positive.", "His disease progressed rapidly from mild to critical illness and was complicated by several nosocomial infections and multiorgan failure.", "Despite multiple invasive procedures and rescue therapies, he died from the disease.", "The management of COVID\u201019 in the posttransplant setting presents complex challenges, emphasizing the importance of strict prevention strategies."], "journal": "Am J Transplant", "publish_time": "2020-05-04", "aliases": []}
{"doc_id": 218856486, "title": "Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China", "abstract": ["OBJECTIVE: The clinical features of rheumatic patients with coronavirus disease 2019 (COVID-19) have not been reported.", "This study aimed to describe the clinical features of COVID-19 in rheumatic patients and provide information for handling this situation in clinical practice.", "METHODS: This is a retrospective case series study.", "Deidentified data, including gender, age, laboratory and radiological results, symptoms, signs, and medication history, were collected from 2326 patients diagnosed with COVID-19, including 21 cases in combination with rheumatic disease, in Tongji Hospital between 13 January and 15 March 2020.", "RESULTS: Length of hospital stay and mortality rate were similar between rheumatic and non-rheumatic groups, while the presence of respiratory failure was more common in rheumatic cases (38% vs 10%, p<0.001).", "Symptoms of fever, fatigue and diarrhoea were seen in 76%, 43% and 23% of patients, respectively.", "There were four rheumatic patients who experienced a flare of rheumatic disease during hospital stay, with symptoms of muscle aches, back pain, joint pain or rash.", "While lymphocytopaenia was seen in 57% of rheumatic patients, only one patient (5%) presented with leucopenia in rheumatic cases.", "Rheumatic patients presented with similar radiological features of ground-glass opacity and consolidation.", "Patients with pre-existing interstitial lung disease showed massive fibrous stripes and crazy-paving signs at an early stage.", "Five rheumatic cases used hydroxychloroquine before the diagnosis of COVID-19 and none progressed to critically ill stage.", "CONCLUSIONS: Respiratory failure was more common in rheumatic patients infected with COVID-19.", "Differential diagnosis between COVID-19 and a flare of rheumatic disease should be considered.", "TRIAL REGISTRATION NUMBER: ChiCTR2000030795."], "journal": "Ann Rheum Dis", "publish_time": "2020-05-22", "aliases": []}
{"doc_id": 235451914, "title": "COVID-19 and Candida Duobushaemulonii Superinfection: a case report", "abstract": ["INTRODUCTION: Critically ill COVID-19 patients are at high risk for nosocomial bacterial and fungal infections due to several predisposing factors such as intensive care unit stay, mechanical ventilation, and broad-spectrum antibiotics.", "Data regarding multidrug resistant (MDR) Candida species in COVID-19 patients is scarce, and nonexistent regarding Candida duobushaemulonii superinfections.", "CASE DESCRIPTION: A 34-year-old male presented to our institution with acute respiratory distress syndrome (ARDS) due to COVID-19 infection and developed Candida duobushaemulonii fungemia after multiple courses of antibiotics and prolonged mechanical ventilation.", "He died after recurrent pneumothorax led to respiratory failure and cardiac arrest.", "DISCUSSION: Bacterial and fungal infections are common complications of viral pneumonia in critically ill patients.", "Data regarding these infections in COVID-19 patients has been poorly studied with only a few cases reporting secondary infection, mostly without identifying specific pathogens.", "Prolonged hospital stays, invasive interventions (central venous catheter, mechanical ventilation), and the use of broad-spectrum antibiotics in COVID-19 infections could carry a high risk of bacterial and/or fungal superinfections.", "CONCLUSION: Strategies to improve outcome in COVID-19 ICU patients should include early recognition of candidemia and appropriate antifungal therapy."], "journal": "J Mycol Med", "publish_time": "2021-06-16", "aliases": []}
{"doc_id": 221012882, "title": "Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19", "abstract": ["Respiratory failure and acute kidney injury (AKI) are associated with high mortality in SARS-CoV-2-associated Coronavirus disease 2019 (COVID-19).", "These manifestations are linked to a hypercoaguable, pro-inflammatory state with persistent, systemic complement activation.", "Three critical COVID-19 patients recalcitrant to multiple interventions had skin biopsies documenting deposition of the terminal complement component C5b-9, the lectin complement pathway enzyme MASP2, and C4d in microvascular endothelium.", "Administration of anti-C5 monoclonal antibody eculizumab led to a marked decline in D-dimers and neutrophil counts in all three cases, and normalization of liver functions and creatinine in two.", "One patient with severe heart failure and AKI had a complete remission.", "The other two individuals had partial remissions, one with resolution of his AKI but ultimately succumbing to respiratory failure, and another with a significant decline in FiO2 requirements, but persistent renal failure.", "In conclusion, anti-complement therapy may be beneficial in at least some patients with critical COVID-19."], "journal": "Clin Immunol", "publish_time": "2020", "aliases": []}
{"doc_id": 221310215, "title": "Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19", "abstract": ["COVID-19 is an infectious disease caused by the coronavirus SARS-CoV-2, which was first reported in Wuhan, China, in December 2019 and has caused a global pandemic.", "Acute respiratory distress syndrome (ARDS) is a common feature of severe forms of COVID-19 and can lead to respiratory failure, especially in older individuals.", "The increasing recognition of the neurotropic potential of SARS-CoV-2 has sparked interest in the role of the nervous system in respiratory failure in people with COVID-19.", "However, the neuroimmune interactions in the lung in the context of ARDS are poorly understood.", "In this Perspectives article, we propose the concept of the neuroimmune unit as a critical determinant of lung function in the context of COVID-19, inflammatory conditions and ageing, focusing particularly on the involvement of the vagus nerve.", "We discuss approaches such as neurostimulation and pharmacological neuromodulation to reduce tissue inflammation with the aim of preventing respiratory failure."], "journal": "Nat Rev Neurol", "publish_time": "2020", "aliases": []}
{"doc_id": 221183252, "title": "Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study", "abstract": ["PURPOSE: An ongoing outbreak of coronavirus disease 2019 (COVID-19) emerged in Wuhan since December 2019 and spread globally.", "However, information about critically ill patients with COVID-19 is still limited.", "We aimed to describe the clinical characteristics and outcomes of critically ill patients with COVID-19 and figure out the risk factors of mortality.", "METHODS: We extracted data retrospectively regarding 733 critically ill adult patients with laboratory-confirmed COVID-19 from 19 hospitals in China through January 1 to February 29, 2020.", "Demographic data, symptoms, laboratory values, comorbidities, treatments, and clinical outcomes were collected.", "The primary outcome was 28-day mortality.", "Data were compared between survivors and non-survivors.", "RESULTS: Of the 733 patients included in the study, the median (IQR) age was 65 (56\u201373) years and 256 (34.9%) were female.", "Among these patients, the median (IQR) APACHE II score was 10 (7 to 14) and 28-day mortality was 53.8%.", "Respiratory failure was the most common organ failure (597 [81.5%]), followed by shock (20%), thrombocytopenia (18.8%), central nervous system (8.6%) and renal dysfunction (8%).", "Multivariate Cox regression analysis showed that older age, malignancies, high APACHE II score, high d-dimer level, low PaO(2)/FiO(2) level, high creatinine level, high hscTnI level and low albumin level were independent risk factors of 28-day mortality in critically ill patients with COVID-19.", "CONCLUSION: In this case series of critically ill patients with COVID-19 who were admitted into the ICU, more than half patients died at day 28.", "The higher percentage of organ failure in these patients indicated a significant demand for critical care resources.", "ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00134-020-06211-2) contains supplementary material, which is available to authorized users."], "journal": "Intensive Care Med", "publish_time": "2020-08-20", "aliases": []}
{"doc_id": 221037859, "title": "Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS)", "abstract": ["Traced back to December 2019, an unexpected outbreak of a highly contagious new coronavirus pneumonia (COVID-19) has rapidly swept around China and the globe.", "There have now been an estimated 2 580 000 infections and more than 170 000 fatal cases around the world.", "The World Health Organization (WHO) estimated that approximately 14% of infections developed into severe disease, 5% were critically ill, and the mortality rate of critically ill patients is reported to be over 50%.", "The shortage of specific anti-viral treatment and vaccines remains a huge challenge.", "In COVID-19, refractory hypoxemia is common among the critically ill with acute respiratory distress syndrome (ARDS) despite invasive mechanical ventilation, and is further complicated by respiratory and circulatory failure.", "This difficult situation calls for the use of extracorporeal membrane oxygenation (ECMO) for assisting respiration and circulation if necessary.", "This article reviews the pertinent clinical literature, technical guidance, and expert recommendations on use of ECMO in critically ill cases of COVID-19.", "Here, we present basic knowledge and opinions about COVID-19 and ECMO, review the evidence on ECMO use in Middle East Respiratory Syndrome (MERS) and H1N1 influenza, share the technical guidance and recommendations on use of ECMO in COVID-19, summarize the current use of ECMO against COVID-19 in China, and discuss the issues in use of ECMO in COVID-19."], "journal": "Med Sci Monit", "publish_time": "2020-08-06", "aliases": []}
{"doc_id": 230597628, "title": "Recovery from respiratory failure after 49-day extracorporeal membrane oxygenation support in a critically ill patient with COVID-19: case report", "abstract": ["background: Respiratory failure is a life-threatening complication of coronavirus disease 2019 (COVID-19) -related acute respiratory distress syndrome.", "Extracorporeal membrane oxygenation (ecmo) in COVID-19 might offer promise based on our clinical experience.", "However, few critically ill cases with COVID-19 have been weaned off ecmo case summary: A 66-year-old chinese woman presented with fever (38 9degreeC), cough, dyspnoea, and headache.", "She had lymphopenia (0 72 x 109/L) and computed tomography findings of ground-glass opacities.", "Subsequently, she was confirmed to have respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.", "She was intubated after transfer to the intensive care unit due to respiratory failure and heart failure.", "However, her condition continued to deteriorate rapidly.", "Veno-veno ECMO was undertaken for respiratory and cardiac support due to refractory hypoxemic respiratory failure and bradyarrhythmia (45 b p m) During hospitalization, she was also administered anti-viral treatment, convalescent plasma therapy, and continuous renal replacement therapy.", "She was maintained on ecmo before she had fully recovered from the condition that necessitated ecmo use and had a negative test for the nucleic acids of SARS-CoV-2 twice.", "Forty-nine days later, this patient was weaned from ecmo at the most recent follow-up visit (3 months after weaning from ecmo), she received respiratory and cardiac rehabilitation and did not complain of any discomfort.", "Discussion: As far as we know, the longest duration of ecmo treatment in this critical case with COVID-19 is supportive of ecmo as the most aggressive form of life support and the last line of defence during the COVID-19 epidemic."], "journal": "European Heart Journal. Case Reports", "publish_time": "2021", "aliases": []}
{"doc_id": 221225656, "title": "Initial Experience of Critically Ill Patients with COVID-19 in Western India: A Case Series", "abstract": ["BACKGROUND: The novel coronavirus, named SARS-CoV-2, was first described in December 2019 as a cluster of pneumonia cases in Wuhan, China.", "It has since been declared a pandemic, with substantial mortality.", "MATERIALS AND METHODS: In our case series, we describe the clinical presentation, characteristics, and outcomes of our initial experience of managing 24 critically ill COVID-19 patients at a designated COVID-19 ICU in Western India.", "RESULTS: Median age of the patients was 54 years, and 58% were males.", "All patients presented with moderate to severe acute respiratory distress syndrome (ARDS); however, only 37.5% failed trials of awake proning and required mechanical ventilation.", "Patients who received mechanical ventilation typically matched the H-phenotype of COVID-19 pneumonia, and 55.5% of these patients were successfully extubated.", "CONCLUSION: The most common reason for ICU admission in our series of 24 patients with severe COVID-19 was hypoxemic respiratory failure, which responded well to conservative measures such as awake proning and oxygen supplementation.", "Mortality in our case series was 16.7%.", "HOW TO CITE THIS ARTICLE: Shukla U, Chavali S, Mukta P, Mapari A, Vyas A.", "Initial Experience of Critically Ill Patients with COVID-19 in Western India: A Case Series.", "Indian J Crit Care Med 2020;24(7):509\u2013513."], "journal": "Indian J Crit Care Med", "publish_time": "2020-07-11", "aliases": []}
{"doc_id": 235447374, "title": "Fatal cytomegalovirus pneumonia in a critically ill patient with COVID\u201019", "abstract": ["Coronavirus disease 2019 (COVID\u201019) can cause severe lymphopenia and respiratory failure requiring prolonged invasive mechanical ventilation (MV).", "COVID\u201019 patients with severe lymphopenia or respiratory failure are at risk of developing secondary infections.", "Here, we present the needle autopsy findings of a critically ill patient with COVID\u201019 who required reintubation and prolonged MV, and eventually died of secondary cytomegalovirus (CMV) pneumonia.", "This case highlights the potential risk of long\u2010term steroid use and the need for routine monitoring for CMV infection in critically ill patients with COVID\u201019."], "journal": "Respirol Case Rep", "publish_time": "2021-06-08", "aliases": []}
{"doc_id": 237241747, "title": "Complete Heart Block as a Clinical Feature in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients: A Case Series of Three Cases", "abstract": ["Background.", "Novel coronavirus-19 disease (COVID-19) is associated with significant cardiovascular morbidity and mortality.", "However, there have been very few reports on complete heart block (CHB) associated with COVID-19.", "This case series describes clinical characteristics, potential mechanisms, and short-term outcomes of critically ill COVID-19 patients complicated by CHB.", "Case Summary.", "We present three cases of new-onset CHB in critically ill COVID-19 patients.", "Patient 1 is a 41-year-old male with well-documented history of Familial Mediterranean Fever (FMF) who required mechanical ventilator support for acute hypoxic respiratory failure from severe COVID-19 pneumonia.", "He developed new-onset CHB without a hemodynamic derangement but subsequently had acute coronary syndrome complicated by cardiogenic shock.", "Patient 2 is a 77-year-old male with no past medical history who required intubation for severe COVID-19 pneumonia acute hypoxic respiratory failure.", "He developed CHB with sinus pause requiring temporary pacing but subsequently developed multiorgan failure.", "Patient 3 is 36-year-old lady 38 + 2 weeks pregnant, gravida 2 para 1 with no other medical history, who had an emergency Lower Section Caesarean Section (LSCS) as she required intubation for acute hypoxic respiratory failure.", "She exhibited new-onset CHB without hemodynamic compromise.", "The CHB resolved spontaneously after 24 hours.", "Discussion.", "COVID-19-associated CHB is a very rare clinical manifestation.", "The potential mechanisms for CHB in patients with COVID-19 include myocardial inflammation or direct viral infiltration as well as other causes such as metabolic derangements or use of sedatives.", "Patients diagnosed with COVID-19 should be monitored closely for the development of bradyarrhythmia and hemodynamic instability."], "journal": "Case Rep Crit Care", "publish_time": "2021-08-11", "aliases": []}
{"doc_id": 221377729, "title": "Two mechanically ventilated cases of COVID-19 successfully managed with a sequential ventilation weaning protocol: Two case reports", "abstract": ["BACKGROUND: Patients with critical coronavirus disease 2019 (COVID-19), characterized by respiratory failure requiring mechanical ventilation (MV), are at high risk of mortality.", "An effective and practical MV weaning protocol is needed for these fragile cases.", "CASE SUMMARY: Here, we present two critical COVID-19 patients who presented with fever, cough and fatigue.", "COVID-19 diagnosis was confirmed based on blood cell counts, chest computed tomography (CT) imaging, and nuclei acid test results.", "To address the patients\u2019 respiratory failure, they first received noninvasive ventilation (NIV).", "When their condition did not improve after 2 h of NIV, each patient was advanced to MV [tidal volume (Vt), 6 mL/kg ideal body weight (IBW); 8-10 cmH(2)O of positive end-expiratory pressure; respiratory rate, 20 breaths/min; and 40%-80% FiO(2)] with prone positioning for 12 h/day for the first 5 d of MV.", "Extensive infection control measures were conducted to minimize morbidity, and pharmacotherapy consisting of an antiviral, immune-enhancer, and thrombosis prophylactic was administered in both cases.", "Upon resolution of lung changes evidenced by CT, the patients were sequentially weaned using a weaning screening test, spontaneous breathing test, and airbag leak test.", "After withdrawal of MV, the patients were transitioned through NIV and high-flow nasal cannula oxygen support.", "Both patients recovered well.", "CONCLUSION: A MV protocol attentive to intubation/extubation timing, prone positioning early in MV, infection control, and sequential withdrawal of respiratory support, may be an effective regimen for patients with critical COVID-19."], "journal": "World J Clin Cases", "publish_time": "2020-08-06", "aliases": []}
{"doc_id": 227056197, "title": "Heparin-binding protein levels correlated with aggravation and multi-organ damage in severe COVID-19", "abstract": ["BACKGROUND: Critically ill COVID-19 patients may suffer persistent systemic inflammation and multiple organ failure, leading to a poor prognosis.", "RESEARCH QUESTION: To examine the relevance of the novel inflammatory factor heparin-binding protein (HBP) in critically ill COVID-19 patients, and evaluate the correlation of the biomarker with disease progression.", "STUDY DESIGN AND METHODS: Eighteen critically ill COVID-19 patients who suffered from respiratory failure and sepsis, including 12 cases who experienced a rapidly deteriorating clinical condition and 6 cases without deterioration, were investigated.", "They were compared with 15 age- and sex- matched COVID-19 negative patients with respiratory failure.", "Clinical data were collected and HBP levels were investigated.", "RESULTS: HBP was significantly increased in critically ill COVID-19 patients following disease aggravation and tracked with disease progression.", "HBP elevation preceded the clinical manifestations for up to 5 days and was closely correlated with patients\u2019 pulmonary ventilation and perfusion status.", "INTERPRETATION: HBP levels are associated with COVID-19 disease progression in critically ill patients.", "As a potential mediator of disease aggravation and multiple organ injuries that are triggered by continuing inflammation and oxygen deficits, HBP warrants further study as a disease biomarker and potential therapeutic target."], "journal": "ERJ Open Res", "publish_time": "2020-11-12", "aliases": []}
{"doc_id": 219451619, "title": "Protracted course of coronavirus disease with severe acute respiratory distress syndrome: a case report", "abstract": ["BACKGROUND: Coronavirus Disease (COVID\u201019) is a growing concern worldwide.", "About 5% of COVID\u201019 cases require intensive care.", "However, the optimal treatment for respiratory failure in COVID\u201019 patients is yet to be determined.", "CASE PRESENTATION: A 79\u2010year\u2010old man with severe acute respiratory distress syndrome due to COVID\u201019 was admitted to our intensive care unit.", "Prone ventilation was effective in treating the patient\u2019s hypoxemia.", "Further, the patient received lung protective ventilation with a tidal volume of 6\u20138 mg/kg (predicted body weight).", "However, the patient\u2019s respiratory failure did not improve and he died 16 days after admission because of multiple organ failure.", "Serial chest computed tomography revealed a change from ground\u2010glass opacity to consolidation pattern in both lungs.", "CONCLUSIONS: We report a protracted case of COVID\u201019 in a critically ill patient in Japan.", "Although prone ventilation may contribute to treating hypoxemia, its efficacy in preventing mortality from COVID\u201019 is unknown."], "journal": "Acute Med Surg", "publish_time": "2020-05-18", "aliases": []}
{"doc_id": 225530384, "title": "Clinical characteristics, treatment, and prognosis in 89 cases of COVID-19/ \u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u80ba\u708e89\u4f8b\u4e34\u5e8a\u7279\u5f81, \u6cbb\u7597\u53ca\u9884\u540e\u5206\u6790", "abstract": ["Objective: To investigate the clinical characteristics, treatment and prognosis of novel coronavirus pneumonia (COVID-19).", "Methods: A total of 89 cases COVID-19 patients in Renmin Hospital of Wuhan University from January 17, 2020 to February 20, 2020 were analyzed retrospectively, and the clinical characteristics, course of treatment and prognosis were summarized.", "Results: According to the guideline for Diagnosis and Treatment of Novel Coronavirus Infected Pneumonia, 89 cases were divided into mild group (n=18, 20.2%), common group (n=40, 44.9%), severe group (n=21, 23.6%), and critical group (n=10, 11.2%).", "There were significant differences in the incidence of fever, dry cough and dyspnea among the four groups (P&lt;0.05).", "Compared with those in mild group, white blood cell count (WBC), neutrophil count (NEUT), lymphocyte count (LYM), and monocyte count (MONO) increased significantly in the other three groups, while the serum levels of C-reactive protein (CRP), procalcitonin (PCT), creatinine (Cr), urea nitrogen (Urea) and troponin I (cTnI) increased significantly in severe and critical groups (P&lt;0.05).", "Compared with those in common group, the LYM of the severe and the critical patients were significantly lower, while the CRP, Cr, urea and cTnI levels increased significantly (P&lt;0.05).", "Among the 89 patients, 6 patients (6.7%) had acute myocardial injury, 6 patients (6.7%) had respiratory failure, 3 patients (3.4%) had renal failure, and 3 patients had shock (3.4%).", "There were significant differences in myocardial injury, respiratory failure, and shock incidences among the four groups (P&lt;0.05).", "Among the 89 patients, 7 patients (7.9%) were died, 82 patients (92.1%) were cured and discharged from hospital.", "Among them, there was no death in mild group, 1 patient (2.5%) was died in common group, 3 patients (14.3%) were died in severe group, and 3 patients (30.0%) were died in critical group.", "There was a significant difference in mortality among the four groups (P&lt;0.05).", "Conclusion: COVID-19 patients in severe and critical classification are more serious in inflammatory reaction, and more prone to myocardial injury, respiratory failure and shock."], "journal": "Med. J. Wuhan Univ.", "publish_time": "2020", "aliases": []}
{"doc_id": 235481737, "title": "Incidence and Outcomes of Acute Kidney Injury in Critically Ill Patients with Coronavirus Disease 2019", "abstract": ["Patients with more severe cases of coronavirus disease-19 (COVID-19) may be at greater risk for developing acute kidney injury (AKI).", "The aim of our study was to analyze incidence and outcomes of AKI in critically ill patients with COVID-19.", "Our study prospectively followed about 198 patients with COVID-19 admitted to intensive care unit (ICU), Al Adan Hospital, Kuwait, for developing AKI and outcomes.", "Age, gender, nationality, history of hypertension, diabetes mellitus, ischemic heart disease, congestive heart failure, bronchial asthma, and chronic obstructive pulmonary disease were analyzed.", "The need for mechanical ventilation (MV), extracorporeal membrane oxygenation, inotropes, and medications was recorded.", "Causes of AKI, indication of dialysis, dialysis modality, dialysis outcomes, and mortality were analyzed.", "Our study reported that61 out of 198 (30.8%) ICU patients positive for COVID-19, developed AKI according to the Kidney Disease Improving Global Outcomes definition of AKI.", "Forty-eight out of 61 (79%) patients need continuous renal replacement therapy using continuous venovenous hemodiafiltration.", "Thirty-seven (61%) out of 61 patients were with severe sepsis syndrome.", "The most common cause of AKI was sepsis, cytokine storm, hypovolemia, heart failure, MV, and nephrotoxic drugs.", "Twenty-four patients (39%) out of 61 patients died, and the most common cause of death was sepsis, cytokine storm with respiratory failure, heart failure, and AKI.", "The outcome of AKI was as follows: six patients (10%) had complete recovery, five patients had partial recovery (8%), and 26 (43%) patients became dialysis dependent.", "Incidence of AKI is high in ICU COVID-19 patients and is associated with poor outcomes and high mortality.", "Early detection and specific therapy of kidney changes, including adequate hemodynamic support and avoidance of nephrotoxic drugs, may help to improve critically ill patients with COVID-19."], "journal": "Saudi J Kidney Dis Transpl", "publish_time": "2021", "aliases": []}
{"doc_id": 244401481, "title": "Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction", "abstract": ["SARS-CoV-2 viral attachment and entry into host cells is mediated by a direct interaction between viral spike glycoproteins and membrane bound angiotensin-converting enzyme 2 (ACE2).", "The receptor binding motif (RBM), located within the S1 subunit of the spike protein, incorporates the majority of known ACE2 contact residues responsible for high affinity binding and associated virulence.", "Observation of existing crystal structures of the SARS-CoV-2 receptor binding domain (S(RBD))\u2013ACE2 interface, combined with peptide array screening, allowed us to define a series of linear native RBM-derived peptides that were selected as potential antiviral decoy sequences with the aim of directly binding ACE2 and attenuating viral cell entry.", "RBM1 (16mer): S(443)KVGGNYNYLYRLFRK(458), RBM2A (25mer): E(484)GFNCYFPLQSYGFQPTNGVGYQPY(508), RBM2B (20mer): F(456)NCYFPLQSYGFQPTNGVGY(505) and RBM2A-Sc (25mer): NYGLQGSPFGYQETPYPFCNFVQYG.", "Data from fluorescence polarisation experiments suggested direct binding between RBM peptides and ACE2, with binding affinities ranging from the high nM to low \u03bcM range (K(d) = 0.207\u20131.206 \u03bcM).", "However, the RBM peptides demonstrated only modest effects in preventing S(RBD) internalisation and showed no antiviral activity in a spike protein trimer neutralisation assay.", "The RBM peptides also failed to suppress S1-protein mediated inflammation in an endogenously expressing ACE2 human cell line.", "We conclude that linear native RBM-derived peptides are unable to outcompete viral spike protein for binding to ACE2 and therefore represent a suboptimal approach to inhibiting SARS-CoV-2 viral cell entry.", "These findings reinforce the notion that larger biologics (such as soluble ACE2, \u2018miniproteins\u2019, nanobodies and antibodies) are likely better suited as SARS-CoV-2 cell-entry inhibitors than short-sequence linear peptides."], "journal": "PLoS One", "publish_time": "2021-11-18", "aliases": []}
{"doc_id": 233429143, "title": "The Role of Cell Surface Sialic Acids for SARS-CoV-2 Infection", "abstract": ["Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a new virus that has higher contagious capacity than any other previous human coronaviruses (HCoV) and causes the current coronavirus disease 2019 (COVID-19) pandemic.", "Sialic acids are a group of nine-carbon acidic &#945;-keto sugars, usually located at the end of glycans of cell surface glycoconjugates and serve as attachment sites for previous HCoVs.", "It is therefore speculated that sialic acids on the host cell surface could serve as co-receptors or attachment factors for SARS-CoV-2 cell entry as well.", "Recent in-silico modeling, molecular modeling predictions and microscopy studies indicate potential sialic acid-binding by SARS-CoV-2 upon cell entry.", "In particular, a flat sialic acid-binding domain was proposed at the N-terminal domain (NTD) of the spike protein, which may lead to the initial contact and interaction of the virus on the epithelium followed by higher affinity binding to ACE2 receptor, likely a two-step attachment fashion.", "However, recent in vitro and ex vivo studies of sialic acids on ACE2 receptor confirmed an opposite role for SARS-CoV-2 binding.", "In particular, neuraminidase treatment of epithelial cells and ACE2-expressing 293 T cells increased SARS-CoV-2 binding.", "Further, the ACE2 glycosylation mutants indicate that sialic acids on ACE2 receptor prevent ACE2-spike protein interaction.", "On the other hand, a most recent study indicates that gangliosides could serve as ligands for receptor-binding domain (RBD) of SARS-CoV-2 spike protein.", "This Mini-review discusses what has been predicted and known so far about the role of sialic acid for SARS-CoV-2 infection and future research perspective."], "journal": "Glycobiology", "publish_time": "2021", "aliases": []}
{"doc_id": 221636903, "title": "Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor", "abstract": ["Study of the interactions established between the viral glycoproteins and their host receptors is of critical importance for a better understanding of virus entry into cells.", "The novel coronavirus SARS-CoV-2 entry into host cells is mediated by its spike glycoprotein (S-glycoprotein), and the angiotensin-converting enzyme 2 (ACE2) has been identified as a cellular receptor.", "Here, we use atomic force microscopy to investigate the mechanisms by which the S-glycoprotein binds to the ACE2 receptor.", "We demonstrate, both on model surfaces and on living cells, that the receptor binding domain (RBD) serves as the binding interface within the S-glycoprotein with the ACE2 receptor and extract the kinetic and thermodynamic properties of this binding pocket.", "Altogether, these results provide a picture of the established interaction on living cells.", "Finally, we test several binding inhibitor peptides targeting the virus early attachment stages, offering new perspectives in the treatment of the SARS-CoV-2 infection."], "journal": "Nat Commun", "publish_time": "2020-09-11", "aliases": []}
{"doc_id": 246285971, "title": "Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells.", "abstract": ["SARS-CoV-2 entry into host cells is a crucial step for virus tropism, transmission, and pathogenesis.", "Angiotensin-converting enzyme 2 (ACE2) has been identified as the primary entry receptor for SARS-CoV-2; however, the possible involvement of other cellular components in the viral entry has not yet been fully elucidated.", "Here we describe the identification of vimentin (VIM), an intermediate filament protein widely expressed in cells of mesenchymal origin, as an important attachment factor for SARS-CoV-2 on human endothelial cells.", "Using liquid chromatography-tandem mass spectrometry, we identified VIM as a protein that binds to the SARS-CoV-2 spike (S) protein.", "We showed that the S-protein receptor binding domain (RBD) is sufficient for S-protein interaction with VIM.", "Further analysis revealed that extracellular VIM binds to SARS-CoV-2 S-protein and facilitates SARS-CoV-2 infection, as determined by entry assays performed with pseudotyped viruses expressing S and with infectious SARS-CoV-2.", "Coexpression of VIM with ACE2 increased SARS-CoV-2 entry in HEK-293 cells, and shRNA-mediated knockdown of VIM significantly reduced SARS-CoV-2 infection of human endothelial cells.", "Moreover, incubation of A549 cells expressing ACE2 with purified VIM increased pseudotyped SARS-CoV-2-S entry.", "CR3022 antibody, which recognizes a distinct epitope on SARS-CoV-2-S-RBD without interfering with the binding of the spike with ACE2, inhibited the binding of VIM with CoV-2 S-RBD, and neutralized viral entry in human endothelial cells, suggesting a key role for VIM in SARS-CoV-2 infection of endothelial cells.", "This work provides insight into the pathogenesis of COVID-19 linked to the vascular system, with implications for the development of therapeutics and vaccines."], "journal": "Proceedings of the National Academy of Sciences of the United States of America", "publish_time": "2022-02-08", "aliases": []}
{"doc_id": 221819877, "title": "Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity", "abstract": ["SARS-CoV-2 is a novel highly virulent pathogen which gains entry to human cells by binding with the cell surface receptor \u2013 angiotensin converting enzyme (ACE2).", "We computationally contrasted the binding interactions between human ACE2 and coronavirus spike protein receptor binding domain (RBD) of the 2002 epidemic-causing SARS-CoV-1, SARS-CoV-2, and bat coronavirus RaTG13 using the Rosetta energy function.", "We find that the RBD of the spike protein of SARS-CoV-2 is highly optimized to achieve very strong binding with human ACE2 (hACE2) which is consistent with its enhanced infectivity.", "SARS-CoV-2 forms the most stable complex with hACE2 compared to SARS-CoV-1 (23% less stable) or RaTG13 (11% less stable).", "Notably, we calculate that the SARS-CoV-2 RBD lowers the binding strength of angiotensin 2 receptor type I (ATR1) which is the native binding partner of ACE2 by 44.2%.", "Strong binding is mediated through strong electrostatic attachments with every fourth residue on the N-terminus alpha-helix (starting from Ser19 to Asn53) as the turn of the helix makes these residues solvent accessible.", "By contrasting the spike protein SARS-CoV-2 Rosetta binding energy with ACE2 of different livestock and pet species we find strongest binding with bat ACE2 followed by human, feline, equine, canine and finally chicken.", "This is consistent with the hypothesis that bats are the viral origin and reservoir species.", "These results offer a computational explanation for the increased infection susceptibility by SARS-CoV-2 and allude to therapeutic modalities by identifying and rank-ordering the ACE2 residues involved in binding with the virus."], "journal": "Comput Struct Biotechnol J", "publish_time": "2020-09-18", "aliases": []}
{"doc_id": 214054683, "title": "Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein", "abstract": ["The recent emergence of a novel coronavirus associated with an ongoing outbreak of pneumonia (Covid-2019) resulted in infections of more than 72,000 people and claimed over 1,800 lives.", "Coronavirus spike (S) glycoprotein trimers promote entry into cells and are the main target of the humoral immune response.", "We show here that SARS-CoV-2 S mediates entry in VeroE6 cells and in BHK cells transiently transfected with human ACE2, establishing ACE2 as a functional receptor for this novel coronavirus.", "We further demonstrate that the receptor-binding domains of SARS-CoV-2 S and SARS-CoV S bind with similar affinities to human ACE2, which correlates with the efficient spread of SARS-CoV-2 among humans.", "We found that the SARS-CoV-2 S glycoprotein harbors a furin cleavage site at the boundary between the S1/S2 subunits, which is processed during biogenesis and sets this virus apart from SARS-CoV and other SARS-related CoVs.", "We determined a cryo-electron microscopy structure of the SARS-CoV-2 S ectodomain trimer, demonstrating spontaneous opening of the receptor-binding domain, and providing a blueprint for the design of vaccines and inhibitors of viral entry.", "Finally, we demonstrate that SARS-CoV S murine polyclonal sera potently inhibited SARS-CoV-2 S-mediated entry into target cells, thereby indicating that cross-neutralizing antibodies targeting conserved S epitopes can be elicited upon vaccination."], "journal": "bioRxiv", "publish_time": "2020-02-20", "aliases": []}
{"doc_id": 235628341, "title": "ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion", "abstract": ["SARS-CoV-2 is responsible for the global COVID-19 pandemic.", "Angiotensin converting enzyme 2 (ACE2) is the membrane-delimited receptor for SARS-CoV-2.", "Lung, intestine and kidney, major sites of viral infection, express ACE2 that harbours an intracellular, carboxy-terminal PDZ-recognition motif.", "These organs prominently express the PDZ protein Na+/H+ exchanger regulatory factor-1 (NHERF1).", "Here, we report NHERF1 tethers ACE2 and augments SARS-CoV-2 cell entry.", "ACE2 directly binds both NHERF1 PDZ domains.", "Disruption of either NHERF1 PDZ core-binding motif or the ACE2 PDZ-recognition sequence eliminates interaction.", "Proximity ligation assays establish that ACE2 and NHERF1 interact at constitutive expression levels in human lung and intestine cells.", "Ablating ACE2 interaction with NHERF1 accelerated SARS-CoV-2 cell entry.", "Conversely, elimination of the ACE2 C-terminal PDZ binding motif decreased ACE2 membrane residence and reduced pseudotyped virus entry.", "We conclude that the PDZ interaction of ACE2 with NHERF1 facilitates SARS-CoV-2 internalization.", "\u00df-arrestin is likely indispensable, as with G protein-coupled receptors."], "journal": "iScience", "publish_time": "2021", "aliases": []}
{"doc_id": 214793574, "title": "Biophysical characterization of the SARS-CoV2 spike protein binding with the ACE2 receptor explains increased COVID-19 pathogenesis", "abstract": ["SARS-CoV-2 is a novel highly virulent pathogen which gains entry to human cells by binding with the cell surface receptor - angiotensin converting enzyme (ACE2).", "We computationally contrasted the binding interactions between human ACE2 and coronavirus spike protein receptor binding domain (RBD) of the 2002 epidemic-causing SARS-CoV-1, SARS-CoV-2, and bat coronavirus RaTG13 using the Rosetta energy function.", "We find that the RBD of the spike protein of SARS-CoV-2 is highly optimized to achieve very strong binding with human ACE2 (hACE2) which is consistent with its enhanced infectivity.", "SARS-CoV-2 forms the most stable complex with hACE2 compared to SARS-CoV-1 (23% less stable) or RaTG13 (11% less stable) while occupying the greatest number of residues in the ATR1 binding site.", "Notably, the SARS-CoV-2 RBD out-competes the angiotensin 2 receptor type I (ATR1) which is the native binding partner of ACE2 by 35% in terms of the calculated binding affinity.", "Strong binding is mediated through strong electrostatic attachments with every fourth residue on the N-terminus alpha-helix (starting from Ser19 to Asn53) as the turn of the helix makes these residues solvent accessible.", "By contrasting the spike protein SARS-CoV-2 Rosetta binding energy with ACE2 of different livestock and pet species we find strongest binding with bat ACE2 followed by human, feline, equine, canine and finally chicken.", "This is consistent with the hypothesis that bats are the viral origin and reservoir species.", "These results offer a computational explanation for the increased infectivity of SARS-CoV-2 and allude to therapeutic modalities by identifying and rank-ordering the ACE2 residues involved in binding with the virus."], "journal": "bioRxiv", "publish_time": "2020-05-11", "aliases": []}
{"doc_id": 221205501, "title": "An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation", "abstract": ["Without an effective prophylactic solution, infections from SARS-CoV-2 continue to rise worldwide with devastating health and economic costs.", "SARS-CoV-2 gains entry into host cells via an interaction between its Spike protein and the host cell receptor angiotensin converting enzyme 2 (ACE2).", "Disruption of this interaction confers potent neutralization of viral entry, providing an avenue for vaccine design and for therapeutic antibodies.", "Here, we develop single-domain antibodies (nanobodies) that potently disrupt the interaction between the SARS-CoV-2 Spike and ACE2.", "By screening a yeast surface-displayed library of synthetic nanobody sequences, we identified a panel of nanobodies that bind to multiple epitopes on Spike and block ACE2 interaction via two distinct mechanisms.", "Cryogenic electron microscopy (cryo-EM) revealed that one exceptionally stable nanobody, Nb6, binds Spike in a fully inactive conformation with its receptor binding domains (RBDs) locked into their inaccessible down-state, incapable of binding ACE2.", "Affinity maturation and structure-guided design of multivalency yielded a trivalent nanobody, mNb6-tri, with femtomolar affinity for SARS-CoV-2 Spike and picomolar neutralization of SARS-CoV-2 infection.", "mNb6-tri retains stability and function after aerosolization, lyophilization, and heat treatment.", "These properties may enable aerosol-mediated delivery of this potent neutralizer directly to the airway epithelia, promising to yield a widely deployable, patient-friendly prophylactic and/or early infection therapeutic agent to stem the worst pandemic in a century."], "journal": "bioRxiv", "publish_time": "2020-08-17", "aliases": []}
{"doc_id": 244662142, "title": "LRRC15 is an inhibitory receptor blocking SARS-CoV-2 spike-mediated entry in trans", "abstract": ["SARS-CoV-2 infection is mediated by the entry receptor ACE2.", "Although attachment factors and co-receptors facilitating entry are extensively studied, cellular entry factors inhibiting viral entry are largely unknown.", "Using a surfaceome CRISPR activation screen, we identified human LRRC15 as an inhibitory receptor for SARS-CoV-2 entry.", "LRRC15 directly binds to the receptor-binding domain (RBD) of spike protein with a moderate affinity and inhibits spike-mediated entry.", "Analysis of human lung single cell RNA sequencing dataset reveals that expression of LRRC15 is primarily detected in fibroblasts and particularly enriched in pathological fibroblasts in COVID-19 patients.", "ACE2 and LRRC15 are not co-expressed in the same cell types in the lung.", "Strikingly, expression of LRRC15 in ACE2-negative cells blocks spike-mediated viral entry in ACE2+ cell in trans, suggesting a protective role of LRRC15 in a physiological context.", "Therefore, LRRC15 represents an inhibitory receptor for SARS-CoV-2 regulating viral entry in trans."], "journal": "bioRxiv", "publish_time": "2021-11-24", "aliases": []}
{"doc_id": 245705130, "title": "A dual-receptor mechanism between integrins and ACE2 widens SARS-CoV-2 tissue tropism", "abstract": ["In addition to the ACE2 receptor, SARS-CoV-2 binds to integrins to gain host cell entry and trigger pro-inflammatory integrin-mediated signalling cascades.", "Integrins, therefore, are likely candidates for a dual-receptor mechanism with ACE2 to explain the increased infectivity seen in SARS-CoV-2 models.", "As integrins are primarily expressed in vasculature and persistent vasculopathy is seen in COVID-19, examining the role of endothelial integrin involvement is crucial in uncovering the pathophysiology of SARS-CoV-2."], "journal": "bioRxiv", "publish_time": "2022-01-03", "aliases": []}
{"doc_id": 227181280, "title": "HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry", "abstract": ["Responsible for the ongoing coronavirus disease 19 (COVID-19) pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells through binding of the viral spike protein (SARS-2-S) to the cell-surface receptor angiotensin-converting enzyme 2 (ace2) Here we show that the high-density lipoprotein (hdl) scavenger receptor B type 1 (SR-B1) facilitates ACE2-dependent entry of SARS-CoV-2 We find that the S1 subunit of SARS-2-S binds to cholesterol and possibly to hdl components to enhance viral uptake in vitro SR-B1 expression facilitates SARS-CoV-2 entry into ACE2-expressing cells by augmenting virus attachment.", "Blockade of the cholesterol-binding site on SARS-2-S1 with a monoclonal antibody, or treatment of cultured cells with pharmacological SR-B1 antagonists, inhibits HDL-enhanced SARS-CoV-2 infection.", "We further show that SR-B1 is coexpressed with ace2 in human pulmonary tissue and in several extrapulmonary tissues.", "Our findings reveal that SR-B1 acts as a host factor that promotes SARS-CoV-2 entry and may help explain viral tropism, identify a possible molecular connection between COVID-19 and lipoprotein metabolism, and highlight SR-B1 as a potential therapeutic target to interfere with SARS-CoV-2 infection."], "journal": "Nat Metab", "publish_time": "2020", "aliases": []}
{"doc_id": 231299808, "title": "Population-Specific ACE2 Single-Nucleotide Polymorphisms Have Limited Impact on SARS-CoV-2 Infectivity In Vitro", "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), employs host-cell angiotensin-converting enzyme 2 (ACE2) for cell entry.", "Genetic analyses of ACE2 have identified several single-nucleotide polymorphisms (SNPs) specific to different human populations.", "Molecular dynamics simulations have indicated that several of these SNPs could affect interactions between SARS-CoV-2 and ACE2, thereby providing a partial explanation for the regional differences observed in SARS-CoV-2 infectivity and severity.", "However, the significance of population-specific ACE2 SNPs in SARS-CoV-2 infectivity is unknown, as no in vitro validation studies have been performed.", "Here, we analyzed the impact of eight SNPs found in specific populations on receptor binding and cell entry in vitro.", "Except for a SNP causing a nonsense mutation that reduced ACE2 expression, none of the selected SNPs markedly altered the interaction between ACE2 and the SARS-CoV-2 spike protein (SARS-2-S), which is responsible for receptor recognition and cell entry, or the efficiency of viral cell entry mediated by SARS-2-S. Our findings indicate that ACE2 polymorphisms have limited impact on the ACE2-dependent cell entry of SARS-CoV-2 and underscore the importance of future studies on the involvement of population-specific SNPs of other host genes in susceptibility toward SARS-CoV-2 infection."], "journal": "Viruses", "publish_time": "2021", "aliases": []}
{"doc_id": 218534865, "title": "Cell entry mechanisms of SARS-CoV-2", "abstract": ["A novel severe acute respiratory syndrome (SARS)-like coronavirus (SARS-CoV-2) is causing the global coronavirus disease 2019 (COVID-19) pandemic.", "Understanding how SARS-CoV-2 enters human cells is a high priority for deciphering its mystery and curbing its spread.", "A virus surface spike protein mediates SARS-CoV-2 entry into cells.", "To fulfill its function, SARS-CoV-2 spike binds to its receptor human ACE2 (hACE2) through its receptor-binding domain (RBD) and is proteolytically activated by human proteases.", "Here we investigated receptor binding and protease activation of SARS-CoV-2 spike using biochemical and pseudovirus entry assays.", "Our findings have identified key cell entry mechanisms of SARS-CoV-2.", "First, SARS-CoV-2 RBD has higher hACE2 binding affinity than SARS-CoV RBD, supporting efficient cell entry.", "Second, paradoxically, the hACE2 binding affinity of the entire SARS-CoV-2 spike is comparable to or lower than that of SARS-CoV spike, suggesting that SARS-CoV-2 RBD, albeit more potent, is less exposed than SARS-CoV RBD.", "Third, unlike SARS-CoV, cell entry of SARS-CoV-2 is preactivated by proprotein convertase furin, reducing its dependence on target cell proteases for entry.", "The high hACE2 binding affinity of the RBD, furin preactivation of the spike, and hidden RBD in the spike potentially allow SARS-CoV-2 to maintain efficient cell entry while evading immune surveillance.", "These features may contribute to the wide spread of the virus.", "Successful intervention strategies must target both the potency of SARS-CoV-2 and its evasiveness."], "journal": "Proc Natl Acad Sci U S A", "publish_time": "2020", "aliases": []}
{"doc_id": 245567282, "title": "Effect of Cysteine Oxidation in SARS-CoV-2 Receptor-Binding Domain on Its Interaction with Two Cell Receptors: Insights from Atomistic Simulations", "abstract": ["[Image: see text] Binding of the SARS-CoV-2 S-glycoprotein to cell receptors is vital for the entry of the virus into cells and subsequent infection.", "ACE2 is the main cell receptor for SARS-CoV-2, which can attach to the C-terminal receptor-binding domain (RBD) of the SARS-CoV-2 S-glycoprotein.", "The GRP78 receptor plays an anchoring role, which attaches to the RBD and increases the chance of other RBDs binding to ACE2.", "Although high levels of reactive oxygen and nitrogen species (RONS) are produced during viral infections, it is not clear how they affect the RBD structure and its binding to ACE2 and GRP78.", "In this research, we apply molecular dynamics simulations to study the effect of oxidation of the highly reactive cysteine (Cys) amino acids of the RBD on its binding to ACE2 and GRP78.", "The interaction energy of both ACE2 and GRP78 with the whole RBD, as well as with the RBD main regions, is compared in both the native and oxidized RBDs.", "Our results show that the interaction energy between the oxidized RBD and ACE2 is strengthened by 155 kJ/mol, increasing the binding of the RBD to ACE2 after oxidation.", "In addition, the interaction energy between the RBD and GRP78 is slightly increased by 8 kJ/mol after oxidation, but this difference is not significant.", "Overall, these findings highlight the role of RONS in the binding of the SARS-CoV-2 S-glycoprotein to host cell receptors and suggest an alternative mechanism by which RONS could modulate the entrance of viral particles into the cells."], "journal": "J Chem Inf Model", "publish_time": "2021-12-30", "aliases": []}
{"doc_id": 245143129, "title": "Host Manipulation Mechanisms of SARS-CoV-2", "abstract": ["Viruses are the simplest of pathogens, but possess sophisticated molecular mechanisms to manipulate host behavior, frequently utilizing molecular mimicry.", "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown to bind to the host receptor neuropilin-1 in order to gain entry into the cell.", "To do this, the virus utilizes its spike protein polybasic cleavage site (PCS), which mimics the CendR motif of neuropilin-1\u2019s endogenous ligands.", "In addition to facilitating cell entry, binding to neuropilin-1 has analgesic effects.", "We discuss the potential impact of neuropilin-1 binding by SARS-CoV-2 in ameliorating sickness behavior of the host, and identify a convergent evolutionary strategy of PCS cleavage and subsequent neuropilin binding in other human viruses.", "In addition, we discuss the evolutionary leap of the ancestor of SARS-COV-2, which involved acquisition of the PCS thus faciliting binding to the neuropilin-1 receptor.", "Acquisition of the PCS by the ancestor of SARS-CoV-2 appears to have led to pleiotropic beneficial effects including enhancement of cell entry via binding to ACE2, facilitation of cell entry via binding to neuropilin-1, promotion of analgesia, and potentially the formation of decoy epitopes via enhanced shedding of the S1 subunit.", "Lastly, other potential neuromanipulation strategies employed by SARS-CoV-2 are discussed, including interferon suppression and the resulting reduction in sickness behavior, enhanced transmission through neurally mediated cough induction, and reduction in sense of smell."], "journal": "Acta Biotheor", "publish_time": "2021-12-13", "aliases": []}
{"doc_id": 233872979, "title": "The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection", "abstract": ["The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the COVID-19 global pandemic, utilizes the host receptor angiotensin-converting enzyme 2 (ACE2) for viral entry.", "However, other host factors might also play important roles in SARS-CoV-2 infection, providing new directions for antiviral treatments.", "GRP78 is a stress-inducible chaperone important for entry and infectivity for many viruses.", "Recent molecular docking analyses revealed putative interaction between GRP78 and the receptor binding domain (RBD) of the SARS-CoV-2 Spike protein (SARS-2-S).", "Here we report that GRP78 can form a complex with SARS-2-S and ACE2 on the surface and at the perinuclear region typical of the endoplasmic reticulum in VeroE6-ACE2 cells, and that the substrate binding domain of GRP78 is critical for this interaction.", "In vitro binding studies further confirmed that GRP78 can directly bind to the RBD of SARS-2-S and ACE2.", "To investigate the role of GRP78 in this complex, we knocked down GRP78 in VeroE6-ACE2 cells.", "Loss of GRP78 markedly reduced cell surface ACE2 expression and led to activation of markers of the unfolded protein response.", "Treatment of lung epithelial cells with a humanized monoclonal antibody (hMAb159) selected for its safe clinical profile in preclinical models, depleted cell surface GRP78 and reduced cell surface ACE2 expression, as well as SARS-2-S-driven viral entry and SARS-CoV-2 infection in vitro.", "Our data suggest that GRP78 is an important host auxiliary factor for SARS-CoV-2 entry and infection and a potential target to combat this novel pathogen and other viruses that utilize GRP78 in combination therapy."], "journal": "J Biol Chem", "publish_time": "2021", "aliases": []}
{"doc_id": 231768534, "title": "Soluble ACE2 as a potential therapy for COVID-19", "abstract": ["Soluble angiotensin-converting enzyme 2 (sACE2) could be a therapeutic option to treat coronavirus disease 2019 (COVID-19) infection.", "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) utilizes ACE2 receptors on cell surfaces to gain intracellular entry, making them an ideal target for therapy.", "High-affinity variants of sACE2, engineered using high-throughput mutagenesis, are capable of neutralizing COVID-19 infection as decoy receptors.", "These variants compete with native ACE2 present on cells by binding with spike (S) protein of SARS-CoV-2, making native ACE2 on cell surfaces available to convert angiotensin II to angiotensin-1,7, thus alleviating the exaggerated inflammatory response associated with COVID-19 infection.", "This article explores the use of sACE2 as potential therapy for COVID-19 infection."], "journal": "Am J Physiol Cell Physiol", "publish_time": "2021", "aliases": []}
{"doc_id": 236319774, "title": "SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling", "abstract": ["Recently emerged severe acute respiratory syndrome coronavirus (SARS-CoV)-1 and -2 initiate virus infection by binding of their spike glycoprotein with the cell-surface receptor angiotensin-converting enzyme 2 (ACE2) and enter into the host cells mainly via the clathrin-mediated endocytosis pathway.", "However, the internalization process post attachment with the receptor is not clear for both SARS-CoV-1 and -2.", "Understanding the cellular factor/s or pathways used by these CoVs for internalization might provide insights into viral pathogenesis, transmission, and development of novel therapeutics.", "Here, we demonstrated that the cytoplasmic tail of ACE2 is not essential for the entry of SARS-CoV-1 and -2 by using bioinformatics, mutational, confocal imaging, and pseudotyped SARS-CoVs infection studies.", "ACE2 cytoplasmic domain (cytACE2) contains a conserved internalization motif and eight putative phosphorylation sites.", "Complete cytoplasmic domain deleted ACE2 (\u2206cytACE2) was properly synthesized and presented on the surface of HEK293T and BHK21 cells like wtACE2.", "The SARS-CoVs S1 or RBD of spike protein binds and colocalizes with the receptors followed by internalization into the host cells.", "Moreover, pseudotyped SARS-CoVs entered into wtACE2- and \u2206cytACE2-transfected cells but not into dipeptidyl peptidase 4 (DPP4)-expressing cells.", "Their entry was significantly inhibited by treatment with dynasore, a dynamin inhibitor, and NH(4)Cl, an endosomal acidification inhibitor.", "Furthermore, SARS-CoV antibodies and the soluble form of ACE2-treated pseudotyped SARS-CoVs were unable to enter the wtACE2 and \u2206cytACE2-expressing cells.", "Altogether, our data show that ACE2 cytoplasmic domain signaling is not essential for the entry of SARS-CoV-1 and -2 and that SARS-CoVs entry might be mediated via known/unknown host factor/s."], "journal": "Cells", "publish_time": "2021-07-17", "aliases": []}
{"doc_id": 241049100, "title": "Binding of SARS-CoV-2 to the avb6 Integrins May Promote Severe COVID in Patients with IPF", "abstract": ["RATIONALE: Patients with idiopathic pulmonary fibrosis (IPF) have worse outcomes following COVID-19.", "SARS-CoV-2 (2019-nCoV) spike protein (S1) harbors an RGD motif in its receptor-binding domain (RBD).", "Although SARS-CoV-2 is to exploit human Angiotensin Converting Enzyme-2 (ACE2) receptors for cell entry.", "Single Cell RNA-seq showed that normal lung expresses low levels of ACE2 with very low expression (1.5%) in Alveolar type 2 epithelial cells.", "It is possible that SARS-CoV-2 needs a cellular co-receptor, which could include integrins, to promote alveolar cell internalization and pneumonitis.METHODS: Solid-phase binding assays were used to investigate S1 binding to ACE2 or \u03b1v containing integrins.", "Pseudovirus entry assays were used to measure the internalization of SARS-CoV-2 into Human embryonic kidney 293T cells expressing different combinations of potential receptors.", "RNAscope was used to visualize the co-localization of SARS-CoV-2, ACE2, and integrin mRNAs.", "Immunohistochemistry was used to evaluate the expression of \u03b1v\u03b26 integrins and ACE2 in lung tissue.RESULTS: Binding assays demonstrated that the RGD containing \u03b1v\u03b23 and \u03b1v\u03b26 integrins bound robustly to the SARS-CoV-2 S1 subunit of Spike protein and overexpression of the \u03b1v\u03b26 integrin modestly augments ACE2 mediated SARS-CoV-2 pseudoviral entry into epithelial cells.", "In COVID-19 damaged lung ACE2 levels are low but the \u03b1v\u03b26 integrin levels are increased in alveolar epithelium whereas both ACE2 and \u03b1v\u03b26 integrin are increased in lung sections from idiopathic pulmonary fibrosis compared with normal lung samples.", "CONCLUSION: The SARS-CoV-2 S1 subunit can bind \u03b1v\u03b26 integrins augmenting ACE2-dependent internalization of pseudovirus.", "In IPF patients, ACE2 levels and \u03b1v\u03b26 integrin levels are increased.", "Increased binding of the SARS-CoV-2 to ACE2 and the \u03b1v\u03b26 integrin within fibrotic lung may explain the increased risk of severe COVID in patients with IPF."], "journal": "American Journal of Respiratory and Critical Care Medicine", "publish_time": "2021", "aliases": []}
{"doc_id": 214768614, "title": "[Editorial] Possibility of transmission through dogs being a contributing factor to the extreme Covid\u00ad19 outbreak in North Italy", "abstract": ["Covid\u00ad19 origin and transmission to humans.", "Covid\u00ad19 infection began in Wuhan (Hubei, China) in December, 2019.", "Although to date it is considered that Covid\u00ad19 originates from bats (96.2% overall genome sequence identity) (1), the type of intermediate animals that caused the transmission to humans remains unknown (2-4).", "Zhou et al (1) mentioned that 'Direct contact with intermediate host animals or consumption of wild animals was suspected to be the main route of SARS\u00adCoV\u00ad2 transmission.", "However, the source(s) and transmission routine(s) of SARS\u00adCoV\u00ad2 remain elusive' (1)."], "journal": "Mol Med Rep", "publish_time": "2020", "aliases": []}
{"doc_id": 211112799, "title": "Initial Cluster of Novel Coronavirus (2019-nCoV) Infections in Wuhan, China Is Consistent with Substantial Human-to-Human Transmission", "abstract": ["Reanalysis of the epidemic curve from the initial cluster of cases with novel coronavirus (2019-nCoV) in December 2019 indicates substantial human-to-human transmission.", "It is possible that the common exposure history at a seafood market in Wuhan originated from the human-to-human transmission events within the market, and the early, strong emphasis that market exposure indicated animal-to-human transmission was potentially the result of observer bias.", "To support the hypothesis of zoonotic origin of 2019-nCoV stemming from the Huanan seafood market, the index case should have had exposure history related to the market and the virus should have been identified from animals sold at the market.", "As these requirements remain unmet, zoonotic spillover at the market must not be overemphasized."], "journal": "J Clin Med", "publish_time": "2020-02-11", "aliases": []}
{"doc_id": 228085216, "title": "An Overview of SARS-CoV-2 and Animal Infection", "abstract": ["A novel coronavirus has been reported as the causative pathogen of the Coronavirus disease 2019 (COVID-19) outbreak in Wuhan city, China in December 2019.", "Due to the rapid spread of the virus worldwide, it has been announced as a pandemic by the World Health Organization (WHO).", "Hospitalized patients in Wuhan were associated with the Huanan seafood wholesale market where live animals, such as poultry, bats, snakes, frogs, rabbits, marmots, and hedgehogs are sold in that market which suggests a possible zoonotic infection.", "It was suggested that bat is the natural host of SARS-CoV-2, but the intermediate host is still unclear.", "It is essential to identify the potential intermediate host to interrupt the transmission chain of the virus.", "Pangolin is a highly suspected candidate as an intermediate host for SARS-CoV-2.", "Recently, SARS-CoV-2 infection has been reported in cats, dogs, tigers, and lions.", "More recently SARS-CoV-2 infection affected minks severely and zoonotic transfer with a variant SARS-CoV-2 strain evidenced in Denmark, Netherlands, USA, and Spain suggesting animal-to-human and animal-to-animal transmission within mink farms.", "Furthermore, experimental studies documented the susceptibility of different animal species to SARS-CoV-2, such as mice, golden hamsters, cats, ferrets, non-human primates, and treeshrews.", "It is also essential to know the possibility of infection for other animal species.", "This short review aims to provide an overview on the relation between severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and animals."], "journal": "Front Vet Sci", "publish_time": "2020-12-11", "aliases": [218805008]}
{"doc_id": 234465405, "title": "Can unconventional meat or bushmeat act as a source for sars-cov-2", "abstract": ["coronavirus disease 2019 (COVID-19), first reported in people exposed to a local seafood wholesale market in wuhan, china has already affected more than 76 million people around the globe resulting in the death of nearly 1 7 million people as of December 21, 2020 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can potentially infect other animal species owing to the superior host adaptability.", "Sporadic cases of natural SARS-CoV-2 infections have been reported in dogs, cats, lion, puma, and tiger while experimental inoculation in several other susceptible animal species resulted in infection.", "Although, bats are considered the reservoir host for SARS-CoV-2, pangolins, a wild mammal of order pholidota, is suspected to be the missing link that contributed to transmitting the virus to human beings due to its wide consumption in the chinese culinary practice.", "Unconventional meat is consumed in a large quantity all around the world since it acts as a \u2018 low cost \u2018 or \u2018 costless \u2018 nutritional source in underdeveloped countries.", "However, in certain communities, geographies, and niches of the globe, meat from wild and other free-ranging mammals, rodents, and reptiles are used as delicacies.", "The overexploitation of these \u2018 unconventional meat animals \u2018 for various reasons threatened biodiversity and contributed to the emergence of novel diseases having significant public health implications.", "With the swift emergence of SARS-CoV-2, humans have recognized the important role played by wildlife and their ecosystem in the emergence of novel infections.", "The interface between human and wild animals is considered the hotspot that facilitate cross-species jumping and disease spillover.", "Establishing an efficient surveillance system at a potential human-animal interface can limit the spread of novel zoonotic diseases such as COVID-19 \u00a9 2020, editorial board of journal of experimental biology and agricultural sciences.", "All rights reserved."], "journal": "Journal of Experimental Biology and Agricultural Sciences", "publish_time": "2020", "aliases": []}
{"doc_id": 220526165, "title": "Illicit wildlife trade, wet markets, and COVID-19: preventing future pandemics. (Special Issue: Symposium on coronavirus 2019: social determinants, disparities, and impacts.)", "abstract": ["Although the exact origin of SARS-CoV-2, the etiologic agent of COVID-19, is currently unknown, there is substantial evidence to suggest the source of transmission of the virus occurred within the wuhan wet market.", "In these markets, bats and wild animals are frequently sold and stored in close contact.", "During several of the world's past pandemics, bats were essential to the spread of zoonotic diseases from bat to another animal or to humans directly.", "Live animal markets create the perfect conditions for novel viruses such as COVID-19 to emerge.", "This paper suggests that to prevent future pandemics, the sale of exotic animals be banned at wet markets.", "It also advocates for the integration of the analysis of illicit trade with the study of zoonotic disease transmission and pandemics."], "journal": "World Medical and Health Policy", "publish_time": "2020", "aliases": []}
{"doc_id": 220501360, "title": "The recent challenges of highly contagious COVID\u201019, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy", "abstract": ["COVID\u201019 is highly contagious pathogenic viral infection initiated from Wuhan seafood wholesale market of China on December 2019 and spread rapidly around the whole world due to onward transmission.", "This recent outbreak of novel coronavirus (CoV) was believed to be originated from bats and causing respiratory infections such as common cold, dry cough, fever, headache, dyspnea, pneumonia, and finally Severe Acute Respiratory Syndrome (SARS) in humans.", "For this widespread zoonotic virus, human\u2010to\u2010human transmission has resulted in nearly 83 lakh cases in 213 countries and territories with 4,50,686 deaths as on 19 June 2020.", "This review presents a report on the origin, transmission, symptoms, diagnosis, possible vaccines, animal models, and immunotherapy for this novel virus and will provide ample references for the researchers toward the ongoing development of therapeutic agents and vaccines and also preventing the spread of this disease."], "journal": "Chem Biol Drug Des", "publish_time": "2020-07-26", "aliases": []}
{"doc_id": 215411826, "title": "Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019-2020", "abstract": ["Wuhan, the city in Hubei province in China is in the focus of global community due to the outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), formerly known as 2019-nCoV.", "The virus emerged in humans from Wuhan seafood market probably via zoonotic transmission.", "Within a few days the virus spread its tentacles rapidly to neighboring cities in China and to different geographical regions through travelers and to some extent by human to human transmission leading to significant disease burden globally.", "More than 2,00,000 people (including more than 8000 deaths) have been infected with this respiratory illness across 167 countries and territories worldwide leading to a pandemic.", "The present review provides an outline about emergence and spread of SARS-CoV-2 from Wuhan, China in 2019-2020.", "We have also provided information about the classification, genome, proteins, clinical presentation of COVID-19, type of clinical specimens to be collected and diagnostic methods adopted to identify the respiratory illness.", "In addition we have also provided information about transmission dynamics, prevention measures and treatment options that are available at the present.", "Subsequently, we have given a comprehensive overview of the spread of this infection from China to the other parts of the globe.", "Management of the ongoing outbreak of SARS-CoV-2 encompassing surveillance, clinical, immunological, genetic and evolutionary investigations are likely to provide the desired results.", "Joint efforts of global scientific community are needed at this hour in terms of enhancement of research on development of accurate diagnostics, antiviral therapeutics and finally into formation of an effective vaccine against the emerging novel coronavirus."], "journal": "Virusdisease", "publish_time": "2020", "aliases": []}
{"doc_id": 225570008, "title": "COVID-19: Recent advances in epidemiology, virology, etiopathogenesis, clinical trials and vaccine development", "abstract": ["background: The causative virus of COVID-19 has been named SARS-CoV-2 It is the seventh coronavirus that is pathogenic to humans and the third in the series of human pathogenic beta coronaviruses patient zero was identified to have contracted the virus in wuhan, china.", "Shortly after the initial identification of the virus and its symptoms, multiple studies concluded that the virus originated from the \u201c Wuhan seafood market \u201d, a notorious market place for illegal wildlife trade based in wuhan, a city in the hubei region of the people \u2019 s republic of china globally, as of 7:02 pm cest, 29 May 2020, there have been 5704736 confirmed cases of COVID-19, including 357736 deaths, reported to the WHO The transmission of COVID-19 is primarily by way of respiratory droplets, which can be developed via means of coughing or sneezing, hence spreading the disease from one person to another person.", "The research proposed indicates the possibility of bats as being the natural cistern of SARS-CoV-2, hence making COVID-19 a zoonotic disease.", "The most suspected intermediate host is the malayan pangolin SARS-CoV-2 is a single-stranded rna virus that has an affinity for ace2 receptors in humans, causing severe pathological symptoms.", "Symptoms like anorexia, dyspnea, fatigue, pyrexia, cough, headache, dizziness, nausea, productive sputum, abdominal pain, myalgia, sore throat, diarrhea, and vomiting.", "Vaccines that are currently in the clinical evaluation are the adenovirus type 5 vector, mRNA-1273, inactivated alum, chadox, LNP-mRNA, dna plasmid vaccine with electroporation and inactivated vaccines A Phase III randomized multicountry clinical trial comprising of 100 countries known as \u201c solidarity \u201d (isrctn83971151) has been initiated by the who to achieve the unified goal of producing an adequate treatment for COVID-19 The present.", "Solidarity trial focuses on the following drugs: Remdesivir, Lopinavir/Ritonavir with or without interferon beta-1a, chloroquine, or hydroxychloroquine & # x0d; Conclusion: It is invariably essential to promote research in this field of study and find an appropriate solution to the virus to allow individuals worldwide to lead a secure and healthy life."], "journal": "Journal of Biomedical Sciences", "publish_time": "2020", "aliases": []}
{"doc_id": 218551651, "title": "The current understanding and potential therapeutic options to combat COVID-19", "abstract": ["The ongoing wreaking global outbreak of the novel human beta coronavirus (CoV) pathogen was presumed to be from a seafood wholesale market in Wuhan, China, belongs to the Coronaviridae family in the Nidovirales order.", "The virus is highly contagious with potential human-human transmission which was named as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has spread across six continents and emerged as a global pandemic in short span with alarming levels of spread and severity.", "This virus associated symptoms and infectious respiratory illness is designated as coronavirus disease 19 (COVID-19).", "The SARS-CoV-2 possesses enveloped club-like spike protein projections with positive-sense large RNA genome and has a unique replication strategy.", "This virus was believed to have zoonotic origin with genetical identity to bat and pangolin CoV.", "In the current review, we introduce a general overview about the human CoVs and the associated diseases, the origin, structure, replication and key clinical events that occur in the COVID-19 pathogenicity.", "Furthermore, we focused on possible therapeutic options such as repurposing drugs including antimalarials, antivirals, antiparasitic drugs, and anti-HIV drugs, as well as monoclonal antibodies, vaccines as potential treatment options.", "Also we have summarized the latest research progress on the usage of stem cell therapy, human convalescent serum, interferon's, in the treatment of COVID-19."], "journal": "Life Sci", "publish_time": "2020", "aliases": []}
{"doc_id": 216553937, "title": "What dentists need to know about COVID-19", "abstract": ["This article aims at collecting all information needed for dentists regarding the COVID-19 pandemic throughout the world by reviewing articles published by now.", "In late 2019, a pneumonia outbreak of uncertain etiology happened in Wuhan, China.", "There were many reports related to a live-animal and seafood market, supporting that the pathogens were transferred from animals to humans, rapidly evolving into transmission from human to human.", "The pathogen was classified as 2019 Novel Corona Virus (2019-nCoV), and the disease was named COrona VIrus Disease 2019 (COVID-19).", "Given that COVID-19 has lately been detected in infected patients' saliva, the COVID-19 outbreak is an alert that all dental and other health professionals must be vigilant in defending against the infectious disease spread, and it may enable to assess whether non-invasive saliva diagnostic for COVID-19.", "There has so far been no evidence from randomized controlled trials to prescribe any particular anti-nCoV treatment or vaccine, and COVID-19 management has been widely supportive.", "Since the ACE-2 was expressing on oral cavity mucosa, there is a potentially huge COVID-19 infectious vulnerability risk for oral cavity and brought up a proof for the future prevention procedure in dental practice and daily life.", "As a result, the whole dental teams should be vigilant and keep patients and themselves in a safe environment by following the guideline in this study."], "journal": "Oral Oncol", "publish_time": "2020", "aliases": []}
{"doc_id": 244174130, "title": "A review of epidemic investigation on cold\u2010chain food\u2010mediated SARS\u2010CoV\u20102 transmission and food safety consideration during COVID\u201019 pandemic", "abstract": ["COVID\u201019 has brought speculations on potential transmission routes of the severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102), the causal agent of the pandemic.", "It is reported that the main route of virus transmission to be person\u2010to\u2010person by respiratory droplets; however, people have raised concerns on the possible transmission of SARS\u2010CoV\u20102 to humans via food and packaging and its potential effects on food safety.", "This review discusses food safety issues in the COVID\u201019 pandemic and reveals its possible transmission in cold\u2010chain food.", "The first outbreak of COVID\u201019 in late 2019 was associated with a seafood market in Wuhan, China, while the second outbreak of COVID\u201019 in June 2020 was also related to a seafood market in Beijing, China.", "As of 2020, several frozen seafood products linked with SARS\u2010CoV\u20102 have been reported in China.", "According to the current survey and scientific studies, the risk of infection by SARS\u2010CoV\u20102 from cold\u2010chain food, food products, and food packaging is thought to be very low.", "However, studies on food cold chain contamination have shown that SARS\u2010CoV\u20102 remained highly stable under refrigerated (4\u00b0C) and even in freezing conditions (\u221210 to \u221280\u00b0C).", "Since one mode of SARS\u2010CoV\u20102 transmission appears to be touching contaminated surfaces, it is important to clean and sanitize food contact surfaces properly.", "Understanding food safety hazard risks is essential to avoid potential negative health effects and SARS\u2010CoV\u20102 transmission in the food supply chain during the COVID\u201019 pandemic."], "journal": "J Food Saf", "publish_time": "2021-10-03", "aliases": []}
{"doc_id": 219702108, "title": "Infection Risk Assessment of COVID-19 through Aerosol Transmission: a Case Study of South China Seafood Market", "abstract": ["[Image: see text] The Corona Virus Disease 2019 (COVID-19) is rapidly spreading throughout the world.", "Aerosol is a potential transmission route.", "We conducted the quantitative microbial risk assessment (QMRA) to evaluate the aerosol transmission risk by using the South China Seafood Market as an example.", "The key processes were integrated, including viral shedding, dispersion, deposition in air, biologic decay, lung deposition, and the infection risk based on the dose\u2013response model.", "The available hospital bed for COVID-19 treatment per capita (1.17 \u00d7 10(\u20133)) in Wuhan was adopted as a reference for manageable risk.", "The median risk of a customer to acquire SARS-CoV-2 infection via the aerosol route after 1 h of exposure in the market with one infected shopkeeper was about 2.23 \u00d7 10(\u20135) (95% confidence interval: 1.90 \u00d7 10(\u20136) to 2.34 \u00d7 10(\u20134)).", "The upper bound could increase and become close to the manageable risk with multiple infected shopkeepers.", "More detailed risk assessment should be conducted in poorly ventilated markets with multiple infected cases.", "The uncertainties were mainly due to the limited information on the dose\u2013response relation and the viral shedding which need further studies.", "The risk rapidly decreased outside the market due to the dilution by ambient air and became below 10(\u20136) at 5 m away from the exit."], "journal": "Environ Sci Technol", "publish_time": "2020-06-16", "aliases": []}
{"doc_id": 216324523, "title": "Regulating wildlife conservation and food safety to prevent human exposure to novel virus", "abstract": ["Epidemiological investigation suggested that the current outbreak of COVID-19 virus was associated with a seafood market, and COVID-19 has been identified a probable bat origin.", "Similar to SARS event in 2003, such a zoonotic disease showed an animal-to-person and even more serious person-to-person spread, and posed a significant threat to the global health and socio-economic development.", "We analyzed the association of both outbreaks with wildlife diet in China and proposed suggestions for regulating wildlife conservation and food safety to prevent human exposure to the novel virus, including increasing social awareness of hazards in eating wild animals, strengthening legislation on eating and trading of wild animals, improving the standards for food safety, and establishing market supervision mechanism.", "Regulatory intervention is not only critical for China but also for other countries where wildlife hunting is prevalent to prevent from novel virus exposures."], "journal": "Ecosyst. Health Sustain.", "publish_time": "2020", "aliases": []}
{"doc_id": 219946986, "title": "in-silica Analysis of SARS-CoV-2 viral strain using Reverse Vaccinology Approach: A Case Study for USA", "abstract": ["The recent pandemic of COVID19 that has struck the world is yet to be battled by a potential cure.", "Countless lives have been claimed due to the existing pandemic and the societal normalcy has been damaged permanently.", "As a result, it becomes crucial for academic researchers in the field of bioinformatics to combat the existing pandemic.", "The study involved collecting the virulent strain sequence of SARS-nCoV19 for the country USA against human host through publically available bioinformatics databases.", "Using in-silica analysis and reverse vaccinology, two leader proteins were identified to be potential vaccine candidates for development of a multi-epitope drug.", "The results of this study can provide further researchers better aspects and direction on developing vaccine and immune responses against COVID19.", "This work also aims at promoting the use of existing bioinformatics tools to faster streamline the pipeline of vaccine development.", "The Situation of COVID19 A new infection respiratory disease was first observed in the month of December 2019, in Wuhan, situated in the Hubei province, China.", "Studies have indicated that the reason of this disease was the emergence of a genetically-novel coronavirus closely related to SARS-CoV.", "This coronavirus, now named as nCoV-19, is the reason behind the spread of this fatal respiratory disease, now named as COVID-19.", "The initial group of infections is supposedly linked with the Huanan seafood market, most likely due to animal contact.", "Eventually, human-to-human interaction occurred and resulted in the transmission of the virus to humans.", "[13].", "Since then, nCoV-19 has been rapidly spreading within China and other parts of World.", "At the time of writing this article (mid-March 2020), COVID-19 has spread across 146 countries.", "A count of 164,837 cases have been confirmed of being diagnosed with COVID-19, and a total of 6470 deaths have occurred.", "The cumulative cases have been depicting a rising trend and the numbers are just increasing.", "WHO has declared COVID-19 to be a \u201cglobal health emergency\u201d.", "[14].", "Current Scenario and Objectives Currently, research is being conducted on a massive level to understand the immunology and genetic characteristics of the disease.", "However, no cure or vaccine of nCoV-19 has been developed at the time of writing this article.", "Though, nCoV-19 and SARS-CoV are almost genetically similar, the respiratory syndrome caused by both of them, COVID-19 and SARS respectively, are completely different.", "Studies have indicated that \u2013 \u201cSARS was more deadly but much less infectious than COVID-19\u201d.", "-World Health Organization"], "journal": "bioRxiv", "publish_time": "2020-06-16", "aliases": []}
{"doc_id": 233742213, "title": "Sane and safe: Forced social distancing to prevent human-to-human transmission of COVID-19.", "abstract": ["The current outbreak of COVID-19, originating from the city of Wuhan in China and ultimately involving over 200 countries, is now a global concern.", "Evidence indicates that COVID-19 spread to humans from wild animals, causing severe respiratory tract infections in humans; the typical symptoms of COVID include cough, high-grade fever, sore throat, and difficulty in breathing.", "The infection spreads from human to human via droplets.", "Therefore, social or physical distancing can reduce spread within communities.", "Asymptomatic spread can also occur during family gatherings or in the workplace; thus, we must enforce physical distancing as much as possible to reduce the spread of cases."], "journal": "Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia", "publish_time": "2021-03-25", "aliases": []}
{"doc_id": 219167438, "title": "Effect of the Wet Market on the coronavirus disease (COVID-19) transmission dynamics in China, 2019-2020", "abstract": ["Abstract Objectives The novel coronavirus (SARS-CoV-2) originating from Wuhan rapidly spread throughout China.", "While its origin remains uncertain, accumulating evidence links a wet market for the early SARS-CoV-2 spread in Wuhan.", "Similarly, the influence of the marketplace on the early transmission dynamics is yet to be investigated.", "Methods Using the daily series of COVID-19 incidence stratified according to contact history with the market, we have conducted quantitative modeling analyses to estimate the reproduction numbers (R) for the market-to-human and human-to-human transmission, the reporting probability and the early effects of public health interventions.", "Results We estimated R at 0.24 (95%CrI: 0.01-1.38) for market-to-human transmission, and 2.37 (95%CrI: 2.08-2.71) for human-to-human transmission during the early spread in China (2019-2020).", "Moreover, we estimated that the reporting rate for cases stemming from market-to-human transmission was 2-34 fold higher than that for cases stemming from human-to-human transmission, suggesting that contact history with the wet market played a key role in identifying COVID-19 cases.", "Conclusions Our R estimate tied to market-to-human transmission has substantial uncertainty, but it was significantly lower compared to the reproduction number driving human-to-human transmission.", "Our results also suggest that asymptomatic and subclinical infections constitute a substantial component of the COVID-19 morbidity burden."], "journal": "Int J Infect Dis", "publish_time": "2020-06-02", "aliases": []}
{"doc_id": 244489459, "title": "The SARS-CoV-2 origin dilemma: Zoonotic transfer or laboratory leak?", "abstract": ["The COVID-19 pandemic is responsible for millions of deaths worldwide yet its origin remains unclear.", "Two potential scenarios of how infection of humans initially occurred include zoonotic transfer from wild animals and a leak of the pathogen from a research laboratory.", "The Wuhan wet markets where wild animals are sold represent a strong scenario for zoonotic transfer.", "However, isolation of SARS-CoV-2 or its immediate predecessor from wild animals in their natural environment has yet to be documented.", "Due to incomplete evidence for a zoonotic origin, a laboratory origin is plausible.", "The Wuhan Institute of Virology is at the epicenter of the pandemic and their work has included manipulation of wild-type coronavirus to enable infection of human cells.", "Although stronger evidence supports the zoonotic transfer, inconclusive reports maintain the laboratory leak hypothesis alive.", "It is imperative to reach a factual conclusion to prevent future pandemics."], "journal": "Bioessays", "publish_time": "2021", "aliases": []}
{"doc_id": 222478253, "title": "Susceptible, Infectious and Recovered (SIR Model) Predictive Model to Understand the Key Factors of COVID-19 Transmission", "abstract": ["On 31 December 2019, who was alerted to several cases of pneumonia in wuhan city, hubei province of china.", "The virus did not match any other known virus.", "This raised concern because when a virus is new, general behavior and how it affects, people do not know initial few cases reportedly had some link to a large seafood and animal market, suggesting animal-to-person spread.", "However, a growing number of patients reportedly have not had exposure to animal markets, indicating person-to-person spread is occurring.", "At this time, it's unclear how easily or sustainably this virus is spreading between people.", "At any given time during a flu epidemic, firstly, should know the number of people who are infected.", "Second, to know the numbers who have been infected and have recovered, because these people now have immunity to the disease well established sir modeling methodology is used to develop a predictive model in order to understand the key factors that impact the COVID-19 transmission."], "journal": "International Journal of Advanced Computer Science and Applications", "publish_time": "2020", "aliases": []}
{"doc_id": 226247555, "title": "Status of Novel Coronavirus Disease 2019 (COVID-19) and Animal Production", "abstract": ["In December 2019, a severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that caused severe disease clusters was first reported in Wuhan, the capital of China's Hubei province.", "This viral disease, which is reported to originate from a seafood market where wild animals are illegally sold, has been transmitted among humans worldwide through close contact.", "Given the growing number of infected people worldwide and the disastrous consequences in all aspects of life, COVID-19 is a serious public health issue that requires special attention.", "In some countries, the epidemic curve of infection which was in the plateau phase or decreasing phase during the lockdown period increases day by day since the reopening, indicating the second phase of contamination.", "Therefore, the preventive measures recommended by the World Health Organization (WHO) must be respected to stop the spread of the disease.", "The international crisis due to the COVID-19 pandemic negatively affects many sectors, including animal production and its related industries.", "Indeed, with the cessation of imports and exports between countries, it is not possible to provide feeds that are considered as basic raw materials in livestock raising.", "This situation impairs animal movements, decreases production inputs availability, and negatively affects the economy.", "The sustainability of animal production is also affected by a shortage of workers due to the lockdown/curfew, the strong decrease in the purchasing power of the consumer, and the intensification of health care tasks.", "To prevent contamination of animal products and the spread of the disease with food, the U.S. Centers for Disease Control and Prevention (CDC) recommends frequent disinfection of food and human contact surfaces at production sites using an appropriate antiseptic.", "The purpose of this review article is to describe the current status of COVID-19 and investigate its effects on animal production.", "We propose potential approaches to keep animal products processing units and staff safe from SARS-CoV-2 infection and some strategies to improve animal production quantity and economy."], "journal": "Front Vet Sci", "publish_time": "2020", "aliases": []}
{"doc_id": 236061486, "title": "COVID-19: a fast evolving pandemic ;Transactions of The Royal Society of Tropical Medicine and Hygiene ;Oxford Academic", "abstract": ["On 31 December 2019, the world.", "Health.", "Organization (who) office in china received a report of 29 pneumonia cases of unknown aetiology in wuhan city in hubei province, central china.", "Within 1 week it became clear that the initial cases were associated with a seafood market where live poultry and wild animals were also sold.", "The virus was quickly identified as a novel beta-coronavirus and the genetic sequence was shared on 12 January 2020 The infection is now officially termed COVID-19 and the virus SARS-CoV-2 News of this outbreak gave many public health officials an involuntary shudder as they recalled the parallels with the severe acute respiratory syndrome (sars) outbreak that arose in china in November 2002 That outbreak was also caused by a novel coronavirus spilling over from an animal reservoir and transmitted by respiratory droplets sars spread to many parts of the world through international air travel, caused more than 8000 cases and 774 deaths and cost in the region US $ 20 billion to control within less than a month COVID-19 had spread throughout china and to neighbouring countries, even to the usa and europe.", "It became clear that the new virus was highly transmissible from person to person but was considerably less virulent, with less than 20% of cases being classified as severe.", "It has the clinical features of an atypical pneumonia with fever, dry cough, fatigue, dyspnoea and myalgia and is more often severe in those with comorbidities and the elderly.", "Since there are no specific therapies or vaccines available, standard public health measures appropriate for a virus spread by droplets, close contact and on environmental surfaces were instituted.", "The chinese authorities conducted active case finding and testing, contact tracing and quarantining of cases and contacts.", "The public was advised to stay at home if sick, in an effort to control the spread of the virus.", "On 30 January 2020 the who declared the outbreak a public health emergency of international concern, their highest level of severity, at a time when there were almost 10 000 confirmed cases, more than 200 deaths and it had spread to 20 countries.", "The chinese authorities had by then instituted highly stringent control measures, including stopping flights and public transport in wuhan and other major cities, closing animal wet markets, extending the new year holiday period in an effort to prevent mass travel, reducing movements within cities, minimizing mass gatherings, keeping schools closed, staggering office and factory working hours and restricting movement on the streets.", "The wearing of face masks became compulsory and, in effect, the population of hubei province, more than 50 million people, were in quarantine.", "The authorities also built two new hospitals with more than 2500 beds within 2 weeks to cope with the surge in demand for medical care.", "By the middle of March, less than 3 months into the epidemic, there had been more than 200 000 cases confirmed worldwide with more than 8000 deaths, vastly surpassing the sars epidemic.", "The number of cases reported has been highest in china, although cases have now been reported in 159 countries and territories on six continents.", "Over 70 countries have instituted travel restrictions.", "The main initial battle to control this epidemic has been in china, where heroic public health measures have bought the rest of the world time and may have reduced the effective reproduction number to close to 1, thereby bringing the epidemic under control.", "However, the rest of the world needs to maintain high vigilance, as this virus is highly transmissible and can cause severe disease and death, as has been seen in countries such as south korea, iran and italy.", "Indeed, the number of new cases is now highest in europe.", "Containment through case finding and isolation and contact tracing and social distancing remain the key public health approaches to controlling the epidemic in all parts of the world.", "This is particularly important for countries in sub-Saharan africa and also those parts of south and central america and asia that are not well-prepared for outbreaks.", "Global solidarity and support are essential, as infectious diseases can easily cross borders, and as john nkengasong, from the africa centres for disease control and Prevention (africa CDC) has said, \u2018 The global health chain is only as strong as its weakest link, so a disease threat anywhere can quickly become a threat everywhere \u2019 Preparedness to respond to outbreaks is weak in many countries.", "Of the 45 low-income countries that have undertaken a national preparedness assessment, none have been deemed ready to respond, making them particularly vulnerable to outbreaks.", "There are many reasons for this, including poor health and nutrition, exacerbated by high rates of concomitant human immunodeficiency virus and tuberculosis, and low influenza vaccination rates; poor quality of healthcare and resource constraints, as low- and middle-income countries (lmics) spend on average only $ 267 annually per person on health; and vulnerable supply chains and weak medicine procurement, and up to 30% of medicines are substandard or falsified.", "In response to the outbreak, the african union commission is strengthening partnerships and coordination across the continent, including a common approach for monitoring and movement restriction of people at risk for COVID-19 and for information sharing.", "The who has found the regional readiness level to be only 66%, with critical gaps and a need to strengthen the capacities for countries to investigate alerts, treat patients in isolation facilities and improve infection, prevention and control (ipc) in health facilities and communities.", "More than 40 experts have deployed to 10 countries to support preparedness activities and the diagnostic capacity for COVID-19 has been strengthened, with 17 countries now having at least some capacity for laboratory testing [ Truncated ]."], "journal": "", "publish_time": "2020", "aliases": []}
{"doc_id": 237381761, "title": "Clinical features of novel coronavirus 2019-infected cases with pre-existing cardiovascular disease, disaggregated by gender", "abstract": ["Objectives: This study was conducted to evaluate the clinical features of 68 coronavirus 2019-infected cardiac cases on gender basis.", "Methodology: Clinical, laboratory and electrocardiographic data of 68 COVID-19 patients with pre-existing cardiovascular diseases, analyzed and compared by gender-wise.", "Results: Dry cough (78% of male, 80% females) and fever (62% of male, 75% females) were the most common symptoms.", "Out of these 97% of them needed O2 supplementation.", "O2 saturation in patients with O2 therapy was 85%;31% of men and 11% of women experienced intubation.", "The most common laboratory abnormalities, were neutrophilia, leukocytosis, lymphopenia, thrombocytopenia, decreased hemoglobin level, increased creatinine and urea, in men and women.", "Troponin level was different between male and female.", "Pneumonia was found in 86-87% patients.", "Approximately, Males and female, respectively53.10 and 52.8%, shown sinus tachycardia (ST arrythmia).", "PVC arrythmia was found in 2.9% of total patients.", "BBB arrythmia was found in 31.20% of males vs. 11.10% of females.", "The mean systole/diastole blood pressures respectively were 130\u00b14/79.7 \u00b12 in males and 134\u00b14/81\u00b13 in females.", "Heart axis changes was identified in 43.8% and 27.8% of males and females respectively.", "Conclusion: Severity of symptoms and outcomes of COVID-19 in cardiac patients showed some differences between men and women which could be associated with differences in immune responses, respiratory tract properties, renin angiotensin system, sex hormones and lifestyle.", "However, more studies to categorize gender differences are required.", "\u00a9 2017 Pakistan Cardiac Society.", "All Rights Reserved."], "journal": "Pakistan Heart Journal", "publish_time": "2021", "aliases": []}
{"doc_id": 215718855, "title": "Sex differences in clinical findings among patients with coronavirus disease 2019 (COVID-19) and severe condition", "abstract": ["Objective: To compare the sex differences in the clinical findings among patients with severe coronavirus disease 2019 (COVID-19).", "Methods: We retrospectively collected data of 47 patients diagnosed as severe type of COVID-19 from February 8 to 22, 2020, including demographics, illness history, physical examination, laboratory test, management, and compared differences between men and women.", "Results: Of the 47 patients, 28 (59.6%) were men.", "The median age was 62 years, and 30 (63.8%) had comorbidities.", "The initial symptoms were mainly fever (34 [72.3%]), cough (36 [76.6%]), myalgia (5 [10.6%]) and fatigue (7 [14.9%]).", "Procalcitonin level was higher in men than in women (0.08 vs. 0.04ng/ml, p=0.002).", "N-terminal-pro brain natriuretic peptide increased in 16 (57.1%) men and 5 (26.3%) women (p=0.037).", "Five men (17.9%) had detected positive influenza A antibody, but no women.", "During 2-week admission, 5 (17.9%) men and 1 (5.3%) woman were reclassified into the critical type due to deterioration.", "Mortality was 3.6% in men and 0 in women respectively.", "Four (21.1%) women and one man (3.6%) recovered and discharged from hospital.", "Conclusion: Sex differences may exist in COVID-19 patients of severe type.", "Men are likely to have more complicated clinical condition and worse in-hospital outcomes as compared to women."], "journal": "", "publish_time": "2020-02-29", "aliases": []}
{"doc_id": 232213202, "title": "Gender-based disparities in COVID-19 patient outcomes", "abstract": ["Studies reported to date suggest that men with COVID-19 have more severe disease and worse outcomes when compared with women.", "The explanation for this finding is not entirely clear.", "The goal of this study was to compare clinical characteristics, inflammatory biomarkers and clinical outcome between men and women.", "This retrospective study included patients with COVID-19 admitted to 10 Virginia hospitals from January 1, 2020, to June 15, 2020.", "Demographic data, comorbidities, and inflammatory markers, including C reactive protein (CRP), D-dimer, ferritin, and the neutrophil:lymphocyte ratio, as well as patient outcomes, were compared between men and women.", "During the study period, 701 patients with PCR-confirmed COVID-19 infection were admitted.", "The patient's mean age was 61\u00b117 years.", "There were 370 men (52.8%).", "There was no difference in age, racial distribution, and comorbidities in the male patients compared with the female patients.", "However, both the baseline and peak levels of CRP and ferritin were significantly higher in men as compared with women.", "While the baseline D-dimer was similar between the sexes, men had a significantly higher maximal D-dimer.", "Men had evidence of greater disease severity, with a significantly greater admission to the intensive care unit and borderline higher hospital mortality.", "Our study supports the observation that COVID-19 causes more severe disease in men.", "The greater disease severity in men was not due to the effect of age or comorbidities; however, in keeping with experimental studies, men had evidence of a heightened inflammatory response, likely contributing to disease severity."], "journal": "J. invest. med", "publish_time": "2021", "aliases": []}
{"doc_id": 246443186, "title": "Estradiol reduces ACE2 and TMPRSS2 mRNA levels in A549 human lung epithelial cells", "abstract": ["Epidemiologic studies suggest slightly higher risk of severe Covid-19 symptoms and fatalities following SARS-CoV-2 infection in men compared with women from similar age groups.", "This bias was suggested to reflect differences in the male and female immune system regulation, driven by different sex hormone levels in men and women, in particular, higher plasma estradiol in women.", "SARS-CoV-2 infects respiratory tract epithelial cells by binding to their cell membrane ACE2, followed by priming for cell entry by the host cell membrane serine protease TMPRSS2.", "The cell protease FURIN facilitates cell exit of mature SARS-CoV-2 virions.", "Our study examined the effects of in vitro treatment of A549 human lung epithelial cells with 17-\u00df-estradiol on mRNA expression of genes coding for these proteins.", "Treatment of A549 human lung epithelial cells with 17-\u00df-estradiol reduced the cellular mRNA levels of ACE2 and TMPRSS2 mRNA, while not affecting FURIN expression.", "Our findings suggest that 17-\u00df-estradiol may reduce SARS-CoV-2 infection of lung epithelial cells, which may in part explain the reduced incidence of severe Covid-19 and fatalities among women compared with men of similar age.", "Studies into the molecular pathways by which 17-\u00df-estradiol reduces ACE2 and TMPRSS2 mRNA expression in lung epithelial cells are needed for assessing its potential protective value against severe Covid-19."], "journal": "Drug dev. res", "publish_time": "2022", "aliases": []}
{"doc_id": 227166462, "title": "Sex and age differences in clinically significant symptoms of depression and anxiety among people in Australia in the first month of COVID-19 restrictions: a national survey", "abstract": ["OBJECTIVES: To identify sex and age differences in clinically significant symptoms of depression and anxiety and the factors associated with these differences among adults in Australia during COVID-19-related restrictions.", "DESIGN: Anonymous online survey.", "SETTING: Australia.", "PARTICIPANTS: Adults aged over 18 years living in Australia were eligible and 13 829 contributed complete data.", "Of these, 13 762 identified as female (10 434) or male (3328) and were included in analyses.", "INTERVENTIONS: None.", "OUTCOME MEASURES: Clinically significant symptoms of depression (\u226510 on Patient Health Questionnaire 9) or anxiety (\u226510 on Generalized Anxiety Disorder Scale 7 (GAD-7)), and experiences of irritability (GAD-7 item 6).", "RESULTS: Women were more likely than men to have clinically significant symptoms of depression (26.3% (95% CI 25.4 to 27.1) vs 20.1% (95% CI 18.7 to 21.5), p<0.001) and anxiety (21.8% (95% CI 21.0 to 22.6) vs 14.2% (95% CI 13.0 to 15.4), p<0.001) and to have experienced irritability in the previous fortnight (63.1% (95% CI 62.1 to 64.0) vs 51.4% (95% CI 49.7 to 53.2), p<0.001).", "They were also more likely than men to be doing unpaid work caring for children (22.8% (95% CI 22.0 to 23.6) vs 8.6% (95% CI 7.7 to 9.6), p<0.001) and dependent relatives (9.8% (95% CI 9.2 to 10.3) vs 5.7% (95% CI 4.9 to 6.5), p<0.001) which made significant contributions to the mental health outcomes of interest.", "Loss of employment, fear of contracting COVID-19 and feeling a severe impact of the restrictions were associated with poorer mental health in women and men of all ages.", "CONCLUSIONS: Rates of clinically significant symptoms of depression and anxiety were higher among women than men.", "Rather than being intrinsically more vulnerable to mental health problems during the COVID-19 pandemic, the higher risk of symptoms of anxiety and depression among women may in part be explained by their disproportionate burden of unpaid caregiving."], "journal": "BMJ Open", "publish_time": "2020-11-24", "aliases": []}
{"doc_id": 235474668, "title": "Testosterone Deficiency Is a Risk Factor for Severe COVID-19", "abstract": ["BACKGROUND: Male sex is related to increased COVID-19 severity and fatality although confirmed infections are similarly distributed between men and women.", "The aim of this retrospective analysis was to investigate the impact of sex hormones on disease progression and immune activation in men with COVID-19.", "PATIENTS AND METHODS: We studied for effects of sex hormones on disease severity and immune activation in 377 patients (230 men, 147 women) with PCR-confirmed SARS-CoV-2 infections hospitalized at the Innsbruck University Hospital between February and December 2020.", "RESULTS: Men had more severe COVID-19 with concomitant higher immune system activation upon hospital admission when compared to women.", "Men with a severe course of infection had lower serum total testosterone (tT) levels whereas luteinizing hormone (LH) and estradiol (E(2)) levels were within the normal range.", "tT deficiency was associated with elevated CRP (rs = - 0.567, p < 0.001), IL-6 levels (rs = - 0.563, p < 0.001), lower cholesterol levels (rs = 0.407, p < 0.001) and an increased morbidity and mortality.", "Men with tT levels < 100 ng/dL had a more than eighteen-fold higher in-hospital mortality risk (OR 18.243 [95%CI 2.301 \u2013 144.639], p = 0.006) compared to men with tT levels > 230 ng/dL.", "Moreover, while morbidity and mortality showed a positive correlation with E(2) levels at admission, we detected a negative correlation with the tT/E(2) ratio upon hospital admission.", "CONCLUSION: Hospitalized men with COVID-19 present with rather low testosterone levels linked to more advanced immune activation, severe clinical manifestations translating into an increased risk for ICU admission or death.", "The underlying mechanisms remain elusive but may include infection driven hypogonadism as well as inflammation mediated cholesterol reduction causing gonadotropin suppression and impaired androgen formation.", "Finally, in elderly late onset hypogonadism might also contribute to lower testosterone levels."], "journal": "Front Endocrinol (Lausanne)", "publish_time": "2021-06-18", "aliases": []}
{"doc_id": 236448167, "title": "Influence of sex on disease severity in children with multisystem inflammatory syndrome and covid-19 in latin america", "abstract": ["Data from adult studies show that COVID-19 is more severe in men than women.", "However, no data are available for the pediatric population.", "For this reason, we performed this study aiming to understand if sex influenced disease severity and outcomes in a large cohort of Latin-American children with COVID-19 and multisystem inflammatory syndrome (MIS-C).", "We found that a higher percentage of male children developed MIS-C (8.9% vs 5% in females) and died (1.2% and 0.4% in females), although on multivariate adjusted analyses the only statistically significant difference was found in need of hospitalization, with females less frequently admitted compared with boys (25.6% vs 35.4%).", "This data are preliminary and need further independent studies to better assess the role of sex.", "\u00a9 2021, Il Pensiero Scientifico Editore s.r.l.. All rights reserved."], "journal": "Italian Journal of Gender-Specific Medicine", "publish_time": "2021", "aliases": [231848176]}
{"doc_id": 235740308, "title": "Sex- and Gender-specific Risk Factors of Post-COVID-19 Syndrome: A Population-based Cohort Study in Switzerland", "abstract": ["Background: Evidence to date indicates that mortality of acute coronavirus disease (COVID-19) is higher in men than in women.", "Conversely, women seem more likely to suffer from long-term consequences of the disease and pronounced negative social and economic impacts.", "Sex- and gender-specific risk factors of COVID-19-related long-term effects are unknown.", "Methods: We conducted a multicentre prospective observational cohort study of 5838 (44.6% women) individuals in Switzerland who were tested positive for SARS-CoV-2 RNA between February and December 2020.", "Of all surviving individuals who met the inclusion criteria, 2799 (1285 [45.9%] women) completed a follow-up questionnaire.", "Findings: After a mean follow-up time of 197{+/-}77 days, women more often reported at least one persistent symptom (43.0% vs 31.5%, p<0.001) with reduced exercise tolerance and reduced resilience being the most frequently reported symptom in both sexes.", "Critical illness (intermediate or intensive care unit admission) during acute SARS-CoV-2 infection (odds ratio[95%CI]: 4.00[2.66-6.02], p<0.0001 was a risk factor of post-COVID-19 syndrome in both women and men.", "Women with pre-existing mental illness (1.81[1.00-3.26], p=0.049), cardiovascular risk factors (1.39[1.03-1.89], p=0.033), higher self-reported domestic stress levels (1.15[1.08-1.22], p<0.0001), and feminine gender identity (1.12[1.02-1.24], p=0.02) increased the odds of experiencing post-COVID syndrome.", "Conversely, obesity (1.44[1.03-2.02], p=0.034) increased the odds of post-COVID-19 syndrome in men, but not in women.", "Being responsible for household work (men, OR 0.82[0.69-0.97], p=0.021), taking care of children/relatives (women, 0.90[0.84-0.96], p=0.002) or being pregnant at the time of acute COVID-19 illness (OR 0.48[0.23-1.01], p=0.054) was associated with lower odds of post-COVID syndrome.", "Interpretation: Predictors of post-COVID syndrome differ between men and women.", "Our data reinforce the importance to include sex and gender to identify patients at risk for post-COVID syndrome so that access to care and early intervention can be tailored to their different needs."], "journal": "", "publish_time": "2021-07-06", "aliases": []}
{"doc_id": 231598771, "title": "Immune determinants of COVID-19 disease presentation and severity", "abstract": ["COVID-19, caused by SARS-CoV-2 infection, is mild to moderate in the majority of previously healthy individuals, but can cause life-threatening disease or persistent debilitating symptoms in some cases.", "The most important determinant of disease severity is age, with individuals over 65 years having the greatest risk of requiring intensive care, and men are more susceptible than women.", "In contrast to other respiratory viral infections, young children seem to be less severely affected.", "It is now clear that mild to severe acute infection is not the only outcome of COVID-19, and long-lasting symptoms are also possible.", "In contrast to severe acute COVID-19, such 'long COVID' is seemingly more likely in women than in men.", "Also, postinfectious hyperinflammatory disease has been described as an additional outcome after SARS-CoV-2 infection.", "Here I discuss our current understanding of the immunological determinants of COVID-19 disease presentation and severity and relate this to known immune-system differences between young and old people and between men and women, and other factors associated with different disease presentations and severity."], "journal": "Nat Med", "publish_time": "2021", "aliases": []}
{"doc_id": 245262000, "title": "Sex-related differences in mortality, acute kidney injury, and respiratory failure among critically ill patients with COVID-19", "abstract": ["Although the number of deaths due to coronavirus disease 2019 (COVID-19) is higher in men than women, prior studies have provided limited sex-stratified clinical data.", "We evaluated sex-related differences in clinical outcomes among critically ill adults with COVID-19.", "Multicenter cohort study of adults with laboratory-confirmed COVID-19 admitted to intensive care units at 67 U.S. hospitals from March 4 to May 9, 2020.", "Multilevel logistic regression was used to evaluate 28-day in-hospital mortality, severe acute kidney injury (AKI requiring kidney replacement therapy), and respiratory failure occurring within 14 days of intensive care unit admission.", "A total of 4407 patients were included (median age, 62 years; 2793 [63.4%] men; 1159 [26.3%] non-Hispanic White; 1220 [27.7%] non-Hispanic Black; 994 [22.6%] Hispanic).", "Compared with women, men were younger (median age, 61 vs 64 years, less likely to be non-Hispanic Black (684 [24.5%] vs 536 [33.2%]), and more likely to smoke (877 [31.4%] vs 422 [26.2%]).", "During median follow-up of 14 days, 1072 men (38.4%) and 553 women (34.3%) died.", "Severe AKI occurred in 590 men (21.8%), and 239 women (15.5%), while respiratory failure occurred in 2255 men (80.7%) and 1234 women (76.5%).", "After adjusting for age, race/ethnicity and clinical variables, compared with women, men had a higher risk of death (OR, 1.50, 95% CI, 1.26\u20131.77), severe AKI (OR, 1.92; 95% CI 1.57\u20132.36), and respiratory failure (OR, 1.42; 95% CI, 1.11\u20131.80).", "In this multicenter cohort of critically ill adults with COVID-19, men were more likely to have adverse outcomes compared with women."], "journal": "Medicine (Baltimore)", "publish_time": "2021-12-17", "aliases": []}
{"doc_id": 233457200, "title": "[COVID-19 and gender: certainties and uncertainties in monitoring the pandemic.]", "abstract": ["OBJECTIVE: Highlighting gender inequalities during the pandemic and its relationship with other axes of social inequality will be decisive for its adequate monitoring.", "The aim of this study was to assess the differences between men and women in the main measures of infection and mortality by COVID-19, considering its temporal evolution, raising awareness about the weaknesses and contradictions between sources of information methods: Cross-sectional analysis based on the microdata on covid cases notified by the national epidemiological.", "Surveillance.", "Network (renave), the death statistics of the national statistical institute (ine) and the estimates of excess mortality from the ine and the daily.", "Mortality.", "Monitoring.", "System (momo) microdata.", "Standardized rates, prevalences and and ratios by sex were calculated for each indicator.", "The percentage of excess mortality without COVID-19 diagnosis in each sex was calculated.", "Male/female ratios for symptoms and risk factors of COVID-19 were also calculated RESULTS: The rate of infection by COVID-19 was higher in women in the three waves of the pandemic, reaching 65% of infections during April and May 2020 Complications were between 1 5 and 2 5 times higher in men, especially in icu admissions, which were 2 5 times more frequent than in women.", "Although mortality rates and excess mortality were also higher in men (around 1 8 times), the percentage of excess mortality without COVID-19 diagnosis was higher in women (44% in men vs 52% in women the first wave) With regard to the symptoms of COVID-19, fever, cough, and dyspnoea were more frequent in men (20%, 10% and 19% more, respectively) compared to sore throat, vomiting or diarrhea that were more prevalent in women (90%, 40% and 10% more, respectively) CONCLUSIONS: The analysis disaggregated by sex has made it possible to identify differences between men and women in the diagnosis, presentation and severity of the COVID-19 that can help a better clinical and epidemiological approach to the disease.", "However, official sources present important gaps when presenting information disaggregated by sex.", "It is therefore necessary to advance in the inclusion of a gender perspective in the statistics on COVID-19, starting with a necessary but not sufficient condition such as the disaggregation by sex of the data."], "journal": "Revista Espanola de Salud Publica", "publish_time": "2021", "aliases": []}
{"doc_id": 232130150, "title": "Gender-Based Differences by Age Range in Patients Hospitalized with COVID-19: A Spanish Observational Cohort Study", "abstract": ["There is some evidence that male gender could have a negative impact on the prognosis and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.", "The aim of the present study was to compare the characteristics of coronavirus disease 2019 (COVID-19) between hospitalized men and women with confirmed SARS-CoV-2 infection.", "This multicenter, retrospective, observational study is based on the SEMI-COVID-19 Registry.", "We analyzed the differences between men and women for a wide variety of demographic, clinical, and treatment variables, and the sex distribution of the reported COVID-19 deaths, as well as intensive care unit (ICU) admission by age subgroups.", "This work analyzed 12,063 patients (56.8% men).", "The women in our study were older than the men, on average (67.9 vs. 65.7 years; p < 001).", "Bilateral condensation was more frequent among men than women (31.8% vs. 29.9%; p = 0.007).", "The men needed non-invasive and invasive mechanical ventilation more frequently (5.6% vs. 3.6%, p < 0.001, and 7.9% vs. 4.8%, p < 0.001, respectively).", "The most prevalent complication was acute respiratory distress syndrome, with severe cases in 19.9% of men (p < 0.001).", "In men, intensive care unit admission was more frequent (10% vs. 6.1%; p < 0.001) and the mortality rate was higher (23.1% vs. 18.9%; p < 0.001).", "Regarding mortality, the differences by gender were statistically significant in the age groups from 55 years to 89 years of age.", "A multivariate analysis showed that female sex was significantly and independently associated with a lower risk of mortality in our study.", "Male sex appears to be related to worse progress in COVID-19 patients and is an independent prognostic factor for mortality.", "In order to fully understand its prognostic impact, other factors associated with sex must be considered."], "journal": "J Clin Med", "publish_time": "2021-02-25", "aliases": []}
{"doc_id": 233746318, "title": "Dying from COVID-19 in nursing homes-sex differences in symptom occurrence", "abstract": ["BACKGROUND: Coronavirus disease 2019 (COVID-19), is a disease with diverse presentation.", "Several studies have shown different occurrence of symptoms for women and men, but no studies have been found examining sex differences in clinical presentation for nursing home residents dying from COVID-19.", "The objective of this study was to describe sex and age differences and the impact of a dementia diagnosis on symptom occurrence during the last week in life for persons dying from COVID-19 in nursing homes.", "METHODS: This is a population-based retrospective study based on data from the Swedish Register of Palliative Care.", "A total of 1994 residents aged 65 or older who died from COVID-19 in nursing homes were identified.", "The impact of sex, age and a dementia diagnosis on six different symptoms was analysed using chi2-test and multivariate logistic regression.", "RESULTS: Residents dying from COVID-19 were more often men (p < .002).", "Men more often had dyspnoea and death rattles (p < .001).", "Nausea was more common in women (p < .001).", "No sex differences in the occurrence of pain, anxiety or confusion were seen.", "Dyspnoea and nausea were less commonly reported in residents with dementia (p < .001).", "CONCLUSIONS: We found sex differences in symptom presentation for fatal COVID-19 in nursing home settings which remained after adjusting for age.", "Residents with a dementia diagnosis had fewer symptoms reported before death compared to those without dementia.", "Clinical presentation of fatal COVID-19 differs between women and men in nursing homes.", "Residents with fatal COVID-19 present with more unspecific and less prominent symptoms when also suffering from dementia.", "SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-021-02228-4."], "journal": "BMC Geriatr", "publish_time": "2021-05-06", "aliases": []}
{"doc_id": 237296464, "title": "Sex-tailored pharmacology and COVID-19: next steps towards appropriateness and health equity()", "abstract": ["Making gender bias visible allows to fill the gaps in knowledge and understand health records and risks of women and men.", "The coronavirus disease 2019 (COVID-19) pandemic has shown a clear gender difference in health outcomes.", "The more severe symptoms and higher mortality in men as compared to women are likely due to sex and age differences in immune responses.", "Age-associated decline in sex steroid hormone levels may mediate proinflammatory reactions in older adults, thereby increasing their risk of adverse outcomes, whereas sex hormones and/or sex hormone receptor modulators may attenuate the inflammatory response and provide benefit to COVID-19 patients.", "While multiple pharmacological options including anticoagulants, glucocorticoids, antivirals, anti-inflammatory agents and traditional Chinese medicine preparations have been tested to treat COVID-19 patients with varied levels of evidence in terms of efficacy and safety, information on sex-targeted treatment strategies is currently limited.", "Women may have more benefit from COVID-19 vaccines than men, despite the occurrence of more frequent adverse effects, and long-term safety data with newly developed vectors are eagerly awaited.", "The prevalent inclusion of men in randomised clinical trials (RCTs) with subsequent extrapolation of results to women needs to be addressed, as reinforcing sex-neutral claims into COVID-19 research may insidiously lead to increased inequities in health care.", "The huge worldwide effort with over 3,000 ongoing RCTs of pharmacological agents should focus on improving knowledge on sex, gender and age as pillars of individual variation in drug responses and enforce appropriateness."], "journal": "Pharmacol Res", "publish_time": "2021-08-26", "aliases": []}
{"doc_id": 233445952, "title": "Sex differences in inflammatory markers in patients hospitalized with COVID-19 infection: Insights from the MGH COVID-19 patient registry", "abstract": ["BACKGROUND: Men are at higher risk for serious complications related to COVID-19 infection than women.", "More robust immune activation in women has been proposed to contribute to decreased disease severity, although systemic inflammation has been associated with worse outcomes in COVID-19 infection.", "Whether systemic inflammation contributes to sex differences in COVID-19 infection is not known.", "STUDY DESIGN AND METHODS: We examined sex differences in inflammatory markers among 453 men (mean age 61) and 328 women (mean age 62) hospitalized with COVID-19 infection at the Massachusetts General Hospital from March 8 to April 27, 2020.", "Multivariable linear regression models were used to examine the association of sex with initial and peak inflammatory markers.", "Exploratory analyses examined the association of sex and inflammatory markers with 28-day clinical outcomes using multivariable logistic regression.", "RESULTS: Initial and peak CRP were higher in men compared with women after adjustment for baseline differences (initial CRP: \u00df 0.29, SE 0.07, p = 0.0001; peak CRP: \u00df 0.31, SE 0.07, p<0.0001) with similar findings for IL-6, PCT, and ferritin (p<0.05 for all).", "Men had greater than 1.5-greater odds of dying compared with women (OR 1.71, 95% CI 1.04-2.80, p = 0.03).", "Sex modified the association of peak CRP with both death and ICU admission, with stronger associations observed in men compared with women (death: OR 9.19, 95% CI 4.29-19.7, p <0.0001 in men vs OR 2.81, 95% CI 1.52-5.18, p = 0.009 in women, Pinteraction = 0.02).", "CONCLUSIONS: In a sample of 781 men and women hospitalized with COVID-19 infection, men exhibited more robust inflammatory activation as evidenced by higher initial and peak inflammatory markers, as well as worse clinical outcomes.", "Better understanding of sex differences in immune responses to COVID-19 infection may shed light on the pathophysiology of COVID-19 infection."], "journal": "PLoS One", "publish_time": "2021", "aliases": []}
{"doc_id": 220848256, "title": "Clinical characteristics of 31 hemodialysis patients with 2019 novel coronavirus: a retrospective study", "abstract": ["AIM: Novel coronavirus pneumonia (COVID-19) has become pandemic.", "It brings serious threat to hemodialysis (HD) patients.", "Therefore, we carried out a study on the clinical characteristics of HD patients with COVID-19.", "METHODS: We retrospectively analyzed the data of 31 HD patients with COVID-19.", "The clinical features of patients include epidemiology, clinical symptoms, laboratory and imaging test, treatment and prognosis.", "RESULTS: 61.3% were severe, and 38.7% were mild.", "83.9% had a close contact history with COVID-19 patients.", "The average age was 62.3 years comprising of 58.1% men and 41.9% women.", "Ninety percent had chronic diseases except ESRD.", "Clinical symptoms include cough (85%), fever (43%), and shortness of breath (48.4%), etc.", "Complications included ARDS (25.8%), AHF (22.6%), and septic shock (16.1%), etc.", "64.5% of patients had remission, and 35.5% of patients had no remission with 6.5% deaths.", "Compared with the baseline before infection, HD patients with COVID-19 had lower lymphocytes, albumin and glucose, and higher D-dimer, albumin, phosphorus, lactate dehydrogenase, and CRP.", "There was no significant correlation between the neutrophils/lymphocytes ratio and the severity of the disease.", "CONCLUSIONS: Compared with the reported general population, the HD patients are susceptible to COVID-19 infection, especially older men and those with other underlying diseases.", "Moreover, HD patients have more severe infection and inflammation with less symptoms and worse outcome.", "COVID-19 infection can cause dialysis patients lower immunity, stronger inflammation, malnutrition, and internal environment disorder.", "Neutrophils/lymphocytes ratio does not reflect the severity of the HD patients with COVID-19."], "journal": "Ren Fail", "publish_time": "2020", "aliases": []}
{"doc_id": 220795455, "title": "Misconceptions on COVID-19 Risk Among Ugandan Men: Results From a Rapid Exploratory Survey, April 2020", "abstract": ["background: Transmission of COVID-19 in developing countries is expected to surpass that in developed countries; however, information on community perceptions of this new disease is scarce.", "The aim of the study was to identify possible misconceptions among males and females toward COVID-19 in uganda using a rapid online survey distributed via social media.", "Methods: A cross-sectional survey carried out in early.", "April 2020 was conducted with 161 Ugandans, who purposively participated in the online questionnaire that assessed understandings of COVID-19 risk and infection.", "Sixty-four percent of respondents were male and 36% were female.", "Results: We found significant divergences of opinion on gendered susceptibility to COVID-19 Most female respondents considered infection risk, symptoms, severe signs, and death to be equally distributed between genders.", "In contrast, male respondents believed they were more at risk of infection, severe symptoms, severe signs, and death (52 7 vs 30 6%, rr = 1 79, 95% CI: 1 14-2 8) Most women did not share this perception and disagreed that males were at higher risk of infection (by a factor of three), symptoms (79% disagree), severe signs (71%, disagree), and death (70 2% disagree) Overall, most respondents considered children less vulnerable (or = 1 12, 95% CI: 0 55-2 2) to COVID-19 than adults, that children present with less symptoms (or = 1 57, 95% CI: 0 77-3 19), and that there would be less mortality in children (or = 0 92, 95% CI: 0 41-1 88) Of female respondents, 76 4% considered mortality from COVID-19 to be different between the young and the elderly (rr = 1 7, 95% CI: 1 01-2 92) and 92 7% believed young adults would show fewer signs than the elderly, and 71 4% agreed that elderly COVID-19 patients would show more severe signs than the young (or = 2 2, 95% CI: 1 4, 4 8) While respondents considered that all races were susceptible to the signs and symptoms of infection as well as death from COVID-19, they considered mortality would be highest among white people from europe and the usa.", "Some respondents (mostly male 33/102, 32 4%) considered COVID-19 to be a `` disease of whites '' (30 2%) Conclusion: The who has identified women and children in rural communities as vulnerable persons who should be given more attention in the COVID-19 national response programs across africa; however, our study has found that men in uganda perceive themselves to be at greater risk and that these contradictory perceptions (including the association of COVID-19 with `` the white '' race) suggest an important discrepancy in the communication of who is most vulnerable and why further research is urgently needed to validate and expand the results of this small exploratory study."], "journal": "Frontiers in public health", "publish_time": "2020", "aliases": []}
{"doc_id": 244324667, "title": "Psychological state characteristics of patients with COVID-19-associated pneumonia in three months after hospital discharge", "abstract": ["COVID-19 (The 2019 Corona Virus Disease) is a highly contagious infectious disease that affects the functioning of many organs and systems.", "The severe cases of the disease contributes to the development of anxiety-depressive and stressful symptoms that are factors make it difficult to recover.", "Objective.", "To study the presence, prevalence of signs of anxiety, depression, stress and their relationship with cardiovascular diseases among patients who have undergone confirmed COVID-19-associated pneumonia 3 months after discharge.", "Material and methods.", "The collection of material was carried out as part of the study \u201cOne-year cardiovascular observation of patients after COVID-19-associated pneumonia\u201d.", "The study included 103 patients aged 18 to 85 years (mean age 46.6\u00b115.8 years) who had undergone confirmed COVID-19-associated pneumonia 3 months\u00b12 weeks after discharge from the hospital including 51 (49.1%) woman.", "The GAD-7 and PHQ-9 scales were used to assess the signs of anxiety and depression, respectively.", "The minimum value of anxiety and depression was considered a total score of 5 points.", "Signs of stress were assessed using Stress Severity Scale 10;the minimum threshold value was 30 point.", "Results.", "Signs of anxiety and depression were found in approximately the same number of patients (29.1 and 27.2%, respectively), a combination of signs of anxiety and depression \u2014 in 18.4% of patients, stress \u2014 in 8.7% of patients.", "In terms of clinical characteristics, no significant differences were found between the groups of men and women.", "The prevalence of depression signs differed significantly depending on gender: significantly more often in women (p=0.023).", "The value of the median scores of the PHQ-9 questionnaire in the group of women is significantly higher than in the group of men (3.00 [1.00;8.00] and 1.00 [0;3.75], respectively;p=0.006).", "Logistic regression analysis showed that female gender increases the likelihood of depression by 2.83 times (95% CI 1.35-7.08).", "Despite the fact that there were no differences in gender in assessing the prevalence of anxiety (18.4 and 10.7% for men and women, respectively;p=0.072) when comparing the values of the median scores of the GAD-7 questionnaire in groups of men and women, the difference was statistically significant (1.00 [0;4.00] and 3.00 [2.00;7.00], respectively;p=0.001).", "Signs of stress among married people were less common compared with unmarried (2.9% versus 5.8%;p=0.037).", "Conclusion.", "Signs of anxiety or depression are characteristic of more than a quarter of patients who have had proven COVID-19-associated pneumonia 3 months after discharge from the hospital.", "Women experience symptoms of depression 3 times more often than men do.", "Unmarried patients tend to experience more stress.", "It seems expedient to organize treatment and prophylactic work with patients who have undergone hospitalization for COVID-19-associated pneumonia using methods of psychological correction and psychotherapy.", "(English) [ABSTRACT FROM AUTHOR] COVID-19 (The 2019 Corona Virus Disease) \u00e2\u20ac\u201d \u00d0\u00b2\u00d1\u2039\u00d1"], "journal": "Profilakticheskaya Meditsina", "publish_time": "2021", "aliases": []}
{"doc_id": 239534959, "title": "Psychological profile of COVID-19 pneumonia survivors three month after hospitalization", "abstract": ["BACKGROUND: COVID-19 is the highly contagious infectious disease, which affects different organs and systems.", "Anxiety and depression symptoms, that are common results of severe diseases, used to make recovery more difficult.", "PURPOSE: To study the prevalence of cardiovascular diseases, signs of anxiety, depression, stress, and their relationship in patients with proven COVID-19 pneumonia 3 months after discharge depending of gender.", "METHODS: The study was carried out within \u201cOne-year Cardiac Follow-up of COVID-19 Pneumonia\u201d.", "103 patients (mean age 46.6\u00b115.8 years) were divided into 2 groups: 52 men (50.9%) and 51 women.", "Anxiety and depression symptoms were measured by GAD-7 and PHQ-9, respectively.", "PSS-10 was used to measure stress symptoms.", "The minimum value of anxiety and depression was a total value of 5 points.", "RESULTS: 48.5% of patients had cardiovascular diseases, out of which arterial hypertension (AH) was the most common (44.7%).", "Less common was coronary artery disease (CAD) (16.5%), which in 14.6% of patients was accompanied by AH.", "Chronic heart failure (CHF) NYHA class I-II was found in 19.4% of patients, and severe CHF (NYHA class III\u2013IV) - in 4.9%.", "Arrhythmia was detected in 11.7% of patients.", "According to the clinical characteristics, no significant differences were found between the groups of men and women.", "AH affected 21.4% of men and 23.3% of women, CAD \u221210.7% and 5.8%, respectively.", "NYHA class I-II CHF were found in 8.7% of men and 10.7% of women, and severe CHF (NYHA class III\u2013IV) - in 2 men and 3 women.", "Arrhythmia had a prevalence of less than 6% among both men and women.", "Anxiety or depression symptoms were reported in 29.1% and 27.2%, respectively.", "Combination of anxiety and depression symptoms was determined in 18.4%, symptoms of stress in 8.7% of patients.", "Symptoms of depression were found in women more often (p=0.023).", "The value of the median scores of the PHQ-9 questionnaire in the group of women was significantly higher than in the group of men (3.00 [1.00; 8.00] and 1.00 [0; 3.75], p=0.006).", "Depression symptoms were associated with female gender (OR 2.83; CI 95% 1.35\u20137.08).", "Despite the absence of gender differences in the prevalence of anxiety (18.4% and 10.7%, p=0.072), when comparing the values of the median scores of the GAD-7 questionnaire in the groups of men and women, the difference was statistically significant (1.00 [0; 4.00] and 3.00 [2.00; 7.00], p=0.001, respectively).", "Signs of stress among married people were less common in comparison with unmarried (2.9% vs 5.8%, p=0.037).", "CONCLUSION: Three months after discharge, no significant differences in clinical characteristics between men and women were found.", "Signs of anxiety or depression were detected in more than a quarter of patients with proven COVID-19-associated pneumonia.", "Women experienced symptoms of depression 3 times more often than men.", "Unmarried patients tended to experience stress more often.", "FUNDUNDING ACKNOWLEDGEMENT: Type of funding sources: None."], "journal": "Eur Heart J", "publish_time": "2021-10-14", "aliases": []}
{"doc_id": 234832246, "title": "Gender differences in COVID-19 patients with arterial hypertension", "abstract": ["objective: To evaluate the gender differences in covid-19 patients with arterial hypertension.", "Design and method: This is a retrospective observational study comparing the association by gender of hypertensive status and with mortality among hospitalized patients with COVID-19 All patients admitted to our Hospitals, from 12 March to 12 April 2020 with confirmed COVID-19 were included in this study.", "Patients with COVID-19 included in this study were diagnosed according to World.", "Health.", "Organization interim guidance patients' demographic characteristics and clinical data (symptoms, comorbidities, laboratory findings, and outcomes) during hospitalization were collected from electronic medical records.", "The primary endpoint was all-cause mortality by gender during hospitalization.", "Other endpoints included the time elapsed between onset of symptoms and discharge, the rates of use of invasive mechanical ventilation, and the differences by gender in the treatment.", "The diagnosis of hypertension was given by the patient's physician prior to the infection with SARS-CoV-2 Results: In total, 877 consecutive hospitalized patients with confirmed COVID-19 were enrolled in the study.", "The median time from symptom onset to hospitalization was 4 6 for men and 2 6 days for women (p & lt; 0 05) Among these patients, 58% had a medical history of hypertension (57% men and 46% for women), p & lt; 0 05 The spectrum of symptoms of COVID-19 at admission between the two cohorts did not differ significantly A total of (15 0%) patients died in the hypertension cohort (14% for men and 16% for women; p ns) In particular, patients with hypertension had the propensity to develop more severe/ critical COVID-19 disease (P for trend & lt; 0 001) and were more likely to receive invasive mechanical ventilation (P & lt; 0 001) Conclusions: Patients with COVID-19 and hypertension have been reported to have an increased risk of adverse outcomes.", "In particular female patients with hypertension require intensive care (16% vs 11% for men, p & lt; 0 05) but no differences by gender for mortality rate we report.", "As described above, these data showed that hypertensive patients are at the highest risk for outcomes adverse.", "To further verify our results, as well as this hypothesis, we have also designed a randomized controlled trial."], "journal": "Journal of Hypertension", "publish_time": "2021", "aliases": []}
{"doc_id": 221494043, "title": "Household Secondary Attack Rate in Gandhinagar district of Gujarat state from Western India", "abstract": ["Objectives: Current retrospective study aims to evaluate household Secondary Attack Rate (SAR) of COVID-19 in Gandhinagar (rural) district of Gujarat, India.", "Methods: Line-listing of 486 laboratory-confirmed patients, tested between 28th March to 2nd July was collected, out of them 80 (15% of overall sample) cases were randomly selected.", "Demographic, clinical and household details of cases were collected through telephonic interview.", "During interview 28 more patients were identified from the same household and were added accordingly.", "So, study included 74 unrelated cluster of households with 74 primary cases and 386 close contacts.", "Results: SAR in household contacts of COVID-19 in Gandhinagar was 8.8%.", "Out of 108, 8 patients expired (7.4%), where higher mortality was observed in primary cases (9.5%) as compared to secondary cases (3%).", "Occupational analysis showed that majority of the secondary cases (88%) were not working and hence had higher contact time with patient.", "No out-of-pocket expenditure occurred in 94% of the patients, in remaining 6% average expenditure of 1,49,633INR (2027 USD) was recorded.", "Conclusions: Key observations from the study are 1) SAR of 8.8% is relatively low and hence home isolation of the cases can be continued 2) Primary case is more susceptible to fatal outcome as compared to secondary cases 3) Government has covered huge population of the COVID-19 patients under cost protection.", "However, more robust studies with larger datasets are needed to further validate the findings."], "journal": "", "publish_time": "2020-09-05", "aliases": []}
{"doc_id": 220669723, "title": "Risk factors associated with occurrence of COVID-19 among household persons exposed to patients with confirmed COVID-19 in Qingdao Municipal, China", "abstract": ["Tracing and isolation of close contacts is used to control outbreaks of coronavirus disease 2019 (COVID-19) in China.", "However, risk factors associated with the occurrence of COVID-19 among close contacts have not been well described.", "A total of 106 household contacts were included in this study, of whom 19 developed into COVID-19 cases, and the secondary attack rate was 17.9%.", "Multivariable analysis showed that increasing risk of occurrence of COVID-19 among household contacts was associated with female index patients (adjusted hazard ratio [aHR] = 3.84, 95% CI = 1.07-13.78), critical disease index patients (aHR = 7.58, 95% CI = 1.66-34.66), effective contact duration with index patients > 2 days (aHR = 4.21, 95% CI = 1.29-13.73), and effective contact duration > 11 days (aHR = 17.88, 95% CI = 3.26-98.01).", "The sex and disease severity of index patients with COVID-19 and longer effective contact duration with patients with confirmed COVID-19 could help epidemiologists to identify potential COVID-19 cases among household contacts at an early stage."], "journal": "Transbound. emerg. dis. (Internet)", "publish_time": "2020", "aliases": []}
{"doc_id": 218984462, "title": "Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China", "abstract": ["INTRODUCTION: Transmission of COVID-19 within families and close contacts accounts for the majority of epidemic growth.", "Community mask wearing, hand washing and social distancing are thought to be effective but there is little evidence to inform or support community members on COVID-19 risk reduction within families.", "METHODS: A retrospective cohort study of 335 people in 124 families and with at least one laboratory confirmed COVID-19 case was conducted from 28 February to 27 March 2020, in Beijing, China.", "The outcome of interest was secondary transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within the family.", "Characteristics and practices of primary cases, of well family contacts and household hygiene practices were analysed as predictors of secondary transmission.", "RESULTS: The secondary attack rate in families was 23.0% (77/335).", "Face mask use by the primary case and family contacts before the primary case developed symptoms was 79% effective in reducing transmission (OR=0.21, 95% CI 0.06 to 0.79).", "Daily use of chlorine or ethanol based disinfectant in households was 77% effective (OR=0.23, 95% CI 0.07 to 0.84).", "Wearing a mask after illness onset of the primary case was not significantly protective.", "The risk of household transmission was 18 times higher with frequent daily close contact with the primary case (OR=18.26, 95% CI 3.93 to 84.79), and four times higher if the primary case had diarrhoea (OR=4.10, 95% CI 1.08 to 15.60).", "Household crowding was not significant.", "CONCLUSION: The study confirms the highest risk of transmission prior to symptom onset, and provides the first evidence of the effectiveness of mask use, disinfection and social distancing in preventing COVID-19.", "We also found evidence of faecal transmission.", "This can inform guidelines for community prevention in settings of intense COVID-19 epidemics."], "journal": "BMJ Glob Health", "publish_time": "2020-05-28", "aliases": []}
{"doc_id": 221478300, "title": "Enhanced contact investigations for nine early travel-related cases of SARS-CoV-2 in the United States", "abstract": ["Coronavirus disease 2019 (COVID-19), the respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, China and has since become pandemic.", "In response to the first cases identified in the United States, close contacts of confirmed COVID-19 cases were investigated to enable early identification and isolation of additional cases and to learn more about risk factors for transmission.", "Close contacts of nine early travel-related cases in the United States were identified and monitored daily for development of symptoms (active monitoring).", "Selected close contacts (including those with exposures categorized as higher risk) were targeted for collection of additional exposure information and respiratory samples.", "Respiratory samples were tested for SARS-CoV-2 by real-time reverse transcription polymerase chain reaction at the Centers for Disease Control and Prevention.", "Four hundred four close contacts were actively monitored in the jurisdictions that managed the travel-related cases.", "Three hundred thirty-eight of the 404 close contacts provided at least basic exposure information, of whom 159 close contacts had \u22651 set of respiratory samples collected and tested.", "Across all actively monitored close contacts, two additional symptomatic COVID-19 cases (i.e., secondary cases) were identified; both secondary cases were in spouses of travel-associated case patients.", "When considering only household members, all of whom had \u22651 respiratory sample tested for SARS-CoV-2, the secondary attack rate (i.e., the number of secondary cases as a proportion of total close contacts) was 13% (95% CI: 4\u201338%).", "The results from these contact tracing investigations suggest that household members, especially significant others, of COVID-19 cases are at highest risk of becoming infected.", "The importance of personal protective equipment for healthcare workers is also underlined.", "Isolation of persons with COVID-19, in combination with quarantine of exposed close contacts and practice of everyday preventive behaviors, is important to mitigate spread of COVID-19."], "journal": "PLoS One", "publish_time": "2020-09-02", "aliases": [218060077]}
{"doc_id": 236565260, "title": "Transmission of COVID-19 and its Determinants among Close Contacts of COVID-19 Patients Running title", "abstract": ["BACKGROUND: This study aimed to determine the secondary attack rate (SAR) and its determinants to describe the clinical features and epidemiological aspects of patients and determine the risk factors of COVID-19 among household contacts in Hamadan Province, west of Iran.", "STUDY DESIGN: A cohort study.", "METHODS: In this cohort study, a total of 323 index cases and 989 related close contacts ages more than 15 years old (family members, relatives, and co-workers) were enrolled using a manual contact tracing approach, and all participants were tested by reverse transcription polymerase chain reaction test.", "In this research, the frequency of symptoms was assessed, the SAR among contacts of index cases was calculated, and the risk factors of COVID-19 were evaluated by the logistic regression model.", "RESULTS: The secondary attack rate for total household members of index cases was estimated at 31.7% (95% CI: 28.8-34.7).", "It was found that among household contacts, the highest SARs were related to spouses 47.1% (95% CI: 38.7-55.7) and grandparents/parents 39.3% (95% CI: 29.4, 49.9) of index cases, who had also higher risks to become secondary cases (adjusted odds ratio [OR]=2.98, 95% CI: 1.31-6.75 and adjusted OR=2.76, 95% CI: 1.18-6.44, respectively).", "Considering the occupation of contacts, unemployed and retired people and housewives were most susceptible for transmission of COVID-19.", "It was revealed that cough was the most prevalent symptom among index and secondary cases.", "CONCLUSION: Our findings indicated that spouses and grandparents/parents of index cases were the most susceptible individuals for COVID-19 transmission.", "Prolonged exposure with index case before COVID-19 diagnosis raised the chance of infection among secondary cases."], "journal": "J Res Health Sci", "publish_time": "2021", "aliases": []}
{"doc_id": 236483851, "title": "Dynamics of transmission of COVID-19 cases and household contacts: A prospective cohort study", "abstract": ["Objective: To study the transmission dynamics of coronavirus disease 2019 (COVID-19) among 101 confirmed cases and their 387 household contacts and to determine risk factors associated with secondary attack among the household contacts.", "Methods: A prospective cohort study was conducted from January 1st 2021 to February 28th 2021, among 101 SARS-CoV-2 cases and 387 household contacts who were followed up for 14 days from the last day of contact with the index case of COVID-19.", "The dynamics of disease transmission was estimated, and factors affecting transmission risk were analyzed.", "Besides, the association between various factors and household secondary attack rate was determined.", "Results: The median incubation period was found to be 5 days, and the observed reproductive number (R) was found to be 1.63 (95% CI: 1.28-1.98).", "The mean household secondary attack rate was 40.7%.", "Contacts with comorbidities like diabetes mellitus, hypertension, dyslipidemia, and hypothyroidism had significantly higher attack rates (P<0.05).", "Conclusions: As new variants of SARS-CoV-2 emerges, it is crucial to know the trasmission dynamics.", "This study shows a high secondary attack rate of COVID-19 among household contacts that must be closely monitored."], "journal": "Journal of Acute Disease", "publish_time": "2021", "aliases": []}
{"doc_id": 221552174, "title": "Household transmission in people infected with SARS-CoV-2 (COVID-19) in Metropolitan Lima", "abstract": ["Objective: Describe the characteristics of SARS-CoV-2 infection among household members with a confirmed primary case of COVID-19 in low burden districts in Metropolitan Lima.", "Materials and Methods: A retrospective, secondary database review study was conducted.", "The information was collected from an epidemiological surveillance activity in close contacts (co-inhabitants) in 52 households in Metropolitan Lima with only one member with COVID-19.", "A reevaluation was carried out in 10 households.", "Epidemiological and clinical variables were evaluated and its association with the result of the rapid serological test (presence of IgG, IgM or both).", "Results: Secondary cases were found in 40 households, which represents an average of 49.9% identification per household.", "A secondary attack rate of 53.0% (125 cases) was found among cohabitants, with 77.6% of cases being symptomatic (symptomatic / asymptomatic ratio: 3.5).", "The presence of fever and / or chills was found in 40.0% of people with a positive result, followed by a sore throat, in 39.2%.", "Ageusia and anosmia were present in 22.4% and 20.8% of cases, respectively.", "A reevaluation in 40 family members 33.6 +/- 2.7 days after the first evaluation, show the persistence of positive IgM and IgG in the 20 positive cases in the first evaluation.", "Conclusion: Having a primary case of COVID-19 in home, the secondary attack rate of this infection is 53%; however, in a significant proportion of households evaluated there was no positive case, beyond the primary case.", "The epidemiological and clinical characteristics found in this case were in accordance with what has already been reported in other international series."], "journal": "", "publish_time": "2020-09-09", "aliases": []}
{"doc_id": 226985536, "title": "Secondary attack rate of COVID-19 in household contacts in the Winnipeg Health Region, Canada", "abstract": ["OBJECTIVES: Understanding important transmission parameters, such as secondary attack rates, can help in strategizing, prioritizing, and planning interventions to curb morbidity and mortality due to COVID-19.", "Early reports suggest the risk of transmission of SARS-CoV-2 (the pathogen that causes COVID-19 disease) is high among household contacts of cases.", "The purpose of this analysis was to determine the household transmissibility of SARS-CoV-2 in residents of the Winnipeg Health Region.", "METHODS: We extracted information on COVID-19 cases and their household contacts from the regional public health surveillance database and used this dataset to calculate secondary attack rates.", "RESULTS: We included 381 individuals from 102 unique households (102 primary cases and 279 household contacts).", "A total of 41 contacts from 25 households became secondary cases in the 14 days since last unprotected exposure to the primary case, resulting in a secondary attack rate of 14.7% (95% CI: 10.5-18.8).", "CONCLUSION: Household transmission of SARS-CoV-2 has been an important contributor to the local COVID-19 epidemic."], "journal": "Can. j. public health", "publish_time": "2020", "aliases": []}
{"doc_id": 245563845, "title": "Risk of Secondary Household Transmission of COVID-19 from Health Care Workers in a Hospital in Spain", "abstract": ["Background: Hospital health care workers are at high risk of developing COVID-19 and transmitting the disease to their family upon returning home;the aim here is to estimate the secondary attack rate of COVID-19 in household contacts of health care workers and their transmission risk factors.", "Material and Methods: COVID-19 cases in the health care workers of an academic hospital in Pamplona, Spain, from 2 March to 26 May 2020, were followed up.", "The secondary attack rate (SAR) was estimated from cases in household contacts of index cases and their risk factors by Poisson regression.", "Results: 89 index cases were studied from 99 notified cases in health care workers (89.0%), excluding secondary cases or those who lived alone.", "Forty-six secondary cases confirmed by the laboratory were found among 326 household contacts, a secondary attack rate of 14.11% (95% CI 10.75\u201318.31), and 33 household contacts with acute infection symptoms without microbiologic confirmation 10.12% (95% CI 7.30\u201313.87).", "Considering all the cases, the secondary attack rate was 27.3 (95% CI 22.75\u201332.38).", "Risk factors were the gender and profession of the index case, the number of people living in the household, and the number of persons per bedroom.", "When the index case health worker used a single room, it had a protective effect, with an incidence rate ratio (IRR) of 0.493 (95% CI 0.246\u20130.985);Conclusions: The secondary attack rate found among household contacts of health care workers is high.", "The preventive isolation of health care workers in individual rooms in their house may reduce the transmission in their families."], "journal": "Epidemiologia", "publish_time": "2022", "aliases": []}
{"doc_id": 237315471, "title": "Seroprevalence of SARS-CoV-2\u2013Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020", "abstract": ["Close contacts of coronavirus disease (COVID-19) patients are at high risk for severe acute respiratory syndrome 2 (SARS-CoV-2) infection.", "We assessed the seroprevalence of SARS-CoV-2\u2013specific antibodies among quarantined close contacts of COVID-19 patients in the Faroe Islands.", "We invited quarantined close contacts of COVID-19 index patients identified during March 3\u2013April 22, 2020, to participate in this study; 584 (81%) contacts consented and underwent serologic testing.", "Among the 584 participants, 32 (5.5%) were seropositive for total antibody against SARS-CoV-2.", "Household and young or elderly contacts had higher risk for seropositivity than other contacts.", "We found a secondary attack rate of 19.2%.", "Seroprevalence among close contacts was almost 10-fold higher than among the general population of the Faroe Islands.", "Regularly testing household close contacts of COVID-19 patients might help track the transmission of SARS-CoV-2."], "journal": "Emerg Infect Dis", "publish_time": "2021-11-11", "aliases": []}
{"doc_id": 232260423, "title": "Household transmission of SARS-CoV-2 (COVID-19) in Lima, Peru.", "abstract": ["The study aimed to describe the characteristics of SARS-CoV-2 transmission among members of households with a confirmed primary case of COVID-19 in districts with low burden of cases in Lima, Peru, compared to a district with high burden.", "This was a retrospective study with a secondary database review.", "Information was collected from an epidemiological surveillance activity in close contacts (household members) in 52 households in Lima, with a single member with COVID-19.", "Reevaluation was conducted in 10 households.", "The study evaluated epidemiological and clinical variables and their association with the result of the rapid serological test (presence of IgG, IgM, or both).", "Secondary cases were found in 40 households, representing mean identification of 49.9% per household.", "Secondary attack rate in household members was 53% (125 cases), and symptomatic individuals accounted for 77.6% of cases (symptomatic/asymptomatic ratio: 3.5).", "Presence of fever and/or chills was found in 40% of persons with positive test results, followed by sore throat with 39.2%.", "Ageusia and anosmia were present in 22.4% and 20.8% of cases, respectively.", "When there was a primary case of COVID-19 in the household, the secondary attack rate was 53%; however, in an important proportion of households there were no positive cases other than the primary case.", "The epidemiological and clinical findings were consistent with reports from other international series."], "journal": "Cadernos de saude publica", "publish_time": "2021", "aliases": []}
{"doc_id": 219959531, "title": "Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study", "abstract": ["BACKGROUND: As of June 8, 2020, the global reported number of COVID-19 cases had reached more than 7 million with over 400 000 deaths.", "The household transmissibility of the causative pathogen, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains unclear.", "We aimed to estimate the secondary attack rate of SARS-CoV-2 among household and non-household close contacts in Guangzhou, China, using a statistical transmission model.", "METHODS: In this retrospective cohort study, we used a comprehensive contact tracing dataset from the Guangzhou Center for Disease Control and Prevention to estimate the secondary attack rate of COVID-19 (defined as the probability that an infected individual will transmit the disease to a susceptible individual) among household and non-household contacts, using a statistical transmission model.", "We considered two alternative definitions of household contacts in the analysis: individuals who were either family members or close relatives, such as parents and parents-in-law, regardless of residential address, and individuals living at the same address regardless of relationship.", "We assessed the demographic determinants of transmissibility and the infectivity of COVID-19 cases during their incubation period.", "FINDINGS: Between Jan 7, 2020, and Feb 18, 2020, we traced 195 unrelated close contact groups (215 primary cases, 134 secondary or tertiary cases, and 1964 uninfected close contacts).", "By identifying households from these groups, assuming a mean incubation period of 5 days, a maximum infectious period of 13 days, and no case isolation, the estimated secondary attack rate among household contacts was 12\u00b74% (95% CI 9\u00b78\u201315\u00b74) when household contacts were defined on the basis of close relatives and 17\u00b71% (13\u00b73\u201321\u00b78) when household contacts were defined on the basis of residential address.", "Compared with the oldest age group (\u226560 years), the risk of household infection was lower in the youngest age group (<20 years; odds ratio [OR] 0\u00b723 [95% CI 0\u00b711\u20130\u00b746]) and among adults aged 20\u201359 years (OR 0\u00b764 [95% CI 0\u00b743\u20130\u00b797]).", "Our results suggest greater infectivity during the incubation period than during the symptomatic period, although differences were not statistically significant (OR 0\u00b761 [95% CI 0\u00b727\u20131\u00b738]).", "The estimated local reproductive number (R) based on observed contact frequencies of primary cases was 0\u00b75 (95% CI 0\u00b741\u20130\u00b762) in Guangzhou.", "The projected local R, had there been no isolation of cases or quarantine of their contacts, was 0\u00b76 (95% CI 0\u00b749\u20130\u00b774) when household was defined on the basis of close relatives.", "INTERPRETATION: SARS-CoV-2 is more transmissible in households than SARS-CoV and Middle East respiratory syndrome coronavirus.", "Older individuals (aged \u226560 years) are the most susceptible to household transmission of SARS-CoV-2.", "In addition to case finding and isolation, timely tracing and quarantine of close contacts should be implemented to prevent onward transmission during the viral incubation period.", "FUNDING: US National Institutes of Health, Science and Technology Plan Project of Guangzhou, Project for Key Medicine Discipline Construction of Guangzhou Municipality, Key Research and Development Program of China."], "journal": "Lancet Infect Dis", "publish_time": "2020-06-17", "aliases": []}
{"doc_id": 221125385, "title": "Contact Settings and Risk for Transmission in 3410 Close Contacts of Patients With COVID-19 in Guangzhou, China : A Prospective Cohort Study", "abstract": ["BACKGROUND: Risk for transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to close contacts of infected persons has not been well estimated.", "OBJECTIVE: To evaluate the risk for transmission of SARS-CoV-2 to close contacts in different settings.", "DESIGN: Prospective cohort study.", "SETTING: Close contacts of persons infected with SARS-CoV-2 in Guangzhou, China.", "PARTICIPANTS: 3410 close contacts of 391 index cases were traced between 13 January and 6 March 2020.", "Data on the setting of the exposure, reverse transcriptase polymerase chain reaction testing, and clinical characteristics of index and secondary cases were collected.", "Measurement: Coronavirus disease 2019 (COVID-19) cases were confirmed by guidelines issued by China.", "Secondary attack rates in different settings were calculated.", "RESULTS: Among 3410 close contacts, 127 (3.7% [95% CI, 3.1% to 4.4%]) were secondarily infected.", "Of these 127 persons, 8 (6.3% [CI, 2.1% to 10.5%]) were asymptomatic.", "Of the 119 symptomatic cases, 20 (16.8%) were defined as mild, 87 (73.1%) as moderate, and 12 (10.1%) as severe or critical.", "Compared with the household setting (10.3%), the secondary attack rate was lower for exposures in healthcare settings (1.0%; odds ratio [OR], 0.09 [CI, 0.04 to 0.20]) and on public transportation (0.1%; OR, 0.01 [CI, 0.00 to 0.08]).", "The secondary attack rate increased with the severity of index cases, from 0.3% (CI, 0.0 to 1.0%) for asymptomatic to 3.3% (CI, 1.8% to 4.8%) for mild, 5.6% (CI, 4.4% to 6.8%) for moderate, and 6.2% (CI, 3.2% to 9.1%) for severe or critical cases.", "Index cases with expectoration were associated with higher risk for secondary infection (13.6% vs. 3.0% for index cases without expectoration; OR, 4.81 [CI, 3.35 to 6.93]).", "LIMITATION: There was potential recall bias regarding symptom onset among patients with COVID-19, and the symptoms and severity of index cases were not assessed at the time of exposure to contacts.", "CONCLUSION: Household contact was the main setting for transmission of SARS-CoV-2, and the risk for transmission of SARS-CoV-2 among close contacts increased with the severity of index cases.", "PRIMARY FUNDING SOURCE: Guangdong Province Higher Vocational Colleges and Schools Pearl River Scholar Funded Scheme."], "journal": "Ann. intern. med", "publish_time": "2020", "aliases": [221125385]}
{"doc_id": 216314663, "title": "High transmissibility of COVID-19 near symptom onset", "abstract": ["Background The dynamics of coronavirus disease 2019 (COVID-19) transmissibility after symptom onset remains unknown.", "Methods We conducted a prospective case-ascertained study on laboratory-confirmed COVID-19 cases and their contacts.", "Secondary clinical attack rate (considering symptomatic cases only) was analyzed for different exposure windows after symptom onset of index cases and for different exposure settings.", "Results Thirty-two confirmed patients were enrolled and 12 paired data (index-secondary cases) were identified among the 1,043 contacts.", "The secondary clinical attack rate was 0.9% (95% CI 0.5-1.7%).", "The attack rate was higher among those whose exposure to index cases started within five days of symptom onset (2.4%, 95% CI 1.1-4.5%) than those who were exposed later (zero case from 605 close contacts, 95% CI 0-0.61%).", "The attack rate was also higher among household contacts (13.6%, 95% CI 4.7-29.5%) and non-household family contacts (8.5%, 95% CI 2.4-20.3%) than that in healthcare or other settings.", "The higher secondary clinical attack rate for contacts near symptom onset remained when the analysis was restricted to household and family contacts.", "There was a trend of increasing attack rate with the age of contacts (p for trend < 0.001).", "Conclusions High transmissibility of COVID-19 near symptom onset suggests that finding and isolating symptomatic patients alone may not suffice to contain the epidemic, and more generalized social distancing measures are required.", "Rapid reduction of transmissibility over time implies that prolonged hospitalization of mild cases might not be necessary in large epidemics."], "journal": "", "publish_time": "2020-03-19", "aliases": []}
{"doc_id": 218473799, "title": "Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset.", "abstract": ["Importance The dynamics of coronavirus disease 2019 (COVID-19) transmissibility are yet to be fully understood.", "Better understanding of the transmission dynamics is important for the development and evaluation of effective control policies.", "Objective To delineate the transmission dynamics of COVID-19 and evaluate the transmission risk at different exposure window periods before and after symptom onset.", "Design, Setting, and Participants This prospective case-ascertained study in Taiwan included laboratory-confirmed cases of COVID-19 and their contacts.", "The study period was from January 15 to March 18, 2020.", "All close contacts were quarantined at home for 14 days after their last exposure to the index case.", "During the quarantine period, any relevant symptoms (fever, cough, or other respiratory symptoms) of contacts triggered a COVID-19 test.", "The final follow-up date was April 2, 2020.", "Main Outcomes and Measures Secondary clinical attack rate (considering symptomatic cases only) for different exposure time windows of the index cases and for different exposure settings (such as household, family, and health care).", "Results We enrolled 100 confirmed patients, with a median age of 44 years (range, 11-88 years), including 56 men and 44 women.", "Among their 2761 close contacts, there were 22 paired index-secondary cases.", "The overall secondary clinical attack rate was 0.7% (95% CI, 0.4%-1.0%).", "The attack rate was higher among the 1818 contacts whose exposure to index cases started within 5 days of symptom onset (1.0% [95% CI, 0.6%-1.6%]) compared with those who were exposed later (0 cases from 852 contacts; 95% CI, 0%-0.4%).", "The 299 contacts with exclusive presymptomatic exposures were also at risk (attack rate, 0.7% [95% CI, 0.2%-2.4%]).", "The attack rate was higher among household (4.6% [95% CI, 2.3%-9.3%]) and nonhousehold (5.3% [95% CI, 2.1%-12.8%]) family contacts than that in health care or other settings.", "The attack rates were higher among those aged 40 to 59 years (1.1% [95% CI, 0.6%-2.1%]) and those aged 60 years and older (0.9% [95% CI, 0.3%-2.6%]).", "Conclusions and Relevance In this study, high transmissibility of COVID-19 before and immediately after symptom onset suggests that finding and isolating symptomatic patients alone may not suffice to contain the epidemic, and more generalized measures may be required, such as social distancing."], "journal": "JAMA internal medicine", "publish_time": "2020-05-01", "aliases": []}
{"doc_id": 221490835, "title": "Transmission dynamics of COVID-19 in household and community settings in the United Kingdom", "abstract": ["Background: Households appear to be the highest risk setting for transmission of COVID-19.", "Large household transmission studies were reported in the early stages of the pandemic in Asia with secondary attack rates ranging from 5-30% but few large scale household transmission studies have been conducted outside of Asia.", "Methods: A prospective case ascertained study design based on the World Health Organization FFX protocol was undertaken in the UK following the detection of the first case in late January 2020.", "Household contacts of cases were followed using enhanced surveillance forms to establish whether they developed symptoms of COVID-19, became confirmed cases and their outcomes.", "Household secondary attack rates and serial intervals were estimated.", "Individual and household basic reproduction numbers were also estimated.", "The incubation period was estimated using known point source exposures that resulted in secondary cases.", "Results: A total of 233 households with two or more people were included with a total of 472 contacts.", "The overall household SAR was 37% (95% CI 31-43%) with a mean serial interval of 4.67 days, an R0 of 1.85 and a household reproduction number of 2.33.", "We find lower secondary attack rates in larger households.", "SARs were highest when the primary case was a child.", "We estimate a mean incubation period of around 4.5 days.", "Conclusions: High rates of household transmission of COVID-19 were found in the UK emphasising the need for preventative measures in this setting.", "Careful monitoring of schools reopening is needed to monitor transmission from children."], "journal": "", "publish_time": "2020-08-22", "aliases": []}
{"doc_id": 236934473, "title": "Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021", "abstract": ["Several studies report high effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe disease, however an important knowledge gap is the vaccine effectiveness against transmission (VET).", "We present estimates of the VET to household and other close contacts in the Netherlands, from February to May 2021, using contact monitoring data.", "The secondary attack rate among household contacts was lower for fully vaccinated than unvaccinated index cases (11% vs 31%), with an adjusted VET of 71% (95% confidence interval: 63\u201377)."], "journal": "Euro Surveill", "publish_time": "2021-08-05", "aliases": []}
{"doc_id": 215782364, "title": "Household Secondary Attack Rate of COVID-19 and Associated Determinants", "abstract": ["BACKGROUND: As of April 2, 2020, the global reported number of COVID-19 cases has crossed over 1 million with more than 55,000 deaths.", "The household transmissibility of SARS-CoV-2, the causative pathogen, remains elusive.", "METHODS: Based on a comprehensive contact-tracing dataset from Guangzhou, we estimated both the population-level effective reproductive number and individual-level secondary attack rate (SAR) in the household setting.", "We assessed age effects on transmissibility and the infectivity of COVID-19 cases during their incubation period.", "RESULTS: A total of 195 unrelated clusters with 212 primary cases, 137 nonprimary (secondary or tertiary) cases and 1938 uninfected close contacts were traced.", "We estimated the household SAR to be 13.8% (95% CI: 11.1\u201317.0%) if household contacts are defined as all close relatives and 19.3% (95% CI: 15.5\u201323.9%) if household contacts only include those at the same residential address as the cases, assuming a mean incubation period of 4 days and a maximum infectious period of 13 days.", "The odds of infection among children (<20 years old) was only 0.26 (95% CI: 0.13\u20130.54) times of that among the elderly (\u226560 years old).", "There was no gender difference in the risk of infection.", "COVID-19 cases were at least as infectious during their incubation period as during their illness.", "On average, a COVID-19 case infected 0.48 (95% CI: 0.39\u20130.58) close contacts.", "Had isolation not been implemented, this number increases to 0.62 (95% CI: 0.51\u20130.75).", "The effective reproductive number in Guangzhou dropped from above 1 to below 0.5 in about 1 week.", "CONCLUSION: SARS-CoV-2 is more transmissible in households than SARS-CoV and MERS-CoV, and the elderly \u226560 years old are the most vulnerable to household transmission.", "Case finding and isolation alone may be inadequate to contain the pandemic and need to be used in conjunction with heightened restriction of human movement as implemented in Guangzhou."], "journal": "medRxiv", "publish_time": "2020-04-15", "aliases": []}
{"doc_id": 245523810, "title": "SARS-CoV-2 Delta Variant Breakthrough Infection and Onward Secondary Transmission in Household", "abstract": ["BACKGROUND: Despite the extraordinary speed of mass vaccination efforts, an outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta variant in a vaccinee with coronavirus disease 2019 (COVID-19) mRNA vaccine was identified in an adult day service center (ADSC) of Jeju, South Korea.", "The primary objective of this study was to investigate the epidemiologic features in infection-vulnerable facilities with a high vaccination rate of BNT162b2 mRNA COVID-19 vaccine.", "The second was to estimate the secondary transmission prevention effect of the vaccine in the household members by vaccination status.", "METHODS: We included all ADSC participants, staff and their household members.", "All COVID-19 infected cases were confirmed by reverse transcriptase polymerase chain reaction.", "We calculated attack rate in ADSC and the secondary attack rate (SAR) in household members by vaccination status.", "RESULTS: Among a total of 42 participants and 16 staff, of which 96.6% were fully vaccinated with BNT162b2 mRNA COVID-19 vaccine, 12 symptomatic cases and 13 asymptomatic confirmed cases of COVID-19 were found.", "The attack rate was 43.1%, with 13 isolates identified as SARS-CoV-2 virus, delta variant.", "The SAR in unvaccinated and partially vaccinated household members were 27.8% (5/18) and 25.0% (5/20), respectively, while the SAR in fully vaccinated household members was 12.5% (1/8).", "CONCLUSION: We describe a SARS-CoV-2 delta variant outbreak in ADSC with high vaccine coverage rate, characterized by high infection rate, high transmissibility, and low clinical severity.", "The outbreak proceeded to unvaccinated or partially vaccinated household members, emphasizing the need for immunizing close contacts of high-risk groups."], "journal": "J Korean Med Sci", "publish_time": "2021-12-17", "aliases": []}
{"doc_id": 229174733, "title": "Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis", "abstract": ["IMPORTANCE: Crowded indoor environments, such as households, are high-risk settings for the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).", "OBJECTIVES: To examine evidence for household transmission of SARS-CoV-2, disaggregated by several covariates, and to compare it with other coronaviruses.", "DATA SOURCE: PubMed, searched through October 19, 2020.", "Search terms included SARS-CoV-2 or COVID-19 with secondary attack rate, household, close contacts, contact transmission, contact attack rate, or family transmission.", "STUDY SELECTION: All articles with original data for estimating household secondary attack rate were included.", "Case reports focusing on individual households and studies of close contacts that did not report secondary attack rates for household members were excluded.", "DATA EXTRACTION AND SYNTHESIS: Meta-analyses were done using a restricted maximum-likelihood estimator model to yield a point estimate and 95% CI for secondary attack rate for each subgroup analyzed, with a random effect for each study.", "To make comparisons across exposure types, study was treated as a random effect, and exposure type was a fixed moderator.", "The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline was followed.", "MAIN OUTCOMES AND MEASURES: Secondary attack rate for SARS-CoV-2, disaggregated by covariates (ie, household or family contact, index case symptom status, adult or child contacts, contact sex, relationship to index case, adult or child index cases, index case sex, number of contacts in household) and for other coronaviruses.", "RESULTS: A total of 54 relevant studies with 77 758 participants reporting household secondary transmission were identified.", "Estimated household secondary attack rate was 16.6% (95% CI, 14.0%-19.3%), higher than secondary attack rates for SARS-CoV (7.5%; 95% CI, 4.8%-10.7%) and MERS-CoV (4.7%; 95% CI, 0.9%-10.7%).", "Household secondary attack rates were increased from symptomatic index cases (18.0%; 95% CI, 14.2%-22.1%) than from asymptomatic index cases (0.7%; 95% CI, 0%-4.9%), to adult contacts (28.3%; 95% CI, 20.2%-37.1%) than to child contacts (16.8%; 95% CI, 12.3%-21.7%), to spouses (37.8%; 95% CI, 25.8%-50.5%) than to other family contacts (17.8%; 95% CI, 11.7%-24.8%), and in households with 1 contact (41.5%; 95% CI, 31.7%-51.7%) than in households with 3 or more contacts (22.8%; 95% CI, 13.6%-33.5%).", "CONCLUSIONS AND RELEVANCE: The findings of this study suggest that given that individuals with suspected or confirmed infections are being referred to isolate at home, households will continue to be a significant venue for transmission of SARS-CoV-2."], "journal": "JAMA Netw Open", "publish_time": "2020-12-14", "aliases": [220885520]}
{"doc_id": 227239676, "title": "FDA efficiency for approval process of COVID-19 therapeutics", "abstract": ["Coronavirus disease 19 (COVID-19) is an infection caused by the novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2).", "The pandemic spread of SARS-CoV-2 has resulted in significant health, economic, and social ramifications.", "There are no U.S. Food and Drug Administration (FDA)-approved prophylactic or therapeutic treatment options for COVID-19.", "This puts unprecedented product development pressure on the medical science community to define treatment options.", "Additionally, in the United States of American (USA) further regulatory and quality assurance pressures impact the FDA.", "The regulatory therapeutic development process is complex as it relates to product mechanism, toxicity profile, and level of efficacy.", "The advert of a worldwide pandemic however, advanced efficiencies within many of the regulatory agencies worldwide in order to facilitate COVID-19 treatment option development within the USA.", "Clinical drug development pathways can include several established approaches: investigational new drug (IND), expanded access IND, emergency IND, treatment IND, and emergency use authorization (EUA).", "Remdesivir, an investigational drug, and hydroxyloroquine, an FDA-approved drug for autoimmune diseases, were the two early potential therapies.", "This review article examines the expedited FDA review process for remdesivir and hydroxychloroquine, and analyzes data and results from early clinical studies of both drugs."], "journal": "Infect Agent Cancer", "publish_time": "2020", "aliases": []}
{"doc_id": 227040040, "title": "Repurposing screens of FDA-approved drugs identify 29 inhibitors of SARS-CoV-2", "abstract": ["COVID-19, caused by a novel coronavirus, SARS-CoV-2, has spread globally and caused serious social and economic problems.", "The WHO has declared this outbreak a pandemic.", "Currently, there are no approved vaccines or antiviral drugs.", "Drugs already approved for clinical use would be ideal candidates for rapid development as COVID-19 treatments.", "In this work, we screened 1,473 FDA-approved drugs to identify inhibitors of SARS-CoV-2 infection using cell-based assays.", "The antiviral activity of each compound was measured based on the immunofluorescent staining of infected cells using anti-dsRNA antibody.", "Twenty-nine drugs were found to show antiviral activity against SARS-CoV-2.", "We report this new list of inhibitors to quickly provide basic information for consideration in developing potential therapies."], "journal": "", "publish_time": "2020", "aliases": []}
{"doc_id": 221220335, "title": "Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo", "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in China at the end of 2019 and has rapidly caused a pandemic, with over 20 million recorded COVID-19 cases in August 2020 (https://covid19.who.int/).", "There are no FDA-approved antivirals or vaccines for any coronavirus, including SARS-CoV-2.", "Current treatments for COVID-19 are limited to supportive therapies and off-label use of FDA-approved drugs.", "Rapid development and human testing of potential antivirals is urgently needed.", "Numerous drugs are already approved for human use, and subsequently, there is a good understanding of their safety profiles and potential side effects, making them easier to fast-track to clinical studies in COVID-19 patients.", "Here, we present data on the antiviral activity of 20 FDA-approved drugs against SARS-CoV-2 that also inhibit SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV).", "We found that 17 of these inhibit SARS-CoV-2 at non-cytotoxic concentrations.", "We directly followed up seven of these to demonstrate that all are capable of inhibiting infectious SARS-CoV-2 production.", "Moreover, we evaluated two of these, chloroquine and chlorpromazine, in vivo using a mouse-adapted SARS-CoV model and found that both drugs protect mice from clinical disease.", "IMPORTANCE There are no FDA-approved antivirals for any coronavirus, including SARS-CoV-2.", "Numerous drugs are already approved for human use that may have antiviral activity and therefore could potentially be rapidly repurposed as antivirals.", "Here, we present data assessing the antiviral activity of 20 FDA-approved drugs against SARS-CoV-2 that also inhibit SARS-CoV and MERS-CoV in vitro.", "We found that 17 of these inhibit SARS-CoV-2, suggesting that they may have pan-anti-coronaviral activity.", "We directly followed up seven of these and found that they all inhibit infectious-SARS-CoV-2 production.", "Moreover, we evaluated chloroquine and chlorpromazine in vivo using mouse-adapted SARS-CoV.", "We found that neither drug inhibited viral replication in the lungs, but both protected against clinical disease."], "journal": "J Virol", "publish_time": "2020-10-14", "aliases": []}
{"doc_id": 214725674, "title": "FDA approved drugs with broad anti-coronaviral activity inhibit SARS-CoV-2 in vitro", "abstract": ["SARS-CoV-2 emerged in China at the end of 2019 and has rapidly become a pandemic with roughly 2.7 million recorded COVID-19 cases and greater than 189,000 recorded deaths by April 23rd, 2020 (www.WHO.org).", "There are no FDA approved antivirals or vaccines for any coronavirus, including SARS-CoV-2.", "Current treatments for COVID-19 are limited to supportive therapies and off-label use of FDA approved drugs.", "Rapid development and human testing of potential antivirals is greatly needed.", "A quick way to test compounds with potential antiviral activity is through drug repurposing.", "Numerous drugs are already approved for human use and subsequently there is a good understanding of their safety profiles and potential side effects, making them easier to fast-track to clinical studies in COVID-19 patients.", "Here, we present data on the antiviral activity of 20 FDA approved drugs against SARS-CoV-2 that also inhibit SARS-CoV and MERS-CoV.", "We found that 17 of these inhibit SARS-CoV-2 at a range of IC50 values at non-cytotoxic concentrations.", "We directly follow up with seven of these to demonstrate all are capable of inhibiting infectious SARS-CoV-2 production.", "Moreover, we have evaluated two of these, chloroquine and chlorpromazine, in vivo using a mouse-adapted SARS-CoV model and found both drugs protect mice from clinical disease."], "journal": "bioRxiv", "publish_time": "2020-04-27", "aliases": []}
{"doc_id": 229714432, "title": "Drug discovery of small molecules for the treatment of COVID-19: A review on clinical studies", "abstract": ["Recently, a sudden outbreak of novel coronavirus disease (COVID-19) was caused by a zoonotic virus known as severe acute respiratory syndrome coronavirus (SARS-CoV-2).", "It has caused pandemic situations around the globe and affecting the lives of millions of people.", "So far, no drug has been approved for the treatment of SARS-CoV-2 infected patients.", "As of now, more than 1000 clinical trials are going on for repurposing of FDA approved drugs and for evaluating the safety & efficiency of experimental antiviral molecules to combat COVID-19.", "Since the development of new drugs may require months to years to reach the market, this review focusses on the potentials of existing small molecule FDA approved drugs and the molecules already in the clinical pipeline against viral infections like HIV, hepatitis B, Ebola virus, and other viruses of coronavirus family (SARS-CoV and MERS-CoV).", "The review also discusses the natural products and traditional medicines in clinical studies against COVID-19.", "Currently, 1978 studies are active, 143 completed and 4 posted results (as on June 13, 2020) on clinicaltrials.gov."], "journal": "Mini-reviews in medicinal chemistry (Online)", "publish_time": "2020", "aliases": []}
{"doc_id": 225272997, "title": "Treatment of COVID-19: Hydroxychloroquine and Chloroquine", "abstract": ["From the Document: To date, the U S Food and drug administration (fda) has not approved any therapeutics -- drugs or biologics -- for the treatment of COVID-19 [ coronavirus disease 2019 ] However, fda has authorized the emergency use of three drugs, including two drugs that have been approved by fda for other uses: hydroxychloroquine sulfate ('hydroxychloroquine') and chloroquine phosphate ('chloroquine') The agency authorized the emergency use of both drugs on March 28, 2020 [ ] Some stakeholders -- including several former fda officials -- have expressed concern regarding fda's eua [ emergency use authorization ], stating that current data regarding the safety and effectiveness of these drugs for treatment of COVID-19 are largely anecdotal and that expanding access may jeopardize research into the drug.", "On.", "April 24, 2020, fda issued a drug safety communication warning against the use of these drugs for treatment of COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems.", "Further, the national institutes of health (nih) treatment guidelines on use of antivirals for COVID-19 state that' [ t ] here are insufficient clinical data to recommend either for or against using chloroquine or hydroxychloroquine for the treatment of COVID-19' and recommend against using high-dose chloroquine for the treatment of COVID-19 COVID-19 (disease); Therapeutics."], "journal": "", "publish_time": "2020", "aliases": []}
{"doc_id": 233016645, "title": "Computational screening of FDA approved drugs of fungal origin that may interfere with SARS-CoV-2 spike protein activation, viral RNA replication, and post\u2010translational modification: a multiple target approach", "abstract": ["Coronavirus spread is an emergency reported globally, and a specific treatment strategy for this significant health issue is not yet identified.", "COVID-19 is a highly contagious disease and needs to be controlled promptly as millions of deaths have been reported.", "Due to the absence of proficient restorative alternatives and preliminary clinical restrictions, FDA-approved medications can be a decent alternative to deal with the coronavirus malady (COVID-19).", "The present study aims to meet the imperative necessity of effective COVID-19 drug treatment with a computational multi-target drug repurposing approach.", "This study focused on screening the FDA-approved drugs derived from the fungal source and its derivatives against the SARS-CoV-2 targets.", "All the selected drugs showed good binding affinity towards these targets, and out of them, bromocriptine was found to be the best candidate after the screening on the COVID-19 targets.", "Further, bromocriptine is analyzed by molecular simulation and MM-PBSA study.", "These studies suggested that bromocriptine can be the best candidate for TMPRSS2, Main protease, and RdRp protein.", "SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40203-021-00089-8."], "journal": "In Silico Pharmacol", "publish_time": "2021-04-04", "aliases": []}
{"doc_id": 237587184, "title": "Inhibitory activity of FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, remdesivir, and hydroxychloroquine on COVID-19 main protease and human ACE2 receptor: A comparative in silico approach", "abstract": ["By September 1, 2021, SARS-CoV-2, a respiratory virus that prompted Coronavirus Disease in 2019, had infected approximately 218,567,442 patients and claimed 4,534,151 lives.", "There are currently no specific treatments available for this lethal virus, although several drugs, including remdesivir and hydroxychloroquine, have been tested.", "The purpose of this study is to assess the activity of FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, remdesivir, and hydroxychloroquine as potential SARS-CoV-2 main protease inhibitors.", "Additionally, this study aims to provide insight into the development of potential inhibitors that may inhibit ACE2, thereby preventing SARS-CoV-2 entry into the host cell and infection.", "To this end, remdesivir and hydroxychloroquine were used as comparator drugs.", "The calculations revealed that cetilistat, abiraterone, diiodohydroxyquinoline, and bexarotene inhibit main protease and ACE2 receptors more effectively than the well-known drug hydroxychloroquine when used against COVID-19.", "Meanwhile, bexarotene and cetilistat bind more tightly to the SARS-CoV-2 main protease and the ACE2 receptor, respectively, than remdesivir, a potential treatment for COVID-19 that is the first FDA-approved drug against this virus.", "As a result, the molecular dynamic simulations of these two drugs in the presence of proteins were investigated.", "The MD simulation results demonstrated that these drugs interact to stabilize the systems, allowing them to be used as effective inhibitors of these proteins.", "Meanwhile, bexarotene, abiraterone, cetilistat, and diiodohydroxyquinoline's systemic effects should be further investigated in suitable ex vivo human organ culture or organoids, animal models, or clinical trials."], "journal": "Inform Med Unlocked", "publish_time": "2021-09-22", "aliases": []}
{"doc_id": 225067011, "title": "Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach", "abstract": ["BACKGROUND: Outbreak of COVID-19 has been recognized as a global health concern since it causes high rates of morbidity and mortality.", "No specific antiviral drugs are available for the treatment of COVID-19 till date.", "Drug repurposing strategy helps to find out the drugs for COVID-19 treatment from existing FDA approved antiviral drugs.", "In this study, FDA approved small molecule antiviral drugs were repurposed against the major viral proteins of SARS-CoV-2.", "METHODS: The 3D structures of FDA approved small molecule antiviral drugs were retrieved from PubChem.", "Virtual screening was performed to find out the lead antiviral drug molecules against main protease (Mpro) and RNA-dependent RNA polymerase (RdRp) using COVID-19 Docking Server.", "Furthermore, lead molecules were individually docked against protein targets using AutoDock 4.0.1 software and their drug-likeness and ADMET properties were evaluated.", "RESULTS: Out of 65 FDA approved small molecule antiviral drugs screened, Raltegravir showed highest interaction energy value of -9 kcal/mol against Mpro of SARS-CoV-2 and Indinavir, Tipranavir, and Pibrentasvir exhibited a binding energy value of \u2265 -8 kcal/mol.", "Similarly Indinavir showed the highest binding energy of -11.5 kcal/mol against the target protein RdRp and Dolutegravir, Elbasvir, Tipranavir, Taltegravir, Grazoprevir, Daclatasvir, Glecaprevir, Ledipasvir, Pibrentasvir and Velpatasvir showed a binding energy value in range from -8 to -11.2 kcal/mol.", "The antiviral drugs Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine also exhibited good bioavailability and drug-likeness properties.", "CONCLUSION: This study suggests that the screened small molecule antiviral drugs Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine could serve as potential drugs for the treatment of COVID-19 with further validation studies."], "journal": "J Infect Public Health", "publish_time": "2020-10-26", "aliases": []}
{"doc_id": 245616543, "title": "Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Patients", "abstract": ["On 4(th) November 2021, the first oral antiviral drug for COVID-19, molnupiravir (Lagevrio(\u00ae)), received full regulatory approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK.", "Molnupiravir is an orally bioavailable antiviral drug for use at home when a SARS-CoV-2 test is positive.", "On 22(nd) December 2022, the FDA granted emergency use authorization (EUA) for the oral antiviral drug, nirmatrelvir/ritonavir (Paxlovid(\u00ae)) for adults and children with mild and moderate COVID-19 at increased risk of progression to severe COVID-19.", "These regulatory drug approvals come at a crucial time when new variants of concern of the SARS-CoV-2 virus are spreading rapidly.", "Although the FDA approved remdesivir (Veklury(\u00ae)) on 22(nd) October 2020 for use in adults and children for the treatment of COVID-19 requiring hospitalization, its use has been limited by the requirement for intravenous administration in a healthcare facility.", "The four FDA-approved therapeutic neutralizing monoclonal antibodies, imdevimab, bamlanivimab, etesevimab, and casirivimab are costly and also require medically-supervised intravenous administration.", "The availability of effective, low-cost oral antiviral drugs available in a community setting that can be used at an early stage of SARS-CoV-2 infection is now a priority in controlling COVID-19.", "An increasing number of repurposed antiviral drugs are currently under investigation or in the early stages of regulatory approval.", "This Editorial aims to present an update on the current status of orally bioavailable antiviral drug treatments for SARS-CoV-2 infection."], "journal": "Med Sci Monit", "publish_time": "2022-01-01", "aliases": []}
{"doc_id": 221342807, "title": "The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine", "abstract": ["The emergence of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; COVID-19) in China, reported to the World Health Organization on December 31, 2019, has led to a large global pandemic and is a major public health issue.", "As a result, there are more than 200 clinical trials of COVID-19 treatments or vaccines that are either ongoing or recruiting patients.", "One potential therapy that has garnered international attention is hydroxychloroquine; a potent immunomodulatory agent FDA-approved for the treatment of numerous inflammatory and autoimmune conditions, including malaria, lupus, and rheumatoid arthritis.", "Hydroxychloroquine has demonstrated promise in vitro and is currently under investigation in clinical trials for the treatment of COVID-19.", "Despite an abundance of empirical data, the mechanism(s) involved in the immunomodulatory activity of hydroxychloroquine have not been characterized.", "Using the unbiased chemical similarity ensemble approach (SEA), we identified C-C chemokine receptor type 4 (CCR4) as an immunomodulatory target of hydroxychloroquine.", "The crystal structure of CCR4 was selected for molecular docking studies using the SwissDock modeling software.", "In silico, hydroxychloroquine interacts with Thr-189 within the CCR4 active site, presumably blocking endogenous ligand binding.", "However, the CCR4 antagonists compound 18a and K777 outperformed hydroxychloroquine in silico, demonstrating energetically favorable binding characteristics.", "Hydroxychloroquine may subject COVID-19 patients to QT-prolongation, increasing the risk of sudden cardiac death.", "The FDA-approved CCR4 antagonist mogalizumab is not known to increase the risk of QT prolongation and may serve as a viable alternative to hydroxychloroquine.", "Results from this report introduce additional FDA-approved drugs that warrant investigation for therapeutic use in the treatment of COVID-19."], "journal": "Front Pharmacol", "publish_time": "2020-08-28", "aliases": []}
{"doc_id": 225609171, "title": "GS-5734: a potentially approved drug by FDA against SARS-Cov-2", "abstract": ["coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection COVID-19 is an ongoing global health crisis.", "Efficacious drugs against COVID-19 are not yet available.", "Therefore, rapid discovery of safe and efficacious agents against SARS-CoV-2 are needed urgently.", "Nucleoside analogs have an integral role in the treatment of viral infections.", "Owing to their broad-spectrum antiviral activities, C-nucleoside analogs have become key components of COVID-19 treatment regimens.", "Here, we review the state-of-the-art C-nucleoside GS-5734 (remdesivir) that is in preclinical research for COVID-19 treatment.", "As a potentially approved drug by the fda against SARS-Cov-2 infection, the efficacy and safety of GS-5734 have been documented repeatedlyin vitro, in animal models, and in humans.", "To better understand the drug-development process, this review focused on the discovery process, preparation methods, broad-spectrum activities, and antiviral mechanism of GS-5734."], "journal": "New Journal of Chemistry", "publish_time": "2020", "aliases": []}
{"doc_id": 225145151, "title": "Nanoparticles\u2010assisted delivery of antiviral\u2010siRNA as inhalable treatment for human respiratory viruses: A candidate approach against SARS\u2010COV\u20102", "abstract": ["The current pandemic of coronavirus disease 2019 (COVID\u201019) caused by severe acute respiratory syndrome coronavirus\u20102 (SARS\u2010CoV\u20102) has challenged healthcare structures across the globe.", "Although a few therapies are approved by FDA, the search for better treatment options is continuously on rise.", "Clinical management includes infection prevention and supportive care such as supplemental oxygen and mechanical ventilatory support.", "Given the urgent nature of the pandemic and the number of companies and researchers developing COVID\u201019 related therapies, FDA has created an emergency program to move potential treatments with already approved drugs to patients as quickly as possible in parallel to the development of new drugs that must first pass the clinical trials.", "In this manuscript, we have reviewed the available literature on the use of sequence\u2010specific degradation of viral genome using short\u2010interfering RNA (siRNA) suggesting it as a possible treatment against SARS\u2010CoV\u20102.", "Delivery of siRNA can be promoted by the use of FDA approved lipids, polymers or lipid\u2010polymer hybrids.", "These nanoparticulate systems can be engineered to exhibit increased targetability and formulated as inhalable aerosols."], "journal": "Nano select : open access", "publish_time": "2020-10-12", "aliases": []}
{"doc_id": 232310172, "title": "Phylogenic analysis of coronavirus genome and molecular studies on potential anti-COVID-19 agents from selected FDA-approved drugs", "abstract": ["The emergence of 2019 novel Coronavirus (COVID-19 or 2019-nCoV) has caused significant global morbidity and mortality with no consensus specific treatment.", "We tested the hypothesis that FDA-approved antiretrovirals, antibiotics, and antimalarials will effectively inhibit COVID-19 two major drug targets, coronavirus nucleocapsid protein (NP) and hemagglutinin-esterase (HE).", "To test this hypothesis, we carried out a phylogenic analysis of coronavirus genome to understand the origins of NP and HE, and also modeled the proteins before molecular docking, druglikeness, toxicity assessment, molecular dynamics simulation (MDS) and ligand-based pharmacophore modeling of the selected FDA-approved drugs.", "Our models for NP and HE had over 95% identity with templates 5EPW and 3CL5 respectively in the PDB database, with majority of the amino acids occupying acceptable regions.", "The active sites of the proteins contained conserved residues that were involved in ligand binding.", "Lopinavir and ritonavir possessed greater binding affinities for NP and HE relative to remdesivir, while levofloxacin and hydroxychloroquine were the most notable among the other classes of drugs.", "The Root Mean Square Deviation (RMSD), Root Mean Square Fluctuation (RMSF), Radius of gyration (Rg), and binding energy values obtained after 100 ns of MDS revealed good stability of these compounds in the binding sites of the proteins while important pharmacophore features were also identified.", "The study showed that COVID-19 likely originated from bat, owing to the over 90% genomic similarity observed, and that lopinavir, levofloxacin, and hydroxychloroquine might serve as potential anti-COVID-19 lead molecules for additional optimization and drug development for the treatment of COVID-19.Communicated by Ramaswamy H. Sarma."], "journal": "J Biomol Struct Dyn", "publish_time": "2021", "aliases": []}
{"doc_id": 221141815, "title": "Maraviroc inhibits SARS-CoV-2 multiplication and s-protein mediated cell fusion in cell culture", "abstract": ["In an effort to identify therapeutic intervention strategies for the treatment of COVID-19, we have investigated a selection of FDA-approved small molecules and biologics that are commonly used to treat other human diseases.", "A screen of 19 small molecules and 3 biologics was conducted in cell culture and the impact of treatment on viral titer was quantified by plaque assay.", "The screen identified 4 FDA-approved small molecules, Maraviroc, FTY720 (Fingolimod), Atorvastatin and Nitazoxanide that were able to inhibit SARS-CoV-2 infection.", "Confocal microscopy with over expressed S protein demonstrated that Maraviroc reduced the extent of S-protein mediated cell fusion as observed by fewer multinucleate cells in drug-treated cells.", "Mathematical modeling of drug-dependent viral multiplication dynamics revealed that prolonged drug treatment will exert an exponential decrease in viral load in a multicellular/tissue environment.", "Taken together, the data demonstrate that Maraviroc, Fingolimod, Atorvastatin and Nitazoxanide inhibit SARS-CoV-2 in cell culture."], "journal": "bioRxiv", "publish_time": "2020-08-13", "aliases": []}
{"doc_id": 219604381, "title": "Several FDA-approved drugs effectively inhibit SARS-CoV-2 infection in vitro", "abstract": ["To identify drugs that are potentially used for the treatment of COVID-19, the potency of 1403 FDA-approved drugs were evaluated using a robust pseudovirus assay and the candidates were further confirmed by authentic SARS-CoV-2 assay.", "Four compounds, Clomiphene (citrate), Vortioxetine, Vortioxetine (hydrobromide) and Asenapine (hydrochloride), showed potent inhibitory effects in both pseudovirus and authentic virus assay.", "The combination of Clomiphene (citrate), Vortioxetine and Asenapine (hydrochloride) is much more potent than used alone, with IC50 of 0.34 \u03bcM."], "journal": "bioRxiv", "publish_time": "2020-06-05", "aliases": []}
{"doc_id": 225071669, "title": "FDA Emergency Use Authorization: Glass Half Empty?", "abstract": ["Recently, the Food and Drug Administration (FDA) issued emergency use authorization (EUA) of convalescent plasma (CP) for the treatment of COVID-19 hospitalized patients based on a non-peer reviewed open label observational study.", "Issuance of an EUA without a proven randomized control trial (RCT) sets a dangerous precedent since the premature action drives health care providers and patients away from RCTs that are essential for determining the efficacy and safety of CP.", "More caution should have been taken based on what was learned from the recently rescinded EUA of hydroxychloroquine and chloroquine debacle which was approved initially based on an anecdotal report.", "The FDA approval process for determining efficacy and safety must be based solely on data from RCTs to sustain public and professional trust for future treatment or vaccine efforts to be successful."], "journal": "Clin. infect. dis", "publish_time": "2020", "aliases": []}
{"doc_id": 231604282, "title": "Remdesivir (Veklury) for COVID-19", "abstract": ["The FDA has approved the antiviral drug remdesivir [Veklury - Gilead) for IV treatment of COVID-19 in hospitalized patients who are &gt;12 years old and weigh &gt;40 kg.", "Hospitalized children who are &lt;12 years old or weigh &lt;40 kg can receive remdesivir through an Emergency Use Authorization (EUA).", "Remdesivir is the first drug to be approved in the US for treatment of COVID-19.", "FDA approval of remdesivir was based on the results of three randomized controlled trials in hospitalized patients with COVID-19."], "journal": "Medical Letter on Drugs and Therapeutics", "publish_time": "2020", "aliases": []}
{"doc_id": 227101675, "title": "Target-Centered Drug Repurposing Predictions of Human Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine Subtype 2 (TMPRSS2) Interacting Approved Drugs for Coronavirus Disease 2019 (COVID-19) Treatment through a Drug-Target Interaction Deep Learning Model", "abstract": ["Previously, our group predicted commercially available Food and Drug Administration (FDA) approved drugs that can inhibit each step of the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using a deep learning-based drug-target interaction model called Molecule Transformer-Drug Target Interaction (MT-DTI).", "Unfortunately, additional clinically significant treatment options since the approval of remdesivir are scarce.", "To overcome the current coronavirus disease 2019 (COVID-19) more efficiently, a treatment strategy that controls not only SARS-CoV-2 replication but also the host entry step should be considered.", "In this study, we used MT-DTI to predict FDA approved drugs that may have strong affinities for the angiotensin-converting enzyme 2 (ACE2) receptor and the transmembrane protease serine 2 (TMPRSS2) which are essential for viral entry to the host cell.", "Of the 460 drugs with K(d) of less than 100 nM for the ACE2 receptor, 17 drugs overlapped with drugs that inhibit the interaction of ACE2 and SARS-CoV-2 spike reported in the NCATS OpenData portal.", "Among them, enalaprilat, an ACE inhibitor, showed a K(d) value of 1.5 nM against the ACE2.", "Furthermore, three of the top 30 drugs with strong affinity prediction for the TMPRSS2 are anti-hepatitis C virus (HCV) drugs, including ombitasvir, daclatasvir, and paritaprevir.", "Notably, of the top 30 drugs, AT1R blocker eprosartan and neuropsychiatric drug lisuride showed similar gene expression profiles to potential TMPRSS2 inhibitors.", "Collectively, we suggest that drugs predicted to have strong inhibitory potencies to ACE2 and TMPRSS2 through the DTI model should be considered as potential drug repurposing candidates for COVID-19."], "journal": "Viruses", "publish_time": "2020-11-18", "aliases": []}
{"doc_id": 226561665, "title": "Can covid-19 affect the eyes?", "abstract": ["The primary mode of human-to-human transmission of coronavirus disease 2019 (COV-ID-19) is through contact with droplets and fomites containing severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) A few studies have reported conjunctivitis as an ocular sign of COVID-19 Although no studies to date have confirmed ocular transmission of COVID-19, the SARS-CoV-2 nucleotide has been detected in conjunctival specimens using reverse transcription polymerase chain reaction.", "This finding suggests that COVID-19 may be transmitted through infected tears and conjunctival secretions.", "Additionally, the eyes may serve as a portal of entry for SARS-CoV-2 when droplets or fomites are transferred from the conjunctiva to the nasopharyngeal space through the lacrimal duct.", "Precautions are therefore recommended to limit the possibility of ocular transmission of COVID-19 \u00a9 2020, british.", "Columbia.", "Medical.", "Association.", "All rights reserved."], "journal": "British Columbia Medical Journal", "publish_time": "2020", "aliases": []}
{"doc_id": 227131389, "title": "Possible Early Vertical Transmission of COVID-19 from an Infected Pregnant Female to Her Neonate: A Case Report", "abstract": ["severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-19) has emerged as a public health emergency in recent times.", "The reported data on the mode of transmission of coronavirus disease 2019 (COVID-19) are largely through contact, droplet, airborne and fomite transmission methods with vertical transmission being a rare entity.", "We hereby report a case of a probable vertical transmission of SARS-CoV-19 from an infected pregnant female to her neonate.", "The transmission has been confirmed by a positive RT-PCR at 16 h of life along with a positive igg antibody test for SARS-CoV-19 in the baby and after excluding the possible environmental contamination of the sample.", "The baby was asymptomatic during the course of hospital stay and was discharged from the facility on Day 9 of life."], "journal": "J Trop Pediatr", "publish_time": "2020", "aliases": []}
{"doc_id": 220981234, "title": "Use of medical face masks versus particulate respirators as a component of personal protective equipment for health care workers in the context of the COVID-19 pandemic", "abstract": ["Currently available evidence supports that the predominant route of human-to-human transmission of the SARS-CoV-2 is through respiratory droplets and/or contact routes.", "The report by the World Health Organization (WHO) Joint Mission on Coronavirus Disease 2019 (COVID-19) in China supports person-to-person droplet and fomite transmission during close unprotected contact with the vast majority of the investigated infection clusters occurring within families, with a household secondary attack rate varying between 3 and 10%, a finding that is not consistent with airborne transmission.", "The reproduction number (R0) for the SARS-CoV-2 is estimated to be between 2.2-2.7, compatible with other respiratory viruses associated with a droplet/contact mode of transmission and very different than an airborne virus like measles with a R0 widely cited to be between 12 and 18.", "Based on the scientific evidence accumulated to date, our view is that SARS-CoV-2 is not spread by the airborne route to any significant extent and the use of particulate respirators offers no advantage over medical masks as a component of personal protective equipment for the routine care of patients with COVID-19 in the health care setting.", "Moreover, prolonged use of particulate respirators may result in unintended harms.", "In conjunction with appropriate hand hygiene, personal protective equipment (PPE) used by health care workers caring for patients with COVID-19 must be used with attention to detail and precision of execution to prevent lapses in adherence and active failures in the donning and doffing of the PPE."], "journal": "Antimicrob Resist Infect Control", "publish_time": "2020", "aliases": []}
{"doc_id": 219468193, "title": "Risk of COVID-19 Transmission During Gastrointestinal Endoscopy", "abstract": ["COVID-19 is a viral illness caused by a novel severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2).", "It is highly contagious virus with human-to-human transmission being primarily attributed to direct contact or air droplets.", "It is highly infectious and contagious due to high-viable viral loads in the upper respiratory tract secretions of infected patients and also similar viral load being detected in both asymptomatic and symptomatic patients.", "The virus stability characteristics and modes of transmission via fomites and air droplets make gastrointestinal (GI) endoscopy a high-risk procedure for COVID-19 transmission.", "This review discusses the currently available literature on risk of transmission of SARS-CoV-2 during GI endoscopy."], "journal": "", "publish_time": "2020-03-11", "aliases": [219468193]}
{"doc_id": 221401415, "title": "COVID-19 and its Modes of Transmission", "abstract": ["The World Health Organization recognized SARS-CoV-2 as a public health concern and declared it as a pandemic on March 11, 2020.", "Over 12 million people have been affected across several countries since it was first recognized.", "SARS-CoV-2 is thought to commonly spread via respiratory droplets formed while talking, coughing, and sneezing of an infected patient.", "As several cases, with an absence of travel history to the majorly affected areas were identified, a strong possibility of community transmission could have been possible.", "Broadly, two modes of transmission of COVID-19 exist-direct and indirect.", "The direct mode includes (1) transmission via aerosols formed via surgical and dental procedures and/or in the form of respiratory droplet nuclei; (2) other body fluids and secretions, for example, feces, saliva, urine, semen, and tears; and (3) mother-to-child.", "Indirect transmission may occur via (1) fomites or surfaces (e.g., furniture and fixtures) present within the immediate environment of an infected patient and (2) objects used on the infected person (e.g., stethoscope or thermometer).", "As many of these modes may be underestimated, it is necessary to emphasize and illustrate them.", "The goal of this paper is to briefly review how SARS-CoV-2 is shown to transmit via various modes and propose measures to reduce the risk of spread within the population and operating personnel."], "journal": "SN Compr Clin Med", "publish_time": "2020", "aliases": []}
{"doc_id": 220387757, "title": "Infection Control in Dental Practice During the COVID-19 Pandemic", "abstract": ["COVID-19 is the disease supported by SARS-CoV-2 infection, which causes a severe form of pneumonia.", "Due to the pathophysiological characteristics of the COVID-19 syndrome, the particular transmissibility of SARS-CoV-2, and the high globalization of our era, the epidemic emergency from China has spread rapidly all over the world.", "Human-to-human transmission seems to occur mainly through close contact with symptomatic people affected by COVID-19, and the main way of contagion is via the inhalation of respiratory droplets, for example when patients talk, sneeze or cough.", "The ability of the virus to survive outside living organisms, in aerosol or on fomites has also been recognized.", "The dental practitioners are particularly exposed to a high risk of SARS-CoV-2 infection because they cannot always respect the interpersonal distance of more than a meter and are exposed to saliva, blood, and other body fluids during surgical procedures.", "Moreover, many dental surgeries can generate aerosol, and the risk of airborne infection is to be considered higher.", "The aim of this paper is to provide practical advice for dentists based on the recent literature, which may be useful in reducing the risk of spreading COVID-19 during clinical practice."], "journal": "Int J Environ Res Public Health", "publish_time": "2020-07-02", "aliases": []}
{"doc_id": 235250028, "title": "Ensuring safe handling of the dead bodies of people succumbing to coronavirus disease-2019 infection", "abstract": ["The coronavirus disease-2019 (COVID-19) pandemic has resulted in the disruption of the lives of everyone, with marginalized and high-risk population groups being the most affected.", "As the transmission of the virus is predominantly through close contact or respiratory droplets or fomites, it becomes a careful consideration to carefully handle the bodies of the people who have lost their lives either as a suspected or as a confirmed case of the disease.", "As there is a definite possibility of the presence of the live virus in the organs of a patient who died when she was infectious, it becomes a mandatory requirement to ensure the provision of safety measures.", "In conclusion, it is of paramount importance to safely deal with the bodies of the people who have died due to COVID-19 infection.", "However, it becomes equally important to maintain the dignity of the dead and respect the cultural norms of the family as well as the community and at the same time taking adequate measures to ensure safety."], "journal": "International Journal of Health and Allied Sciences", "publish_time": "2021", "aliases": []}
{"doc_id": 229318664, "title": "Questioning COVID-19 Surface Stability and Fomite Spreading in Three Aeromedical Cases: A Case Series", "abstract": ["It is well established that coronavirus disease 2019 is primarily transmitted through respiratory droplets, and there is mounting research speculation that it may also be transmitted via fomites.", "Several studies have shown that the virus can persist on both porous and nonporous surfaces for hours to days, depending upon the material.", "This article examines three cases of polymerase chain reaction\u2013proven severe acute respiratory syndrome coronavirus 2 infection with several additional individuals meeting CDC close contact criteria.", "In 1 case, 195 downstream contacts were all tested to prevent a mass outbreak in a deployment posture.", "Analysis of these contacts yielded only a single positive test, which could be reasonably ascribed to respiratory droplet transmission.", "While these cases and their contacts ultimately represent a small sample size, we suggest fomite spread may not be a significant means of transmission for severe acute respiratory syndrome coronavirus 2 in real-world operational scenarios."], "journal": "Mil Med", "publish_time": "2020-12-17", "aliases": []}
{"doc_id": 235735328, "title": "COVID-19 global pandemic planning: Presence of SARS-CoV-2 fomites in a university hospital setting", "abstract": ["As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has surged across the globe, great effort has been expended to understand mechanisms of transmission and spread.", "From a hospital perspective, this topic is critical to limit and prevent SARS-CoV-2 iatrogenic transmission within the healthcare environment.", "Currently, the virus is believed to be transmitted primarily through respiratory droplets, but a growing body of evidence suggests that spread is also possible through aerosolized particles and fomites.", "Amidst a growing volume of patients with coronavirus disease 2019 (COVID-19), the purpose of this study was to evaluate the potential for SARS-CoV-2 transmission through fomites.", "Samples collected from the exposed skin of clinicians (n = 42) and high-touch surfaces (n = 40) were collected before and after encounters with COVID-19 patients.", "Samples were analyzed using two assays: the CDC 2019-nCoV Real-Time Reverse Transcription polymerase chain reaction (RT-qPCR) assay, and a SYBR Green assay that targeted a 121 bp region within the S-gene of SARS-CoV-2.", "None of the samples tested positive with the CDC assay, while two high-touch surface areas tested positive for SARS-CoV-2 using the Spike assay.", "However, viral culture did not reveal viable SARS-CoV-2 from the positive samples.", "Overall, the results from this study suggest that SARS-CoV-2 RNA were not widely present either on exposed skin flora or high-touch surface areas in the hospital locations tested.", "The inability to recover viable virus from samples that tested positive by the molecular assays, however, does not rule out the possibility of SARS-CoV-2 transmission through fomites."], "journal": "Exp Biol Med (Maywood)", "publish_time": "2021-07-04", "aliases": []}
{"doc_id": 236570430, "title": "Saltwater as a Disinfectant and Cleaning agent for Environmental Surfaces in the context of SARS-COV-II", "abstract": ["According to the Centers for Disease Control and Prevention (CDC), the transmission of SARS-COV-II occurs mostly person-to-person via respiratory droplets within a range of 180 cm.", "The virus can also be transmitted if a person touches a mucosal surface after touching an object with the virus on it.14 Human-to-human transmission of the Severe acute respiratory syndrome coronavirus 2 (SARS-COV-II) occurs most often when people are in the incubation stage of the disease or are carriers and have no symptoms.", "[...]the role of environmental factors and conditions such as temperature, humidity, wind speed as well as food, water and sewage, air, insects, inanimate surfaces, and hands in COVID-19 transmission.", "[...]SARS-COV-II transmission through food, food packages, and food handlers has not been identified as a risk factor for the disease.15 Transmission may also occur through fomites in the immediate environment around the infected person.", "[...]the transmission of the COVID-19 virus can occur by direct contact with infected people and indirect contact with surfaces in the immediate environment or with objects used on the infected person like a stethoscope or thermometer.16 Consumption of alcohol will not kill the virus in the inhaled air;it will not disinfect your mouth and throat, and it will not give you any kind of protection against COVID-19.17 1.2 Introduction of Disinfectant and Sanitizer: Germ-killing products are used in foodservice and health care.", "Disinfectants kill 100% of certain microorganisms, but they are not used on people, only inanimate surfaces.", "Because disinfectants do not kill all microorganisms, especially bacterial spores, they are different from sterilants.18 1.2.2 Sanitizer: An agent that reduces the number of disease-causing (pathogenic) bacteria on an inanimate food contact surface to safe levels as judged by public health requirements."], "journal": "Asian Journal of Research in Pharmaceutical Science", "publish_time": "2021", "aliases": []}
{"doc_id": 221016151, "title": "Laparoscopic surgery and coronavirus disease: What do we know now?", "abstract": ["Questions regarding the transmissibility of the novel coronavirus disease (COVID-19) remain unanswered.", "It is known that the transmission of the severe acute respiratory syndrome coronavirus (SARS-CoV) occurs predominantly through droplets and contact.", "However, aerosols can be generated in some situations, such as orotracheal intubation, ventilation, and the use of electric or ultrasonic scalpels, and can therefore potentially contaminate the care team if adequate protection is not used.", "It is therefore necessary to assess issues of transmissibility of COVID-19 during surgery in infected patients.", "This review gathers the recent research pertaining to this topic.", "A search of the literature was performed using the PubMed and UpToDate databases with the search terms \u201csurgery\u201d and \u201ccovid-2019,\u201d in addition to other MeSH variants of these terms.", "We do not have consistent evidence on the exposure of healthcare professionals assisting patients with COVID-19 undergoing laparoscopy or the impact of such exposure.", "In view of the evidence obtained and drawing parallels with other infectious and contagious diseases, medical personnel must wear complete protective attire for proper protection against the generated aerosol.", "Further studies are required to assess the impact of such surgeries on healthcare professionals conducing or assisting with these procedures."], "journal": "Clinics (Sao Paulo)", "publish_time": "2020-07-27", "aliases": []}
{"doc_id": 243418717, "title": "Exposure Profile of Severe Acute Respiratory Syndrome Coronavirus 2 in Canadian Food Sources", "abstract": ["ABSTRACT: A new coronavirus strain known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide.", "This virus is the causative agent for coronavirus disease 2019 (COVID-19) and spreads primarily through human-to-human transmission via infected droplets and aerosols generated by infected persons.", "Although COVID-19 is a respiratory virus, the potential for transmission of SARS-CoV-2 via food is considered theoretically possible and remains a concern for Canadian consumers.", "We have conducted an exposure assessment of the likelihood of exposure of SARS-CoV-2 in Canadian food sources at the time of consumption.", "This article describes the exposure routes considered most relevant in the context of food contamination with SARS-CoV-2, including contaminated food of animal origin, other contaminated fresh foods, fomites, and SARS-CoV-2-contaminated feces.", "The likelihood of foodborne infection of SARS-CoV-2 via the human digestive tract also was considered.", "Our analysis indicates that there is no evidence that foodborne transmission of SARS-CoV-2 has occurred, and we consider the likelihood of contracting COVID-19 via food and food packaging in Canada as low to remote.", "Adherence to safe food practices and cleaning procedures would in any case prevent a potential foodborne infection with SARS-CoV-2."], "journal": "J Food Prot", "publish_time": "2021", "aliases": []}
{"doc_id": 231804504, "title": "Mechanistic transmission modeling of COVID-19 on the Diamond Princess cruise ship demonstrates the importance of aerosol transmission", "abstract": ["Several lines of existing evidence support the possibility of airborne transmission of coronavirus disease 2019 (COVID-19).", "However, quantitative information on the relative importance of transmission pathways of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains limited.", "To evaluate the relative importance of multiple transmission routes for SARS-CoV-2, we developed a modeling framework and leveraged detailed information available from the Diamond Princess cruise ship outbreak that occurred in early 2020.", "We modeled 21,600 scenarios to generate a matrix of solutions across a full range of assumptions for eight unknown or uncertain epidemic and mechanistic transmission factors.", "A total of 132 model iterations met acceptability criteria (R(2) > 0.95 for modeled vs. reported cumulative daily cases and R(2) > 0 for daily cases).", "Analyzing only these successful model iterations quantifies the likely contributions of each defined mode of transmission.", "Mean estimates of the contributions of short-range, long-range, and fomite transmission modes to infected cases across the entire simulation period were 35%, 35%, and 30%, respectively.", "Mean estimates of the contributions of larger respiratory droplets and smaller respiratory aerosols were 41% and 59%, respectively.", "Our results demonstrate that aerosol inhalation was likely the dominant contributor to COVID-19 transmission among the passengers, even considering a conservative assumption of high ventilation rates and no air recirculation conditions for the cruise ship.", "Moreover, close-range and long-range transmission likely contributed similarly to disease progression aboard the ship, with fomite transmission playing a smaller role.", "The passenger quarantine also affected the importance of each mode, demonstrating the impacts of the interventions."], "journal": "Proc Natl Acad Sci U S A", "publish_time": "2021-02-23", "aliases": [220525013]}
{"doc_id": 225157240, "title": "Clinical features of SARS-CoV-2 infection", "abstract": ["Viral diseases continue to emerge and represent a serious issue to public health.", "Since viral transmission occurs through respiratory droplets, most patients with coronavirus disease 2019 (COVID-19) predominantly have respiratory tract involvement.", "The clinical spectrum of COVID-19 ranges from asymptomatic to symptomatic with mild, moderate, and severe degrees of illnesses.", "There are no specific clinical features that can yet reliably distinguish COVID-19 from other viral respiratory infections.", "Unexplained worsening of underlying chronic illnesses and comorbidities should raise the suspicion of COVID-19 Beyond the life-threatening pulmonary complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the widespread organ-specific manifestations of COVID-19 are increasingly being appreciated.", "Given that angiotensin-converting enzyme 2, the entry receptor for the SARS-CoV-2, is expressed in multiple extrapulmonary tissues and that all might contribute to these extrapulmonary manifestations of COVID-19, here we review the pulmonary and extrapulmonary presentations for patients with COVID-19."], "journal": "Indian Journal of Cardiovascular Disease in Women - WINCARS", "publish_time": "2020", "aliases": []}
{"doc_id": 231758698, "title": "Exploring the emergence of vertical transmission of SARS-CoV-2: A Rapid Review", "abstract": ["Novel Coronavirus, SARS-CoV-2 is responsible for the global pandemic of COVID-19.", "It has been shown to spread through respiratory droplets, direct contact and environmental fomites.", "The possibility of its spread by other modes viz.", "airborne, fecal-oral, vertical, etc.", "is being explored and can have implications in planning preventive strategies and disease management.", "A systematic analysis was carried out using the keywords; \"COVID 19 vertical transmission\", \"SARS-CoV-2 pregnancy\", and \"SARS-CoV-2 vertical transmission\", and the cases suggestive of possible vertical transmission of SARS-CoV-2 were studied in detail.", "The available evidences point at a possibility of vertical transmission of SARS-CoV-2."], "journal": "Acta Biomed", "publish_time": "2020", "aliases": []}
{"doc_id": 221825635, "title": "Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).", "abstract": ["INTRODUCTION Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is the pathogen responsible for the global pandemic of coronavirus disease 2019 (COVID-19).", "From the first reported cases in December 2019, the virus has spread to over 4 million people worldwide.", "Human-to-human transmission occurs mainly through the aerosolization of respiratory droplets.", "Transmission also occurs through contact with contaminated surfaces and other fomites.", "Improved antisepsis of human and nonhuman surfaces has been identified as a key feature of transmission reduction.", "There are no previous studies of povidone iodine (PVP-I) against SARS-CoV-2.", "This study evaluated nasal and oral antiseptic formulations of PVP-I for virucidal activity against SARS-CoV-2.", "This is the first report on the efficacy of PVP-I against the virus that causes COVID-19.", "METHODS Povidone iodine nasal antiseptic formulations and PVP-I oral rinse antiseptic formulations from 1% to 5% concentrations as well as controls were studied for virucidal efficacy against the SARS-CoV-2.", "Test compounds were evaluated for ability to inactivate SARS-CoV-2 as measured in a virucidal assay.", "SARS-CoV-2 was exposed directly to the test compound for 60 seconds, compounds were then neutralized, and surviving virus was quantified.", "RESULTS All concentrations of nasal antiseptics and oral rinse antiseptics evaluated completely inactivated the SARS-CoV-2.", "CONCLUSIONS Nasal and oral PVP-I antiseptic solutions are effective at inactivating the SARS-CoV-2 at a variety of concentrations after 60-second exposure times.", "The formulations tested may help to reduce the transmission of SARS-CoV-2 if used for nasal decontamination, oral decontamination, or surface decontamination in known or suspected cases of COVID-19."], "journal": "Ear, nose, & throat journal", "publish_time": "2020-09-21", "aliases": []}
{"doc_id": 230823829, "title": "Monitoring COVID-19 Transmission Risks by Quantitative Real-Time PCR Tracing of Droplets in Hospital and Living Environments", "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination occurs through droplets and biological fluids released in the surroundings from patients or asymptomatic carriers.", "Surfaces and objects contaminated by saliva or nose secretions represent a risk for indirect transmission of coronavirus disease 2019 (COVID-19).", "We assayed surfaces from hospital and living spaces to identify the presence of viral RNA and the spread of fomites in the environment.", "Anthropic contamination by droplets and biological fluids was monitored by detecting the microbiota signature using multiplex quantitative real-time PCR (qPCR) on selected species and massive sequencing on 16S amplicons.", "A total of 92 samples (flocked swabs) were collected from critical areas during the pandemic, including indoor (three hospitals and three public buildings) and outdoor surfaces exposed to anthropic contamination (handles and handrails, playgrounds).", "Traces of biological fluids were frequently detected in spaces open to the public and on objects that are touched with the hands (>80%).", "However, viral RNA was not detected in hospital wards or other indoor and outdoor surfaces either in the air system of a COVID hospital but only in the surroundings of an infected patient, in consistent association with droplet traces and fomites.", "Handled objects accumulated the highest level of multiple contaminations by saliva, nose secretions, and fecal traces, further supporting the priority role of handwashing in prevention.", "In conclusion, anthropic contamination by droplets and biological fluids is widespread in spaces open to the public and can be traced by qPCR.", "Monitoring fomites can support evaluation of indirect transmission risks for coronavirus or other flu-like viruses in the environment.IMPORTANCE Several studies have evaluated the presence of SARS-CoV-2 in the environment.", "Saliva and nasopharyngeal droplets can land on objects and surfaces, creating fomites.", "A suitable indicator would allow the detection of droplets or biofluids carrying the virus.", "Therefore, we searched for viral RNA and droplets and fomites on at risk surfaces.", "We monitored by qPCR or next generation sequencing (NGS) droplets through their microbiota.", "Although the study was performed during the pandemic, SARS-CoV-2 was not significantly found on surfaces, with the only exception of environmental areas near infectious patients.", "Conversely, anthropic contamination was frequent, suggesting a role for biofluids as putative markers of indirect transmission and risk assessment.", "Moreover, all SARS-CoV-2-contaminated surfaces showed droplets' microbiota.", "Fomite monitoring by qPCR may have an impact on public health strategies, supporting prevention of indirect transmission similarly to what is done for other communicable diseases (e.g., influenza and influenza-like infections)."], "journal": "MSphere", "publish_time": "2021", "aliases": [221275437]}
{"doc_id": 234010957, "title": "Is COVID-19 infection transmitted through food?", "abstract": ["coronavirus disease (covid) has had a growing outbreak around the world china reported COVID-19 infection for the first time in December 2019 Symptoms of this disease often include respiratory symptoms, but gastrointestinal symptoms (nausea, vomiting, and diarrhea) were also reported in COVID-19 infection coronavirus transmits through direct droplets, contact, or fomites.", "However, other modes of transmission include airborne, fecal-oral, blood-borne, and mother-to-child transmission furthermore, studies showed that the virus was excreted through the feces.", "Case presentation: In this study, we introduced two cases of the disease in a mother and her daughter, who were contaminated with the disease through contact with the contaminated food."], "journal": "Journal of Nutrition and Food Security", "publish_time": "2021", "aliases": []}
{"doc_id": 220797875, "title": "High Viral Load and Poor Ventilation: Cause of High Mortality From COVID-19", "abstract": ["There is a huge disparity between the mortality from COVID-19 in developed Western countries and developing Asian countries.", "Low viral load in the nasal cavity due to open air ventilation is a plausible reason for this difference.", "The transmission of SARS-CoV-2 occurs through respiratory droplets and fomites.", "There is ample evidence that the virus is airborne as well.", "The biggest factor in the transmission of SARS-C-V-2 are asymptomatic or paucisymptomatic carriers.", "Lack of open air ventilation is a major compounding factor as the virus remains in the environment, especially on fomites, leading to regular and repeated exposure to the virus.", "As a result, people living in developed countries tend to build up high viral load in their nasal cavity and nasopharynx.", "Studies have clearly shown that the severity of COVID-19 is directly proportional to the viral load harbored in the upper respiratory tract.", "These factors indicate a strong association between high viral load and poor ventilation, which, in turn, leads to high mortality from COVID-19 in developed Western nations."], "journal": "Asia Pac J Public Health", "publish_time": "2020-07-25", "aliases": []}
{"doc_id": 226237710, "title": "Environmental factors involved in SARS-CoV-2 transmission: effect and role of indoor environmental quality in the strategy for COVID-19 infection control", "abstract": ["The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new zoonotic agent that emerged in December 2019, causes coronavirus disease 2019 (COVID-19).", "This infection can be spread by asymptomatic, presymptomatic, and symptomatic carriers.", "SARS-CoV-2 spreads primarily via respiratory droplets during close person-to-person contact in a closed space, especially a building.", "This article summarizes the environmental factors involved in SARS-CoV-2 transmission, including a strategy to prevent SARS-CoV-2 transmission in a building environment.", "SARS-CoV-2 can persist on surfaces of fomites for at least 3 days depending on the conditions.", "If SARS-CoV-2 is aerosolized intentionally, it is stable for at least several hours.", "SARS-CoV-2 is inactivated rapidly on surfaces with sunlight.", "Close-contact aerosol transmission through smaller aerosolized particles is likely to be combined with respiratory droplets and contact transmission in a confined, crowded, and poorly ventilated indoor environment, as suggested by some cluster cases.", "Although evidence of the effect of aerosol transmission is limited and uncertainty remains, adequate preventive measures to control indoor environmental quality are required, based on a precautionary approach, because COVID-19 has caused serious global damages to public health, community, and the social economy.", "The expert panel for COVID-19 in Japan has focused on the \u201c3 Cs,\u201d namely, \u201cclosed spaces with poor ventilation,\u201d \u201ccrowded spaces with many people,\u201d and \u201cclose contact.\u201d In addition, the Ministry of Health, Labour and Welfare of Japan has been recommending adequate ventilation in all closed spaces in accordance with the existing standards of the Law for Maintenance of Sanitation in Buildings as one of the initial political actions to prevent the spread of COVID-19.", "However, specific standards for indoor environmental quality control have not been recommended and many scientific uncertainties remain regarding the infection dynamics and mode of SARS-CoV-2 transmission in closed indoor spaces.", "Further research and evaluation are required regarding the effect and role of indoor environmental quality control, especially ventilation."], "journal": "Environ Health Prev Med", "publish_time": "2020-11-03", "aliases": []}
{"doc_id": 218538780, "title": "Asymptomatic COVID-19 Infection in a Child with Nasal Foreign Body", "abstract": ["Abstract While children, particularly infants, are susceptible to severe and critical COVID-19 disease, over 55% of pediatric cases are present in asymptomatic or mildly symptomatic children.", "Aerosolized SARS-CoV-2 viral particles remain viable for up to 3 hours, raising concern about risk to healthcare workers during aerosol generating procedures (APGs) in the airway and nasopharynx.", "Herein we describe the first case of a nasal foreign body in an asymptomatic child with SARS-CoV-2 infection.", "We discuss management of this child and highlight the importance of considering asymptomatic infection and preoperative testing when planning procedures of the airway in the COVID-19 era."], "journal": "Int J Pediatr Otorhinolaryngol", "publish_time": "2020-05-08", "aliases": []}
{"doc_id": 222181492, "title": "The SARS-CoV-2 Virus may Remain Viable on Oral Appliances for up to 3 Days?", "abstract": ["The SARS-CoV-2 virus has created havoc in the world by causing the COVID-19 pandemic.1 The affected patients exhibit fever, cough, and apnea.", "Hospitalization is often due to progressive respiratory distress, which, in a proportion of patients, had led to fatalities.2 The geriatric population is at a higher risk, because of their reduced immunity and the presence of comorbid conditions like diabetes mellitus, hypertension, and cardiovascular diseases.", "Health authorities have advocated social distancing as a method to contain the spread of this contagious disease.", "A landmark study has shown that the SARS-CoV-2 virus can remain viable on various surfaces like cardboard, stainless steel, plastic, and copper for a long duration.", "The research conducted by van Doremalen et al.3 has created an aerosolized environment using SARS-CoV-2 (105.25 50% tissue-culture infectious dose [TCID50] per milliliter) in a Goldberg drum using a 3 jet collision nebulizer and has exposed various materials such as cardboard, paper, stainless steel, plastic, and copper to the virus.", "The SARS-Cov-2 virus was found to be viable in aerosol for only 3 hours, although its presence on material surfaces lasted significantly longer, especially in stainless steel and plastic surfaces, wherein the virus was detected for up to 72 hours.3."], "journal": "The journal of contemporary dental practice", "publish_time": "2020-06-01", "aliases": []}
{"doc_id": 226600149, "title": "Use of heated air filtration to inactivate COVID-19", "abstract": ["The onset of the COVID-19 pandemic has significantly affected the lives of those who work in the tribology and lubrication field.", "Initially discovered in china late in 2019, COVID-19 has now spread throughout the world impacting every region.", "The best scientific evidence indicates that SARS-CoV-2 readily transmits through the air A recent update from the world.", "Health.", "Organization (who) 1 defines two forms of particles that can cause infection: Respiratory droplets that are five to 10 microns in diameter and droplet nuclei or aerosols with diameters less than five microns.", "The who reports that experimental studies conducted under laboratory conditions determined that aerosols containing SARS-CoV-2 can remain in the air for up to three hours.", "For those in the northern hemisphere, the summer has been very hot, and air conditioning has been in high demand.", "But concern has been present that individuals in an indoor air-conditioned environment might be highly vulnerable to infection.", "On the other hand, the us center for disease control and Prevention published an article written by researchers in china about an outbreak of COVID-19 generated by individuals eating indoors in an air-conditioned restaurant in guangzhou, china."], "journal": "Tribology &amp; Lubrication Technology", "publish_time": "2020", "aliases": []}
{"doc_id": 246388616, "title": "Is hydrogen peroxide an effective mouthwash for reducing the viral load of SARS-CoV-2 in dental clinics?", "abstract": ["BACKGROUND: Previous studies have demonstrated that SARS-CoV-2 is mainly transmitted by inhalation of aerosols and can remain viable in the air for hours.", "Viruses can spread in dental settings and put professionals and patients at high risk of infection due to proximity and aerosol-generating procedures, and poor air ventilation.", "OBJECTIVES: The aim of this study was to investigate the effects of a 1% hydrogen peroxide (H(2)O(2)) mouth rinse on reducing the intraoral SARS-CoV-2 load.", "METHODS: Portable air cleaners with HEPA filters exposed for 3 months were analysed to test for virus presence in a waiting room (where patients wore a face mask but did not undergo mouth rinsing) and three treatment rooms (where patients wore no mask but carried out mouth rinsing).", "As CO(2) is co-exhaled with aerosols containing SARS-CoV-2 by COVID-19 infected people, we also measured CO(2) as a proxy of infection risk indoors.", "Specific primer and probe RT-PCR were applied to detect viral genomes of the SARS-CoV-2 virus in the filters.", "Specifically, we amplified the nucleocapsid gene (Nuclv) of SARS-CoV-2.", "RESULTS: CO(2) levels ranged from 860 to 907 ppm, thus indicating low ventilation and the risk of COVID-19 transmission.", "However, we only found viral load in filters from the waiting room and not from the treatment rooms.", "The results revealed the efficiency of 1-minute mouth rinsing with 1% H(2)O(2) since patients rinsed their mouths immediately after removing their mask in the treatment rooms.", "CONCLUSIONS: Our findings suggest that dental clinics would be safer and more COVID-19 free by implementing mouth rinsing 1 min with 1% H(2)O(2) immediately after the patients arrive at the clinic."], "journal": "Saudi Dent J", "publish_time": "2022-01-29", "aliases": []}
{"doc_id": 235265355, "title": "Aerosol SARS-CoV-2 in hospitals and long-term care homes during the COVID-19 pandemic.", "abstract": ["Background: Few studies have quantified aerosol concentrations of SARS-CoV-2 in hospitals and long-term care homes, and fewer still have examined samples for viability.", "This information is needed to clarify transmission risks beyond close contact.", "Methods: We deployed particulate air samplers in rooms with COVID-19 positive patients in hospital ward and ICU rooms, rooms in long-term care homes experiencing outbreaks, and a correctional facility experiencing an outbreak.", "Samplers were placed between 2 and 3 meters from the patient.", "Aerosol (small liquid particles suspended in air) samples were collected onto gelatin filters by Ultrasonic Personal Air Samplers (UPAS) fitted with <2.5{micro}m (micrometer) and <10{micro}m size-selective inlets operated for 16 hours (total 1.92m3), and with a Coriolis Biosampler over 10 minutes (total 1.5m3).", "Samples were assayed for viable SARS-CoV-2 virus and for the viral genome by multiplex PCR using the E and N protein target sequences.", "We validated the sampling methods by inoculating gelatin filters with viable vesicular stomatitis virus (VSV), and with three concentrations of viable SARS-CoV-2, operating personal samplers for 16hrs, and quantifying viable virus recovery by TCID50 assay.", "Results: In total, 138 samples were collected from 99 rooms.", "RNA samples were positive in 9.1% (6/66) of samples obtained with the UPAS 2.5{micro}m samplers, 13.5% (7/52) with the UPAS 10{micro}m samplers, and 10.0% (2/20) samples obtained with the Coriolis samplers.", "Culturable virus was not recovered in any samples.", "Viral RNA was detected in 10.9% of the rooms sampled.", "There was no significant difference in viral RNA recovery between the different room locations or samplers.", "Method development experiments indicated minimal loss of SARS-CoV-2 viability via the personal air sampler operation.", "Key Findings: Although a subset of aerosol samples exhibited detectable SARS-CoV-2 RNA at low titres, the presence of viable SARS-CoV-2 virus in aerosols appears to be infrequent at >2m distance."], "journal": "", "publish_time": "2021-06-01", "aliases": [238236813]}
{"doc_id": 227121537, "title": "Aerosol Transmission of SARS-CoV-2: Physical Principles and Implications", "abstract": ["Evidence has emerged that SARS-CoV-2, the coronavirus that causes COVID-19, can be transmitted airborne in aerosol particles as well as in larger droplets or by surface deposits.", "This minireview outlines the underlying aerosol science, making links to aerosol research in other disciplines.", "SARS-CoV-2 is emitted in aerosol form during normal breathing by both asymptomatic and symptomatic people, remaining viable with a half-life of up to about an hour during which air movement can carry it considerable distances, although it simultaneously disperses.", "The proportion of the droplet size distribution within the aerosol range depends on the sites of origin within the respiratory tract and on whether the distribution is presented on a number or volume basis.", "Evaporation and fragmentation reduce the size of the droplets, whereas coalescence increases the mean droplet size.", "Aerosol particles containing SARS-CoV-2 can also coalesce with pollution particulates, and infection rates correlate with pollution.", "The operation of ventilation systems in public buildings and transportation can create infection hazards via aerosols, but provides opportunities for reducing the risk of transmission in ways as simple as switching from recirculated to outside air.", "There are also opportunities to inactivate SARS-CoV-2 in aerosol form with sunlight or UV lamps.", "The efficiency of masks for blocking aerosol transmission depends strongly on how well they fit.", "Research areas that urgently need further experimentation include the basis for variation in droplet size distribution and viral load, including droplets emitted by \u201csuperspreader\u201d individuals; the evolution of droplet sizes after emission, their interaction with pollutant aerosols and their dispersal by turbulence, which gives a different basis for social distancing."], "journal": "Front Public Health", "publish_time": "2020-11-23", "aliases": []}
{"doc_id": 218474412, "title": "Consideration of the Aerosol Transmission for COVID-19 and Public Health", "abstract": ["This article analyzes the available evidence to address airborne, aerosol transmission of the SARS-CoV-2.", "We review and present three lines of evidence: case reports of transmission for asymptomatic individuals in association with studies that show that normal breathing and talking produce predominantly small droplets of the size that are subject to aerosol transport; limited empirical data that have recorded aerosolized SARS-CoV-2 particles that remain suspended in the air for hours and are subject to transport over distances including outside of rooms and intrabuilding, and the broader literature that further supports the importance of aerosol transmission of infectious diseases.", "The weight of the available evidence warrants immediate attention to address the significance of aerosols and implications for public health protection."], "journal": "Risk Anal", "publish_time": "2020", "aliases": []}
{"doc_id": 239020573, "title": "Infectious SARS-CoV-2 Is Emitted in Aerosol Particles", "abstract": ["Respiratory viruses such as SARS-CoV-2 are transmitted in respiratory droplets and aerosol particles, which are released during talking, breathing, coughing, and sneezing.", "Noncontact transmission of SARS-CoV-2 has been demonstrated, suggesting transmission via virus carried through the air.", "Here, we demonstrate that golden Syrian hamsters produce infectious SARS-CoV-2 in aerosol particles prior to and concurrent with the onset of mild clinical signs of disease.", "The average emission rate in this study was 25 infectious virions/hour on days 1 and 2 postinoculation, with average viral RNA levels 200-fold higher than infectious virus in aerosol particles.", "The majority of virus was contained within particles <5 \u03bcm in size.", "Thus, we provide direct evidence that, in hamsters, SARS-CoV-2 is an airborne virus."], "journal": "mBio", "publish_time": "2021-10-19", "aliases": []}
{"doc_id": 245426397, "title": "Direct capture and smartphone quantification of airborne SARS-CoV-2 on a paper microfluidic chip", "abstract": ["SARS, a new type of respiratory disease caused by SARS-CoV, was identified in 2003 with significant levels of morbidity and mortality.", "The recent pandemic of COVID-19, caused by SARS-CoV-2, has generated even greater extents of morbidity and mortality across the entire world.", "Both SARS-CoV and SARS-CoV-2 spreads through the air in the form of droplets and potentially smaller droplets (aerosols) via exhaling, coughing, and sneezing.", "Direct detection from such airborne droplets would be ideal for protecting general public from potential exposure before they infect individuals.", "However, the number of viruses in such droplets and aerosols is too low to be detected directly.", "A separate air sampler and enough collection time (several hours) are necessary to capture a sufficient number of viruses.", "In this work, we have demonstrated the direct capture of the airborne droplets on the paper microfluidic chip without the need for any other equipment.", "10% human saliva samples were spiked with the known concentration of SARS-CoV-2 and sprayed to generate liquid droplets and aerosols into the air.", "Antibody-conjugated submicron particle suspension is then added to the paper channel, and a smartphone-based fluorescence microscope isolated and counted the immunoagglutinated particles on the paper chip.", "The total capture-to-assay time was <30 min, compared to several hours with the other methods.", "In this manner, SARS-CoV-2 could be detected directly from the air in a handheld and low-cost manner, contributing to slowing the spread of SARS-CoV-2.", "We can presumably adapt this technology to a wide range of other respiratory viruses."], "journal": "Biosens Bioelectron", "publish_time": "2022-03-15", "aliases": []}
{"doc_id": 235425145, "title": "SARS\u2010CoV\u20102, other respiratory viruses and bacteria in aerosols: Report from Kuwait's hospitals", "abstract": ["The role of airborne particles in the spread of severe acute respiratory syndrome coronavirus type 2 (SARS\u2010CoV\u20102) is well explored.", "The novel coronavirus can survive in aerosol for extended periods, and its interaction with other viral communities can cause additional virulence and infectivity.", "This baseline study reports concentrations of SARS\u2010CoV\u20102, other respiratory viruses, and pathogenic bacteria in the indoor air from three major hospitals (Sheikh Jaber, Mubarak Al\u2010Kabeer, and Al\u2010Amiri) in Kuwait dealing with coronavirus disease 2019 (COVID\u201019) patients.", "The indoor aerosol samples showed 12\u201399 copies of SARS\u2010CoV\u20102 per m(3) of air.", "Two non\u2010SARS\u2010coronavirus (strain HKU1 and NL63), respiratory syncytial virus (RSV), and human bocavirus, human rhinoviruses, Influenza B (FluB), and human enteroviruses were also detected in COVID\u2010positive areas of Mubarak Al Kabeer hospital (MKH).", "Pathogenic bacteria such as Mycoplasma pneumonia, Streptococcus pneumonia and, Haemophilus influenza were also found in the hospital aerosols.", "Our results suggest that the existing interventions such as social distancing, use of masks, hand hygiene, surface sanitization, and avoidance of crowded indoor spaces are adequate to prevent the spread of SARS\u2010CoV\u20102 in enclosed areas.", "However, increased ventilation can significantly reduce the concentration of SARS\u2010CoV\u20102 in indoor aerosols.", "The synergistic or inhibitory effects of other respiratory pathogens in the spread, severity, and complexity of SARS\u2010CoV\u20102 need further investigation."], "journal": "Indoor Air", "publish_time": "2021-06-14", "aliases": []}
{"doc_id": 222132614, "title": "Testing mobile air purifiers in a school classroom: Reducing the airborne transmission risk for SARS-CoV-2", "abstract": ["Airborne transmission of SARS-CoV-2 through virus-containing aerosol particles has been established as an important pathway for Covid-19 infection.", "Suitable measures to prevent such infections are imperative, especially in situations when a high number of persons convene in closed rooms.", "Here we tested the efficiency and practicability of operating four air purifiers equipped with HEPA filters in a high school classroom while regular classes were taking place.", "We monitored the aerosol number concentration for particles > 3 nm at two locations in the room, the aerosol size distribution in the range from 10 nm to 10 {micro}m, PM10 and CO2 concentration.", "For comparison, we performed similar measurements in a neighboring classroom without purifiers.", "In times when classes were conducted with windows and door closed, the aerosol concentration was reduced by more than 90 % within less than 30 minutes when running the purifiers (air exchange rate 5.5 h-1).", "The reduction was homogeneous throughout the room and for all particle sizes.", "The measurements are supplemented by a calculation estimating the maximum concentration levels of virus-containing aerosol from a highly contagious person speaking in a closed room with and without air purifiers.", "Measurements and calculation demonstrate that air purifiers represent a well suited measure to reduce the risks of airborne transmission of SARS-CoV-2 substantially.", "Staying for two hours in a closed room with a super infective person, we estimate that the inhaled dose is reduced by a factor of six when using air purifiers with a total air exchange rate of 5.7 h-1."], "journal": "", "publish_time": "2020-10-05", "aliases": []}
{"doc_id": 233309278, "title": "SARS-Cov-2: The Relevance and Prevention of Aerosol Transmission", "abstract": ["Coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), has claimed many victims worldwide due to its high virulence and contagiousness.", "The person-to-person transmission of SARS-Cov-2 when in close contact is facilitated by respiratory droplets containing the virus particles, and by skin contact with contaminated surfaces.", "However, the large number of COVID-19 infections cannot be explained only by droplet deposition or contact contamination.", "It seems very plausible that aerosols are important in transmitting SARS-Cov-2.", "It has been demonstrated that SARS-CoV-2 remains viable in aerosols for hours, facilitating rapid distribution of the virus over great distances.", "Aerosols may, therefore, also be responsible for so-called super-spreader events.", "Indirect evidence points to a correlation between ventilation and the transmission and spread of SARS-Cov-2, supporting ventilation as an important factor in preventing airborne transmission.", "Further actions to avoid transmission of COVID-19 include social distancing, hygiene measures, and barrier measures, such as face-coverings.", "Professional masks offer better protection than cloth masks.", "These protection measures are especially relevant to health care workers, when performing endotracheal intubation, but the risk from non-invasive ventilation and nebulizing treatment seems to be moderate."], "journal": "J Occup Environ Med", "publish_time": "2021", "aliases": []}
{"doc_id": 233374512, "title": "Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness", "abstract": ["OBJECTIVE: To determine if viable virus could be isolated from the air within a car driven by a patient infected with SARS-CoV-2, and to assess the size range of the infectious particles.", "METHODS: We used a Sioutas personal cascade impactor sampler (PCIS) to screen for SARS-CoV-2 in a car driven by a COVID-19 patient.", "The patient, who had only mild illness without fever or cough and was not wearing a mask, drove the car for 15 minutes with the air conditioning turned on and windows closed.", "The PCIS was clipped to the sun-visor above the front passenger seat and was retrieved from the car two hours after completion of the drive.", "RESULTS: SARS-CoV-2 was detectable at all PCIS stages by PCR and was cultured from the section of the sampler collecting particles in the 0.25 to 0.50 \u03bcm size range.", "CONCLUSIONS: Our data highlight the potential risk of SARS-CoV-2 transmission by minimally symptomatic persons in the closed space inside of a car and suggest that a substantial component of that risk is via aerosolized virus."], "journal": "Int J Infect Dis", "publish_time": "2021-04-24", "aliases": [231609871]}
{"doc_id": 238261052, "title": "Airborne transmission of SARS-CoV-2 in indoor environments: A comprehensive review", "abstract": ["The COVID-19 pandemic has caused millions of deaths and great economic loss globally.", "There has been substantial evidence supporting the airborne transmission of SARS-CoV-2.", "Airborne route has been considered as a major transmission pathway, which can spread the disease over a longer distance and time.", "The viral loads in the respiratory tract of a virus carrier are typically below 109 RNA copies/mL and are related to the emission rate of pathogens.", "Most particles expelled during respiratory activities are smaller than 1-2\u00b5m in diameter.", "Viral aerosols can remain infectious for hours under typical indoor conditions.", "Sunlight contributes greatly to the viability inactivation of SARS-CoV-2.", "The outbreaks in different scenarios are reviewed based on existing data.", "Most outbreaks were related to long-term care facilities, K-12 schools, restaurants, retail facilities, and offices.", "The Wells-Riley model for estimating the risk of airborne transmission is introduced, along with model parameters such as the quanta generation rate, virus-containing particle size distribution, and inactivation rate.", "The effectiveness of various IAQ control strategies for mitigating the airborne transmission risk is analyzed, including PPE, ventilation strategies, partitions, air cleaning, and disinfection technologies, and occupancy control strategies.", "Both benefits and costs should be considered in designing the control strategies.", "[ABSTRACT FROM AUTHOR] Copyright of Science & Technology for the Built Environment is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission.", "However, users may print, download, or email articles for individual use.", "This abstract may be abridged.", "No warranty is given about the accuracy of the copy.", "Users should refer to the original published version of the material for the full abstract.", "(Copyright applies to all Abstracts.)"], "journal": "Science & Technology for the Built Environment", "publish_time": "2021", "aliases": []}
{"doc_id": 231884734, "title": "Positive no-touch surfaces and undetectable SARS-CoV-2 aerosols in long-term care facilities: An attempt to understand the contributing factors and the importance of timing in air sampling campaigns", "abstract": ["BACKGROUND: Long-term care facilities (LTCF) are environments particularly favorable to coronavirus disease (SARS-CoV-2) pandemic outbreaks, due to the at-risk population they welcome and the close proximity of residents.", "Yet, the transmission dynamics of the disease in these establishments remain unclear.", "METHODS: Air and no-touch surfaces of 31 rooms from 7 LTCFs were sampled and SARS-CoV-2 was quantified by real-time reverse transcription polymerase chain reaction (RT-qPCR).", "RESULTS: Air samples were negative but viral genomes were recovered from 20 of 62 surface samples at concentrations ranging from 13 to 36,612 genomes/surface.", "Virus isolation (culture) from surface samples (n\u00e2\u0080\u00af=\u00e2\u0080\u00af7) was negative.", "CONCLUSIONS: The presence of viral RNA on no-touch surfaces is evidence of viral dissemination through air, but the lack of airborne viral particles in air samples suggests that they were not aerosolized in a significant manner during air sampling sessions.", "The air samples were collected 8 to 30 days after the residents' symptom onset, which could indicate that viruses are aerosolized early in the infection process.", "Additional research is needed to evaluate viral viability conservation and the potential role of direct contact and aerosols in SARS-CoV-2 transmission in these institutions."], "journal": "Am. j. infect. control", "publish_time": "2021", "aliases": []}
{"doc_id": 220486800, "title": "A Physics Modeling Study of SARS-CoV-2 Transport in Air", "abstract": ["Health threat from SARS-CoV-2 airborne infection has become a public emergency of international concern.", "During the ongoing coronavirus pandemic, people have been advised by the Centers for Disease Control and Prevention to maintain social distancing of at least 2 m to limit the risk of exposure to the coronavirus.", "We carry out a physics modeling study for SARS-CoV-2 transport in air.", "We show that if aerosols and droplets follow semi-ballistic emission trajectories, then their horizontal range is proportional to the particle's diameter.", "For standard ambient temperature and pressure conditions, the horizontal range of these aerosols remains safely below 2 m. We also show that aerosols and droplets can remain suspended for hours in the air, providing a health threat of airborne infection.", "The latter argues in favor of implementing additional precautions to the recommended 2~m social distancing, e.g.", "wearing a face mask when we are out in public."], "journal": "", "publish_time": "2020-07-10", "aliases": []}
{"doc_id": 241835704, "title": "Particle Aerosolization during Tracheostomy Procedure as Modeled by Computational Fluid Dynamics", "abstract": ["Introduction SARS-CoV-2 has created a hazardous environment for healthcare workers, with some of the riskiest procedures being those that generate aerosolized particles, such as tracheostomy surgery.", "Tracheostomy is both particle aerosolizing and extremely common, particularly for patients in respiratory distress.", "We utilized computational fluid dynamics (CFD) to model aerosolized particle spread during tracheostomy to deduce the viral loading risks posed to surgeons and anesthesiologists by aerosolized viruses.", "Additionally, we studied how these risks change with varying tracheal incision sizes.", "MethodsAn intubated subject's CT scan was virtually modified to replicate the tracheostomy procedure.", "An anatomically accurate trachea, thorax, incision, and operating room were created.", "Airflow simulations were performed to reproduce the exhalation occurring with removal of the intubation tube and opening of the airway to room pressure.", "Particles were released into the trachea from the primary bronchi, which then escaped into open air via the tracheal incision.", "Three tracheal incision sizes were modeled.", "Four particle sizes were released (0.2\u03bc m-20\u03bc m).", "Airflow was modeled for 20 seconds.", "ResultsFor small, medium, and large incisions, 68.7%, 68.4%, and 68.5% of particles by mass remained in the trachea, respectively (68.5% average of the three) (Figure1).", "Average size of escaped particles was 5.31\u03bc m, 5.27\u03bc m, and 5.29\u03bc m for the small, medium, and large incisions respectively, while average particle size remaining in the trachea was 14.0\u03bc m, 14.66\u03bc m, 14.29\u03bc m.From 4 to 8 seconds after initial particle release, the average particle size falling to the level of the patient's forehead increased from 11.6\u03bc m to 18.4\u03bc m. Large particles (10\u03bc -20\u03bc m) fell quickly, while smaller particles (0.2\u03bc m to 2\u03bc m) were more likely to remain suspended in air after 20 seconds.", "ConclusionsCFD particle aerosolization modeling of tracheostomy procedures can predict the viral loads healthcare workers are exposed to for the purpose of implementing proper safety precautions.", "These results highlight the extended residence times of aerosols in the absence of room ventilation which should ordinarily clear suspended particles, as well as the importance of considering smaller particles when designing personal protective equipment (PPE) for hospital staff.", "Large particles fall due to gravity relatively quickly, meaning the largest viral loads are airborne immediately after exhalation.", "Tracheal incision size was insignificant to the amount of aerosol generated during tracheostomy.", "In the absence of proper room ventilation, particles remained suspended in highest concentration directly above the patient's forehead, not directly above the tracheal incision.", "This implies physicians in this relative danger zone, such as anesthesiologists, need additional safety precautions."], "journal": "American Journal of Respiratory and Critical Care Medicine", "publish_time": "2021", "aliases": []}
{"doc_id": 232761317, "title": "Quantitative Microbial Risk Assessment for Airborne Transmission of SARS-CoV-2 via Breathing, Speaking, Singing, Coughing, and Sneezing", "abstract": ["BACKGROUND: Evidence for indoor airborne transmission of SARS-CoV-2 is accumulating.", "OBJECTIVES: We assessed of the risk of illness due to airborne SARS-CoV-2 particles from breathing, speaking, singing, coughing, and sneezing in indoor environments.", "METHODS: A risk assessment model, AirCoV2, for exposure to SARS-CoV-2 particles in aerosol droplets was developed.", "Previously published data on droplets expelled by breathing, speaking, singing, coughing, and sneezing by an infected person were used as inputs.", "Scenarios encompassed virus concentration, exposure time, and ventilation.", "Newly collected data of virus RNA copies in mucus from patients are presented.", "RESULTS: The expelled volume of aerosols was highest for a sneeze, followed by a cough, singing, speaking, and breathing.", "After 20 min of exposure, at 107 RNA copies/mL in mucus, all mean illness risks were largely estimated to be below 0.001, except for the \"high\" sneeze scenario.", "At virus concentrations above 108 RNA copies/mL, and after 2 h of exposure, in the high and \"low\" sneeze scenarios, the high cough scenario and the singing scenario, risks exceeded 0.01 and may become very high, whereas the low coughing scenario, the high and low speaking scenarios and the breathing scenario remained below 0.1.", "After 2 h of exposure, singing became the second highest risk scenario.", "One air exchange per hour reduced risk of illness by about a factor of 2.", "Six air exchanges per hour reduced risks of illness by a factor of 8-13 for the sneeze and cough scenarios and by a factor of 4-9 for the other scenarios.", "DISCUSSION: The large variation in the volume of expelled aerosols is discussed.", "The model calculations indicated that SARS-CoV-2 transmission via aerosols outside of the 1.5-m social distancing norm can occur.", "Virus concentrations in aerosols and/or the amount of expelled aerosol droplets need to be high for substantial transmission via this route.", "AirCoV2 is made available as interactive computational tool.", "https://doi.org/10.1289/EHP7886."], "journal": "Environ Health Perspect", "publish_time": "2021", "aliases": []}
{"doc_id": 232124498, "title": "Airborne transmission of SARS-CoV-2 is the dominant route of transmission: droplets and aerosols", "abstract": ["coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic worldwide.", "On a daily basis the number of deaths associated with COVID-19 is rapidly increasing.", "The main transmission route of SARS-CoV-2 is through the air (airborne transmission) This review details the airborne transmission of SARS-CoV-2, the aerodynamics, and different modes of transmission (e g droplets, droplet nuclei, and aerosol particles) SARS-CoV-2 can be transmitted by an infected person during activities such as expiration, coughing, sneezing, and talking.", "During such activities and some medical procedures, aerosols and droplets contaminated with SARS-CoV-2 particles are formed.", "Depending on their sizes and the environmental conditions, such particles stay viable in the air for varying time periods and can cause infection in a susceptible host.", "Very few studies have been conducted to establish the mechanism or the aerodynamics of virus-loaded particles and droplets in causing infection.", "In this review we discuss the various forms in which SARS-CoV-2 virus particles can be transmitted in air and cause infections."], "journal": "Infezioni in Medicina", "publish_time": "2021", "aliases": []}
{"doc_id": 227152972, "title": "Cold atmospheric plasma for SARS-CoV-2 inactivation", "abstract": ["Syndrome coronavirus 2 (SARS-CoV-2) infectious virions are viable on various surfaces (e.g., plastic, metals, and cardboard) for several hours.", "This presents a transmission cycle for human infection that can be broken by developing new inactivation approaches.", "We employed an efficient cold atmospheric plasma (CAP) with argon feed gas to inactivate SARS-CoV-2 on various surfaces including plastic, metal, cardboard, basketball composite leather, football leather, and baseball leather.", "These results demonstrate the great potential of CAP as a safe and effective means to prevent virus transmission and infections for a wide range of surfaces that experience frequent human contact.", "Since this is the first-ever demonstration of cold plasma inactivation of SARS-CoV-2, it is a significant milestone in the prevention and treatment of coronavirus disease 2019 (COVID-19) and presents a new opportunity for the scientific, engineering, and medical communities."], "journal": "Phys Fluids (1994)", "publish_time": "2020", "aliases": [221853716]}
{"doc_id": 229615675, "title": "Nanomedicine for covid-19: Potential of copper nanoparticles", "abstract": ["The COVID-19 pandemic has fuelled a global demand to establish novel diagnostic and treatment options, apart from the search for a vaccine.", "This, coupled with the need to mitigate the spread of infections, called for large-scale strategies, including alternative anti-viral methods, together with classical disinfection and prevention protocols.", "One such approach exists in the form of the essential micronutrient, copper.", "Copper surfaces have been observed to exhibit viral survival of fewer than 4 hours, compared to cardboard, stainless steel, and plastic with an average survival time of 24 hours, 48 hours, and 72 hours, respectively copper's natural ability to aid in the functioning of critical immune cells, including B cells, natural killer cells, T helper cells, macrophages, and neutrophils, make it a potential therapeutic agent against SARS-CoV-2, both internally and externally to the host.", "This antiviral property can be enhanced by the generation of copper nanoparticles for use in nanomedicine.", "Copper nanoparticles can generate reactive oxygen species that interfere with viral operations and disrupt the viral membrane.", "This review paper focuses on copper nanoparticles for favorable therapeutic outcomes, together with its targeted interaction with cells expressing the angiotensin-converting enzyme 2 (ace2), for the treatment of COVID-19 \u00a9 2020 by the authors."], "journal": "Biointerface Research in Applied Chemistry", "publish_time": "2020", "aliases": []}
{"doc_id": 242035136, "title": "Assessment of the viability of SARS-CoV-2 Coronavirus on various types of test surfaces, as well as in drinking and sea water", "abstract": ["The aim of this study was to determine the dynamics of the residual infectious activity of the SARS-CoV-2 virus on various types of surfaces, including banknotes and coins, in samples of drinking dechlorinated water and samples imitating seawater, with a concentration of sodium chloride salts of 0.9 and 3.5 % at a temperature of 24\u201328 \u00baC.", "Materials and methods.", "The studies were carried out using the SARS-CoV-2 coronavirus strain nCoV/Victoria/1/2020, from the collection of the SSC VB \u201cVector\u201d, the initial titer being (6.0\u00b10.2) lg TCD50/ml.", "We used a Vero E6 cell culture from the collection of the SSC VB \u201cVector\u201d in the form of a 2-day monolayer with a confluence of 95\u2013100 %, grown in 96-well culture plates.", "Results and conclusions.", "The SARS-CoV-2 coronavirus is viable in both fresh and sea water, regardless of its salinity, for at least 48 hours, and the degree of preservation of the residual infectious activity of the virus depends on the water temperature: the lower it is, the better the virus is preserved.", "It was found that at a temperature of 24\u201328 C, the SARS-CoV-2 coronavirus is able to maintain infectious activity on all types of test surfaces studied for at least 48 hours, while the degree of the residual infectious activity of the virus depends on the type of surface.", "The virus is best preserved on stainless steel, plastic and glass.", "It is demonstrated that SARS-CoV-2 virus activity is retained on the surface of paper money and coins for longer than 24 hours.", "The conducted studies have confirmed the ability of the SARS-CoV-2 coronavirus to maintain its infectious activity in the environment under favorable conditions and, accordingly, to pose an epidemiological threat to the population.", "\u00a9 2021 Russian Research Anti-Plague Institute.", "All rights reserved."], "journal": "Problemy Osobo Opasnykh Infektsii", "publish_time": "2021", "aliases": []}
{"doc_id": 222182965, "title": "End-to-End Protocol for the Detection of SARS-CoV-2 from Built Environments", "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019, is a respiratory virus primarily transmitted person to person through inhalation of droplets or aerosols, laden with viral particles.", "However, as recent studies have shown, virions can remain infectious for up to 72 h on surfaces, which can lead to transmission through contact.", "Thus, a comprehensive study was conducted to determine the efficiency of protocols to recover SARS-CoV-2 from surfaces in built environments.", "This end-to-end (E2E) study showed that the effective combination for monitoring SARS-CoV-2 on surfaces includes using an Isohelix swab collection tool, DNA/RNA Shield as a preservative, an automated system for RNA extraction, and reverse transcriptase quantitative PCR (RT-qPCR) as the detection assay.", "Using this E2E approach, this study showed that, in some cases, noninfectious viral fragments of SARS-CoV-2 persisted on surfaces for as long as 8 days even after bleach treatment.", "Additionally, debris associated with specific built environment surfaces appeared to inhibit and negatively impact the recovery of RNA; Amerstat demonstrated the highest inhibition (>90%) when challenged with an inactivated viral control.", "Overall, it was determined that this E2E protocol required a minimum of 1,000 viral particles per 25 cm(2) to successfully detect virus from test surfaces.", "Despite our findings of viral fragment longevity on surfaces, when this method was employed to evaluate 368 samples collected from various built environmental surfaces, all samples tested negative, indicating that the surfaces were either void of virus or below the detection limit of the assay.", "IMPORTANCE The ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (the virus responsible for coronavirus disease 2019 [COVID-19]) pandemic has led to a global slowdown with far-reaching financial and social impacts.", "The SARS-CoV-2 respiratory virus is primarily transmitted from person to person through inhalation of infected droplets or aerosols.", "However, some studies have shown that virions can remain infectious on surfaces for days and can lead to human infection from contact with infected surfaces.", "Thus, a comprehensive study was conducted to determine the efficiency of protocols to recover SARS-CoV-2 from surfaces in built environments.", "This end-to-end study showed that the effective combination for monitoring SARS-CoV-2 on surfaces required a minimum of 1,000 viral particles per 25 cm(2) to successfully detect virus from surfaces.", "This comprehensive study can provide valuable information regarding surface monitoring of various materials as well as the capacity to retain viral RNA and allow for effective disinfection."], "journal": "mSystems", "publish_time": "2020-10-06", "aliases": [221140534]}
{"doc_id": 222178243, "title": "The effect of temperature on persistence of SARS-CoV-2 on common surfaces", "abstract": ["BACKGROUND: The rate at which COVID-19 has spread throughout the globe has been alarming.", "While the role of fomite transmission is not yet fully understood, precise data on the environmental stability of SARS-CoV-2 is required to determine the risks of fomite transmission from contaminated surfaces.", "METHODS: This study measured the survival rates of infectious SARS-CoV-2, suspended in a standard ASTM E2197 matrix, on several common surface types.", "All experiments were carried out in the dark, to negate any effects of UV light.", "Inoculated surfaces were incubated at 20 \u00b0C, 30 \u00b0C and 40 \u00b0C and sampled at various time points.", "RESULTS: Survival rates of SARS-CoV-2 were determined at different temperatures and D-values, Z-values and half-life were calculated.", "We obtained half lives of between 1.7 and 2.7 days at 20 \u00b0C, reducing to a few hours when temperature was elevated to 40 \u00b0C.", "With initial viral loads broadly equivalent to the highest titres excreted by infectious patients, viable virus was isolated for up to 28 days at 20 \u00b0C from common surfaces such as glass, stainless steel and both paper and polymer banknotes.", "Conversely, infectious virus survived less than 24 h at 40 \u00b0C on some surfaces.", "CONCLUSION: These findings demonstrate SARS-CoV-2 can remain infectious for significantly longer time periods than generally considered possible.", "These results could be used to inform improved risk mitigation procedures to prevent the fomite spread of COVID-19."], "journal": "Virol J", "publish_time": "2020-10-07", "aliases": []}
{"doc_id": 218870070, "title": "Droplet evaporation residue indicating SARS-COV-2 survivability on surfaces", "abstract": ["SARS-CoV-2 survives and remains viable on surfaces for several days under different environments as reported in recent studies.", "However, it is unclear how the viruses survive for such a long time and why their survivability varies across different surfaces.", "To address these questions, we conduct systematic experiments investigating the evaporation of droplets produced by a nebulizer and human-exhaled gas on surfaces.", "We found that these droplets do not disappear with evaporation, but instead shrink to a size of a few micrometers (referred to as residues), persist for more than 24 hours, and are highly durable against changes of environmental conditions.", "The characteristics of these residues change significantly across surface types.", "Specifically, surfaces with high thermal conductivity like copper do not leave any resolvable residues, while stainless steel, plastic, and glass surfaces form residues from a varying fraction of all deposited droplets at 40% relative humidity.", "Lowering humidity level suppresses the formation of residues while increasing humidity level enhances it.", "Our results suggest that these microscale residues can potentially insulate the virus against environmental changes, allowing them to survive inhospitable environments and remain infectious for prolonged durations after deposition.", "Our findings can also be extended to other viruses transmitted through respiratory droplets (e.g., SARS-CoV, flu viruses, etc.", "), and can thus lead to practical guidelines for disinfecting surfaces and other prevention measures (e.g., humidity control) for limiting viral transmission."], "journal": "", "publish_time": "2020-05-25", "aliases": []}
{"doc_id": 229637467, "title": "Paper-based record file of patients could be a fomite for SARS-CoV-2 transmission in hospital setting of low and middle income countries (LMICs)", "abstract": ["In the wake of the present COVID-19 pandemic, there has been a much needed increase in awareness among the general public of hand washing, social distancing, and observing cough and sneeze etiquette, and even disinfecting other fomites.", "We miss to focus on the paper documents, which has been the method and in some low and middle economy countries (lmics), \u2018 the only method \u2019 of patients \u2019 documentation.", "Worthy of note is that the virus can survive on paper and on cardboard for up to 3 to 24 hours.", "Most of the hospitals in LMICs are using paper to keep patient records, owing to poor funding and lack of proper databases.", "Each record file is exchanged many times between health care workers, patient \u2019 s caretakers as well as various administrative people in the hospital; also it travels to different wards or rooms for various purposes along with patients during the course of medical check-up and treatment.", "The virus could be transmitted during this process.", "At present, very little is known regarding surface distribution of SARS-CoV-2 in hospitals of lmics which rely on paper documentation of patient.", "This paper raises the question regarding the risk of using paper based record keeping inside hospitals during the COVID-19 pandemic \u00a9 2020 lahore medical and dental college.", "All rights reserved."], "journal": "Pakistan Journal of Medical and Health Sciences", "publish_time": "2020", "aliases": []}
{"doc_id": 233731973, "title": "Evaluation of the persistence of SARS-CoV-2 (ATCC\u00ae VR-1986HK\u2122) on two different food contact materials: flow pack polyethylene and polystyrene food trays", "abstract": ["Even though SARS-CoV-2 \u2019 s primary transmission pathway is person-to-person, the role played by surfaces and food contact materials in carrying viral rna should be further explored.", "For this purpose, the study aimed to investigate the persistence of SARS-CoV-2 using the strain ATCC\u00ae VR-1986HK\u2122 on flow pack polyethylene (fpp) and polystyrene food trays (pft) samples of fpp and pft were contaminated with heat-inactivated SARS-CoV-2 and were incubated at a temperature of 24 \u00b1 1\u00b0C and at controlled relative humidity (RH 65%) The experimental design included analyses at the time 0, 3, 6, 12, 24, 36, 48 and after every 24 hours until the viral rna was no longer detectable.", "The results showed a significant decrease (P & lt; 0 001) in viral copies number on pft within 3 hours (24% reduction) and, at 72 hours, the viral rna had fallen below the limit of detection.", "Regarding the fpp, it was necessary to wait 24 hours for a significant decrease (P=0 015) in the viral load (14% reduction), while the detection threshold was reached at 96 hours.", "These findings showed that the viral rna persists longer on polyethylene flow pack samples than on polystyrene food trays, thus highlighting the importance of material characteristics in the persistence of SARS-CoV-2."], "journal": "LWT", "publish_time": "2021", "aliases": []}
{"doc_id": 220381759, "title": "Minimization of spreading of SARS-CoV-2 via household waste produced by subjects affected by COVID-19 or in quarantine", "abstract": ["Currently available evidence supports that the predominant route of human-to-human transmission of the SARS-CoV-2 is through respiratory droplets.", "Indirect hands contact with surfaces contaminated by infectious droplets subsequently touching the mouth, nose or eyes seems to be another route of an indirect contact transmission.", "Persistence of the virus on different surfaces and other materials has been reported in recent studies: SARS-CoV-2 was more stable on plastic and stainless steel than on copper and cardboard.", "Viable virus was detected up to 72 h after application to different surfaces, although infectivity decay was also observed.", "This evidence suggests the likelihood that waste generated from patients affected by COVID-19 or subjects in quarantine treated in private houses or in areas different from hospitals and medical centres could be contaminated by SARS-CoV-2.", "Consequently, waste streams may represent a route for viral spreading being a potential risk also for the operators directly involved in the different phases of waste management.", "To address this concern, a specific multidisciplinary working group was settled by the Italian National Institute of Health (ISS) during the COVID-19 emergency, in order to establish guidelines related to solid waste collection, delivering, withdrawal, transport, treatment and disposal.", "Temporary stop of waste sorting, instructions for the population on how to package waste, instructions for Companies and operators for the adoption of adequate personal protection equipment (PPE), the use and sanitation of proper vehicles were among the main recommendations provided to the community by publications of freely downloadable reports and infographics in layman language.", "Incineration, sterilization and properly managed landfills were identified as the facilities to be preferentially adopted for the treatment of this kind of waste, considering the main inactivation strategies of SARS-CoV-2 (e.g.", "treatment length > 9 days and temperature > 70 \u00b0C for more than 5 min)."], "journal": "Sci Total Environ", "publish_time": "2020", "aliases": []}
{"doc_id": 237297656, "title": "Presence and Stability of SARS-CoV-2 on Environmental Currency and Money Cards", "abstract": ["The highly contagious nature of SARS-CoV-2 has led to several studies on the transmission of the virus.", "A little studied potential fomite of great concern in the community is currency, which has been shown to harbor microbial pathogens in several studies.", "Since the onset of the COVID-19 pandemic, many businesses in the United States have limited the use of banknotes in favor of credit cards.", "However, SARS-CoV-2 has shown greater stability on plastic in several studies.", "Herein, the stability of SARS-CoV-2 at room temperature on banknotes, money cards and coins was investigated.", "In vitro studies with live virus suggested SARS-CoV-2 was highly unstable on banknotes, showing an initial rapid reduction in viable virus and no viral detection by 24 hours.", "In contrast, SARS-CoV-2 was far more stable on money cards with live virus detected after 48 hours.", "Environmental swabbing of currency and money cards on and near the campus of Brigham Young University supported these results, with no detection of SARS-CoV-2 RNA on banknotes, and a low level on money cards.", "No viable virus was detected on either.", "These preliminary results suggest that the use of money cards over banknotes in order to slow the spread of this virus may be ill-advised.", "These findings should be investigated further through larger environmental studies involving more locations."], "journal": "bioRxiv", "publish_time": "2021-08-23", "aliases": []}
{"doc_id": 234433063, "title": "Revisi\u00f3n r\u00e1pida de la transmisi\u00f3n del SARS-CoV-2 por contacto con objetos y superficies", "abstract": ["Objective.", "To identify scientific evidence on the indirect transmission of SARS-CoV-2 in out-of-hospital spaces and population measures for its prevention.", "Materials and methods A rapid review of what has been published in pubmed and medrxiv between 12/01/2019 and 04/24/2020, on the topics: 1) the contamination and viability of SARS-CoV-2 in different inanimate surfaces; 2) products accessible at home level with disinfectant efficacy against sars-cov-2; 3) the cases and outbreaks of SARS-CoV-2 transmitted through surfaces results A high proportion of the objects people infected with SARS-CoV-2 use (toilet, pots and electronic tablets) are contaminated.", "This virus remains viable from hours to days in paper, cardboard, cloth, glass, wood, plastic, steel and face masks ethanol, 2-propanol, chlorine, and soap are effective in deactivating it There is little evidence on cases and outbreaks by indirect contact conclusions studies are required to determine the minimum infectious dose by autoinoculation.", "Appealing to the precautionary principle, we include recommendations to reduce the risk of indirect contagion \u00a9 2020 All.", "Rights.", "Reserved.", "Objetivo.", "Identificar evidencia cient\u00edfica sobre la transmisi\u00f3n indirecta del SARS-CoV-2 en espacios extrahospitalarios y medidas poblacionales para su prevenci\u00f3n.", "Material y m\u00e9todos.", "Una revisi\u00f3n r\u00e1pida de lo publicado en pubmed y medrxiv entre 01/12/2019 y 24/04/2020 sobre los temas 1) la contaminaci\u00f3n y viabilidad del SARS-CoV-2 en distintas superficies inanimadas; 2) la efectividad desinfectante ante SARS-CoV-2 de productos accesibles a nivel domiciliario; 3) los casos y brotes de contagio de SARS-CoV-2 por medio de superficies resultados una alta proporci\u00f3n de los objetos de personas infectadas con SARS-CoV-2 (inodoro, ollas y tabletas electr\u00f3nicas) se encuentran contaminados este virus permanece viable desde horas hasta d\u00edas en papel, cart\u00f3n, tela, vidrio, madera, pl\u00e1stico, acero y cubrebocas.", "El etanol, 2-pro-panol, cloro y jab\u00f3n son efectivos para desactivarlo existe poca evidencia sobre casos y brotes por contagio indirecto conclusiones se requieren estudios que determinen la dosis m\u00ednima infectante por autoinoculaci\u00f3n apelando al principio precautorio, se incluyeron recomendaciones para reducir el riesgo de contagio indirecto \u00a9 2020 All.", "Rights.", "Reserved."], "journal": "Salud Publica de Mexico", "publish_time": "2020", "aliases": []}
{"doc_id": 246284970, "title": "Presence and stability of SARS-CoV-2 on environmental currency and money cards in Utah reveals a lack of live virus", "abstract": ["The highly contagious nature of SARS-CoV-2 has led to several studies on the transmission of the virus.", "A little studied potential fomite of great concern in the community is currency, which has been shown to harbor microbial pathogens in several studies.", "Since the onset of the COVID-19 pandemic, many businesses in the United States have limited the use of banknotes in favor of credit cards.", "However, SARS-CoV-2 has shown greater stability on plastic in several studies.", "Herein, the stability of SARS-CoV-2 at room temperature on banknotes, money cards and coins was investigated.", "In vitro studies with live virus suggested SARS-CoV-2 was highly unstable on banknotes, showing an initial rapid reduction in viable virus and no viral detection by 24 hours.", "In contrast, SARS-CoV-2 displayed increased stability on money cards with live virus detected after 48 hours.", "Environmental swabbing of currency and money cards on and near the campus of Brigham Young University supported these results, with no detection of SARS-CoV-2 RNA on banknotes, and a low level on money cards.", "However, no viable virus was detected on either.", "These preliminary results suggest that the use of money cards over banknotes in order to slow the spread of this virus may be ill-advised.", "These findings should be investigated further through larger environmental studies involving more locations."], "journal": "PLoS One", "publish_time": "2022-01-25", "aliases": []}
{"doc_id": 225246468, "title": "Silicon Nitride Inactivates SARS-CoV-2 in vitro", "abstract": ["IntroductionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for the COVID-19 pandemic, remains viable and therefore potentially infectious on several materials.", "One strategy to discourage the fomite-mediated spread of COVID-19 is the development of materials whose surface chemistry can spontaneously inactivate SARS-CoV-2.", "Silicon nitride (Si3N4), a material used in spine fusion surgery, is one such candidate because it has been shown to inactivate several bacterial species and viral strains.", "This study hypothesized that contact with Si3N4 would inactivate SARS-CoV-2, while mammalian cells would remain unaffected.", "MaterialsSARS-CoV-2 virions (2x104 PFU/mL diluted in growth media) were exposed to 5, 10, 15, and 20% (w/v) of an aqueous suspension of sintered Si3N4 particles for durations of 1, 5, and 10 minutes, respectively.", "Before exposure to the virus, cytotoxicity testing of Si3N4 alone was assessed in Vero cells at 24 and 48 hour post-exposure times.", "Following each exposure to Si3N4, the remaining infectious virus was quantitated by plaque assay.", "ResultsVero cell viability increased at 5% and 10% (w/v) concentrations of Si3N4 at exposure times up to 10 minutes, and there was only minimal impact on cell health and viability up to 20% (w/v).", "However, the SARS-CoV-2 titers were markedly reduced when exposed to all concentrations of Si3N4; the reduction in viral titers was between 85% - 99.6%, depending on the dose and duration of exposure.", "ConclusionsSi3N4 was non-toxic to the Vero cells while showing strong antiviral activity against SARS-CoV-2.", "The viricidal effect increased with increasing concentrations of Si3N4 and longer duration of exposure.", "Surface treatment strategies based on Si3N4 may offer novel methods to discourage SARS-CoV-2 persistence and infectivity on surfaces and discourage the spread of COVID-19."], "journal": "bioRxiv", "publish_time": "2020-08-29", "aliases": []}
{"doc_id": 224819714, "title": "Structural stability of SARS-CoV-2 degrades with temperature", "abstract": ["SARS-CoV-2 is a novel coronavirus which has caused the COVID-19 pandemic.", "Other known coronaviruses show a strong pattern of seasonality, with the infection cases in humans being more prominent in winter.", "Although several plausible origins of such seasonal variability have been proposed, its mechanism is unclear.", "SARS-CoV-2 is transmitted via airborne droplets ejected from the upper respiratory tract of the infected individuals.", "It has been reported that SARS-CoV-2 can remain infectious for hours on surfaces.", "As such, the stability of viral particles both in liquid droplets as well as dried on surfaces is essential for infectivity.", "Here we have used atomic force microscopy to examine the structural stability of individual SARS-CoV-2 virus like particles at different temperatures.", "We demonstrate that even a mild temperature increase, commensurate with what is common for summer warming, leads to dramatic disruption of viral structural stability, especially when the heat is applied in the dry state.", "This is consistent with other existing non-mechanistic studies of viral infectivity, provides a single particle perspective on viral seasonality, and strengthens the case for a resurgence of COVID-19 in winter.", "Statement of Scientific Significance The economic and public health impact of the COVID-19 pandemic are very significant.", "However scientific information needed to underpin policy decisions are limited partly due to novelty of the SARS-CoV-2 pathogen.", "There is therefore an urgent need for mechanistic studies of both COVID-19 disease and the SARS-CoV-2 virus.", "We show that individual virus particles suffer structural destabilization at relatively mild but elevated temperatures.", "Our nanoscale results are consistent with recent observations at larger scales.", "Our work strengthens the case for COVID-19 resurgence in winter."], "journal": "bioRxiv", "publish_time": "2020-10-14", "aliases": [227188713]}
{"doc_id": 232018606, "title": "SARS-CoV-2 Viability on 16 Common Indoor Surface Finish Materials.", "abstract": ["AIM This study investigated the stability of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on 16 common environmental surface materials.", "BACKGROUND SARS-CoV-2 is the causative agent of severe coronavirus disease, a significant public health concern that quickly led to a pandemic.", "Contamination of environmental surface materials is of concern, with previous studies identifying long-term detection of infectious particles on surfaces.", "These contaminated surfaces create an increased risk for contact transmission.", "METHODS Surface materials were inoculated with 10,000 plaque forming units and samples were collected 4, 8, 12, 24, 30, 48, and 168 hours post infection (hpi).", "Viral titers were determined for each sample and time point using plaque assays.", "Nonparametric modeling utilized the Turnbull algorithm for interval-censored data.", "Maximum likelihood estimates for the survival curve were calculated.", "Parametric proportional hazards regression models for interval censored data were used to explore survival time across the surface materials.", "RESULTS There was a sharp decline in recoverable virus after 4 hpi for all tested surfaces.", "By 12 hpi, infectious SARS-CoV-2 was recoverable from only four surfaces; and by 30 hr, the virus was recoverable from only one surface.", "There were differences in survival curves based on the materials although some groups of materials are similar, both statistically and practically.", "CONCLUSIONS While very low amounts of infectious SARS-CoV-2 are recoverable over time, there remains a risk of viral transmission by surface contamination in indoor environments.", "Individuals and institutions must follow appropriate procedures to decontaminate indoor environment and increase diligence for hand hygiene and personal protective equipment."], "journal": "HERD", "publish_time": "2021-02-23", "aliases": []}
{"doc_id": 232412652, "title": "Dry Swab Method of sample collection for SARS-CoV2 testing can be used for culturing virus", "abstract": ["Back ground Earlier studies suggested the use of dry swab method for SARS-CoV-2 detection as it does not need VTM and subsequent RNA extraction step making the process cheaper, safer and faster.", "In this study we explore whether the virus in the dry swab is viable and can be cultured and propagated.", "Method Swabs were spiked with SARS-CoV-2 and stored in three different conditions: a) as dry swab (SD, eluted in 1 mL DMEM), b) in 1 mL of Viral Transport Medium (SVTM), and c) in 1 mL of Tris-EDTA buffer (STE).", "The sample groups were stored either at room temperature (RT, 25\u00b0C\u00b11\u00b0C) or at 4\u00b0C for 1, 4, 8, 12, 24, 48 and 72 hours before being used as viral inoculums for the propagation studies in Vero cells.", "Results The RT-qPCR data suggests that SD incubated both at RT and 4\u00b0C harbors viral particles that are viable and culturable at par with SVTM and STE.", "Conclusion The dry swab method, in addition to its advantages in detection of the virus, also renders viable viral particles that can be cultured and propagated."], "journal": "bioRxiv", "publish_time": "2021-03-23", "aliases": []}
{"doc_id": 224912419, "title": "The pandemic of 21st century - COVID-19", "abstract": ["BACKGROUND The global pandemic of novel coronavirus disease is mainly caused by the infection of coronavirus 'SARS-CoV-2' It is infecting persons of all ethnicity, race and community corona viruses are enveloped rna viruses which range from 60 to 140 nm in diameter with spike like projections on their top coronavirus is affecting 199 countries, territories and international transport systems.", "Covid-19 is a recent pandemic, which started in wuhan, china, at the end of 2019 and now it is affecting the whole world WHO declared this outbreak as a pandemic on March 11, 2020 COVID-19 infection is transmitted by inhalation or contact with infected droplets or aerosols of infected persons, and the incubation period ranges from 5 to 14 days.", "Viral aerosols remain active for 3 hours in the air, 24 hours on cardboards, and 2 to 3 days on stainless steel and plastic.", "Symptoms are usually fever, cough, breathlessness, sore throat, malaise and fatigue.", "In some people, it may progress to pneumonia, multiple organ dysfunction, and acute respiratory distress syndrome.", "People with heart diseases, lung diseases, cancer, old age, diabetics, Immunosuppressed, and pregnant women are at higher risk for COVID-19 infection.", "To date, there are now more than 2,732,701 cases of covid 19 globally with more than 191,150 deaths.", "In india, total cases are 23,502 with 722 deaths.", "First case of coronavirus was seen on 29 January 2020 On 24 March 2020, the government of india under Prime.", "Minister shri narendra modi ordered a nationwide lockdown for 21 days, after a 14-hour voluntary public curfew on 22nd.", "March india is one of the most populous countries of the world india has the second largest population in the world.", "Due to the lack of vaccines, ventilators, targeted therapies, mass gatherings, the indian government started lockdown, the largest exercise in the world with the second largest population.", "To reduce public movement, section 144 was implemented in many states A full lockdown will help the collapse of the whole national health system."], "journal": "Journal of Evolution of Medical and Dental Sciences", "publish_time": "2020", "aliases": []}
{"doc_id": 220502291, "title": "A Surface Coating that Rapidly Inactivates SARS-CoV-2", "abstract": ["[Image: see text] SARS-CoV-2, the virus that causes the disease COVID-19, remains viable on solids for periods of up to 1 week, so one potential route for human infection is via exposure to an infectious dose from a solid.", "We have fabricated and tested a coating that is designed to reduce the longevity of SARS-CoV-2 on solids.", "The coating consists of cuprous oxide (Cu(2)O) particles bound with polyurethane.", "After 1 h on coated glass or stainless steel, the viral titer was reduced by about 99.9% on average compared to the uncoated sample.", "An advantage of a polyurethane-based coating is that polyurethane is already used to coat a large number of everyday objects.", "Our coating adheres well to glass and stainless steel as well as everyday items that people may fear to touch during a pandemic, such as a doorknob, a pen, and a credit card keypad button.", "The coating performs well in the cross-hatch durability test and remains intact and active after 13 days of being immersed in water or after exposure to multiple cycles of exposure to the virus and disinfection."], "journal": "ACS Appl Mater Interfaces", "publish_time": "2020-07-13", "aliases": []}
{"doc_id": 226298059, "title": "Modeling the stability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on skin, currency, and clothing", "abstract": ["A new coronavirus (SARS-CoV-2) emerged in the winter of 2019 in Wuhan, China, and rapidly spread around the world.", "The extent and efficiency of SARS-CoV-2 pandemic is far greater than previous coronaviruses that emerged in the 21(st) Century.", "Here, we modeled stability of SARS-CoV-2 on skin, paper currency, and clothing to determine if these surfaces may factor in the fomite transmission dynamics of SARS-CoV-2.", "Skin, currency, and clothing samples were exposed to SARS-CoV-2 under laboratory conditions and incubated at three different temperatures (4\u00b0C\u00b1 2\u00b0C, 22\u00b0C\u00b1 2\u00b0C, and 37\u00b0C \u00b1 2\u00b0C).", "We evaluated stability at 0 hours (h), 4 h, 8 h, 24 h, 72 h, 96 h, 7 days, and 14 days post-exposure.", "SARS-CoV-2 was stable on skin through the duration of the experiment at 4\u00b0C (14 days).", "Virus remained stable on skin for at least 96 h at 22\u00b0C and for at least 8h at 37\u00b0C.", "There were minimal differences between the tested currency samples.", "The virus remained stable on the $1 U.S.A. Bank Note for at least 96 h at 4\u00b0C while we did not detect viable virus on the $20 U.S.A. Bank Note samples beyond 72 h. The virus remained stable on both Bank Notes for at least 8 h at 22\u00b0C and 4 h at 37\u00b0C.", "Clothing samples were similar in stability to the currency.", "Viable virus remained for at least 96 h at 4\u00b0C and at least 4 h at 22\u00b0C.", "We did not detect viable virus on clothing samples at 37\u00b0C after initial exposure.", "This study confirms the inverse relationship between virus stability and temperature.", "Furthermore, virus stability on skin demonstrates the need for continued hand hygiene practices to minimize fomite transmission both in the general population as well as in workplaces where close contact is common."], "journal": "PLoS Negl Trop Dis", "publish_time": "2020-11-09", "aliases": [220303815]}
{"doc_id": 219602682, "title": "Stability of SARS-CoV-2 on Critical Personal Protective Equipment", "abstract": ["The spread of COVID-19 in healthcare settings is concerning, with healthcare workers representing a disproportionately high percentage of confirmed cases.", "Although SARS-CoV-2 virus has been found to persist on surfaces for a number of days, the extent and duration of fomites as a mode of transmission, particularly in healthcare settings, has not been fully characterized.", "To shed light on this critical matter, the present study provides the first comprehensive assessment of SARS-CoV-2 stability on experimentally contaminated personal protective equipment (PPE) widely used by healthcare workers and the general public.", "Persistence of viable virus was monitored over 21 days on eight different materials, including nitrile medical examination gloves, reinforced chemical resistant gloves, N-95 and N-100 particulate respirator masks, Tyvek, plastic, cotton, and stainless steel.", "Unlike previous reports, viable SARS-CoV-2 in the presence of a soil load persisted for up to 21 days on experimentally inoculated PPE, including materials from filtering facepiece respirators (N-95 and N-100 masks) and a plastic visor.", "Conversely, when applied to 100% cotton fabric, the virus underwent rapid degradation and became undetectable in less than 24 hours.", "These findings underline the importance of appropriate handling of contaminated PPE during and following use in high-risk settings and provide interesting insight into the potential utility of cotton, including cotton masks, in limiting COVID-19 transmission."], "journal": "", "publish_time": "2020-06-12", "aliases": [231598461]}
{"doc_id": 216492972, "title": "Effects of temperature on COVID-19 transmission", "abstract": ["Coronavirus disease 2019 (COVID19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV2), it was first identified in 2019 in Wuhan, China and has resulted in the 2019-20 coronavirus pandemic.", "As of March 1, 2020, 79,968 patients in China and 7169 outside of China had tested positive for COVID19 and a mortality rate of 3.6% has been observed amongst Chinese patients.", "Its primary mode of transmission is via respiratory droplets from coughs and sneezes.", "The virus can remain viable for up to three days on plastic and stainless steel or in aerosols for upto 3 hours and is relatively more stable than the known human coronaviruses.", "It is stable in faeces at room temperature for at least 1-2 days and can be stable in infected patients for up to 4 days.", "Heat at 56 degree Celsius kills the SARS coronavirus at around 10000 units per 15 minutes.", "Thus, temperature is an important factor in survival of COVID19 virus and this article focuses on understanding the relationship between temperature and COVID19 transmission from the data available between January-March 2020."], "journal": "", "publish_time": "2020-03-30", "aliases": []}
{"doc_id": 233997476, "title": "Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus and Viral RNA in Relation to Surface Type and Contamination Concentration", "abstract": ["The transmission of SARS-CoV-2 is likely to occur through a number of routes, including contact with contaminated surfaces.", "Many studies have used reverse transcription-PCR (RT-PCR) analysis to detect SARS-CoV-2 RNA on surfaces, but seldom has viable virus been detected.", "This paper investigates the viability over time of SARS-CoV-2 dried onto a range of materials and compares viability of the virus to RNA copies recovered and whether virus viability is concentration dependent.", "Viable virus persisted for the longest time on surgical mask material and stainless steel, with a 99.9% reduction in viability by 122 and 114 h, respectively.", "Viability of SARS-CoV-2 reduced the fastest on a polyester shirt, with a 99.9% reduction within 2.5 h. Viability on the bank note was reduced second fastest, with 99.9% reduction in 75 h. RNA on all surfaces exhibited a 1-log reduction in genome copy number recovery over 21 days.", "The findings show that SARS-CoV-2 is most stable on nonporous hydrophobic surfaces.", "RNA is highly stable when dried on surfaces, with only 1-log reduction in recovery over 3 weeks.", "In comparison, SARS-CoV-2 viability reduced more rapidly, but this loss in viability was found to be independent of starting concentration.", "Expected levels of SARS-CoV-2 viable environmental surface contamination would lead to undetectable levels within 2 days.", "Therefore, when RNA is detected on surfaces, it does not directly indicate the presence of viable virus, even at low cycle threshold values.", "IMPORTANCE This study shows the impact of material type on the viability of SARS-CoV-2 on surfaces.", "It demonstrates that the decay rate of viable SARS-CoV-2 is independent of starting concentration.", "However, RNA shows high stability on surfaces over extended periods.", "This has implications for interpretation of surface sampling results using RT-PCR to determine the possibility of viable virus from a surface, where RT-PCR is not an appropriate technique to determine viable virus.", "Unless sampled immediately after contamination, it is difficult to align RNA copy numbers to quantity of viable virus on a surface."], "journal": "Appl Environ Microbiol", "publish_time": "2021", "aliases": []}
{"doc_id": 232385529, "title": "SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light", "abstract": ["The aim of this study was to establish the persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on inanimate surfaces such as plastic, stainless steel, and glass during UV-C irradiation which is a physical means commonly utilized in sanitization procedures.", "The viral inactivation rate, virus half-life, and percentage of titer reduction after UV-C irradiation were assessed infectivity was maintained on plastic and glass until 120 h and on stainless steel until 72 h.", "The virus half-life was 5 3, 4 4, and 4 2 h on plastic, stainless steel, and glass, respectively.", "In all cases, titer decay was & gt; 99% after drop drying UV-C irradiation efficiently reduced virus titer (99 99%), with doses ranging from 10 25 to 23 71 mJ/cm2 plastic and stainless steel needed higher doses to achieve target reduction.", "The total inactivation of SARS-CoV-2 on glass was obtained with the lower dose applied SARS-CoV-2 survival can be long lasting on inanimate surfaces.", "It is worth recommending efficient disinfection protocols as a measure of prevention of viral spread UV-C can provide rapid, efficient and sustainable sanitization procedures of different materials and surfaces.", "The dosages and mode of irradiation are important parameters to consider in their implementation as an important means to fight the SARS-CoV-2 pandemic."], "journal": "Viruses", "publish_time": "2021", "aliases": []}
{"doc_id": 244966192, "title": "Antiviral Nanostructures That Reduce the Viability of Coronaviruses SARS-CoV-2 and HCoV-NL63 (preprint)", "abstract": ["Background: The rapid emergence and global spread of the COVID-19 causing Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and its subsequent mutated strains, has caused unprecedented health, economic and social devastation.", "Respiratory viruses can be transmitted through both direct and indirect channels, including aerosol respiratory droplets and contamination of inanimate surfaces.", "Current methods of virus inactivation on surfaces include chemicals and biocides and while effective, continuous, and repetitive cleaning of all surfaces is not always viable.", "Recent work in the field of biomaterials engineering has established the antibacterial effects of hydrothermally synthesised TiO 2 nanostructured surfaces against both Gram-negative and positive bacteria.", "This study investigates the effectiveness of TiO 2 nanostructured surfaces against two human coronaviruses: SARS-CoV-2 and HCoV-NL63 for surface-based inactivation.", "Results: : Results show that structured surfaces reduced live infectious viral loads of SARS-CoV-2 and HCoV-NL63 by 5 log and 3 log, respectively after 5 hours compared to non-structured surfaces.", "Interestingly, infectious virus remained present on the control plastic surface after 7 hours exposure.", "Conclusions: : These encouraging results establish the potential use of nanostructured surfaces to reduce the transmission and spread of coronaviruses, by reducing the virus\u2019 infectious period on a surface.", "The dual antiviral and antibacterial properties of these surfaces give them potential application in high-risk environments such as hospitals and healthcare settings."], "journal": "", "publish_time": "2021", "aliases": []}
{"doc_id": 227145329, "title": "A simple, effective enclosure with disposable coverings for inexpensive containment of aerosolized COVID viruses during tracheal intubation and extubation", "abstract": ["Background: SARS-CoV-2 (COVID-19) is a severe respiratory virus that can be transmitted through aerosol particles produced by coughing, talking, and breathing.", "Medical procedures used to treat severe cases such as tracheal intubation, extubation, and tracheal suctioning produce infectious aerosol particles.", "This presents significant risk for viral exposure of nearby healthcare workers during and following tracheal operations.", "This study looks at an enclosure to limit exposure for medical personnel to these particles.", "Methods: A low-cost plastic enclosure was designed to reduce aerosol spread and viral transmission during intubation and extubation procedures.", "The enclosure consists of clear polycarbonate for maximum visibility.", "Large side cutouts provide health care providers with ease of access to the patient.", "Aerosol particle instruments measured the aerosol containment efficacy after applying various types of plastic coverings to seal the side openings.", "The use of negative pressure was also tested.", "Results: The enclosure with 2 layers of plastic coverings sealing the side openings reduced total escaped particle number concentrations (diameter > 10 nm) by over 93% at 3 inches away from all openings.", "Concentration decay experiments indicated that the enclosure without active suction should be left on the patient for 15-20 minutes following a tracheal manipulation to allow sufficient time for >90% of aerosol particles to settle upon interior surfaces.", "This decreases to 5 minutes when 30 LPM suction is applied.", "Conclusions: This enclosure is an inexpensive, easily implemented additional layer of protection that can be used to reduce the risk of SARS-CoV-2 aerosol transmission between patients and healthcare workers."], "journal": "", "publish_time": "2020-11-24", "aliases": []}
{"doc_id": 235964844, "title": "Rapid determination of infectious SARS-CoV-2 in PCR-positive samples by SDS-PMA assisted RT-qPCR()", "abstract": ["The ongoing COVID-19 pandemic has generated a global health crisis that needs well management of not only patients but also environments to reduce SARS-CoV-2 transmission.", "The gold standard RT-qPCR method is sensitive and rapid to detect SARS-CoV-2 nucleic acid, but does not answer if PCR-positive samples contain infectious virions.", "To circumvent this problem, we report an SDS-propidium monoazide (PMA) assisted RT-qPCR method that enables rapid discrimination of live and dead SARS-CoV-2 within 3 h. PMA, a photo-reactive dye, can react with viral RNA released or inside inactivated SARS-CoV-2 virions under assistance of 0.005% SDS, but not viral RNA inside live virions.", "Formation of PMA-RNA conjugates prevents PCR amplification, leaving only infectious virions to be detected.", "Under optimum conditions, RT-qPCR detection of heat-inactivated SARS-CoV-2 resulted in larger than 9 Ct value differences between PMA-treated and PMA-free groups, while less than 0.5 Ct differences were observed in the detection of infectious SARS-CoV-2 ranging from 20 to 5148 viral particles.", "Using a cutoff Ct difference of 8.6, this method could differentiate as low as 8 PFU live viruses in the mixtures of live and heat-inactivated virions.", "Further experiments showed that this method could successfully monitor the natural inactivation process of SARS-CoV-2 on plastic surfaces during storage with comparable results to the gold standard plaque assay.", "We believe that the culture-free method established here could be used for rapid and convenient determination of infectious SARS-CoV-2 virions in PCR-positive samples, which will facilitate better control of SARS-CoV-2 transmission."], "journal": "Sci Total Environ", "publish_time": "2021-11-25", "aliases": []}
{"doc_id": 219166720, "title": "SARS-CoV-2 infection: the environmental endurance of the virus can be influenced by the increase of temperature", "abstract": ["The COVID-19 disease, a respiratory disease transmitted by a new betacoronavirus SARS-CoV-2.", "As for other viral respiratory agents, SARS-CoV-2 spreads by person to person through respiratory droplets and direct contact and potentially by indirect contact through fomites.", "The goal of the current study is to evaluate whether the increase of temperature can influence the environmental endurance of SARS-CoV-2.We tested SARS-CoV-2 environmental stability in parallel at room temperature (RT, 20-25 Celsius degrees) and at average maximum temperature of June (JT) estimated at 28 Celsius degrees in Italy.", "The virus inoculated on plastic surface was harvested at predefined time-points and tested to evaluate viral titres on Vero cells by TCID50.", "Our results confirm that fomite transmission of the emerging SARS-CoV2 is possible, since the virus remains viable on surfaces up to 84 hours at both RT and JT.", "Moreover, a remarkable difference between the two temperatures exists, suggesting that virus vitality can be influenced by the environmental temperature.", "Our results support the hypothesis that in the hot season the increase of temperature could influence the environmental endurance of SARS-CoV2 and reduce Covid-19 transmission probability."], "journal": "", "publish_time": "2020-06-01", "aliases": []}
{"doc_id": 233985095, "title": "Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19", "abstract": ["The exact duration of viable SARS-CoV-2 shedding in kidney transplant recipients (KTRs) remains unclear.", "Here, we retrospectively investigated this issue using cell cultures of SARS-CoV-2 RT-PCR-positive nasopharyngeal samples (n = 40) obtained from 16 KTRs with symptomatic COVID-19 up to 39 days from symptom onset.", "A length of viable SARS-CoV-2 shedding >3 weeks from the onset of symptoms was identified in four KTRs (25%).", "These results suggest that a significant proportion of KTRs can shed viable SARS-CoV-2 for at least three weeks, which may favor the emergence of new variants.", "Based on these data, we recommend prolonging the isolation of KTRs with COVID-19 until negative SARS-CoV-2 RT-PCR testing."], "journal": "Am. j. transplant", "publish_time": "2021", "aliases": []}
{"doc_id": 228079098, "title": "An overview of the effect of bioaerosol size in coronavirus disease 2019 transmission", "abstract": ["The fast spread of coronavirus disease 2019 (COVID-19) constitutes a worldwide challenge to the public health, educational and trade systems, affecting the overall well-being of human societies.", "The high transmission and mortality rates of this virus, and the unavailability of a vaccine or treatment, resulted in the decision of multiple governments to enact measures of social distancing.", "Such measures can reduce the exposure to bioaerosols, which can result in pathogen deposition in the respiratory tract of the host causing disease and an immunological response.", "Thus, it is important to consider the validity of the proposal for keeping a distance of at least 2 m from other persons to avoid the spread of COVID-19.", "This work reviews the effect of aerodynamic diameter (size) of particles carrying RNA copies of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).", "A SARS-CoV-2 carrier person talking, sneezing or coughing at distance of 2 m can still provide a pathogenic bioaerosol load with submicron particles that remain viable in air for up to 3 h for exposure of healthy persons near and far from the source in a stagnant environment.", "The deposited bioaerosol creates contaminated surfaces, which if touched can act as a path to introduce the pathogen by mouth, nose or eyes and cause disease."], "journal": "Int. j. health plann. manage", "publish_time": "2020", "aliases": []}
{"doc_id": 236779738, "title": "Discrimination of non-infectious SARS-CoV-2 particles from fomites by viability RT-qPCR", "abstract": ["The ongoing coronavirus 2019 (COVID-19) pandemic constitutes a concerning global threat to public health and economy.", "In the midst of this pandemic scenario, the role of environment-to-human COVID-19 spread is still a matter of debate because mixed results have been reported concerning SARS-CoV-2 stability on high-touch surfaces in real-life scenarios.", "Up to now, no alternative and accessible procedures for cell culture have been applied to evaluate SARS-CoV-2 infectivity on fomites.", "Several strategies based on viral capsid integrity have latterly been developed using viability markers to selectively remove false-positive qPCR signals resulting from free nucleic acids and damaged viruses.", "These have finally allowed an estimation of viral infectivity.", "The present study aims to provide a rapid molecular-based protocol for detection and quantification of viable SARS-CoV-2 from fomites based on the discrimination of non-infectious SARS-CoV-2 particles by platinum chloride (IV) (PtCl(4)) viability RT-qPCR.", "An initial assessment compared two different swabbing procedures to recover inactivated SARS-CoV-2 particles from fomites coupled with two RNA extraction methods.", "Procedures were validated with human (E229) and porcine (PEDV) coronavirus surrogates, and compared with inactivated SARS-CoV-2 suspensions on glass, steel and plastic surfaces.", "The viability RT-qPCR efficiently removed the PCR amplification signals from heat and gamma-irradiated inactivated SARS-CoV-2 suspensions that had been collected from specified surfaces.", "This study proposes a rapid viability RT-qPCR that discriminates non-infectious SARS-CoV-2 particles on surfaces thus helping researchers to better understand the risk of contracting COVID-19 through contact with fomites and to develop more efficient epidemiological measures."], "journal": "Environ Res", "publish_time": "2021-08-02", "aliases": []}
{"doc_id": 229935424, "title": "Development of a novel hybrid alphavirus-SARS-CoV-2 particle for rapid in vitro screening and quantification of neutralization antibodies, viral variants, and antiviral drugs", "abstract": ["Timely development of vaccines and antiviral drugs is critical to control the COVID-19 pandemic 1\u20136.", "Current methods for quantifying vaccine-induced neutralizing antibodies involve the use of pseudoviruses, such as the SARS-CoV-2 spike protein (S) pseudotyped lentivirus7\u201314.", "However, these pseudoviruses contain structural proteins foreign to SARS-CoV-2, and require days to infect and express reporter genes15.", "Here we describe the development of a new hybrid alphavirus-SARS-CoV-2 (Ha-CoV-2) particle for rapid and accurate quantification of neutralization antibodies and viral variants.", "Ha-CoV-2 is a non-replicating SARS-CoV-2 virus-like particle, composed of SARS-CoV-2 structural proteins (S, M, N, and E) and a RNA genome derived from a fast expressing alphavirus vector 16.", "We demonstrated that Ha-CoV-2 can rapidly and robustly express reporter genes in target cells within 3-6 hours.", "We further validated Ha-CoV-2 for rapid quantification of neutralization antibodies, viral variants, and antiviral drugs.", "In addition, as a proof-of-concept, we assembled and compared the relative infectivity of a panel of 10 Ha-CoV-2 variant isolates (D614G, P.1, B.1.1.207, B.1.351, B.1.1.7, B.1.429, B.1.258, B.1.494, B.1.2, B.1.1298), and demonstrated that these variants in general are 2-10 fold more infectious.", "Furthermore, we quantified the anti-serum from an infected and vaccinated individual; the one dose vaccination with Moderna mRNA-1273 has greatly increased the anti-serum titer for approximately 6 fold.", "The post-vaccination serum has also demonstrated various neutralizing activities against all 9 variants tested.", "These results demonstrated that Ha-CoV-2 can be used as a robust platform for rapid quantification of neutralizing antibodies against SARS-CoV-2 and its variants."], "journal": "bioRxiv", "publish_time": "2021-05-05", "aliases": []}
{"doc_id": 232283132, "title": "Persistence of SARS-CoV-2 virus and viral RNA on hydrophobic and hydrophilic surfaces and investigating contamination concentration", "abstract": ["The transmission of SARS-CoV-2 is likely to occur through a number of routes, including contact with contaminated surfaces.", "Many studies have used RT-PCR analysis to detect SARS-CoV-2 RNA on surfaces but seldom has viable virus been detected.", "This paper investigates the viability over time of SARS-CoV-2 dried onto a range of materials and compares viability of the virus to RNA copies recovered, and whether virus viability is concentration dependant.", "Viable virus persisted for the longest time on surgical mask material and stainless steel with a 99.9% reduction in viability by 124 and 113 hours respectively.", "Viability of SARS-CoV-2 reduced the fastest on a polyester shirt, with a 99.9% reduction within 2.5 hours.", "Viability on cotton was reduced second fastest, with 99.9% reduction in 72 hours.", "RNA on all the surfaces exhibited a one log reduction in genome copy recovery over 21 days.", "The findings show that SARS-CoV-2 is most stable on non-porous hydrophobic surfaces.", "RNA is highly stable when dried on surfaces with only one log reduction in recovery over three weeks.", "In comparison, SARS-CoV-2 viability reduced more rapidly, but this loss in viability was found to be independent of starting concentration.", "Expected levels of SARS-CoV-2 viable environmental surface contamination would lead to undetectable levels within two days.", "Therefore, when RNA is detected on surfaces it does not directly indicate presence of viable virus even at high CT values.", "Importance This study shows the impact of material type on the viability of SARS-CoV-2 on surfaces.", "It demonstrates that the decay rate of viable SARS-CoV-2 is independent of starting concentration.", "However, RNA shows high stability on surfaces over extended periods.", "This has implications for interpretation of surface sampling results using RT-PCR to determine the possibility of viable virus from a surface.", "Unless sampled immediately after contamination it is difficult to align RNA copy numbers to quantity of viable virus on a surface."], "journal": "bioRxiv", "publish_time": "2021-04-23", "aliases": []}
{"doc_id": 244530561, "title": "Anti-pathogen stainless steel combating COVID-19", "abstract": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibits strong stability on conventional stainless steel (SS) surface, with infectious virus detected even after two days, posing a high risk of virus transmission via surface touching in public areas.", "In order to mitigate the surface toughing transmission, the present study develops the first SS with excellent anti-pathogen properties against SARS-COV-2.", "The stabilities of SARS-CoV-2, H1N1 influenza A virus (H1N1), and Escherichia coli (E.coli) on the surfaces of Cu-contained SS, pure Cu, Ag-contained SS, and pure Ag were investigated.", "It is discovered that pure Ag and Ag-contained SS surfaces do not display apparent inhibitory effects on SARS-CoV-2 and H1N1.", "In comparison, both pure Cu and Cu-contained SS with a high Cu content exhibit significant antiviral properties.", "Significantly, the developed anti-pathogen SS with 20 wt.% Cu can distinctly reduce 99.75% and 99.99% of viable SARS-CoV-2 on its surface within 3 and 6 hours, respectively.", "In addition, the present anti-pathogen SS also exhibits an excellent inactivation ability for H1N1 influenza A virus (H1N1), and Escherichia coli (E.coli).", "Interestingly, the Cu ion concentration released from the anti-pathogen SS with 10 wt.% and 20 wt.% Cu was notably higher than the Ag ion concentration released from Ag and the Ag-contained SS.", "Lift buttons made of the present anti-pathogen SS are produced using mature powder metallurgy technique, demonstrating its potential applications in public areas and fighting the transmission of SARS-CoV-2 and other pathogens via surface touching."], "journal": "Chem Eng J", "publish_time": "2021-11-25", "aliases": []}
{"doc_id": 226964936, "title": "Survival of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Virus on Human Skin: Importance of Hand Hygiene in Coronavirus Disease 2019 (COVID-19)", "abstract": ["BACKGROUND: The stability of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on human skin remains unknown, considering the hazards of viral exposure to humans.", "We generated a model that allows the safe reproduction of clinical studies on the application of pathogens to human skin and elucidated the stability of SARS-CoV-2 on human skin.", "METHODS: We evaluated the stability of SARS-CoV-2 and influenza A virus (IAV), mixed with culture medium or upper respiratory mucus, on human skin surfaces and the dermal disinfection effectiveness of 80% (weight/weight) ethanol against SARS-CoV-2 and IAV.", "RESULTS: SARS-CoV-2 and IAV were inactivated more rapidly on skin surfaces than on other surfaces (stainless steel/glass/plastic); the survival time was significantly longer for SARS-CoV-2 than for IAV (9.04 hours [95% confidence interval, 7.96\u2013 10.2 hours] vs 1.82 hours [1.65\u20132.00 hours]).", "IAV on other surfaces was inactivated faster in mucus versus medium conditions, while SARS-CoV-2 showed similar stability in the mucus and medium; the survival time was significantly longer for SARS-CoV-2 than for IAV (11.09 hours [10.22\u201312.00 hours] vs 1.69 hours [1.57\u20131.81 hours]).", "Moreover, both SARS-CoV-2 and IAV in the mucus/medium on human skin were completely inactivated within 15 seconds by ethanol treatment.", "CONCLUSIONS: The 9-hour survival of SARS-CoV-2 on human skin may increase the risk of contact transmission in comparison with IAV, thus accelerating the pandemic.", "Proper hand hygiene is important to prevent the spread of SARS-CoV-2 infections."], "journal": "Clin Infect Dis", "publish_time": "2020-10-03", "aliases": []}
{"doc_id": 233036614, "title": "Comparison of the Modified Centers for Disease Control and Prevention 2019-Novel Coronavirus Real-Time RT-PCR Method for Detection of Infectious and Heat-Inactivated Virus on Stainless Steel", "abstract": ["BACKGROUND: Infectious Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) was used in the validation of methods for detection of SARS-CoV-2 on stainless steel surfaces in the AOAC Research Institute Emergency Response Validation project.", "Handling infectious virus requires Biosafety Level (BSL)-3 facilities.", "OBJECTIVE: To compare the recovery and detection of infectious and heat-inactivated (65 \u00b0C for 30 min) SARS-CoV-2 from stainless steel by the modified US Centers for Disease Control and Prevention (CDC) 2019-Novel Coronavirus Real Time Reverse Transcription Polymerase Chain Reaction (RT-PCR) Diagnostic Panel.", "METHODS: Viral stocks were diluted in viral transport medium and deposited onto stainless steel test areas at 2 x 10(3) and 2 x 10(4) genomic copies for low and high, respectively.", "Test areas were sampled, and aliquots of the resulting test solutions analyzed by RT-qPCR according to the CDC method.", "Results were analyzed by Probability of Detection (POD) statistics.", "RESULTS: The low level, where fractional positive results (25\u201375%) are expected, yielded POD(I) = 0.80 (0.58, 0.92) for the infectious virus and POD(HI) = 0.15 (0.05, 0.36) for the heat-inactivated virus.", "The bias, dPOD(HI) = -0.65 (-0.80, -0.35), demonstrated a statistical difference between infectious and heat-inactivated virus detection.", "No difference was observed at the high inoculation level.", "CONCLUSION: Despite the statistical difference observed, the use of the heat-inactivated virus is a viable alternative for matrix extension studies using a method comparison study design.", "HIGHLIGHTS: The use of heat-inactivated SARS-CoV-2 can mitigate the need for a BSL-3 facility for matrix extension validation of alternative methods in SARS-CoV-2 studies."], "journal": "J AOAC Int", "publish_time": "2021-04-02", "aliases": []}
